11058428
D013256_D013119 NONE steroid_2\NN\14727670 (r_compound) myopathy_3\NN\14204950 (r_nsubj) recovers_4\VBZ\2210855 (l_conj) be_15\VB\14625458 (l_attr) recording_18\NN\6791372 (l_cc) of_30\IN\0 (l_pobj) protection_32\NN\407535 (l_relcl) methylprednisolone_34\NN\0 (l_dobj) offers_35\VBZ\7160883 (l_prep) to_36\IN\0 (l_pobj) injury_40\NN\14052046
D013256_D013119 NONE steroid_26\NN\14727670 (r_compound) myopathy_27\NNS\14204950 (r_pobj) from_24\IN\0 (r_prep) recovery_23\NN\7357388 (r_pobj) of_19\IN\0 (r_prep) recording_18\NN\6791372 (l_cc) of_30\IN\0 (l_pobj) protection_32\NN\407535 (l_relcl) methylprednisolone_34\NN\0 (l_dobj) offers_35\VBZ\7160883 (l_prep) to_36\IN\0 (l_pobj) injury_40\NN\14052046
D013256_D009135 NONE steroid_2\NN\14727670 (r_compound) myopathy_3\NN\14204950
D013256_D009135 NONE steroid_2\NN\14727670 (r_compound) myopathy_3\NN\14204950 (r_nsubj) recovers_4\VBZ\2210855 (l_conj) be_15\VB\14625458 (l_attr) recording_18\NN\6791372 (l_prep) of_19\IN\0 (l_pobj) recovery_23\NN\7357388 (l_prep) from_24\IN\0 (l_pobj) myopathy_27\NNS\14204950
D013256_D009135 NONE steroid_26\NN\14727670 (r_compound) myopathy_27\NNS\14204950 (r_pobj) from_24\IN\0 (r_prep) recovery_23\NN\7357388 (r_pobj) of_19\IN\0 (r_prep) recording_18\NN\6791372 (r_attr) be_15\VB\14625458 (r_conj) recovers_4\VBZ\2210855 (l_nsubj) myopathy_3\NN\14204950
D013256_D009135 NONE steroid_26\NN\14727670 (r_compound) myopathy_27\NNS\14204950
D000305_D009135 NONE corticosteroid_13\NN\14745635 (r_pobj) of_11\IN\0 (r_prep) possibility_10\NN\5944958 (l_prep) myopathy_14\NNS\14204950
D000305_D009135 NONE corticosteroid_21\NN\14745635 (r_nsubj) myopathy_22\NNS\14204950
D008775_D009135 CID methylprednisolone_19\NN\0 (r_nsubj) cause_21\VB\7323922 (r_acl) possibility_10\NN\5944958 (l_prep) myopathy_14\NNS\14204950
D008775_D009135 CID methylprednisolone_34\NN\0 (r_relcl) protection_32\NN\407535 (r_pobj) of_30\IN\0 (r_cc) recording_18\NN\6791372 (r_attr) be_15\VB\14625458 (r_conj) recovers_4\VBZ\2210855 (l_nsubj) myopathy_3\NN\14204950
D008775_D009135 CID methylprednisolone_34\NN\0 (r_relcl) protection_32\NN\407535 (r_pobj) of_30\IN\0 (r_cc) recording_18\NN\6791372 (l_prep) of_19\IN\0 (l_pobj) recovery_23\NN\7357388 (l_prep) from_24\IN\0 (l_pobj) myopathy_27\NNS\14204950
D008775_D009135 CID methylprednisolone_14\NN\0 (r_nsubj) cause_19\VB\7323922 (l_ccomp) myopathy_22\NNS\14204950
D008775_D013119 NONE methylprednisolone_3\NN\0 (r_nsubj) do_5\VB\7447641 (l_dobj) harm_7\NN\14052046 (l_prep) for_8\IN\0 (l_pobj) injury_11\NN\14052046
D008775_D013119 NONE methylprednisolone_16\NN\0 (r_nsubj) became_17\VBD\146138 (l_prep) because_0\IN\0 (l_pobj) studies_8\NNP\635850 (l_compound) injury_7\NNP\14052046
D008775_D013119 NONE methylprednisolone_16\NN\0 (r_nsubj) became_17\VBD\146138 (l_attr) standard_19\NN\13577171 (l_prep) for_22\IN\0 (l_pobj) injury_27\NN\14052046
D008775_D013119 NONE methylprednisolone_34\NN\0 (l_dobj) offers_35\VBZ\7160883 (l_prep) to_36\IN\0 (l_pobj) injury_40\NN\14052046
7785794
D008790_D007022 CID metoprolol_32\NN\2832168 (r_pobj) of_31\IN\0 (r_prep) use_30\NN\407535 (r_pobj) with_28\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) after_19\IN\0 (r_prep) presented_9\VBN\2137132 (l_prep) with_10\IN\0 (l_pobj) block_13\NN\21939 (l_conj) hypotension_16\NN\14057371
D004298_D007022 NONE dopamine_28\NN\14807737 (r_pobj) as_27\IN\14622893 (r_prep) agents_25\NNS\7347 (r_pobj) of_23\IN\0 (r_prep) doses_22\NNS\3740161 (r_conj) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694
D004280_D007022 NONE dobutamine_30\NN\0 (r_conj) dopamine_28\NN\14807737 (r_pobj) as_27\IN\14622893 (r_prep) agents_25\NNS\7347 (r_pobj) of_23\IN\0 (r_prep) doses_22\NNS\3740161 (r_conj) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694
D001285_D007022 NONE atropine_17\NN\14712692 (r_pobj) of_15\IN\0 (r_prep) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694
D008790_D006327 CID metoprolol_11\NN\2832168 (r_conj) shock_2\NN\7510495 (l_conj) block_6\NN\21939
D008790_D006327 CID metoprolol_32\NN\2832168 (r_pobj) of_31\IN\0 (r_prep) use_30\NN\407535 (r_pobj) with_28\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) after_19\IN\0 (r_prep) presented_9\VBN\2137132 (l_prep) with_10\IN\0 (l_pobj) block_13\NN\21939
D008790_D012770 NONE metoprolol_11\NN\2832168 (r_conj) shock_2\NN\7510495
D004280_D006327 NONE dobutamine_30\NN\0 (r_conj) dopamine_28\NN\14807737 (r_pobj) as_27\IN\14622893 (r_prep) agents_25\NNS\7347 (r_pobj) of_23\IN\0 (r_prep) doses_22\NNS\3740161 (r_conj) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694 (l_prep) with_6\IN\0 (l_pobj) block_9\NN\21939
D002122_D006327 NONE chloride_9\NN\14818238 (l_conj) hypotension_13\NN\14057371 (l_conj) block_17\NN\21939
D014700_D007022 CID verapamil_27\NN\2938514 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) after_19\IN\0 (r_prep) presented_9\VBN\2137132 (l_prep) with_10\IN\0 (l_pobj) block_13\NN\21939 (l_conj) hypotension_16\NN\14057371
D002122_D007022 NONE chloride_9\NN\14818238 (l_conj) hypotension_13\NN\14057371
D004298_D006327 NONE dopamine_28\NN\14807737 (r_pobj) as_27\IN\14622893 (r_prep) agents_25\NNS\7347 (r_pobj) of_23\IN\0 (r_prep) doses_22\NNS\3740161 (r_conj) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694 (l_prep) with_6\IN\0 (l_pobj) block_9\NN\21939
D014700_D012770 NONE verapamil_8\NN\2938514 (r_compound) sr_9\NNP\14625458 (r_pobj) after_7\IN\0 (r_prep) shock_2\NN\7510495
D001285_D006327 NONE atropine_17\NN\14712692 (r_pobj) of_15\IN\0 (r_prep) uses_14\NNS\407535 (r_pobj) with_12\IN\0 (r_prep) remain_4\VB\2604760 (l_acomp) hypotensive_5\JJ\10405694 (l_prep) with_6\IN\0 (l_pobj) block_9\NN\21939
D014700_D006327 CID verapamil_8\NN\2938514 (r_compound) sr_9\NNP\14625458 (r_pobj) after_7\IN\0 (r_prep) shock_2\NN\7510495 (l_conj) block_6\NN\21939
D014700_D006327 CID verapamil_27\NN\2938514 (r_pobj) of_23\IN\0 (r_prep) dose_22\NN\3740161 (r_pobj) after_19\IN\0 (r_prep) presented_9\VBN\2137132 (l_prep) with_10\IN\0 (l_pobj) block_13\NN\21939
3057041
C020976_D006255 NONE azelastine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) trial_16\NN\786195 (r_conj) efficacy_13\NN\5199286 (l_prep) in_24\IN\13603305 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) rhinitis_30\NN\14336539
C020976_D006255 NONE azelastine_0\NNP\0 (r_nsubjpass) compared_8\VBN\644583 (l_prep) with_9\IN\0 (l_pobj) maleate_11\NN\2718811 (l_prep) for_14\IN\0 (l_pobj) efficacy_15\NN\5199286 (l_prep) in_18\IN\13603305 (l_pobj) treatment_20\NN\654885 (l_prep) of_21\IN\0 (l_pobj) rhinitis_24\NN\14336539
C020976_D006255 NONE azelastine_0\NNP\0 (r_nsubj) appears_1\VBZ\2604760 (l_xcomp) be_3\VB\14625458 (l_attr) medication_8\NN\3247620 (l_prep) for_9\IN\0 (l_pobj) rhinitis_12\NN\14336539
C020976_D006970 CID azelastine_16\NN\0 (r_compound) group_17\NN\2137 (r_pobj) in_11\IN\13603305 (r_prep) increased_6\VBN\169651 (l_nsubjpass) drowsiness_0\VB\14015731
D002744_D006255 NONE chlorpheniramine_20\NN\0 (r_conj) azelastine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) trial_16\NN\786195 (r_conj) efficacy_13\NN\5199286 (l_prep) in_24\IN\13603305 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) rhinitis_30\NN\14336539
D002744_D006255 NONE maleate_11\NN\2718811 (l_prep) for_14\IN\0 (l_pobj) efficacy_15\NN\5199286 (l_prep) in_18\IN\13603305 (l_pobj) treatment_20\NN\654885 (l_prep) of_21\IN\0 (l_pobj) rhinitis_24\NN\14336539
C020976_D013651 CID azelastine_16\NN\0 (r_compound) group_17\NN\2137 (r_pobj) in_11\IN\13603305 (r_prep) increased_6\VBN\169651 (l_nsubjpass) drowsiness_0\VB\14015731 (l_conj) perception_4\NN\5926676
9214597
D004967_D009369 NONE estrogen_14\NN\14745635 (r_npadvmod) induced_16\VBN\1627355 (r_amod) rat_17\NN\2329401 (r_nmod) tumors_19\NNS\14234074 (r_pobj) of_13\IN\0 (r_prep) development_12\NN\248977 (r_pobj) during_10\IN\0 (r_prep) receptor_9\NN\5225602 (r_conj) factor_6\NN\7326557 (r_pobj) of_2\IN\0 (r_prep) expression_1\NN\4679549 (r_pobj) over_0\IN\5867413 (r_prep) mediate_21\VB\761713 (l_dobj) angiogenesis_26\NN\13489037 (l_compound) tumor_25\NN\14234074
D004967_D009369 NONE estrogen_22\NN\14745635 (r_npadvmod) initiated_24\VBN\1617192 (r_amod) angiogenesis_26\NN\13489037 (l_compound) tumor_25\NN\14234074
D004967_D009369 NONE estrogens_0\NNP\14745635 (l_relcl) associated_5\VBN\628491 (l_prep) with_6\IN\0 (l_pobj) types_8\NNS\5839024 (l_prep) of_9\IN\0 (l_pobj) cancers_13\NNS\14239425
D004967_D009369 NONE estrogens_0\NNP\14745635 (r_nsubj) induce_16\VB\1627355 (l_dobj) angiogenesis_18\NN\13489037 (l_compound) tumor_17\NN\14234074
D004967_D009369 NONE estrogen_9\NN\14745635 (r_compound) carcinogenesis_10\NN\0 (r_pobj) during_8\IN\0 (r_prep) are_12\VBP\13600404 (l_nsubj) details_2\NNS\6634376 (l_prep) of_3\IN\0 (l_pobj) angiogenesis_5\NN\13489037 (l_compound) tumor_4\NN\14234074
D004967_D009369 NONE estrogen_5\NN\14745635 (r_pobj) of_4\IN\0 (r_prep) role_3\NN\719494 (r_dobj) elucidate_1\VB\939277 (l_prep) in_6\IN\13603305 (l_pobj) regulation_8\NN\6652242 (l_prep) of_9\IN\0 (l_pobj) angiogenesis_11\NN\13489037 (l_compound) tumor_10\NN\14234074
D004967_D009369 NONE estrogen_27\NN\14745635 (r_pobj) of_26\IN\0 (r_prep) regulation_25\NN\6652242 (r_pobj) of_23\IN\0 (r_prep) step_22\NN\168237 (r_pobj) in_19\IN\13603305 (r_prep) play_15\VB\7007684 (r_ccomp) suggest_2\VBP\1010118 (l_ccomp) induced_28\VBN\1627355 (l_dobj) angiogenesis_30\NN\13489037 (l_compound) tumor_29\NN\14234074
D004967_D010911 NONE estrogen_14\NN\14745635 (r_npadvmod) induced_16\VBN\1627355 (r_amod) rat_17\NN\2329401 (r_nmod) tumors_19\NNS\14234074
D004967_D010911 NONE estrogen_22\NN\14745635 (r_npadvmod) initiated_24\VBN\1617192 (r_amod) angiogenesis_26\NN\13489037 (r_dobj) mediate_21\VB\761713 (l_prep) over_0\IN\5867413 (l_pobj) expression_1\NN\4679549 (l_prep) of_2\IN\0 (l_pobj) factor_6\NN\7326557 (l_conj) receptor_9\NN\5225602 (l_prep) during_10\IN\0 (l_pobj) development_12\NN\248977 (l_prep) of_13\IN\0 (l_pobj) tumors_19\NNS\14234074
D004967_D063646 NONE estrogen_9\NN\14745635 (r_compound) carcinogenesis_10\NN\0
15893386
D015742_D008305 NONE propofol_5\JJ\0 (r_amod) infusion_6\NN\14589223 (r_pobj) with_4\IN\0 (r_prep) continued_2\VBN\2367363 (l_advcl) were_10\VBD\0 (l_acomp) available_11\JJ\0 (l_xcomp) detect_13\VB\2163746 (l_conj) treat_15\VB\7570720 (l_dobj) hyperthermia_17\NN\14034177
D013390_D014313 CID succinylcholine_0\NN\3800001 (r_npadvmod) induced_2\VBN\1627355 (r_amod) rigidity_5\NN\5023233
D013390_D014313 CID succinylcholine_17\NN\3800001 (r_nmod) administration_21\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) describe_3\VBP\1001294 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) rigidity_10\NN\5023233
D013390_D014313 CID succinylcholine_17\NN\3800001 (r_nmod) administration_21\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) describe_3\VBP\1001294 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) rigidity_10\NN\5023233 (l_appos) jaw_12\NN\5269901 (l_prep) of_13\IN\0 (l_pobj) steel_14\NN\14586769
D013390_D014313 CID sch_19\NNP\0 (r_nmod) administration_21\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) describe_3\VBP\1001294 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) rigidity_10\NN\5023233
D013390_D014313 CID sch_19\NNP\0 (r_nmod) administration_21\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) describe_3\VBP\1001294 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) rigidity_10\NN\5023233 (l_appos) jaw_12\NN\5269901 (l_prep) of_13\IN\0 (l_pobj) steel_14\NN\14586769
3461217
D013739_D011471 NONE testosterone_21\NN\14747587 (r_conj) methylurea_19\NN\0 (r_pobj) with_12\IN\0 (r_prep) treatments_11\NNS\654885 (r_pobj) by_10\IN\0 (r_prep) production_0\NN\30358 (l_prep) of_1\IN\0 (l_pobj) cancer_4\NN\14239425
D043343_D009369 NONE tp_6\NNP\0 (r_nsubj) acted_7\VBD\0 (l_prep) as_8\IN\14622893 (l_pobj) agent_12\NN\7347 (l_compound) enhancement_11\NN\248977 (l_compound) tumor_10\NN\14234074
D043343_D011471 CID propionate_45\NN\0 (r_conj) cas_35\NN\14625458 (r_appos) methylurea_33\NN\0 (r_pobj) with_26\IN\0 (r_prep) treatments_25\NNS\654885 (r_pobj) following_24\VBG\8180190 (r_prep) developed_15\VBD\1753788 (l_dobj) pas_22\FW\285557 (l_nmod) adenocarcinomas_20\NNS\14242337
D043343_D011471 CID propionate_45\NN\0 (r_conj) cas_35\NN\14625458 (r_appos) methylurea_33\NN\0 (r_pobj) with_26\IN\0 (r_prep) treatments_25\NNS\654885 (r_pobj) following_24\VBG\8180190 (r_prep) developed_15\VBD\1753788 (l_dobj) pas_22\FW\285557
D043343_D011471 CID tp_19\NNP\0 (r_pobj) with_18\IN\0 (r_prep) treated_16\VBN\2376958 (r_advcl) developed_10\VBD\1753788 (l_dobj) pa_14\NNP\10080869
D043343_D011471 CID tp_6\NNP\0 (r_nsubj) acted_7\VBD\0 (l_prep) with_14\IN\0 (l_pobj) emphasis_16\NN\14434681 (l_prep) on_17\IN\0 (l_pobj) development_19\NN\248977 (l_prep) of_20\IN\0 (l_pobj) cancer_22\NN\14239425
D008770_D011471 CID methylurea_19\NN\0 (r_pobj) with_12\IN\0 (r_prep) treatments_11\NNS\654885 (r_pobj) by_10\IN\0 (r_prep) production_0\NN\30358 (l_prep) of_1\IN\0 (l_pobj) cancer_4\NN\14239425
D008770_D011471 CID methylurea_33\NN\0 (r_pobj) with_26\IN\0 (r_prep) treatments_25\NNS\654885 (r_pobj) following_24\VBG\8180190 (r_prep) developed_15\VBD\1753788 (l_dobj) pas_22\FW\285557 (l_nmod) adenocarcinomas_20\NNS\14242337
D008770_D011471 CID methylurea_33\NN\0 (r_pobj) with_26\IN\0 (r_prep) treatments_25\NNS\654885 (r_pobj) following_24\VBG\8180190 (r_prep) developed_15\VBD\1753788 (l_dobj) pas_22\FW\285557
8251368
D017311_D013684 CID amlodipine_6\NN\0 (r_dobj) commenced_1\VBD\0 (l_prep) with_11\IN\0 (l_pobj) recurrence_12\NN\7342049 (l_prep) of_13\IN\0 (l_pobj) telangiectasia_14\NN\0
D009543_D013684 CID nifedipine_1\RB\2938514 (r_advmod) induced_3\VBN\1627355 (r_amod) telangiectasia_5\NN\0
D009543_D013684 CID nifedipine_4\NN\2938514 (r_dobj) starting_3\VBG\457382 (r_pcomp) after_2\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) telangiectasia_14\NN\0
D009543_D013684 CID adalat_6\NNP\0 (r_oprd) starting_3\VBG\457382 (r_pcomp) after_2\IN\0 (r_prep) developed_11\VBD\1753788 (l_dobj) telangiectasia_14\NN\0
17019386
D008353_D009362 NONE mannitol_2\NN\3214670 (r_appos) methods_0\NNS\5616786 (r_nsubjpass) administered_14\VBN\2436349 (l_parataxis) had_22\VBD\0 (l_dobj) glioma_24\NN\14236743 (l_conj) metastases_28\NNS\13533470
D008353_D009362 NONE mannitol_8\NN\3214670 (r_pobj) of_7\IN\0 (r_prep) concentrations_6\NNS\4916342 (l_compound) patients_4\NNS\9898892 (l_nmod) meningioma_1\NN\14235200 (l_conj) metastases_3\NNS\13533470
D008353_D004487 NONE mannitol_13\NN\3214670 (r_nsubj) leak_15\VB\9304465 (l_advcl) reversing_23\VBG\109660 (l_conj) aggravating_34\VBG\126264 (l_dobj) edema_36\NN\14315192
D008353_D005910 NONE mannitol_2\NN\3214670 (r_pobj) of_1\IN\0 (r_prep) passage_0\NN\199130 (r_nsubj) gliomas_7\NNS\14236743
D008353_D005910 NONE mannitol_2\NN\3214670 (r_appos) methods_0\NNS\5616786 (r_nsubjpass) administered_14\VBN\2436349 (l_parataxis) had_22\VBD\0 (l_dobj) glioma_24\NN\14236743
D008353_D005910 NONE mannitol_5\NN\3214670 (r_amod) concentrations_6\NNS\4916342 (r_nsubj) were_10\VBD\0 (l_prep) in_0\IN\13603305 (l_pobj) patients_3\NNS\9898892 (l_compound) glioma_2\NN\14236743
D008353_D005910 NONE mannitol_13\NN\3214670 (r_nsubj) leak_15\VB\9304465 (l_prep) near_20\IN\1849221 (l_pobj) gliomas_21\NNS\14236743
D008353_D019586 CID mannitol_5\NN\3214670 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (l_acl) reduce_7\VB\441445 (l_dobj) edema_9\NN\14315192 (l_conj) icp_13\NNP\0
D008353_D008579 NONE mannitol_2\NN\3214670 (r_appos) methods_0\NNS\5616786 (r_nsubjpass) administered_14\VBN\2436349 (l_parataxis) had_22\VBD\0 (l_dobj) glioma_24\NN\14236743 (l_conj) metastases_28\NNS\13533470 (l_conj) meningioma_31\NN\14235200
D008353_D008579 NONE mannitol_8\NN\3214670 (r_pobj) of_7\IN\0 (r_prep) concentrations_6\NNS\4916342 (l_compound) patients_4\NNS\9898892 (l_nmod) meningioma_1\NN\14235200
D008353_D001929 NONE mannitol_5\NN\3214670 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (l_acl) reduce_7\VB\441445 (l_dobj) edema_9\NN\14315192
D008353_D001932 NONE mannitol_5\NN\3214670 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (l_acl) reduce_7\VB\441445 (l_dobj) edema_9\NN\14315192 (l_conj) icp_13\NNP\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_compound) tumor_16\NN\14234074
D008353_D001932 NONE mannitol_14\NN\3214670 (r_pobj) of_13\IN\0 (r_prep) passage_12\NN\199130 (r_dobj) research_9\VB\633864 (l_prep) to_20\IN\0 (l_pobj) patients_24\NNS\9898892 (l_compound) tumor_23\NN\14234074
9209318
D015215_D009190 CID azidothymidine_5\NN\0 (r_pcomp) with_4\IN\0 (r_prep) treatment_1\NN\654885 (r_nsubj) produces_9\VBZ\7555863 (l_dobj) myelodysplasia_10\NN\0
D015215_D009190 CID azt_7\NNP\3834836 (r_appos) treatment_1\NN\654885 (r_nsubj) produces_9\VBZ\7555863 (l_dobj) myelodysplasia_10\NN\0
D015215_D009190 CID azt_2\NNP\3834836 (r_compound) incorporation_3\NN\1237415 (r_nsubj) induced_6\VBN\1627355 (l_dobj) hemopoiesis_9\NN\13526110 (l_prep) in_10\IN\13603305 (l_pobj) cells_15\NNS\3080309 (l_relcl) known_19\VBN\0 (l_xcomp) seen_22\VBN\2106506 (l_prep) in_24\IN\13603305 (l_pobj) syndrome_27\NN\5870365
D015215_D000748 CID azt_0\NNP\3834836 (r_nsubj) induced_2\VBN\1627355 (l_dobj) anemia_5\NN\14189204
D015215_D000748 CID azt_12\NNP\3834836 (r_compound) therapy_13\NN\657604 (r_appos) term_11\NN\6286395 (r_pobj) on_9\IN\0 (r_prep) anemia_5\NN\14189204
D015215_D000163 NONE azt_0\NNP\3834836 (r_nsubj) induced_2\VBN\1627355 (l_dobj) anemia_5\NN\14189204 (l_prep) in_6\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_compound) aids_7\NNP\13974317
D015215_D000163 NONE azt_12\NNP\3834836 (r_compound) therapy_13\NN\657604 (r_appos) term_11\NN\6286395 (r_pobj) on_9\IN\0 (r_prep) anemia_5\NN\14189204 (l_prep) in_6\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_compound) aids_7\NNP\13974317
8514073
D003975_D010146 NONE diazepam_18\NN\2830852 (r_compound) group_19\NN\2137 (r_pobj) in_16\IN\13603305 (r_prep) patients_15\NNS\9898892 (r_pobj) of_14\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_nsubj) pain_0\NN\14299637
D000431_D014652 NONE alcohol_19\NN\7881800 (r_compound) use_20\NN\407535 (r_conj) time_14\NN\7308889 (r_conj) site_11\NN\8673395 (r_conj) use_7\NN\407535 (r_appos) smoking_0\NN\831191 (r_nsubj) had_27\VBD\0 (l_dobj) effect_29\NN\34213 (l_prep) on_30\IN\0 (l_pobj) incidence_32\NN\13821570 (l_prep) of_33\IN\0 (l_pobj) complications_35\NNS\1073995
D008874_D010146 NONE midazolam_32\JJ\2830852 (r_amod) group_33\NN\2137 (r_pobj) in_30\IN\13603305 (r_prep) %_23\NN\0 (r_pobj) with_21\IN\0 (r_prep) compared_20\VBN\644583 (r_prep) occurred_5\VBD\0 (l_nsubj) pain_0\NN\14299637
D000431_D010146 NONE alcohol_19\NN\7881800 (r_compound) use_20\NN\407535 (l_conj) pain_23\NN\14299637
D008874_D014652 CID midazolam_3\FW\2830852 (r_pobj) of_2\IN\0 (r_prep) complications_1\NNS\1073995
D008874_D014652 CID midazolam_11\DT\2830852 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (l_nsubjpass) complications_7\NNS\1073995
D008874_D014652 CID midazolam_14\NN\2830852 (r_conj) diazepam_12\NN\2830852 (r_pobj) of_11\IN\0 (r_prep) injection_10\NN\320852 (r_pobj) after_8\IN\0 (r_prep) evaluated_2\VBD\670261 (l_dobj) incidence_4\NN\13821570 (l_prep) of_5\IN\0 (l_pobj) complications_7\NNS\1073995
D008874_D014652 CID midazolam_17\NNP\2830852 (r_pobj) with_16\IN\0 (r_prep) than_15\IN\0 (r_prep) 22_10\CD\13745420 (r_npadvmod) were_4\VBD\0 (l_nsubj) complications_3\NNS\1073995
D003975_D014652 CID diazepam_5\NN\2830852 (r_pobj) versus_4\FW\0 (r_prep) midazolam_3\FW\2830852 (r_pobj) of_2\IN\0 (r_prep) complications_1\NNS\1073995
D003975_D014652 CID diazepam_14\NN\2830852 (r_pobj) with_13\IN\0 (r_prep) than_12\IN\0 (r_prep) midazolam_11\DT\2830852 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (l_nsubjpass) complications_7\NNS\1073995
D003975_D014652 CID diazepam_12\NN\2830852 (r_pobj) of_11\IN\0 (r_prep) injection_10\NN\320852 (r_pobj) after_8\IN\0 (r_prep) evaluated_2\VBD\670261 (l_dobj) incidence_4\NN\13821570 (l_prep) of_5\IN\0 (l_pobj) complications_7\NNS\1073995
D003975_D014652 CID diazepam_8\NN\2830852 (r_pobj) with_7\IN\0 (r_prep) frequent_6\JJ\2556126 (r_acomp) were_4\VBD\0 (l_nsubj) complications_3\NNS\1073995
6892185
D002122_D015878 NONE chloride_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubj) injected_5\VBD\81072 (l_advcl) fighting_26\VBG\958896 (l_conj) mydriasis_43\NN\365995
D002122_D015878 NONE chloride_24\NN\14818238 (r_pobj) by_22\IN\0 (r_agent) changed_21\VBN\0 (l_nsubjpass) mydriasis_5\NN\365995
D002122_D015878 NONE chloride_5\NN\14818238 (r_nsubj) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995
D002217_D004830 CID carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375
D002217_D004830 CID carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926 (l_conj) convulsions_12\NNS\14081375
D002217_D004830 CID carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926 (l_conj) convulsions_27\NNS\14081375
D002122_D014202 NONE chloride_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubj) injected_5\VBD\81072 (l_advcl) fighting_26\VBG\958896 (l_conj) mydriasis_43\NN\365995 (l_conj) tremor_45\NN\345926
D002122_D014202 NONE chloride_24\NN\14818238 (r_pobj) by_22\IN\0 (r_agent) changed_21\VBN\0 (l_nsubjpass) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926
D002122_D014202 NONE chloride_5\NN\14818238 (r_nsubj) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926
D010830_D015878 CID eserine_55\NN\0 (r_conj) carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375 (r_conj) tremor_45\NN\345926 (r_conj) mydriasis_43\NN\365995
D010830_D015878 CID eserine_17\NN\0 (r_conj) carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995
D010830_D015878 CID eserine_32\NN\0 (r_conj) carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995
D010830_D014202 CID eserine_55\NN\0 (r_conj) carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375 (r_conj) tremor_45\NN\345926
D010830_D014202 CID eserine_17\NN\0 (r_conj) carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926
D010830_D014202 CID eserine_32\NN\0 (r_conj) carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926
D002217_D015878 CID carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375 (r_conj) tremor_45\NN\345926 (r_conj) mydriasis_43\NN\365995
D002217_D015878 CID carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995
D002217_D015878 CID carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995
D002217_D014202 CID carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375 (r_conj) tremor_45\NN\345926
D002217_D014202 CID carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926
D002217_D014202 CID carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926
D002122_D004830 NONE chloride_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubj) injected_5\VBD\81072 (l_advcl) fighting_26\VBG\958896 (l_conj) mydriasis_43\NN\365995 (l_conj) tremor_45\NN\345926 (l_conj) convulsions_50\NNS\14081375
D002122_D004830 NONE chloride_24\NN\14818238 (r_pobj) by_22\IN\0 (r_agent) changed_21\VBN\0 (l_nsubjpass) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926 (l_conj) convulsions_12\NNS\14081375
D002122_D004830 NONE chloride_5\NN\14818238 (r_nsubj) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926 (l_conj) convulsions_27\NNS\14081375
D010830_D004830 CID eserine_55\NN\0 (r_conj) carbachol_53\NN\0 (r_pobj) by_52\IN\0 (r_agent) produced_51\VBN\1617192 (r_acl) convulsions_50\NNS\14081375
D010830_D004830 CID eserine_17\NN\0 (r_conj) carbachol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) evoked_13\VBN\1617192 (r_acl) mydriasis_5\NN\365995 (l_conj) tremor_7\NN\345926 (l_conj) convulsions_12\NNS\14081375
D010830_D004830 CID eserine_32\NN\0 (r_conj) carbachol_30\NN\0 (r_pobj) by_29\IN\0 (r_agent) caused_28\VBN\1617192 (r_acl) dissociate_8\VB\2431320 (l_prep) from_13\IN\0 (l_pobj) phenomena_17\NNS\29677 (l_prep) as_19\IN\14622893 (l_pobj) mydriasis_20\NN\365995 (l_conj) tremor_22\NN\345926 (l_conj) convulsions_27\NNS\14081375
11337188
D010068_D011693 NONE oxacillin_9\NN\3910417 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_19\VBD\1753788 (l_dobj) failure_21\NN\66216 (l_appos) lesions_29\NNS\14204950
D010068_D051437 CID oxacillin_9\NN\3910417 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_19\VBD\1753788 (l_dobj) failure_21\NN\66216
D010068_D013203 NONE oxacillin_9\NN\3910417 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (l_prep) because_13\IN\0 (l_pobj) bacteremia_17\NN\14204950
D010068_D018366 CID oxacillin_5\NN\3910417 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) vasculitis_2\NN\14336539
D010068_D018366 CID oxacillin_0\NNP\3910417 (r_nsubjpass) included_3\VBN\0 (l_prep) among_4\IN\0 (l_pobj) drugs_6\NNS\14778436 (l_relcl) cause_9\VB\7323922 (l_dobj) vasculitis_11\NN\14336539
D010068_D016470 NONE oxacillin_9\NN\3910417 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (l_prep) because_13\IN\0 (l_pobj) bacteremia_17\NN\14204950
6111982
D011433_D001145 NONE propranolol_6\NN\0 (l_conj) pindolol_8\NN\2832168 (l_xcomp) inhibiting_9\VBG\2510337 (l_dobj) arrhythmia_12\NN\14103288
D010042_D001145 CID ouabain_11\JJ\0 (r_compound) arrhythmia_12\NN\14103288
D010869_D001145 NONE pindolol_8\NN\2832168 (l_xcomp) inhibiting_9\VBG\2510337 (l_dobj) arrhythmia_12\NN\14103288
10533019
D004110_D013746 CID diltiazem_6\NN\2938514 (r_npadvmod) induced_8\VBN\1627355 (r_amod) tetany_9\NN\14304060
D004110_D013746 CID diltiazem_16\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) infusion_13\NN\14589223 (r_pobj) after_11\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) tetany_6\NN\14304060
D004110_D013746 CID diltiazem_17\NN\2938514 (r_pobj) of_15\IN\0 (r_prep) administration_14\NN\1133281 (r_dobj) accompany_12\VB\0 (l_nsubj) tetany_10\NN\14304060
D004110_D012131 NONE diltiazem_16\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) infusion_13\NN\14589223 (r_pobj) after_11\IN\0 (r_prep) developed_5\VBD\1753788 (l_prep) with_7\IN\0 (l_pobj) arrest_10\NN\88481
D002122_D013746 NONE chloride_12\NN\14818238 (r_pobj) with_10\IN\0 (r_prep) tetany_9\NN\14304060
D002122_D013746 NONE chloride_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) resolved_6\VBD\352826 (l_dobj) tetany_10\NN\14304060
D002122_D013746 NONE chloride_21\NN\14818238 (r_nsubj) be_23\VB\14625458 (r_conj) accompany_12\VB\0 (l_nsubj) tetany_10\NN\14304060
14982270
D011433_D006980 NONE propranolol_21\NN\0 (l_prep) for_27\IN\0 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) hyperthyroidism_30\NN\14059928
D008713_D011537 CID methimazole_14\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_pcomp) after_12\IN\0 (r_prep) itching_9\NN\5723210
D011433_D007565 NONE propranolol_21\NN\0 (r_conj) receiving_13\VBG\2210855 (r_pcomp) after_12\IN\0 (r_prep) itching_9\NN\5723210 (r_conj) had_5\VBD\0 (l_dobj) jaundice_7\NN\14299637
D008713_D002779 NONE methimazole_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cholestasis_3\NN\14052403
D011433_D002779 NONE propranolol_8\NN\0 (r_conj) diagnosed_5\VBN\644583 (l_nsubjpass) cholestasis_3\NN\14052403
D008713_D041781 CID methimazole_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) jaundice_4\NN\14299637
D008713_D007565 NONE methimazole_14\NN\0 (r_dobj) receiving_13\VBG\2210855 (r_pcomp) after_12\IN\0 (r_prep) itching_9\NN\5723210 (r_conj) had_5\VBD\0 (l_dobj) jaundice_7\NN\14299637
D008713_D006980 NONE methimazole_14\NN\0 (r_dobj) receiving_13\VBG\2210855 (l_conj) propranolol_21\NN\0 (l_prep) for_27\IN\0 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) hyperthyroidism_30\NN\14059928
D011433_D011537 NONE propranolol_21\NN\0 (r_conj) receiving_13\VBG\2210855 (r_pcomp) after_12\IN\0 (r_prep) itching_9\NN\5723210
8638876
D011374_D012640 NONE progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (l_dobj) hemiparesis_17\NN\0 (l_conj) seizure_19\NN\14081375
D011374_D014839 NONE progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687
D011374_D009325 NONE progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637
D011374_D002341 CID progesterone_13\NN\14747338 (r_conj) estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_nsubj) increased_18\VBD\169651 (l_dobj) thrombogenicity_20\NN\0 (l_relcl) provided_23\VBD\2199590 (l_dobj) denominator_26\NN\13733167 (l_prep) for_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_prep) of_29\IN\0 (l_pobj) ica_32\NNP\0 (l_conj) sinus_36\NN\5248181
D004958_D009325 NONE estradiol_28\NN\14749794 (r_conj) progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637
D011374_D003920 NONE progesterone_13\NN\14747338 (r_conj) estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (l_conj) dm_17\NNP\14117805
D004958_D010291 NONE estradiol_28\NN\14749794 (r_conj) progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (l_dobj) hemiparesis_17\NN\0
D004958_D006261 NONE estradiol_28\NN\14749794 (r_conj) progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480
D011374_D006261 NONE progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480
D004958_D002341 CID estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_nsubj) increased_18\VBD\169651 (l_dobj) thrombogenicity_20\NN\0 (l_relcl) provided_23\VBD\2199590 (l_dobj) denominator_26\NN\13733167 (l_prep) for_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_prep) of_29\IN\0 (l_pobj) ica_32\NNP\0 (l_conj) sinus_36\NN\5248181
D004958_D014839 NONE estradiol_28\NN\14749794 (r_conj) progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (r_conj) developed_9\VBD\1753788 (l_dobj) headache_10\NN\5829480 (l_conj) nausea_12\NN\14299637 (l_conj) vomiting_14\NN\116687
D011374_D010291 NONE progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (l_dobj) hemiparesis_17\NN\0
D004958_D003920 NONE estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (l_conj) dm_17\NNP\14117805
D011374_D012851 CID progesterone_13\NN\14747338 (r_conj) estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_nsubj) increased_18\VBD\169651 (l_dobj) thrombogenicity_20\NN\0 (l_relcl) provided_23\VBD\2199590 (l_dobj) denominator_26\NN\13733167 (l_prep) for_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_prep) of_29\IN\0 (l_pobj) ica_32\NNP\0 (l_conj) sinus_36\NN\5248181
D004958_D012851 CID estradiol_11\NN\14749794 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_nsubj) increased_18\VBD\169651 (l_dobj) thrombogenicity_20\NN\0 (l_relcl) provided_23\VBD\2199590 (l_dobj) denominator_26\NN\13733167 (l_prep) for_27\IN\0 (l_pobj) thrombosis_28\NN\14100769 (l_prep) of_29\IN\0 (l_pobj) ica_32\NNP\0 (l_conj) sinus_36\NN\5248181
D004958_D012640 NONE estradiol_28\NN\14749794 (r_conj) progesterone_26\NN\14747338 (r_pobj) of_25\IN\0 (r_prep) use_24\NN\407535 (r_pobj) after_22\IN\0 (r_prep) left_16\VBD\8621598 (l_dobj) hemiparesis_17\NN\0 (l_conj) seizure_19\NN\14081375
6732043
D000728_D020181 CID androgen_12\JJ\14745635 (r_compound) administration_13\NN\1133281 (r_pobj) by_10\IN\0 (r_prep) woman_9\NN\9605289 (r_pobj) in_7\IN\13603305 (r_prep) syndrome_6\NN\5870365
D000728_D020181 CID androgens_36\NNS\14745635 (r_dobj) administered_34\VBN\2436349 (r_advcl) developed_22\VBN\1753788 (l_dobj) changes_24\NNS\7283608 (l_conj) syndrome_27\NN\5870365 (l_prep) of_28\IN\0 (l_pobj) apnea_31\NN\14299637
D000728_D020181 CID androgen_3\NN\14745635 (r_nmod) symptoms_5\NNS\5823932 (l_prep) of_6\IN\0 (l_pobj) apnea_9\NN\14299637
D000728_D020181 CID androgen_15\NN\14745635 (r_compound) therapy_16\NN\657604 (r_pobj) of_14\IN\0 (r_prep) effect_13\NN\34213 (r_oprd) considered_9\VBN\689344 (l_nsubjpass) development_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) syndrome_6\NN\5870365
D000728_D012891 NONE androgens_7\NNS\14745635 (r_pobj) of_6\IN\0 (r_prep) role_5\NN\719494 (r_dobj) favored_3\VBN\2397637 (l_prep) in_8\IN\13603305 (l_pobj) pathogenesis_10\NN\13533470 (l_prep) of_11\IN\0 (l_pobj) apnea_13\NN\14299637
15814210
D003907_D009422 CID dexamethasone_19\NN\2721538 (r_compound) treatment_20\NN\654885 (r_pobj) after_18\IN\0 (r_prep) dysfunction_2\NN\14204950
D003907_D009422 CID dexamethasone_19\NN\2721538 (r_compound) therapy_20\NN\657604 (r_pobj) after_18\IN\0 (r_prep) assess_7\VB\5220461 (l_dobj) dysfunction_10\NN\14204950
D003907_D009422 CID dexamethasone_1\NN\2721538 (r_compound) treatment_2\NN\654885 (r_pobj) after_0\IN\0 (r_prep) showed_5\VBD\2137132 (l_dobj) rate_8\NN\13815152 (l_prep) of_9\IN\0 (l_pobj) dysfunctions_12\NNS\14204950
6153967
D004737_D012640 CID enflurane_4\NN\3299929 (r_nsubj) resulted_10\VBD\2633881 (l_prep) in_11\IN\13603305 (l_pobj) seizures_15\NNS\14081375
D004737_D012640 CID enflurane_6\NN\3299929 (r_pobj) by_5\IN\0 (r_agent) activated_4\VBN\1641914 (r_conj) delineated_2\VBN\2137132 (l_conj) are_13\VBP\13600404 (l_acomp) free_17\JJ\7942152 (l_npadvmod) seizure_15\NN\14081375
D004737_D004827 NONE enflurane_6\NN\3299929 (r_pobj) by_5\IN\0 (r_agent) activated_4\VBN\1641914 (r_conj) delineated_2\VBN\2137132 (l_nsubj) foci_1\NN\5704266 (l_amod) epileptic_0\JJ\10595647
D004737_D004827 NONE enflurane_5\NN\3299929 (r_nsubj) prove_7\VB\2604760 (l_xcomp) be_9\VB\14625458 (l_attr) activator_14\NN\19613 (l_prep) of_15\IN\0 (l_pobj) foci_17\VBD\5704266 (l_amod) epileptic_16\JJ\10595647
17574447
D010634_D004827 NONE pb_15\NNP\14625458 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) history_10\NN\15120823 (l_prep) of_11\IN\0 (l_pobj) epilepsy_12\NN\14085708
D010634_D006323 NONE pb_15\NNP\14625458 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) history_10\NN\15120823 (r_pobj) with_7\IN\0 (r_prep) report_2\VBP\6470073 (l_appos) one_20\CD\13741022 (l_prep) as_21\IN\14622893 (l_pobj) consequence_22\NN\34213 (l_prep) of_23\IN\0 (l_pobj) arrest_25\NN\88481
D010634_D056487 NONE pb_15\NNP\14625458 (r_npadvmod) related_17\VBN\628491 (r_amod) dysfunction_22\NN\14204950
D010634_-1 NONE phenobarbital_8\JJ\2792049 (r_amod) therapy_9\NN\657604 (r_pobj) to_4\IN\0 (r_prep) related_3\VBN\628491 (r_acl) hepatonecrosis_0\NNP\0
D010634_D008107 CID phenobarbital_0\NNP\2792049 (r_nsubj) has_4\VBZ\13888491 (l_conj) believed_14\VBN\686447 (l_ccomp) indicate_26\VB\952524 (l_conj) predict_28\VB\916909 (l_dobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) disease_35\NN\14061805
D010634_D008107 CID pb_2\NNP\14625458 (r_appos) phenobarbital_0\NNP\2792049 (r_nsubj) has_4\VBZ\13888491 (l_conj) believed_14\VBN\686447 (l_ccomp) indicate_26\VB\952524 (l_conj) predict_28\VB\916909 (l_dobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) disease_35\NN\14061805
D010634_D008107 CID pb_16\NNP\14625458 (r_npadvmod) related_18\VBN\628491 (r_amod) increases_19\NNS\13576355 (r_nsubj) indicate_26\VB\952524 (l_conj) predict_28\VB\916909 (l_dobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) disease_35\NN\14061805
D010634_D008107 CID pb_4\NNP\14625458 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) damage_11\NN\7296428
D010634_D001996 NONE pb_15\NNP\14625458 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) history_10\NN\15120823 (r_pobj) with_7\IN\0 (r_prep) report_2\VBP\6470073 (l_appos) one_20\CD\13741022 (l_appos) other_28\JJ\0 (l_prep) of_29\IN\0 (l_pobj) bronchopneumonia_31\NN\14147627
D010634_D002761 CID phenobarbital_8\JJ\2792049 (r_amod) therapy_9\NN\657604 (r_pobj) to_4\IN\0 (r_prep) related_3\VBN\628491 (r_acl) hepatonecrosis_0\NNP\0 (l_conj) cholangitis_2\NN\14336539
2220369
C015173_D020246 CID epinephrine_6\NN\14807929 (r_conj) thrombosis_2\NN\14100769
C015173_D020246 CID epinephrine_28\NN\14807929 (r_pobj) with_26\IN\0 (r_prep) started_23\VBN\0 (r_pcomp) after_21\IN\0 (r_prep) acquired_11\VBD\0 (l_dobj) thrombosis_14\NN\14100769
C015173_D005901 NONE epinephrine_28\NN\14807929 (l_prep) for_29\IN\0 (l_pobj) glaucoma_31\NN\14252864
17366349
C092292_D009459 CID ziprasidone_5\NN\0 (r_pobj) by_4\IN\0 (r_prep) induced_3\VBN\1627355 (l_nsubj) syndrome_2\NN\5870365
C092292_D009459 CID ziprasidone_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) use_14\NN\407535 (r_pobj) with_12\IN\0 (r_prep) associated_11\VBN\628491 (r_acl) syndrome_7\NN\5870365
C092292_D009459 CID ziprasidone_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) use_14\NN\407535 (r_pobj) with_12\IN\0 (r_prep) associated_11\VBN\628491 (r_acl) syndrome_7\NN\5870365 (l_appos) nms_9\NNP\13649268
C092292_D009459 CID ziprasidone_14\NN\0 (r_pobj) like_13\IN\5839024 (r_prep) drugs_12\NNS\14778436 (l_nmod) nms_8\NNP\13649268
C092292_D009459 CID ziprasidone_34\NNP\0 (r_pobj) of_31\IN\0 (r_prep) dose_30\NN\3740161 (r_pobj) with_25\IN\0 (r_prep) treatment_24\NN\654885 (r_pobj) of_23\IN\0 (r_prep) days_22\NNS\15140892 (r_pobj) after_20\IN\0 (r_prep) developed_14\VBD\1753788 (l_dobj) signs_15\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) nms_19\NNP\13649268
C092292_D009459 CID ziprasidone_3\NNP\0 (r_xcomp) due_1\IN\5174653 (r_amod) nms_0\NNP\13649268
C092292_D012559 NONE ziprasidone_34\NNP\0 (r_pobj) of_31\IN\0 (r_prep) dose_30\NN\3740161 (r_pobj) with_25\IN\0 (r_prep) treatment_24\NN\654885 (r_pobj) of_23\IN\0 (r_prep) days_22\NNS\15140892 (r_pobj) after_20\IN\0 (r_prep) developed_14\VBD\1753788 (r_relcl) schizophrenia_12\NN\14398067
19370593
D004967_D001943 NONE oestrogen_3\NN\14745635 (r_nmod) ht_6\NNP\0 (r_nsubj) increased_8\VBD\169651 (l_conj) increase_42\VB\13576355 (l_dobj) risk_44\NN\14541044 (l_prep) of_45\IN\0 (l_pobj) cancer_47\NN\14239425
D004967_D020521 CID oestrogen_3\NN\14745635 (r_nmod) ht_6\NNP\0 (r_nsubj) increased_8\VBD\169651 (l_dobj) risk_10\NN\14541044 (l_prep) of_11\IN\0 (l_pobj) embolism_15\NN\15269513 (l_appos) disease_20\NN\14061805 (l_nmod) stroke_17\NN\556313
D004967_D005705 CID oestrogen_3\NN\14745635 (r_nmod) ht_6\NNP\0 (r_nsubj) increased_8\VBD\169651 (l_dobj) risk_10\NN\14541044 (l_prep) of_11\IN\0 (l_pobj) embolism_15\NN\15269513 (l_appos) disease_20\NN\14061805
D004967_D054556 CID oestrogen_3\NN\14745635 (r_nmod) ht_6\NNP\0 (r_nsubj) increased_8\VBD\169651 (l_dobj) risk_10\NN\14541044 (l_prep) of_11\IN\0 (l_pobj) embolism_15\NN\15269513
2466960
D005472_D009369 NONE 5-fu_11\CD\0 (r_compound) infusion_12\NN\14589223 (l_prep) for_13\IN\0 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) tumors_17\NNS\14234074
D005472_D003324 NONE 5-fu_3\CD\0 (r_compound) infusion_4\NN\14589223 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) increase_10\NN\13576355 (l_prep) among_21\IN\0 (l_pobj) patients_22\NNS\9898892 (l_prep) with_23\IN\0 (l_pobj) disease_26\NN\14061805
D005472_D066126 NONE fluorouracil_11\NN\2722166 (r_nmod) therapy_15\NN\657604 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) toxicity_8\NN\13576101
D005472_D066126 NONE 5-fu_13\CD\0 (r_nmod) therapy_15\NN\657604 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) toxicity_8\NN\13576101
D005472_D000787 CID 5-fu_12\CD\0 (r_nummod) infusion_13\NN\14589223 (r_pobj) during_11\IN\0 (r_prep) had_8\VBD\0 (l_ccomp) were_2\VBD\0 (l_nsubj) episodes_1\NNS\7283608 (l_compound) anginal_0\JJ\0
D005472_D000787 CID 5-fu_12\CD\0 (r_nummod) infusion_13\NN\14589223 (r_pobj) during_11\IN\0 (r_prep) had_8\VBD\0 (l_dobj) angina_9\NN\14171682
D005472_D007511 CID 5-fu_11\CD\0 (r_compound) infusion_12\NN\14589223 (r_dobj) undergoing_10\VBG\109660 (r_acl) patients_9\NNS\9898892 (r_pobj) on_7\IN\0 (r_prep) monitoring_6\NN\879759 (r_dobj) performed_2\VBD\0 (l_prep) in_18\IN\13603305 (l_pobj) order_19\NN\7168131 (l_acl) assess_21\VB\5220461 (l_dobj) incidence_23\NN\13821570 (l_prep) of_24\IN\0 (l_pobj) changes_27\NNS\7283608 (l_compound) st_26\NNP\0 (l_amod) ischemic_25\JJ\0
D005472_D007511 CID 5-fu_15\CD\0 (r_nummod) infusion_16\NN\14589223 (r_pobj) to_14\IN\0 (r_prep) prior_13\RB\10675876 (r_advmod) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) ischemic_3\JJ\0
D005472_D007511 CID 5-fu_22\CD\0 (r_nummod) infusion_23\NN\14589223 (r_pobj) during_21\IN\0 (r_prep) infusion_16\NN\14589223 (r_pobj) to_14\IN\0 (r_prep) prior_13\RB\10675876 (r_advmod) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) ischemic_3\JJ\0
D005472_D007511 CID 5-fu_46\CD\0 (r_pobj) before_45\IN\0 (r_prep) was_36\VBD\0 (l_ccomp) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) ischemic_3\JJ\0
D005472_D007511 CID 5-fu_57\CD\0 (r_pobj) during_56\IN\0 (r_prep) was_36\VBD\0 (l_ccomp) was_9\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) ischemic_3\JJ\0
D005472_D007511 CID 5-fu_3\CD\0 (r_compound) infusion_4\NN\14589223 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) increase_10\NN\13576355 (l_prep) in_11\IN\13603305 (l_pobj) deviation_15\NN\7337390 (l_amod) suggestive_16\JJ\0 (l_prep) of_17\IN\0 (l_pobj) ischemia_18\NN\14195315
12448656
D013792_D002292 NONE thalidomide_5\NN\4166841 (r_pobj) of_4\IN\0 (r_prep) study_3\NN\635850 (l_prep) in_6\IN\13603305 (l_pobj) carcinoma_11\NN\14239918
D013792_D002292 NONE thalidomide_9\NN\4166841 (r_pobj) of_8\IN\0 (r_prep) toxicity_5\NN\13576101 (r_dobj) evaluate_3\VB\670261 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) cancer_17\NN\14239425
D013792_D002292 NONE thalidomide_11\NN\4166841 (r_pobj) of_10\IN\0 (r_prep) activity_9\NN\30358 (r_pobj) of_8\IN\0 (r_prep) level_7\NN\4916342 (l_prep) in_12\IN\13603305 (l_pobj) carcinoma_15\NN\14239918
D013792_D002292 NONE thalidomide_10\NN\4166841 (l_prep) for_11\IN\0 (l_pobj) carcinoma_14\NN\14239918
D013792_D064420 NONE thalidomide_9\NN\4166841 (r_pobj) of_8\IN\0 (r_prep) toxicity_5\NN\13576101
6942642
D011188_D007008 NONE potassium_13\NN\14625458 (r_pobj) of_11\IN\0 (r_prep) depletion_10\NN\351638 (r_conj) hypokalemia_8\NN\14299637
D049971_D001145 NONE thiazide_0\NNP\3214670 (r_compound) diuretics_1\NNS\3247620 (l_conj) hypokalemia_3\JJ\14299637 (l_conj) arrhythmias_6\NNS\14103288
D006852_C563897 NONE hydrochlorothiazide_18\NN\4423288 (r_pobj) with_17\IN\0 (r_prep) hypertension_16\NN\14057371
D006852_C563897 NONE hctc_20\NNP\0 (r_appos) hydrochlorothiazide_18\NN\4423288 (r_pobj) with_17\IN\0 (r_prep) hypertension_16\NN\14057371
D049971_D007008 NONE thiazide_0\NNP\3214670 (r_compound) diuretics_1\NNS\3247620 (l_conj) hypokalemia_3\JJ\14299637
D049971_D007008 NONE thiazide_9\NN\3214670 (r_compound) therapy_10\NN\657604 (r_pobj) of_7\IN\0 (r_prep) consequence_6\NN\34213 (r_attr) is_1\VBZ\0 (l_nsubj) hypokalemia_0\NNP\14299637
D049971_D007008 NONE thiazide_5\JJ\3214670 (r_csubj) cause_7\VBP\7323922 (l_dobj) hypokalemia_8\NN\14299637
2598570
D013496_D021501 CID suprofen_9\NN\0 (r_pobj) from_8\IN\0 (r_prep) epidemiology_1\NN\6043075 (l_prep) of_2\IN\0 (l_pobj) syndrome_7\NN\5870365 (l_compound) pain_6\NN\14299637
D007052_D007674 NONE ibuprofen_15\NNP\3828465 (r_appos) agents_12\NNS\7347 (r_pobj) of_9\IN\0 (r_prep) use_8\NN\407535 (r_appos) age_5\NN\4916342 (l_conj) disease_20\NN\14061805
D007052_D006073 NONE ibuprofen_15\NNP\3828465 (r_appos) agents_12\NNS\7347 (r_pobj) of_9\IN\0 (r_prep) use_8\NN\407535 (r_appos) age_5\NN\4916342 (l_conj) disease_20\NN\14061805 (l_conj) history_29\NN\15120823 (l_prep) of_30\IN\0 (l_pobj) gout_31\NN\14186541
D000431_D006255 NONE alcohol_83\NN\7881800 (r_dobj) use_82\VB\407535 (r_conj) participate_47\VB\2367363 (l_ccomp) were_2\VBD\0 (l_conj) suffer_24\VB\2110220 (l_prep) from_25\IN\0 (l_pobj) fever_27\NN\14299637
D007052_D007669 NONE ibuprofen_15\NNP\3828465 (r_appos) agents_12\NNS\7347 (r_pobj) of_9\IN\0 (r_prep) use_8\NN\407535 (r_appos) age_5\NN\4916342 (l_conj) disease_20\NN\14061805 (l_conj) history_23\NN\15120823 (l_prep) of_24\IN\0 (l_pobj) stones_26\NNS\19128
D000431_D001249 NONE alcohol_83\NN\7881800 (r_dobj) use_82\VB\407535 (r_conj) participate_47\VB\2367363 (l_ccomp) were_2\VBD\0 (l_conj) suffer_24\VB\2110220 (l_prep) from_25\IN\0 (l_pobj) fever_27\NN\14299637 (l_conj) asthma_29\NN\14145095
458486
D063325_D010300 NONE tiapride_0\NNP\0 (l_appos) movements_18\NNS\191142 (l_prep) in_19\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) disease_26\NN\14061805
D008787_D010300 NONE metoclopramide_9\NN\0 (r_pobj) to_8\IN\0 (r_prep) related_7\JJ\628491 (r_acl) derivative_5\JJ\5802185 (r_amod) movements_18\NNS\191142 (l_prep) in_19\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) disease_26\NN\14061805
D007980_D004409 CID levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) movements_6\NNS\191142
D007980_D004409 CID levodopa_12\NN\14604959 (r_npadvmod) induced_14\VBN\1627355 (r_amod) peak_15\NN\13758296 (r_nmod) movements_18\NNS\191142
D007980_D004409 CID levodopa_8\RB\14604959 (r_npadvmod) induced_10\VBN\1627355 (r_amod) dyskinesias_11\NNS\14084880
C037689_D004409 NONE benzamide_4\RB\0 (r_amod) derivative_5\JJ\5802185 (r_amod) movements_18\NNS\191142
C037689_D010300 NONE benzamide_4\RB\0 (r_amod) derivative_5\JJ\5802185 (r_amod) movements_18\NNS\191142 (l_prep) in_19\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) disease_26\NN\14061805
D063325_D004421 NONE tiapride_0\NNP\0 (r_nsubj) had_1\VBD\0 (l_advcl) induced_7\VBN\1627355 (l_prep) of_10\IN\0 (l_pobj) dystonia_17\NN\0
D008787_D004409 NONE metoclopramide_9\NN\0 (r_pobj) to_8\IN\0 (r_prep) related_7\JJ\628491 (r_acl) derivative_5\JJ\5802185 (r_amod) movements_18\NNS\191142
D007980_D004421 NONE levodopa_5\NN\14604959 (r_npadvmod) induced_7\VBN\1627355 (l_prep) of_10\IN\0 (l_pobj) dystonia_17\NN\0
D004298_D004409 NONE dopamine_21\NN\14807737 (r_compound) receptors_22\NNS\5225602 (r_pobj) of_20\IN\0 (r_prep) group_19\NN\2137 (r_pobj) of_16\IN\0 (r_prep) overstimulation_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) caused_13\VBN\1617192 (l_nsubjpass) dyskinesias_11\NNS\14084880
D063325_D004409 NONE tiapride_0\NNP\0 (l_prep) in_1\IN\13603305 (l_pobj) movements_6\NNS\191142
D063325_D004409 NONE tiapride_0\NNP\0 (l_appos) movements_18\NNS\191142
D007980_D010300 NONE levodopa_12\NN\14604959 (r_npadvmod) induced_14\VBN\1627355 (r_amod) peak_15\NN\13758296 (r_nmod) movements_18\NNS\191142 (l_prep) in_19\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) disease_26\NN\14061805
17786501
D004221_D000437 NONE disulfiram_15\NN\3740161 (r_pobj) of_14\IN\0 (r_prep) use_13\NN\407535 (l_prep) for_16\IN\0 (l_pobj) management_19\NN\1123598 (l_compound) dependence_18\NN\24720
D004221_D000437 NONE disulfiram_4\NN\3740161 (r_dobj) taking_3\VBG\37396 (l_prep) for_5\IN\0 (l_pobj) dependence_7\NN\24720
D004221_D009901 NONE disulfiram_0\NNP\3740161 (r_npadvmod) induced_2\VBN\1627355 (r_amod) optic_4\JJ\5299178 (l_conj) neuropathy_7\NN\14204950
D004221_D009901 NONE disulfiram_15\NN\3740161 (r_pobj) of_14\IN\0 (r_prep) use_13\NN\407535 (r_pobj) after_11\IN\0 (r_prep) report_3\VB\6470073 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) optic_7\JJ\5299178 (l_conj) neuropathy_10\NN\14204950
D004221_D010523 NONE disulfiram_0\NNP\3740161 (r_npadvmod) induced_2\VBN\1627355 (r_amod) optic_4\JJ\5299178 (l_conj) neuropathy_7\NN\14204950
D004221_D010523 NONE disulfiram_15\NN\3740161 (r_pobj) of_14\IN\0 (r_prep) use_13\NN\407535 (r_pobj) after_11\IN\0 (r_prep) report_3\VB\6470073 (l_dobj) case_5\NN\7283608 (l_prep) of_6\IN\0 (l_pobj) optic_7\JJ\5299178 (l_conj) neuropathy_10\NN\14204950
3961813
C025541_D020258 NONE totp_6\NNP\0 (r_pobj) after_5\IN\0 (r_prep) activities_2\NNS\30358 (l_compound) esterase_1\NN\0 (l_amod) neurotoxic_0\JJ\0
D003345_D009422 NONE corticosterone_9\NN\14752057 (l_prep) on_10\IN\0 (l_pobj) neuropathy_15\NN\14204950
D003345_D009422 NONE corticosterone_13\NN\14752057 (r_pobj) of_12\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_nsubj) had_14\VBD\0 (l_dobj) effects_16\NNS\13245626 (l_prep) on_17\IN\0 (l_pobj) neuropathy_21\NN\14204950
D007531_D009422 CID dfp_39\NNP\0 (r_conj) totp_37\NNP\0 (r_pobj) given_35\VBN\5892096 (r_acl) signs_32\NNS\6643763 (r_dobj) had_14\VBD\0 (l_dobj) effects_16\NNS\13245626 (l_prep) on_17\IN\0 (l_pobj) neuropathy_21\NN\14204950
C025541_D009410 CID totp_16\NNP\0 (r_pobj) given_15\VBN\5892096 (r_prep) were_3\VBD\0 (l_nsubj) fibers_2\NNS\14580897
D010755_D020258 NONE organophosphorous_21\JJ\0 (r_amod) compounds_22\NNS\5869584 (r_dobj) given_20\VBN\5892096 (r_prep) were_9\VBD\0 (l_nsubj) activities_2\NNS\30358 (l_compound) esterase_1\NN\0 (l_amod) neurotoxic_0\JJ\0
D007531_D009410 CID dfp_18\NNP\0 (r_conj) totp_16\NNP\0 (r_pobj) given_15\VBN\5892096 (r_prep) were_3\VBD\0 (l_nsubj) fibers_2\NNS\14580897
C025541_D009422 CID totp_18\NNP\0 (r_npadvmod) induced_20\VBN\1627355 (r_amod) neuropathy_21\NN\14204950
C025541_D009422 CID totp_37\NNP\0 (r_pobj) given_35\VBN\5892096 (r_acl) signs_32\NNS\6643763 (r_dobj) had_14\VBD\0 (l_dobj) effects_16\NNS\13245626 (l_prep) on_17\IN\0 (l_pobj) neuropathy_21\NN\14204950
D010755_D009422 NONE organophosphorus_11\NN\0 (r_npadvmod) induced_13\VBN\1627355 (r_amod) neuropathy_15\NN\14204950
D007531_D020258 NONE dfp_8\NNP\0 (r_conj) totp_6\NNP\0 (r_pobj) after_5\IN\0 (r_prep) activities_2\NNS\30358 (l_compound) esterase_1\NN\0 (l_amod) neurotoxic_0\JJ\0
1504402
D007741_D004342 CID dilevalol_7\NN\0 (r_npadvmod) associated_9\VBN\628491 (r_amod) hepatitis_10\NN\14127211 (r_pobj) for_6\IN\0 (r_prep) mechanism_5\NN\13446390 (r_pobj) as_3\IN\14622893 (r_prep) reaction_2\NN\13446390 (l_nmod) hypersensitivity_0\NN\14531772
D007741_D056486 CID dilevalol_7\NN\0 (r_npadvmod) associated_9\VBN\628491 (r_amod) hepatitis_10\NN\14127211
D007741_D056486 CID dilevalol_7\VB\0 (l_conj) serum_10\VB\5397468 (l_prep) in_19\IN\13603305 (l_pobj) case_21\NN\7283608 (l_prep) of_22\IN\0 (l_pobj) injury_27\NN\14052046
D007741_D056486 CID dilevalol_15\JJ\0 (r_compound) antigens_16\NNS\20090 (r_dobj) containing_11\VBG\2632940 (r_xcomp) serum_10\VB\5397468 (l_prep) in_19\IN\13603305 (l_pobj) case_21\NN\7283608 (l_prep) of_22\IN\0 (l_pobj) injury_27\NN\14052046
D007741_D056486 CID dilevalol_23\NN\0 (r_npadvmod) induced_25\VBN\1627355 (r_amod) injury_27\NN\14052046
D007741_D056486 CID dilevalol_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) injury_14\NN\14052046
D007741_D056486 CID dilevalol_16\JJ\0 (r_compound) antigens_17\NNS\20090 (r_dobj) containing_11\VBG\2632940 (r_acl) sera_10\NN\5397468 (r_pobj) to_9\IN\0 (r_prep) sensitization_8\NN\14531772 (r_pobj) of_6\IN\0 (r_prep) detection_5\NN\5708432 (r_dobj) allowed_3\VBD\0 (l_advcl) suggesting_19\VBG\1010118 (l_dobj) involvement_21\NN\1080366 (l_prep) of_22\IN\0 (l_pobj) mechanism_25\NN\13446390 (l_prep) in_26\IN\13603305 (l_pobj) injury_31\NN\14052046
D007741_D056486 CID dilevalol_27\NN\0 (r_npadvmod) induced_29\VBN\1627355 (r_amod) injury_31\NN\14052046
12760988
D003907_D063806 NONE dexamethasone_18\NN\2721538 (r_conj) saline_16\NN\14849367 (r_pobj) with_15\IN\0 (r_prep) pretreated_14\VBN\0 (r_acl) patients_13\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) determined_10\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_4\IN\0 (l_pobj) myalgia_8\NN\14322699
D003907_D063806 NONE dexamethasone_18\NN\2721538 (r_compound) group_19\NN\2137 (r_pobj) in_16\IN\13603305 (r_prep) patients_15\NNS\9898892 (r_nsubj) complained_20\VBD\0 (r_acl) groups_12\NNS\2137 (r_pobj) between_9\IN\0 (r_prep) differ_7\VB\0 (l_nsubj) incidence_0\NN\13821570 (l_conj) severity_2\NN\5036394 (l_prep) of_3\IN\0 (l_pobj) myalgia_4\NN\14322699
D003907_D063806 NONE dexamethasone_18\NN\2721538 (r_compound) group_19\NN\2137 (r_pobj) in_16\IN\13603305 (r_prep) patients_15\NNS\9898892 (r_nsubj) complained_20\VBD\0 (l_prep) of_21\IN\0 (l_pobj) myalgia_22\NN\14322699
D003907_D063806 NONE dexamethasone_18\NN\2721538 (r_compound) group_19\NN\2137 (r_pobj) in_16\IN\13603305 (r_prep) patients_15\NNS\9898892 (r_nsubj) complained_20\VBD\0 (l_conj) reported_36\VBN\831651 (l_nsubjpass) myalgia_34\NN\14322699
D003907_D010149 NONE dexamethasone_4\NN\2721538 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_appos) implications_0\NNS\5774614 (r_nsubj) was_7\VBD\0 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pcomp) decreasing_11\VBG\169651 (l_dobj) incidence_13\NN\13821570 (l_conj) severity_16\NN\5036394 (l_prep) of_17\IN\0 (l_pobj) myalgia_22\NN\14322699
D003907_D010149 NONE dexamethasone_2\NN\2721538 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) is_3\VBZ\0 (l_acomp) justified_5\VBN\1012073 (l_xcomp) prevent_7\VB\0 (l_dobj) myalgia_9\NN\14322699
D013390_D010149 CID succinylcholine_3\NN\3800001 (r_pobj) after_2\IN\0 (r_prep) myalgia_1\NN\14322699
D013390_D010149 CID succinylcholine_6\NN\3800001 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) effect_3\NN\34213 (r_nsubj) is_7\VBZ\0 (l_attr) myalgia_9\NN\14322699
D013390_D010149 CID succinylcholine_6\NN\3800001 (r_pobj) before_5\IN\0 (r_punct) implications_0\NNS\5774614 (r_nsubj) was_7\VBD\0 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pcomp) decreasing_11\VBG\169651 (l_dobj) incidence_13\NN\13821570 (l_conj) severity_16\NN\5036394 (l_prep) of_17\IN\0 (l_pobj) myalgia_22\NN\14322699
D013390_D010149 CID succinylcholine_18\NN\3800001 (r_npadvmod) induced_20\VBN\1627355 (r_amod) myalgia_22\NN\14322699
D013390_D010149 CID succinylcholine_11\NN\3800001 (r_pobj) after_10\IN\0 (r_prep) prevent_7\VB\0 (l_dobj) myalgia_9\NN\14322699
D013390_D063806 CID succinylcholine_5\NN\3800001 (r_npadvmod) associated_7\VBN\628491 (r_amod) myalgia_8\NN\14322699
D013390_D063806 CID succinylcholine_20\NN\3800001 (r_pobj) before_19\IN\0 (r_prep) pretreated_14\VBN\0 (r_acl) patients_13\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) determined_10\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_4\IN\0 (l_pobj) myalgia_8\NN\14322699
D013390_D063806 CID succinylcholine_12\NN\3800001 (r_npadvmod) associated_14\VBN\628491 (r_amod) myalgia_15\NN\14322699
11827497
D006493_D013921 CID heparin_3\NN\2718259 (r_npadvmod) induced_5\VBN\1627355 (r_amod) thrombocytopenia_6\NN\14189204
D006493_D013921 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204
D006493_D013921 CID heparin_10\JJ\2718259 (r_compound) exposure_11\NN\5042871 (r_pobj) after_9\IN\0 (r_prep) presents_4\VBZ\28270 (l_nsubj) thrombocytopenia_3\NN\14189204
D006493_D013921 CID heparin_5\NN\2718259 (r_npadvmod) induced_7\VBN\1627355 (r_amod) thrombocytopenia_8\NN\14189204
D006493_D013921 CID heparin_16\NN\2718259 (r_npadvmod) induced_18\VBN\1627355 (r_amod) thrombocytopenia_19\NN\14189204
D006493_D013921 CID heparin_9\NN\2718259 (r_npadvmod) induced_11\VBN\1627355 (r_amod) thrombocytopenia_12\NN\14189204
D006493_D013921 CID heparin_9\JJ\2718259 (r_compound) exposure_10\NN\5042871 (r_dobj) included_8\VBN\0 (r_relcl) hospitalizations_5\NNS\15113229 (r_pobj) after_4\IN\0 (r_prep) went_2\VBD\0 (l_prep) with_16\IN\0 (l_pobj) thrombocytopenia_18\NN\14189204
D006493_D013921 CID heparin_8\NN\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) thrombocytopenia_11\NN\14189204
D006493_D013921 CID heparin_27\VBN\2718259 (r_appos) anticoagulants_24\NNS\3740161 (r_pobj) with_22\IN\0 (r_prep) therapy_21\NN\657604 (r_nsubjpass) initiated_31\VBN\1617192 (l_ccomp) consider_7\VB\689344 (l_dobj) thrombocytopenia_11\NN\14189204
D006493_D001157 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204 (r_nsubj) presents_4\VBZ\28270 (l_prep) after_9\IN\0 (l_pobj) exposure_11\NN\5042871 (l_prep) with_13\IN\0 (l_conj) without_15\IN\0 (l_pobj) thromboemboli_19\NN\0
D006493_D001157 CID heparin_10\JJ\2718259 (r_compound) exposure_11\NN\5042871 (l_prep) with_13\IN\0 (l_conj) without_15\IN\0 (l_pobj) thromboemboli_19\NN\0
D006493_D054556 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204 (r_nsubj) presents_4\VBZ\28270 (l_prep) after_9\IN\0 (l_pobj) exposure_11\NN\5042871 (l_prep) with_13\IN\0 (l_conj) without_15\IN\0 (l_pobj) thromboemboli_19\NN\0
D006493_D054556 CID heparin_10\JJ\2718259 (r_compound) exposure_11\NN\5042871 (l_prep) with_13\IN\0 (l_conj) without_15\IN\0 (l_pobj) thromboemboli_19\NN\0
D006493_D013923 NONE heparin_9\NN\2718259 (r_npadvmod) induced_11\VBN\1627355 (r_amod) thrombocytopenia_12\NN\14189204 (r_nsubj) became_13\VBD\146138 (l_prep) on_15\IN\0 (l_pobj) presentation_17\NN\1027379 (l_prep) with_18\IN\0 (l_pobj) complications_20\NNS\1073995 (l_compound) thromboembolic_19\JJ\0
D006493_D013923 NONE heparin_13\NN\2718259 (r_npadvmod) induced_15\VBN\1627355 (r_nmod) factor_17\NN\7326557 (r_pobj) of_12\IN\0 (r_prep) results_11\NNS\34213 (r_appos) counts_3\VBZ\13582013 (l_appos) onset_5\NN\7325190 (l_prep) of_6\IN\0 (l_pobj) thromboembolism_9\NN\14100769
D006493_D013923 NONE heparin_9\JJ\2718259 (r_compound) exposure_10\NN\5042871 (r_dobj) included_8\VBN\0 (r_relcl) hospitalizations_5\NNS\15113229 (r_pobj) after_4\IN\0 (r_prep) went_2\VBD\0 (l_advcl) return_23\VB\6479665 (l_prep) with_33\IN\0 (l_pobj) complications_35\NNS\1073995 (l_compound) thromboembolic_34\JJ\0
D006493_D013923 NONE heparin_8\NN\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) thrombocytopenia_11\NN\14189204 (r_dobj) consider_7\VB\689344 (l_advcl) returns_17\NNS\6479665 (l_prep) with_18\IN\0 (l_pobj) thromboembolism_19\NN\14100769
D006493_D013923 NONE heparin_27\VBN\2718259 (r_appos) anticoagulants_24\NNS\3740161 (r_pobj) with_22\IN\0 (r_prep) therapy_21\NN\657604 (r_nsubjpass) initiated_31\VBN\1617192 (l_ccomp) consider_7\VB\689344 (l_advcl) returns_17\NNS\6479665 (l_prep) with_18\IN\0 (l_pobj) thromboembolism_19\NN\14100769
1355091
D009638_D001919 CID noradrenaline_33\NN\14807929 (r_conj) responses_2\NNS\11410625 (l_conj) bradycardia_4\NNS\14110674
D009638_D001919 CID noradrenaline_7\NN\14807929 (r_npadvmod) induced_9\VBN\1627355 (r_amod) effect_11\NN\34213 (r_dobj) accompanied_5\VBD\0 (r_relcl) bradycardia_3\NN\14110674
C014282_D001919 CID cirazoline_9\NN\0 (r_pobj) to_5\IN\0 (r_prep) bradycardia_4\NNS\14110674
C014282_D001919 CID cirazoline_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (l_amod) bradycardia_4\NN\14110674
D015016_D007024 NONE rauwolscine_33\JJ\0 (r_pobj) with_32\IN\0 (r_prep) treated_31\VBN\2376958 (r_acl) shr_30\NN\0 (r_pobj) in_28\IN\13603305 (r_conj) induced_7\VBN\1627355 (l_dobj) hypotension_9\NN\14057371
D011224_D006973 NONE prazosin_9\NN\2698769 (r_npadvmod) pretreated_11\VBN\0 (r_amod) conscious_12\JJ\0 (r_amod) rats_15\NNS\2329401 (l_amod) hypertensive_14\JJ\10405694
D011224_D006973 NONE prazosin_7\NN\2698769 (r_compound) treatment_8\NN\654885 (r_nsubj) alters_9\VBZ\0 (l_prep) for_14\IN\0 (l_pobj) control_16\NN\5190804 (l_prep) in_21\IN\13603305 (l_pobj) rats_25\NNS\2329401 (l_amod) hypertensive_24\JJ\10405694
D011224_D001919 NONE prazosin_51\NN\2698769 (r_compound) pretreatment_52\NN\0 (r_pobj) without_49\IN\0 (r_conj) with_47\IN\0 (r_prep) determined_43\VBN\0 (l_nsubjpass) responses_2\NNS\11410625 (l_conj) bradycardia_4\NNS\14110674
D011224_D001919 NONE prazosin_12\NN\2698769 (r_pobj) in_10\IN\13603305 (r_prep) abolished_9\VBN\0 (l_nsubjpass) pressor_2\NN\9190918 (l_conj) effects_5\NNS\13245626 (l_amod) bradycardia_4\NN\14110674
D011224_D001919 NONE prazosin_28\NN\2698769 (r_compound) treatment_29\NN\654885 (r_pobj) with_26\IN\0 (r_prep) shr_25\NNP\0 (r_pobj) in_24\IN\13603305 (r_prep) greater_23\JJR\0 (r_acomp) was_22\VBD\0 (l_nsubj) bradycardia_21\NN\14110674
D011224_D001919 NONE prazosin_20\NN\2698769 (r_compound) treatment_21\NN\654885 (r_pobj) without_18\IN\0 (r_conj) with_16\IN\0 (r_prep) similar_15\JJ\0 (r_acomp) was_14\VBD\0 (l_nsubj) bradycardia_3\NN\14110674
D011224_D007024 CID prazosin_9\NN\2698769 (r_npadvmod) pretreated_11\VBN\0 (r_amod) conscious_12\JJ\0 (r_amod) rats_15\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) blockade_6\NN\952963 (r_pobj) following_3\VBG\8180190 (r_prep) occurs_2\VBZ\0 (l_nsubj) hypotension_1\NN\14057371
D011224_D007024 CID prazosin_15\NN\2698769 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) hypotension_9\NN\14057371
D011224_D007024 CID prazosin_22\NN\2698769 (r_pobj) of_21\IN\0 (r_prep) dosing_20\NN\515154 (r_pobj) after_18\IN\0 (r_conj) to_16\IN\0 (r_prep) prior_15\RB\10675876 (r_advmod) performed_13\VBN\0 (r_advcl) produce_9\VB\7555863 (l_dobj) hypotension_11\NN\14057371
C056299_D001919 CID abbott-53693_22\NNP\0 (r_appos) responses_2\NNS\11410625 (l_conj) bradycardia_4\NNS\14110674
C056299_D001919 CID abbott-53693_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (r_nsubj) were_10\VBD\0 (l_conj) was_22\VBD\0 (l_nsubj) bradycardia_21\NN\14110674
15579441
D011692_D000860 CID aminonucleoside_15\NN\0 (r_advmod) induced_17\VBN\1627355 (r_amod) syndrome_19\NN\5870365 (r_appos) puromycin_14\NNS\0 (r_pobj) in_12\IN\13603305 (r_prep) identify_8\VB\699815 (l_dobj) hypoxia_11\NN\14035298
D011692_D000860 CID aminonucleoside_15\NN\0 (r_advmod) induced_17\VBN\1627355 (r_amod) syndrome_19\NN\5870365 (l_conj) hypoxia_24\NN\14035298
D011692_D000860 CID aminonucleoside_21\NN\0 (r_compound) model_22\NN\5888929 (r_pobj) in_18\IN\13603305 (r_prep) reaching_13\VBG\331950 (r_advcl) increased_7\VBD\169651 (l_nsubj) expression_0\NN\4679549 (l_prep) of_1\IN\0 (l_pobj) transgene_6\NN\5436752 (l_amod) responsive_5\JJ\0 (l_npadvmod) hypoxia_3\NN\14035298
D011692_D009404 CID aminonucleoside_15\NN\0 (r_advmod) induced_17\VBN\1627355 (r_amod) syndrome_19\NN\5870365
8988571
D003042_D064420 NONE cocaine_4\NN\3492717 (r_compound) use_5\NN\407535 (r_dobj) following_3\VBG\8180190 (r_acl) delirium_2\NN\14391660 (r_dep) provide_9\VBP\2199590 (l_dobj) evidence_11\NN\5816287 (l_prep) for_12\IN\0 (l_pobj) mechanisms_13\NNS\13446390 (l_prep) of_14\IN\0 (l_pobj) toxicity_16\NN\13576101
D003042_D064420 NONE cocaine_15\NN\3492717 (r_compound) toxicity_16\NN\13576101
D003042_D003645 CID cocaine_11\NN\3492717 (r_compound) use_12\NN\407535 (r_nsubj) disrupts_13\VBZ\362348 (r_acl) hypothesis_8\NN\7162194 (r_pobj) with_6\IN\0 (r_prep) consistent_5\JJ\0 (r_acomp) are_3\VBP\13600404 (l_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660 (l_conj) thermoregulation_32\NN\0 (l_conj) rhabdomyolysis_34\NN\0 (l_conj) death_38\NN\7296428
D003042_D003645 CID cocaine_22\NN\3492717 (r_compound) use_23\NN\407535 (r_pobj) with_20\IN\0 (r_prep) coupled_19\VBN\1295275 (r_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660 (l_conj) thermoregulation_32\NN\0 (l_conj) rhabdomyolysis_34\NN\0 (l_conj) death_38\NN\7296428
D003042_D062787 NONE cocaine_5\NN\3492717 (r_npadvmod) related_7\VBN\628491 (r_amod) deaths_8\NNS\7296428 (r_pobj) of_3\IN\0 (r_prep) registry_2\NN\6502378 (r_pobj) from_0\IN\0 (r_prep) compared_23\VBN\644583 (l_prep) with_24\IN\0 (l_pobj) victims_26\NNS\9630641 (l_prep) of_27\IN\0 (l_pobj) overdose_30\NN\84738
D003042_D062787 NONE cocaine_29\NN\3492717 (r_compound) overdose_30\NN\84738
C005618_D003693 NONE benzoylecgonine_6\NN\0 (r_conj) cocaine_4\NN\3492717 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_dobj) had_1\VBD\0 (l_nsubj) edds_0\NNS\6702458
D003042_D012206 CID cocaine_11\NN\3492717 (r_compound) use_12\NN\407535 (r_nsubj) disrupts_13\VBZ\362348 (r_acl) hypothesis_8\NN\7162194 (r_pobj) with_6\IN\0 (r_prep) consistent_5\JJ\0 (r_acomp) are_3\VBP\13600404 (l_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660 (l_conj) thermoregulation_32\NN\0 (l_conj) rhabdomyolysis_34\NN\0
D003042_D012206 CID cocaine_22\NN\3492717 (r_compound) use_23\NN\407535 (r_pobj) with_20\IN\0 (r_prep) coupled_19\VBN\1295275 (r_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660 (l_conj) thermoregulation_32\NN\0 (l_conj) rhabdomyolysis_34\NN\0
D003042_D003693 CID cocaine_4\NN\3492717 (r_compound) use_5\NN\407535 (r_dobj) following_3\VBG\8180190 (r_acl) delirium_2\NN\14391660
D003042_D003693 CID cocaine_15\NN\3492717 (r_compound) toxicity_16\NN\13576101 (r_pobj) of_14\IN\0 (r_prep) mechanisms_13\NNS\13446390 (r_pobj) for_12\IN\0 (r_prep) evidence_11\NN\5816287 (r_dobj) provide_9\VBP\2199590 (l_dep) delirium_2\NN\14391660
D003042_D003693 CID cocaine_7\NN\3492717 (r_npadvmod) induced_9\VBN\1627355 (r_amod) delirium_11\NN\14391660
D003042_D003693 CID cocaine_7\NN\3492717 (r_npadvmod) induced_9\VBN\1627355 (r_amod) delirium_11\NN\14391660 (l_appos) edds_13\NNP\6702458
D003042_D003693 CID cocaine_5\NN\3492717 (r_npadvmod) related_7\VBN\628491 (r_amod) deaths_8\NNS\7296428 (r_pobj) of_3\IN\0 (r_prep) registry_2\NN\6502378 (r_pobj) from_0\IN\0 (r_prep) compared_23\VBN\644583 (l_nsubjpass) edds_21\NNS\6702458
D003042_D003693 CID cocaine_5\NN\3492717 (r_npadvmod) related_7\VBN\628491 (r_amod) deaths_8\NNS\7296428 (r_pobj) of_3\IN\0 (r_prep) registry_2\NN\6502378 (r_pobj) from_0\IN\0 (r_prep) compared_23\VBN\644583 (l_prep) with_24\IN\0 (l_pobj) victims_26\NNS\9630641 (l_prep) without_31\IN\0 (l_pobj) delirium_33\NN\14391660
D003042_D003693 CID cocaine_29\NN\3492717 (r_compound) overdose_30\NN\84738 (r_pobj) of_27\IN\0 (r_prep) victims_26\NNS\9630641 (r_pobj) with_24\IN\0 (r_prep) compared_23\VBN\644583 (l_nsubjpass) edds_21\NNS\6702458
D003042_D003693 CID cocaine_29\NN\3492717 (r_compound) overdose_30\NN\84738 (r_pobj) of_27\IN\0 (r_prep) victims_26\NNS\9630641 (l_prep) without_31\IN\0 (l_pobj) delirium_33\NN\14391660
D003042_D003693 CID cocaine_4\NN\3492717 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_dobj) had_1\VBD\0 (l_nsubj) edds_0\NNS\6702458
D003042_D003693 CID cocaine_11\NN\3492717 (r_compound) use_12\NN\407535 (r_nsubj) disrupts_13\VBZ\362348 (r_acl) hypothesis_8\NN\7162194 (r_pobj) with_6\IN\0 (r_prep) consistent_5\JJ\0 (r_acomp) are_3\VBP\13600404 (l_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660
D003042_D003693 CID cocaine_22\NN\3492717 (r_compound) use_23\NN\407535 (r_pobj) with_20\IN\0 (r_prep) coupled_19\VBN\1295275 (r_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582 (l_conj) delirium_29\NN\14391660
D003042_D011595 NONE cocaine_11\NN\3492717 (r_compound) use_12\NN\407535 (r_nsubj) disrupts_13\VBZ\362348 (r_acl) hypothesis_8\NN\7162194 (r_pobj) with_6\IN\0 (r_prep) consistent_5\JJ\0 (r_acomp) are_3\VBP\13600404 (l_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582
D003042_D011595 NONE cocaine_22\NN\3492717 (r_compound) use_23\NN\407535 (r_pobj) with_20\IN\0 (r_prep) coupled_19\VBN\1295275 (r_advcl) precipitate_26\VB\15046900 (l_dobj) agitation_27\NN\14373582
3934126
D000617_D006311 NONE aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_nsubjpass) nephrotoxicity_9\NN\0 (l_conj) ototoxicity_11\NN\0
D014640_D006311 CID vancomycin_20\NNP\2716866 (r_appos) aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_nsubjpass) nephrotoxicity_9\NN\0 (l_conj) ototoxicity_11\NN\0
D014640_D007674 NONE vancomycin_20\NNP\2716866 (r_appos) aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_nsubjpass) nephrotoxicity_9\NN\0
D000617_D007674 NONE aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_nsubjpass) nephrotoxicity_9\NN\0
D014640_D013924 CID vancomycin_20\NNP\2716866 (r_appos) aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_ccomp) occurred_1\VBD\0 (l_nsubj) thrombophlebitis_0\NNP\14352890
D014640_D007239 NONE vancomycin_0\NNP\2716866 (r_nsubj) was_1\VBD\0 (l_acomp) curative_2\JJ\3740161 (l_prep) in_3\IN\13603305 (l_pobj) %_5\NN\0 (l_prep) of_6\IN\0 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) infection_11\NN\14052046
D014640_D007239 NONE vancomycin_3\NNP\2716866 (r_nsubj) constitutes_8\VBZ\0 (l_dobj) therapy_12\NN\657604 (l_prep) for_13\IN\0 (l_pobj) infections_14\NNS\14052046
D000617_D013924 NONE aminoglycoside_18\NN\0 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) to_14\IN\0 (r_prep) confined_13\VBN\2510337 (l_ccomp) occurred_1\VBD\0 (l_nsubj) thrombophlebitis_0\NNP\14352890
16844102
D003676_D009422 NONE dfo_7\NNP\0 (r_conj) tc_5\NNP\14625458 (r_nsubj) ameliorate_8\VB\126264 (l_dobj) damage_14\NN\7296428
D008694_D020258 NONE methamphetamine_8\NN\2704153 (r_npadvmod) induced_10\VBN\1627355 (r_amod) neurotoxicity_11\NN\0
D008694_D020258 NONE methamphetamine_0\NN\2704153 (l_appos) neurotoxicity_4\NN\0
D008694_D020258 NONE ma)-induced_2\VBN\0 (r_amod) neurotoxicity_4\NN\0
D008694_D020258 NONE ma_34\NNP\10332385 (r_npadvmod) induced_36\VBN\1627355 (r_amod) neurotoxicity_37\NN\0
D003676_D005334 NONE dfo_4\NNP\0 (r_conj) tc_2\NNP\14625458 (r_nsubj) attenuated_5\VBD\224901 (l_dobj) hyperthermia_10\NN\14034177
D024502_D009422 NONE tc_5\NNP\14625458 (r_nsubj) ameliorate_8\VB\126264 (l_dobj) damage_14\NN\7296428
D024502_D020258 NONE tocopherol_4\NN\14724645 (l_conj) deferoxamine_6\NN\0 (l_prep) on_7\IN\0 (l_pobj) neurotoxicity_11\NN\0
D024502_D020258 NONE tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D024502_D020258 NONE tc_12\NNP\14625458 (r_appos) tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D008694_D005334 CID ma_7\NNP\10332385 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperthermia_10\NN\14034177
D010100_D020258 NONE oxygen_19\NN\14622893 (r_compound) species_20\NNS\7992450 (r_pobj) of_17\IN\0 (r_prep) scavenger_16\NN\14779550 (r_appos) tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D007501_D020258 NONE iron_29\NN\14625458 (r_compound) chelator_30\NN\0 (r_appos) tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D024502_D005334 NONE tc_2\NNP\14625458 (r_nsubj) attenuated_5\VBD\224901 (l_dobj) hyperthermia_10\NN\14034177
D003676_D020258 NONE deferoxamine_6\NN\0 (l_prep) on_7\IN\0 (l_pobj) neurotoxicity_11\NN\0
D003676_D020258 NONE deferoxamine_23\NN\0 (r_nmod) dfo_25\NNP\0 (r_conj) scavenger_16\NN\14779550 (r_appos) tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D003676_D020258 NONE dfo_25\NNP\0 (r_conj) scavenger_16\NN\14779550 (r_appos) tocopherol_8\NN\14724645 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (l_prep) on_32\IN\0 (l_pobj) neurotoxicity_37\NN\0
D008694_D009422 CID ma_10\NNP\10332385 (r_npadvmod) induced_12\VBN\1627355 (r_amod) damage_14\NN\7296428
15867025
D006514_D012409 NONE antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (r_pobj) to_38\IN\0 (r_prep) born_37\VBN\0 (r_relcl) infants_34\NNS\9918248 (r_pobj) to_33\IN\0 (r_prep) administration_27\NN\1133281 (r_conj) dose_22\NN\3740161 (r_conj) screening_8\NN\6887726 (l_prep) for_9\IN\0 (l_pobj) b_11\NNP\1355326 (l_conj) rubella_13\NN\14123044
D006514_D012409 NONE antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (l_conj) immunity_48\NN\13920835 (l_compound) rubella_47\NN\14123044
D006514_D012409 NONE antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (l_conj) immunity_48\NN\13920835 (l_conj) administration_51\NN\1133281 (l_prep) of_52\IN\0 (l_pobj) vaccine_58\NN\3562739 (l_compound) rubella_57\NN\14123044
D006514_D012409 NONE antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (r_pobj) to_38\IN\0 (r_prep) born_37\VBN\0 (l_prep) to_59\TO\0 (l_pobj) women_62\NNS\9605289 (l_compound) rubella_60\VB\14123044
D006514_D006509 CID antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (r_pobj) to_38\IN\0 (r_prep) born_37\VBN\0 (r_relcl) infants_34\NNS\9918248 (r_pobj) to_33\IN\0 (r_prep) administration_27\NN\1133281 (r_conj) dose_22\NN\3740161 (r_conj) screening_8\NN\6887726 (l_prep) for_9\IN\0 (l_pobj) b_11\NNP\1355326
D006514_D006509 CID antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (r_pobj) to_38\IN\0 (r_prep) born_37\VBN\0 (r_relcl) infants_34\NNS\9918248 (r_pobj) to_33\IN\0 (r_prep) administration_27\NN\1133281 (r_conj) dose_22\NN\3740161 (l_nsubj) administration_15\NN\1133281 (l_prep) of_16\IN\0 (l_pobj) birth_21\NN\15265518 (l_compound) vaccine_20\NN\3562739 (l_compound) b_19\NNP\1355326
D006514_D006509 CID antigen_42\NN\20090 (r_npadvmod) positive_44\JJ\6321702 (r_amod) mothers_45\NNS\10399491 (r_pobj) to_38\IN\0 (r_prep) born_37\VBN\0 (r_relcl) infants_34\NNS\9918248 (r_pobj) to_33\IN\0 (r_prep) administration_27\NN\1133281 (l_prep) of_28\IN\0 (l_pobj) globulin_32\NN\14736972 (l_compound) b_30\NNP\1355326
D006514_D006509 CID antigen_9\NN\20090 (r_npadvmod) positive_11\JJ\6321702 (r_amod) mothers_12\NNS\10399491 (r_pobj) to_5\IN\0 (r_prep) born_4\VBN\0 (r_relcl) infants_1\NNS\9918248 (r_nsubj) received_14\VBD\2210855 (l_dobj) globulin_18\NN\14736972 (l_compound) b_16\NN\1355326
16471092
C099041_D053201 NONE tolterodine_14\JJ\0 (r_amod) treatment_15\NN\654885 (r_pobj) after_13\IN\0 (r_prep) symptoms_1\NNS\5823932 (l_conj) quality_3\NN\24264 (l_prep) of_4\IN\0 (l_pobj) changes_6\NNS\7283608 (l_prep) with_10\IN\0 (l_pobj) bladder_12\NN\5515670
C099041_D053201 NONE tolterodine_22\JJ\0 (r_amod) treatment_23\NN\654885 (r_pobj) after_21\IN\0 (r_prep) study_3\VB\635850 (l_dobj) symptoms_6\NNS\5823932 (l_conj) quality_8\NN\24264 (l_prep) of_9\IN\0 (l_pobj) changes_11\NNS\7283608 (l_prep) with_15\IN\0 (l_pobj) bladder_17\NN\5515670
C099041_D053201 NONE tolterodine_22\JJ\0 (r_amod) treatment_23\NN\654885 (r_pobj) after_21\IN\0 (r_prep) study_3\VB\635850 (l_dobj) symptoms_6\NNS\5823932 (l_conj) quality_8\NN\24264 (l_prep) of_9\IN\0 (l_pobj) changes_11\NNS\7283608 (l_prep) with_15\IN\0 (l_pobj) bladder_17\NN\5515670 (l_appos) oab_19\NNP\0
C099041_D053201 NONE tolterodine_0\NNP\0 (r_nsubjpass) tolerated_3\VBN\802318 (l_conj) improved_7\VBD\126264 (l_dobj) quality_9\NN\24264 (l_prep) with_15\IN\0 (l_pobj) oab_16\NNP\0
15974569
D005557_D006930 NONE formalin_17\NN\14589223 (r_npadvmod) induced_19\VBN\1627355 (r_amod) licking_21\NN\7291312 (r_pobj) of_16\IN\0 (r_prep) reversal_15\NN\199130 (l_conj) hyperalgesia_27\NN\0
D005557_D006930 NONE formalin_17\NN\14589223 (r_npadvmod) induced_19\VBN\1627355 (r_amod) licking_21\NN\7291312 (r_pobj) of_16\IN\0 (r_prep) reversal_15\NN\199130 (l_conj) hyperalgesia_27\NN\0 (l_conj) hyperalgesia_34\NN\0
D002211_D006930 CID capsaicin_30\NN\15032661 (r_npadvmod) induced_32\VBN\1627355 (r_amod) hyperalgesia_34\NN\0 (r_conj) hyperalgesia_27\NN\0
D002211_D006930 CID capsaicin_30\NN\15032661 (r_npadvmod) induced_32\VBN\1627355 (r_amod) hyperalgesia_34\NN\0
D002351_D006930 CID carrageenan_23\NN\14898470 (r_npadvmod) induced_25\VBN\1627355 (r_amod) hyperalgesia_27\NN\0
D002351_D006930 CID carrageenan_23\NN\14898470 (r_npadvmod) induced_25\VBN\1627355 (r_amod) hyperalgesia_27\NN\0 (l_conj) hyperalgesia_34\NN\0
D002351_D010146 NONE carrageenan_23\NN\14898470 (r_npadvmod) induced_25\VBN\1627355 (r_amod) hyperalgesia_27\NN\0 (r_conj) reversal_15\NN\199130 (r_appos) models_11\NNS\5888929 (l_prep) of_12\IN\0 (l_pobj) pain_13\NN\14299637
D007608_D010146 NONE kainate_7\NN\0 (r_compound) antagonists_9\NNS\7846 (r_compound) actives_10\NNS\14779550 (l_prep) in_11\IN\13603305 (l_pobj) models_14\NNS\5888929 (l_prep) of_15\IN\0 (l_pobj) pain_16\NN\14299637
D005557_D010146 NONE formalin_17\NN\14589223 (r_npadvmod) induced_19\VBN\1627355 (r_amod) licking_21\NN\7291312 (r_pobj) of_16\IN\0 (r_prep) reversal_15\NN\199130 (r_appos) models_11\NNS\5888929 (l_prep) of_12\IN\0 (l_pobj) pain_13\NN\14299637
D002211_D010146 NONE capsaicin_30\NN\15032661 (r_npadvmod) induced_32\VBN\1627355 (r_amod) hyperalgesia_34\NN\0 (r_conj) hyperalgesia_27\NN\0 (r_conj) reversal_15\NN\199130 (r_appos) models_11\NNS\5888929 (l_prep) of_12\IN\0 (l_pobj) pain_13\NN\14299637
6504332
D010634_D004409 CID phenobarbital_0\NN\2792049 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesia_3\NN\14084880
D010634_D004409 CID phenobarbital_15\JJ\2792049 (r_amod) therapy_16\NN\657604 (r_dobj) starting_14\VBG\457382 (r_pcomp) after_13\IN\0 (r_prep) developed_9\VBD\1753788 (l_dobj) dyskinesia_11\JJ\14084880
D010634_D004409 CID phenobarbital_4\JJ\2792049 (r_pobj) with_3\IN\0 (r_prep) challenge_2\NN\13927383 (r_pobj) on_0\IN\0 (r_prep) recurred_8\VBD\339934 (l_nsubj) dyskinesia_7\NN\14084880
D010634_D009069 NONE phenobarbital_0\NN\2792049 (r_nsubjpass) added_3\VBN\156601 (l_prep) to_4\IN\0 (l_pobj) list_6\NN\6637824 (l_prep) of_7\IN\0 (l_pobj) drugs_9\NNS\14778436 (l_relcl) cause_12\VB\7323922 (l_dobj) disorders_14\NNS\14034177
D010634_D012640 NONE phenobarbital_15\JJ\2792049 (r_amod) therapy_16\NN\657604 (l_prep) for_17\IN\0 (l_pobj) seizures_18\NNS\14081375
D010634_D009422 NONE phenobarbital_0\NN\2792049 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesia_3\NN\14084880 (l_prep) in_4\IN\13603305 (l_pobj) child_9\NN\9622049 (l_amod) impaired_8\VBN\258857
D010634_D009422 NONE phenobarbital_15\JJ\2792049 (r_amod) therapy_16\NN\657604 (r_dobj) starting_14\VBG\457382 (r_pcomp) after_13\IN\0 (r_prep) developed_9\VBD\1753788 (l_nsubj) child_4\NN\9622049 (l_prep) with_5\IN\0 (l_pobj) impairment_8\NN\7296428
18356633
D000583_D007674 CID amikacin_3\JJ\0 (r_amod) nephrotoxicity_4\NN\0
D000583_D007674 CID amikacin_2\RB\0 (r_npadvmod) associated_4\VBN\628491 (r_amod) nephrotoxicity_5\NN\0
D000583_D007674 CID amikacin_17\JJ\0 (r_prep) via_16\IN\0 (r_prep) evaluation_13\NN\874067 (r_conj) creatinine_11\NN\0 (r_pobj) in_9\IN\13603305 (r_prep) increase_8\NN\13576355 (r_pobj) of_6\IN\0 (r_prep) means_5\NNS\44150 (r_pobj) by_4\IN\0 (r_prep) occurrence_1\NN\29378 (l_prep) of_2\IN\0 (l_pobj) nephrotoxicity_3\NN\0
D000617_D009369 NONE aminoglycoside_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) treatment_14\NN\654885 (r_dobj) required_13\VBD\0 (r_relcl) disorder_11\NN\14034177
D000583_D009503 NONE amikacin_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) aminoglycoside_3\NN\0 (l_acl) used_5\VBN\0 (l_xcomp) provide_7\VB\2199590 (l_dobj) treatment_13\NN\654885 (l_prep) for_14\IN\0 (l_pobj) neutropenia_16\NN\14196405
D003404_D007674 NONE creatinine_11\NN\0 (r_pobj) in_9\IN\13603305 (r_prep) increase_8\NN\13576355 (r_pobj) of_6\IN\0 (r_prep) means_5\NNS\44150 (r_pobj) by_4\IN\0 (r_prep) occurrence_1\NN\29378 (l_prep) of_2\IN\0 (l_pobj) nephrotoxicity_3\NN\0
D000583_D007239 NONE amikacin_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) aminoglycoside_3\NN\0 (l_acl) used_5\VBN\0 (l_xcomp) provide_7\VB\2199590 (l_dobj) treatment_13\NN\654885 (l_prep) for_14\IN\0 (l_pobj) neutropenia_16\NN\14196405 (l_conj) infections_20\NNS\14052046
D000617_D007239 NONE aminoglycoside_3\NN\0 (l_acl) used_5\VBN\0 (l_xcomp) provide_7\VB\2199590 (l_dobj) treatment_13\NN\654885 (l_prep) for_14\IN\0 (l_pobj) neutropenia_16\NN\14196405 (l_conj) infections_20\NNS\14052046
D000617_D006402 NONE aminoglycoside_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) treatment_14\NN\654885 (r_dobj) required_13\VBD\0 (r_relcl) disorder_11\NN\14034177
D000583_D006402 NONE amikacin_27\JJ\0 (r_pobj) to_20\IN\0 (r_prep) randomized_19\VBN\278117 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) diagnosis_4\NN\152018 (l_amod) consistent_5\JJ\0 (l_prep) with_6\IN\0 (l_pobj) disorder_11\NN\14034177
D000617_D009503 NONE aminoglycoside_3\NN\0 (l_acl) used_5\VBN\0 (l_xcomp) provide_7\VB\2199590 (l_dobj) treatment_13\NN\654885 (l_prep) for_14\IN\0 (l_pobj) neutropenia_16\NN\14196405
D000583_D009369 NONE amikacin_27\JJ\0 (r_pobj) to_20\IN\0 (r_prep) randomized_19\VBN\278117 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) diagnosis_4\NN\152018 (l_amod) consistent_5\JJ\0 (l_prep) with_6\IN\0 (l_pobj) disorder_11\NN\14034177
1564236
D013793_D023921 NONE thallium-201_18\JJ\0 (r_amod) tomography_23\NN\900375 (r_pobj) with_17\IN\0 (r_prep) correlation_16\NN\13841213 (r_appos) observed_4\VBN\2163746 (l_prep) with_5\IN\0 (l_pobj) contrast_7\NN\13854649 (l_prep) to_9\IN\0 (l_pobj) severity_11\NN\5036394 (l_prep) of_12\IN\0 (l_pobj) stenosis_14\NN\14204950
D004176_D023921 NONE dipyridamole_1\NN\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperemia_4\NN\14320394 (r_pobj) during_0\IN\0 (r_prep) had_16\VBD\0 (l_nsubj) 12_6\CD\13745420 (l_prep) of_7\IN\0 (l_pobj) dogs_10\NNS\2083346 (l_prep) with_11\IN\0 (l_pobj) stenosis_15\NN\14204950
D004176_D006940 CID dipyridamole_1\NN\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) hyperemia_4\NN\14320394
D004176_D006940 CID dipyridamole_24\NN\0 (r_npadvmod) induced_26\VBN\1627355 (r_amod) hyperemia_27\NN\14320394
D004176_D006940 CID dipyridamole_11\NN\0 (r_npadvmod) induced_13\VBN\1627355 (r_amod) hyperemia_14\NN\14320394
9305828
D010862_D012640 NONE pilocarpine_1\NN\14712692 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_acl) followed_17\VBN\1835496 (l_agent) by_18\IN\0 (l_pobj) seizures_21\NNS\14081375
D010862_D012640 NONE pilo_3\NNP\0 (r_nmod) model_5\NN\5888929 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_acl) followed_17\VBN\1835496 (l_agent) by_18\IN\0 (l_pobj) seizures_21\NNS\14081375
D010862_D004827 NONE pilocarpine_1\NN\14712692 (r_nsubjpass) characterized_9\VBN\609683 (l_nsubjpass) model_5\NN\5888929 (l_prep) of_6\IN\0 (l_pobj) epilepsy_7\NN\14085708
D010862_D004827 NONE pilo_3\NNP\0 (r_nmod) model_5\NN\5888929 (l_prep) of_6\IN\0 (l_pobj) epilepsy_7\NN\14085708
D010862_D013226 NONE pilocarpine_1\NN\14712692 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_prep) of_14\IN\0 (l_pobj) epilepticus_16\NN\0
D010862_D013226 NONE pilo_3\NNP\0 (r_nmod) model_5\NN\5888929 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_prep) of_14\IN\0 (l_pobj) epilepticus_16\NN\0
D010862_D004833 CID pilocarpine_6\NN\14712692 (r_amod) model_7\NN\5888929 (l_prep) of_8\IN\0 (l_pobj) epilepsy_11\NN\14085708
D010862_D004833 CID pilo_30\NNP\0 (r_amod) model_31\NN\5888929 (l_prep) of_32\IN\0 (l_pobj) tle_33\NNP\0
D010862_D001930 NONE pilocarpine_1\NN\14712692 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_acl) followed_17\VBN\1835496 (l_agent) by_18\IN\0 (l_pobj) seizures_21\NNS\14081375 (l_conj) damage_25\NN\7296428
D010862_D001930 NONE pilo_3\NNP\0 (r_nmod) model_5\NN\5888929 (r_nsubjpass) characterized_9\VBN\609683 (l_agent) by_10\IN\0 (l_pobj) period_13\NN\13575869 (l_acl) followed_17\VBN\1835496 (l_agent) by_18\IN\0 (l_pobj) seizures_21\NNS\14081375 (l_conj) damage_25\NN\7296428
7791169
D016595_D010146 NONE misoprostol_2\NNP\0 (r_pobj) of_1\IN\0 (r_prep) addition_0\NN\3081021 (r_nsubj) minimize_4\VB\441445 (l_prep) without_8\IN\0 (l_pcomp) affecting_9\VBG\126264 (l_dobj) control_11\NN\5190804 (l_compound) pain_10\NN\14299637
D016595_D007674 NONE misoprostol_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubj) induced_6\VBD\1627355 (l_dobj) dysfunction_8\NN\14204950
D016595_D007674 NONE misoprostol_2\NNP\0 (r_pobj) of_1\IN\0 (r_prep) addition_0\NN\3081021 (r_nsubj) minimize_4\VB\441445 (l_dobj) impairment_7\NN\7296428
D007213_D007674 CID indomethacin_5\NN\3828465 (r_pobj) on_4\IN\0 (r_prep) misoprostol_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubj) induced_6\VBD\1627355 (l_dobj) dysfunction_8\NN\14204950
D007213_D007674 CID indomethacin_8\NN\3828465 (r_nmod) dysfunction_11\NN\14204950
2021202
D007530_D007022 CID isoflurane_6\RB\3570838 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypotension_9\NN\14057371
D007530_D007022 CID isoflurane_3\RB\3570838 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hypotension_6\NN\14057371
D007530_D007022 CID isoflurane_11\NN\3570838 (r_amod) concentration_13\NN\4916342 (r_dobj) increasing_9\VBG\169651 (r_pcomp) by_8\IN\0 (r_prep) induced_2\VBN\1627355 (l_nsubjpass) hypotension_0\NNP\14057371
D007530_D007022 CID isoflurane_9\RB\3570838 (r_npadvmod) induced_11\VBN\1627355 (r_amod) hypotension_12\NN\14057371
17285209
D000809_D000799 NONE angiotensin_3\NN\4522421 (r_npadvmod) converting_5\VBG\126264 (r_amod) enzyme_6\NN\14723628 (r_pobj) of_2\IN\0 (r_prep) recognition_1\NN\13932421 (r_nsubj) constitutes_19\VBZ\0 (l_nsubj) angioedema_18\NN\14316714
D000809_D000799 NONE angiotensin_11\NN\4522421 (r_compound) blocker_13\NN\10101634 (r_conj) enzyme_6\NN\14723628 (r_pobj) of_2\IN\0 (r_prep) recognition_1\NN\13932421 (r_nsubj) constitutes_19\VBZ\0 (l_nsubj) angioedema_18\NN\14316714
D000809_D007410 NONE angiotensin_3\NN\4522421 (r_npadvmod) converting_5\VBG\126264 (r_amod) enzyme_6\NN\14723628 (r_pobj) of_2\IN\0 (r_prep) recognition_1\NN\13932421 (r_nsubj) constitutes_19\VBZ\0 (l_nsubj) angioedema_18\NN\14316714
D000809_D007410 NONE angiotensin_11\NN\4522421 (r_compound) blocker_13\NN\10101634 (r_conj) enzyme_6\NN\14723628 (r_pobj) of_2\IN\0 (r_prep) recognition_1\NN\13932421 (r_nsubj) constitutes_19\VBZ\0 (l_nsubj) angioedema_18\NN\14316714
C044946_D006973 NONE benazapril_28\NN\0 (r_compound) mg._30\CD\0 (r_appos) pill_24\NN\4424218 (r_pobj) on_21\IN\0 (r_prep) started_20\VBN\0 (r_relcl) female_12\NN\15388 (l_prep) with_13\IN\0 (l_pobj) hypertension_16\NN\14057371
D017311_D006973 NONE amlodipine_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) pill_24\NN\4424218 (r_pobj) on_21\IN\0 (r_prep) started_20\VBN\0 (r_relcl) female_12\NN\15388 (l_prep) with_13\IN\0 (l_pobj) hypertension_16\NN\14057371
7752389
D011453_D053201 NONE prostanoids_0\NNS\0 (r_nsubj) contribute_8\VBP\126264 (l_prep) to_9\IN\0 (l_pobj) urge_11\VB\23773 (l_conj) hyperactivity_14\NN\14052403
D015232_D053201 CID e2-induced_1\JJ\0 (r_amod) hyperactivity_3\NN\14052403
D015320_D053201 NONE tachykinins_12\NNS\0 (r_pobj) of_11\IN\0 (r_prep) involvement_10\NN\1080366 (r_appos) rats_8\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) hyperactivity_3\NN\14052403
D015320_D053201 NONE tachykinins_6\NNS\0 (r_pobj) of_5\IN\0 (r_prep) release_4\NN\3748886 (r_pobj) via_3\IN\0 (r_prep) contribute_8\VBP\126264 (l_prep) to_9\IN\0 (l_pobj) urge_11\VB\23773 (l_conj) hyperactivity_14\NN\14052403
12907924
D008774_D000544 NONE methylphenidate_18\NN\4320126 (r_pobj) on_17\IN\0 (r_prep) started_16\VBN\0 (l_nsubjpass) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) depression_9\NN\14373582 (l_conj) disease_14\NN\14061805
D008774_D009771 CID methylphenidate_0\NNP\4320126 (r_npadvmod) induced_2\VBN\1627355 (r_amod) symptoms_6\NNS\5823932
D008774_D009771 CID methylphenidate_12\NN\4320126 (r_nsubjpass) replaced_14\VBN\1631072 (r_advcl) diminished_7\VBN\169651 (r_conj) ensued_5\VBD\2633881 (l_nsubj) behavior_4\NN\407535
D016666_D009771 NONE fluvoxamine_16\NN\0 (r_pobj) by_15\IN\0 (r_agent) replaced_14\VBN\1631072 (r_advcl) diminished_7\VBN\169651 (r_conj) ensued_5\VBD\2633881 (l_nsubj) behavior_4\NN\407535
D008774_D061218 NONE methylphenidate_18\NN\4320126 (r_pobj) on_17\IN\0 (r_prep) started_16\VBN\0 (l_nsubjpass) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) depression_9\NN\14373582
8643973
D017239_D010051 NONE paclitaxel_0\NNP\0 (l_acl) combined_1\VBD\2630189 (l_prep) in_4\IN\13603305 (l_pobj) treatment_9\NN\654885 (l_prep) of_10\IN\0 (l_pobj) cancer_13\NN\14239425
D017239_D010051 NONE paclitaxel_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) dose_10\NN\3740161 (r_dobj) determine_6\VB\0 (l_prep) given_26\VBN\5892096 (l_prep) as_27\IN\14622893 (l_pobj) infusion_30\NN\14589223 (l_acl) administered_35\VBN\2436349 (l_prep) to_39\IN\0 (l_pobj) women_40\NNS\9605289 (l_prep) with_41\IN\0 (l_pobj) cancer_44\NN\14239425
D017239_D010051 NONE taxol_14\NNP\0 (r_appos) dose_10\NN\3740161 (r_dobj) determine_6\VB\0 (l_prep) given_26\VBN\5892096 (l_prep) as_27\IN\14622893 (l_pobj) infusion_30\NN\14589223 (l_acl) administered_35\VBN\2436349 (l_prep) to_39\IN\0 (l_pobj) women_40\NNS\9605289 (l_prep) with_41\IN\0 (l_pobj) cancer_44\NN\14239425
D017239_D010051 NONE paclitaxel_46\NN\0 (r_compound) doses_47\NNS\3740161 (r_nsubjpass) escalated_49\VBN\153263 (r_conj) study_4\VBP\635850 (l_xcomp) determine_6\VB\0 (l_prep) given_26\VBN\5892096 (l_prep) as_27\IN\14622893 (l_pobj) infusion_30\NN\14589223 (l_acl) administered_35\VBN\2436349 (l_prep) to_39\IN\0 (l_pobj) women_40\NNS\9605289 (l_prep) with_41\IN\0 (l_pobj) cancer_44\NN\14239425
D016190_D010051 NONE carboplatin_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) combined_1\VBD\2630189 (l_prep) in_4\IN\13603305 (l_pobj) treatment_9\NN\654885 (l_prep) of_10\IN\0 (l_pobj) cancer_13\NN\14239425
D016190_D010051 NONE carboplatin_34\NN\0 (r_pobj) with_33\IN\0 (r_prep) combination_32\NN\7951464 (r_pobj) in_31\IN\13603305 (r_prep) infusion_30\NN\14589223 (l_acl) administered_35\VBN\2436349 (l_prep) to_39\IN\0 (l_pobj) women_40\NNS\9605289 (l_prep) with_41\IN\0 (l_pobj) cancer_44\NN\14239425
11912119
D007980_D004409 CID levodopa_3\RB\14604959 (r_npadvmod) induced_5\VBN\1627355 (r_amod) dyskinesias_6\NNS\14084880
D007980_D004409 CID levodopa_18\NN\14604959 (r_compound) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) complications_16\NNS\1073995 (r_pobj) to_14\IN\0 (r_prep) relationship_13\NN\31921 (r_conj) disease_10\NN\14061805 (r_pobj) in_7\IN\13603305 (r_prep) assessed_1\VBD\670261 (l_prep) to_22\IN\0 (l_pobj) dyskinesias_26\NNS\14084880
D007980_D004409 CID levodopa_18\NN\14604959 (r_compound) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) complications_16\NNS\1073995 (r_pobj) to_14\IN\0 (r_prep) relationship_13\NN\31921 (r_conj) disease_10\NN\14061805 (r_pobj) in_7\IN\13603305 (r_prep) assessed_1\VBD\670261 (l_prep) to_22\IN\0 (l_pobj) dyskinesias_26\NNS\14084880 (l_appos) lid_28\NNP\5313679
D007980_D004409 CID levodopa_23\VB\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880
D007980_D004409 CID levodopa_23\VB\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (l_appos) lid_28\NNP\5313679
D007980_D004409 CID levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (r_pobj) without_22\IN\0 (r_conj) with_9\IN\0 (l_pobj) disease_13\NN\14061805 (l_conj) lid_15\NNP\5313679
D007980_D004409 CID levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880
D007980_D004409 CID levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (l_appos) lid_32\NNP\5313679
D007980_D004409 CID levodopa_28\RB\14604959 (r_dobj) assessed_24\VBN\670261 (l_nsubjpass) score_2\NN\5736149 (l_prep) of_3\IN\0 (l_pobj) scale_10\NNP\7260623 (l_appos) score_14\NN\5736149 (l_compound) dyskinesia_13\JJ\14084880
D007980_D004409 CID levodopa_21\NN\14604959 (r_pobj) by_20\IN\0 (r_agent) increased_19\VBN\169651 (l_prep) in_0\IN\13603305 (l_pobj) disease_3\NN\14061805 (l_conj) lid_5\NNP\5313679
D007980_D010300 NONE levodopa_3\RB\14604959 (r_npadvmod) induced_5\VBN\1627355 (r_amod) dyskinesias_6\NNS\14084880 (l_prep) in_7\IN\13603305 (l_pobj) disease_10\NN\14061805
D007980_D010300 NONE levodopa_18\NN\14604959 (r_compound) therapy_19\NN\657604 (r_pobj) of_17\IN\0 (r_prep) complications_16\NNS\1073995 (r_pobj) to_14\IN\0 (r_prep) relationship_13\NN\31921 (r_conj) disease_10\NN\14061805
D007980_D010300 NONE levodopa_23\VB\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (r_pobj) to_22\IN\0 (r_prep) assessed_1\VBD\670261 (l_prep) in_7\IN\13603305 (l_pobj) disease_10\NN\14061805
D007980_D010300 NONE levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (r_pobj) without_22\IN\0 (r_conj) with_9\IN\0 (r_prep) studied_1\VBD\0 (l_dobj) groups_3\NNS\2137 (l_prep) of_4\IN\0 (l_pobj) patients_8\NNS\9898892 (l_compound) disease_7\NN\14061805
D007980_D010300 NONE levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (r_pobj) without_22\IN\0 (r_conj) with_9\IN\0 (l_pobj) disease_13\NN\14061805
D007980_D010300 NONE levodopa_23\NN\14604959 (r_npadvmod) induced_25\VBN\1627355 (r_amod) dyskinesias_26\NNS\14084880 (l_appos) lid_32\NNP\5313679 (l_compound) disease_30\NN\14061805
D007980_D010300 NONE levodopa_28\RB\14604959 (r_dobj) assessed_24\VBN\670261 (l_nsubjpass) score_2\NN\5736149 (l_prep) of_3\IN\0 (l_pobj) scale_10\NNP\7260623 (l_compound) rating_9\NNP\5733583 (l_compound) disease_8\NNP\14061805
D007980_D010300 NONE levodopa_21\NN\14604959 (r_pobj) by_20\IN\0 (r_agent) increased_19\VBN\169651 (l_prep) in_0\IN\13603305 (l_pobj) disease_3\NN\14061805
3108839
D016685_D013274 NONE c_29\NN\13714184 (r_pobj) with_27\IN\0 (r_prep) treatment_26\NN\654885 (r_pobj) on_25\IN\0 (r_advcl) describe_1\VBP\1001294 (l_prep) in_8\IN\13603305 (l_pobj) man_14\NN\9605289 (l_prep) with_15\IN\0 (l_pobj) adenocarcinoma_17\NN\14242337
D016685_D000743 NONE c_15\NN\13714184 (r_compound) treatment_16\NN\654885 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_acl) failure_11\NN\66216 (r_conj) thrombocytopenia_7\JJ\14189204 (r_conj) anemia_5\NN\14189204
D016685_D011654 NONE c_14\NN\13714184 (r_compound) treatment_15\NN\654885 (r_pobj) of_12\IN\0 (r_prep) start_11\NN\7290905 (r_pobj) after_10\IN\0 (r_prep) develops_4\VBZ\1753788 (l_conj) is_19\VBZ\0 (l_attr) %_22\NN\0 (l_prep) from_23\IN\0 (l_pobj) failure_25\NN\66216 (l_conj) edema_28\NN\14315192
D016685_D011654 NONE c_29\NN\13714184 (r_pobj) with_27\IN\0 (r_prep) treatment_26\NN\654885 (r_pobj) on_25\IN\0 (r_advcl) describe_1\VBP\1001294 (l_conj) died_31\VBD\146138 (l_prep) in_32\IN\13603305 (l_pobj) edema_34\NN\14315192
D016685_D006463 CID c_1\NNP\13714184 (r_nsubj) associated_2\VBD\628491 (l_dobj) syndrome_5\NN\5870365
D016685_D006463 CID c_1\NNP\13714184 (r_nsubj) associated_2\VBD\628491 (l_dobj) syndrome_5\NNP\5870365
D016685_D006463 CID c_1\NNP\13714184 (r_nsubj) associated_2\VBD\628491 (l_dobj) syndrome_5\NNP\5870365 (l_appos) hus_7\NNP\0
D016685_D051437 CID c_15\NN\13714184 (r_compound) treatment_16\NN\654885 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_acl) failure_11\NN\66216
D016685_D051437 CID c_14\NN\13714184 (r_compound) treatment_15\NN\654885 (r_pobj) of_12\IN\0 (r_prep) start_11\NN\7290905 (r_pobj) after_10\IN\0 (r_prep) develops_4\VBZ\1753788 (l_nsubj) failure_2\NN\66216
D016685_D051437 CID c_14\NN\13714184 (r_compound) treatment_15\NN\654885 (r_pobj) of_12\IN\0 (r_prep) start_11\NN\7290905 (r_pobj) after_10\IN\0 (r_prep) develops_4\VBZ\1753788 (l_conj) is_19\VBZ\0 (l_attr) %_22\NN\0 (l_prep) from_23\IN\0 (l_pobj) failure_25\NN\66216
D016685_D051437 CID c_29\NN\13714184 (r_pobj) with_27\IN\0 (r_prep) treatment_26\NN\654885 (r_pobj) on_25\IN\0 (r_advcl) describe_1\VBP\1001294 (l_prep) in_8\IN\13603305 (l_pobj) man_14\NN\9605289 (l_relcl) developed_19\VBD\1753788 (l_dobj) failure_21\NN\66216
D016685_D013921 NONE c_15\NN\13714184 (r_compound) treatment_16\NN\654885 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_acl) failure_11\NN\66216 (r_conj) thrombocytopenia_7\JJ\14189204
D016685_D013921 NONE c_29\NN\13714184 (r_pobj) with_27\IN\0 (r_prep) treatment_26\NN\654885 (r_pobj) on_25\IN\0 (r_advcl) describe_1\VBP\1001294 (l_prep) in_8\IN\13603305 (l_pobj) man_14\NN\9605289 (l_relcl) developed_19\VBD\1753788 (l_conj) thrombocytopenia_23\NN\14189204
17682013
D008727_D002544 NONE methotrexate_21\NN\2722166 (r_pobj) of_19\IN\0 (r_prep) recipients_18\NNS\9764201 (r_pobj) in_17\IN\13603305 (r_prep) described_8\VBN\1001294 (l_nsubjpass) leukoencephalopathy_2\JJ\0 (l_acl) mimicking_3\VBG\1742886 (l_dobj) accident_5\NN\7314427
D008727_D056784 CID methotrexate_21\NN\2722166 (r_pobj) of_19\IN\0 (r_prep) recipients_18\NNS\9764201 (r_pobj) in_17\IN\13603305 (r_prep) described_8\VBN\1001294 (l_nsubjpass) leukoencephalopathy_2\JJ\0
D008727_D056784 CID methotrexate_12\NNP\2722166 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (r_acl) patients_9\NNS\9898892 (r_pobj) in_8\IN\13603305 (r_prep) leukoencephalopathy_7\JJ\0
C017367_D056784 CID carmofur_23\NN\0 (r_conj) identified_2\VBD\699815 (l_dobj) reports_4\NNS\6470073 (l_prep) of_5\IN\0 (l_pobj) leukoencephalopathy_7\JJ\0
D005472_D056784 CID 5-fluorouracil_19\CD\0 (r_punct) identified_2\VBD\699815 (l_dobj) reports_4\NNS\6470073 (l_prep) of_5\IN\0 (l_pobj) leukoencephalopathy_7\JJ\0
C110904_D056784 CID capecitabine_26\NN\0 (r_conj) carmofur_23\NN\0 (r_conj) identified_2\VBD\699815 (l_dobj) reports_4\NNS\6470073 (l_prep) of_5\IN\0 (l_pobj) leukoencephalopathy_7\JJ\0
D008727_D007938 NONE methotrexate_21\NN\2722166 (l_prep) for_22\IN\0 (l_pobj) leukaemia_24\NN\14239918
6216862
D010396_D006527 NONE penicillamine_32\NN\3740161 (r_pobj) with_31\IN\0 (r_prep) treated_30\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) in_25\IN\13603305 (r_conj) reported_11\VBN\831651 (l_prep) as_12\IN\14622893 (l_pobj) effect_16\NN\34213 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) disease_22\NN\14061805
D010396_D017285 CID penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (r_pobj) as_17\IN\14622893 (r_prep) recorded_16\VBN\2225492 (l_nsubjpass) rashes_1\NNS\14321469 (l_conj) proteinuria_3\NN\14299637 (l_conj) erythematosus_7\NN\0 (l_conj) polymyositis_9\NN\14350292
D010396_D005076 CID penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (r_pobj) as_17\IN\14622893 (r_prep) recorded_16\VBN\2225492 (l_nsubjpass) rashes_1\NNS\14321469
D010396_D001172 NONE penicillamine_4\NN\3740161 (r_compound) therapy_5\NN\657604 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) in_6\IN\13603305 (l_pobj) patient_8\NN\9898892 (l_prep) with_9\IN\0 (l_pobj) arthritis_11\NN\14171682
D010396_D001172 NONE penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (l_prep) in_22\IN\13603305 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) arthritis_26\NN\14171682
D010396_D001172 NONE penicillamine_32\NN\3740161 (r_pobj) with_31\IN\0 (r_prep) treated_30\VBN\2376958 (r_acl) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) arthritis_29\NN\14171682
D010396_D012871 NONE penicillamine_32\NN\3740161 (r_pobj) with_31\IN\0 (r_prep) treated_30\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) in_25\IN\13603305 (r_conj) reported_11\VBN\831651 (r_relcl) serpiginosa_6\NN\0 (r_dobj) resembled_3\VBD\2657219 (l_nsubj) lesion_2\NN\14204950
D010396_D011507 CID penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (r_pobj) as_17\IN\14622893 (r_prep) recorded_16\VBN\2225492 (l_nsubjpass) rashes_1\NNS\14321469 (l_conj) proteinuria_3\NN\14299637
D010396_D008180 CID penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (r_pobj) as_17\IN\14622893 (r_prep) recorded_16\VBN\2225492 (l_nsubjpass) rashes_1\NNS\14321469 (l_conj) proteinuria_3\NN\14299637 (l_conj) erythematosus_7\NN\0
D010396_C536202 NONE penicillamine_32\NN\3740161 (r_pobj) with_31\IN\0 (r_prep) treated_30\VBN\2376958 (r_acl) patients_26\NNS\9898892 (r_pobj) in_25\IN\13603305 (r_conj) reported_11\VBN\831651 (r_relcl) serpiginosa_6\NN\0
D010396_D009157 CID penicillamine_20\NN\3740161 (r_compound) therapy_21\NN\657604 (r_pobj) of_19\IN\0 (r_prep) complications_18\NNS\1073995 (r_pobj) as_17\IN\14622893 (r_prep) recorded_16\VBN\2225492 (l_nsubjpass) rashes_1\NNS\14321469 (l_conj) proteinuria_3\NN\14299637 (l_conj) erythematosus_7\NN\0 (l_conj) polymyositis_9\NN\14350292 (l_conj) gravis_12\NN\0
9636837
D016190_D010523 CID cbdca_5\NNP\0 (r_nmod) schedules_9\NNS\5898568 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (r_nsubj) cause_20\VB\7323922 (l_dobj) concern_22\NN\5682950 (l_prep) about_23\IN\0 (l_pobj) safety_25\NN\13920835 (l_prep) with_26\IN\0 (l_pobj) respect_27\NN\5817845 (l_prep) to_28\IN\0 (l_pobj) damage_32\NN\7296428
D016190_D010523 CID cbdca_0\JJ\0 (r_compound) administration_1\NN\1133281 (r_nsubj) induced_2\VBD\1627355 (l_dobj) neurotoxicity_7\NN\0
D016190_D020258 NONE carboplatin_4\NN\0 (r_poss) advantages_6\NNS\5154517 (r_pobj) of_3\IN\0 (r_prep) striking_2\JJ\7283608 (r_nsubj) is_15\VBZ\0 (l_attr) rate_19\NN\13815152 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_amod) neurotoxic_21\JJ\0
D016190_D020258 NONE cbdca_8\NNP\0 (r_appos) advantages_6\NNS\5154517 (r_pobj) of_3\IN\0 (r_prep) striking_2\JJ\7283608 (r_nsubj) is_15\VBZ\0 (l_attr) rate_19\NN\13815152 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_amod) neurotoxic_21\JJ\0
D016190_D020258 NONE cbdca_5\NNP\0 (r_nmod) schedules_9\NNS\5898568 (l_conj) association_12\NN\8008335 (l_prep) with_13\IN\0 (l_pobj) drugs_16\NNS\14778436 (l_amod) neurotoxic_15\JJ\0
D016190_D020258 NONE cbdca_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_acomp) neurotoxic_2\JJ\0
D016190_D020258 NONE cbdca_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_conj) are_15\VBP\13600404 (l_ccomp) is_26\VBZ\0 (l_ccomp) induced_31\VBN\1627355 (l_nsubjpass) neurotoxicity_29\NN\0
D002945_D020258 NONE cisplatin_11\NN\0 (r_nmod) cddp_13\NNP\0 (r_pobj) over_10\IN\5867413 (r_prep) striking_2\JJ\7283608 (r_nsubj) is_15\VBZ\0 (l_attr) rate_19\NN\13815152 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_amod) neurotoxic_21\JJ\0
D002945_D020258 NONE cddp_13\NNP\0 (r_pobj) over_10\IN\5867413 (r_prep) striking_2\JJ\7283608 (r_nsubj) is_15\VBZ\0 (l_attr) rate_19\NN\13815152 (l_prep) of_20\IN\0 (l_pobj) effects_22\NNS\13245626 (l_amod) neurotoxic_21\JJ\0
D002945_D020258 NONE cddp_23\NNP\0 (r_pobj) by_22\IN\0 (r_agent) caused_21\VBN\1617192 (r_acl) those_20\DT\0 (r_pobj) to_19\IN\0 (r_prep) similar_18\JJ\0 (r_acomp) are_15\VBP\13600404 (r_conj) is_1\VBZ\0 (l_acomp) neurotoxic_2\JJ\0
D002945_D020258 NONE cddp_23\NNP\0 (r_pobj) by_22\IN\0 (r_agent) caused_21\VBN\1617192 (r_acl) those_20\DT\0 (r_pobj) to_19\IN\0 (r_prep) similar_18\JJ\0 (r_acomp) are_15\VBP\13600404 (l_ccomp) is_26\VBZ\0 (l_ccomp) induced_31\VBN\1627355 (l_nsubjpass) neurotoxicity_29\NN\0
1728915
D002220_D062787 NONE carbamazepine_12\NN\0 (r_compound) overdose_13\NN\84738
D002220_D001523 NONE carbamazepine_1\NN\0 (r_nsubjpass) used_4\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) conditions_13\NNS\14512817 (l_amod) neurologic_10\JJ\0 (l_conj) psychiatric_12\JJ\0
D002220_D013616 CID carbamazepine_12\NN\0 (r_compound) overdose_13\NN\84738 (r_pobj) of_9\IN\0 (r_prep) setting_8\NN\8567235 (r_pobj) in_6\IN\13603305 (r_prep) developed_3\VBD\1753788 (l_dobj) tachycardias_5\NNS\14110674
D002220_D001919 CID carbamazepine_11\NN\0 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) bradycardia_4\NNP\14110674
D002220_D001919 CID carbamazepine_28\NN\0 (r_compound) levels_30\NNS\4916342 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_advcl) consisted_3\VBD\2603699 (l_advmod) exclusively_5\RB\0 (l_prep) of_6\IN\0 (l_pobj) women_8\NNS\9605289 (l_relcl) developed_10\VBD\1753788 (l_dobj) bradyarrhythmias_15\NNS\0
D002220_D054537 CID carbamazepine_11\NN\0 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) bradycardia_4\NNP\14110674 (l_conj) block_7\NN\21939
D002220_D054537 CID carbamazepine_28\NN\0 (r_compound) levels_30\NNS\4916342 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_advcl) consisted_3\VBD\2603699 (l_advmod) exclusively_5\RB\0 (l_prep) of_6\IN\0 (l_pobj) women_8\NNS\9605289 (l_relcl) developed_10\VBD\1753788 (l_dobj) bradyarrhythmias_15\NNS\0 (l_conj) delay_19\NN\15271008
D002220_D006331 NONE carbamazepine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dysfunction_4\NN\14204950
D002220_D006331 NONE carbamazepine_11\NN\0 (r_npadvmod) associated_13\VBN\628491 (r_amod) dysfunction_15\NN\14204950
6323692
D009020_D000699 NONE morphine_11\NN\2707683 (r_appos) pretreatment_9\NN\0 (r_conj) verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0
D014700_D000699 NONE verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0
D014700_D000699 NONE verapamil_29\NN\2938514 (r_nsubj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0
D002118_D022124 NONE calcium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_dobj) exerts_5\VBZ\1158872 (l_nsubj) hyperammonemia_4\NN\0
D000079_D003866 NONE acetaldehyde_18\NN\14584765 (r_pobj) by_17\IN\0 (r_prep) release_16\NN\3748886 (r_nsubjpass) blocked_21\VBN\1476483 (r_conj) reversed_4\VBD\109660 (l_dobj) depression_6\NN\14373582
D003975_D000699 NONE diazepam_14\NN\2830852 (r_npadvmod) induced_16\VBN\1627355 (r_amod) incoordination_18\NN\5648247 (r_conj) analgesia-_12\JJ\0
D002395_D003866 NONE catecholamine_15\NN\5407119 (r_compound) release_16\NN\3748886 (r_nsubjpass) blocked_21\VBN\1476483 (r_conj) reversed_4\VBD\109660 (l_dobj) depression_6\NN\14373582
C018824_D003866 NONE nh4ac_23\NNPS\0 (r_pobj) by_22\IN\0 (r_agent) blocked_21\VBN\1476483 (r_conj) reversed_4\VBD\109660 (l_dobj) depression_6\NN\14373582
D014700_D001259 NONE verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
D014700_D001259 NONE verapamil_29\NN\2938514 (r_nsubj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
D010433_D000699 NONE metrazol_37\NN\3740161 (r_pobj) of_36\IN\0 (r_prep) action_35\NN\30358 (r_dobj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0
D000661_D000699 NONE amphetamine_21\NN\3248958 (r_npadvmod) induced_23\VBN\1627355 (r_amod) activity_25\NN\30358 (r_dobj) antagonized_20\VBN\1787955 (r_conj) analgesia-_12\JJ\0
D010433_D001259 NONE metrazol_37\NN\3740161 (r_pobj) of_36\IN\0 (r_prep) action_35\NN\30358 (r_dobj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
C018824_D000699 NONE nh4ac_8\NNP\0 (r_nmod) pretreatment_9\NN\0 (r_conj) verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0
C018824_D000699 NONE nh4ac_31\NNP\0 (r_conj) verapamil_29\NN\2938514 (r_nsubj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0
C018824_D001259 CID acetate_3\NN\15010703 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) doubled_15\VBD\247390 (l_npadvmod) time_17\NN\7308889 (l_relcl) remained_22\VBD\2604760 (l_conj) incoordination_31\NN\5648247
C018824_D001259 CID nh4ac_5\NNP\0 (r_appos) acetate_3\NN\15010703 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) doubled_15\VBD\247390 (l_npadvmod) time_17\NN\7308889 (l_relcl) remained_22\VBD\2604760 (l_conj) incoordination_31\NN\5648247
C018824_D001259 CID nh4ac_36\NNP\0 (r_compound) treatment_37\NN\654885 (r_nsubj) had_39\VBD\0 (r_conj) remained_22\VBD\2604760 (l_conj) incoordination_31\NN\5648247
C018824_D001259 CID nh4ac_8\NNP\0 (r_nmod) pretreatment_9\NN\0 (r_conj) verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
C018824_D001259 CID nh4ac_31\NNP\0 (r_conj) verapamil_29\NN\2938514 (r_nsubj) affected_32\VBD\126264 (r_conj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
D009020_D001259 NONE morphine_18\NN\2707683 (r_npadvmod) treated_20\VBN\2376958 (r_amod) mice_21\NNS\2329401 (r_nsubj) remained_22\VBD\2604760 (l_conj) incoordination_31\NN\5648247
D009020_D001259 NONE morphine_11\NN\2707683 (r_appos) pretreatment_9\NN\0 (r_conj) verapamil_1\NN\2938514 (r_nsubj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
D000661_D001259 NONE amphetamine_21\NN\3248958 (r_npadvmod) induced_23\VBN\1627355 (r_amod) activity_25\NN\30358 (r_dobj) antagonized_20\VBN\1787955 (r_conj) analgesia-_12\JJ\0 (l_conj) incoordination_18\NN\5648247
D003975_D001259 CID diazepam_33\NN\2830852 (r_pobj) by_32\IN\0 (r_prep) incoordination_31\NN\5648247
D003975_D001259 CID diazepam_14\NN\2830852 (r_npadvmod) induced_16\VBN\1627355 (r_amod) incoordination_18\NN\5648247
D002118_D003866 NONE calcium_3\NN\14625458 (r_pobj) of_1\IN\0 (r_prep) addition_0\NN\3081021 (r_nsubj) reversed_4\VBD\109660 (l_dobj) depression_6\NN\14373582
D002118_D003866 NONE calcium_12\NN\14625458 (r_npadvmod) independent_14\JJ\9619824 (r_amod) release_16\NN\3748886 (r_nsubjpass) blocked_21\VBN\1476483 (r_conj) reversed_4\VBD\109660 (l_dobj) depression_6\NN\14373582
7072798
D002701_D001855 NONE chloramphenicol_13\NN\2716866 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_pobj) after_9\IN\0 (r_prep) report_4\NN\6470073 (r_attr) was_1\VBD\0 (l_advcl) reported_29\VBN\831651 (l_nsubjpass) cases_20\NNS\7283608 (l_prep) of_21\IN\0 (l_pobj) hypoplasia_25\NN\14365950
D002701_D002386 NONE chloramphenicol_22\NN\2716866 (r_pobj) with_21\IN\0 (r_prep) therapy_20\NN\657604 (r_dobj) beginning_18\VBG\7283608 (r_conj) undergoing_14\VBG\109660 (l_dobj) extraction_16\NN\13518963 (l_compound) cataract_15\NN\14252864
D002701_D005128 NONE chloramphenicol_11\NN\2716866 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_acl) toxicity_6\NN\13576101
D002701_D000741 CID chloramphenicol_8\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) following_3\VBG\8180190 (r_prep) anemia_2\NN\14189204
D002701_D000741 CID chloramphenicol_22\NN\2716866 (r_pobj) with_21\IN\0 (r_prep) therapy_20\NN\657604 (r_dobj) beginning_18\VBG\7283608 (r_conj) undergoing_14\VBG\109660 (r_pcomp) after_13\IN\0 (r_prep) died_5\VBD\146138 (l_prep) of_6\IN\0 (l_pobj) anemia_8\NN\14189204
D002701_D000741 CID chloramphenicol_13\NN\2716866 (r_acl) response_11\NN\11410625 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (l_nsubjpass) pattern_1\NN\5726345 (l_prep) of_2\IN\0 (l_pobj) anemia_5\NN\14189204
D002701_D000741 CID chloramphenicol_13\NN\2716866 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_pobj) after_9\IN\0 (r_prep) report_4\NN\6470073 (l_prep) of_5\IN\0 (l_pobj) anemia_8\NN\14189204
8441146
D010396_D000741 CID penicillamine_19\NN\3740161 (r_conj) case_15\NN\7283608 (r_pobj) in_13\IN\13603305 (r_prep) caused_10\VBN\1617192 (r_relcl) anemia_7\NN\14189204
D006046_D000741 CID gold_12\NN\13371489 (r_pobj) by_11\IN\0 (r_agent) caused_10\VBN\1617192 (r_relcl) anemia_7\NN\14189204
8911359
D003520_D014523 NONE cyclophosphamide_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) etiology_7\NN\7326557 (r_pobj) of_5\IN\0 (r_prep) knowledge_4\NN\23100 (r_dobj) gained_3\VBD\2238085 (l_dobj) cancer_16\NN\14239425
D003520_D001749 CID cyclophosphamide_0\NN\0 (r_nmod) cancer_3\NN\14239425
D003520_D001749 CID cyclophosphamide_17\NN\0 (r_pobj) with_16\IN\0 (l_pobj) cancer_20\NN\14239425
D003520_D001749 CID cyclophosphamide_0\NN\0 (r_nmod) tumor_3\NN\14234074
10193809
D011692_D011507 CID aminonucleoside_1\NN\0 (r_amod) puromycin_0\NNP\0 (r_nsubjpass) administered_6\VBN\2436349 (l_advcl) induce_12\VB\1627355 (l_dobj) proteinuria_13\NN\14299637
D011692_D011507 CID pan_3\NNP\3101986 (r_appos) aminonucleoside_1\NN\0 (r_amod) puromycin_0\NNP\0 (r_nsubjpass) administered_6\VBN\2436349 (l_advcl) induce_12\VB\1627355 (l_dobj) proteinuria_13\NN\14299637
3780814
D010634_D011230 NONE pb_22\NNP\14625458 (r_nsubjpass) given_24\VBN\5892096 (r_advcl) reduced_20\VBN\441445 (l_nsubjpass) number_8\NN\5107765 (l_conj) size_11\NN\5090441 (l_prep) of_12\IN\0 (l_pcomp) induced_13\VBN\1627355 (l_dobj) foci_17\NN\5704266
D010634_D063646 NONE phenobarbital_5\JJ\2792049 (r_pobj) of_4\IN\0 (r_prep) action_3\NN\30358 (l_amod) carcinogenic_2\JJ\0
D010634_D063646 NONE phenobarbital_13\JJ\2792049 (r_pobj) of_12\IN\0 (r_prep) effect_11\NN\34213 (l_prep) on_25\IN\0 (l_pobj) carcinogenesis_26\NN\0
D010634_D063646 NONE pb_15\NNP\14625458 (r_appos) phenobarbital_13\JJ\2792049 (r_pobj) of_12\IN\0 (r_prep) effect_11\NN\34213 (l_prep) on_25\IN\0 (l_pobj) carcinogenesis_26\NN\0
D010634_D063646 NONE pb_15\NNP\14625458 (r_conj) den_13\NNP\8580803 (r_pobj) by_12\IN\0 (r_conj) by_8\IN\0 (r_agent) treated_7\VBN\2376958 (l_prep) according_23\VBG\2657219 (l_prep) to_24\IN\0 (l_pobj) schedule_26\NN\5898568 (l_prep) for_27\IN\0 (l_pobj) hepatocarcinogenesis_28\NN\0
D010634_D063646 NONE pb_4\NNP\14625458 (l_relcl) promotes_7\VBZ\2556126 (l_dobj) carcinogenesis_8\NN\0
D004052_D011230 CID den_27\NNP\8580803 (r_pobj) with_26\IN\0 (r_prep) given_24\VBN\5892096 (r_advcl) reduced_20\VBN\441445 (l_nsubjpass) number_8\NN\5107765 (l_conj) size_11\NN\5090441 (l_prep) of_12\IN\0 (l_pcomp) induced_13\VBN\1627355 (l_dobj) foci_17\NN\5704266
D004052_D009369 NONE den_1\NNP\8580803 (r_nsubj) treated_4\VBN\2376958 (r_ccomp) was_9\VBD\0 (l_conj) decreased_15\VBD\169651 (l_nsubj) incidence_14\NN\13821570 (l_compound) tumor_13\NN\14234074
D004052_D009369 NONE den_23\NNP\8580803 (r_pobj) by_22\IN\0 (r_agent) obtained_21\VBN\2210855 (r_acl) results_20\NNS\34213 (r_pobj) with_18\IN\0 (r_prep) compared_17\VBN\644583 (r_prep) as_16\IN\14622893 (r_prep) decreased_15\VBD\169651 (l_nsubj) incidence_14\NN\13821570 (l_compound) tumor_13\NN\14234074
D004052_D063646 NONE diethylnitrosamine_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) given_6\VBN\5892096 (r_prep) action_3\NN\30358 (l_amod) carcinogenic_2\JJ\0
D004052_D063646 NONE diethylnitrosamine_33\JJ\0 (r_pobj) with_32\IN\0 (r_prep) administered_30\VBN\2436349 (r_advcl) elucidate_9\VB\939277 (l_dobj) effect_11\NN\34213 (l_prep) on_25\IN\0 (l_pobj) carcinogenesis_26\NN\0
D004052_D063646 NONE den_35\NNP\8580803 (r_parataxis) planned_5\VBN\708538 (l_prep) in_6\IN\13603305 (l_pobj) order_7\NN\7168131 (l_acl) elucidate_9\VB\939277 (l_dobj) effect_11\NN\34213 (l_prep) on_25\IN\0 (l_pobj) carcinogenesis_26\NN\0
D004052_D063646 NONE den_9\NNP\8580803 (r_pobj) by_8\IN\0 (r_agent) treated_7\VBN\2376958 (l_prep) according_23\VBG\2657219 (l_prep) to_24\IN\0 (l_pobj) schedule_26\NN\5898568 (l_prep) for_27\IN\0 (l_pobj) hepatocarcinogenesis_28\NN\0
D004052_D063646 NONE den_13\NNP\8580803 (r_pobj) by_12\IN\0 (r_conj) by_8\IN\0 (r_agent) treated_7\VBN\2376958 (l_prep) according_23\VBG\2657219 (l_prep) to_24\IN\0 (l_pobj) schedule_26\NN\5898568 (l_prep) for_27\IN\0 (l_pobj) hepatocarcinogenesis_28\NN\0
D004052_D063646 NONE den_13\NNP\8580803 (r_compound) treatment_14\NN\654885 (r_pobj) after_11\IN\0 (r_prep) administered_10\VBN\2436349 (r_advcl) promotes_7\VBZ\2556126 (l_dobj) carcinogenesis_8\NN\0
D004052_D063646 NONE den_24\NNP\8580803 (r_pobj) with_23\IN\0 (r_prep) given_21\VBN\5892096 (r_advcl) reduces_16\VBZ\441445 (l_nsubj) pb_4\NNP\14625458 (l_relcl) promotes_7\VBZ\2556126 (l_dobj) carcinogenesis_8\NN\0
D010634_D009369 NONE pb_3\NNP\14625458 (r_conj) den_1\NNP\8580803 (r_nsubj) treated_4\VBN\2376958 (r_ccomp) was_9\VBD\0 (l_conj) decreased_15\VBD\169651 (l_nsubj) incidence_14\NN\13821570 (l_compound) tumor_13\NN\14234074
20683499
C029036_D008569 NONE crocin_3\NNS\0 (l_prep) in_4\IN\13603305 (l_pobj) impairment_14\NN\7296428
C029036_D007859 NONE crocin_3\NNS\0 (l_prep) in_4\IN\13603305 (l_pobj) impairment_14\NN\7296428
D013311_D008569 NONE stz_17\NNP\0 (r_npadvmod) injected_19\VBN\81072 (r_amod) group_20\NN\2137 (r_pobj) in_15\IN\13603305 (r_prep) impairment_14\NN\7296428
D013311_D000544 CID streptozocin_11\NNS\0 (r_npadvmod) induced_13\VBN\1627355 (r_amod) model_14\NN\5888929 (l_prep) of_15\IN\0 (l_pobj) disease_19\NN\14061805
D013311_D000544 CID streptozocin_20\NNP\0 (r_appos) effect_6\NN\34213 (l_prep) of_7\IN\0 (l_pobj) crocins_8\NNS\0 (l_prep) on_9\IN\0 (l_pobj) disease_13\NN\14061805
D013311_D000544 CID stz_22\NNP\0 (r_appos) streptozocin_20\NNP\0 (r_appos) effect_6\NN\34213 (l_prep) of_7\IN\0 (l_pobj) crocins_8\NNS\0 (l_prep) on_9\IN\0 (l_pobj) disease_13\NN\14061805
D013311_D000544 CID stz_10\NNP\0 (r_compound) icv_12\NN\0 (r_pobj) with_9\IN\0 (r_prep) injected_8\VBN\81072 (l_prep) in_0\IN\13603305 (l_pobj) groups_4\NNS\2137 (l_compound) disease_3\NN\14061805
D013311_D000544 CID stz_28\NNP\0 (r_compound) icv_30\NN\0 (r_compound) application_31\NN\947128 (r_nsubjpass) repeated_33\VBN\952524 (l_ccomp) injected_8\VBN\81072 (l_prep) in_0\IN\13603305 (l_pobj) groups_4\NNS\2137 (l_compound) disease_3\NN\14061805
D013311_D000544 CID stz_20\NNP\0 (r_compound) icv_22\NN\0 (r_pobj) by_19\IN\0 (r_agent) caused_18\VBN\1617192 (l_prep) in_23\IN\13603305 (l_pobj) rats_24\NNS\2329401 (l_conj) potential_27\NN\14481929 (l_prep) in_28\IN\13603305 (l_pobj) treatment_30\NN\654885 (l_prep) of_31\IN\0 (l_pobj) diseases_33\NNS\14061805 (l_prep) as_35\IN\14622893 (l_pobj) disease_38\NN\14061805
C029036_D000544 NONE crocin_9\NNS\0 (l_prep) on_10\IN\0 (l_pobj) model_14\NN\5888929 (l_prep) of_15\IN\0 (l_pobj) disease_19\NN\14061805
C029036_D000544 NONE crocins_8\NNS\0 (l_prep) on_9\IN\0 (l_pobj) disease_13\NN\14061805
C029036_D000544 NONE crocin_8\NNS\0 (r_pobj) of_7\IN\0 (r_prep) effectiveness_6\NN\5190804 (l_prep) in_13\IN\13603305 (l_pcomp) antagonizing_14\VBG\1787955 (l_dobj) deficits_17\NNS\5113133 (l_acl) caused_18\VBN\1617192 (l_prep) in_23\IN\13603305 (l_pobj) rats_24\NNS\2329401 (l_conj) potential_27\NN\14481929 (l_prep) in_28\IN\13603305 (l_pobj) treatment_30\NN\654885 (l_prep) of_31\IN\0 (l_pobj) diseases_33\NNS\14061805 (l_prep) as_35\IN\14622893 (l_pobj) disease_38\NN\14061805
D013311_D019636 NONE stz_20\NNP\0 (r_compound) icv_22\NN\0 (r_pobj) by_19\IN\0 (r_agent) caused_18\VBN\1617192 (l_prep) in_23\IN\13603305 (l_pobj) rats_24\NNS\2329401 (l_conj) potential_27\NN\14481929 (l_prep) in_28\IN\13603305 (l_pobj) treatment_30\NN\654885 (l_prep) of_31\IN\0 (l_pobj) diseases_33\NNS\14061805
D013311_D003072 CID stz_20\NNP\0 (r_compound) icv_22\NN\0 (r_pobj) by_19\IN\0 (r_agent) caused_18\VBN\1617192 (r_acl) deficits_17\NNS\5113133
C029036_D019636 NONE crocin_8\NNS\0 (r_pobj) of_7\IN\0 (r_prep) effectiveness_6\NN\5190804 (l_prep) in_13\IN\13603305 (l_pcomp) antagonizing_14\VBG\1787955 (l_dobj) deficits_17\NNS\5113133 (l_acl) caused_18\VBN\1617192 (l_prep) in_23\IN\13603305 (l_pobj) rats_24\NNS\2329401 (l_conj) potential_27\NN\14481929 (l_prep) in_28\IN\13603305 (l_pobj) treatment_30\NN\654885 (l_prep) of_31\IN\0 (l_pobj) diseases_33\NNS\14061805
D013311_D007859 NONE stz_17\NNP\0 (r_npadvmod) injected_19\VBN\81072 (r_amod) group_20\NN\2137 (r_pobj) in_15\IN\13603305 (r_prep) impairment_14\NN\7296428
C029036_D003072 NONE crocin_8\NNS\0 (r_pobj) of_7\IN\0 (r_prep) effectiveness_6\NN\5190804 (l_prep) in_13\IN\13603305 (l_pcomp) antagonizing_14\VBG\1787955 (l_dobj) deficits_17\NNS\5113133
19674115
D011718_D033461 NONE pyrazinamide_0\NNP\0 (r_nsubj) have_2\VB\7846 (l_dobj) effects_4\NNS\13245626 (l_prep) as_6\IN\14622893 (l_pobj) toxicity_8\NN\13576101 (l_conj) disorders_13\NNS\14034177 (l_nmod) hyperuricemia_10\NN\0
D011718_D000857 CID pyrazinamide_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubj) dysosmia_1\NN\14052403
D011718_D000857 CID pyrazinamide_10\VB\0 (r_xcomp) related_8\VBN\628491 (r_acl) disorder_7\NN\14034177
D011718_D000857 CID pyrazinamide_4\JJ\0 (r_compound) withdrawal_5\NN\7206096 (r_pobj) after_3\IN\0 (r_prep) disappeared_1\VBD\0 (l_nsubj) dysosmia_0\NNP\14052403
D011718_D056486 NONE pyrazinamide_0\NNP\0 (r_nsubj) have_2\VB\7846 (l_dobj) effects_4\NNS\13245626 (l_prep) as_6\IN\14622893 (l_pobj) toxicity_8\NN\13576101
19944736
D018021_D012640 CID licl_4\NNP\0 (r_pobj) in_3\IN\13603305 (r_prep) administered_2\VBN\2436349 (r_acl) tacrine_0\NNP\0 (r_nsubj) induces_10\VBZ\1627355 (l_dobj) seizures_12\NNS\14081375
D013619_D004827 NONE tacrine_5\NN\0 (r_npadvmod) loaded_7\VBN\452512 (r_amod) nanoparticles_8\NNS\0 (r_pobj) with_4\IN\0 (r_prep) treated_3\VBN\2376958 (r_csubj) showed_9\VBD\2137132 (l_dobj) outcome_12\NN\7291312 (l_prep) of_13\IN\0 (l_pobj) symptoms_16\NNS\5823932 (l_appos) onset_20\NN\7325190 (l_amod) epileptic_19\JJ\10595647
D013619_D004827 NONE tacrine_22\NN\0 (r_compound) lithium_24\NN\14625458 (r_compound) model_25\NN\5888929 (l_prep) of_26\IN\0 (l_pobj) epilepsy_27\NN\14085708
D008094_D004827 NONE lithium_24\NN\14625458 (r_compound) model_25\NN\5888929 (l_prep) of_26\IN\0 (l_pobj) epilepsy_27\NN\14085708
D013619_D001930 CID tacrine_0\NNP\0 (r_nsubj) induces_10\VBZ\1627355 (l_conj) delayed_14\VBD\439958 (l_dobj) damage_16\NN\7296428
D013619_D001930 CID tacrine_3\NN\0 (r_npadvmod) loaded_5\VBN\452512 (r_amod) administration_7\NN\1133281 (r_nsubj) induced_8\VBD\1627355 (l_dobj) damage_9\NN\7296428 (l_prep) of_10\IN\0 (l_pobj) cells_12\NNS\3080309
D013619_D001930 CID tacrine_29\NN\0 (r_pobj) of_28\IN\0 (r_prep) solution_27\NN\14586258 (r_advcl) induced_8\VBD\1627355 (l_dobj) damage_9\NN\7296428 (l_prep) of_10\IN\0 (l_pobj) cells_12\NNS\3080309
D018021_D001930 CID licl_4\NNP\0 (r_pobj) in_3\IN\13603305 (r_prep) administered_2\VBN\2436349 (r_acl) tacrine_0\NNP\0 (r_nsubj) induces_10\VBZ\1627355 (l_conj) delayed_14\VBD\439958 (l_dobj) damage_16\NN\7296428
D013619_D012640 CID tacrine_0\NNP\0 (r_nsubj) induces_10\VBZ\1627355 (l_dobj) seizures_12\NNS\14081375
1141447
D008094_D003919 CID lithium_7\NN\14625458 (r_npadvmod) induced_9\VBN\1627355 (r_amod) insipidus_11\NN\0
D008094_D003919 CID lithium_3\NN\14625458 (r_npadvmod) induced_5\VBN\1627355 (r_amod) insipidus_7\NN\0
8686832
D000431_D010146 NONE alcohol_27\NN\7881800 (r_compound) intake_28\NN\13440063 (r_pobj) to_24\IN\0 (r_prep) admitted_23\VBD\822367 (r_acl) pain_22\NN\14299637 (r_pobj) without_21\IN\0 (r_prep) pain_10\NN\14299637
D000431_D010146 NONE alcohol_27\NN\7881800 (r_compound) intake_28\NN\13440063 (r_pobj) to_24\IN\0 (r_prep) admitted_23\VBD\822367 (r_acl) pain_22\NN\14299637
D008012_D001416 CID lignocaine_11\NN\0 (r_dobj) involving_7\VBG\2676054 (r_acl) anaesthesia_6\NN\14034177 (r_pobj) after_4\IN\0 (r_prep) pain_3\NN\14299637
D008012_D001416 CID lignocaine_14\NN\0 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (l_nsubjpass) leg_0\NNP\5560244 (l_conj) pain_3\NN\14299637
11185967
D000431_D019969 NONE alcohol_8\NN\7881800 (r_npadvmod) related_10\VBN\628491 (r_amod) disorder_12\NN\14034177 (r_conj) drug_6\NN\14778436 (r_pobj) of_4\IN\0 (r_prep) history_3\NN\15120823 (r_appos) demographics_1\NNS\6021499 (r_nsubj) estimated_14\VBN\637259 (l_prep) from_16\IN\0 (l_prep) to_18\IN\0 (l_pobj) collection_20\NN\31264 (l_conj) history_22\NN\15120823 (l_conj) suspicion_24\NN\5916739 (l_prep) of_25\IN\0 (l_pobj) cocaine_26\NN\3492717 (l_conj) abuse_29\NN\418025
D000431_D012640 NONE alcohol_8\NN\7881800 (r_npadvmod) related_10\VBN\628491 (r_amod) disorder_12\NN\14034177 (l_compound) seizure_11\NN\14081375
D000431_D012640 NONE alcohol_8\NN\7881800 (r_npadvmod) related_10\VBN\628491 (r_amod) disorder_12\NN\14034177 (r_conj) drug_6\NN\14778436 (r_pobj) of_4\IN\0 (r_prep) history_3\NN\15120823 (r_appos) demographics_1\NNS\6021499 (r_nsubj) estimated_14\VBN\637259 (l_prep) from_16\IN\0 (l_pobj) seizure_17\NN\14081375
D000431_D019970 NONE alcohol_8\NN\7881800 (r_npadvmod) related_10\VBN\628491 (r_amod) disorder_12\NN\14034177 (r_conj) drug_6\NN\14778436 (r_pobj) of_4\IN\0 (r_prep) history_3\NN\15120823 (r_appos) demographics_1\NNS\6021499 (r_nsubj) estimated_14\VBN\637259 (l_prep) from_16\IN\0 (l_prep) to_18\IN\0 (l_pobj) collection_20\NN\31264 (l_conj) history_22\NN\15120823 (l_conj) suspicion_24\NN\5916739 (l_prep) of_25\IN\0 (l_pobj) cocaine_26\NN\3492717 (l_conj) abuse_29\NN\418025
D003042_D012640 NONE cocaine_16\NN\3492717 (l_prep) in_19\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_compound) seizure_23\NN\14081375
D003042_D012640 NONE cocaine_9\NN\3492717 (l_prep) in_12\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_compound) seizure_14\NN\14081375
D000661_D012640 NONE amphetamine_18\NN\3248958 (r_conj) cocaine_16\NN\3492717 (l_prep) in_19\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_compound) seizure_23\NN\14081375
D000662_D012640 NONE amphetamines_11\NNS\3248958 (r_conj) cocaine_9\NN\3492717 (l_prep) in_12\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_compound) seizure_14\NN\14081375
9564988
D064704_D012852 NONE levofloxacin_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) assessment_3\NN\5732756 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) sinusitis_12\NN\14336539
D064704_D012852 NONE levofloxacin_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) efficacy_3\NN\5199286 (r_dobj) evaluate_1\VB\670261 (l_prep) in_20\IN\13603305 (l_pcomp) treating_21\VBG\2376958 (l_prep) with_24\IN\0 (l_pobj) sinusitis_27\NN\14336539
D064704_D012852 NONE levofloxacin_7\VBZ\0 (r_ccomp) indicate_5\VBP\952524 (l_ccomp) is_12\VBZ\0 (l_attr) treatment_17\NN\654885 (l_prep) for_18\IN\0 (l_pobj) sinusitis_21\NN\14336539
10565806
C076029_D001714 CID olanzapine_6\NN\0 (r_pobj) by_5\IN\0 (r_prep) induced_4\VBN\1627355 (l_nsubj) hypomania_0\NNP\0
C076029_D001714 CID olanzapine_28\JJ\0 (r_compound) treatment_29\NN\654885 (r_pobj) of_27\IN\0 (r_prep) introduction_26\NN\235435 (r_pobj) after_24\IN\0 (r_prep) developed_21\VBD\1753788 (l_dobj) hypomania_22\NN\0
C076029_D011618 NONE olanzapine_28\JJ\0 (r_compound) treatment_29\NN\654885 (r_pobj) of_27\IN\0 (r_prep) introduction_26\NN\235435 (r_pobj) after_24\IN\0 (r_prep) developed_21\VBD\1753788 (r_relcl) disorder_14\NN\14034177
9672273
D013629_D014652 CID tamoxifen_20\NN\2714883 (r_pobj) on_19\IN\0 (r_prep) women_18\NNS\9605289 (r_pobj) among_17\IN\0 (r_prep) events_14\NNS\23100
D013629_D016889 NONE tamoxifen_0\NNP\2714883 (r_nsubj) is_1\VBZ\0 (l_advcl) associated_15\VBN\628491 (l_prep) with_16\IN\0 (l_pobj) development_18\NN\248977 (l_prep) of_19\IN\0 (l_pobj) cancer_21\NN\14239425
D013629_D001943 NONE tamoxifen_5\NN\2714883 (r_pobj) with_4\IN\0 (r_prep) prevention_0\NN\1073995 (l_prep) of_1\IN\0 (l_pobj) cancer_3\NN\14239425
D013629_D001943 NONE tamoxifen_0\NNP\2714883 (r_nsubj) is_1\VBZ\0 (l_attr) agent_5\NN\7347 (l_prep) in_6\IN\13603305 (l_pobj) cancer_8\NN\14239425
D013629_D001943 NONE tamoxifen_18\NN\2714883 (r_pobj) of_17\IN\0 (r_prep) trial_16\NN\786195 (l_relcl) have_29\VB\7846 (l_dobj) cancer_31\NN\14239425
D013629_D001943 NONE tamoxifen_17\NN\2714883 (r_nmod) arms_21\NNS\3575240 (r_conj) placebo_11\NN\3740161 (r_pobj) between_9\IN\0 (r_prep) frequency_8\NN\15286249 (l_compound) cancer_7\NN\14239425
D013629_D001943 NONE tamoxifen_12\NN\2714883 (r_dobj) receiving_11\VBG\2210855 (r_acl) women_10\NNS\9605289 (r_pobj) among_9\IN\0 (r_prep) reduction_5\NN\351485 (l_prep) of_6\IN\0 (l_pobj) cancer_8\NN\14239425
D013629_D001943 NONE tamoxifen_12\NN\2714883 (r_dobj) receiving_11\VBG\2210855 (r_acl) women_10\NNS\9605289 (r_pobj) among_9\IN\0 (r_prep) reduction_5\NN\351485 (r_attr) is_1\VBZ\0 (r_ccomp) found_36\VBD\13279262 (l_dobj) cases_38\NNS\7283608 (l_prep) of_39\IN\0 (l_pobj) cancer_41\NN\14239425
D013629_D001943 NONE tamoxifen_51\NN\2714883 (r_pobj) to_50\IN\0 (r_prep) allocated_49\VBN\2228698 (r_acl) women_48\NNS\9605289 (r_pobj) among_46\IN\0 (r_prep) case_45\NN\7283608 (r_pobj) with_43\IN\0 (r_prep) compared_42\VBN\644583 (r_prep) found_36\VBD\13279262 (l_ccomp) is_1\VBZ\0 (l_attr) reduction_5\NN\351485 (l_prep) of_6\IN\0 (l_pobj) cancer_8\NN\14239425
D013629_D001943 NONE tamoxifen_51\NN\2714883 (r_pobj) to_50\IN\0 (r_prep) allocated_49\VBN\2228698 (r_acl) women_48\NNS\9605289 (r_pobj) among_46\IN\0 (r_prep) case_45\NN\7283608 (r_pobj) with_43\IN\0 (r_prep) compared_42\VBN\644583 (r_prep) found_36\VBD\13279262 (l_dobj) cases_38\NNS\7283608 (l_prep) of_39\IN\0 (l_pobj) cancer_41\NN\14239425
D013629_D001943 NONE tamoxifen_29\NN\2714883 (r_pobj) of_28\IN\0 (r_prep) effects_27\NNS\13245626 (r_nsubj) are_30\VBP\13600404 (l_prep) in_8\IN\13603305 (l_prep) at_13\IN\14622893 (l_pobj) risk_19\NN\14541044 (l_prep) of_20\IN\0 (l_pobj) cancer_22\NN\14239425
D013629_D015228 CID tamoxifen_20\NN\2714883 (r_pobj) on_19\IN\0 (r_prep) women_18\NNS\9605289 (r_pobj) among_17\IN\0 (r_prep) events_14\NNS\23100 (l_conj) hypertriglyceridaemia_16\NN\0
11077455
D020888_D014786 CID vigabatrin_16\NN\0 (r_npadvmod) attributed_18\VBN\670261 (r_amod) constriction_21\NN\5071027
D020888_D014786 CID vigabatrin_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_xcomp) thought_4\NN\5809192 (l_nsubj) constriction_3\NN\5071027
D020888_D014786 CID vigabatrin_15\NN\0 (r_npadvmod) attributed_17\VBN\670261 (r_amod) loss_20\NN\13252973
D020888_D014786 CID vigabatrin_9\NN\0 (r_compound) therapy_10\NN\657604 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_xcomp) appears_4\VBZ\2604760 (l_nsubj) constriction_3\NN\5071027
1423339
D011433_D064420 NONE propranolol_4\JJ\0 (r_amod) toxicity_5\NN\13576101
D011433_D064420 NONE propranolol_14\JJ\0 (r_amod) toxicity_15\NN\13576101
D011433_D003704 NONE propranolol_14\JJ\0 (r_amod) toxicity_15\NN\13576101 (r_pobj) of_13\IN\0 (r_prep) result_12\NN\34213 (r_pobj) as_10\IN\14622893 (r_prep) developed_3\VBD\1753788 (l_dobj) dementia_9\NN\14395018
D011433_D000647 CID propranolol_4\JJ\0 (r_amod) toxicity_5\NN\13576101 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) syndrome_1\NN\5870365
D011433_D000544 NONE propranolol_14\JJ\0 (r_amod) toxicity_15\NN\13576101 (r_pobj) of_13\IN\0 (r_prep) result_12\NN\34213 (r_pobj) as_10\IN\14622893 (r_prep) developed_3\VBD\1753788 (l_dobj) dementia_9\NN\14395018 (l_amod) like_7\JJ\5839024 (l_npadvmod) alzheimer_5\NNP\0
7710775
D001241_D007511 NONE acetylsalicylate_4\VBP\0 (l_prep) before_7\IN\0 (l_pobj) ischemia_8\NN\14195315
D008315_D007022 NONE malondialdehyde_23\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) was_24\VBD\0 (r_advcl) min_13\NN\15154774 (l_prep) of_0\IN\0 (l_pobj) drug_3\NN\14778436 (l_amod) hypotensive_2\JJ\10405694
D009705_D002545 NONE nucleosides_9\NNS\14887305 (l_prep) during_10\IN\0 (l_pobj) ischemia_13\NN\14195315
-1_D007511 NONE oxypurines_10\NNS\0 (r_pobj) of_8\IN\0 (r_prep) increase_7\NN\13576355 (r_nsubjpass) observed_14\VBN\2163746 (l_prep) during_0\IN\0 (l_pobj) ischemia_1\NN\14195315
-1_D007511 NONE oxypurines_10\NNS\0 (r_conj) malondialdehyde_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) determination_6\NN\43195 (r_nsubjpass) used_20\VBN\0 (l_xcomp) monitor_22\VB\10676877 (l_dobj) alterations_25\NNS\7283608 (l_acl) occurring_28\VBG\0 (l_prep) during_29\IN\0 (l_pobj) phenomena_31\NNS\29677 (l_amod) ischemic_30\JJ\0
D008315_D007511 NONE malondialdehyde_1\NN\0 (r_nsubj) increased_23\VBD\169651 (l_prep) after_24\IN\0 (l_pobj) min_26\NN\15154774 (l_prep) of_27\IN\0 (l_pobj) ischemia_28\NN\14195315
D008315_D007511 NONE malondialdehyde_23\NN\0 (r_pobj) in_19\IN\13603305 (r_prep) was_24\VBD\0 (r_advcl) min_13\NN\15154774 (l_prep) during_15\IN\0 (l_pobj) ischemia_16\NN\14195315
D008315_D007511 NONE malondialdehyde_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) determination_6\NN\43195 (r_nsubjpass) used_20\VBN\0 (l_xcomp) monitor_22\VB\10676877 (l_dobj) alterations_25\NNS\7283608 (l_acl) occurring_28\VBG\0 (l_prep) during_29\IN\0 (l_pobj) phenomena_31\NNS\29677 (l_amod) ischemic_30\JJ\0
-1_D002545 NONE oxypurines_6\NNS\0 (l_conj) nucleosides_9\NNS\14887305 (l_prep) during_10\IN\0 (l_pobj) ischemia_13\NN\14195315
D008315_D002545 CID malondialdehyde_4\NN\0 (r_pobj) of_2\IN\0 (r_prep) dependence_1\NN\24720 (r_nsubj) oxypurines_6\NNS\0 (l_conj) nucleosides_9\NNS\14887305 (l_prep) during_10\IN\0 (l_pobj) ischemia_13\NN\14195315
D009599_D007511 NONE nitroprusside_4\NN\0 (r_acl) drug_3\NN\14778436 (r_pobj) of_0\IN\0 (r_prep) min_13\NN\15154774 (l_prep) during_15\IN\0 (l_pobj) ischemia_16\NN\14195315
D009705_D007511 NONE nucleosides_12\NNS\14887305 (r_conj) oxypurines_10\NNS\0 (r_pobj) of_8\IN\0 (r_prep) increase_7\NN\13576355 (r_nsubjpass) observed_14\VBN\2163746 (l_prep) during_0\IN\0 (l_pobj) ischemia_1\NN\14195315
D009705_D007511 NONE nucleosides_13\NNS\14887305 (r_conj) oxypurines_10\NNS\0 (r_conj) malondialdehyde_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) determination_6\NN\43195 (r_nsubjpass) used_20\VBN\0 (l_xcomp) monitor_22\VB\10676877 (l_dobj) alterations_25\NNS\7283608 (l_acl) occurring_28\VBG\0 (l_prep) during_29\IN\0 (l_pobj) phenomena_31\NNS\29677 (l_amod) ischemic_30\JJ\0
D009599_D007022 NONE nitroprusside_4\NN\0 (r_acl) drug_3\NN\14778436 (l_amod) hypotensive_2\JJ\10405694
8888541
D012701_D011595 NONE serotonin_3\NN\14807737 (r_nmod) receptors_5\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) stimulation_1\NN\242808 (r_nsubj) causes_6\VBZ\7323922 (l_dobj) syndrome_8\NN\5870365 (l_prep) of_9\IN\0 (l_pobj) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797 (l_conj) agitation_24\NN\14373582
D012701_D011595 NONE serotonin_10\NN\14807737 (r_compound) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797 (l_conj) agitation_24\NN\14373582
D014191_D003866 NONE tranylcypromine_22\NN\3783017 (l_prep) for_23\IN\0 (l_pobj) depression_24\NN\14373582
D012701_D012798 NONE serotonin_3\NN\14807737 (r_nmod) receptors_5\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) stimulation_1\NN\242808 (r_nsubj) causes_6\VBZ\7323922 (l_dobj) syndrome_8\NN\5870365 (l_prep) of_9\IN\0 (l_pobj) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916
D012701_D012798 NONE serotonin_10\NN\14807737 (r_compound) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916
C047426_D020230 CID venlafaxine_3\NNP\0 (r_compound) tranylcypromine_5\NN\3783017 (r_compound) interaction_6\NN\37396 (r_pobj) from_2\IN\0 (r_prep) syndrome_1\NN\5870365
C047426_D020230 CID venlafaxine_3\NNP\0 (r_compound) maoi_5\NNP\2718811 (r_compound) interaction_6\NN\37396 (l_relcl) resulted_8\VBD\2633881 (l_prep) in_9\IN\13603305 (l_pobj) syndrome_12\NN\5870365
D012701_D005334 NONE serotonin_3\NN\14807737 (r_nmod) receptors_5\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) stimulation_1\NN\242808 (r_nsubj) causes_6\VBZ\7323922 (l_dobj) syndrome_8\NN\5870365 (l_prep) of_9\IN\0 (l_pobj) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797 (l_conj) agitation_24\NN\14373582 (l_conj) hyperthermia_26\NN\14034177
D012701_D005334 NONE serotonin_10\NN\14807737 (r_compound) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797 (l_conj) agitation_24\NN\14373582 (l_conj) hyperthermia_26\NN\14034177
D012701_D003221 NONE serotonin_3\NN\14807737 (r_nmod) receptors_5\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) stimulation_1\NN\242808 (r_nsubj) causes_6\VBZ\7323922 (l_dobj) syndrome_8\NN\5870365 (l_prep) of_9\IN\0 (l_pobj) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797
D012701_D003221 NONE serotonin_10\NN\14807737 (r_compound) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233 (l_conj) salivation_20\NN\13553916 (l_conj) confusion_22\NN\13972797
D012701_D009127 NONE serotonin_3\NN\14807737 (r_nmod) receptors_5\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) stimulation_1\NN\242808 (r_nsubj) causes_6\VBZ\7323922 (l_dobj) syndrome_8\NN\5870365 (l_prep) of_9\IN\0 (l_pobj) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233
D012701_D009127 NONE serotonin_10\NN\14807737 (r_compound) excess_11\NN\5119367 (l_relcl) consists_13\VBZ\2603699 (l_prep) of_14\IN\0 (l_pcomp) shivering_15\VBG\14299637 (l_conj) rigidity_18\NN\5023233
C047426_D003866 NONE venlafaxine_3\NNP\0 (r_compound) maoi_5\NNP\2718811 (r_compound) interaction_6\NN\37396 (l_relcl) resulted_8\VBD\2633881 (l_prep) in_13\IN\13603305 (l_pobj) male_18\NN\15388 (l_relcl) taking_21\VBG\37396 (l_dobj) tranylcypromine_22\NN\3783017 (l_prep) for_23\IN\0 (l_pobj) depression_24\NN\14373582
D003975_D009127 NONE diazepam_4\NN\2830852 (r_pobj) of_3\IN\0 (r_prep) mg_2\NN\13717155 (r_pobj) after_0\IN\0 (r_prep) remained_7\VBD\2604760 (l_acomp) tremulous_8\JJ\0 (l_prep) with_9\IN\0 (l_pobj) rigidity_11\NN\5023233
D014191_D020230 CID tranylcypromine_5\NN\3783017 (r_compound) interaction_6\NN\37396 (r_pobj) from_2\IN\0 (r_prep) syndrome_1\NN\5870365
D014191_D020230 CID tranylcypromine_22\NN\3783017 (r_dobj) taking_21\VBG\37396 (r_relcl) male_18\NN\15388 (r_pobj) in_13\IN\13603305 (r_prep) resulted_8\VBD\2633881 (l_prep) in_9\IN\13603305 (l_pobj) syndrome_12\NN\5870365
7282516
D004317_D009202 CID doxorubicin_9\NN\2716866 (r_compound) cardiomyopathy_10\NN\14103288
D004317_D009202 CID doxorubicin_10\NN\2716866 (l_nsubj) cm_3\NNP\13649268 (l_amod) cardiomyopathy_1\NN\14103288
D004317_D009202 CID doxorubicin_10\NN\2716866 (l_nsubj) cm_3\NNP\13649268
D004317_D009202 CID dxr_12\NN\0 (r_appos) doxorubicin_10\NN\2716866 (l_nsubj) cm_3\NNP\13649268 (l_amod) cardiomyopathy_1\NN\14103288
D004317_D009202 CID dxr_12\NN\0 (r_appos) doxorubicin_10\NN\2716866 (l_nsubj) cm_3\NNP\13649268
D004317_D009202 CID adriamycin_1\NNP\0 (r_nsubj) provides_3\VBZ\2199590 (l_dobj) opportunity_6\NN\14481929 (l_acl) analyze_8\VB\0 (l_dobj) relationships_16\NNS\31921 (l_prep) during_17\IN\0 (l_pobj) development_18\NN\248977 (l_prep) of_19\IN\0 (l_pobj) disease_21\NN\14061805
D004317_D009202 CID dxr_1\NNP\0 (r_compound) cm_3\NNP\13649268
D004317_D009202 CID dxr_1\NNP\0 (r_compound) cm_3\NNP\13649268 (r_nmod) damage_5\NN\7296428
D004317_D009202 CID dxr_15\NNP\0 (r_compound) dose_16\NN\3740161 (r_appos) insult_13\NN\6714976 (r_pobj) of_11\IN\0 (r_prep) degree_10\NN\4916342 (r_pobj) to_8\IN\0 (r_prep) proportional_7\JJ\5855125 (r_acomp) is_6\VBZ\0 (l_prep) in_0\IN\13603305 (l_pobj) damage_5\NN\7296428 (l_nmod) cm_3\NNP\13649268
D004317_D009202 CID dxr_15\NNP\0 (r_compound) dose_16\NN\3740161 (r_appos) insult_13\NN\6714976 (r_pobj) of_11\IN\0 (r_prep) degree_10\NN\4916342 (r_pobj) to_8\IN\0 (r_prep) proportional_7\JJ\5855125 (r_acomp) is_6\VBZ\0 (l_prep) in_0\IN\13603305 (l_pobj) damage_5\NN\7296428
11838826
C047047_D011605 NONE cabergoline_55\NN\0 (r_pobj) with_54\IN\0 (r_prep) treated_53\VBN\2376958 (l_nsubjpass) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177 (l_conj) psychoses_24\NNS\14380140
D018967_D001714 NONE risperidone_27\NN\0 (r_npadvmod) induced_29\VBN\1627355 (r_amod) elevations_30\NNS\7445480 (r_pobj) with_26\IN\0 (r_prep) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177
D018967_D001523 NONE risperidone_27\NN\0 (r_npadvmod) induced_29\VBN\1627355 (r_amod) elevations_30\NNS\7445480 (r_pobj) with_26\IN\0 (r_prep) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177 (l_amod) diagnostic_10\NNP\0 (l_conj) manual_13\NNP\6421301 (l_prep) of_14\IN\0 (l_pobj) disorders_16\NNPS\14034177
C047047_D001714 NONE cabergoline_55\NN\0 (r_pobj) with_54\IN\0 (r_prep) treated_53\VBN\2376958 (l_nsubjpass) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177
C047047_D006966 NONE cabergoline_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) hyperprolactinemia_9\NN\0
C047047_D006966 NONE cabergoline_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) treated_14\VBN\2376958 (r_acl) hyperprolactinemia_13\NN\0
C047047_D006966 NONE cabergoline_0\NNP\0 (r_nsubj) be_2\VB\14625458 (l_prep) for_4\IN\0 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) hyperprolactinemia_11\NN\0
D004298_D006966 NONE dopamine_8\NN\14807737 (r_compound) agonist_9\NN\0 (r_pobj) with_6\IN\0 (r_prep) hyperprolactinemia_5\NN\0
D018967_D006966 CID risperidone_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) hyperprolactinemia_5\NN\0
D018967_D006966 CID risperidone_0\NNP\0 (r_nsubjpass) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) hyperprolactinemia_18\NN\0
D018967_D006966 CID risperidone_6\NN\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hyperprolactinemia_9\NN\0
D018967_D006966 CID risperidone_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hyperprolactinemia_13\NN\0
D018967_D006966 CID risperidone_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hyperprolactinemia_11\NN\0
D018967_D011605 NONE risperidone_27\NN\0 (r_npadvmod) induced_29\VBN\1627355 (r_amod) elevations_30\NNS\7445480 (r_pobj) with_26\IN\0 (r_prep) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177 (l_conj) psychoses_24\NNS\14380140
C047047_D001523 NONE cabergoline_55\NN\0 (r_pobj) with_54\IN\0 (r_prep) treated_53\VBN\2376958 (l_nsubjpass) males_1\NNS\15388 (l_prep) with_9\IN\0 (l_pobj) disorder_22\NN\14034177 (l_amod) diagnostic_10\NNP\0 (l_conj) manual_13\NNP\6421301 (l_prep) of_14\IN\0 (l_pobj) disorders_16\NNPS\14034177
16192988
D008694_D001523 CID methamphetamine_0\NN\2704153 (r_nsubj) causes_1\VBZ\7323922 (l_dobj) alterations_2\NNS\7283608 (l_relcl) display_16\VBP\6879180 (l_dobj) aggressiveness_18\NN\4835724
D008694_D001523 CID methamphetamine_18\NN\2704153 (r_pobj) in_17\IN\13603305 (r_prep) common_16\JJ\8673395 (r_acomp) are_15\VBP\13600404 (r_conj) reported_4\VBN\831651 (l_nsubjpass) behaviors_1\NNS\407535
D008694_D001523 CID methamphetamine_18\NN\2704153 (r_pobj) in_17\IN\13603305 (r_prep) common_16\JJ\8673395 (r_acomp) are_15\VBP\13600404 (r_conj) reported_4\VBN\831651 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_relcl) suffer_8\VBP\2110220 (l_prep) from_9\IN\0 (l_pobj) disorders_12\NNS\14034177
D008694_D001523 CID meth_20\NN\2704153 (r_nmod) abusers_22\NNS\9633969 (r_appos) methamphetamine_18\NN\2704153 (r_pobj) in_17\IN\13603305 (r_prep) common_16\JJ\8673395 (r_acomp) are_15\VBP\13600404 (r_conj) reported_4\VBN\831651 (l_nsubjpass) behaviors_1\NNS\407535
D008694_D001523 CID meth_20\NN\2704153 (r_nmod) abusers_22\NNS\9633969 (r_appos) methamphetamine_18\NN\2704153 (r_pobj) in_17\IN\13603305 (r_prep) common_16\JJ\8673395 (r_acomp) are_15\VBP\13600404 (r_conj) reported_4\VBN\831651 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_relcl) suffer_8\VBP\2110220 (l_prep) from_9\IN\0 (l_pobj) disorders_12\NNS\14034177
D008694_D001523 CID meth_13\NNP\2704153 (r_pobj) of_12\IN\0 (r_prep) injections_11\NNS\320852 (r_nsubj) increased_15\VBD\169651 (l_dobj) aggressiveness_16\NN\4835724
D008694_D001523 CID meth_8\NNP\2704153 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hyperactivity_11\NN\14052403 (r_pobj) to_7\IN\0 (r_prep) secondary_6\JJ\8426461 (r_acomp) was_4\VBD\0 (l_nsubj) increase_1\NN\13576355 (l_prep) in_2\IN\13603305 (l_pobj) aggressiveness_3\NN\4835724
D008694_D006948 NONE meth_8\NNP\2704153 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hyperactivity_11\NN\14052403
1732442
D004317_D009202 CID adriamycin_8\NNS\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) cardiomyopathy_11\NN\14103288
D004317_D009202 CID adriamycin_5\NNS\0 (r_amod) induced_7\VBN\1627355 (r_amod) cardiomyopathy_8\NN\14103288
D004317_D009202 CID adriamycin_5\NNS\0 (r_amod) induced_7\VBN\1627355 (r_amod) cardiomyopathy_8\NN\14103288 (r_pobj) of_4\IN\0 (r_prep) model_3\NN\5888929 (r_dobj) using_0\VBG\418025 (r_advcl) tested_11\VBD\670261 (l_dobj) hypothesis_13\NN\7162194 (l_acl) appear_21\VB\2604760 (l_conj) exacerbated_24\VBN\126264 (l_advmod) dependently_27\RB\0 (l_prep) in_28\IN\13603305 (l_pobj) cardiomyopathy_30\NN\14103288
D004317_D009202 CID adriamycin_29\FW\0 (r_amod) cardiomyopathy_30\NN\14103288 (r_pobj) in_28\IN\13603305 (r_prep) dependently_27\RB\0 (r_advmod) exacerbated_24\VBN\126264 (r_conj) appear_21\VB\2604760 (r_acl) hypothesis_13\NN\7162194 (r_dobj) tested_11\VBD\670261 (l_advcl) using_0\VBG\418025 (l_dobj) model_3\NN\5888929 (l_prep) of_4\IN\0 (l_pobj) cardiomyopathy_8\NN\14103288
D004317_D009202 CID adriamycin_29\FW\0 (r_amod) cardiomyopathy_30\NN\14103288
D004317_D009202 CID adriamycin_34\NNS\0 (r_amod) induced_36\VBN\1627355 (r_amod) cardiomyopathy_37\NN\14103288 (r_pobj) of_33\IN\0 (r_prep) detection_32\NN\5708432 (r_pobj) for_31\IN\0 (r_prep) method_30\NN\5616786 (r_attr) be_27\VB\14625458 (r_ccomp) indicates_22\VBZ\952524 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) presence_10\NN\13954253 (l_prep) of_11\IN\0 (l_pobj) impairment_14\NN\7296428
D004317_D009202 CID adriamycin_34\NNS\0 (r_amod) induced_36\VBN\1627355 (r_amod) cardiomyopathy_37\NN\14103288
D004317_C536522 NONE adriamycin_16\JJ\0 (r_amod) treatment_17\NN\654885 (r_pobj) of_15\IN\0 (r_prep) duration_14\NN\15113229 (r_pobj) to_12\IN\0 (r_prep) relation_11\NN\2137 (r_pobj) in_10\IN\13603305 (r_prep) analyzed_9\VBN\0 (l_nsubjpass) degree_1\NN\4916342 (l_prep) of_2\IN\0 (l_pobj) degeneration_4\NN\29677 (l_prep) of_5\IN\0 (l_pobj) cells_7\NNS\3080309
D004317_C536522 NONE adriamycin_34\NNS\0 (r_amod) induced_36\VBN\1627355 (r_amod) cardiomyopathy_37\NN\14103288 (r_pobj) of_33\IN\0 (r_prep) detection_32\NN\5708432 (r_pobj) for_31\IN\0 (r_prep) method_30\NN\5616786 (r_attr) be_27\VB\14625458 (r_ccomp) indicates_22\VBZ\952524 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) presence_10\NN\13954253 (l_prep) of_11\IN\0 (l_pobj) impairment_14\NN\7296428 (l_appos) degeneration_20\NN\29677
D019797_C536522 NONE mibg_24\NNP\0 (r_compound) scintigraphy_25\NN\0 (r_nsubj) be_27\VB\14625458 (r_ccomp) indicates_22\VBZ\952524 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) presence_10\NN\13954253 (l_prep) of_11\IN\0 (l_pobj) impairment_14\NN\7296428 (l_appos) degeneration_20\NN\29677
D019797_D009202 NONE iodine-125-metaiodobenzylguanidine_13\NNP\0 (r_pcomp) with_12\IN\0 (r_prep) cardiomyopathy_11\NN\14103288
D019797_D009202 NONE mibg_24\NNP\0 (r_compound) scintigraphy_25\NN\0 (r_nsubj) be_27\VB\14625458 (r_ccomp) indicates_22\VBZ\952524 (l_nsubj) appearance_1\NN\4723816 (l_prep) of_2\IN\0 (l_pobj) activity_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) presence_10\NN\13954253 (l_prep) of_11\IN\0 (l_pobj) impairment_14\NN\7296428
D019797_D009202 NONE mibg_24\NNP\0 (r_compound) scintigraphy_25\NN\0 (r_nsubj) be_27\VB\14625458 (l_attr) method_30\NN\5616786 (l_prep) for_31\IN\0 (l_pobj) detection_32\NN\5708432 (l_prep) of_33\IN\0 (l_pobj) cardiomyopathy_37\NN\14103288
33969
D011352_D001008 NONE procyclindine_17\JJ\0 (r_compound) treatment_18\NN\654885 (r_pobj) during_16\IN\0 (r_prep) condition_15\NN\24720 (r_pobj) to_13\IN\0 (r_prep) compared_12\VBN\644583 (r_prep) had_5\VBD\0 (l_conj) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582
D011352_D010302 NONE procyclidine_18\NN\3800001 (r_pobj) as_17\IN\14622893 (r_prep) efficacious_16\JJ\0 (r_acomp) were_14\VBD\0 (r_conj) found_4\VBN\13279262 (l_xcomp) be_6\VB\14625458 (l_acomp) effective_8\JJ\0 (l_prep) in_9\IN\13603305 (l_pcomp) controlling_10\VBG\0 (l_dobj) symptoms_12\NNS\5823932
C084820_D003866 NONE ethopropazine_27\NN\0 (r_pobj) than_26\IN\0 (r_mark) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582 (l_conj) depression_25\NN\14373582
C017610_D010302 CID enanthate_18\NN\0 (r_amod) fluphenazine_17\JJ\3713736 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_advcl) benztropine_9\VB\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) parkinsonism_14\NN\14085708
C084820_D004409 NONE ethopropazine_27\NN\0 (r_pobj) than_26\IN\0 (r_mark) treated_28\VBN\2376958 (r_conj) had_5\VBD\0 (l_dobj) increase_8\NN\13576355 (l_prep) in_9\IN\13603305 (l_pobj) dyskinesia_11\JJ\14084880
C084820_D001008 NONE ethopropazine_27\NN\0 (r_pobj) than_26\IN\0 (r_mark) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582
D001590_D010302 NONE benztropine_2\NN\0 (l_prep) in_3\IN\13603305 (l_pobj) parkinsonism_7\NN\14085708
D001590_D010302 NONE benztropine_9\VB\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) parkinsonism_14\NN\14085708
D001590_D010302 NONE benztropine_2\NN\0 (r_conj) ethopropazine_0\NN\0 (r_nsubjpass) found_4\VBN\13279262 (l_xcomp) be_6\VB\14625458 (l_acomp) effective_8\JJ\0 (l_prep) in_9\IN\13603305 (l_pcomp) controlling_10\VBG\0 (l_dobj) symptoms_12\NNS\5823932
D001590_D010302 NONE benztropine_3\NN\0 (r_nsubj) is_4\VBZ\0 (l_attr) drug_8\NN\14778436 (l_prep) in_11\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) symptoms_19\NNS\5823932
C084820_D012559 NONE ethopropazine_5\NN\0 (r_pobj) in_0\IN\13603305 (r_prep) compared_7\VBN\644583 (l_xcomp) benztropine_9\VB\0 (l_advcl) induced_15\VBN\1627355 (l_agent) by_16\IN\0 (l_pobj) fluphenazine_17\JJ\3713736 (l_amod) enanthate_18\NN\0 (l_prep) in_19\IN\13603305 (l_pobj) outpatients_22\NNS\10405694 (l_amod) schizophrenic_21\JJ\10490141
D011352_D003866 NONE procyclindine_17\JJ\0 (r_compound) treatment_18\NN\654885 (r_pobj) during_16\IN\0 (r_prep) condition_15\NN\24720 (r_pobj) to_13\IN\0 (r_prep) compared_12\VBN\644583 (r_prep) had_5\VBD\0 (l_conj) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582 (l_conj) depression_25\NN\14373582
D011352_D004409 NONE procyclindine_17\JJ\0 (r_compound) treatment_18\NN\654885 (r_pobj) during_16\IN\0 (r_prep) condition_15\NN\24720 (r_pobj) to_13\IN\0 (r_prep) compared_12\VBN\644583 (r_prep) had_5\VBD\0 (l_dobj) increase_8\NN\13576355 (l_prep) in_9\IN\13603305 (l_pobj) dyskinesia_11\JJ\14084880
C017610_D012559 NONE enanthate_18\NN\0 (l_prep) in_19\IN\13603305 (l_pobj) outpatients_22\NNS\10405694 (l_amod) schizophrenic_21\JJ\10490141
D001590_D004409 CID benztropine_2\NN\0 (r_nsubj) had_5\VBD\0 (l_dobj) increase_8\NN\13576355 (l_prep) in_9\IN\13603305 (l_pobj) dyskinesia_11\JJ\14084880
C084820_D010302 NONE ethopropazine_0\NN\0 (l_conj) benztropine_2\NN\0 (l_prep) in_3\IN\13603305 (l_pobj) parkinsonism_7\NN\14085708
C084820_D010302 NONE ethopropazine_5\NN\0 (r_pobj) in_0\IN\13603305 (r_prep) compared_7\VBN\644583 (l_xcomp) benztropine_9\VB\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) parkinsonism_14\NN\14085708
C084820_D010302 NONE ethopropazine_0\NN\0 (r_nsubjpass) found_4\VBN\13279262 (l_xcomp) be_6\VB\14625458 (l_acomp) effective_8\JJ\0 (l_prep) in_9\IN\13603305 (l_pcomp) controlling_10\VBG\0 (l_dobj) symptoms_12\NNS\5823932
D001590_D001008 CID benztropine_2\NN\0 (r_nsubj) had_5\VBD\0 (l_conj) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582
D001590_D012559 NONE benztropine_9\VB\0 (l_advcl) induced_15\VBN\1627355 (l_agent) by_16\IN\0 (l_pobj) fluphenazine_17\JJ\3713736 (l_amod) enanthate_18\NN\0 (l_prep) in_19\IN\13603305 (l_pobj) outpatients_22\NNS\10405694 (l_amod) schizophrenic_21\JJ\10490141
D001590_D003866 CID benztropine_2\NN\0 (r_nsubj) had_5\VBD\0 (l_conj) treated_28\VBN\2376958 (l_nsubj) anxiety_23\NN\14373582 (l_conj) depression_25\NN\14373582
591536
D006493_D001791 NONE heparin_8\VBN\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) aggregation_12\NN\31264
D006493_D013921 CID heparin_6\JJ\2718259 (r_compound) therapy_7\NN\657604 (r_dobj) receiving_4\VBG\2210855 (r_acl) patients_3\NNS\9898892 (r_pobj) in_2\IN\13603305 (r_prep) thromboembolism_1\NN\14100769 (l_appos) complication_10\NN\1073995 (l_acl) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) thrombocytopenia_16\NN\14189204
D006493_D013921 CID heparin_13\NN\2718259 (r_npadvmod) induced_15\VBN\1627355 (r_amod) thrombocytopenia_16\NN\14189204
D006493_D013921 CID heparin_24\JJ\2718259 (r_compound) therapy_25\NN\657604 (r_pobj) of_23\IN\0 (r_prep) initiation_22\NN\7450842 (r_pobj) after_20\IN\0 (r_prep) occurring_15\VBG\0 (r_pcomp) by_7\IN\0 (r_prep) occlusion_6\NN\14081375 (l_acl) preceded_27\VBN\0 (l_agent) by_28\IN\0 (l_pobj) thrombocytopenia_30\NN\14189204
D006493_D013921 CID heparin_8\VBN\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) aggregation_12\NN\31264 (r_attr) is_7\VBZ\0 (l_nsubj) factor_2\NN\7326557 (l_acl) relating_3\VBG\628491 (l_dobj) thromboembolism_4\NN\14100769 (l_conj) thrombocytopenia_6\NN\14189204
D006493_D001157 CID heparin_24\JJ\2718259 (r_compound) therapy_25\NN\657604 (r_pobj) of_23\IN\0 (r_prep) initiation_22\NN\7450842 (r_pobj) after_20\IN\0 (r_prep) occurring_15\VBG\0 (r_pcomp) by_7\IN\0 (r_prep) occlusion_6\NN\14081375
D006493_D013923 NONE heparin_6\JJ\2718259 (r_compound) therapy_7\NN\657604 (r_dobj) receiving_4\VBG\2210855 (r_acl) patients_3\NNS\9898892 (r_pobj) in_2\IN\13603305 (r_prep) thromboembolism_1\NN\14100769
D006493_D013923 NONE heparin_13\NN\2718259 (r_npadvmod) induced_15\VBN\1627355 (r_amod) thrombocytopenia_16\NN\14189204 (r_pobj) with_12\IN\0 (r_prep) associated_11\VBN\628491 (r_acl) complication_10\NN\1073995 (r_appos) thromboembolism_1\NN\14100769
D006493_D013923 NONE heparin_8\JJ\2718259 (r_compound) therapy_9\NN\657604 (r_pobj) of_6\IN\0 (r_prep) complication_5\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) thromboembolism_1\NN\14100769
D006493_D013923 NONE heparin_8\VBN\2718259 (r_npadvmod) induced_10\VBN\1627355 (r_amod) aggregation_12\NN\31264 (r_attr) is_7\VBZ\0 (l_nsubj) factor_2\NN\7326557 (l_acl) relating_3\VBG\628491 (l_dobj) thromboembolism_4\NN\14100769
D006493_D013927 NONE heparin_24\JJ\2718259 (r_compound) therapy_25\NN\657604 (r_pobj) of_23\IN\0 (r_prep) initiation_22\NN\7450842 (r_pobj) after_20\IN\0 (r_prep) occurring_15\VBG\0 (r_pcomp) by_7\IN\0 (l_pobj) thrombi_11\NN\5402091
D006493_D007511 NONE heparin_24\JJ\2718259 (r_compound) therapy_25\NN\657604 (r_pobj) of_23\IN\0 (r_prep) initiation_22\NN\7450842 (r_pobj) after_20\IN\0 (r_prep) occurring_15\VBG\0 (r_pcomp) by_7\IN\0 (l_pobj) thrombi_11\NN\5402091 (l_prep) with_12\IN\0 (l_pobj) ischemia_14\NN\14195315
133615
D003276_D013923 NONE contraceptive_6\NN\3183080 (r_amod) therapy_7\NN\657604 (r_pobj) of_4\IN\0 (r_prep) complications_3\NNS\1073995 (l_amod) thromboembolic_0\JJ\0
D003276_D001778 CID contraceptive_6\NN\3183080 (r_amod) therapy_7\NN\657604 (r_pobj) of_4\IN\0 (r_prep) complications_3\NNS\1073995 (l_prep) in_8\IN\13603305 (l_pobj) relationship_9\NN\31921 (l_prep) to_10\IN\0 (l_pobj) levels_12\NNS\4916342 (l_prep) of_13\IN\0 (l_pobj) factors_16\NNS\7326557 (l_compound) coagulation_15\NN\13518963
19944333
C471405_D003329 CID sorafenib_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_prep) due_6\IN\5174653 (l_pobj) spasm_10\NN\14299637
C471405_D003329 CID sorafenib_6\NN\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) spasm_11\NN\14299637
D020108_D060050 NONE nicorandil_3\NN\0 (r_pobj) of_1\IN\0 (r_prep) addition_0\NN\3081021 (r_nsubj) reduced_4\VBD\441445 (l_conj) maintained_8\VBD\0 (l_dobj) status_11\NN\24720 (l_compound) angina_10\NN\14171682
C471405_D009203 NONE sorafenib_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) infarction_5\NN\14204950
16174948
D003042_D013345 CID cocaine_6\NN\3492717 (r_npadvmod) associated_8\VBN\628491 (r_amod) hemorrhage_10\NN\14285662
D003042_D013345 CID cocaine_12\NN\3492717 (r_npadvmod) associated_14\VBN\628491 (r_amod) hemorrhage_16\NN\14285662
D003042_D013345 CID cocaine_12\NN\3492717 (r_npadvmod) associated_14\VBN\628491 (r_amod) hemorrhage_16\NN\14285662 (l_appos) sah_18\NNP\0
D003042_D013345 CID cocaine_25\NN\3492717 (r_compound) use_26\NN\407535 (r_pobj) after_24\IN\0 (r_prep) underwent_21\VBD\109660 (r_relcl) hemorrhage_16\NN\14285662
D003042_D013345 CID cocaine_25\NN\3492717 (r_compound) use_26\NN\407535 (r_pobj) after_24\IN\0 (r_prep) underwent_21\VBD\109660 (r_relcl) hemorrhage_16\NN\14285662 (l_appos) sah_18\NNP\0
D003042_D013345 CID cocaine_14\NN\3492717 (r_pobj) for_13\IN\0 (r_prep) toxicology_12\NN\6054892 (r_pobj) with_9\IN\0 (r_prep) those_8\DT\0 (r_dobj) identified_7\VBD\699815 (r_conj) screened_1\VBD\2533282 (l_dobj) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) sah_4\NNP\0
D003042_D013345 CID cocaine_31\NN\3492717 (r_compound) use_32\NN\407535 (r_pobj) with_30\IN\0 (r_prep) associated_29\VBN\628491 (r_acl) sah_28\NNP\0
D003042_D014657 NONE cocaine_0\NN\3492717 (r_compound) use_1\NN\407535 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) complications_7\NNS\1073995 (l_prep) including_9\VBG\0 (l_pobj) vasoconstriction_11\NN\1149911 (l_conj) vasculitis_13\NN\14336539
D003042_D014657 NONE cocaine_31\NN\3492717 (r_compound) use_32\NN\407535 (r_pobj) with_30\IN\0 (r_prep) associated_29\VBN\628491 (r_acl) sah_28\NNP\0 (r_pobj) after_26\IN\0 (r_prep) underwent_24\VBD\109660 (r_relcl) patients_22\NNS\9898892 (r_pobj) in_21\IN\13603305 (r_prep) found_20\VBN\13279262 (l_nsubjpass) evidence_2\NN\5816287 (l_prep) for_3\IN\0 (l_pobj) narrowing_4\VBG\5064037 (l_prep) of_5\IN\0 (l_pobj) arteries_8\NNS\5417975 (l_conj) evidence_12\NN\5816287 (l_prep) for_13\IN\0 (l_pobj) narrowing_15\NN\5064037 (l_conj) vasculitis_17\NN\14336539
D003042_D017542 CID cocaine_31\NN\3492717 (r_compound) use_32\NN\407535 (r_pobj) with_30\IN\0 (r_prep) associated_29\VBN\628491 (r_acl) sah_28\NNP\0 (l_amod) aneurysmal_27\NN\0
D003042_D013901 NONE cocaine_0\NN\3492717 (r_compound) use_1\NN\407535 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) complications_7\NNS\1073995
8267029
D010396_D001172 NONE penicillamine_0\NN\3740161 (r_nsubj) induced_2\VBN\1627355 (l_prep) in_6\IN\13603305 (l_pobj) patient_8\NN\9898892 (l_prep) with_9\IN\0 (l_pobj) arthritis_11\NN\14171682
D010396_D001172 NONE penicillamine_21\NN\3740161 (r_nmod) treatment_28\NN\654885 (r_pobj) of_18\IN\0 (r_prep) months_17\NNS\15113229 (r_pobj) after_15\IN\0 (r_prep) presented_8\VBD\2137132 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
D010396_D005921 CID penicillamine_0\NN\3740161 (r_nsubj) induced_2\VBN\1627355 (l_dobj) glomerulonephritis_5\NN\14113798
D010396_D005921 CID penicillamine_21\NN\3740161 (r_nmod) treatment_28\NN\654885 (r_pobj) of_18\IN\0 (r_prep) months_17\NNS\15113229 (r_pobj) after_15\IN\0 (r_prep) presented_8\VBD\2137132 (l_dobj) glomerulonephritis_11\NN\14113798
D010396_D005921 CID penicillamine_21\NN\3740161 (r_nmod) treatment_28\NN\654885 (r_pobj) of_18\IN\0 (r_prep) months_17\NNS\15113229 (r_pobj) after_15\IN\0 (r_prep) presented_8\VBD\2137132 (l_dobj) glomerulonephritis_11\NN\14113798 (l_appos) rpgn_13\NNP\0
D010396_D005921 CID penicillamine_11\NN\3740161 (r_compound) treatment_12\NN\654885 (r_pobj) of_8\IN\0 (r_prep) course_7\NN\883297 (r_pobj) in_5\IN\13603305 (r_prep) case_2\NN\7283608 (l_prep) of_3\IN\0 (l_pobj) rpgn_4\NNP\0
D010396_D011507 NONE penicillamine_11\NN\3740161 (r_compound) treatment_12\NN\654885 (r_pobj) of_8\IN\0 (r_prep) course_7\NN\883297 (r_pobj) in_5\IN\13603305 (r_prep) case_2\NN\7283608 (r_nsubj) emphasizes_13\VBZ\943837 (l_dobj) need_15\NN\13920835 (l_prep) for_16\IN\0 (l_pobj) monitoring_18\NN\879759 (l_prep) of_19\IN\0 (l_pobj) function_21\NN\13783581 (l_conj) evaluation_23\NN\874067 (l_prep) of_24\IN\0 (l_pobj) sediment_26\NN\20827 (l_conj) proteinuria_28\NN\14299637
2435991
D004837_D001145 CID adrenaline_10\RB\14807929 (r_npadvmod) induced_12\VBN\1627355 (r_conj) digitalis-_7\NN\0 (r_conj) ligation-_5\JJ\0 (r_nmod) arrhythmias_15\NNS\14103288
D004837_D001145 CID adrenaline_10\RB\14807929 (r_npadvmod) induced_12\VBN\1627355 (r_conj) digitalis-_7\NN\0 (r_conj) ligation-_5\JJ\0 (r_nmod) arrhythmias_15\NNS\14103288 (r_dobj) using_0\VBG\418025 (r_advcl) examined_22\VBN\0 (l_conj) determined_34\VBN\0 (l_nsubjpass) concentration_28\NN\4916342 (l_prep) for_29\IN\0 (l_pobj) model_32\NN\5888929 (l_compound) arrhythmia_31\NN\14103288
D004837_D001145 CID adrenaline_27\NN\14807929 (r_conj) digitalis_24\NN\15059939 (r_conj) ligation_22\NN\149084 (r_appos) ligation_18\NN\149084 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_conj) suppressed_1\VBD\2510337 (l_dobj) arrhythmias_4\NNS\14103288
D004837_D001145 CID adrenaline_27\NN\14807929 (r_conj) digitalis_24\NN\15059939 (r_conj) ligation_22\NN\149084 (r_appos) ligation_18\NN\149084 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_nsubj) concentrations_11\NNS\4916342 (l_prep) for_12\IN\0 (l_pobj) arrhythmias_13\NNS\14103288
D004837_D001145 CID adrenaline_3\NN\14807929 (r_npadvmod) induced_5\VBN\1627355 (r_amod) arrhythmia_6\NN\14103288
D004837_D001145 CID adrenaline_3\NN\14807929 (r_npadvmod) induced_5\VBN\1627355 (r_amod) arrhythmia_6\NN\14103288 (r_pobj) for_2\IN\0 (r_prep) concentration_1\NN\4916342 (r_nsubj) was_7\VBD\0 (l_acomp) higher_9\JJR\0 (l_prep) than_10\IN\0 (l_pobj) those_11\DT\0 (l_prep) for_12\IN\0 (l_pobj) types_15\NNS\5839024 (l_prep) of_16\IN\0 (l_pobj) arrhythmias_17\NNS\14103288
C032151_D007022 NONE cibenzoline_1\NN\0 (r_nsubj) had_2\VBD\0 (l_dobj) effects_10\NNS\13245626 (l_nmod) node_8\NN\13870805 (l_amod) hypotensive_5\JJ\10405694
D004071_D001145 CID digitalis-_7\NN\0 (r_conj) ligation-_5\JJ\0 (r_nmod) arrhythmias_15\NNS\14103288
D004071_D001145 CID digitalis-_7\NN\0 (r_conj) ligation-_5\JJ\0 (r_nmod) arrhythmias_15\NNS\14103288 (r_dobj) using_0\VBG\418025 (r_advcl) examined_22\VBN\0 (l_conj) determined_34\VBN\0 (l_nsubjpass) concentration_28\NN\4916342 (l_prep) for_29\IN\0 (l_pobj) model_32\NN\5888929 (l_compound) arrhythmia_31\NN\14103288
D004071_D001145 CID digitalis_24\NN\15059939 (r_conj) ligation_22\NN\149084 (r_appos) ligation_18\NN\149084 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_conj) suppressed_1\VBD\2510337 (l_dobj) arrhythmias_4\NNS\14103288
D004071_D001145 CID digitalis_24\NN\15059939 (r_conj) ligation_22\NN\149084 (r_appos) ligation_18\NN\149084 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_nsubj) concentrations_11\NNS\4916342 (l_prep) for_12\IN\0 (l_pobj) arrhythmias_13\NNS\14103288
C032151_D003866 NONE cibenzoline_1\NN\0 (r_nsubj) had_2\VBD\0 (l_dobj) effects_10\NNS\13245626 (l_amod) depressive_9\JJ\10595647
C032151_D001145 NONE cibenzoline_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (l_prep) on_5\IN\0 (l_pobj) arrhythmias_8\NNS\14103288
C032151_D001145 NONE cibenzoline_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) effects_18\NNS\13245626 (r_nsubjpass) examined_22\VBN\0 (l_advcl) using_0\VBG\418025 (l_dobj) arrhythmias_15\NNS\14103288
C032151_D001145 NONE cibenzoline_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) effects_18\NNS\13245626 (r_nsubjpass) examined_22\VBN\0 (l_conj) determined_34\VBN\0 (l_nsubjpass) concentration_28\NN\4916342 (l_prep) for_29\IN\0 (l_pobj) model_32\NN\5888929 (l_compound) arrhythmia_31\NN\14103288
C032151_D001145 NONE cibenzoline_0\NNP\0 (r_nsubj) suppressed_1\VBD\2510337 (l_dobj) arrhythmias_4\NNS\14103288
C032151_D001145 NONE cibenzoline_0\NNP\0 (r_nsubj) suppressed_1\VBD\2510337 (l_conj) induced_14\VBN\1627355 (l_nsubj) concentrations_11\NNS\4916342 (l_prep) for_12\IN\0 (l_pobj) arrhythmias_13\NNS\14103288
C032151_D001145 NONE cibenzoline_1\NN\0 (r_nsubj) had_2\VBD\0 (l_advcl) given_19\VBN\5892096 (l_prep) to_20\IN\0 (l_pobj) dogs_24\NNS\2083346 (l_compound) arrhythmia_23\NN\14103288
7102237
D012601_D001049 NONE scopolamine_4\NN\14712692 (r_pobj) with_3\IN\0 (r_prep) premedicated_2\VBN\0 (r_acl) patients_1\NNS\9898892 (r_pobj) in_0\IN\13603305 (r_prep) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D009567_D001049 NONE nitrazepam_11\NN\2830852 (r_amod) mg_10\IN\13717155 (r_conj) scopolamine_4\NN\14712692 (r_pobj) with_3\IN\0 (r_prep) premedicated_2\VBN\0 (r_acl) patients_1\NNS\9898892 (r_pobj) in_0\IN\13603305 (r_prep) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D009020_D001049 NONE morphine_6\NN\2707683 (r_conj) scopolamine_4\NN\14712692 (r_pobj) with_3\IN\0 (r_prep) premedicated_2\VBN\0 (r_acl) patients_1\NNS\9898892 (r_pobj) in_0\IN\13603305 (r_prep) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D008874_D001049 CID midazolam_24\JJ\2830852 (r_pobj) of_23\IN\0 (r_prep) effect_22\NN\34213 (r_nsubj) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D008874_D001049 CID midazolam_50\JJ\2830852 (r_amod) group_51\NN\2137 (r_pobj) in_48\IN\13603305 (r_prep) found_47\VBN\13279262 (r_conj) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D008874_D001049 CID midazolam_62\JJ\2830852 (r_amod) group_63\NN\2137 (r_pobj) in_60\IN\13603305 (r_prep) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
D013874_D001049 CID thiopentone_36\NN\0 (r_pobj) of_35\IN\0 (r_prep) that_34\DT\0 (r_pobj) than_33\IN\0 (r_prep) onset_32\NN\7325190 (r_pobj) in_31\IN\13603305 (r_prep) slower_30\JJR\0 (r_acomp) was_28\VBD\0 (l_advcl) occurred_57\VBD\0 (l_nsubj) apnoea_56\NN\0
2051906
D001379_D017285 NONE azathioprine_30\NN\3740161 (r_amod) therapy_31\NN\657604 (r_pobj) of_29\IN\0 (r_prep) initiation_28\NN\7450842 (r_pobj) after_27\IN\0 (r_prep) developed_17\VBD\1753788 (l_nsubj) patient_4\NN\9898892 (l_prep) with_6\IN\0 (l_pobj) polymyositis_8\NN\14350292
D001379_D002779 CID azathioprine_7\JJ\3740161 (r_amod) therapy_8\NN\657604 (r_pobj) following_6\VBG\8180190 (r_prep) cholestasis_1\NN\14052403
D001379_D002779 CID azathioprine_7\JJ\3740161 (r_amod) therapy_8\NN\657604 (r_pobj) following_6\VBG\8180190 (r_prep) cholestasis_1\NN\14052403 (l_prep) with_2\IN\0 (l_pobj) injury_5\NN\14052046
D001379_D002779 CID azathioprine_30\NN\3740161 (r_amod) therapy_31\NN\657604 (r_pobj) of_29\IN\0 (r_prep) initiation_28\NN\7450842 (r_pobj) after_27\IN\0 (r_prep) developed_17\VBD\1753788 (l_dobj) features_21\NNS\5849040 (l_prep) of_22\IN\0 (l_pobj) cholestasis_24\NN\14052403
D001379_D002779 CID azathioprine_12\RB\3740161 (r_advmod) induced_14\VBN\1627355 (r_amod) cholestasis_15\NN\14052403
D001379_D002779 CID azathioprine_12\RB\3740161 (r_advmod) induced_14\VBN\1627355 (r_amod) cholestasis_15\NN\14052403 (l_acl) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) evidence_19\NN\5816287 (l_prep) of_20\IN\0 (l_pobj) injury_23\NN\14052046
D001379_D008107 NONE azathioprine_30\NN\3740161 (r_amod) therapy_31\NN\657604 (r_pobj) of_29\IN\0 (r_prep) initiation_28\NN\7450842 (r_pobj) after_27\IN\0 (r_prep) developed_17\VBD\1753788 (l_nsubj) patient_4\NN\9898892 (l_prep) with_6\IN\0 (l_conj) without_10\IN\0 (l_pobj) evidence_12\NN\5816287 (l_prep) of_13\IN\0 (l_pobj) disease_15\NN\14061805
803783
D010121_D001247 NONE oxytocin_0\NN\5407119 (r_compound) administration_1\NN\1133281 (r_nsubjpass) advocated_8\VBN\875394 (l_advcl) carried_14\VBN\1850315 (l_conj) instructed_33\VBD\831651 (l_xcomp) watch_35\VB\4437953 (l_conj) report_39\VB\6470073 (l_dobj) signs_42\NNS\6643763 (l_prep) as_46\IN\14622893 (l_pobj) asthenia_47\NNP\14547643
D010121_D001523 NONE oxytocin_0\NN\5407119 (r_compound) administration_1\NN\1133281 (r_nsubjpass) advocated_8\VBN\875394 (l_advcl) carried_14\VBN\1850315 (l_conj) instructed_33\VBD\831651 (l_xcomp) watch_35\VB\4437953 (l_conj) report_39\VB\6470073 (l_dobj) signs_42\NNS\6643763 (l_prep) as_46\IN\14622893 (l_pobj) asthenia_47\NNP\14547643 (l_conj) irritability_50\NN\7552087
D010121_D000031 NONE oxytocin_4\NN\5407119 (r_compound) administration_5\NN\1133281 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (l_prep) during_6\IN\0 (l_pobj) abortion_10\NN\209943
D010121_D000031 NONE oxytocin_8\NN\5407119 (r_compound) administration_9\NN\1133281 (r_pobj) with_7\IN\0 (r_prep) connection_6\NN\31921 (l_prep) during_10\IN\0 (l_pobj) abortions_14\NNS\209943
D010121_D000031 NONE oxytocin_0\NN\5407119 (r_compound) administration_1\NN\1133281 (l_prep) during_2\IN\0 (l_pobj) abortions_6\NNS\209943
D010121_D014869 CID oxytocin_4\NN\5407119 (r_compound) administration_5\NN\1133281 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) intoxication_1\NN\14034177
D010121_D014869 CID oxytocin_8\NN\5407119 (r_compound) administration_9\NN\1133281 (r_pobj) with_7\IN\0 (r_prep) connection_6\NN\31921 (r_pobj) in_5\IN\13603305 (r_prep) intoxication_4\NN\14034177
D010121_D014869 CID oxytocin_0\NN\5407119 (r_compound) administration_1\NN\1133281 (r_nsubjpass) advocated_8\VBN\875394 (l_advcl) carried_14\VBN\1850315 (l_advcl) aware_25\JJ\0 (l_prep) of_26\IN\0 (l_pobj) symptoms_28\NNS\5823932 (l_prep) of_29\IN\0 (l_pobj) intoxication_31\NN\14034177
D010121_D006261 NONE oxytocin_0\NN\5407119 (r_compound) administration_1\NN\1133281 (r_nsubjpass) advocated_8\VBN\875394 (l_advcl) carried_14\VBN\1850315 (l_conj) instructed_33\VBD\831651 (l_xcomp) watch_35\VB\4437953 (l_conj) report_39\VB\6470073 (l_dobj) signs_42\NNS\6643763 (l_prep) as_46\IN\14622893 (l_pobj) asthenia_47\NNP\14547643 (l_conj) irritability_50\NN\7552087 (l_conj) headaches_53\NNS\5829480
3001299
D008094_D007037 CID lithium_22\NN\14625458 (r_compound) treatment_23\NN\654885 (r_pobj) during_21\IN\0 (r_prep) development_13\NN\248977 (l_prep) of_14\IN\0 (l_pobj) insipidus_18\NN\0 (l_conj) hypothyroidism_20\NN\14059928
D008094_D007037 CID lithium_9\NN\14625458 (r_dobj) taking_8\VBG\37396 (r_advcl) developed_1\VBD\1753788 (l_nsubj) hypothyroidism_0\NN\14059928
D008094_D018500 NONE lithium_22\NN\14625458 (r_compound) treatment_23\NN\654885 (r_pobj) during_21\IN\0 (r_prep) development_13\NN\248977 (l_prep) of_14\IN\0 (l_pobj) insipidus_18\NN\0
1711760
D010656_D006973 CID phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371
D007530_D006973 NONE isoflurane_1\JJ\3570838 (r_amod) anesthesia_2\NN\14034177 (r_pobj) under_0\IN\0 (r_prep) occluded_12\VBN\2451370 (l_nsubjpass) mca_5\NNP\0 (l_prep) of_6\IN\0 (l_pobj) rats_10\NNS\2329401 (l_amod) hypertensive_9\JJ\10405694
C009591_D009410 NONE 2,3,5-triphenyltetrazolium_8\CD\0 (r_nummod) staining_9\VBG\275424 (r_pobj) by_7\IN\0 (r_agent) determined_6\VBN\0 (l_nsubjpass) extent_1\NN\13939892 (l_prep) of_2\IN\0 (l_pobj) injury_4\NN\14052046
D010656_D009410 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_dobj) edema_16\NN\14315192 (l_acl) improves_24\VBZ\126264 (l_conj) reduces_37\VBZ\441445 (l_dobj) area_39\NN\8630985 (l_prep) of_40\IN\0 (l_pobj) dysfunction_43\NN\14204950
D010656_D007511 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_dobj) edema_16\NN\14315192 (l_prep) in_17\IN\13603305 (l_pobj) core_20\NN\7996689 (l_amod) ischemic_19\JJ\0
D010656_D007511 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_dobj) edema_16\NN\14315192 (l_acl) improves_24\VBZ\126264 (l_dobj) edema_25\NN\14315192 (l_prep) in_26\IN\13603305 (l_pobj) periphery_28\NN\13903079 (l_prep) of_29\IN\0 (l_pobj) territory_32\NN\8630985 (l_amod) ischemic_31\JJ\0
D010656_D020244 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_nsubj) mcao_12\NNP\0
D010656_D004487 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_dobj) edema_16\NN\14315192
D010656_D004487 NONE phenylephrine_4\NN\2682038 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371 (r_nsubj) instituted_8\VBD\1641914 (l_advcl) aggravate_15\VB\126264 (l_dobj) edema_16\NN\14315192 (l_acl) improves_24\VBZ\126264 (l_dobj) edema_25\NN\14315192
20735774
D000082_D056486 NONE paracetamol_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) injury_14\NN\14052046
D000082_D056486 NONE paracetamol_16\RB\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) injury_20\NN\14052046
D000082_D017114 CID paracetamol_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) failure_15\NN\66216
D000082_D017114 CID paracetamol_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) failure_13\NN\66216
D000082_D017114 CID paracetamol_5\NN\0 (r_advmod) induced_7\VBN\1627355 (r_nmod) increases_11\VBZ\13576355 (l_nsubj) failure_10\NN\66216
D000082_D017114 CID paracetamol_16\RB\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) injury_20\NN\14052046 (r_nsubj) caused_22\VBN\1617192 (l_dobj) failure_26\NN\66216
D000082_D017114 CID paracetamol_16\RB\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) injury_20\NN\14052046 (r_nsubj) caused_22\VBN\1617192 (r_relcl) patients_14\NNS\9898892 (r_pobj) for_11\IN\0 (r_prep) higher_10\JJR\0 (r_acomp) were_8\VBD\0 (l_conj) was_46\VBD\0 (l_conj) died_58\VBD\146138 (l_nsubj) survivors_53\NNS\9630641 (l_prep) of_54\IN\0 (l_pobj) failure_57\NN\66216
D000082_D017114 CID paracetamol_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) failure_5\NN\66216
D000082_D008107 NONE paracetamol_16\RB\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) injury_20\NN\14052046 (r_nsubj) caused_22\VBN\1617192 (r_relcl) patients_14\NNS\9898892 (r_pobj) for_11\IN\0 (r_prep) higher_10\JJR\0 (r_acomp) were_8\VBD\0 (l_conj) was_46\VBD\0 (l_conj) died_58\VBD\146138 (l_prep) of_59\IN\0 (l_pobj) disease_61\NN\14061805
20705401
D012701_D006948 NONE serotonin_1\NN\14807737 (r_nsubjpass) targeted_9\VBN\1151110 (l_agent) by_10\IN\0 (l_pobj) antipsychotics_14\NNS\4470232 (l_prep) as_17\IN\14622893 (l_pobj) clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D012701_D006948 NONE 5-ht6_4\CD\0 (r_nummod) receptor_6\NN\5225602 (r_appos) serotonin_1\NN\14807737 (r_nsubjpass) targeted_9\VBN\1151110 (l_agent) by_10\IN\0 (l_pobj) antipsychotics_14\NNS\4470232 (l_prep) as_17\IN\14622893 (l_pobj) clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D012701_D006948 NONE 5-ht6_39\CD\0 (r_nummod) antagonist_41\NN\7846 (r_pobj) of_36\IN\0 (r_prep) use_35\NN\407535 (r_pobj) with_33\IN\0 (r_prep) corrected_32\VBN\138508 (r_conj) targeted_9\VBN\1151110 (l_agent) by_10\IN\0 (l_pobj) antipsychotics_14\NNS\4470232 (l_prep) as_17\IN\14622893 (l_pobj) clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D012701_D012559 NONE 5-ht6_20\CD\0 (r_nummod) receptors_21\NNS\5225602 (r_nsubjpass) involved_23\VBN\2676054 (r_ccomp) suggests_17\VBZ\1010118 (r_conj) considered_4\VBN\689344 (l_xcomp) reflect_6\VB\923793 (l_dobj) symptoms_9\NNS\5823932 (l_prep) of_10\IN\0 (l_pobj) schizophrenia_11\NN\14398067
C076029_D006948 NONE olanzapine_20\NN\0 (r_conj) clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D008694_D011605 CID methamphetamine_7\NN\2704153 (r_npadvmod) induced_9\VBN\1627355 (r_amod) psychosis_10\NN\14380140
D008694_D011605 CID methamphetamine_3\NN\2704153 (r_pobj) of_2\IN\0 (r_prep) symptoms_1\NNS\5823932 (l_appos) psychosis_6\NN\14380140
D008694_D011605 CID meth)-induced_5\JJ\0 (r_amod) psychosis_6\NN\14380140
D008694_D011605 CID meth_17\NNP\2704153 (r_npadvmod) induced_19\VBN\1627355 (r_amod) psychosis_20\NN\14380140
D008694_D011605 CID meth_29\NN\2704153 (r_npadvmod) induced_31\VBN\1627355 (r_amod) patients_33\NNS\9898892 (l_compound) psychosis_32\NN\14380140
D008694_D011605 CID meth_4\NNP\2704153 (r_npadvmod) induced_6\VBN\1627355 (r_amod) patients_8\NNS\9898892 (l_compound) psychosis_7\NN\14380140
D008694_D011605 CID meth_32\NNP\2704153 (r_npadvmod) induced_34\VBN\1627355 (r_amod) patients_36\NNS\9898892 (l_compound) psychosis_35\NN\14380140
D008694_D011605 CID meth_10\NNP\2704153 (r_npadvmod) induced_12\VBN\1627355 (r_amod) psychosis_13\NN\14380140
D012701_D011605 NONE serotonin_0\NN\14807737 (r_nmod) gene_3\NN\8459252 (r_nsubjpass) associated_5\VBN\628491 (l_prep) with_6\IN\0 (l_pobj) psychosis_10\NN\14380140
D012701_D011605 NONE 5-ht6_20\CD\0 (r_nummod) receptors_21\NNS\5225602 (r_nsubjpass) involved_23\VBN\2676054 (l_prep) in_24\IN\13603305 (l_pobj) pathophysiology_26\NN\0 (l_prep) of_27\IN\0 (l_pobj) disorders_29\NNS\14034177
D012701_D011605 NONE 5-ht6_11\CD\0 (r_nummod) gene_12\NN\8459252 (l_prep) with_16\IN\0 (l_pobj) psychosis_20\NN\14380140
D003024_D006948 NONE clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D003913_D006948 NONE amphetamine_25\NN\3248958 (r_npadvmod) induced_27\VBN\1627355 (r_conj) clozapine_18\NN\3713736 (l_conj) hyperactivity_28\NN\14052403
D008694_D012563 NONE methamphetamine_3\NN\2704153 (r_pobj) of_2\IN\0 (r_prep) symptoms_1\NNS\5823932 (r_nsubj) are_7\VBP\13600404 (l_acomp) similar_8\JJ\0 (l_prep) to_9\IN\0 (l_pobj) those_10\DT\0 (l_prep) of_11\IN\0 (l_pobj) schizophrenia_14\NN\14398067
D008694_D012563 NONE meth)-induced_5\JJ\0 (r_amod) psychosis_6\NN\14380140 (r_appos) symptoms_1\NNS\5823932 (r_nsubj) are_7\VBP\13600404 (l_acomp) similar_8\JJ\0 (l_prep) to_9\IN\0 (l_pobj) those_10\DT\0 (l_prep) of_11\IN\0 (l_pobj) schizophrenia_14\NN\14398067
14704468
C066440_D012640 NONE loreclezole_0\NNP\0 (r_nsubj) exerted_5\VBD\1158872 (l_advcl) reducing_16\VBG\13447361 (l_dobj) seizure_18\NN\14081375
18006530
D015742_D010146 CID propofol_9\NN\0 (r_pobj) with_5\IN\0 (r_prep) induction_4\NN\7450842 (r_pobj) during_3\IN\0 (r_prep) reduction_0\NN\351485 (l_prep) of_1\IN\0 (l_pobj) pain_2\NN\14299637
D015742_D010146 CID propofol_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) injection_2\NN\320852 (r_pobj) on_1\IN\0 (r_prep) pain_0\NN\14299637
D015742_D010146 CID propofol_3\JJ\0 (r_amod) pain_5\NN\14299637
D015742_D010146 CID propofol_15\JJ\0 (r_amod) infusion_16\NN\14589223 (r_dobj) starting_13\VBG\457382 (r_pcomp) before_12\IN\0 (r_prep) infusing_10\VBG\606335 (r_pcomp) by_9\IN\0 (r_prep) prevented_8\VBN\0 (l_nsubjpass) pain_5\NN\14299637
D015742_D010146 CID propofol_15\NN\0 (r_pobj) by_14\IN\0 (r_agent) caused_13\VBN\1617192 (r_acl) pain_12\NN\14299637
D015742_D010146 CID propofol_26\JJ\0 (r_amod) infusion_27\NN\14589223 (r_pobj) during_24\IN\0 (r_prep) using_18\VBG\418025 (r_advcl) evaluated_17\VBN\670261 (l_nsubjpass) pain_12\NN\14299637
D015742_D010146 CID propofol_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) anaesthesia_3\NN\14034177 (r_pobj) of_2\IN\0 (r_prep) induction_1\NN\7450842 (r_pobj) during_0\IN\0 (r_prep) achieved_19\VBN\2524171 (l_nsubjpass) reduction_13\NN\351485 (l_prep) in_14\IN\13603305 (l_pobj) pain_17\NN\14299637
D015742_D010146 CID propofol_15\JJ\0 (r_amod) pain_17\NN\14299637
C071741_D010146 NONE remifentanil_11\NN\0 (r_conj) propofol_9\NN\0 (r_pobj) with_5\IN\0 (r_prep) induction_4\NN\7450842 (r_pobj) during_3\IN\0 (r_prep) reduction_0\NN\351485 (l_prep) of_1\IN\0 (l_pobj) pain_2\NN\14299637
C071741_D010146 NONE remifentanil_11\NN\0 (r_dobj) infusing_10\VBG\606335 (r_pcomp) by_9\IN\0 (r_prep) prevented_8\VBN\0 (l_nsubjpass) pain_5\NN\14299637
C071741_D010146 NONE remifentanil_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) ce_23\NNP\14625458 (r_appos) concentration_21\NN\4916342 (l_relcl) prevent_28\VB\0 (l_dobj) pain_30\NN\14299637
C071741_D010146 NONE remifentanil_0\NN\0 (r_npadvmod) related_2\VBN\628491 (r_amod) complications_3\NNS\1073995 (r_nsubjpass) assessed_5\VBN\670261 (l_conj) evaluated_17\VBN\670261 (l_nsubjpass) pain_12\NN\14299637
C071741_D010146 NONE remifentanil_8\NN\0 (r_compound) infusion_9\NN\14589223 (r_pobj) during_6\IN\0 (r_prep) assessed_5\VBN\670261 (l_conj) evaluated_17\VBN\670261 (l_nsubjpass) pain_12\NN\14299637
C071741_D010146 NONE remifentanil_9\NN\0 (r_conj) propofol_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) anaesthesia_3\NN\14034177 (r_pobj) of_2\IN\0 (r_prep) induction_1\NN\7450842 (r_pobj) during_0\IN\0 (r_prep) achieved_19\VBN\2524171 (l_nsubjpass) reduction_13\NN\351485 (l_prep) in_14\IN\13603305 (l_pobj) pain_17\NN\14299637
C071741_D010146 NONE remifentanil_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) administration_25\NN\1133281 (r_pobj) by_23\IN\0 (r_prep) complications_22\NNS\1073995 (r_pobj) without_20\IN\0 (r_prep) achieved_19\VBN\2524171 (l_nsubjpass) reduction_13\NN\351485 (l_prep) in_14\IN\13603305 (l_pobj) pain_17\NN\14299637
8045270
C061282_D002375 CID 21680_29\CD\0 (r_nummod) cgs_28\NNP\13577934 (r_appos) agonist_26\NN\0 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) responses_16\NNS\11410625 (l_amod) cataleptic_15\JJ\10490141
D006220_D002375 CID haloperidol_7\NN\3713736 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (r_acl) catalepsy_4\NN\14023236
D000241_D002375 NONE adenosine_23\NN\14964367 (r_amod) agonist_26\NN\0 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) responses_16\NNS\11410625 (l_amod) cataleptic_15\JJ\10490141
C081198_D010302 NONE kf17837_2\NN\0 (r_nsubj) be_4\VB\14625458 (l_attr) drug_7\NN\14778436 (l_prep) in_8\IN\13603305 (l_pobj) treatment_10\NN\654885 (l_prep) of_11\IN\0 (l_pobj) parkinsonism_12\NN\14085708
C081198_D002375 NONE kf17837_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) ameliorated_13\VBD\126264 (l_dobj) responses_16\NNS\11410625 (l_amod) cataleptic_15\JJ\10490141
C081198_D002375 NONE kf17837_0\NN\0 (r_nsubj) reduced_2\VBD\441445 (l_dobj) catalepsy_4\NN\14023236
D012110_D002375 CID reserpine_15\NN\2721160 (r_pobj) by_14\IN\0 (r_conj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (r_acl) catalepsy_4\NN\14023236
17344330
D008691_D008133 CID methadone_8\NN\3808564 (r_pobj) with_7\IN\0 (r_prep) treated_6\VBN\2376958 (r_acl) patients_5\NNS\9898892 (r_pobj) among_4\IN\0 (r_prep) syncope_0\NNP\7478169 (l_conj) prolongation_3\NN\1017987
D008691_D008133 CID methadone_5\NN\3808564 (r_pobj) with_4\IN\0 (r_prep) treated_3\VBN\2376958 (r_acl) subjects_2\NNS\6598915 (r_pobj) among_0\IN\0 (r_prep) had_14\VBD\0 (l_dobj) interval_17\NN\33615
D008691_D008133 CID methadone_0\NNP\3808564 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) prolongation_5\NN\1017987
D003932_D016171 NONE heroin_1\NN\3492717 (r_compound) addicts_2\NNS\10059582 (r_nsubj) faint_4\JJ\7478169 (r_advcl) attribute_12\VB\5835747 (l_conj) underestimate_24\VBP\5803379 (l_dobj) incidence_26\NN\13821570 (l_prep) of_27\IN\0 (l_pobj) tdp_28\NNP\0
D003932_D013575 NONE heroin_10\NN\3492717 (r_compound) dependence_11\NN\24720 (r_pobj) for_9\IN\0 (r_prep) treated_6\VBN\2376958 (r_acl) patients_5\NNS\9898892 (r_pobj) among_4\IN\0 (r_prep) syncope_0\NNP\7478169
D003932_D013575 NONE heroin_1\NN\3492717 (r_compound) addicts_2\NNS\10059582 (r_nsubj) faint_4\JJ\7478169 (r_advcl) attribute_12\VB\5835747 (l_dobj) episodes_15\NNS\7283608 (l_prep) of_16\IN\0 (l_pobj) syncope_17\NN\7478169
D003932_D013575 NONE heroin_15\NN\3492717 (r_compound) addicts_16\NNS\10059582 (r_pobj) of_14\IN\0 (r_prep) population_13\NN\7942152 (r_pobj) in_11\IN\13603305 (r_prep) syncope_10\NN\7478169
D008691_D013575 CID methadone_8\NN\3808564 (r_pobj) with_7\IN\0 (r_prep) treated_6\VBN\2376958 (r_acl) patients_5\NNS\9898892 (r_pobj) among_4\IN\0 (r_prep) syncope_0\NNP\7478169
D008691_D013575 CID methadone_53\NN\3808564 (r_pobj) of_52\IN\0 (r_prep) effect_51\NN\34213 (r_pobj) by_48\IN\0 (r_agent) caused_47\VBN\1617192 (r_conj) attribute_12\VB\5835747 (l_dobj) episodes_15\NNS\7283608 (l_prep) of_16\IN\0 (l_pobj) syncope_17\NN\7478169
D008691_D013575 CID methadone_9\NN\3808564 (r_compound) dose_10\NN\3740161 (l_conj) reporting_12\NN\6681177 (l_prep) of_13\IN\0 (l_pobj) syncope_14\NN\7478169
D008691_D013575 CID methadone_4\NN\3808564 (r_compound) dose_5\NN\3740161 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) ci_14\NNP\13635336 (l_appos) odds_21\NNS\4756635 (l_prep) for_22\IN\0 (l_pobj) syncope_23\NN\7478169
D008691_D013575 CID methadone_0\NNP\3808564 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) prolongation_5\NN\1017987 (l_conj) reporting_8\NN\6681177 (l_prep) of_9\IN\0 (l_pobj) syncope_10\NN\7478169
D003932_D008133 NONE heroin_10\NN\3492717 (r_compound) dependence_11\NN\24720 (r_pobj) for_9\IN\0 (r_prep) treated_6\VBN\2376958 (r_acl) patients_5\NNS\9898892 (r_pobj) among_4\IN\0 (r_prep) syncope_0\NNP\7478169 (l_conj) prolongation_3\NN\1017987
D003932_D008133 NONE heroin_15\NN\3492717 (r_compound) addicts_16\NNS\10059582 (r_pobj) of_14\IN\0 (r_prep) population_13\NN\7942152 (r_pobj) in_11\IN\13603305 (r_prep) syncope_10\NN\7478169 (r_pobj) of_9\IN\0 (r_prep) reporting_8\NN\6681177 (r_conj) prolongation_5\NN\1017987
D008691_D016171 NONE methadone_21\NN\3808564 (r_compound) users_22\NNS\7846 (r_pobj) in_20\IN\13603305 (r_prep) reported_19\VBN\831651 (l_nsubjpass) prolongation_0\NN\1017987 (l_prep) of_1\IN\0 (l_pobj) interval_4\NN\33615 (l_prep) in_5\IN\13603305 (l_pobj) ecg_7\NNP\7000195 (l_prep) of_8\IN\0 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) pointes_13\FW\831651
D008691_D016171 NONE methadone_21\NN\3808564 (r_compound) users_22\NNS\7846 (r_pobj) in_20\IN\13603305 (r_prep) reported_19\VBN\831651 (l_nsubjpass) prolongation_0\NN\1017987 (l_prep) of_1\IN\0 (l_pobj) interval_4\NN\33615 (l_prep) in_5\IN\13603305 (l_pobj) ecg_7\NNP\7000195 (l_prep) of_8\IN\0 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) pointes_13\FW\831651 (l_appos) tdp_15\NN\0
D008691_D016171 NONE methadone_53\NN\3808564 (r_pobj) of_52\IN\0 (r_prep) effect_51\NN\34213 (r_pobj) by_48\IN\0 (r_agent) caused_47\VBN\1617192 (r_conj) attribute_12\VB\5835747 (l_conj) underestimate_24\VBP\5803379 (l_dobj) incidence_26\NN\13821570 (l_prep) of_27\IN\0 (l_pobj) tdp_28\NNP\0
9799166
D000661_D020521 CID amphetamine_4\NN\3248958 (r_conj) cocaine_2\NN\3492717 (r_conj) stroke_0\NN\556313
D000661_D020521 CID amphetamine_5\NN\3248958 (r_compound) use_6\NN\407535 (r_conj) cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) association_1\NN\8008335 (l_prep) with_7\IN\0 (l_pobj) stroke_11\NN\556313
D000661_D020521 CID amphetamine_13\NN\3248958 (r_conj) cocaine_11\NN\3492717 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_conj) stroke_7\NN\556313
D000661_D020521 CID amphetamine_15\NN\3248958 (r_conj) cocaine_13\NN\3492717 (r_dobj) using_12\VBG\418025 (r_pcomp) to_11\IN\0 (r_prep) admitted_10\VBD\822367 (r_relcl) stroke_6\NN\556313
D000661_D020521 CID amphetamine_5\NN\3248958 (r_conj) cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubj) is_6\VBZ\0 (l_attr) factor_10\NN\7326557 (l_prep) for_11\IN\0 (l_pobj) stroke_12\NN\556313
D003042_D007511 NONE cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) association_1\NN\8008335 (l_prep) with_7\IN\0 (l_pobj) stroke_11\NN\556313 (l_amod) hemorrhagic_8\JJ\0 (l_conj) ischemic_10\JJ\0
D000661_D007511 NONE amphetamine_5\NN\3248958 (r_compound) use_6\NN\407535 (r_conj) cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) association_1\NN\8008335 (l_prep) with_7\IN\0 (l_pobj) stroke_11\NN\556313 (l_amod) hemorrhagic_8\JJ\0 (l_conj) ischemic_10\JJ\0
D003042_D020521 CID cocaine_2\NN\3492717 (r_conj) stroke_0\NN\556313
D003042_D020521 CID cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) association_1\NN\8008335 (l_prep) with_7\IN\0 (l_pobj) stroke_11\NN\556313
D003042_D020521 CID cocaine_11\NN\3492717 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_conj) stroke_7\NN\556313
D003042_D020521 CID cocaine_13\NN\3492717 (r_dobj) using_12\VBG\418025 (r_pcomp) to_11\IN\0 (r_prep) admitted_10\VBD\822367 (r_relcl) stroke_6\NN\556313
D003042_D020521 CID cocaine_3\NN\3492717 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubj) is_6\VBZ\0 (l_attr) factor_10\NN\7326557 (l_prep) for_11\IN\0 (l_pobj) stroke_12\NN\556313
11226639
D008550_D053608 CID melatonin_3\NN\5407119 (l_prep) on_4\IN\0 (l_pobj) narcosis_8\NN\5678932
D008550_D053608 CID melatonin_0\NNP\5407119 (r_nsubj) affects_1\VBZ\26192 (l_conj) is_11\VBZ\0 (l_ccomp) influence_17\VB\5190804 (l_dobj) narcosis_21\NN\5678932
D008550_D053608 CID melatonin_0\NNP\5407119 (r_nsubjpass) found_20\VBN\13279262 (l_punct) ,_11\,\0 (l_punct) affected_4\VBN\126264 (l_prep) in_5\IN\13603305 (l_pobj) narcosis_10\NN\5678932
D008550_D053608 CID melatonin_7\NN\5407119 (r_pobj) of_6\IN\0 (r_prep) dose_5\NN\3740161 (r_nsubj) caused_12\VBD\1617192 (l_conj) produced_20\VBD\1617192 (l_dobj) reduction_23\NN\351485 (l_prep) of_24\IN\0 (l_pobj) duration_26\NN\15113229 (l_prep) of_27\IN\0 (l_pobj) narcosis_28\NN\5678932
D008550_D053608 CID melatonin_0\NNP\5407119 (r_nsubj) influenced_5\VBD\137313 (l_dobj) duration_7\NN\15113229 (l_conj) latency_11\NN\15269513 (l_prep) of_12\IN\0 (l_pobj) narcosis_18\NN\5678932
D008550_D053608 CID melatonin_6\NN\5407119 (l_prep) on_7\IN\0 (l_pobj) narcosis_9\NN\5678932
D007649_D053608 CID ketamine-_13\NNS\0 (r_nmod) narcosis_18\NN\5678932
C032232_D053608 NONE barbiturate_5\NN\4166841 (r_npadvmod) induced_7\VBN\1627355 (r_amod) narcosis_8\NN\5678932
C032232_D053608 NONE barbiturate_9\NN\4166841 (r_compound) narcosis_10\NN\5678932
C032232_D053608 NONE barbiturate_14\NN\4166841 (r_compound) narcosis_15\NN\5678932
C032232_D053608 NONE barbiturate_16\JJ\4166841 (r_compound) mechanism_17\NN\13446390 (r_pobj) for_14\IN\0 (r_prep) specific_13\JJ\5817396 (r_acomp) be_12\VB\14625458 (r_xcomp) seems_10\VBZ\2604760 (l_nsubj) action_4\NN\30358 (l_prep) of_5\IN\0 (l_pobj) melatonin_6\NN\5407119 (l_prep) on_7\IN\0 (l_pobj) narcosis_9\NN\5678932
D003975_D053608 CID diazepam_15\NN\2830852 (r_npadvmod) induced_17\VBN\1627355 (r_conj) ketamine-_13\NNS\0 (r_nmod) narcosis_18\NN\5678932
2894433
D001569_D001919 NONE benzodiazepine_36\JJ\3771443 (r_amod) complex_43\NN\5869584 (r_pobj) with_34\IN\0 (r_prep) associated_33\VBN\628491 (r_acl) sites_32\NNS\8673395 (r_pobj) to_31\IN\0 (r_prep) binding_30\VBG\4688246 (r_pcomp) by_29\IN\0 (r_prep) blocks_26\NNS\21939 (r_appos) picrotoxin_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) dose_20\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) pretreatment_14\NN\0 (r_pobj) by_13\IN\0 (r_agent) antagonized_12\VBN\1787955 (l_nsubjpass) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D001569_D001919 NONE benzodiazepine_8\JJ\3771443 (r_amod) complex_15\NN\5869584 (r_pobj) through_6\IN\0 (r_prep) acts_5\VBZ\0 (l_advcl) facilitate_22\VB\2547586 (l_dobj) bradycardia_24\NN\14110674
D005680_D001919 NONE gaba_38\NNP\14601829 (r_compound) chloride_40\NN\14818238 (r_compound) complex_43\NN\5869584 (r_pobj) with_34\IN\0 (r_prep) associated_33\VBN\628491 (r_acl) sites_32\NNS\8673395 (r_pobj) to_31\IN\0 (r_prep) binding_30\VBG\4688246 (r_pcomp) by_29\IN\0 (r_prep) blocks_26\NNS\21939 (r_appos) picrotoxin_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) dose_20\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) pretreatment_14\NN\0 (r_pobj) by_13\IN\0 (r_agent) antagonized_12\VBN\1787955 (l_nsubjpass) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D005680_D001919 NONE gaba_10\NNP\14601829 (r_compound) chloride_12\NN\14818238 (r_compound) complex_15\NN\5869584 (r_pobj) through_6\IN\0 (r_prep) acts_5\VBZ\0 (l_advcl) facilitate_22\VB\2547586 (l_dobj) bradycardia_24\NN\14110674
D004837_D001919 CID adrenaline_12\NN\14807929 (r_pobj) of_11\IN\0 (r_prep) infusion_10\NN\14589223 (r_pobj) by_8\IN\0 (r_agent) produced_5\VBN\1617192 (l_nsubjpass) bradycardia_3\NN\14110674
D004837_D001919 CID adrenaline_14\NN\14807929 (r_npadvmod) induced_16\VBN\1627355 (r_amod) effect_18\NN\34213 (r_pobj) in_12\IN\13603305 (r_prep) change_11\NN\7283608 (r_dobj) causing_9\VBG\30358 (r_advcl) pretreatment_1\NN\0 (r_nsubj) enhance_21\VB\227165 (l_dobj) bradycardia_27\NN\14110674
D004837_D001919 CID adrenaline_23\NN\14807929 (r_npadvmod) induced_25\VBN\1627355 (r_amod) bradycardia_27\NN\14110674
D004837_D001919 CID adrenaline_6\NN\14807929 (r_npadvmod) induced_8\VBN\1627355 (r_amod) bradycardia_10\NN\14110674
D010852_D001919 NONE picrotoxin_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) dose_20\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) pretreatment_14\NN\0 (r_pobj) by_13\IN\0 (r_agent) antagonized_12\VBN\1787955 (l_nsubjpass) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D002712_D001919 NONE chloride_27\NN\14818238 (r_compound) channels_28\NNS\6251781 (r_dobj) blocks_26\NNS\21939 (r_appos) picrotoxin_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) dose_20\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) pretreatment_14\NN\0 (r_pobj) by_13\IN\0 (r_agent) antagonized_12\VBN\1787955 (l_nsubjpass) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D002712_D001919 NONE chloride_40\NN\14818238 (r_compound) complex_43\NN\5869584 (r_pobj) with_34\IN\0 (r_prep) associated_33\VBN\628491 (r_acl) sites_32\NNS\8673395 (r_pobj) to_31\IN\0 (r_prep) binding_30\VBG\4688246 (r_pcomp) by_29\IN\0 (r_prep) blocks_26\NNS\21939 (r_appos) picrotoxin_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) dose_20\NN\3740161 (r_pobj) with_17\IN\0 (r_prep) pretreatment_14\NN\0 (r_pobj) by_13\IN\0 (r_agent) antagonized_12\VBN\1787955 (l_nsubjpass) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D002712_D001919 NONE chloride_12\NN\14818238 (r_compound) complex_15\NN\5869584 (r_pobj) through_6\IN\0 (r_prep) acts_5\VBZ\0 (l_advcl) facilitate_22\VB\2547586 (l_dobj) bradycardia_24\NN\14110674
D003975_D001919 CID diazepam_0\NNP\2830852 (r_nsubj) facilitates_1\VBZ\2547586 (l_dobj) bradycardia_3\NN\14110674
D003975_D001919 CID diazepam_6\NN\2830852 (r_pobj) with_5\IN\0 (r_prep) pretreatment_1\NN\0 (r_nsubj) enhance_21\VB\227165 (l_dobj) bradycardia_27\NN\14110674
D003975_D001919 CID diazepam_3\NN\2830852 (r_compound) enhancement_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) bradycardia_10\NN\14110674
D003975_D001919 CID diazepam_4\NN\2830852 (r_nsubj) acts_5\VBZ\0 (l_advcl) facilitate_22\VB\2547586 (l_dobj) bradycardia_24\NN\14110674
7905523
D015215_D015658 NONE zidovudine_15\NN\3834836 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) infection_20\NN\14052046
C059896_D007153 NONE sc-48334_2\VBP\0 (r_nmod) level_7\NN\4916342 (r_nsubj) was_16\VBD\0 (l_prep) below_17\IN\0 (l_pobj) concentration_22\NN\4916342 (l_prep) for_23\IN\0 (l_pobj) virus_26\NN\9312843 (l_compound) immunodeficiency_25\NN\13973990
C059896_D015658 NONE deoxynojirimycin_10\NNP\0 (l_conj) zidovudine_15\NN\3834836 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) infection_20\NN\14052046
C059896_D015658 NONE sc-48334_12\NNP\0 (r_appos) deoxynojirimycin_10\NNP\0 (l_conj) zidovudine_15\NN\3834836 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) infection_20\NN\14052046
19289093
D002809_D007022 CID sulfate_19\NN\15010703 (r_nmod) derivative_23\NN\5802185 (l_relcl) elicit_26\VB\1617192 (l_dobj) response_29\NN\11410625 (l_amod) hypotensive_28\JJ\10405694
D006493_D007022 NONE heparin_8\JJ\2718259 (r_compound) products_9\NNS\3076708 (r_pobj) of_7\IN\0 (r_prep) lots_6\NNS\13757724 (r_pobj) of_4\IN\0 (r_prep) number_3\NN\5107765 (r_nsubjpass) found_11\VBN\13279262 (l_xcomp) contaminated_14\VBN\1534147 (l_prep) with_15\IN\0 (l_pobj) derivative_23\NN\5802185 (l_relcl) elicit_26\VB\1617192 (l_dobj) response_29\NN\11410625 (l_amod) hypotensive_28\JJ\10405694
D006493_D007022 NONE heparin_3\JJ\2718259 (r_compound) products_4\NNS\3076708 (r_dobj) using_0\VBG\418025 (r_advcl) showed_12\VBD\2137132 (l_ccomp) produces_16\VBZ\7555863 (l_dobj) hypotension_20\NN\14057371
12231232
C095756_D009127 NONE aida_0\NNP\0 (r_nsubj) diminished_9\VBD\169651 (l_dobj) rigidity_15\NN\5023233
D006220_D009127 CID haloperidol_0\NN\3713736 (r_nsubj) induced_6\VBD\1627355 (l_dobj) rigidity_11\NN\5023233
D006220_D009127 CID haloperidol_11\NN\3713736 (r_npadvmod) induced_13\VBN\1627355 (r_amod) rigidity_15\NN\5023233
D006220_D010300 NONE haloperidol_0\NN\3713736 (r_nsubj) induced_6\VBD\1627355 (l_dobj) rigidity_11\NN\5023233 (l_amod) parkinsonian_7\JJ\0
871943
D013390_D001049 CID succinylcholine_6\NN\3800001 (r_compound) apnoea_7\NN\0
D013390_D001049 CID succinylcholine_10\NN\3800001 (r_nsubjpass) treated_13\VBN\2376958 (r_advcl) demonstrating_2\VBG\2137132 (l_dobj) apnoea_5\NN\0
19692487
D015232_D011141 NONE )_29\-RRB-\0 (r_punct) pge(2_28\NNP\0 (r_appos) urine_27\NN\14853947 (r_pobj) of_25\IN\0 (r_prep) blockade_24\NN\952963 (r_pobj) by_21\IN\0 (r_agent) accompanied_20\VBN\0 (r_advcl) were_6\VBD\0 (l_acomp) resistant_8\JJ\0 (l_prep) to_9\IN\0 (l_pobj) polyuria_13\NN\14113228
D015232_D011141 NONE )_5\-RRB-\0 (r_punct) pge(2_4\NNP\0 (r_nsubj) mediates_6\VBZ\761713 (l_dobj) polyuria_10\NN\14113228
D008094_D011141 NONE lithium_6\NN\14625458 (r_npadvmod) induced_8\VBN\1627355 (r_amod) polyuria_9\NN\14113228
D008094_D011141 NONE lithium_8\NN\14625458 (r_npadvmod) induced_10\VBN\1627355 (r_amod) polyuria_11\NN\14113228
D008094_D011141 NONE lithium_7\NN\14625458 (r_npadvmod) induced_9\VBN\1627355 (r_amod) polyuria_10\NN\14113228
D008094_D011141 NONE lithium_10\NN\14625458 (r_npadvmod) induced_12\VBN\1627355 (r_amod) polyuria_13\NN\14113228
D011458_D011141 NONE e_17\NN\14724645 (r_appos) microsomal_15\JJ\0 (r_pobj) in_14\IN\13603305 (r_prep) deficient_13\JJ\0 (r_pobj) in_11\IN\13603305 (r_prep) polyuria_10\NN\14113228
2907585
-1_D002375 NONE piperazine_10\NN\4528630 (r_nmod) drugs_12\NNS\14778436 (r_pobj) by_6\IN\0 (r_prep) reversal_0\NN\199130 (l_prep) of_1\IN\0 (l_pobj) catalepsy_5\NN\14023236
-1_D002375 NONE piperazine_5\NN\4528630 (r_compound) analogues_6\NNS\4743605 (r_pobj) of_2\IN\0 (r_prep) series_1\NN\8456993 (r_nsubjpass) tested_14\VBN\670261 (l_conj) induced_21\VBN\1627355 (l_dobj) catalepsy_22\NN\14023236
D006220_D002375 CID haloperidol_11\NN\3713736 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) catalepsy_8\NN\14023236
D006220_D002375 CID haloperidol_20\NN\3713736 (r_dobj) reverse_19\VB\13854649 (r_acl) ability_17\NN\4723816 (r_pobj) for_15\IN\0 (r_prep) tested_14\VBN\670261 (l_conj) induced_21\VBN\1627355 (l_dobj) catalepsy_22\NN\14023236
D002065_D002375 NONE buspirone_5\NN\3771443 (r_appos) drug_3\NN\14778436 (r_nsubj) reverses_7\VBZ\13854649 (l_dobj) catalepsy_8\NN\14023236
D002065_D002375 NONE buspirone_8\NN\3771443 (r_pobj) of_7\IN\0 (r_prep) analogues_6\NNS\4743605 (r_pobj) of_2\IN\0 (r_prep) series_1\NN\8456993 (r_nsubjpass) tested_14\VBN\670261 (l_conj) induced_21\VBN\1627355 (l_dobj) catalepsy_22\NN\14023236
D058825_D002375 NONE agonists_12\NNS\0 (r_conj) buspirone_8\NN\3771443 (r_pobj) of_7\IN\0 (r_prep) analogues_6\NNS\4743605 (r_pobj) of_2\IN\0 (r_prep) series_1\NN\8456993 (r_nsubjpass) tested_14\VBN\670261 (l_conj) induced_21\VBN\1627355 (l_dobj) catalepsy_22\NN\14023236
D012701_D002375 NONE 5-hydroxytryptamine1a_6\CD\0 (r_compound) receptors_7\NNS\5225602 (r_pobj) for_5\IN\0 (r_prep) affinity_4\NN\11426530 (r_pobj) with_2\IN\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) were_8\VBD\0 (l_acomp) able_9\JJ\0 (l_xcomp) reverse_11\VB\13854649 (l_dobj) catalepsy_12\NN\14023236
D012701_D002375 NONE 5-ht_5\CD\0 (r_compound) receptors_6\NNS\5225602 (r_pobj) of_3\IN\0 (r_prep) inhibition_2\NN\1068773 (r_nsubj) inhibited_8\VBN\2510337 (l_conj) potentiated_10\VBN\229605 (l_dobj) reversal_11\NN\199130 (l_prep) of_12\IN\0 (l_pobj) catalepsy_13\NN\14023236
9098464
D005473_D062788 CID hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) effects_7\NNS\13245626 (r_appos) model_2\NN\5888929 (l_prep) of_3\IN\0 (l_pobj) adenomyosis_4\NN\14204950
D005473_D062788 CID hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (l_prep) on_21\IN\0 (l_pobj) induction_23\NN\7450842 (l_compound) adenomyosis_22\NN\14204950
D005473_D062788 CID fluoxetine_9\NN\4169152 (r_nsubj) caused_16\VBD\1617192 (l_dobj) hyperprolactinemia_17\NN\0 (l_conj) effects_20\NNS\13245626 (l_prep) with_21\IN\0 (l_pobj) respect_22\NN\5817845 (l_prep) to_23\IN\0 (l_pobj) adenomyosis_24\NN\14204950
D005473_D062788 CID fluoxetine_14\NN\4169152 (r_dobj) receiving_13\VBG\2210855 (r_acl) group_12\NN\2137 (r_pobj) within_9\IN\0 (r_prep) revealed_2\VBD\2137132 (l_dobj) cases_4\NNS\7283608 (l_prep) of_5\IN\0 (l_pobj) adenomyosis_6\NN\14204950
D005473_D006966 CID hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) effects_7\NNS\13245626 (l_prep) of_8\IN\0 (l_pobj) hyperprolactinemia_9\NN\0
D005473_D006966 CID fluoxetine_9\NN\4169152 (r_nsubj) caused_16\VBD\1617192 (l_dobj) hyperprolactinemia_17\NN\0
D005473_D006966 CID fluoxetine_0\NNP\4169152 (r_nsubjpass) given_8\VBN\5892096 (l_advcl) produce_17\VB\7555863 (l_dobj) hyperprolactinemia_18\NN\0
D012701_D062788 NONE serotonin_17\NN\14807737 (r_compound) inhibitor_19\NN\20090 (r_appos) hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) effects_7\NNS\13245626 (r_appos) model_2\NN\5888929 (l_prep) of_3\IN\0 (l_pobj) adenomyosis_4\NN\14204950
D012701_D062788 NONE serotonin_17\NN\14807737 (r_compound) inhibitor_19\NN\20090 (r_appos) hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (l_prep) on_21\IN\0 (l_pobj) induction_23\NN\7450842 (l_compound) adenomyosis_22\NN\14204950
D012701_D006966 NONE serotonin_17\NN\14807737 (r_compound) inhibitor_19\NN\20090 (r_appos) hydrochloride_13\NN\14817592 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) effects_7\NNS\13245626 (l_prep) of_8\IN\0 (l_pobj) hyperprolactinemia_9\NN\0
D012701_D006966 NONE serotonin_3\NN\14807737 (r_compound) inhibitor_5\NN\20090 (r_appos) fluoxetine_0\NNP\4169152 (r_nsubjpass) given_8\VBN\5892096 (l_advcl) produce_17\VB\7555863 (l_dobj) hyperprolactinemia_18\NN\0
28952
D011188_D007008 NONE potassium_1\NN\14625458 (r_compound) loss_2\NN\13252973 (l_conj) hypokalaemia_4\NN\0
D011188_D007008 NONE potassium_4\NN\14625458 (r_compound) loss_5\NN\13252973 (l_conj) development_7\NN\248977 (l_prep) of_8\IN\0 (l_pobj) hypokalaemia_9\NN\0
D011188_D007008 NONE potassium_4\NN\14625458 (r_compound) loss_5\NN\13252973 (r_dobj) investigate_1\VB\644583 (r_csubjpass) performed_22\VBN\0 (l_prep) in_23\IN\13603305 (l_pobj) patients_25\NNS\9898892 (l_prep) with_26\IN\0 (l_pobj) hypertension_28\NN\14057371 (l_relcl) shown_31\VBN\2137132 (l_dobj) hypokalaemia_32\NN\0
D002752_D006973 NONE chlorthalidone_6\NN\3214670 (r_compound) administration_7\NN\1133281 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) hypertension_12\NN\14057371
D012964_D007008 NONE sodium_18\NN\14625458 (r_compound) restriction_19\NN\5846054 (r_pobj) of_16\IN\0 (r_prep) influence_15\NN\5190804 (r_appos) loss_2\NN\13252973 (l_conj) hypokalaemia_4\NN\0
D011188_D006973 NONE potassium_1\NN\14625458 (r_compound) loss_2\NN\13252973 (l_conj) hypokalaemia_4\NN\0 (l_prep) during_5\IN\0 (l_pobj) administration_7\NN\1133281 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) hypertension_12\NN\14057371
D011188_D006973 NONE potassium_4\NN\14625458 (r_compound) loss_5\NN\13252973 (r_dobj) investigate_1\VB\644583 (r_csubjpass) performed_22\VBN\0 (l_prep) in_23\IN\13603305 (l_pobj) patients_25\NNS\9898892 (l_prep) with_26\IN\0 (l_pobj) hypertension_28\NN\14057371
D002752_D007008 CID chlorthalidone_6\NN\3214670 (r_compound) administration_7\NN\1133281 (r_pobj) during_5\IN\0 (r_prep) hypokalaemia_4\NN\0
D012964_D006973 NONE sodium_18\NN\14625458 (r_compound) restriction_19\NN\5846054 (r_pobj) of_16\IN\0 (r_prep) influence_15\NN\5190804 (r_appos) loss_2\NN\13252973 (l_conj) hypokalaemia_4\NN\0 (l_prep) during_5\IN\0 (l_pobj) administration_7\NN\1133281 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) hypertension_12\NN\14057371
12042105
C052342_D053040 CID topiramate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) nephrolithiasis_3\NN\14115914
C052342_D053040 CID topiramate_7\RB\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) nephrolithiasis_10\NN\14115914
C052342_D004827 NONE topiramate_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) medication_6\NN\3247620 (l_relcl) becoming_9\VBG\146138 (l_prep) because_13\IN\0 (l_pobj) efficacy_16\NN\5199286 (l_prep) in_17\IN\13603305 (l_pcomp) treating_18\VBG\2376958 (l_dobj) seizures_20\NNS\14081375
C020243_D053040 NONE phosphate_29\NN\15010703 (r_compound) nephrolithiasis_30\NN\14115914
15858223
D005978_D056486 NONE glutathione_11\NN\0 (r_compound) transferase_14\NNP\14732946 (r_pobj) of_8\IN\0 (r_prep) levels_7\NNS\4916342 (r_pobj) on_5\IN\0 (r_prep) based_4\VBN\0 (r_prep) evaluated_3\VBN\670261 (l_nsubjpass) toxicity_1\NN\13576101
C075750_D009336 NONE 15-f(2t)-isop_18\CD\0 (r_pobj) of_17\IN\0 (r_prep) levels_16\NNS\4916342 (l_relcl) precedes_21\VBZ\0 (l_dobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) necrosis_25\NN\11444117
D014635_D005234 CID vpa_6\NNP\0 (r_compound) results_8\NNS\34213 (l_advcl) measured_14\VBN\697589 (l_agent) by_15\IN\0 (l_pobj) levels_16\NNS\4916342 (l_relcl) precedes_21\VBZ\0 (l_dobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) necrosis_25\NN\11444117 (l_conj) steatosis_27\NN\0
D014635_D056486 CID acid_14\NN\14818238 (r_compound) metabolite_15\NN\20090 (r_amod) levels_16\NNS\4916342 (r_conj) toxicity_10\NN\13576101
D014635_D056486 CID vpa_9\NNP\0 (r_npadvmod) associated_11\VBN\628491 (r_amod) stress_13\NN\7083732 (l_conj) hepatotoxicity_15\NN\0
D014635_D056486 CID vpa_27\NNP\0 (r_pobj) with_26\IN\0 (r_prep) treated_24\VBN\2376958 (l_advcl) determine_1\VB\0 (l_ccomp) was_4\VBD\0 (l_attr) relationship_7\NN\31921 (l_prep) between_8\IN\0 (l_pobj) stress_13\NN\7083732 (l_conj) hepatotoxicity_15\NN\0
D014635_D009336 CID vpa_6\NNP\0 (r_compound) results_8\NNS\34213 (l_advcl) measured_14\VBN\697589 (l_agent) by_15\IN\0 (l_pobj) levels_16\NNS\4916342 (l_relcl) precedes_21\VBZ\0 (l_dobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) necrosis_25\NN\11444117
C075750_D005234 NONE 15-f(2t)-isop_18\CD\0 (r_pobj) of_17\IN\0 (r_prep) levels_16\NNS\4916342 (l_relcl) precedes_21\VBZ\0 (l_dobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) necrosis_25\NN\11444117 (l_conj) steatosis_27\NN\0
16820346
D013481_D006973 NONE superoxide_25\RB\14971519 (r_advmod) decreased_23\VBD\169651 (r_conj) reversed_1\VBN\109660 (l_dobj) hypertension_5\NN\14057371
D003907_D006973 CID dexamethasone_4\NN\2721538 (r_npadvmod) induced_6\VBN\1627355 (r_amod) hypertension_7\NN\14057371
D003907_D006973 CID dexamethasone_11\NN\2721538 (l_appos) hypertension_14\NN\14057371
D003907_D006973 CID dex)-induced_13\VBN\0 (r_amod) hypertension_14\NN\14057371
D003907_D006973 CID dex_2\NN\0 (r_npadvmod) induced_4\VBN\1627355 (r_amod) hypertension_5\NN\14057371
D003907_D006973 CID dexamethasone_6\NN\2721538 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypertension_9\NN\14057371
C065179_D006973 NONE atorvastatin_0\NNS\3676175 (r_nsubj) prevented_1\VBD\0 (l_conj) reversed_3\VBD\109660 (l_dobj) hypertension_7\NN\14057371
C065179_D006973 NONE atorvastatin_6\NN\3676175 (r_nmod) atorva_8\NN\0 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (l_prep) on_10\IN\0 (l_pobj) dexamethasone_11\NN\2721538 (l_appos) hypertension_14\NN\14057371
C065179_D006973 NONE atorva_8\NN\0 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (l_prep) on_10\IN\0 (l_pobj) dexamethasone_11\NN\2721538 (l_appos) hypertension_14\NN\14057371
C065179_D006973 NONE atorva_25\NN\0 (r_nmod) water_34\NN\14618834 (r_pobj) with_24\IN\0 (r_prep) treated_23\VBN\2376958 (l_advcl) assess_1\VB\5220461 (l_dobj) effects_4\NNS\13245626 (l_prep) on_10\IN\0 (l_pobj) dexamethasone_11\NN\2721538 (l_appos) hypertension_14\NN\14057371
C065179_D006973 NONE atorva_0\NN\0 (r_nsubj) reversed_1\VBN\109660 (l_dobj) hypertension_5\NN\14057371
C065179_D006973 NONE atorvastatin_2\NN\3676175 (r_nsubj) prevented_3\VBN\0 (l_conj) reversed_5\VBN\109660 (l_dobj) hypertension_9\NN\14057371
18674790
D004317_D009765 NONE doxorubicin_11\RB\2716866 (r_npadvmod) induced_13\VBN\1627355 (r_compound) cardiotoxicity_14\NN\0 (r_pobj) to_10\IN\0 (r_prep) sensitive_9\JJ\10488309 (r_acomp) are_7\VBP\13600404 (l_nsubj) rats_6\NNS\2329401 (l_amod) obese_5\JJ\0
D004317_D009765 NONE doxorubicin_40\RB\2716866 (r_npadvmod) induced_42\VBN\1627355 (r_compound) cardiotoxicity_43\NN\0 (r_pobj) to_39\IN\0 (r_prep) sensitizes_38\VBZ\126264 (l_nsubj) intervention_10\NN\1239064 (l_prep) by_11\IN\0 (l_pcomp) feeding_12\VBG\838098 (l_dobj) diet_17\NN\7560652 (l_relcl) induces_23\VBZ\1627355 (l_dobj) obesity_24\NN\4999401
D004317_D009765 NONE doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0 (l_conj) dysfunction_28\NN\14204950 (l_conj) peroxidation_31\NN\0 (l_conj) mortality_36\NN\5054863 (l_prep) in_37\IN\13603305 (l_pobj) rats_43\NNS\2329401 (l_amod) obese_39\JJ\0
D004317_D009765 NONE doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0 (l_conj) dysfunction_28\NN\14204950 (l_conj) peroxidation_31\NN\0 (l_conj) mortality_36\NN\5054863 (l_prep) in_37\IN\13603305 (l_pobj) rats_43\NNS\2329401 (l_nmod) ob_41\NNP\0
D004317_D009765 NONE doxorubicin_0\NNP\2716866 (r_compound) toxicokinetics_1\NNS\0 (r_compound) studies_2\NNS\635850 (r_nsubj) revealed_3\VBD\2137132 (l_dobj) change_5\NN\7283608 (l_conj) hearts_27\NNS\496167 (l_compound) ob_26\NNP\0
D004317_D009765 NONE doxorubicin_9\NN\2716866 (r_pobj) of_8\IN\0 (r_prep) accumulation_7\NN\13497135 (r_pobj) in_6\IN\13603305 (r_prep) change_5\NN\7283608 (l_conj) hearts_27\NNS\496167 (l_compound) ob_26\NNP\0
D004317_D009765 NONE doxorubicin_109\NN\2716866 (r_compound) administration_110\NN\1133281 (r_pobj) after_108\IN\0 (r_prep) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (r_ccomp) revealed_2\VBD\2137132 (l_ccomp) sensitized_7\VBN\126264 (l_nsubjpass) rats_5\NNS\2329401 (l_compound) ob_4\NNP\0
D004317_D009765 NONE doxorubicin_109\NN\2716866 (r_compound) administration_110\NN\1133281 (r_pobj) after_108\IN\0 (r_prep) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (l_nsubj) stress_16\NN\7083732 (l_acl) activated_35\VBN\1641914 (l_dobj) oxidation_56\NN\13447361 (l_appos) heart_64\NN\5919034 (l_prep) versus_67\IN\0 (l_pobj) heart_74\NN\5919034 (l_prep) in_75\IN\13603305 (l_pobj) ob_76\NNP\0
D004317_D009765 NONE doxorubicin_12\RB\2716866 (r_npadvmod) induced_14\VBN\1627355 (r_amod) cardiotoxicity_15\NN\0 (r_pobj) to_11\IN\0 (r_prep) sensitized_10\JJ\126264 (r_acomp) are_8\VBP\13600404 (l_nsubj) rats_7\NNS\2329401 (l_amod) obese_6\JJ\0
D004317_D066126 NONE doxorubicin_11\RB\2716866 (r_npadvmod) induced_13\VBN\1627355 (r_compound) cardiotoxicity_14\NN\0
D004317_D066126 NONE doxorubicin_4\NN\2716866 (r_pobj) by_3\IN\0 (r_prep) chemotherapy_2\NN\661091 (r_nsubjpass) limited_9\VBN\4019101 (l_prep) due_10\IN\5174653 (l_pobj) life_12\NN\13954253 (l_acl) threatening_13\VBG\2603699 (l_dobj) cardiotoxicity_14\NN\0
D004317_D066126 NONE adriamycin_6\NNP\0 (r_punct) )_7\-RRB-\0 (r_punct) is_8\VBZ\0 (r_auxpass) limited_9\VBN\4019101 (l_prep) due_10\IN\5174653 (l_pobj) life_12\NN\13954253 (l_acl) threatening_13\VBG\2603699 (l_dobj) cardiotoxicity_14\NN\0
D004317_D066126 NONE doxorubicin_12\RB\2716866 (r_npadvmod) induced_14\VBN\1627355 (r_amod) cardiotoxicity_15\NN\0
D004317_D066126 NONE doxorubicin_40\RB\2716866 (r_npadvmod) induced_42\VBN\1627355 (r_compound) cardiotoxicity_43\NN\0
D004317_D066126 NONE doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0
C010013_D009765 NONE doxorubicinol_11\NN\0 (r_conj) doxorubicin_9\NN\2716866 (r_pobj) of_8\IN\0 (r_prep) accumulation_7\NN\13497135 (r_pobj) in_6\IN\13603305 (r_prep) change_5\NN\7283608 (l_conj) hearts_27\NNS\496167 (l_compound) ob_26\NNP\0
D004317_D056486 NONE doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0 (l_conj) dysfunction_28\NN\14204950 (l_conj) peroxidation_31\NN\0 (l_conj) mortality_36\NN\5054863 (l_prep) in_44\IN\13603305 (l_pobj) absence_46\NN\14449405 (l_prep) of_47\IN\0 (l_pobj) toxicity_53\NN\13576101
D000255_D066126 NONE atp_21\NNP\14964590 (r_compound) generation_22\NN\7942152 (r_dobj) downregulating_18\VBG\0 (r_pcomp) by_16\IN\0 (r_prep) sensitized_10\JJ\126264 (l_prep) to_11\IN\0 (l_pobj) cardiotoxicity_15\NN\0
D004041_D066126 NONE fat_1\JJ\14938907 (r_amod) rats_6\NNS\2329401 (r_nsubj) are_7\VBP\13600404 (l_acomp) sensitive_9\JJ\10488309 (l_prep) to_10\IN\0 (l_pobj) cardiotoxicity_14\NN\0
D004041_D066126 NONE fat_16\JJ\14938907 (r_amod) diet_17\NN\7560652 (r_dobj) feeding_12\VBG\838098 (r_pcomp) by_11\IN\0 (r_prep) intervention_10\NN\1239064 (r_nsubj) sensitizes_38\VBZ\126264 (l_prep) to_39\IN\0 (l_pobj) cardiotoxicity_43\NN\0
D004317_D007674 NONE doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0 (l_conj) dysfunction_28\NN\14204950 (l_conj) peroxidation_31\NN\0 (l_conj) mortality_36\NN\5054863 (l_prep) in_44\IN\13603305 (l_pobj) absence_46\NN\14449405 (l_prep) of_47\IN\0 (l_pobj) toxicity_53\NN\13576101
D000244_D009765 NONE adp_106\NNP\14964590 (r_compound) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (r_ccomp) revealed_2\VBD\2137132 (l_ccomp) sensitized_7\VBN\126264 (l_nsubjpass) rats_5\NNS\2329401 (l_compound) ob_4\NNP\0
D000244_D009765 NONE adp_106\NNP\14964590 (r_compound) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (l_nsubj) stress_16\NN\7083732 (l_acl) activated_35\VBN\1641914 (l_dobj) oxidation_56\NN\13447361 (l_appos) heart_64\NN\5919034 (l_prep) versus_67\IN\0 (l_pobj) heart_74\NN\5919034 (l_prep) in_75\IN\13603305 (l_pobj) ob_76\NNP\0
D004041_D009765 CID fat_1\JJ\14938907 (r_amod) rats_6\NNS\2329401 (l_amod) obese_5\JJ\0
D004041_D009765 CID fat_16\JJ\14938907 (r_amod) diet_17\NN\7560652 (l_relcl) induces_23\VBZ\1627355 (l_dobj) obesity_24\NN\4999401
D004317_D006331 CID doxorubicin_7\NN\2716866 (r_nmod) kg_9\NNS\13717155 (r_appos) dose_3\NN\3740161 (l_acl) administered_13\VBN\2436349 (l_prep) on_14\IN\0 (l_pobj) day_15\NN\15154774 (l_nummod) 43_16\CD\0 (l_prep) of_17\IN\0 (l_pobj) regimen_21\NN\5898568 (l_acl) led_22\VBD\3202760 (l_prep) to_23\IN\0 (l_pobj) cardiotoxicity_25\NN\0 (l_conj) dysfunction_28\NN\14204950
D000255_D009765 NONE atp_99\NNP\14964590 (r_compound) levels_100\NNS\4916342 (r_pobj) in_97\IN\13603305 (r_prep) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (r_ccomp) revealed_2\VBD\2137132 (l_ccomp) sensitized_7\VBN\126264 (l_nsubjpass) rats_5\NNS\2329401 (l_compound) ob_4\NNP\0
D000255_D009765 NONE atp_99\NNP\14964590 (r_compound) levels_100\NNS\4916342 (r_pobj) in_97\IN\13603305 (r_prep) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (l_nsubj) stress_16\NN\7083732 (l_acl) activated_35\VBN\1641914 (l_dobj) oxidation_56\NN\13447361 (l_appos) heart_64\NN\5919034 (l_prep) versus_67\IN\0 (l_pobj) heart_74\NN\5919034 (l_prep) in_75\IN\13603305 (l_pobj) ob_76\NNP\0
D000255_D009765 NONE atp_104\NNP\14964590 (r_nmod) adp_106\NNP\14964590 (r_compound) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (r_ccomp) revealed_2\VBD\2137132 (l_ccomp) sensitized_7\VBN\126264 (l_nsubjpass) rats_5\NNS\2329401 (l_compound) ob_4\NNP\0
D000255_D009765 NONE atp_104\NNP\14964590 (r_nmod) adp_106\NNP\14964590 (r_compound) ratio_107\NN\13815152 (r_pobj) by_102\IN\0 (r_agent) accompanied_101\VBN\0 (r_acl) drop_96\NN\13899200 (r_conj) decreased_82\VBD\169651 (l_nsubj) stress_16\NN\7083732 (l_acl) activated_35\VBN\1641914 (l_dobj) oxidation_56\NN\13447361 (l_appos) heart_64\NN\5919034 (l_prep) versus_67\IN\0 (l_pobj) heart_74\NN\5919034 (l_prep) in_75\IN\13603305 (l_pobj) ob_76\NNP\0
D000255_D009765 NONE atp_21\NNP\14964590 (r_compound) generation_22\NN\7942152 (r_dobj) downregulating_18\VBG\0 (r_pcomp) by_16\IN\0 (r_prep) sensitized_10\JJ\126264 (r_acomp) are_8\VBP\13600404 (l_nsubj) rats_7\NNS\2329401 (l_amod) obese_6\JJ\0
D000249_D009765 NONE amp_84\NN\13633375 (r_compound) alpha2_86\NN\0 (r_compound) kinase_88\NN\14732946 (r_dobj) decreased_82\VBD\169651 (r_ccomp) revealed_2\VBD\2137132 (l_ccomp) sensitized_7\VBN\126264 (l_nsubjpass) rats_5\NNS\2329401 (l_compound) ob_4\NNP\0
D000249_D009765 NONE amp_84\NN\13633375 (r_compound) alpha2_86\NN\0 (r_compound) kinase_88\NN\14732946 (r_dobj) decreased_82\VBD\169651 (l_nsubj) stress_16\NN\7083732 (l_acl) activated_35\VBN\1641914 (l_dobj) oxidation_56\NN\13447361 (l_appos) heart_64\NN\5919034 (l_prep) versus_67\IN\0 (l_pobj) heart_74\NN\5919034 (l_prep) in_75\IN\13603305 (l_pobj) ob_76\NNP\0
8424298
D007530_D007022 CID isoflurane_8\NN\3570838 (r_pobj) with_7\IN\0 (r_prep) labetalol_6\NN\2721160 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (r_acl) hypotension_3\NN\14057371
D007530_D007022 CID isoflurane_18\JJ\3570838 (r_amod) group_21\NN\2137 (r_pobj) with_17\IN\0 (r_prep) labetalol_16\NN\2721160 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) hypotension_13\NN\14057371
D007530_D007022 CID isoflurane_18\JJ\3570838 (r_amod) group_21\NN\2137 (l_amod) hypotensive_20\JJ\10405694
D007530_D007022 CID isoflurane_9\NN\3570838 (r_pobj) with_8\IN\0 (r_prep) labetalol_7\NN\2721160 (r_pobj) by_6\IN\0 (r_prep) induced_5\VBN\1627355 (l_nsubj) hypotension_4\NN\14057371
D007741_D007022 CID labetalol_6\NN\2721160 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (r_acl) hypotension_3\NN\14057371
D007741_D007022 CID labetalol_16\NN\2721160 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) hypotension_13\NN\14057371
D007741_D007022 CID labetalol_16\NN\2721160 (l_prep) with_17\IN\0 (l_pobj) group_21\NN\2137 (l_amod) hypotensive_20\JJ\10405694
D007741_D007022 CID labetalol_7\NN\2721160 (r_pobj) by_6\IN\0 (r_prep) induced_5\VBN\1627355 (l_nsubj) hypotension_4\NN\14057371
9758264
D005492_D008180 CID acid_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) activity_1\NN\30358 (r_nsubj) induces_7\VBZ\1627355 (l_dobj) sle_8\NNP\14229912
D005492_D008180 CID acid_11\NN\14818238 (r_appos) sle_8\NNP\14229912
D005492_D008180 CID acid_35\NN\14818238 (r_pobj) of_33\IN\0 (r_prep) dose_25\NN\3740161 (r_nsubj) triggered_36\VBD\1641914 (l_ccomp) damage_15\VB\7296428 (l_nsubj) disease_6\NN\14061805 (l_appos) lupus_12\NN\14219661
D005492_D012640 CID acid_35\NN\14818238 (r_pobj) of_33\IN\0 (r_prep) dose_25\NN\3740161 (r_nsubj) triggered_36\VBD\1641914 (l_dobj) cluster_38\NN\7959269 (l_prep) of_39\IN\0 (l_pobj) seizures_40\NNS\14081375
D005492_D001327 NONE acid_35\NN\14818238 (r_pobj) of_33\IN\0 (r_prep) dose_25\NN\3740161 (r_nsubj) triggered_36\VBD\1641914 (l_ccomp) damage_15\VB\7296428 (l_nsubj) disease_6\NN\14061805
D005492_D001327 NONE acid_9\NN\14818238 (r_pobj) of_7\IN\0 (r_prep) mg_5\NN\13717155 (r_appos) dose_1\NN\3740161 (l_prep) without_19\IN\0 (l_pobj) disease_22\NN\14061805
D005492_D004827 NONE acid_4\NN\14818238 (r_pobj) of_2\IN\0 (r_prep) activity_1\NN\30358 (r_nsubj) induces_7\VBZ\1627355 (l_dobj) sle_8\NNP\14229912 (l_appos) acid_11\NN\14818238 (l_conj) epilepsy_13\NN\14085708
D005492_D004827 NONE acid_11\NN\14818238 (l_conj) epilepsy_13\NN\14085708
D005492_D004827 NONE acid_6\NN\14818238 (r_npadvmod) containing_8\VBG\2632940 (r_amod) supplementation_10\NN\5108947 (l_prep) in_11\IN\13603305 (l_pobj) women_13\NNS\9605289 (l_amod) epileptic_12\JJ\10595647
D005492_D004827 NONE acid_6\NN\14818238 (r_npadvmod) containing_8\VBG\2632940 (r_amod) supplementation_10\NN\5108947 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) study_1\VB\635850 (l_prep) in_18\IN\13603305 (l_pobj) order_19\NN\7168131 (l_acl) determine_21\VB\0 (l_dobj) rate_23\NN\13815152 (l_prep) of_24\IN\0 (l_pobj) defects_27\NNS\14462666 (l_conj) effects_33\NNS\13245626 (l_amod) related_31\VBN\628491 (l_npadvmod) epilepsy_29\NN\14085708
D005492_D004827 NONE acid_7\NN\14818238 (r_pobj) with_4\IN\0 (r_prep) women_3\NNS\9605289 (l_amod) epileptic_2\JJ\10595647
D005492_D004827 NONE acid_7\NN\14818238 (l_appos) effects_21\NNS\13245626 (l_amod) related_19\VBN\628491 (l_npadvmod) epilepsy_17\NN\14085708
D005492_D004827 NONE acid_14\NN\14818238 (r_conj) carbamazepine_10\NN\0 (r_pobj) by_9\IN\0 (r_agent) treated_7\VBN\2376958 (l_nsubjpass) woman_5\NN\9605289 (l_amod) epileptic_4\JJ\10595647
D005492_D004827 NONE acid_35\NN\14818238 (r_pobj) of_33\IN\0 (r_prep) dose_25\NN\3740161 (r_nsubj) triggered_36\VBD\1641914 (l_ccomp) damage_15\VB\7296428 (l_nsubj) disease_6\NN\14061805 (l_poss) patient_3\NN\9898892 (l_amod) epileptic_1\JJ\10595647
D005492_D004827 NONE acid_9\NN\14818238 (r_pobj) of_7\IN\0 (r_prep) mg_5\NN\13717155 (r_appos) dose_1\NN\3740161 (l_prep) in_11\IN\13603305 (l_pobj) women_16\NNS\9605289 (l_amod) epileptic_15\JJ\10595647
D005492_D004827 NONE acid_9\NN\14818238 (r_pobj) of_7\IN\0 (r_prep) mg_5\NN\13717155 (r_appos) dose_1\NN\3740161 (r_nsubj) increase_26\VB\13576355 (l_dobj) risk_28\NN\14541044 (l_prep) for_29\IN\0 (l_pobj) seizures_31\NNS\14081375
D002220_D004827 NONE carbamazepine_10\NN\0 (r_pobj) by_9\IN\0 (r_agent) treated_7\VBN\2376958 (l_nsubjpass) woman_5\NN\9605289 (l_amod) epileptic_4\JJ\10595647
D005492_D000014 NONE acid_6\NN\14818238 (r_npadvmod) containing_8\VBG\2632940 (r_amod) supplementation_10\NN\5108947 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) study_1\VB\635850 (l_prep) in_18\IN\13603305 (l_pobj) order_19\NN\7168131 (l_acl) determine_21\VB\0 (l_dobj) rate_23\NN\13815152 (l_prep) of_24\IN\0 (l_pobj) defects_27\NNS\14462666
9875685
D014031_D064420 NONE tobramicyn_17\NN\0 (l_prep) on_18\IN\0 (l_pobj) concentrations_23\NNS\4916342 (l_conj) toxicity_25\NN\13576101
D003404_D007674 NONE creatinine_2\NN\0 (r_nsubjpass) observed_4\VBN\2163746 (l_prep) without_20\IN\0 (l_pobj) evidence_21\NN\5816287 (l_prep) of_22\IN\0 (l_pobj) nephrotoxicity_23\NN\0
20331935
D013739_D006966 NONE testosterone_1\NN\14747587 (r_compound) concentration_2\NN\4916342 (r_nsubj) increased_3\VBD\169651 (l_conj) affected_10\VBN\126264 (l_agent) by_11\IN\0 (l_pobj) hyperprolactinemia_12\NN\0
D018967_D050723 NONE risperidone_8\NN\0 (r_nsubjpass) started_12\VBN\0 (r_advcl) occurred_6\VBD\0 (l_nsubj) fractures_3\NNS\14285662
D018967_D006966 CID risperidone_12\NN\0 (r_npadvmod) induced_14\VBN\1627355 (r_amod) hyperprolactinemia_15\NN\0
D018967_D006966 CID risperidone_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) %_6\NN\0 (r_pobj) in_4\IN\13603305 (r_prep) present_3\JJ\28270 (r_acomp) was_2\VBD\0 (l_nsubj) hyperprolactinemia_1\NNP\0
D018967_D006966 CID risperidone_8\NN\0 (r_nsubjpass) started_12\VBN\0 (r_advcl) occurred_6\VBD\0 (l_conj) occurred_16\VBD\0 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) hyperprolactinemia_20\NN\0
D018967_D006966 CID risperidone_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hyperprolactinemia_10\NN\0
16225977
C076029_D013981 NONE olanzapine_13\NN\0 (r_conj) risperidone_11\NN\0 (r_pobj) as_10\IN\14622893 (r_prep) antipsychotics_8\NNS\4470232 (r_pobj) by_6\IN\0 (r_agent) treated_5\VBN\2376958 (l_nsubjpass) disorders_1\NNS\14034177
C092292_D013981 NONE ziprasidone_15\NN\0 (r_conj) olanzapine_13\NN\0 (r_conj) risperidone_11\NN\0 (r_pobj) as_10\IN\14622893 (r_prep) antipsychotics_8\NNS\4470232 (r_pobj) by_6\IN\0 (r_agent) treated_5\VBN\2376958 (l_nsubjpass) disorders_1\NNS\14034177
C012052_D012559 NONE amisulpride_0\NNP\0 (r_amod) symptoms_5\NNS\5823932 (l_prep) in_6\IN\13603305 (l_pobj) schizophrenic_9\NN\10490141
C012052_D012559 NONE amisulpride_20\JJ\0 (r_amod) treatment_21\NN\654885 (r_pobj) of_19\IN\0 (r_prep) months_18\NNS\15113229 (r_pobj) after_16\IN\0 (r_prep) developed_9\VBD\1753788 (r_relcl) schizophrenic_7\NN\10490141
C012052_D020820 NONE amisulpride_20\JJ\0 (r_amod) treatment_21\NN\654885 (r_pobj) of_19\IN\0 (r_prep) months_18\NNS\15113229 (r_pobj) after_16\IN\0 (r_prep) developed_9\VBD\1753788 (l_dobj) movements_15\NNS\191142
D003024_D013981 NONE clozapine_26\NN\3713736 (r_conj) quetiapine_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) occurring_20\VBG\0 (r_xcomp) show_8\VBP\429048 (l_dobj) symptoms_12\NNS\5823932
D003024_D013981 NONE clozapine_29\NN\3713736 (r_conj) quetiapine_27\NN\0 (r_pobj) as_26\IN\14622893 (r_prep) antipsychotics_24\NNS\4470232 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) during_20\IN\0 (r_prep) occur_15\VB\0 (l_nsubj) symptoms_13\NNS\5823932
C069541_D013981 NONE quetiapine_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) occurring_20\VBG\0 (r_xcomp) show_8\VBP\429048 (l_dobj) symptoms_12\NNS\5823932
C069541_D013981 NONE quetiapine_27\NN\0 (r_pobj) as_26\IN\14622893 (r_prep) antipsychotics_24\NNS\4470232 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) during_20\IN\0 (r_prep) occur_15\VB\0 (l_nsubj) symptoms_13\NNS\5823932
C012052_D013981 CID amisulpride_0\NNP\0 (r_amod) symptoms_5\NNS\5823932
C012052_D013981 CID amisulpride_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) dose_11\NN\3740161 (r_dobj) reduced_9\VBD\441445 (r_advcl) resolved_5\VBN\352826 (l_nsubj) symptoms_4\NNS\5823932
C012052_D013981 CID amisulpride_32\NN\0 (r_conj) clozapine_29\NN\3713736 (r_conj) quetiapine_27\NN\0 (r_pobj) as_26\IN\14622893 (r_prep) antipsychotics_24\NNS\4470232 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) during_20\IN\0 (r_prep) occur_15\VB\0 (l_nsubj) symptoms_13\NNS\5823932
D018967_D013981 NONE risperidone_11\NN\0 (r_pobj) as_10\IN\14622893 (r_prep) antipsychotics_8\NNS\4470232 (r_pobj) by_6\IN\0 (r_agent) treated_5\VBN\2376958 (l_nsubjpass) disorders_1\NNS\14034177
6540303
D007649_D002389 CID ketamine_5\NN\3054098 (r_compound) catatonia_6\NN\14544672
D007649_D002389 CID ketamine_15\NN\3054098 (r_npadvmod) induced_17\VBN\1627355 (r_amod) catatonia_18\NN\14544672
D007649_D002389 CID ketamine_17\NN\3054098 (r_pobj) after_16\IN\0 (r_prep) increased_8\VBD\169651 (l_dobj) duration_10\NN\15113229 (l_prep) of_11\IN\0 (l_pobj) catatonia_12\NNP\14544672
D007649_D002389 CID ketamine_15\NN\3054098 (r_compound) catatonia_16\NNP\14544672
D004298_D002389 CID dopamine_7\NN\14807737 (r_pobj) with_6\IN\0 (r_prep) pretreatment_5\NN\0 (r_nsubj) increased_8\VBD\169651 (l_dobj) duration_10\NN\15113229 (l_prep) of_11\IN\0 (l_pobj) catatonia_12\NNP\14544672
D004298_D002389 CID dopamine_2\NN\14807737 (r_nsubj) appeared_3\VBD\2604760 (l_xcomp) act_5\VB\6479665 (l_prep) on_6\IN\0 (l_pobj) systems_7\NNS\3575240 (l_acl) involved_10\JJ\2676054 (l_prep) with_11\IN\0 (l_pobj) induction_13\NN\7450842 (l_prep) of_14\IN\0 (l_pobj) catatonia_16\NNP\14544672
D002395_D002389 NONE catecholamines_10\NNS\5407119 (r_pobj) of_9\IN\0 (r_prep) role_8\NN\719494 (l_prep) on_14\IN\0 (l_pobj) catatonia_18\NN\14544672
D009638_D002389 NONE norepinephrine_22\NN\14807929 (r_pobj) with_21\IN\0 (r_prep) pretreatment_20\NN\0 (r_nsubj) did_23\VBD\0 (r_conj) increased_8\VBD\169651 (l_dobj) duration_10\NN\15113229 (l_prep) of_11\IN\0 (l_pobj) catatonia_12\NNP\14544672
D000588_D002389 NONE amine_2\NN\14951377 (r_compound) pretreatment_3\NN\0 (l_prep) on_4\IN\0 (l_pobj) catatonia_6\NN\14544672
6292680
D004317_D009202 CID doxorubicin_0\JJ\2716866 (r_nsubj) cardiomyopathy_1\NN\14103288
D004317_D009202 CID doxorubicin_23\NN\2716866 (r_pobj) of_22\IN\0 (r_prep) dosage_21\NN\13576355 (r_conj) bed_18\NN\2821943 (r_pobj) to_15\IN\0 (r_prep) irradiation_14\NN\13920835 (r_pobj) after_13\IN\0 (r_prep) experienced_9\VBD\2108377 (l_dobj) cardiomyopathy_12\NN\14103288
D004317_D009202 CID doxorubicin_30\NN\2716866 (r_pobj) of_29\IN\0 (r_prep) interaction_28\NN\37396 (r_pobj) to_26\IN\0 (r_prep) include_16\VBP\0 (r_acl) fact_8\NN\5816287 (r_pobj) to_6\IN\0 (r_prep) attributed_3\VBN\670261 (l_nsubjpass) cardiomyopathy_1\NN\14103288
D018943_D009202 NONE anthracycline_11\NN\0 (r_amod) cardiomyopathy_12\NN\14103288
D004317_D009369 NONE doxorubicin_23\NN\2716866 (r_pobj) of_22\IN\0 (r_prep) dosage_21\NN\13576355 (r_conj) bed_18\NN\2821943 (l_compound) tumor_17\NN\14234074
D004317_D009396 NONE doxorubicin_0\JJ\2716866 (r_nsubj) cardiomyopathy_1\NN\14103288 (l_prep) in_2\IN\13603305 (l_pobj) children_3\NNS\9622049 (l_prep) with_4\IN\0 (l_pobj) tumor_9\NN\14234074
D004317_D009396 NONE doxorubicin_23\NN\2716866 (r_pobj) of_22\IN\0 (r_prep) dosage_21\NN\13576355 (r_conj) bed_18\NN\2821943 (r_pobj) to_15\IN\0 (r_prep) irradiation_14\NN\13920835 (r_pobj) after_13\IN\0 (r_prep) experienced_9\VBD\2108377 (l_nsubj) children_1\NNS\9622049 (l_prep) with_2\IN\0 (l_pobj) tumor_4\NN\14234074
D004317_D009396 NONE doxorubicin_30\NN\2716866 (r_pobj) of_29\IN\0 (r_prep) interaction_28\NN\37396 (r_pobj) to_26\IN\0 (r_prep) include_16\VBP\0 (l_nsubj) fields_11\VBZ\0 (l_prep) for_12\IN\0 (l_pobj) tumor_15\NN\14234074
D004317_D009396 NONE doxorubicin_4\NN\2716866 (r_compound) dosage_5\NN\13576355 (r_nsubjpass) restricted_8\VBN\235368 (l_prep) in_9\IN\13603305 (l_pobj) children_10\NNS\9622049 (l_prep) with_11\IN\0 (l_pobj) tumor_13\NN\14234074
D018943_D009369 NONE anthracycline_11\NN\0 (r_amod) cardiomyopathy_12\NN\14103288 (r_dobj) experienced_9\VBD\2108377 (l_prep) after_13\IN\0 (l_pobj) irradiation_14\NN\13920835 (l_prep) to_15\IN\0 (l_pobj) bed_18\NN\2821943 (l_compound) tumor_17\NN\14234074
D018943_D009396 NONE anthracycline_11\NN\0 (r_amod) cardiomyopathy_12\NN\14103288 (r_dobj) experienced_9\VBD\2108377 (l_nsubj) children_1\NNS\9622049 (l_prep) with_2\IN\0 (l_pobj) tumor_4\NN\14234074
2826064
D013726_D007008 CID terbutaline_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) hypokalemia_12\NN\14299637
D013726_D007008 CID terbutaline_4\JJ\0 (r_compound) concentrations_5\NNS\4916342 (r_pobj) of_2\IN\0 (r_prep) spite_1\NN\7550369 (r_pobj) in_0\IN\13603305 (r_prep) antagonized_15\VBN\1787955 (l_nsubjpass) hypokalemia_11\NN\14299637
D010096_D007008 NONE oxprenolol_8\NN\0 (r_pobj) by_7\IN\0 (r_prep) abolishment_6\NN\209943 (r_conj) hypokalemia_3\NN\14299637
D010096_D007008 NONE oxprenolol_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) efficacy_4\NN\5199286 (r_dobj) investigated_2\VBD\644583 (l_prep) in_7\IN\13603305 (l_pcomp) antagonizing_8\VBG\1787955 (l_dobj) hypokalemia_10\NN\14299637
D010096_D007008 NONE oxprenolol_7\NN\0 (r_amod) pretreatment_8\NN\0 (r_pobj) after_6\IN\0 (r_prep) concentrations_5\NNS\4916342 (r_pobj) of_2\IN\0 (r_prep) spite_1\NN\7550369 (r_pobj) in_0\IN\13603305 (r_prep) antagonized_15\VBN\1787955 (l_nsubjpass) hypokalemia_11\NN\14299637
9915601
D005680_D001919 NONE acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_prep) to_15\IN\0 (l_pobj) bradycardia_16\NNP\14110674
D005680_D001919 NONE gaba_31\NNP\14601829 (r_appos) acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_prep) to_15\IN\0 (l_pobj) bradycardia_16\NNP\14110674
D007538_D001919 CID isoniazid_12\NN\2716205 (r_pobj) with_11\IN\0 (r_prep) pretreated_10\VBD\0 (r_acl) rats_9\NNS\2329401 (r_pobj) in_8\IN\13603305 (r_prep) antagonists_7\NNS\7846 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) bradycardia_1\NNS\14110674
D007538_D001919 CID isoniazid_3\NN\2716205 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_prep) to_15\IN\0 (l_pobj) bradycardia_16\NNP\14110674
D007538_D001919 CID isoniazid_9\NN\2716205 (l_prep) of_10\IN\0 (l_pobj) bradycardia_11\NN\14110674
D007538_D001919 CID isoniazid_0\NNP\2716205 (r_nsubj) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D018738_D001919 NONE hexamethonium_22\NN\0 (r_pobj) after_21\IN\0 (r_conj) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D001262_D001919 NONE atenolol_11\NN\2832168 (r_conj) labetalol_9\JJ\2721160 (r_conj) pindolol_7\NN\2832168 (r_conj) propranolol_5\NN\0 (r_advcl) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D003000_D001919 NONE clonidine_17\NN\2721160 (r_pobj) after_16\IN\0 (r_prep) as_15\IN\14622893 (r_cc) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D007538_D013610 NONE isoniazid_3\NN\2716205 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_dobj) tachycardia_14\NN\14110674
D007538_D007022 CID isoniazid_3\NN\2716205 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371
D011433_D001919 NONE propranolol_5\NN\0 (r_advcl) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D007741_D001919 NONE labetalol_9\JJ\2721160 (r_conj) pindolol_7\NN\2832168 (r_conj) propranolol_5\NN\0 (r_advcl) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D010869_D001919 NONE pindolol_7\NN\2832168 (r_conj) propranolol_5\NN\0 (r_advcl) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D014520_D001919 NONE urethane_26\NN\14850483 (r_pobj) with_23\IN\0 (r_prep) anaesthetised_22\VBN\84738 (r_acl) rats_21\NNS\2329401 (r_pobj) in_20\IN\13603305 (r_prep) determined_19\VBN\0 (l_nsubjpass) enhancement_7\NN\248977 (l_prep) by_8\IN\0 (l_pobj) isoniazid_9\NN\2716205 (l_prep) of_10\IN\0 (l_pobj) bradycardia_11\NN\14110674
D005680_D007022 NONE acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371
D005680_D007022 NONE gaba_31\NNP\14601829 (r_appos) acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371
D002217_D001919 NONE carbachol_24\NN\0 (r_conj) hexamethonium_22\NN\0 (r_pobj) after_21\IN\0 (r_conj) increased_2\VBD\169651 (l_acomp) bradycardia_3\NNP\14110674
D002698_D001919 NONE chloralose_24\NN\0 (r_compound) urethane_26\NN\14850483 (r_pobj) with_23\IN\0 (r_prep) anaesthetised_22\VBN\84738 (r_acl) rats_21\NNS\2329401 (r_pobj) in_20\IN\13603305 (r_prep) determined_19\VBN\0 (l_nsubjpass) enhancement_7\NN\248977 (l_prep) by_8\IN\0 (l_pobj) isoniazid_9\NN\2716205 (l_prep) of_10\IN\0 (l_pobj) bradycardia_11\NN\14110674
D005680_D013610 NONE acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_dobj) tachycardia_14\NN\14110674
D005680_D013610 NONE gaba_31\NNP\14601829 (r_appos) acid_29\NN\14818238 (r_pobj) of_24\IN\0 (r_prep) synthesis_23\NN\13446390 (r_pobj) to_21\IN\0 (r_prep) attributed_20\VBN\670261 (r_acl) interaction_19\NN\37396 (r_appos) doses_1\NNS\3740161 (l_appos) hypotension_5\NN\14057371 (l_conj) change_10\VB\7283608 (l_dobj) tachycardia_14\NN\14110674
6496797
D014196_D006327 CID trazodone_8\NN\3829085 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) following_3\VBG\8180190 (r_prep) block_2\NN\21939
D014196_D006327 CID trazodone_9\NN\3829085 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_dobj) receiving_3\VBG\2210855 (r_pcomp) after_2\IN\0 (r_prep) developed_13\VBD\1753788 (l_dobj) block_16\NN\21939
7604176
D017035_D009220 CID pravastatin_11\NN\3676175 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (r_acl) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) myopathy_5\NNS\14204950
D017035_D009135 NONE pravastatin_0\NNP\3676175 (r_npadvmod) associated_2\VBN\628491 (r_amod) myopathy_3\NN\14204950
D017035_D009135 NONE pravastatin_17\JJ\3676175 (r_amod) discontinuation_18\NN\209943 (r_pobj) after_16\IN\0 (r_prep) resolved_11\VBD\352826 (r_relcl) limbs_9\NNS\5559908 (r_pobj) of_6\IN\0 (r_prep) myopathy_5\NN\14204950
D017035_D009135 NONE pravastatin_11\RB\3676175 (r_npadvmod) associated_13\VBN\628491 (r_amod) myopathy_14\NNS\14204950 (r_nsubj) represent_16\VB\2664769 (l_advcl) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) myopathy_9\NNS\14204950
D017035_D009135 NONE pravastatin_11\RB\3676175 (r_npadvmod) associated_13\VBN\628491 (r_amod) myopathy_14\NNS\14204950
D019821_D009135 NONE simvastatin_3\NN\3676175 (r_conj) lovastatin_1\NN\3676175 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) myopathy_9\NNS\14204950
D019821_D009135 NONE simvastatin_3\NN\3676175 (r_conj) lovastatin_1\NN\3676175 (r_nsubjpass) associated_6\VBN\628491 (r_advcl) represent_16\VB\2664769 (l_nsubj) myopathy_14\NNS\14204950
D008148_D009135 NONE lovastatin_1\NN\3676175 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) myopathy_9\NNS\14204950
D008148_D009135 NONE lovastatin_1\NN\3676175 (r_nsubjpass) associated_6\VBN\628491 (r_advcl) represent_16\VB\2664769 (l_nsubj) myopathy_14\NNS\14204950
D017035_D006937 NONE pravastatin_2\RB\3676175 (r_dobj) assumed_1\VBD\719734 (l_prep) because_9\IN\0 (l_pobj) hypercholesterolemia_11\NN\14299637
20466178
D016559_D003872 NONE tacrolimus_5\NN\0 (r_compound) treatment_6\NN\654885 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) dermatitis_1\NN\14226056
D016559_D003872 NONE tacrolimus_19\NN\0 (r_compound) ointment_20\NN\4074482 (r_dobj) using_13\VBG\418025 (r_advcl) developed_6\VBD\1753788 (l_dobj) eruptions_11\NNS\7307754 (l_compound) dermatitis_10\NN\14226056
D016559_D003872 NONE tacrolimus_7\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) immunomodulators_4\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) regarded_12\VBN\689344 (l_prep) as_13\IN\14622893 (l_pobj) cause_16\NN\7323922 (l_prep) of_17\IN\0 (l_pobj) dermatitis_19\NN\14226056
C117268_D003872 CID pimecrolimus_9\NN\0 (r_conj) tacrolimus_7\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) immunomodulators_4\NNS\0 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubjpass) regarded_12\VBN\689344 (l_prep) as_13\IN\14622893 (l_pobj) cause_16\NN\7323922 (l_prep) of_17\IN\0 (l_pobj) dermatitis_19\NN\14226056
D016559_D003875 NONE tacrolimus_19\NN\0 (r_compound) ointment_20\NN\4074482 (r_dobj) using_13\VBG\418025 (r_advcl) developed_6\VBD\1753788 (l_dobj) eruptions_11\NNS\7307754
D016559_D005148 NONE tacrolimus_19\NN\0 (r_compound) ointment_20\NN\4074482 (r_dobj) using_13\VBG\418025 (l_prep) for_21\IN\0 (l_pobj) dermatitis_23\NN\14226056
D016559_D012393 NONE tacrolimus_19\NN\0 (r_compound) ointment_20\NN\4074482 (r_dobj) using_13\VBG\418025 (r_advcl) developed_6\VBD\1753788 (l_dobj) eruptions_11\NNS\7307754 (l_amod) like_9\JJ\5839024 (l_npadvmod) rosacea_7\NN\14222112
663266
D003974_D014693 NONE renografin_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) occurred_2\VBD\0 (l_nsubj) fibrillation_1\NN\14361664
C027278_D064420 NONE %_5\NN\0 (r_appos) toxicity_1\NN\13576101
C027278_D064420 NONE %_13\NN\0 (r_npadvmod) compared_7\VBN\644583 (l_nsubjpass) toxicity_1\NN\13576101
D003973_D014693 NONE diatrizoate_3\JJ\0 (r_pobj) from_2\IN\0 (r_prep) fibrillation_1\NN\14361664
D003974_D064420 NONE renografin_7\NNP\0 (r_pobj) with_6\IN\0 (r_prep) occurred_2\VBD\0 (l_advcl) suggesting_9\VBG\1010118 (l_ccomp) contribute_13\VBP\126264 (l_prep) to_14\IN\0 (l_pobj) toxicity_15\NN\13576101
15638391
D006220_D006966 CID haloperidol_16\NN\3713736 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_nsubj) process_1\NN\407535 (l_prep) of_2\IN\0 (l_pobj) cells_4\NNS\3080309 (l_prep) of_5\IN\0 (l_pobj) lobe_10\NN\5220461 (l_prep) in_11\IN\13603305 (l_pobj) hyperprolactinemia_13\NN\0
D006220_D006966 CID haloperidol_15\NN\3713736 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_advcl) was_5\VBD\0 (l_xcomp) examine_7\VB\0 (l_dobj) influence_9\NN\5190804 (l_prep) of_10\IN\0 (l_pobj) hyperprolactinemia_11\NN\0
D006220_D006966 CID hal_17\NNP\0 (r_appos) haloperidol_15\NN\3713736 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_advcl) was_5\VBD\0 (l_xcomp) examine_7\VB\0 (l_dobj) influence_9\NN\5190804 (l_prep) of_10\IN\0 (l_pobj) hyperprolactinemia_11\NN\0
15266362
D004280_D004342 CID dobutamine_13\NN\0 (r_xcomp) related_11\VBN\628491 (l_nsubjpass) hypersensitivity_5\NN\14531772
D004280_D004802 CID dobutamine_13\NN\0 (r_xcomp) related_11\VBN\628491 (l_nsubjpass) hypersensitivity_5\NN\14531772 (l_amod) eosinophilic_7\JJ\0
D004280_D018754 NONE dobutamine_22\NN\0 (r_compound) infusion_23\NN\14589223 (r_pobj) with_21\IN\0 (r_prep) managed_19\VBD\2524171 (r_conj) admitted_14\VBN\822367 (l_prep) with_15\IN\0 (l_pobj) failure_17\NN\66216
D004280_D009205 CID dobutamine_13\NN\0 (r_xcomp) related_11\VBN\628491 (l_nsubjpass) hypersensitivity_5\NN\14531772 (l_amod) myocarditis_9\NN\14338942
D004280_D002312 NONE dobutamine_22\NN\0 (r_compound) infusion_23\NN\14589223 (r_pobj) with_21\IN\0 (r_prep) managed_19\VBD\2524171 (r_conj) admitted_14\VBN\822367 (l_nsubjpass) patient_5\NN\9898892 (l_acl) known_7\VBN\0 (l_xcomp) have_9\VB\7846 (l_dobj) cardiomyopathy_11\NN\14103288
2004015
D015215_D007239 NONE azt_28\NNP\3834836 (r_npadvmod) induced_30\VBN\1627355 (r_amod) anaemia_31\NN\14299637 (r_nsubj) is_32\VBZ\0 (r_ccomp) determine_26\VB\0 (r_xcomp) used_2\VBN\0 (l_dobj) model_5\NN\5888929 (l_prep) of_6\IN\0 (l_pobj) aids_7\NNP\13974317 (l_appos) infection_9\NN\14052046
D015215_C565469 NONE azidothymidine_8\NN\0 (r_advmod) treated_9\VBN\2376958 (l_dobj) mice_11\NNS\2329401 (l_amod) immunodeficient_10\JJ\0
D015215_D000163 NONE azt_28\NNP\3834836 (r_npadvmod) induced_30\VBN\1627355 (r_amod) anaemia_31\NN\14299637 (r_nsubj) is_32\VBZ\0 (r_ccomp) determine_26\VB\0 (r_xcomp) used_2\VBN\0 (l_dobj) model_5\NN\5888929 (l_prep) of_6\IN\0 (l_pobj) aids_7\NNP\13974317
D015215_D000740 CID 3'-azido-3'dideoxythymidine_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) anaemia_1\NN\14299637
D015215_D000740 CID azt_6\NNP\3834836 (r_appos) 3'-azido-3'dideoxythymidine_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) anaemia_1\NN\14299637
D015215_D000740 CID azt_28\NNP\3834836 (r_npadvmod) induced_30\VBN\1627355 (r_amod) anaemia_31\NN\14299637
D015215_D000740 CID azt_0\NNP\3834836 (r_nsubj) produced_1\VBD\1617192 (l_dobj) anaemia_2\NN\14299637
D015215_D000740 CID azt_15\NNP\3834836 (r_pobj) in_14\IN\13603305 (r_prep) e_13\NNP\14724645 (r_pobj) of_6\IN\0 (r_prep) number_5\NN\5107765 (r_nsubj) treated_16\VBD\2376958 (l_prep) despite_0\IN\7501545 (l_pobj) anaemia_2\NN\14299637
D015215_D000740 CID azt_8\NNP\3834836 (r_pobj) in_7\IN\13603305 (r_prep) observed_6\VBD\2163746 (l_conj) were_11\VBD\0 (l_acomp) appropriate_12\JJ\2228698 (l_prep) for_13\IN\0 (l_pobj) degree_15\NN\4916342 (l_prep) of_16\IN\0 (l_pobj) anaemia_17\NN\14299637
D015215_D000740 CID azt_17\NNP\3834836 (r_nsubj) treated_20\VBD\2376958 (l_prep) with_22\IN\0 (l_pobj) degrees_24\NNS\4916342 (l_prep) of_25\IN\0 (l_pobj) anaemia_26\NN\14299637
D015215_D000740 CID azt_12\NNP\3834836 (r_pobj) in_11\IN\13603305 (r_prep) observed_10\VBN\2163746 (r_acl) degree_7\NN\4916342 (l_prep) of_8\IN\0 (l_pobj) anaemia_9\NN\14299637
D015215_D000740 CID azt_0\NNP\3834836 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) anaemia_4\NN\14299637
D015215_D007938 NONE azt_28\NNP\3834836 (r_npadvmod) induced_30\VBN\1627355 (r_amod) anaemia_31\NN\14299637 (r_nsubj) is_32\VBZ\0 (r_ccomp) determine_26\VB\0 (r_xcomp) used_2\VBN\0 (l_dobj) model_5\NN\5888929 (l_prep) of_6\IN\0 (l_pobj) aids_7\NNP\13974317 (l_appos) infection_9\NN\14052046 (l_prep) of_10\IN\0 (l_pobj) mice_13\NNS\2329401 (l_prep) with_14\IN\0 (l_pobj) leukaemia_19\NN\14239918
D015215_D045262 NONE azt_12\NNP\3834836 (r_pobj) in_11\IN\13603305 (r_prep) observed_10\VBN\2163746 (r_acl) degree_7\NN\4916342 (r_pobj) for_5\IN\0 (r_prep) inappropriate_4\JJ\0 (r_acomp) was_3\VBD\0 (l_nsubj) reticulocytosis_2\NN\0
C030299_D000740 NONE phenylhydrazine_22\NN\0 (r_npadvmod) treated_26\VBD\2376958 (r_conj) observed_6\VBD\2163746 (l_conj) were_11\VBD\0 (l_acomp) appropriate_12\JJ\2228698 (l_prep) for_13\IN\0 (l_pobj) degree_15\NN\4916342 (l_prep) of_16\IN\0 (l_pobj) anaemia_17\NN\14299637
C030299_D000740 NONE phz_24\NNP\0 (r_nsubj) treated_26\VBD\2376958 (r_conj) observed_6\VBD\2163746 (l_conj) were_11\VBD\0 (l_acomp) appropriate_12\JJ\2228698 (l_prep) for_13\IN\0 (l_pobj) degree_15\NN\4916342 (l_prep) of_16\IN\0 (l_pobj) anaemia_17\NN\14299637
C030299_D000740 NONE phz_19\NNP\0 (r_conj) azt_17\NNP\3834836 (r_nsubj) treated_20\VBD\2376958 (l_prep) with_22\IN\0 (l_pobj) degrees_24\NNS\4916342 (l_prep) of_25\IN\0 (l_pobj) anaemia_26\NN\14299637
188339
D013256_D008113 NONE steroids_19\NNS\14727670 (r_dobj) using_16\VBG\418025 (r_advcl) seen_12\VBN\2106506 (l_nsubjpass) tumors_9\NNS\14234074
D003276_D008113 CID contraceptives_11\NNS\3183080 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) tumors_7\NNS\14234074
D003276_D008113 CID contraceptive_18\JJ\3183080 (r_amod) steroids_19\NNS\14727670 (r_dobj) using_16\VBG\418025 (r_advcl) seen_12\VBN\2106506 (l_nsubjpass) tumors_9\NNS\14234074
6293644
D006220_D002375 CID haloperidol_7\NN\3713736 (r_npadvmod) induced_9\VBN\1627355 (r_amod) catalepsy_10\NN\14023236
D001058_D006948 CID apomorphine_16\NN\3786417 (r_npadvmod) induced_18\VBN\1627355 (r_amod) hyperactivity_19\NN\14052403
D001058_D002375 NONE apomorphine_16\NN\3786417 (r_npadvmod) induced_18\VBN\1627355 (r_amod) hyperactivity_19\NN\14052403 (r_pobj) of_15\IN\0 (r_prep) prevention_14\NN\1073995 (r_conj) potentiation_5\NN\13564910 (l_prep) of_6\IN\0 (l_pobj) catalepsy_10\NN\14023236
D006220_D006948 NONE haloperidol_7\NN\3713736 (r_npadvmod) induced_9\VBN\1627355 (r_amod) catalepsy_10\NN\14023236 (r_pobj) of_6\IN\0 (r_prep) potentiation_5\NN\13564910 (l_conj) prevention_14\NN\1073995 (l_prep) of_15\IN\0 (l_pobj) hyperactivity_19\NN\14052403
11243580
D009569_D012640 NONE oxide_20\NN\14818238 (r_appos) ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D009569_D012640 NONE no_22\NNP\7204911 (r_intj) inhibitor_25\NN\20090 (r_appos) oxide_20\NN\14818238 (r_appos) ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D009569_D012640 NONE no_32\JJ\7204911 (r_det) precursor_33\NN\14580897 (r_appos) oxide_20\NN\14818238 (r_appos) ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D009569_D012640 NONE no_5\DT\7204911 (r_nsubj) is_6\VBZ\0 (l_attr) mediator_9\NN\10351874 (l_prep) in_10\IN\13603305 (l_pobj) convulsions_14\NNS\14081375
D001120_D012640 NONE arginine_29\NN\14605787 (r_conj) inhibitor_25\NN\20090 (r_appos) oxide_20\NN\14818238 (r_appos) ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D001120_D012640 NONE arginine_6\NN\14605787 (r_compound) treatment_7\NN\654885 (r_nsubj) increased_8\VBD\169651 (l_dobj) incidence_10\NN\13821570 (l_appos) convulsions_18\NNS\14081375
D019331_D012640 NONE ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D019331_D012640 NONE name_16\NN\6284225 (r_appos) ester_12\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) investigated_36\VBN\644583 (l_prep) on_37\IN\0 (l_pobj) convulsions_41\NNS\14081375
D019331_D012640 NONE name_2\NNP\6284225 (r_nsubj) decreased_16\VBD\169651 (l_dobj) incidence_18\NN\13821570 (l_appos) convulsions_26\NNS\14081375
D003975_D012640 NONE diazepam_10\NN\2830852 (r_conj) name_2\NNP\6284225 (r_nsubj) decreased_16\VBD\169651 (l_dobj) incidence_18\NN\13821570 (l_appos) convulsions_26\NNS\14081375
D008012_D012640 CID lidocaine_6\NN\3681148 (r_npadvmod) induced_8\VBN\1627355 (r_amod) convulsion_9\NN\14081375
D008012_D012640 CID lidocaine_38\NN\3681148 (r_npadvmod) induced_40\VBN\1627355 (r_amod) convulsions_41\NNS\14081375
D008012_D012640 CID lidocaine_20\NN\3681148 (r_pobj) of_19\IN\0 (r_prep) incidence_18\NN\13821570 (l_appos) convulsions_26\NNS\14081375
D008012_D012640 CID lidocaine_12\NN\3681148 (r_pobj) of_11\IN\0 (r_prep) incidence_10\NN\13821570 (l_appos) convulsions_18\NNS\14081375
D008012_D012640 CID lidocaine_11\NN\3681148 (r_npadvmod) induced_13\VBN\1627355 (r_amod) convulsions_14\NNS\14081375
326460
D001539_D007008 CID bendrofluazide_2\NN\0 (r_advmod) induced_4\VBN\1627355 (r_amod) hypokalemia_5\NN\14299637
D001539_D007008 CID bendrofluazide_17\NN\0 (r_amod) treatment_18\NN\654885 (r_pobj) of_13\IN\0 (r_prep) hypokalemia_12\NN\14299637
D013999_D007008 NONE timolol_7\NN\2832168 (r_pobj) by_6\IN\0 (r_prep) amelioration_0\NN\248977 (l_prep) of_1\IN\0 (l_pobj) hypokalemia_5\NN\14299637
D013999_D007008 NONE timolol_6\NN\2832168 (r_appos) drug_4\NN\14778436 (r_nsubj) tended_8\VBD\2604760 (l_xcomp) correct_10\VB\138508 (l_dobj) hypokalemia_12\NN\14299637
17923537
D005446_D009798 CID acetonide_21\NN\0 (r_pobj) with_18\IN\0 (r_prep) treated_17\VBN\2376958 (r_acl) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) incidence_3\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) pressure_9\NN\11419404
D005446_D009798 CID fa_23\NNP\6868043 (r_nmod) implant_26\NN\4013729 (r_appos) acetonide_21\NN\0 (r_pobj) with_18\IN\0 (r_prep) treated_17\VBN\2376958 (r_acl) patients_14\NNS\9898892 (r_pobj) in_13\IN\13603305 (r_prep) incidence_3\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) pressure_9\NN\11419404
D005446_D014605 NONE acetonide_9\NN\0 (r_compound) implants_10\NNS\4013729 (r_pobj) with_7\IN\0 (r_prep) treated_6\VBN\2376958 (r_acl) pressure_1\NN\11419404 (l_prep) in_2\IN\13603305 (l_pobj) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) uveitis_5\NN\14336539
D005446_D014605 NONE acetonide_21\NN\0 (r_pobj) with_18\IN\0 (r_prep) treated_17\VBN\2376958 (r_acl) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) uveitis_16\NN\14336539
D005446_D014605 NONE fa_23\NNP\6868043 (r_nmod) implant_26\NN\4013729 (r_appos) acetonide_21\NN\0 (r_pobj) with_18\IN\0 (r_prep) treated_17\VBN\2376958 (r_acl) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) uveitis_16\NN\14336539
14736955
D013481_D007674 NONE superoxide_41\JJ\14971519 (r_amod) production_42\NN\30358 (r_pobj) with_40\IN\0 (r_prep) correlated_39\VBN\2657219 (r_conj) correlated_10\VBN\2657219 (l_prep) among_0\IN\0 (l_pobj) injury_7\NN\14052046
D013481_D007674 NONE superoxide_25\NN\14971519 (l_prep) in_26\IN\13603305 (l_pobj) lesions_31\NNS\14204950
C102006_D007674 NONE citrate_32\NN\14850483 (r_compound) synthase_33\NN\0 (r_compound) activity_34\NN\30358 (r_conj) activities_15\NNS\30358 (r_appos) lesions_12\NNS\14204950
D004317_D009401 CID doxorubicin_10\NN\2716866 (r_compound) nephrosis_11\NN\14304060
D004317_D007674 NONE doxorubicin_0\NNP\2716866 (r_nsubj) induces_1\VBZ\1627355 (l_dobj) nephropathy_6\NN\14573196
D004317_D007674 NONE doxorubicin_0\NNP\2716866 (r_nsubj) induces_1\VBZ\1627355 (l_dobj) nephropathy_6\NN\14573196 (l_acl) characterized_7\VBN\609683 (l_agent) by_8\IN\0 (l_pobj) lesions_16\NNS\14204950
D004317_D007674 NONE doxorubicin_27\RB\2716866 (r_npadvmod) induced_29\VBN\1627355 (r_amod) lesions_31\NNS\14204950
20727411
-1_D011605 NONE ketamine_5\NN\3054098 (r_pobj) of_2\IN\0 (r_prep) correlates_1\NNS\5857459 (r_nsubj) induced_6\VBD\1627355 (l_dobj) psychosis_7\NN\14380140
D016202_D012559 NONE aspartate_8\NNP\0 (r_nmod) receptor_12\NN\5225602 (r_nsubjpass) implicated_15\VBN\2677097 (l_prep) in_16\IN\13603305 (l_pobj) pathophysiology_18\NN\0 (l_prep) of_19\IN\0 (l_pobj) schizophrenia_20\NN\14398067
D016202_D012559 NONE nmda_10\NNP\0 (r_nmod) receptor_12\NN\5225602 (r_nsubjpass) implicated_15\VBN\2677097 (l_prep) in_16\IN\13603305 (l_pobj) pathophysiology_18\NN\0 (l_prep) of_19\IN\0 (l_pobj) schizophrenia_20\NN\14398067
D016202_D012559 NONE nmda_13\NNP\0 (r_compound) antagonist_15\NN\7846 (r_compound) ketamine_16\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_nsubj) leads_17\VBZ\5155821 (l_prep) to_18\IN\0 (l_pobj) symptoms_20\NNS\5823932 (l_amod) similar_21\JJ\0 (l_prep) to_22\IN\0 (l_pobj) those_23\DT\0 (l_acl) observed_24\VBN\2163746 (l_prep) in_25\IN\13603305 (l_pobj) schizophrenia_26\NN\14398067
D016202_D012559 NONE nmda_10\NNP\0 (r_compound) dysfunction_12\NN\14204950 (l_prep) in_13\IN\13603305 (l_pobj) pathophysiology_15\NN\0 (l_prep) of_16\IN\0 (l_pobj) schizophrenia_17\NN\14398067
D007649_D011605 CID ketamine_0\NN\3054098 (r_nsubj) elicited_1\VBD\1617192 (l_dobj) psychosis_2\NN\14380140
D007649_D012559 NONE ketamine_16\NN\3054098 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_nsubj) leads_17\VBZ\5155821 (l_prep) to_18\IN\0 (l_pobj) symptoms_20\NNS\5823932 (l_amod) similar_21\JJ\0 (l_prep) to_22\IN\0 (l_pobj) those_23\DT\0 (l_acl) observed_24\VBN\2163746 (l_prep) in_25\IN\13603305 (l_pobj) schizophrenia_26\NN\14398067
D007649_D012559 NONE ketamine_5\NN\3054098 (r_nsubj) exacerbates_6\VBZ\126264 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) schizophrenia_3\NN\14398067
D007649_D012559 NONE ketamine_0\NN\3054098 (r_nsubj) induces_1\VBZ\1627355 (l_dobj) changes_3\NNS\7283608 (l_prep) in_4\IN\13603305 (l_pobj) subjects_6\NNS\6598915 (l_amod) similar_7\JJ\0 (l_prep) to_8\IN\0 (l_pobj) those_9\DT\0 (l_acl) observed_10\VBN\2163746 (l_prep) in_11\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) schizophrenia_14\NN\14398067
D007649_D018754 NONE ketamine_5\NN\3054098 (r_nsubj) exacerbates_6\VBZ\126264 (l_advcl) supporting_13\VBG\407535 (l_dobj) hypothesis_15\NN\7162194 (l_prep) of_16\IN\0 (l_pobj) dysfunction_19\NN\14204950
3969369
D013739_D063646 NONE testosterone_3\NN\14747587 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_7\IN\0 (l_pobj) carcinogenesis_9\NN\0
D013739_D011471 CID testosterone_6\NN\14747587 (r_pobj) with_5\IN\0 (r_prep) implanted_4\VBN\1421622 (r_acl) rats_2\NNS\2329401 (r_nsubj) developed_12\VBD\1753788 (l_dobj) incidence_15\NN\13821570 (l_prep) of_16\IN\0 (l_pobj) cancer_18\NN\14239425
D013739_D011471 CID testosterone_4\NN\14747587 (r_npadvmod) treated_6\VBN\2376958 (r_amod) rats_8\NNS\2329401 (l_relcl) fed_11\VBN\10373801 (l_dobj) diet_14\NN\7560652 (l_relcl) supplemented_18\VBN\182406 (l_dobj) fat_26\NN\14938907 (l_conj) cancer_30\NN\14239425
D013739_D009369 NONE testosterone_6\NN\14747587 (r_pobj) with_5\IN\0 (r_prep) implanted_4\VBN\1421622 (r_acl) rats_2\NNS\2329401 (r_nsubj) developed_12\VBD\1753788 (r_ccomp) developed_30\VBN\1753788 (l_dobj) tumors_32\NNS\14234074
D013739_D009369 NONE testosterone_6\NN\14747587 (r_pobj) with_5\IN\0 (r_prep) implanted_4\VBN\1421622 (r_acl) rats_2\NNS\2329401 (r_nsubj) developed_12\VBD\1753788 (r_ccomp) developed_30\VBN\1753788 (l_conj) %_36\NN\0 (l_advcl) included_39\VBD\0 (l_dobj) tumors_41\NNS\14234074
D013739_D011472 CID testosterone_9\NN\14747587 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (l_advcl) developed_10\VBD\1753788 (l_dobj) prostatitis_12\NN\14336539
2339463
D015119_D008595 NONE acid_22\NN\14818238 (r_compound) therapy_23\NN\657604 (l_prep) for_24\IN\0 (l_pobj) menorrhagia_25\NN\13513747
D015119_D020227 NONE acid_22\NN\14818238 (r_compound) therapy_23\NN\657604 (r_pobj) with_17\IN\0 (r_prep) associated_16\VBN\628491 (r_acl) thrombosis_15\NN\14100769
D015119_D020225 NONE acid_22\NN\14818238 (r_compound) therapy_23\NN\657604 (r_pobj) with_17\IN\0 (r_prep) associated_16\VBN\628491 (r_acl) thrombosis_15\NN\14100769
D015119_D012851 NONE acid_15\NN\14818238 (l_appos) thrombosis_19\NN\14100769
D015119_D013923 NONE acid_15\NN\14818238 (r_pobj) with_11\IN\0 (r_prep) treatment_10\NN\654885 (r_pobj) during_9\IN\0 (r_prep) reported_8\VBN\831651 (l_nsubjpass) risk_2\NN\14541044 (l_prep) of_3\IN\0 (l_pobj) disease_5\NN\14061805
8268147
D010396_D003882 NONE penicillamine_14\NN\3740161 (r_compound) treatment_15\NN\654885 (r_pobj) of_11\IN\0 (r_prep) complications_10\NNS\1073995 (r_pobj) of_7\IN\0 (r_prep) one_6\CD\13741022 (r_pobj) as_5\IN\14622893 (r_prep) develop_4\VB\1753788 (l_nsubj) dermatomyositis_2\NN\14350292
D010396_D003882 NONE penicillamine_4\NN\3740161 (r_compound) therapy_5\NN\657604 (r_dobj) receiving_1\VBG\2210855 (r_acl) patients_0\NNS\9898892 (r_nsubjpass) followed_8\VBN\1835496 (l_prep) for_10\IN\0 (l_pobj) development_12\NN\248977 (l_prep) of_13\IN\0 (l_pobj) complications_15\NNS\1073995 (l_prep) like_16\IN\5839024 (l_pobj) dermatomyositis_19\NN\14350292
D010396_D017285 CID penicillamine_15\NN\3740161 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) cirrhosis_10\NN\14116321 (r_pobj) with_7\IN\0 (r_prep) patient_6\NN\9898892 (r_pobj) in_4\IN\13603305 (r_prep) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) polymyositis_3\NN\14350292
D010396_D017285 CID penicillamine_14\NN\3740161 (r_compound) treatment_15\NN\654885 (r_pobj) of_11\IN\0 (r_prep) complications_10\NNS\1073995 (r_pobj) of_7\IN\0 (r_prep) one_6\CD\13741022 (r_pobj) as_5\IN\14622893 (r_prep) develop_4\VB\1753788 (l_nsubj) dermatomyositis_2\NN\14350292 (l_nmod) polymyositis_0\NNP\14350292
D010396_D017285 CID penicillamine_16\NN\3740161 (r_compound) therapy_17\NN\657604 (r_dobj) receiving_13\VBG\2210855 (r_advcl) developed_10\VBD\1753788 (l_dobj) polymyositis_11\NN\14350292
D010396_D017285 CID penicillamine_4\NN\3740161 (r_compound) therapy_5\NN\657604 (r_dobj) receiving_1\VBG\2210855 (r_acl) patients_0\NNS\9898892 (r_nsubjpass) followed_8\VBN\1835496 (l_prep) for_10\IN\0 (l_pobj) development_12\NN\248977 (l_prep) of_13\IN\0 (l_pobj) complications_15\NNS\1073995 (l_prep) like_16\IN\5839024 (l_pobj) dermatomyositis_19\NN\14350292 (l_nmod) polymyositis_17\NN\14350292
D010396_D012216 NONE penicillamine_3\NN\3740161 (r_nsubjpass) used_6\VBN\0 (l_prep) for_7\IN\0 (l_pobj) diseases_10\NNS\14061805
D010396_D008105 NONE penicillamine_15\NN\3740161 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) cirrhosis_10\NN\14116321
D010396_D008105 NONE penicillamine_16\NN\3740161 (r_compound) therapy_17\NN\657604 (r_dobj) receiving_13\VBG\2210855 (r_advcl) developed_10\VBD\1753788 (r_relcl) cirrhosis_7\NN\14116321
D010396_D064420 NONE penicillamine_3\NN\3740161 (r_nsubjpass) used_6\VBN\0 (r_advcl) limits_13\VBZ\5123416 (l_nsubj) toxicity_12\NN\13576101
9165568
D018967_D001480 NONE risperidone_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) frequency_9\NN\15286249 (l_prep) of_10\IN\0 (l_pobj) symptoms_12\NNS\5823932
D004298_D009459 NONE dopamine_10\NN\14807737 (r_compound) blockade_13\NN\952963 (r_pobj) of_9\IN\0 (r_prep) result_8\NN\34213 (r_attr) be_6\VB\14625458 (r_xcomp) thought_4\VBN\5809192 (l_nsubjpass) syndrome_2\NN\5870365
D018967_D009459 CID risperidone_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) syndrome_2\NN\5870365
D018967_D009459 CID risperidone_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) monotherapy_10\NN\0 (r_pobj) after_9\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) syndrome_8\NN\5870365
D018967_D009459 CID risperidone_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) observed_9\VBN\2163746 (r_ccomp) appears_1\VBZ\2604760 (l_conj) ensure_14\VB\0 (l_dobj) protection_15\NN\407535 (l_prep) from_16\IN\0 (l_pobj) syndrome_19\NN\5870365
20164825
D008687_D014652 NONE metformin_3\NN\2719105 (r_nsubj) diminish_5\VB\169651 (l_conj) prevent_15\VB\0 (l_dobj) dysfunction_17\NN\14204950
D005839_D058186 CID gentamicin_4\NN\2716866 (r_npadvmod) mediated_6\VBN\761713 (r_amod) failure_9\NN\66216
D005839_D007674 NONE gentamicin_3\NN\2716866 (r_npadvmod) induced_5\VBN\1627355 (r_amod) nephropathy_6\NN\14573196
D005839_D007674 NONE gentamicin_12\NN\2716866 (r_amod) nephrotoxicity_13\NN\0
D008687_D007674 NONE metformin_0\NNP\2719105 (r_nsubj) prevents_1\VBZ\0 (l_dobj) nephropathy_6\NN\14573196
D008687_D007674 NONE metformin_11\NN\2719105 (r_pobj) by_10\IN\0 (r_prep) correction_9\NN\248977 (r_conj) markers_3\NNS\21939 (l_prep) of_4\IN\0 (l_pobj) dysfunction_6\NN\14204950
D008687_D007674 NONE metformin_9\NN\2719105 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (r_nsubj) lessen_11\VB\169651 (l_dobj) nephrotoxicity_13\NN\0
D005839_D064420 NONE gentamicin_14\NN\2716866 (r_amod) toxicity_15\NN\13576101
D008687_D058186 NONE metformin_0\NNP\2719105 (r_compound) treatment_1\NN\654885 (r_nsubj) blocked_3\VBD\1476483 (l_dobj) failure_9\NN\66216
6728084
D000617_D007674 NONE aminoglycoside_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_amod) nephrotoxic_0\JJ\0
D000617_D007674 NONE aminoglycosides_2\NNS\0 (r_nsubj) act_4\VB\6479665 (l_prep) as_5\IN\14622893 (l_pobj) nephrotoxicants_6\NNS\0 (l_prep) at_7\IN\14622893 (l_pobj) impairment_13\NN\7296428 (l_prep) of_14\IN\0 (l_pobj) reabsorption_16\NN\13526110
625456
D002119_D006934 CID ate_24\VBN\0 (r_amod) sodium_26\NN\14625458 (r_compound) powders_28\NNS\15046900 (r_pobj) of_20\IN\0 (r_prep) amounts_19\NNS\13329641 (r_dobj) consumed_17\VBN\1168468 (r_relcl) patients_13\NNS\9898892 (r_pobj) in_12\IN\13603305 (r_prep) reported_11\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) hypercalcaemia_4\NN\14299637
D017693_D006934 CID bicarbonate_27\NN\14798450 (r_compound) powders_28\NNS\15046900 (r_pobj) of_20\IN\0 (r_prep) amounts_19\NNS\13329641 (r_dobj) consumed_17\VBN\1168468 (r_relcl) patients_13\NNS\9898892 (r_pobj) in_12\IN\13603305 (r_prep) reported_11\VBN\831651 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) hypercalcaemia_4\NN\14299637
D002119_D053040 CID ate_24\VBN\0 (r_amod) sodium_26\NN\14625458 (r_compound) powders_28\NNS\15046900 (r_pobj) of_20\IN\0 (r_prep) amounts_19\NNS\13329641 (r_dobj) consumed_17\VBN\1168468 (r_relcl) patients_13\NNS\9898892 (r_pobj) in_12\IN\13603305 (r_prep) reported_11\VBN\831651 (l_nsubjpass) two_6\CD\13741022 (l_prep) of_7\IN\0 (l_pobj) nephrolithiasis_9\NN\14115914
D017693_D053040 CID bicarbonate_27\NN\14798450 (r_compound) powders_28\NNS\15046900 (r_pobj) of_20\IN\0 (r_prep) amounts_19\NNS\13329641 (r_dobj) consumed_17\VBN\1168468 (r_relcl) patients_13\NNS\9898892 (r_pobj) in_12\IN\13603305 (r_prep) reported_11\VBN\831651 (l_nsubjpass) two_6\CD\13741022 (l_prep) of_7\IN\0 (l_pobj) nephrolithiasis_9\NN\14115914
18363626
D010100_D001919 NONE oxygen_30\NN\14622893 (r_compound) saturations_31\NNS\13534954 (r_conj) range_28\NN\5123416 (r_pobj) of_23\IN\0 (r_prep) %_22\NN\0 (r_pobj) within_20\IN\0 (r_prep) were_19\VBD\0 (l_advcl) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) bradycardia_11\NN\14110674
D020927_D001919 CID dexmedetomidine_1\NN\0 (r_amod) sedation_2\NN\14034177 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) bradycardia_11\NN\14110674
1286498
D005442_D009325 CID flumazenil_11\JJ\0 (r_compound) group_12\NN\2137 (r_pobj) in_9\IN\13603305 (r_prep) vomiting_8\VBG\116687 (r_conj) nausea_6\NN\14299637
D005442_D009325 CID flumazenil_11\JJ\0 (r_compound) group_12\NN\2137 (l_conj) pain_19\NN\14299637 (l_nmod) nausea_14\NN\14299637
D005442_D010146 NONE flumazenil_11\JJ\0 (r_compound) group_12\NN\2137 (l_conj) pain_19\NN\14299637
D005442_D014839 CID flumazenil_11\JJ\0 (r_compound) group_12\NN\2137 (r_pobj) in_9\IN\13603305 (r_prep) vomiting_8\VBG\116687
8599504
D004329_D000799 CID droperidol_3\NN\0 (r_compound) administration_4\NN\1133281 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBD\628491 (r_acl) angioedema_0\NNP\14316714
D004329_D000799 CID droperidol_39\NN\0 (r_pobj) of_38\IN\0 (r_prep) dose_37\NN\3740161 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) of_30\IN\0 (r_prep) minutes_29\NNS\6502378 (r_pobj) within_27\IN\0 (r_prep) developed_26\VBN\1753788 (l_nsubj) angioedema_19\NN\14316714
D004329_D004487 NONE droperidol_39\NN\0 (r_pobj) of_38\IN\0 (r_prep) dose_37\NN\3740161 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) of_30\IN\0 (r_prep) minutes_29\NNS\6502378 (r_pobj) within_27\IN\0 (r_prep) developed_26\VBN\1753788 (l_nsubj) angioedema_19\NN\14316714 (l_prep) with_20\IN\0 (l_pobj) swelling_23\NN\14315071
D004329_D004342 NONE droperidol_39\NN\0 (r_pobj) of_38\IN\0 (r_prep) dose_37\NN\3740161 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) of_30\IN\0 (r_prep) minutes_29\NNS\6502378 (r_pobj) within_27\IN\0 (r_prep) developed_26\VBN\1753788 (r_relcl) allergies_16\NNS\14533203
D004329_D014060 NONE droperidol_39\NN\0 (r_pobj) of_38\IN\0 (r_prep) dose_37\NN\3740161 (r_pobj) of_33\IN\0 (r_prep) administration_32\NN\1133281 (r_pobj) of_30\IN\0 (r_prep) minutes_29\NNS\6502378 (r_pobj) within_27\IN\0 (r_prep) developed_26\VBN\1753788 (l_nsubj) angioedema_19\NN\14316714 (l_prep) with_20\IN\0 (l_pobj) swelling_23\NN\14315071
9514561
D002211_D010146 CID capsaicin_5\NN\15032661 (r_pobj) by_4\IN\0 (r_agent) elicited_3\VBN\1617192 (r_acl) pain_2\NN\14299637
D002211_D010146 CID capsaicin_4\NN\15032661 (r_pobj) of_3\IN\0 (r_prep) amount_2\NN\13329641 (r_nsubjpass) administered_6\VBN\2436349 (l_advcl) evoke_13\VB\1617192 (l_dobj) sensation_17\NN\5708432 (l_amod) painful_16\JJ\0
9848575
D004317_D009202 CID doxorubicin_15\RB\2716866 (r_npadvmod) induced_17\VBN\1627355 (r_amod) cardiomyopathy_18\NN\14103288
D004317_D009202 CID doxorubicin_7\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) courses_5\NNS\883297 (r_dobj) received_2\VBD\2210855 (r_relcl) animals_0\NNS\4475 (r_nsubj) demonstrated_8\VBD\2137132 (l_dobj) decrease_16\NN\7296428 (l_prep) of_17\IN\0 (l_pobj) pressure_19\NN\11419404 (l_conj) cardiomyopathy_25\NN\14103288
D004317_D009202 CID doxorubicin_22\NN\2716866 (r_pobj) of_21\IN\0 (r_prep) courses_20\NNS\883297 (r_pobj) by_18\IN\0 (r_agent) induced_15\VBN\1627355 (l_csubjpass) examine_1\VB\0 (l_dobj) effect_6\NN\34213 (l_prep) of_7\IN\0 (l_pobj) cardiomyopathy_13\NN\14103288
D018943_D009202 NONE anthracycline_6\NN\0 (r_amod) derivative_7\JJ\5802185 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_11\IN\0 (l_pobj) heart_13\NN\5919034 (l_conj) cardiomyopathy_18\NN\14103288
D004317_D066126 NONE doxorubicin_28\NN\2716866 (r_appos) potential_9\NN\14481929 (l_amod) cardiotoxic_8\JJ\0
D004317_D066126 NONE doxorubicin_28\NN\2716866 (r_appos) potential_9\NN\14481929 (l_conj) effect_16\NN\34213 (l_prep) on_19\IN\0 (l_pobj) cardiotoxicity_23\NN\0
D004317_D066126 NONE doxorubicin_22\NN\2716866 (r_pobj) of_21\IN\0 (r_prep) courses_20\NNS\883297 (r_pobj) by_18\IN\0 (r_agent) induced_15\VBN\1627355 (l_csubjpass) examine_1\VB\0 (l_dobj) effect_6\NN\34213 (l_amod) cardiotoxic_5\JJ\0
D004317_D066126 NONE doxorubicin_11\NN\2716866 (r_compound) treatment_12\NN\654885 (r_pobj) by_8\IN\0 (r_agent) enhanced_7\VBN\227165 (l_nsubjpass) changes_5\NNS\7283608 (l_amod) cardiotoxic_4\JJ\0
D004317_D066126 NONE doxorubicin_16\RB\2716866 (r_npadvmod) induced_18\VBN\1627355 (r_amod) cardiotoxicity_19\NN\0 (r_pobj) on_15\IN\0 (r_prep) effect_14\NN\34213 (r_conj) cardiotoxicity_11\NN\0
D004317_D066126 NONE doxorubicin_16\RB\2716866 (r_npadvmod) induced_18\VBN\1627355 (r_amod) cardiotoxicity_19\NN\0
C055866_D009202 NONE sm-5887_9\NNP\0 (r_appos) derivative_7\JJ\5802185 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_11\IN\0 (l_pobj) heart_13\NN\5919034 (l_conj) cardiomyopathy_18\NN\14103288
C055866_D009202 NONE sm-5887_35\NNP\0 (r_compound) administration_36\NN\1133281 (r_nsubj) show_39\VB\429048 (r_advcl) demonstrated_8\VBD\2137132 (l_dobj) decrease_16\NN\7296428 (l_prep) of_17\IN\0 (l_pobj) pressure_19\NN\11419404 (l_conj) cardiomyopathy_25\NN\14103288
C055866_D009202 NONE sm-5887_8\NNP\0 (r_nmod) cardiomyopathy_13\NN\14103288
C055866_D009202 NONE sm-5887_5\NNP\0 (r_compound) treatment_6\NN\654885 (r_nsubj) progress_9\VB\250259 (l_dobj) grade_11\NN\7975026 (l_prep) of_12\IN\0 (l_pobj) cardiomyopathy_13\NN\14103288
C055866_D066126 NONE sm-5887_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) potential_9\NN\14481929 (l_amod) cardiotoxic_8\JJ\0
C055866_D066126 NONE sm-5887_11\NNP\0 (r_pobj) of_10\IN\0 (r_prep) potential_9\NN\14481929 (l_conj) effect_16\NN\34213 (l_prep) on_19\IN\0 (l_pobj) cardiotoxicity_23\NN\0
C055866_D066126 NONE sm-5887_18\NNP\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (r_conj) potential_9\NN\14481929 (l_amod) cardiotoxic_8\JJ\0
C055866_D066126 NONE sm-5887_18\NNP\0 (r_pobj) of_17\IN\0 (r_prep) effect_16\NN\34213 (l_prep) on_19\IN\0 (l_pobj) cardiotoxicity_23\NN\0
C055866_D066126 NONE sm-5887_8\NNP\0 (r_nmod) cardiomyopathy_13\NN\14103288 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (l_amod) cardiotoxic_5\JJ\0
C055866_D066126 NONE sm-5887_3\NNP\0 (r_nsubj) have_6\VB\7846 (l_dobj) potential_8\NN\14481929 (l_prep) of_9\IN\0 (l_pobj) cardiotoxicity_11\NN\0
C055866_D066126 NONE sm-5887_3\NNP\0 (r_nsubj) have_6\VB\7846 (l_dobj) potential_8\NN\14481929 (l_prep) of_9\IN\0 (l_pobj) cardiotoxicity_11\NN\0 (l_conj) effect_14\NN\34213 (l_prep) on_15\IN\0 (l_pobj) cardiotoxicity_19\NN\0
11573852
D000666_D004830 NONE b_18\NNP\1355326 (r_pobj) of_16\IN\0 (r_prep) infusion_15\NN\14589223 (r_pobj) during_13\IN\0 (r_prep) experienced_8\VBD\2108377 (l_dobj) seizures_12\NNS\14081375
D000666_D012640 CID b_1\NN\1355326 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375
D000666_D012640 CID b_16\NNP\1355326 (r_compound) infusion_17\NN\14589223 (r_pobj) following_14\VBG\8180190 (r_prep) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) episodes_6\NNS\7283608 (l_prep) of_7\IN\0 (l_pobj) activity_9\NN\30358 (l_compound) seizure_8\NN\14081375
D000666_D012640 CID b_18\NNP\1355326 (r_pobj) of_16\IN\0 (r_prep) infusion_15\NN\14589223 (r_pobj) during_13\IN\0 (r_prep) experienced_8\VBD\2108377 (l_conj) stopped_28\VBN\0 (l_nsubjpass) seizures_23\NNS\14081375
D000666_D012640 CID b_15\NNP\1355326 (r_compound) administration_16\NN\1133281 (r_pobj) during_13\IN\0 (r_prep) occurred_11\VBD\0 (r_conj) persisted_9\VBD\118523 (l_nsubj) seizures_8\NNS\14081375
D000666_D012640 CID b_8\NNP\1355326 (r_nsubj) was_9\VBD\0 (l_attr) cause_11\NN\7323922 (l_prep) of_12\IN\0 (l_pobj) seizures_14\NNS\14081375
D000666_D012640 CID b_1\NNP\1355326 (r_nsubj) seems_2\VBZ\2604760 (l_xcomp) be_4\VB\14625458 (l_attr) cause_7\NN\7323922 (l_prep) of_8\IN\0 (l_pobj) seizures_10\NNS\14081375
D000666_D012640 CID b_11\NNP\1355326 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (r_acl) seizures_7\NNS\14081375
D000431_D012640 NONE alcohol_9\NN\7881800 (r_compound) intake_10\NN\13440063 (r_conj) history_4\NN\15120823 (r_dobj) had_2\VBD\0 (l_conj) cause_17\VB\7323922 (l_dobj) seizures_18\NNS\14081375
D016049_D012640 NONE didanosine_0\NNP\2725367 (r_nsubj) has_2\VBZ\13888491 (l_dobj) potential_4\NN\14481929 (l_prep) for_5\IN\0 (l_pcomp) inducing_6\VBG\42311 (l_dobj) seizures_7\NNS\14081375
D000666_D000163 NONE b_1\NN\1355326 (r_npadvmod) induced_3\VBN\1627355 (r_amod) seizures_4\NNS\14081375 (l_prep) in_5\IN\13603305 (l_pobj) patient_7\NN\9898892 (l_prep) with_8\IN\0 (l_pobj) aids_9\NNP\13974317
D000666_D000163 NONE b_16\NNP\1355326 (r_compound) infusion_17\NN\14589223 (r_pobj) following_14\VBG\8180190 (r_prep) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) episodes_6\NNS\7283608 (l_prep) in_10\IN\13603305 (l_pobj) patent_13\NN\6470073 (l_compound) aids_12\NNP\13974317
D000666_D000163 NONE b_8\NNP\1355326 (r_nsubj) was_9\VBD\0 (l_attr) cause_11\NN\7323922 (l_prep) of_12\IN\0 (l_pobj) seizures_14\NNS\14081375 (l_prep) in_15\IN\13603305 (l_pobj) patient_18\NN\9898892 (l_compound) aids_17\NNP\13974317
D000431_D000437 NONE alcohol_9\NN\7881800 (r_compound) intake_10\NN\13440063 (r_conj) history_4\NN\15120823 (l_prep) of_5\IN\0 (l_pobj) abuse_7\NN\418025
D008140_D012640 NONE lorazepam_5\NN\2830852 (r_conj) phenytoin_3\NN\3550533 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_pobj) despite_0\IN\7501545 (r_prep) persisted_9\VBD\118523 (l_nsubj) seizures_8\NNS\14081375
D010672_D012640 NONE phenytoin_3\NN\3550533 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_pobj) despite_0\IN\7501545 (r_prep) persisted_9\VBD\118523 (l_nsubj) seizures_8\NNS\14081375
8012887
D006493_D013927 CID heparin_7\NN\2718259 (r_npadvmod) induced_9\VBN\1627355 (r_amod) thrombosis_11\NN\14100769
D006493_D013927 CID heparin_6\NN\2718259 (r_npadvmod) induced_8\VBN\1627355 (r_amod) thrombosis_9\NN\14100769
D006493_D013927 CID heparin_14\JJ\2718259 (r_pobj) with_13\IN\0 (r_prep) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) used_3\VBN\0 (l_prep) for_5\IN\0 (l_pobj) prophylaxis_6\NN\1077350 (l_prep) against_7\IN\0 (l_pobj) development_8\NN\248977 (l_prep) of_9\IN\0 (l_pobj) thrombosis_10\NN\14100769
D006493_D013927 CID heparin_14\JJ\2718259 (r_pobj) with_13\IN\0 (r_prep) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) used_3\VBN\0 (l_conj) defined_39\VBN\2604760 (l_auxpass) is_36\VBZ\0 (l_nsubj) success_27\NN\7283608 (l_prep) in_28\IN\13603305 (l_pobj) patients_29\NNS\9898892 (l_relcl) developed_32\VBN\1753788 (l_dobj) syndrome_35\NN\5870365 (l_compound) thrombosis_34\NN\14100769
D006493_D013927 CID heparin_23\NN\2718259 (r_pobj) to_22\IN\0 (r_prep) reexposure_21\NN\0 (r_dobj) require_19\VBP\0 (r_relcl) aggregation_17\NN\31264 (r_dobj) induced_15\VBN\1627355 (r_advcl) used_3\VBN\0 (l_prep) for_5\IN\0 (l_pobj) prophylaxis_6\NN\1077350 (l_prep) against_7\IN\0 (l_pobj) development_8\NN\248977 (l_prep) of_9\IN\0 (l_pobj) thrombosis_10\NN\14100769
D006493_D013927 CID heparin_23\NN\2718259 (r_pobj) to_22\IN\0 (r_prep) reexposure_21\NN\0 (r_dobj) require_19\VBP\0 (r_relcl) aggregation_17\NN\31264 (r_dobj) induced_15\VBN\1627355 (r_advcl) used_3\VBN\0 (l_conj) defined_39\VBN\2604760 (l_auxpass) is_36\VBZ\0 (l_nsubj) success_27\NN\7283608 (l_prep) in_28\IN\13603305 (l_pobj) patients_29\NNS\9898892 (l_relcl) developed_32\VBN\1753788 (l_dobj) syndrome_35\NN\5870365 (l_compound) thrombosis_34\NN\14100769
D006493_D013927 CID heparin_14\NN\2718259 (r_npadvmod) induced_16\VBN\1627355 (r_amod) thrombosis_17\NN\14100769
D006493_D001791 NONE heparin_14\JJ\2718259 (r_pobj) with_13\IN\0 (r_prep) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) used_3\VBN\0 (l_advcl) induced_15\VBN\1627355 (l_dobj) aggregation_17\NN\31264
D006493_D001791 NONE heparin_23\NN\2718259 (r_pobj) to_22\IN\0 (r_prep) reexposure_21\NN\0 (r_dobj) require_19\VBP\0 (r_relcl) aggregation_17\NN\31264
8766220
D017374_-1 NONE paroxetine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) association_5\NN\8008335 (r_pobj) in_4\IN\13603305 (r_prep) initiated_3\VBN\1617192 (l_conj) dosulepine_9\JJ\0 (l_prep) in_11\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_amod) tetraparetic_13\JJ\0
D014147_D006212 CID tramadol_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) intake_7\NN\13440063 (r_pobj) after_3\IN\0 (r_prep) nightmares_0\NNS\14411243 (l_conj) hallucinations_2\NNS\14376855
D014147_D006212 CID tramadol_25\NN\0 (r_conj) drugs_23\NNS\14778436 (r_pobj) of_19\IN\0 (r_prep) withdrawal_18\NN\7206096 (r_pobj) after_16\IN\0 (r_prep) stopped_15\VBD\0 (r_relcl) hallucinations_12\NNS\14376855
D004308_D059350 NONE hydrochloride_10\NN\14817592 (r_dobj) dosulepine_9\JJ\0 (l_prep) in_11\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_prep) with_15\IN\0 (l_pobj) pain_17\NN\14299637
D004308_-1 NONE hydrochloride_10\NN\14817592 (r_dobj) dosulepine_9\JJ\0 (l_prep) in_11\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_amod) tetraparetic_13\JJ\0
D017374_D059350 NONE paroxetine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) association_5\NN\8008335 (r_pobj) in_4\IN\13603305 (r_prep) initiated_3\VBN\1617192 (l_conj) dosulepine_9\JJ\0 (l_prep) in_11\IN\13603305 (l_pobj) patient_14\NN\9898892 (l_prep) with_15\IN\0 (l_pobj) pain_17\NN\14299637
D014147_D010146 NONE tramadol_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) opioid_4\NN\0 (l_prep) with_5\IN\0 (l_pobj) effects_6\NNS\13245626 (l_relcl) used_14\VBN\0 (l_xcomp) treat_16\VB\7570720 (l_dobj) pain_18\NN\14299637
D014147_D010146 NONE tramadol_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) opioid_4\NN\0 (l_prep) with_5\IN\0 (l_pobj) effects_6\NNS\13245626 (l_relcl) used_14\VBN\0 (l_xcomp) treat_16\VB\7570720 (l_dobj) pain_18\NN\14299637 (l_conj) pain_23\NN\14299637
D014147_D009369 NONE tramadol_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) opioid_4\NN\0 (l_prep) with_5\IN\0 (l_pobj) effects_6\NNS\13245626 (l_relcl) used_14\VBN\0 (l_xcomp) treat_16\VB\7570720 (l_dobj) pain_18\NN\14299637 (l_compound) cancer_17\NN\14239425
3088349
D000661_-1 NONE amphetamine_17\NN\3248958 (r_pobj) by_16\IN\0 (r_prep) exhaustion_15\NN\14016361 (r_pobj) to_14\TO\0 (r_prep) reflects_8\VBZ\923793 (l_nsubj) rotation_2\NN\331950 (l_prep) following_3\VBG\8180190 (l_pobj) lesion_7\NN\14204950
D000661_D009069 CID amphetamine_17\NN\3248958 (r_pobj) by_16\IN\0 (r_prep) exhaustion_15\NN\14016361 (r_pobj) to_14\TO\0 (r_prep) reflects_8\VBZ\923793 (l_nsubj) rotation_2\NN\331950
D000661_D009069 CID amphetamine_26\NN\3248958 (r_npadvmod) induced_28\VBN\1627355 (r_amod) behavior_30\NN\407535 (r_pobj) on_25\IN\0 (r_prep) examined_12\VBD\0 (l_prep) in_0\IN\13603305 (l_pobj) order_1\NN\7168131 (l_acl) clarify_3\VB\939277 (l_dobj) nature_5\NN\4723816 (l_prep) of_6\IN\0 (l_pobj) rotation_10\NN\331950
D000661_D009069 CID amphetamine_26\NN\3248958 (r_npadvmod) induced_28\VBN\1627355 (r_amod) behavior_30\NN\407535
D000661_D009069 CID amphetamine_10\NN\3248958 (r_nsubjpass) administered_12\VBN\2436349 (r_advcl) was_6\VBD\0 (l_advcl) indicating_22\VBG\952524 (l_dobj) involvement_23\NN\1080366 (l_prep) of_24\IN\0 (l_pobj) cells_26\NNS\3080309 (l_prep) in_27\IN\13603305 (l_pobj) rotation_30\NN\331950
D000661_D009069 CID amphetamine_16\NN\3248958 (r_compound) dose_17\NN\3740161 (r_conj) volume_14\NN\33615 (r_pobj) of_11\IN\0 (r_prep) irrespective_10\RB\0 (r_conj) duration_5\NN\15113229 (r_pobj) of_3\IN\0 (r_prep) regardless_2\RB\0 (r_advmod) tended_31\VBD\2604760 (l_nsubj) rotation_30\NN\331950
D000661_D009069 CID amphetamine_27\NN\3248958 (r_npadvmod) induced_29\VBN\1627355 (r_amod) rotation_30\NN\331950
D000661_D009069 CID amphetamine_55\NN\3248958 (r_compound) injections_56\NNS\320852 (r_pobj) to_53\IN\0 (r_prep) response_52\NN\11410625 (r_pobj) in_51\IN\13603305 (r_prep) circled_46\VBD\1835496 (r_conj) tended_31\VBD\2604760 (l_nsubj) rotation_30\NN\331950
D000661_D009069 CID amphetamine_4\NN\3248958 (r_nsubj) has_5\VBZ\13888491 (l_dobj) effect_8\NN\34213 (l_prep) on_9\IN\0 (l_pobj) pool_15\NN\3302121 (l_acl) contributing_16\VBG\126264 (l_prep) to_17\IN\0 (l_pobj) rotation_19\NN\331950
D016627_-1 NONE 6-ohda_2\CD\0 (r_pobj) following_0\VBG\8180190 (r_prep) induced_3\VBN\1627355 (l_dobj) lesion_5\NN\14204950
D016627_D009069 NONE 6-ohda_2\CD\0 (r_pobj) following_0\VBG\8180190 (r_prep) induced_3\VBN\1627355 (r_ccomp) reported_15\VBN\831651 (l_nsubjpass) period_9\NN\13575869 (l_prep) of_10\IN\0 (l_pobj) rotation_12\NN\331950
D016627_D009069 NONE 6-ohda_2\CD\0 (r_pobj) following_0\VBG\8180190 (r_prep) induced_3\VBN\1627355 (r_ccomp) reported_15\VBN\831651 (l_xcomp) precede_17\VB\0 (l_dobj) circling_21\NN\1835496
12739036
D003401_D008180 NONE creatine_5\NN\14601829 (r_compound) levels_7\NNS\4916342 (l_prep) in_8\IN\13603305 (l_pobj) erythematosus_11\NN\0
D003520_D007674 NONE cyclophosphamide_25\NN\0 (r_conj) azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) with_14\IN\0 (l_pobj) involvement_16\NN\1080366
D001379_D007674 NONE azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) with_14\IN\0 (l_pobj) involvement_16\NN\1080366
D013256_D009220 NONE steroids_10\NNS\14727670 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_conj) suspected_2\VBN\916909 (l_nsubjpass) myositis_0\NNP\14336539
D002738_D009135 NONE chloroquine_15\NN\2721948 (r_advmod) induced_17\VBN\1627355 (r_amod) myopathy_18\NN\14204950
D002738_D009135 NONE chloroquine_3\NN\2721948 (r_npadvmod) induced_5\VBN\1627355 (r_compound) myopathy_6\NN\14204950
D003520_D008180 NONE cyclophosphamide_25\NN\0 (r_conj) azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) from_7\IN\0 (l_pobj) erythematosus_10\NN\0
D003520_D008180 NONE cyclophosphamide_25\NN\0 (r_conj) azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) from_7\IN\0 (l_pobj) erythematosus_10\NN\0 (l_appos) sle_12\NNP\14229912
D002738_D018771 NONE chloroquine_3\NN\2721948 (r_amod) cq_5\NNP\0 (r_pobj) with_2\IN\0 (r_prep) therapy_1\NN\657604 (r_nsubjpass) started_8\VBN\0 (l_prep) because_9\IN\0 (l_pobj) arthralgia_11\NN\14322699
D002738_D018771 NONE cq_5\NNP\0 (r_pobj) with_2\IN\0 (r_prep) therapy_1\NN\657604 (r_nsubjpass) started_8\VBN\0 (l_prep) because_9\IN\0 (l_pobj) arthralgia_11\NN\14322699
D001379_D008180 NONE azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) from_7\IN\0 (l_pobj) erythematosus_10\NN\0
D001379_D008180 NONE azathioprine_23\NN\3740161 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) of_20\IN\0 (r_prep) periods_19\NNS\13575869 (r_dobj) undergone_18\JJ\109660 (r_conj) suffering_6\VBG\14322699 (l_prep) from_7\IN\0 (l_pobj) erythematosus_10\NN\0 (l_appos) sle_12\NNP\14229912
3220106
D009538_D006948 CID nicotine_3\NN\14712692 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hyperactivity_7\NN\14052403
D009538_D006948 CID nicotine_10\NN\14712692 (r_npadvmod) treated_12\VBN\2376958 (r_amod) rats_13\NNS\2329401 (r_pobj) in_8\IN\13603305 (r_prep) hyperactivity_7\NN\14052403
D009538_D006948 CID nicotine_5\NN\14712692 (r_npadvmod) treated_7\VBN\2376958 (r_amod) rats_8\NNS\2329401 (r_nsubj) develop_9\VBP\1753788 (l_dobj) hyperactivity_11\NN\14052403
D009538_D006948 CID nicotine_15\NN\14712692 (r_pobj) to_14\IN\0 (r_prep) response_13\NN\11410625 (r_pobj) in_12\IN\13603305 (r_prep) develop_9\VBP\1753788 (l_dobj) hyperactivity_11\NN\14052403
D004298_D006948 NONE da_28\NNP\10484858 (r_compound) concentration_29\NN\4916342 (r_conj) receptors_26\NNS\5225602 (r_pobj) of_24\IN\0 (r_prep) density_23\NN\4941325 (r_pobj) of_20\IN\0 (r_prep) increases_19\NNS\13576355 (r_pobj) due_17\JJ\5174653 (r_prep) develop_9\VBP\1753788 (l_dobj) hyperactivity_11\NN\14052403
D004298_D006948 NONE da_34\NNP\10484858 (r_compound) supersensitivity_36\NN\0 (r_dobj) inducing_33\VBG\42311 (r_pcomp) by_32\IN\0 (r_agent) followed_31\VBN\1835496 (r_advcl) suggest_2\VBP\1010118 (l_ccomp) develop_9\VBP\1753788 (l_dobj) hyperactivity_11\NN\14052403
2790457
D003042_D012640 CID cocaine_11\NN\3492717 (r_pobj) by_10\IN\0 (r_agent) kindled_9\VBN\2764245 (r_acl) seizures_8\NNS\14081375
D003042_D012640 CID cocaine_10\NN\3492717 (r_npadvmod) induced_12\VBN\1627355 (r_conj) lidocaine-_8\NN\0 (r_nmod) seizures_13\NNS\14081375
D003042_D012640 CID cocaine_10\NN\3492717 (r_npadvmod) induced_12\VBN\1627355 (r_conj) lidocaine-_8\NN\0 (r_nmod) seizures_13\NNS\14081375 (r_pobj) of_6\IN\0 (r_prep) development_5\NN\248977 (r_dobj) inhibited_3\VBD\2510337 (l_conj) had_16\VBD\0 (l_dobj) effect_18\NN\34213 (l_prep) on_19\IN\0 (l_pobj) seizures_25\NNS\14081375
D003042_D012640 CID cocaine_13\NN\3492717 (r_npadvmod) injected_15\VBN\81072 (r_amod) rats_16\NNS\2329401 (r_pobj) in_11\IN\13603305 (r_prep) mortality_10\NN\5054863 (l_amod) related_9\VBN\628491 (l_npadvmod) seizure_7\NN\14081375
D003042_D012640 CID cocaine_23\NN\3492717 (r_npadvmod) induced_25\VBN\1627355 (r_amod) seizures_26\NNS\14081375
D003042_D012640 CID cocaine_19\NN\3492717 (r_npadvmod) kindled_21\VBN\2764245 (r_amod) seizures_22\NNS\14081375
D002220_D012640 NONE carbamazepine_1\NN\0 (r_nsubj) inhibits_2\VBZ\2510337 (l_dobj) development_4\NN\248977 (l_prep) of_5\IN\0 (l_pobj) seizures_8\NNS\14081375
D002220_D012640 NONE carbamazepine_3\NN\0 (l_appos) treatment_7\NN\654885 (l_prep) on_8\IN\0 (l_pobj) seizures_13\NNS\14081375
D002220_D012640 NONE cbz_5\NNP\0 (r_nmod) treatment_7\NN\654885 (l_prep) on_8\IN\0 (l_pobj) seizures_13\NNS\14081375
D002220_D012640 NONE cbz_30\NNP\0 (r_compound) administration_31\NN\1133281 (r_pobj) of_29\IN\0 (r_prep) methods_28\NNS\5616786 (r_pobj) under_26\IN\0 (r_conj) in_18\IN\13603305 (r_prep) evaluated_17\VBN\670261 (l_nsubjpass) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) carbamazepine_3\NN\0 (l_appos) treatment_7\NN\654885 (l_prep) on_8\IN\0 (l_pobj) seizures_13\NNS\14081375
D002220_D012640 NONE cbz_2\NN\0 (r_nsubj) inhibited_3\VBD\2510337 (l_dobj) development_5\NN\248977 (l_prep) of_6\IN\0 (l_pobj) seizures_13\NNS\14081375
D002220_D012640 NONE cbz_2\NN\0 (r_nsubj) inhibited_3\VBD\2510337 (l_conj) had_16\VBD\0 (l_dobj) effect_18\NN\34213 (l_prep) on_19\IN\0 (l_pobj) seizures_25\NNS\14081375
D002220_D012640 NONE cbz_1\NN\0 (r_nsubj) decreased_3\VBD\169651 (l_dobj) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) mortality_10\NN\5054863 (l_amod) related_9\VBN\628491 (l_npadvmod) seizure_7\NN\14081375
D002220_D012640 NONE cbz_1\NN\0 (r_nsubj) had_13\VBD\0 (l_dobj) effect_15\NN\34213 (l_prep) on_16\IN\0 (l_pobj) seizures_26\NNS\14081375
D002220_D012640 NONE cbz_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) injection_2\NN\320852 (r_nsubj) was_10\VBD\0 (l_prep) without_11\IN\0 (l_pobj) effect_12\NN\34213 (l_prep) on_13\IN\0 (l_pobj) development_15\NN\248977 (l_prep) of_16\IN\0 (l_pobj) seizures_22\NNS\14081375
D002220_D012640 NONE cbz_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (l_prep) depending_5\VBG\2604760 (l_prep) upon_6\IN\0 (l_pobj) stage_7\NN\15113229 (l_prep) of_8\IN\0 (l_pobj) development_10\NN\248977 (l_compound) seizure_9\NN\14081375
D002220_D012640 NONE cbz_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) suggest_11\VBP\1010118 (l_ccomp) underlie_15\VBP\2604760 (l_dobj) development_17\NN\248977 (l_prep) versus_18\IN\0 (l_pobj) maintenance_19\NN\266806 (l_prep) of_20\IN\0 (l_pobj) seizures_25\NNS\14081375
D008012_D012640 CID lidocaine_13\NN\3681148 (r_conj) cocaine_11\NN\3492717 (r_pobj) by_10\IN\0 (r_agent) kindled_9\VBN\2764245 (r_acl) seizures_8\NNS\14081375
D008012_D012640 CID lidocaine-_8\NN\0 (r_nmod) seizures_13\NNS\14081375
D008012_D012640 CID lidocaine-_8\NN\0 (r_nmod) seizures_13\NNS\14081375 (r_pobj) of_6\IN\0 (r_prep) development_5\NN\248977 (r_dobj) inhibited_3\VBD\2510337 (l_conj) had_16\VBD\0 (l_dobj) effect_18\NN\34213 (l_prep) on_19\IN\0 (l_pobj) seizures_25\NNS\14081375
D008012_D012640 CID lidocaine_18\NN\3681148 (r_npadvmod) kindled_20\VBN\2764245 (r_amod) seizures_26\NNS\14081375
D008012_D012640 CID lidocaine-_17\NN\0 (r_nmod) seizures_22\NNS\14081375
16116131
D007980_D004409 CID levodopa_7\RB\14604959 (r_npadvmod) induced_9\VBN\1627355 (r_amod) dyskinesia_10\NN\14084880
D001058_D004409 NONE apomorphine_46\NN\3786417 (r_compound) infusion_47\NN\14589223 (r_pobj) by_44\IN\0 (r_agent) induced_43\VBN\1627355 (r_acl) state_42\NN\8491826 (l_amod) dyskinetic_41\JJ\0
D001058_D010300 NONE apomorphine_46\NN\3786417 (r_compound) infusion_47\NN\14589223 (r_pobj) by_44\IN\0 (r_agent) induced_43\VBN\1627355 (r_acl) state_42\NN\8491826 (r_pobj) of_39\IN\0 (r_prep) modification_38\NN\191142 (r_pobj) in_36\IN\13603305 (r_prep) result_35\VB\34213 (r_ccomp) investigated_28\VBN\644583 (l_advcl) using_0\VBG\418025 (l_parataxis) rtms_6\NN\0 (l_prep) over_8\IN\5867413 (l_pobj) area_12\NN\8630985 (l_prep) in_16\IN\13603305 (l_pobj) group_18\NN\2137 (l_prep) of_19\IN\0 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) disease_24\NN\14061805
9867728
D005277_D006349 NONE fenfluramine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) users_6\NNS\7846 (r_pobj) among_5\IN\0 (r_prep) disease_4\NN\14061805
D005277_D006349 NONE fenfluramine_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) users_14\NNS\7846 (r_pobj) of_13\IN\0 (r_prep) %_12\NN\0 (r_nsubj) had_19\VBD\0 (l_dobj) disease_21\NN\14061805
D005277_D006349 NONE fenfluramine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) users_11\NNS\7846 (r_pobj) among_10\IN\0 (r_prep) abnormalities_9\NNS\14034177
D005277_D006349 NONE fenfluramine_18\JJ\0 (r_compound) phentermine_20\NN\0 (r_dobj) receiving_17\VBG\2210855 (r_acl) patients_1\NNS\9898892 (r_nsubj) developed_21\VBD\1753788 (l_dobj) disease_24\NN\14061805
D010645_D006349 NONE phentermine_20\NN\0 (r_dobj) receiving_17\VBG\2210855 (r_acl) patients_1\NNS\9898892 (r_nsubj) developed_21\VBD\1753788 (l_dobj) disease_24\NN\14061805
D020372_D006349 NONE dexfenfluramine_10\NN\0 (r_conj) fenfluramine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) users_6\NNS\7846 (r_pobj) among_5\IN\0 (r_prep) disease_4\NN\14061805
D020372_D006349 NONE dexfenfluramine_18\NN\0 (r_conj) fenfluramine_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) users_14\NNS\7846 (r_pobj) of_13\IN\0 (r_prep) %_12\NN\0 (r_nsubj) had_19\VBD\0 (l_dobj) disease_21\NN\14061805
D020372_D006349 NONE dexfenfluramine_15\NN\0 (r_conj) fenfluramine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) users_11\NNS\7846 (r_pobj) among_10\IN\0 (r_prep) abnormalities_9\NNS\14034177
804391
D012293_D011507 CID rifampin_8\NN\2716205 (r_advmod) treated_9\VBN\2376958 (r_amod) patients_10\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) proteinuria_2\NN\14299637
D012293_D011507 CID rifampin_13\NN\2716205 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_advcl) found_4\VBN\13279262 (l_nsubjpass) proteinuria_2\NN\14299637
D012293_D014376 NONE rifampin_8\NN\2716205 (r_advmod) treated_9\VBN\2376958 (r_amod) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) tuberculosis_12\NN\14127211
D012293_D014376 NONE rifampin_13\NN\2716205 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (l_nsubj) patients_10\NNS\9898892 (l_compound) tuberculosis_9\NN\14127211
9523850
D008775_D063806 NONE methylprednisolone_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) value_0\NN\5856066 (l_prep) in_3\IN\13603305 (l_pobj) prevention_4\NN\1073995 (l_prep) of_5\IN\0 (l_pobj) syndrome_10\NN\5870365 (l_compound) myalgia_9\NN\14322699
D008775_D063806 NONE mp_6\NNP\10249459 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) reduces_11\VBZ\441445 (l_dobj) frequency_13\NN\15286249 (l_prep) of_16\IN\0 (l_pobj) syndrome_21\NN\5870365 (l_compound) myalgia_20\NN\14322699
D008775_D018771 NONE methylprednisolone_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) value_0\NN\5856066 (l_prep) in_3\IN\13603305 (l_pobj) prevention_4\NN\1073995 (l_prep) of_5\IN\0 (l_pobj) syndrome_10\NN\5870365 (l_compound) myalgia_9\NN\14322699 (l_compound) arthralgia_7\JJ\14322699
D008775_D018771 NONE mp_6\NNP\10249459 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_nsubj) reduces_11\VBZ\441445 (l_dobj) frequency_13\NN\15286249 (l_prep) of_16\IN\0 (l_pobj) syndrome_21\NN\5870365 (l_compound) myalgia_20\NN\14322699 (l_compound) arthralgia_18\JJ\14322699
D007505_D018771 CID dextran_19\NN\0 (r_pobj) of_17\IN\0 (r_prep) infusion_16\NN\14589223 (r_pobj) with_12\IN\0 (r_prep) associated_11\VBN\628491 (r_acl) syndrome_10\NN\5870365 (l_compound) myalgia_9\NN\14322699 (l_compound) arthralgia_7\JJ\14322699
D007505_D063806 NONE dextran_19\NN\0 (r_pobj) of_17\IN\0 (r_prep) infusion_16\NN\14589223 (r_pobj) with_12\IN\0 (r_prep) associated_11\VBN\628491 (r_acl) syndrome_10\NN\5870365 (l_compound) myalgia_9\NN\14322699
2569282
D020927_D009123 NONE dexmedetomidine_7\NN\0 (r_nsubj) is_13\VBZ\0 (l_acomp) capable_14\JJ\0 (l_prep) of_15\IN\0 (l_pcomp) inducing_16\VBG\42311 (l_dobj) flaccidity_18\NN\4938228
D020927_D009123 NONE med_11\NNP\6700447 (r_appos) dexmedetomidine_7\NN\0 (r_nsubj) is_13\VBZ\0 (l_acomp) capable_14\JJ\0 (l_prep) of_15\IN\0 (l_pcomp) inducing_16\VBG\42311 (l_dobj) flaccidity_18\NN\4938228
D015760_D009127 CID alfentanil_23\NN\0 (r_compound) anesthesia_24\NN\14034177 (r_pobj) by_19\IN\0 (r_agent) caused_18\VBN\1617192 (r_acl) rigidity_17\NN\5023233
D015760_D009127 CID alfentanil_7\NN\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) rigidity_11\NN\5023233
D020927_D009127 NONE dexmedetomidine_0\NNP\0 (r_nsubj) prevents_8\VBZ\0 (l_dobj) rigidity_13\NN\5023233
D020927_D009127 NONE med_13\NNP\6700447 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_nsubj) prevents_14\VBZ\0 (l_dobj) rigidity_17\NN\5023233
D020927_D009127 NONE med_5\NNP\6700447 (r_nsubj) prevented_6\VBD\0 (l_dobj) rigidity_11\NN\5023233
D020927_D018476 NONE med_6\NNP\6700447 (r_compound) animals_7\NNS\4475 (r_nsubj) were_8\VBD\0 (l_acomp) flaccid_9\JJ\0 (l_conj) akinetic_11\JJ\0
D020927_D012021 NONE med_6\NNP\6700447 (r_compound) animals_7\NNS\4475 (r_nsubj) were_8\VBD\0 (l_conj) lacked_14\VBD\0 (l_dobj) response_17\NN\11410625 (l_compound) startle_16\JJ\863513
12481039
D012964_D012640 NONE sodium_1\NN\14625458 (r_compound) channel_2\NN\6251781 (r_compound) density_3\NN\4941325 (l_appos) dependence_7\NN\24720 (l_conj) susceptibility_13\NN\13920835 (l_prep) to_14\IN\0 (l_pobj) seizures_15\NNS\14081375
D012964_D012640 NONE sodium_19\NN\14625458 (r_compound) channel_20\NN\6251781 (r_compound) 2-subunits_22\NNS\0 (r_dobj) lacking_18\VBG\0 (r_pcomp) in_16\IN\13603305 (r_prep) seizures_15\NNS\14081375
D010862_D012640 CID pilocarpine_17\NN\14712692 (r_npadvmod) induced_19\VBN\1627355 (r_amod) seizures_20\NNS\14081375 (r_pobj) for_16\IN\0 (r_prep) threshold_15\NN\15265518 (r_conj) latency_13\NN\15269513 (r_pobj) by_11\IN\0 (r_agent) indicated_10\VBN\952524 (r_advcl) displayed_3\VBD\2137132 (l_dobj) susceptibility_5\NN\13920835 (l_prep) to_6\IN\0 (l_pobj) seizures_7\NNS\14081375
D010862_D012640 CID pilocarpine_17\NN\14712692 (r_npadvmod) induced_19\VBN\1627355 (r_amod) seizures_20\NNS\14081375
20195852
C038192_D003490 NONE iopromide_17\JJ\0 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (r_dobj) determined_3\VBD\0 (l_prep) among_21\IN\0 (l_conj) compared_29\VBD\644583 (l_dobj) rates_31\NNS\13308999 (l_prep) for_32\IN\0 (l_pobj) complication_34\NN\1073995 (l_prep) in_35\IN\13603305 (l_pobj) relation_36\NN\2137 (l_prep) to_37\IN\0 (l_pobj) type_39\NN\5839024 (l_conj) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) cyanosis_48\NN\14299637
D007472_D003490 NONE iohexol_19\NN\0 (r_conj) iopromide_17\JJ\0 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (r_dobj) determined_3\VBD\0 (l_prep) among_21\IN\0 (l_conj) compared_29\VBD\644583 (l_dobj) rates_31\NNS\13308999 (l_prep) for_32\IN\0 (l_pobj) complication_34\NN\1073995 (l_prep) in_35\IN\13603305 (l_pobj) relation_36\NN\2137 (l_prep) to_37\IN\0 (l_pobj) type_39\NN\5839024 (l_conj) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) cyanosis_48\NN\14299637
D007472_D007674 CID iohexol_19\NN\0 (r_conj) iopromide_17\JJ\0 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) cin_7\NNP\0
C038192_D007674 CID iopromide_17\JJ\0 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID media_8\NNS\3575240 (r_dobj) contrast_7\NN\13854649 (l_nsubj) risk_0\NN\14541044 (l_prep) of_1\IN\0 (l_pobj) nephropathy_2\NN\14573196
D003287_D007674 CID media_6\NNS\3575240 (r_npadvmod) induced_8\VBN\1627355 (r_amod) nephropathy_9\NN\14573196
D003287_D007674 CID media_6\NNS\3575240 (r_npadvmod) induced_8\VBN\1627355 (r_amod) nephropathy_9\NN\14573196 (l_appos) cin_11\NNP\0
D003287_D007674 CID media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID cm_14\NNP\13649268 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID cm_43\NNP\13649268 (r_pobj) of_42\IN\0 (r_prep) type_39\NN\5839024 (r_pobj) to_37\IN\0 (r_prep) relation_36\NN\2137 (r_pobj) in_35\IN\13603305 (r_prep) complication_34\NN\1073995 (r_pobj) for_32\IN\0 (r_prep) rates_31\NNS\13308999 (r_dobj) compared_29\VBD\644583 (r_conj) among_21\IN\0 (r_prep) determined_3\VBD\0 (l_dobj) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID cm_17\NNP\13649268 (r_pobj) of_16\IN\0 (r_prep) dosage_15\NN\13576355 (r_dobj) received_12\VBD\2210855 (r_relcl) those_10\DT\0 (r_pobj) among_9\IN\0 (r_prep) were_8\VBD\0 (l_nsubj) %_2\NN\0 (l_prep) of_3\IN\0 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID cm_17\NNP\13649268 (r_pobj) of_16\IN\0 (r_prep) dosage_15\NN\13576355 (r_dobj) received_12\VBD\2210855 (r_relcl) those_10\DT\0 (r_pobj) among_9\IN\0 (r_prep) were_8\VBD\0 (r_advcl) increased_21\VBD\169651 (l_prep) with_32\IN\0 (l_pobj) difference_35\NN\4723816 (l_prep) in_36\IN\13603305 (l_pobj) incidence_38\NN\13821570 (l_prep) of_39\IN\0 (l_pobj) cin_40\NNP\0
D003287_D007674 CID cm_47\NNP\13649268 (r_pobj) of_46\IN\0 (r_prep) dosages_45\NNS\13576355 (r_pobj) to_42\IN\0 (r_prep) related_41\VBN\628491 (r_acl) incidence_38\NN\13821570 (r_pobj) in_36\IN\13603305 (r_prep) difference_35\NN\4723816 (r_pobj) with_32\IN\0 (r_prep) increased_21\VBD\169651 (l_advcl) were_8\VBD\0 (l_nsubj) %_2\NN\0 (l_prep) of_3\IN\0 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) cin_7\NNP\0
D003287_D007674 CID cm_47\NNP\13649268 (r_pobj) of_46\IN\0 (r_prep) dosages_45\NNS\13576355 (r_pobj) to_42\IN\0 (r_prep) related_41\VBN\628491 (r_acl) incidence_38\NN\13821570 (l_prep) of_39\IN\0 (l_pobj) cin_40\NNP\0
D003287_D007674 CID cm_13\NNP\13649268 (r_pobj) of_10\IN\0 (r_prep) type_9\NN\5839024 (r_pobj) on_7\IN\0 (r_conj) on_3\IN\0 (r_prep) depends_2\VBZ\2604760 (l_conj) needed_32\VBN\0 (l_advcl) is_26\VBZ\0 (l_nsubj) cin_24\NNP\0
D003287_D003490 NONE media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (r_dobj) determined_3\VBD\0 (l_prep) among_21\IN\0 (l_conj) compared_29\VBD\644583 (l_dobj) rates_31\NNS\13308999 (l_prep) for_32\IN\0 (l_pobj) complication_34\NN\1073995 (l_prep) in_35\IN\13603305 (l_pobj) relation_36\NN\2137 (l_prep) to_37\IN\0 (l_pobj) type_39\NN\5839024 (l_conj) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) cyanosis_48\NN\14299637
D003287_D003490 NONE cm_14\NNP\13649268 (r_appos) media_12\NNS\3575240 (r_pobj) for_8\IN\0 (r_prep) incidence_5\NN\13821570 (r_dobj) determined_3\VBD\0 (l_prep) among_21\IN\0 (l_conj) compared_29\VBD\644583 (l_dobj) rates_31\NNS\13308999 (l_prep) for_32\IN\0 (l_pobj) complication_34\NN\1073995 (l_prep) in_35\IN\13603305 (l_pobj) relation_36\NN\2137 (l_prep) to_37\IN\0 (l_pobj) type_39\NN\5839024 (l_conj) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) cyanosis_48\NN\14299637
D003287_D003490 NONE cm_43\NNP\13649268 (r_pobj) of_42\IN\0 (r_prep) type_39\NN\5839024 (l_conj) presence_46\NN\13954253 (l_prep) of_47\IN\0 (l_pobj) cyanosis_48\NN\14299637
D003287_D003490 NONE cm_13\NNP\13649268 (r_pobj) of_10\IN\0 (r_prep) type_9\NN\5839024 (r_pobj) on_7\IN\0 (l_conj) on_16\IN\0 (l_pobj) presence_18\NN\13954253 (l_prep) of_19\IN\0 (l_pobj) cyanosis_20\NN\14299637
15673851
D016202_D020760 NONE aspartate_10\NN\0 (r_compound) receptors_11\NNS\5225602 (r_pobj) of_2\IN\0 (r_prep) activation_1\NN\13561719 (r_nsubj) contribute_13\VB\126264 (l_prep) to_14\IN\0 (l_pobj) degeneration_15\NN\29677 (l_acl) induced_20\VBN\1627355 (l_prep) after_24\IN\0 (l_pobj) interval_27\NN\33615 (l_prep) of_28\IN\0 (l_pobj) ischemia_31\NN\14195315
D016202_D020760 NONE nmda_15\NNP\0 (r_compound) activation_17\NN\13561719 (r_pobj) via_14\IN\0 (r_prep) ischemia_13\NN\14195315
D016202_D020258 NONE nmda_15\NNP\0 (r_compound) activation_17\NN\13561719 (r_pobj) via_14\IN\0 (r_prep) ischemia_13\NN\14195315 (r_pobj) of_10\IN\0 (r_prep) setting_9\NN\8567235 (r_pobj) in_7\IN\13603305 (r_prep) be_5\VB\14625458 (l_acomp) neurotoxic_6\JJ\0
D016202_D001157 NONE aspartate_20\NNP\0 (r_nmod) receptors_24\NNS\5225602 (r_pobj) of_13\IN\0 (r_prep) activation_12\NN\13561719 (r_conj) neurons_10\NNS\5430628 (r_pobj) of_7\IN\0 (r_prep) degeneration_6\NN\29677 (l_prep) following_28\VBG\8180190 (l_pobj) interval_31\NN\33615 (l_prep) of_32\IN\0 (l_pobj) occlusion_34\NN\14081375
D016202_D001157 NONE nmda_22\NNP\0 (r_nmod) receptors_24\NNS\5225602 (r_pobj) of_13\IN\0 (r_prep) activation_12\NN\13561719 (r_conj) neurons_10\NNS\5430628 (r_pobj) of_7\IN\0 (r_prep) degeneration_6\NN\29677 (l_prep) following_28\VBG\8180190 (l_pobj) interval_31\NN\33615 (l_prep) of_32\IN\0 (l_pobj) occlusion_34\NN\14081375
D018698_D020336 NONE glutamate_15\NN\15010703 (r_pobj) in_13\IN\13603305 (r_prep) increase_12\NN\13576355 (r_pobj) with_9\IN\0 (r_prep) induces_6\VBZ\1627355 (l_dobj) paraparesis_8\NN\14558599
D016202_D020336 NONE nmda_21\NNP\0 (r_compound) activation_23\NN\13561719 (r_pobj) in_20\IN\13603305 (r_prep) involved_19\VBN\2676054 (r_relcl) glutamate_15\NN\15010703 (r_pobj) in_13\IN\13603305 (r_prep) increase_12\NN\13576355 (r_pobj) with_9\IN\0 (r_prep) induces_6\VBZ\1627355 (l_dobj) paraparesis_8\NN\14558599
D009020_D020760 NONE morphine_23\NN\2707683 (r_pobj) by_21\IN\0 (r_agent) induced_20\VBN\1627355 (l_prep) after_24\IN\0 (l_pobj) interval_27\NN\33615 (l_prep) of_28\IN\0 (l_pobj) ischemia_31\NN\14195315
D016291_D020336 NONE mk-801_8\NNP\0 (r_punct) (_9\-LRB-\0 (r_punct) mug_11\NN\13756125 (l_prep) on_13\IN\0 (l_pobj) changes_16\NNS\7283608 (l_prep) after_21\IN\0 (l_pobj) paraparesis_26\NN\14558599
D016291_D020336 NONE mk-801_1\NNP\0 (r_punct) reduced_3\VBD\441445 (l_prep) after_13\IN\0 (l_pobj) paraparesis_18\NN\14558599
D009020_D020336 CID morphine_22\NN\2707683 (r_npadvmod) induced_24\VBN\1627355 (r_amod) paraparesis_26\NN\14558599
D009020_D020336 CID morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) paraparesis_18\NN\14558599
D009020_D020336 CID morphine_5\NN\2707683 (r_nsubj) induces_6\VBZ\1627355 (l_dobj) paraparesis_8\NN\14558599
D009020_D001157 NONE morphine_27\NN\2707683 (r_pobj) after_25\IN\0 (r_prep) degeneration_6\NN\29677 (l_prep) following_28\VBG\8180190 (l_pobj) interval_31\NN\33615 (l_prep) of_32\IN\0 (l_pobj) occlusion_34\NN\14081375
7647582
D014269_D056486 NONE trifluoroacetyl_11\JJ\0 (r_compound) adduct_12\NN\14818238 (r_appos) product_9\NN\3076708 (r_pobj) to_3\IN\0 (r_prep) response_2\NN\11410625 (r_nsubjpass) detected_16\VBN\2163746 (l_prep) on_17\IN\0 (l_pobj) patients_20\NNS\9898892 (l_compound) hepatitis_19\NN\14127211
D006221_D056486 CID halothane_25\NN\3570838 (r_relcl) exposure_23\NN\5042871 (r_pobj) following_21\VBG\8180190 (r_agent) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) injury_17\NN\14052046
D006221_D056486 CID halothane_0\NNP\3570838 (r_compound) hepatitis_1\NN\14127211
D006221_D056486 CID halothane_18\NN\3570838 (r_amod) patients_20\NNS\9898892 (l_compound) hepatitis_19\NN\14127211
D006221_D056486 CID halothane_23\NN\3570838 (r_compound) hepatitis_24\NN\14127211
D006221_D056486 CID halothane_30\NN\3570838 (r_advcl) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_amod) similar_19\JJ\0 (l_prep) to_20\IN\0 (l_pobj) that_21\DT\0 (l_prep) of_22\IN\0 (l_pobj) hepatitis_24\NN\14127211
D004737_D004342 NONE enflurane_10\NN\3299929 (l_conj) isoflurane_12\RB\3570838 (l_prep) with_13\IN\0 (l_pobj) hypersensitivity_15\NN\14531772
D004737_D004342 NONE enflurane_11\NN\3299929 (r_nsubj) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_compound) hypersensitivity_17\NN\14531772
D007530_D056486 CID isoflurane_6\RB\3570838 (r_conj) enflurane_4\NN\3299929 (r_conj) anesthetics_2\NNS\3247620 (r_nsubjpass) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) injury_17\NN\14052046
D007530_D056486 CID isoflurane_13\NN\3570838 (r_conj) enflurane_11\NN\3299929 (r_nsubj) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_amod) similar_19\JJ\0 (l_prep) to_20\IN\0 (l_pobj) that_21\DT\0 (l_prep) of_22\IN\0 (l_pobj) hepatitis_24\NN\14127211
D007530_D004342 NONE isoflurane_12\RB\3570838 (l_prep) with_13\IN\0 (l_pobj) hypersensitivity_15\NN\14531772
D007530_D004342 NONE isoflurane_13\NN\3570838 (r_conj) enflurane_11\NN\3299929 (r_nsubj) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_compound) hypersensitivity_17\NN\14531772
D006221_D004342 NONE halothane_18\NN\3570838 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) hypersensitivity_15\NN\14531772
D006221_D004342 NONE halothane_23\NN\3570838 (r_compound) hepatitis_24\NN\14127211 (r_pobj) of_22\IN\0 (r_prep) that_21\DT\0 (r_pobj) to_20\IN\0 (r_prep) similar_19\JJ\0 (r_amod) condition_18\NN\24720 (l_compound) hypersensitivity_17\NN\14531772
D006221_D004342 NONE halothane_30\NN\3570838 (r_advcl) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_compound) hypersensitivity_17\NN\14531772
D004737_D056486 CID enflurane_4\NN\3299929 (r_conj) anesthetics_2\NNS\3247620 (r_nsubjpass) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) injury_17\NN\14052046
D004737_D056486 CID enflurane_11\NN\3299929 (r_nsubj) produce_15\VB\7555863 (l_dobj) condition_18\NN\24720 (l_amod) similar_19\JJ\0 (l_prep) to_20\IN\0 (l_pobj) that_21\DT\0 (l_prep) of_22\IN\0 (l_pobj) hepatitis_24\NN\14127211
7059267
D002747_D003924 NONE chlorpropamide_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) diabetes_9\NNS\14075199
D002747_D003924 NONE diabenese_14\NNP\0 (r_appos) chlorpropamide_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) diabetes_9\NNS\14075199
D002747_D003924 NONE chlorpropamide_26\NN\0 (r_amod) therapy_27\NN\657604 (r_pobj) of_25\IN\0 (r_prep) discontinuation_24\NN\209943 (r_pobj) with_23\IN\0 (r_prep) resolved_22\VBD\352826 (r_relcl) neuropathy_20\NN\14204950 (r_dobj) had_16\VBD\0 (l_csubj) treated_10\VBN\2376958 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) diabetes_9\NNS\14075199
D002747_D009901 CID chlorpropamide_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) neuropathy_4\NN\14204950
D002747_D009901 CID chlorpropamide_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (r_csubj) had_16\VBD\0 (l_dobj) neuropathy_20\NN\14204950
D002747_D009901 CID diabenese_14\NNP\0 (r_appos) chlorpropamide_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (r_csubj) had_16\VBD\0 (l_dobj) neuropathy_20\NN\14204950
D002747_D009901 CID chlorpropamide_26\NN\0 (r_amod) therapy_27\NN\657604 (r_pobj) of_25\IN\0 (r_prep) discontinuation_24\NN\209943 (r_pobj) with_23\IN\0 (r_prep) resolved_22\VBD\352826 (r_relcl) neuropathy_20\NN\14204950
11208990
D000109_D007674 NONE acetylcholine_5\NN\14807558 (r_npadvmod) related_6\VBN\628491 (r_conj) phenylephrine_3\NN\2682038 (r_nmod) responses_7\NNS\11410625 (r_pobj) in_0\IN\13603305 (r_prep) were_8\VBD\0 (l_acomp) impaired_10\VBN\258857 (l_prep) in_11\IN\13603305 (l_pobj) group_16\NN\2137 (l_compound) nephropathy_15\NN\14573196
D004317_D009401 NONE adr_15\NNP\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) nephrosis_18\NN\14304060
D009569_D007674 NONE oxide_3\NN\14818238 (r_compound) production_4\NN\30358 (r_pobj) of_1\IN\0 (r_prep) association_0\NN\8008335 (l_conj) apoptosis_6\NN\11486178 (l_prep) in_7\IN\13603305 (l_pobj) model_9\NN\5888929 (l_prep) of_10\IN\0 (l_pobj) nephropathy_12\NN\14573196
D004317_D009395 NONE adr_9\NNP\0 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_acl) rats_6\NNS\2329401 (r_pobj) of_5\IN\0 (r_prep) kidneys_4\NNS\5333259 (r_pobj) of_2\IN\0 (r_prep) examination_1\NN\633864 (r_nsubj) revealed_10\VBD\2137132 (l_dobj) areas_12\NNS\8630985 (l_prep) of_13\IN\0 (l_pobj) proliferation_15\NN\13489037 (l_conj) inflammation_19\NN\14299637
D009569_D009401 NONE no_5\UH\7204911 (r_intj) between_4\IN\0 (r_prep) interactions_3\NNS\37396 (r_nsubj) are_8\VBP\13600404 (l_prep) in_10\IN\13603305 (l_pobj) pathogenesis_12\NN\13533470 (l_prep) of_13\IN\0 (l_pobj) nephrosis_18\NN\14304060
D010656_D007674 NONE phenylephrine_3\NN\2682038 (r_nmod) responses_7\NNS\11410625 (r_pobj) in_0\IN\13603305 (r_prep) were_8\VBD\0 (l_acomp) impaired_10\VBN\258857 (l_prep) in_11\IN\13603305 (l_pobj) group_16\NN\2137 (l_compound) nephropathy_15\NN\14573196
D004317_D007674 NONE adr_7\NNP\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) nephropathy_10\NN\14573196
D004317_D007674 NONE adr_8\NNP\0 (r_compound) nephropathy_10\NN\14573196
D004317_D007674 NONE adr_13\NNP\0 (r_compound) nephropathy_15\NN\14573196
D004317_D007674 NONE adr_4\NNP\0 (r_compound) nephropathy_6\NN\14573196
D009569_D009404 NONE no_6\DT\7204911 (r_intj) of_5\IN\0 (l_pobj) association_9\NN\8008335 (l_prep) with_10\IN\0 (l_pobj) apoptosis_11\NN\11486178 (l_prep) in_12\IN\13603305 (l_pobj) model_15\NN\5888929 (l_prep) of_16\IN\0 (l_pobj) syndrome_18\NN\5870365
D009573_D007674 NONE nitrite_1\NN\14621446 (r_compound) levels_2\NNS\4916342 (r_nsubjpass) increased_5\VBN\169651 (l_prep) in_6\IN\13603305 (l_pobj) group_11\NN\2137 (l_compound) nephropathy_10\NN\14573196
D004317_D009404 CID adriamycin_25\NNS\0 (r_pobj) of_24\IN\0 (r_prep) injection_23\NN\320852 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) model_15\NN\5888929 (l_prep) of_16\IN\0 (l_pobj) syndrome_18\NN\5870365
D004317_D009404 CID adr_27\NNP\0 (r_appos) adriamycin_25\NNS\0 (r_pobj) of_24\IN\0 (r_prep) injection_23\NN\320852 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) model_15\NN\5888929 (l_prep) of_16\IN\0 (l_pobj) syndrome_18\NN\5870365
D004317_C537346 NONE adr_9\NNP\0 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_acl) rats_6\NNS\2329401 (r_pobj) of_5\IN\0 (r_prep) kidneys_4\NNS\5333259 (r_pobj) of_2\IN\0 (r_prep) examination_1\NN\633864 (r_nsubj) revealed_10\VBD\2137132 (l_dobj) areas_12\NNS\8630985 (l_prep) of_13\IN\0 (l_pobj) proliferation_15\NN\13489037
16634859
D000431_D006130 CID alcohol_9\NN\7881800 (r_npadvmod) related_11\VBN\628491 (r_amod) impairment_14\NN\7296428
D000431_D006130 CID alcohol_1\NN\7881800 (r_compound) consumption_2\NN\13440063 (r_compound) recognition_4\NN\13932421 (r_nsubj) resulted_9\VBD\2633881 (l_prep) in_10\IN\13603305 (l_pobj) growth_13\NN\13526110
D000431_D006130 CID alcohol_1\NN\7881800 (r_compound) consumption_2\NN\13440063 (r_compound) recognition_4\NN\13932421 (r_nsubj) resulted_9\VBD\2633881 (l_prep) in_10\IN\13603305 (l_pobj) growth_13\NN\13526110 (l_conj) cranial_18\JJ\0 (l_acl) body_20\NN\19128 (l_dobj) growth_21\NN\13526110
16428827
D012601_D007859 NONE scopolamine_12\NN\14712692 (r_npadvmod) induced_14\VBN\1627355 (r_amod) impairments_15\NNS\7296428 (l_prep) of_16\IN\0 (l_pobj) learning_17\NN\5701944 (l_conj) memory_19\NN\5926676
D012601_D000647 CID scopolamine_16\NN\14712692 (r_npadvmod) induced_18\VBN\1627355 (r_amod) amnesia_19\NN\5669934
D012601_D000647 CID scopolamine_22\NN\14712692 (r_npadvmod) induced_24\VBN\1627355 (r_amod) amnesia_25\NN\5669934
D000109_D000544 NONE acetylcholine_20\NN\14807558 (r_nmod) ach_22\NNS\0 (r_pobj) of_19\IN\0 (r_prep) production_18\NN\30358 (r_pobj) of_15\IN\0 (r_prep) augmentation_14\NN\7356676 (r_pobj) via_12\IN\0 (r_prep) enhances_9\VBZ\227165 (r_relcl) activator_6\NN\19613 (r_appos) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805
D000109_D000544 NONE acetylcholine_20\NN\14807558 (r_nmod) ach_22\NNS\0 (r_pobj) of_19\IN\0 (r_prep) production_18\NN\30358 (r_pobj) of_15\IN\0 (r_prep) augmentation_14\NN\7356676 (r_pobj) via_12\IN\0 (r_prep) enhances_9\VBZ\227165 (r_relcl) activator_6\NN\19613 (r_appos) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805 (l_appos) ad_37\NN\7247071
D000109_D000544 NONE ach_22\NNS\0 (r_pobj) of_19\IN\0 (r_prep) production_18\NN\30358 (r_pobj) of_15\IN\0 (r_prep) augmentation_14\NN\7356676 (r_pobj) via_12\IN\0 (r_prep) enhances_9\VBZ\227165 (r_relcl) activator_6\NN\19613 (r_appos) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805
D000109_D000544 NONE ach_22\NNS\0 (r_pobj) of_19\IN\0 (r_prep) production_18\NN\30358 (r_pobj) of_15\IN\0 (r_prep) augmentation_14\NN\7356676 (r_pobj) via_12\IN\0 (r_prep) enhances_9\VBZ\227165 (r_relcl) activator_6\NN\19613 (r_appos) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805 (l_appos) ad_37\NN\7247071
D000109_D000647 NONE acetylcholine_10\NN\14807558 (r_compound) biosynthesis_11\NN\13565379 (r_pobj) in_9\IN\13603305 (r_prep) role_8\NN\719494 (r_dobj) play_6\VB\7007684 (l_conj) ameliorates_21\VBZ\126264 (l_dobj) amnesia_25\NN\5669934
C004742_D008569 NONE daidzein_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (l_prep) from_8\IN\0 (l_pobj) thunbergiana_10\NNS\0 (l_prep) on_11\IN\0 (l_pobj) impairments_15\NNS\7296428 (l_prep) of_16\IN\0 (l_pobj) learning_17\NN\5701944 (l_conj) memory_19\NN\5926676
D002794_D000647 NONE choline_2\NN\15090742 (r_compound) acetyltransferase_3\NN\0 (r_dobj) activates_1\VBZ\1641914 (l_conj) improves_10\VBZ\126264 (l_dobj) amnesia_14\NN\5669934
D012601_D008569 NONE scopolamine_12\NN\14712692 (r_npadvmod) induced_14\VBN\1627355 (r_amod) impairments_15\NNS\7296428 (l_prep) of_16\IN\0 (l_pobj) learning_17\NN\5701944 (l_conj) memory_19\NN\5926676
D002794_D000544 NONE choline_1\NN\15090742 (r_compound) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805
D002794_D000544 NONE choline_1\NN\15090742 (r_compound) acetyltransferase_2\NN\0 (r_nsubj) is_25\VBZ\0 (l_attr) factor_28\NN\7326557 (l_prep) in_29\IN\13603305 (l_pobj) treatment_31\NN\654885 (l_prep) of_32\IN\0 (l_pobj) disease_35\NN\14061805 (l_appos) ad_37\NN\7247071
C004742_D000647 NONE daidzein_0\NNP\0 (r_nsubj) activates_1\VBZ\1641914 (l_conj) improves_10\VBZ\126264 (l_dobj) amnesia_14\NN\5669934
C004742_D000647 NONE daidzein_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (r_nsubjpass) shown_12\VBN\2137132 (l_xcomp) reverse_15\VB\13854649 (l_dobj) amnesia_19\NN\5669934
C004742_D000647 NONE daidzein_4\NN\0 (r_nsubj) play_6\VB\7007684 (l_conj) ameliorates_21\VBZ\126264 (l_dobj) amnesia_25\NN\5669934
C004742_D007859 NONE daidzein_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (l_prep) from_8\IN\0 (l_pobj) thunbergiana_10\NNS\0 (l_prep) on_11\IN\0 (l_pobj) impairments_15\NNS\7296428 (l_prep) of_16\IN\0 (l_pobj) learning_17\NN\5701944 (l_conj) memory_19\NN\5926676
7910951
D003473_D009468 CID nmba_21\NNP\0 (r_pobj) due_17\IN\5174653 (r_prep) likely_16\JJ\0 (r_parataxis) pathology_8\NN\6045562 (l_prep) at_9\IN\14622893 (l_pobj) junction_13\NN\8664443
D000305_D009468 NONE corticosteroids_30\NNS\14745635 (r_pobj) due_28\IN\5174653 (r_prep) likely_27\JJ\0 (r_parataxis) likely_16\JJ\0 (r_parataxis) pathology_8\NN\6045562 (l_prep) at_9\IN\14622893 (l_pobj) junction_13\NN\8664443
D003473_D018908 CID agents_9\NNS\7347 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_nsubjpass) implicated_18\VBN\2677097 (l_prep) as_19\IN\14622893 (l_pobj) cause_21\NN\7323922 (l_prep) of_22\IN\0 (l_pobj) weakness_25\NN\14462666
D003473_D018908 CID nmba_13\NNP\0 (r_appos) agents_9\NNS\7347 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_nsubjpass) implicated_18\VBN\2677097 (l_prep) as_19\IN\14622893 (l_pobj) cause_21\NN\7323922 (l_prep) of_22\IN\0 (l_pobj) weakness_25\NN\14462666
D003473_D018908 CID nmbas_25\NNP\0 (r_pobj) of_22\IN\0 (r_prep) discontinuation_21\NN\209943 (r_pobj) following_19\VBG\8180190 (r_prep) weakness_18\NN\14462666
D003473_D018908 CID nmba_21\NNP\0 (r_pobj) due_17\IN\5174653 (r_prep) likely_16\JJ\0 (r_parataxis) pathology_8\NN\6045562 (r_pobj) due_6\JJ\5174653 (r_acomp) is_5\VBZ\0 (l_nsubj) weakness_1\NN\14462666
D000305_D018908 NONE corticosteroids_30\NNS\14745635 (r_pobj) due_28\IN\5174653 (r_prep) likely_27\JJ\0 (r_parataxis) likely_16\JJ\0 (r_parataxis) pathology_8\NN\6045562 (r_pobj) due_6\JJ\5174653 (r_acomp) is_5\VBZ\0 (l_nsubj) weakness_1\NN\14462666
D003473_D012131 NONE nmbas_25\NNP\0 (r_pobj) of_22\IN\0 (r_prep) discontinuation_21\NN\209943 (r_pobj) following_19\VBG\8180190 (r_prep) weakness_18\NN\14462666 (r_dobj) developed_16\VBD\1753788 (r_relcl) insufficiency_14\NN\14462946
D003473_D010243 NONE agents_7\NNS\7347 (r_appos) neuromuscular_5\JJ\0 (r_pobj) due_2\IN\5174653 (r_prep) paralysis_1\NN\14557898
D000305_D010243 NONE corticosteroids_9\NNS\14745635 (r_conj) agents_7\NNS\7347 (r_appos) neuromuscular_5\JJ\0 (r_pobj) due_2\IN\5174653 (r_prep) paralysis_1\NN\14557898
6127992
D014700_D007022 CID verapamil_18\NN\2938514 (r_nmod) drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371
D014700_D001919 CID verapamil_18\NN\2938514 (r_nmod) drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674
D000319_D007022 CID drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371
D000319_D006333 CID drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371 (r_conj) failure_9\NN\66216
D014700_D006333 CID verapamil_18\NN\2938514 (r_nmod) drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371 (r_conj) failure_9\NN\66216
D000319_D017202 NONE drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371 (r_conj) failure_9\NN\66216 (r_dobj) developed_6\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disease_5\NN\14061805
D014700_D017202 NONE verapamil_18\NN\2938514 (r_nmod) drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674 (r_conj) hypotension_11\NN\14057371 (r_conj) failure_9\NN\66216 (r_dobj) developed_6\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disease_5\NN\14061805
D000319_D001919 CID drugs_24\NNS\14778436 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) during_14\IN\0 (r_prep) bradycardia_13\NN\14110674
15764424
D000661_D006948 CID amphetamine_2\NN\3248958 (r_compound) levels_3\NNS\4916342 (r_conj) methamphetamine_0\NN\2704153 (r_nsubjpass) related_5\VBN\628491 (l_prep) to_6\IN\0 (l_pobj) scores_9\NNS\13757724 (l_conj) rating_14\NN\5733583 (l_compound) hyperkinesia_13\NN\0
D002395_D006948 NONE catecholamines_12\NNS\5407119 (l_conj) hyperkinesia_14\NN\0
D002395_D011605 NONE catecholamines_12\NNS\5407119 (r_conj) severity_10\NN\5036394 (r_pobj) to_8\IN\0 (r_prep) relationship_7\NN\31921 (r_appos) levels_2\NNS\4916342 (l_prep) in_3\IN\13603305 (l_pobj) psychosis_5\NN\14380140
D002395_D011605 NONE catecholamines_10\NNS\5407119 (l_conj) symptoms_14\NNS\5823932
D002395_D011605 NONE catecholamines_10\NNS\5407119 (r_conj) levels_8\NNS\4916342 (r_pobj) between_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) examine_1\VB\0 (r_advcl) interviewed_34\VBN\964694 (l_nsubjpass) patients_17\NNS\9898892 (l_prep) in_18\IN\13603305 (l_pobj) service_22\NN\575741 (l_prep) with_23\IN\0 (l_pobj) diagnosis_25\NN\152018 (l_prep) of_26\IN\0 (l_pobj) psychosis_32\NN\14380140
D002395_D011605 NONE catecholamine_49\NN\5407119 (r_conj) drug_47\NN\14778436 (r_nmod) levels_51\NNS\4916342 (r_pobj) of_45\IN\0 (r_prep) assays_44\NNS\5733583 (r_pobj) for_42\IN\0 (r_prep) collected_41\VBN\2281093 (r_conj) interviewed_34\VBN\964694 (l_advcl) examine_1\VB\0 (l_dobj) relationship_3\NN\31921 (l_prep) between_4\IN\0 (l_pobj) levels_8\NNS\4916342 (l_conj) catecholamines_10\NNS\5407119 (l_conj) symptoms_14\NNS\5823932
D002395_D011605 NONE catecholamine_49\NN\5407119 (r_conj) drug_47\NN\14778436 (r_nmod) levels_51\NNS\4916342 (r_pobj) of_45\IN\0 (r_prep) assays_44\NNS\5733583 (r_pobj) for_42\IN\0 (r_prep) collected_41\VBN\2281093 (r_conj) interviewed_34\VBN\964694 (l_nsubjpass) patients_17\NNS\9898892 (l_prep) in_18\IN\13603305 (l_pobj) service_22\NN\575741 (l_prep) with_23\IN\0 (l_pobj) diagnosis_25\NN\152018 (l_prep) of_26\IN\0 (l_pobj) psychosis_32\NN\14380140
D003042_D001523 NONE cocaine_29\NN\3492717 (r_conj) amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140 (r_pobj) of_26\IN\0 (r_prep) diagnosis_25\NN\152018 (r_pobj) with_23\IN\0 (r_prep) service_22\NN\575741 (l_amod) psychiatric_20\JJ\0
D000661_D001523 NONE amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140 (r_pobj) of_26\IN\0 (r_prep) diagnosis_25\NN\152018 (r_pobj) with_23\IN\0 (r_prep) service_22\NN\575741 (l_amod) psychiatric_20\JJ\0
D003042_D011605 CID cocaine_29\NN\3492717 (r_conj) amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140 (r_pobj) of_26\IN\0 (r_prep) diagnosis_25\NN\152018 (r_pobj) with_23\IN\0 (r_prep) service_22\NN\575741 (r_pobj) in_18\IN\13603305 (r_prep) patients_17\NNS\9898892 (r_nsubjpass) interviewed_34\VBN\964694 (l_advcl) examine_1\VB\0 (l_dobj) relationship_3\NN\31921 (l_prep) between_4\IN\0 (l_pobj) levels_8\NNS\4916342 (l_conj) catecholamines_10\NNS\5407119 (l_conj) symptoms_14\NNS\5823932
D003042_D011605 CID cocaine_29\NN\3492717 (r_conj) amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140
D008694_D006948 CID methamphetamine_0\NN\2704153 (r_nsubjpass) related_5\VBN\628491 (l_prep) to_6\IN\0 (l_pobj) scores_9\NNS\13757724 (l_conj) rating_14\NN\5733583 (l_compound) hyperkinesia_13\NN\0
D002395_D001523 NONE catecholamines_10\NNS\5407119 (r_conj) levels_8\NNS\4916342 (r_pobj) between_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) examine_1\VB\0 (r_advcl) interviewed_34\VBN\964694 (l_nsubjpass) patients_17\NNS\9898892 (l_prep) in_18\IN\13603305 (l_pobj) service_22\NN\575741 (l_amod) psychiatric_20\JJ\0
D002395_D001523 NONE catecholamine_49\NN\5407119 (r_conj) drug_47\NN\14778436 (r_nmod) levels_51\NNS\4916342 (r_pobj) of_45\IN\0 (r_prep) assays_44\NNS\5733583 (r_pobj) for_42\IN\0 (r_prep) collected_41\VBN\2281093 (r_conj) interviewed_34\VBN\964694 (l_nsubjpass) patients_17\NNS\9898892 (l_prep) in_18\IN\13603305 (l_pobj) service_22\NN\575741 (l_amod) psychiatric_20\JJ\0
D000661_D011605 CID amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140 (r_pobj) of_26\IN\0 (r_prep) diagnosis_25\NN\152018 (r_pobj) with_23\IN\0 (r_prep) service_22\NN\575741 (r_pobj) in_18\IN\13603305 (r_prep) patients_17\NNS\9898892 (r_nsubjpass) interviewed_34\VBN\964694 (l_advcl) examine_1\VB\0 (l_dobj) relationship_3\NN\31921 (l_prep) between_4\IN\0 (l_pobj) levels_8\NNS\4916342 (l_conj) catecholamines_10\NNS\5407119 (l_conj) symptoms_14\NNS\5823932
D000661_D011605 CID amphetamine-_27\JJ\0 (r_npadvmod) induced_31\VBN\1627355 (r_amod) psychosis_32\NN\14380140
2343592
C044650_D006259 NONE cilastatin_32\NN\0 (r_pobj) of_29\IN\0 (r_prep) doses_28\NNS\3740161 (r_dobj) receiving_26\VBG\2210855 (r_advcl) developed_23\VBN\1753788 (r_conj) head_15\NN\5225090 (l_dobj) trauma_16\NN\14052046
C044650_D012640 CID cilastatin_32\NN\0 (r_pobj) of_29\IN\0 (r_prep) doses_28\NNS\3740161 (r_dobj) receiving_26\VBG\2210855 (r_advcl) developed_23\VBN\1753788 (l_dobj) seizures_24\NNS\14081375
C044650_D020521 NONE cilastatin_32\NN\0 (r_pobj) of_29\IN\0 (r_prep) doses_28\NNS\3740161 (r_dobj) receiving_26\VBG\2210855 (r_advcl) developed_23\VBN\1753788 (r_conj) head_15\NN\5225090 (l_nsubj) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) history_5\NN\15120823 (l_prep) of_6\IN\0 (l_pobj) accident_10\NN\7314427
C044650_D020521 NONE cilastatin_32\NN\0 (r_pobj) of_29\IN\0 (r_prep) doses_28\NNS\3740161 (r_dobj) receiving_26\VBG\2210855 (r_advcl) developed_23\VBN\1753788 (r_conj) head_15\NN\5225090 (l_nsubj) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) history_5\NN\15120823 (l_prep) of_6\IN\0 (l_pobj) accident_10\NN\7314427 (l_appos) cva_12\NNP\14081375
D047090_D012640 NONE lactam_10\NN\0 (r_compound) antibiotics_11\NNS\2716205 (r_pobj) of_6\IN\0 (r_prep) doses_5\NNS\3740161 (r_dobj) received_3\VBN\2210855 (l_prep) without_12\IN\0 (l_pobj) evidence_13\NN\5816287 (l_prep) of_14\IN\0 (l_pobj) activity_16\NN\30358 (l_compound) seizure_15\NN\14081375
C044650_D007674 NONE cilastatin_32\NN\0 (r_pobj) of_29\IN\0 (r_prep) doses_28\NNS\3740161 (r_dobj) receiving_26\VBG\2210855 (r_advcl) developed_23\VBN\1753788 (l_nsubj) evidence_19\NN\5816287 (l_prep) of_20\IN\0 (l_pobj) disease_22\NN\14061805
D015378_D012640 NONE imipenem_3\NN\0 (r_compound) therapy_4\NN\657604 (r_pobj) with_2\IN\0 (r_prep) activity_1\NN\30358 (l_compound) seizure_0\NN\14081375
D010672_D012640 NONE phenytoin_8\NN\3550533 (r_pobj) of_7\IN\0 (r_prep) doses_6\NNS\3740161 (r_pobj) with_4\IN\0 (r_prep) controlled_3\VBN\0 (l_nsubjpass) seizures_1\NNS\14081375
18161408
D002996_D013927 NONE cc_9\NN\13616054 (r_pobj) of_8\IN\0 (r_prep) complication_7\NN\1073995 (r_attr) be_2\VB\14625458 (l_nsubj) thrombosis_0\NN\14100769
D002996_D013923 CID cc_17\NN\13616054 (r_pobj) with_16\IN\0 (r_prep) induction_15\NN\7450842 (r_pobj) after_13\IN\0 (r_prep) reported_12\VBN\831651 (r_relcl) complication_8\NN\1073995 (r_attr) is_1\VBZ\0 (l_nsubj) thromboembolism_0\NN\14100769
D002996_D009203 CID citrate_7\NN\14850483 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) infarction_1\NN\14204950
D002996_D009203 CID cc_13\NN\13616054 (l_conj) infarction_16\NN\14204950
D002996_D002637 NONE cc_12\NN\13616054 (r_dobj) received_11\VBN\2210855 (l_conj) presented_17\VBD\2137132 (l_prep) with_18\IN\0 (l_pobj) pain_20\NN\14299637
16960342
D019259_D005355 NONE lamivudine_17\NN\3834836 (r_amod) monotherapy_18\NN\0 (r_pobj) with_16\IN\0 (r_prep) treatment_15\NN\654885 (r_pobj) after_14\IN\0 (r_prep) improvement_2\NN\7359599 (l_prep) of_3\IN\0 (l_pobj) patient_5\NN\9898892 (l_prep) with_6\IN\0 (l_pobj) cirrhosis_13\NN\14116321
D019259_D005355 NONE lamivudine_3\NN\3834836 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (l_prep) to_4\IN\0 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) cirrhosis_10\NN\14116321
D019259_D006509 NONE lamivudine_17\NN\3834836 (r_amod) monotherapy_18\NN\0 (r_pobj) with_16\IN\0 (r_prep) treatment_15\NN\654885 (r_pobj) after_14\IN\0 (r_prep) improvement_2\NN\7359599 (l_prep) of_3\IN\0 (l_pobj) patient_5\NN\9898892 (l_prep) with_6\IN\0 (l_pobj) cirrhosis_13\NN\14116321 (l_amod) related_12\VBN\628491 (l_npadvmod) virus_10\NN\9312843 (l_compound) b_9\NNP\1355326
3300918
D004876_D008881 CID ergot_6\NN\14276936 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) of_2\IN\0 (r_prep) discussion_1\NN\6252138 (r_nsubj) includes_7\VBZ\0 (l_dobj) discovery_10\NN\30358 (l_appos) epidemics_13\NNS\7435273 (l_relcl) caused_19\VBN\1617192 (l_prep) through_20\IN\0 (l_pobj) ages_22\NNS\4916342 (l_conj) role_28\NN\719494 (l_prep) in_29\IN\13603305 (l_pobj) management_31\NN\1123598 (l_prep) of_32\IN\0 (l_pobj) headache_34\NN\5829480
D004876_D008881 CID ergot_13\NN\14276936 (r_compound) preparations_14\NNS\407535 (r_nsubj) continue_15\VBP\2367363 (l_xcomp) play_17\VB\7007684 (l_dobj) role_20\NN\719494 (l_prep) in_21\IN\13603305 (l_pobj) therapy_23\NN\657604 (l_compound) migraine_22\NN\14326607
D002118_D004881 NONE calcium_4\NN\14625458 (r_compound) channel_5\NN\6251781 (r_compound) blockers_6\NNS\10101634 (r_pobj) of_3\IN\0 (r_prep) advent_2\NN\48225 (r_pobj) despite_0\IN\7501545 (r_prep) continue_15\VBP\2367363 (l_advcl) persists_34\VBZ\118523 (l_nsubj) danger_28\NN\13920835 (l_prep) of_29\IN\0 (l_pobj) fire_33\NN\7283608
D004876_D004881 NONE ergot_13\NN\14276936 (r_compound) preparations_14\NNS\407535 (r_nsubj) continue_15\VBP\2367363 (l_advcl) persists_34\VBZ\118523 (l_nsubj) danger_28\NN\13920835 (l_prep) of_29\IN\0 (l_pobj) fire_33\NN\7283608
D002118_D008881 NONE calcium_4\NN\14625458 (r_compound) channel_5\NN\6251781 (r_compound) blockers_6\NNS\10101634 (r_pobj) of_3\IN\0 (r_prep) advent_2\NN\48225 (r_pobj) despite_0\IN\7501545 (r_prep) continue_15\VBP\2367363 (l_xcomp) play_17\VB\7007684 (l_dobj) role_20\NN\719494 (l_prep) in_21\IN\13603305 (l_pobj) therapy_23\NN\657604 (l_compound) migraine_22\NN\14326607
D008784_D014652 CID methysergide_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) ingestion_18\NN\13440063 (r_pobj) to_16\IN\0 (r_prep) described_14\VBN\1001294 (l_nsubjpass) case_2\NN\7283608 (l_prep) of_3\IN\0 (l_pobj) vasospasm_5\NN\0
D004876_D005734 NONE ergot_6\NN\14276936 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) of_2\IN\0 (r_prep) discussion_1\NN\6252138 (r_nsubj) includes_7\VBZ\0 (l_dobj) discovery_10\NN\30358 (l_appos) epidemics_13\NNS\7435273 (l_prep) of_14\IN\0 (l_pobj) gangrene_15\NN\14204950
19642243
D014640_D051437 NONE vancomycin_8\NNP\2716866 (r_amod) therapy_9\NN\657604 (r_pobj) of_7\IN\0 (r_prep) course_6\NN\883297 (r_pobj) after_3\IN\0 (r_prep) developed_2\VBD\1753788 (l_nsubj) failure_1\NN\66216
D014640_D051437 NONE vancomycin_17\NNP\2716866 (r_pobj) of_16\IN\0 (r_prep) administration_15\NN\1133281 (r_pobj) during_13\IN\0 (r_prep) raise_7\VB\5108947 (l_dobj) risk_9\NN\14541044 (l_prep) of_10\IN\0 (l_pobj) failure_12\NN\66216
C418563_D051437 NONE fumarate_18\NN\0 (r_dobj) receiving_15\VBG\2210855 (r_relcl) patients_12\NNS\9898892 (r_pobj) in_10\IN\13603305 (r_prep) course_6\NN\883297 (r_pobj) after_3\IN\0 (r_prep) developed_2\VBD\1753788 (l_nsubj) failure_1\NN\66216
D014640_D007674 NONE vancomycin_0\NNP\2716866 (r_compound) nephrotoxicity_1\NN\0
D014640_D007674 NONE vancomycin_0\NNP\2716866 (r_compound) nephrotoxicity_1\NN\0 (r_nsubj) is_2\VBZ\0 (l_conj) result_6\VB\34213 (l_prep) from_7\IN\0 (l_pobj) coadministration_8\NN\0 (l_prep) with_9\IN\0 (l_pobj) agent_12\NN\7347 (l_amod) nephrotoxic_11\JJ\0
D014640_D058186 CID vancomycin_12\NNP\2716866 (r_amod) course_13\NN\883297 (r_dobj) receiving_10\VBG\2210855 (r_advcl) failure_2\NN\66216
C096918_D005198 NONE tenofovir_0\NNP\0 (r_nsubjpass) implicated_3\VBN\2677097 (l_prep) in_4\IN\13603305 (l_pobj) development_6\NN\248977 (l_prep) of_7\IN\0 (l_pobj) syndrome_9\NN\5870365
D014640_D010019 NONE vancomycin_12\NNP\2716866 (r_amod) course_13\NN\883297 (r_dobj) receiving_10\VBG\2210855 (l_prep) for_14\IN\0 (l_pobj) osteomyelitis_15\NN\14351321
C096918_D058186 NONE tenofovir_8\NNS\0 (r_pobj) on_7\IN\0 (r_prep) patients_4\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) failure_2\NN\66216
D014640_D000163 NONE vancomycin_12\NNP\2716866 (r_amod) course_13\NN\883297 (r_dobj) receiving_10\VBG\2210855 (r_advcl) failure_2\NN\66216 (l_prep) in_3\IN\13603305 (l_pobj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) aids_6\NNP\13974317
C096918_D010019 NONE tenofovir_8\NNS\0 (r_pobj) on_7\IN\0 (r_prep) patients_4\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) failure_2\NN\66216 (l_advcl) receiving_10\VBG\2210855 (l_prep) for_14\IN\0 (l_pobj) osteomyelitis_15\NN\14351321
C096918_D000163 NONE tenofovir_8\NNS\0 (r_pobj) on_7\IN\0 (r_prep) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) aids_6\NNP\13974317
C096918_D051437 NONE tenofovir_0\NNP\0 (r_nsubjpass) implicated_3\VBN\2677097 (l_prep) in_4\IN\13603305 (l_pobj) development_6\NN\248977 (l_prep) of_7\IN\0 (l_pobj) syndrome_9\NN\5870365 (l_conj) insufficiency_12\NN\14462946
C096918_D051437 NONE tenofovir_5\NNS\0 (r_nsubj) raise_7\VB\5108947 (l_dobj) risk_9\NN\14541044 (l_prep) of_10\IN\0 (l_pobj) failure_12\NN\66216
6454943
D002216_D011507 NONE captopril_2\NN\2673637 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_10\VBN\1627355 (l_dobj) proteinuria_11\NN\14299637
D002216_D011507 NONE captopril_6\NN\2673637 (r_compound) treatment_7\NN\654885 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (r_attr) is_1\VBZ\0 (l_nsubj) proteinuria_0\NNP\14299637
D002216_D011507 NONE captopril_3\NN\2673637 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) failed_10\VBD\0 (l_xcomp) aggravate_12\VB\126264 (l_dobj) proteinuria_13\JJ\14299637
D002216_D011507 NONE captopril_2\NN\2673637 (r_compound) treatment_3\NN\654885 (r_nsubj) failed_4\VBD\0 (l_xcomp) potentiate_6\VB\229605 (l_conj) facilitate_8\VB\2547586 (l_dobj) development_9\NN\248977 (l_prep) of_10\IN\0 (l_pobj) proteinuria_12\NN\14299637
D011692_D006973 NONE aminonucleoside_8\RB\0 (r_punct) -_9\HYPH\0 (r_punct) induced_10\VBN\1627355 (l_prep) in_12\IN\13603305 (l_pobj) rats_15\NNS\2329401 (l_amod) hypertensive_14\JJ\10405694
D002216_D007674 NONE captopril_9\NN\2673637 (r_pobj) with_8\IN\0 (r_prep) abnormality_7\NN\14034177
D002216_D006973 NONE captopril_2\NN\2673637 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_10\VBN\1627355 (l_prep) in_12\IN\13603305 (l_pobj) rats_15\NNS\2329401 (l_amod) hypertensive_14\JJ\10405694
D002216_D006973 NONE captopril_6\NN\2673637 (r_compound) treatment_7\NN\654885 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_amod) hypertensive_9\JJ\10405694
D011692_D011507 CID aminonucleoside_8\RB\0 (r_punct) -_9\HYPH\0 (r_punct) induced_10\VBN\1627355 (l_dobj) proteinuria_11\NN\14299637
D011692_D011507 CID aminonucleoside_16\NN\0 (r_amod) puromycin_15\NNS\0 (r_pobj) by_14\IN\0 (r_agent) invoked_13\VBN\1617192 (r_acl) proteinuria_12\NN\14299637
10328196
D003907_D011565 NONE dexamethasone_15\NN\2721538 (r_npadvmod) induced_17\VBN\1627355 (r_conj) spontaneous_13\JJ\0 (r_amod) apoptosis_18\NN\11486178 (r_oprd) exhibit_11\VB\6733939 (r_xcomp) tended_9\VBD\2604760 (r_ccomp) activated_0\VBN\1641914 (l_dobj) cells_4\NNS\3080309 (l_prep) from_5\IN\0 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) psoriasis_8\NN\14219661
D020123_D011565 NONE sirolimus_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_dobj) following_2\VBG\8180190 (r_prep) toxicity_1\NN\13576101 (l_prep) for_10\IN\0 (l_pobj) psoriasis_11\NN\14219661
D020123_D011565 NONE rapamycin_8\VBZ\0 (r_appos) toxicity_1\NN\13576101 (l_prep) for_10\IN\0 (l_pobj) psoriasis_11\NN\14219661
D020123_D011565 NONE sirolimus_14\NN\0 (r_nmod) cells_17\NNS\3080309 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_pobj) following_10\VBG\8180190 (r_acl) syndrome_9\NN\5870365 (r_dobj) developed_5\VBD\1753788 (l_nsubj) individuals_2\NNS\7347 (l_prep) with_3\IN\0 (l_pobj) psoriasis_4\NN\14219661
D020123_D011565 NONE sirolimus_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) syndrome_13\NN\5870365 (r_pobj) with_7\IN\0 (r_prep) patient_6\NN\9898892 (r_pobj) from_4\IN\0 (r_prep) specimen_3\NN\5820620 (r_nsubj) had_14\VBD\0 (l_prep) compared_28\VBN\644583 (l_prep) with_29\IN\0 (l_pobj) patient_35\NN\9898892 (l_prep) with_36\IN\0 (l_pobj) psoriasis_37\NN\14219661
D020123_D011565 NONE sirolimus_32\NN\0 (r_npadvmod) treated_34\VBN\2376958 (r_amod) patient_35\NN\9898892 (l_prep) with_36\IN\0 (l_pobj) psoriasis_37\NN\14219661
D020123_D011565 NONE sirolimus_30\NN\0 (r_pobj) of_29\IN\0 (r_prep) presence_28\NN\13954253 (r_pobj) in_26\IN\13603305 (r_prep) did_20\VBD\0 (r_advcl) apoptosis_18\NN\11486178 (r_oprd) exhibit_11\VB\6733939 (r_xcomp) tended_9\VBD\2604760 (r_ccomp) activated_0\VBN\1641914 (l_dobj) cells_4\NNS\3080309 (l_prep) from_5\IN\0 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) psoriasis_8\NN\14219661
D020123_D019559 CID sirolimus_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_dobj) following_2\VBG\8180190 (r_prep) toxicity_1\NN\13576101 (l_appos) association_13\NN\8008335 (l_prep) of_14\IN\0 (l_pobj) syndrome_17\NN\5870365
D020123_D019559 CID rapamycin_8\VBZ\0 (r_appos) toxicity_1\NN\13576101 (l_appos) association_13\NN\8008335 (l_prep) of_14\IN\0 (l_pobj) syndrome_17\NN\5870365
D020123_D019559 CID sirolimus_14\NN\0 (r_nmod) cells_17\NNS\3080309 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_pobj) following_10\VBG\8180190 (r_acl) syndrome_9\NN\5870365
D020123_D019559 CID sirolimus_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) syndrome_13\NN\5870365
D020123_D019559 CID sirolimus_32\NN\0 (r_npadvmod) treated_34\VBN\2376958 (r_amod) patient_35\NN\9898892 (r_pobj) with_29\IN\0 (r_prep) compared_28\VBN\644583 (r_prep) had_14\VBD\0 (l_nsubj) specimen_3\NN\5820620 (l_prep) from_4\IN\0 (l_pobj) patient_6\NN\9898892 (l_prep) with_7\IN\0 (l_pobj) syndrome_13\NN\5870365
D020123_D019559 CID sirolimus_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) include_5\VBP\0 (l_dobj) fever_6\NN\14299637 (l_conj) anemia_8\NN\14189204 (l_conj) syndrome_13\NN\5870365
D020123_D005334 NONE sirolimus_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) include_5\VBP\0 (l_dobj) fever_6\NN\14299637
D020123_D000740 NONE sirolimus_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) effects_2\NNS\13245626 (r_nsubj) include_5\VBP\0 (l_dobj) fever_6\NN\14299637 (l_conj) anemia_8\NN\14189204
D020123_D064420 NONE sirolimus_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) administration_3\NN\1133281 (r_dobj) following_2\VBG\8180190 (r_prep) toxicity_1\NN\13576101
D020123_D064420 NONE rapamycin_8\VBZ\0 (r_appos) toxicity_1\NN\13576101
2716967
D009020_D009127 NONE morphine_21\NN\2707683 (r_conj) ketamine_19\NN\3054098 (r_pobj) of_18\IN\0 (r_prep) predominance_17\NN\14441825 (r_dobj) reflected_14\VBD\923793 (l_nsubj) latency_0\NN\15269513 (l_prep) to_1\IN\0 (l_pobj) loss_3\NN\13252973 (l_prep) of_4\IN\0 (l_pobj) reflex_6\NN\859001 (l_conj) rigidity_8\NN\5023233
D009270_D002375 NONE naloxone_0\NN\3808977 (r_nsubj) inhibited_1\VBD\2510337 (l_dobj) effects_5\NNS\13245626 (l_amod) cataleptic_4\JJ\10490141
D009270_D002375 NONE naloxone_36\NN\3808977 (r_pobj) for_35\IN\0 (r_prep) id50_34\NNP\0 (r_conj) asymmetry_24\NN\5062748 (r_conj) differences_16\NNS\4723816 (r_conj) catalepsy_14\NN\14023236
D009020_D000699 NONE morphine_7\NN\2707683 (r_conj) ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D009020_D000699 NONE morphine_26\NN\2707683 (r_pobj) to_25\IN\0 (r_prep) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D009020_D000699 NONE morphine_31\NN\2707683 (r_pobj) with_30\IN\0 (r_prep) pretreatment_29\NN\0 (r_nsubj) induce_34\VB\1627355 (r_advcl) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D009020_D000699 NONE morphine_53\NN\2707683 (r_pobj) to_51\IN\0 (r_prep) attributed_50\VBN\670261 (l_ccomp) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D007649_D000699 NONE ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D007649_D000699 NONE ketamine_20\NN\3054098 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_nsubj) produced_21\VBD\1617192 (r_amod) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D007649_D000699 NONE ketamine_39\NN\3054098 (r_pobj) to_38\IN\0 (r_prep) tolerance_37\NN\5032565 (r_dobj) induce_34\VB\1627355 (r_advcl) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177
D009270_D009127 NONE naloxone_36\NN\3808977 (r_pobj) for_35\IN\0 (r_prep) id50_34\NNP\0 (r_conj) asymmetry_24\NN\5062748 (r_conj) differences_16\NNS\4723816 (l_prep) in_17\IN\13603305 (l_pobj) latency_18\NN\15269513 (l_conj) rigidity_20\NN\5023233
D007649_D002375 CID ketamine_5\NN\3054098 (r_pobj) of_4\IN\0 (r_prep) combinations_3\NNS\7951464 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) catalepsy_0\NNP\14023236
D007649_D002375 CID ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D007649_D002375 CID ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (r_ccomp) demonstrated_2\VBD\2137132 (l_advcl) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D007649_D002375 CID ketamine_20\NN\3054098 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_nsubj) produced_21\VBD\1617192 (r_amod) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D007649_D002375 CID ketamine_20\NN\3054098 (r_pobj) with_19\IN\0 (r_prep) treatment_18\NN\654885 (r_nsubj) produced_21\VBD\1617192 (r_amod) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_advcl) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D007649_D002375 CID ketamine_39\NN\3054098 (r_pobj) to_38\IN\0 (r_prep) tolerance_37\NN\5032565 (r_dobj) induce_34\VB\1627355 (r_advcl) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D007649_D002375 CID ketamine_39\NN\3054098 (r_pobj) to_38\IN\0 (r_prep) tolerance_37\NN\5032565 (r_dobj) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D009020_D002375 CID morphine_7\NN\2707683 (r_conj) ketamine_5\NN\3054098 (r_pobj) of_4\IN\0 (r_prep) combinations_3\NNS\7951464 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) catalepsy_0\NNP\14023236
D009020_D002375 CID morphine_7\NN\2707683 (r_conj) ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D009020_D002375 CID morphine_7\NN\2707683 (r_conj) ketamine_5\NN\3054098 (r_nsubj) induced_8\VBN\1627355 (r_ccomp) demonstrated_2\VBD\2137132 (l_advcl) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D009020_D002375 CID morphine_26\NN\2707683 (r_pobj) to_25\IN\0 (r_prep) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D009020_D002375 CID morphine_26\NN\2707683 (r_pobj) to_25\IN\0 (r_prep) tolerance_24\NN\5032565 (r_dobj) demonstrated_2\VBD\2137132 (l_advcl) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D009020_D002375 CID morphine_31\NN\2707683 (r_pobj) with_30\IN\0 (r_prep) pretreatment_29\NN\0 (r_nsubj) induce_34\VB\1627355 (r_advcl) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D009020_D002375 CID morphine_31\NN\2707683 (r_pobj) with_30\IN\0 (r_prep) pretreatment_29\NN\0 (r_nsubj) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D009020_D002375 CID morphine_53\NN\2707683 (r_pobj) to_51\IN\0 (r_prep) attributed_50\VBN\670261 (l_ccomp) demonstrated_2\VBD\2137132 (l_ccomp) induced_8\VBN\1627355 (l_dobj) analgesia_9\NN\14034177 (l_conj) catalepsy_11\NN\14023236
D009020_D002375 CID morphine_53\NN\2707683 (r_pobj) to_51\IN\0 (r_prep) attributed_50\VBN\670261 (l_ccomp) demonstrated_2\VBD\2137132 (l_advcl) induce_34\VB\1627355 (l_conj) augmented_42\VBD\153263 (l_dobj) response_45\NN\11410625 (l_amod) cataleptic_44\JJ\10490141
D007649_D009127 NONE ketamine_19\NN\3054098 (r_pobj) of_18\IN\0 (r_prep) predominance_17\NN\14441825 (r_dobj) reflected_14\VBD\923793 (l_nsubj) latency_0\NN\15269513 (l_prep) to_1\IN\0 (l_pobj) loss_3\NN\13252973 (l_prep) of_4\IN\0 (l_pobj) reflex_6\NN\859001 (l_conj) rigidity_8\NN\5023233
11861791
D004317_D006333 CID doxorubicin_11\NN\2716866 (r_npadvmod) induced_13\VBN\1627355 (r_amod) failure_15\NN\66216
D004317_D006331 NONE dox_36\NNP\0 (r_pobj) by_35\IN\0 (r_agent) induced_34\VBN\1627355 (r_acl) dysfunction_33\NN\14204950
D004317_D005117 NONE dox_16\NNP\0 (r_compound) treatment_17\NN\654885 (r_pobj) with_14\IN\0 (r_prep) associated_13\VBN\628491 (r_acl) complications_12\NNS\1073995
D004317_D066126 NONE doxorubicin_12\NN\2716866 (r_pobj) of_11\IN\0 (r_prep) cardiotoxicity_10\NN\0
D004317_D066126 NONE dox_14\NNP\0 (r_appos) doxorubicin_12\NN\2716866 (r_pobj) of_11\IN\0 (r_prep) cardiotoxicity_10\NN\0
D004317_D066126 NONE dox_13\NNP\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) cardiotoxicity_16\NN\0
D004317_D066126 NONE dox_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) cardiotoxicity_7\NN\0
C434926_D006331 NONE pj34_19\NNP\0 (r_pobj) with_14\IN\0 (r_prep) inhibition_13\NN\1068773 (r_conj) deletion_10\NN\13508333 (r_pobj) by_8\IN\0 (r_prep) using_0\VBG\418025 (r_advcl) demonstrate_23\VBP\2137132 (l_dobj) role_25\NN\719494 (l_prep) in_28\IN\13603305 (l_pobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) dysfunction_33\NN\14204950
C434926_D006331 NONE pj34_3\NNP\0 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubj) improved_5\VBD\126264 (l_dobj) dysfunction_7\NN\14204950
D018943_D066126 NONE anthracycline_21\NN\0 (r_amod) antibiotic_22\NN\2716205 (r_appos) doxorubicin_12\NN\2716866 (r_pobj) of_11\IN\0 (r_prep) cardiotoxicity_10\NN\0
D011064_D006333 NONE )_5\-RRB-\0 (r_punct) polymerase_6\NN\14732946 (r_pobj) of_1\IN\0 (r_prep) activation_0\NN\13561719 (r_nsubj) contributes_7\VBZ\126264 (l_prep) to_8\IN\0 (l_pobj) development_9\NN\248977 (l_prep) of_10\IN\0 (l_pobj) failure_15\NN\66216
3131282
C009166_D013274 NONE acetate_6\NN\15010703 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (l_prep) on_7\IN\0 (l_pobj) carcinogenesis_9\NN\0
C009166_D013274 NONE acetate_6\NN\15010703 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_nsubjpass) examined_19\VBN\0 (l_nsubjpass) tumorigenesis_17\NN\0
C009166_D013274 NONE ra_8\NNP\14625458 (r_appos) acetate_6\NN\15010703 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_nsubjpass) examined_19\VBN\0 (l_nsubjpass) tumorigenesis_17\NN\0
C009166_D013274 NONE ra_27\NNP\14625458 (r_nsubj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_prep) of_38\IN\0 (l_pobj) tumors_40\NNS\14234074
C009166_D013274 NONE ra_74\NNP\14625458 (r_npadvmod) free_76\JJ\7942152 (r_amod) water_77\NN\14618834 (r_dobj) given_73\VBN\5892096 (r_acl) group_72\NN\2137 (r_pobj) in_70\IN\13603305 (r_prep) from_59\IN\0 (r_prep) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_prep) of_38\IN\0 (l_pobj) tumors_40\NNS\14234074
C009166_D013274 NONE ra_4\NNP\14625458 (r_nsubj) acted_5\VBD\0 (l_dobj) carcinogenesis_15\NN\0
D002083_D063646 NONE hydroxyanisole_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) induced_14\VBN\1627355 (l_nsubj) effect_3\NN\34213 (l_amod) carcinogenic_2\JJ\0
D002083_D013274 CID hydroxyanisole_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) induced_14\VBN\1627355 (l_nsubj) effect_3\NN\34213 (l_prep) on_7\IN\0 (l_pobj) carcinogenesis_9\NN\0
D002083_D013274 CID hydroxyanisole_12\NN\0 (r_pobj) on_10\IN\0 (r_prep) effect_3\NN\34213 (r_nsubjpass) examined_19\VBN\0 (l_nsubjpass) tumorigenesis_17\NN\0
D002083_D013274 CID bha)-induced_14\JJ\0 (r_amod) rat_15\NN\2329401 (r_compound) tumorigenesis_17\NN\0
D002083_D013274 CID bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) groups_1\NNS\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_16\VBN\2163746 (l_conj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_prep) of_38\IN\0 (l_pobj) tumors_40\NNS\14234074
D002083_D013274 CID bha_13\NNP\0 (r_compound) carcinogenesis_15\NN\0
C009166_D063646 NONE acetate_6\NN\15010703 (r_pobj) of_4\IN\0 (r_prep) effect_3\NN\34213 (l_amod) carcinogenic_2\JJ\0
C009166_D017573 NONE ra_7\NNP\14625458 (r_punct) co_8\NNP\14954601 (r_punct) -_9\HYPH\0 (r_punct) administered_10\VBN\2436349 (r_punct) at_11\IN\14622893 (r_prep) given_2\VBN\5892096 (r_acl) rats_1\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) showed_23\VBD\2137132 (l_dobj) effect_29\NN\34213 (l_prep) on_30\IN\0 (l_pobj) development_32\NN\248977 (l_prep) of_33\IN\0 (l_pobj) hyperplasia_39\NN\14365950
D002083_D017573 NONE bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) rats_1\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) showed_23\VBD\2137132 (l_dobj) effect_29\NN\34213 (l_prep) on_30\IN\0 (l_pobj) development_32\NN\248977 (l_prep) of_33\IN\0 (l_pobj) hyperplasia_39\NN\14365950
D002083_D017573 NONE bha_35\NNP\0 (r_npadvmod) induced_37\VBN\1627355 (r_amod) hyperplasia_39\NN\14365950
C009166_D002277 NONE ra_27\NNP\14625458 (r_nsubj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226 (l_conj) carcinoma_46\NN\14239918
C009166_D002277 NONE ra_27\NNP\14625458 (r_nsubj) increased_35\VBD\169651 (l_prep) to_48\IN\0 (l_pobj) %_50\NN\0 (l_appos) rats_55\NNS\2329401 (l_prep) with_56\IN\0 (l_pobj) carcinoma_57\NN\14239918
C009166_D002277 NONE ra_27\NNP\14625458 (r_nsubj) increased_35\VBD\169651 (l_prep) from_59\IN\0 (l_pobj) %_61\NN\0 (l_appos) rat_66\NN\2329401 (l_prep) with_67\IN\0 (l_pobj) carcinoma_68\NN\14239918
C009166_D002277 NONE ra_74\NNP\14625458 (r_npadvmod) free_76\JJ\7942152 (r_amod) water_77\NN\14618834 (r_dobj) given_73\VBN\5892096 (r_acl) group_72\NN\2137 (r_pobj) in_70\IN\13603305 (r_prep) from_59\IN\0 (r_prep) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226 (l_conj) carcinoma_46\NN\14239918
C009166_D002277 NONE ra_74\NNP\14625458 (r_npadvmod) free_76\JJ\7942152 (r_amod) water_77\NN\14618834 (r_dobj) given_73\VBN\5892096 (r_acl) group_72\NN\2137 (r_pobj) in_70\IN\13603305 (r_prep) from_59\IN\0 (r_prep) increased_35\VBD\169651 (l_prep) to_48\IN\0 (l_pobj) %_50\NN\0 (l_appos) rats_55\NNS\2329401 (l_prep) with_56\IN\0 (l_pobj) carcinoma_57\NN\14239918
C009166_D002277 NONE ra_74\NNP\14625458 (r_npadvmod) free_76\JJ\7942152 (r_amod) water_77\NN\14618834 (r_dobj) given_73\VBN\5892096 (r_acl) group_72\NN\2137 (r_pobj) in_70\IN\13603305 (r_prep) from_59\IN\0 (l_pobj) %_61\NN\0 (l_appos) rat_66\NN\2329401 (l_prep) with_67\IN\0 (l_pobj) carcinoma_68\NN\14239918
C009166_D009369 NONE ra_17\NN\14625458 (r_pobj) with_14\IN\0 (r_prep) rats_9\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) induced_6\VBN\1627355 (l_nsubjpass) tumors_0\NNS\14234074
C009166_D009369 NONE ra_29\NNP\14625458 (r_compound) administration_32\NN\1133281 (r_punct) ._33\.\0 (r_punct) induced_6\VBN\1627355 (l_nsubjpass) tumors_0\NNS\14234074
D002083_D002277 NONE bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) groups_1\NNS\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_16\VBN\2163746 (l_conj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226 (l_conj) carcinoma_46\NN\14239918
D002083_D002277 NONE bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) groups_1\NNS\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_16\VBN\2163746 (l_conj) increased_35\VBD\169651 (l_prep) to_48\IN\0 (l_pobj) %_50\NN\0 (l_appos) rats_55\NNS\2329401 (l_prep) with_56\IN\0 (l_pobj) carcinoma_57\NN\14239918
D002083_D002277 NONE bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) groups_1\NNS\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_16\VBN\2163746 (l_conj) increased_35\VBD\169651 (l_prep) from_59\IN\0 (l_pobj) %_61\NN\0 (l_appos) rat_66\NN\2329401 (l_prep) with_67\IN\0 (l_pobj) carcinoma_68\NN\14239918
D002083_D010212 NONE bha_5\NNP\0 (r_dobj) given_2\VBN\5892096 (r_acl) groups_1\NNS\2137 (r_pobj) in_0\IN\13603305 (r_prep) observed_16\VBN\2163746 (l_conj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226
C009166_D010212 NONE ra_27\NNP\14625458 (r_nsubj) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226
C009166_D010212 NONE ra_74\NNP\14625458 (r_npadvmod) free_76\JJ\7942152 (r_amod) water_77\NN\14618834 (r_dobj) given_73\VBN\5892096 (r_acl) group_72\NN\2137 (r_pobj) in_70\IN\13603305 (r_prep) from_59\IN\0 (r_prep) increased_35\VBD\169651 (l_dobj) incidence_37\NN\13821570 (l_appos) papilloma_44\NN\14236226
C009166_D010212 NONE ra_17\NN\14625458 (r_pobj) with_14\IN\0 (r_prep) rats_9\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) induced_6\VBN\1627355 (l_nsubjpass) tumors_0\NNS\14234074 (l_appos) papillomas_3\NNS\14236226
C009166_D010212 NONE ra_29\NNP\14625458 (r_compound) administration_32\NN\1133281 (r_punct) ._33\.\0 (r_punct) induced_6\VBN\1627355 (l_nsubjpass) tumors_0\NNS\14234074 (l_appos) papillomas_3\NNS\14236226
19234905
D014635_D006423 NONE valproate_33\NNP\0 (r_pobj) with_32\IN\0 (r_prep) improved_28\VBD\126264 (r_advcl) developed_18\VBN\1753788 (r_conj) had_8\VBD\0 (l_dobj) hemianopsia_12\NN\14552802
D007980_D004409 CID levodopa_55\RB\14604959 (r_npadvmod) induced_57\VBN\1627355 (r_amod) dyskinesias_58\NNS\14084880
8600333
C053519_D001859 NONE protocol_23\NN\6652242 (r_pobj) to_17\IN\0 (r_prep) according_16\VBG\2657219 (r_prep) treated_15\VBN\2376958 (r_relcl) survivors_8\NNS\9630641 (l_prep) of_9\IN\0 (l_pobj) tumors_12\NNS\14234074
D004317_D066126 NONE doxorubicin_3\NN\2716866 (r_npadvmod) induced_5\VBN\1627355 (r_compound) cardiotoxicity_6\NN\0
D004317_D001859 NONE doxorubicin_27\NN\2716866 (r_pobj) including_26\VBG\0 (r_prep) both_25\DT\0 (r_appos) protocol_23\NN\6652242 (r_pobj) to_17\IN\0 (r_prep) according_16\VBG\2657219 (r_prep) treated_15\VBN\2376958 (r_relcl) survivors_8\NNS\9630641 (l_prep) of_9\IN\0 (l_pobj) tumors_12\NNS\14234074
6308526
D009020_D007035 CID morphine_5\NN\2707683 (r_dobj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177 (l_conj) catalepsy_8\NN\14023236 (l_conj) hypothermia_10\VBN\14034177
D009020_D000699 NONE morphine_5\NN\2707683 (r_dobj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177
D009020_D012131 NONE morphine_6\NN\2707683 (r_npadvmod) induced_8\VBN\1627355 (r_amod) depression_12\NN\14373582
D009020_D012131 NONE morphine_15\NN\2707683 (r_npadvmod) induced_17\VBN\1627355 (r_amod) bradycardia_18\NN\14110674 (r_nsubj) was_19\VBD\0 (r_advcl) attenuated_4\VBD\224901 (l_dobj) depression_12\NN\14373582
D009020_D007022 CID morphine_6\NN\2707683 (r_npadvmod) induced_8\VBN\1627355 (r_amod) depression_12\NN\14373582 (l_nmod) hypotension_9\NN\14057371
D009020_D007022 CID morphine_15\NN\2707683 (r_npadvmod) induced_17\VBN\1627355 (r_amod) bradycardia_18\NN\14110674 (r_nsubj) was_19\VBD\0 (r_advcl) attenuated_4\VBD\224901 (l_dobj) depression_12\NN\14373582 (l_nmod) hypotension_9\NN\14057371
C024224_D007022 NONE naloxazone_2\NN\0 (r_nsubj) attenuated_4\VBD\224901 (l_dobj) depression_12\NN\14373582 (l_nmod) hypotension_9\NN\14057371
D009020_D002375 CID morphine_5\NN\2707683 (r_dobj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177 (l_conj) catalepsy_8\NN\14023236
C024224_D002375 NONE naloxazone_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177 (l_conj) catalepsy_8\NN\14023236
C024224_D000699 NONE naloxazone_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177
C024224_D007035 NONE naloxazone_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) blocked_4\VBD\1476483 (l_npadvmod) analgesia_6\NN\14034177 (l_conj) catalepsy_8\NN\14023236 (l_conj) hypothermia_10\VBN\14034177
D009020_D001919 CID morphine_6\NN\2707683 (r_npadvmod) induced_8\VBN\1627355 (r_amod) depression_12\NN\14373582 (r_dobj) attenuated_4\VBD\224901 (l_advcl) was_19\VBD\0 (l_nsubj) bradycardia_18\NN\14110674
D009020_D001919 CID morphine_15\NN\2707683 (r_npadvmod) induced_17\VBN\1627355 (r_amod) bradycardia_18\NN\14110674
C024224_D001919 NONE naloxazone_2\NN\0 (r_nsubj) attenuated_4\VBD\224901 (l_advcl) was_19\VBD\0 (l_nsubj) bradycardia_18\NN\14110674
C024224_D012131 NONE naloxazone_2\NN\0 (r_nsubj) attenuated_4\VBD\224901 (l_dobj) depression_12\NN\14373582
9326871
D004917_D005759 CID erythromycin_7\NNP\2716866 (r_pobj) of_6\IN\0 (r_prep) profile_5\NN\6999802 (r_nsubjpass) established_9\VBN\2426171 (r_advcl) recorded_35\VBN\2225492 (l_nsubjpass) experience_27\NN\5984287 (l_prep) including_11\VBG\0 (l_pobj) gastroenteritis_12\JJ\14171682
D004917_D066126 NONE erythromycin_11\NNP\2716866 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) after_4\IN\0 (r_prep) demonstrated_3\VBN\2137132 (l_nsubjpass) cardiotoxicity_0\NN\0
D017291_D001145 NONE clarithromycin_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) doses_12\NNS\3740161 (r_pobj) after_9\IN\0 (r_prep) occurred_8\VBD\0 (r_relcl) dysrhythmias_6\NNS\0
D018942_D005759 NONE macrolides_31\NNS\0 (r_pobj) with_28\IN\0 (r_prep) experience_27\NN\5984287 (l_prep) including_11\VBG\0 (l_pobj) gastroenteritis_12\JJ\14171682
D017291_D017180 CID clarithromycin_0\NN\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) tachycardia_4\NN\14110674
D018942_D066126 NONE macrolides_20\NNS\0 (r_pobj) with_17\IN\0 (r_prep) reported_16\VBN\831651 (r_conj) demonstrated_3\VBN\2137132 (l_nsubjpass) cardiotoxicity_0\NN\0
2594614
D002045_D007022 CID bupivacaine_5\NN\0 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (r_nsubj) elicited_16\VBD\1617192 (l_dobj) decrease_19\NN\7296428 (l_prep) of_20\IN\0 (l_pobj) pressure_24\NN\11419404 (l_appos) mbp_26\NNP\0 (l_conj) rate_30\NN\13815152 (l_punct) )_33\-RRB-\0
D002045_D007022 CID bupivacaine_23\NN\0 (r_compound) administration_24\NN\1133281 (r_pobj) before_22\IN\0 (r_prep) min_21\NN\15154774 (r_appos) injection_1\NN\320852 (r_nsubj) suppressed_30\VBD\2510337 (l_dobj) decrease_33\NN\7296428 (l_prep) of_34\IN\0 (l_pobj) mbp_35\NNP\0 (l_conj) hr_37\NN\15154774
D002045_D007022 CID bupivacaine_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) injected_9\VBN\81072 (r_advcl) observed_29\VBN\2163746 (l_nsubjpass) reversion_20\NN\13286801 (l_prep) of_21\IN\0 (l_pobj) decrease_23\NN\7296428 (l_prep) of_24\IN\0 (l_pobj) mbp_25\NNP\0 (l_conj) hr_27\NN\15154774
D002045_D002318 NONE bupivacaine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) impairments_19\NNS\7296428
D002045_D002318 NONE bupivacaine_44\NN\0 (r_npadvmod) induced_46\VBN\1627355 (r_amod) toxicity_48\NN\13576101
C045856_D002318 NONE 52021_12\CD\0 (r_nummod) bn_11\NNP\0 (r_appos) antagonist_9\NN\7846 (l_prep) on_14\IN\0 (l_pobj) impairments_19\NNS\7296428
C045856_D002318 NONE 52021_5\CD\0 (r_nummod) bn_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) alter_14\VB\0 (r_advcl) demonstrate_29\VBP\2137132 (l_dobj) action_32\NN\30358 (l_prep) against_43\IN\0 (l_pobj) toxicity_48\NN\13576101
C045856_D002318 NONE 52021_35\CD\0 (r_nummod) bn_34\NNP\0 (r_pobj) of_33\IN\0 (r_prep) action_32\NN\30358 (l_prep) against_43\IN\0 (l_pobj) toxicity_48\NN\13576101
C045856_D001919 NONE 52021_14\CD\0 (r_appos) antagonist_12\NN\7846 (r_appos) injection_1\NN\320852 (r_nsubj) suppressed_30\VBD\2510337 (l_dobj) decrease_33\NN\7296428 (l_prep) of_34\IN\0 (l_pobj) mbp_35\NNP\0 (l_conj) hr_37\NN\15154774
C045856_D001919 NONE 52021_2\CD\0 (r_nummod) bn_1\NNP\0 (r_nsubjpass) injected_9\VBN\81072 (r_advcl) observed_29\VBN\2163746 (l_nsubjpass) reversion_20\NN\13286801 (l_prep) of_21\IN\0 (l_pobj) decrease_23\NN\7296428 (l_prep) of_24\IN\0 (l_pobj) mbp_25\NNP\0 (l_conj) hr_27\NN\15154774
D002045_D018376 NONE bupivacaine_16\NN\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) alterations_20\NNS\7283608
D002045_D001919 CID bupivacaine_5\NN\0 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (r_nsubj) elicited_16\VBD\1617192 (l_dobj) decrease_19\NN\7296428 (l_prep) of_20\IN\0 (l_pobj) pressure_24\NN\11419404 (l_appos) mbp_26\NNP\0 (l_conj) rate_30\NN\13815152 (l_punct) )_33\-RRB-\0
D002045_D001919 CID bupivacaine_23\NN\0 (r_compound) administration_24\NN\1133281 (r_pobj) before_22\IN\0 (r_prep) min_21\NN\15154774 (r_appos) injection_1\NN\320852 (r_nsubj) suppressed_30\VBD\2510337 (l_dobj) decrease_33\NN\7296428 (l_prep) of_34\IN\0 (l_pobj) mbp_35\NNP\0 (l_conj) hr_37\NN\15154774
D002045_D001919 CID bupivacaine_12\NN\0 (r_pobj) after_11\IN\0 (r_prep) injected_9\VBN\81072 (r_advcl) observed_29\VBN\2163746 (l_nsubjpass) reversion_20\NN\13286801 (l_prep) of_21\IN\0 (l_pobj) decrease_23\NN\7296428 (l_prep) of_24\IN\0 (l_pobj) mbp_25\NNP\0 (l_conj) hr_27\NN\15154774
C045856_D007022 NONE 52021_14\CD\0 (r_appos) antagonist_12\NN\7846 (r_appos) injection_1\NN\320852 (r_nsubj) suppressed_30\VBD\2510337 (l_dobj) decrease_33\NN\7296428 (l_prep) of_34\IN\0 (l_pobj) mbp_35\NNP\0 (l_conj) hr_37\NN\15154774
C045856_D007022 NONE 52021_2\CD\0 (r_nummod) bn_1\NNP\0 (r_nsubjpass) injected_9\VBN\81072 (r_advcl) observed_29\VBN\2163746 (l_nsubjpass) reversion_20\NN\13286801 (l_prep) of_21\IN\0 (l_pobj) decrease_23\NN\7296428 (l_prep) of_24\IN\0 (l_pobj) mbp_25\NNP\0 (l_conj) hr_27\NN\15154774
9061311
D010100_D017114 NONE oxygen_5\NN\14622893 (r_nmod) production_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) alf_11\NNP\0
D013481_D001424 NONE superoxide_2\NN\14971519 (r_amod) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046
D006861_D001424 NONE peroxide_5\NN\14780040 (r_compound) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046
D009240_D017114 NONE phenylalanine_15\NN\14605787 (r_nmod) fmlp_17\NN\0 (r_pobj) with_8\IN\0 (r_prep) stimulated_7\VBN\137313 (l_prep) from_19\IN\0 (l_pobj) patients_24\NNS\9898892 (l_compound) alf_23\NNP\0
D009240_D017114 NONE fmlp_17\NN\0 (r_pobj) with_8\IN\0 (r_prep) stimulated_7\VBN\137313 (l_prep) from_19\IN\0 (l_pobj) patients_24\NNS\9898892 (l_compound) alf_23\NNP\0
D000082_D017114 CID paracetamol_14\JJ\0 (r_compound) overdose_15\NN\84738 (r_pobj) due_12\IN\5174653 (r_amod) production_7\NN\30358 (l_prep) in_8\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_prep) with_10\IN\0 (l_pobj) alf_11\NNP\0
D000082_D017114 CID paracetamol_10\JJ\0 (r_compound) overdose_11\NN\84738 (r_pobj) due_8\IN\5174653 (r_prep) demonstrate_2\VBP\2137132 (l_dobj) defect_5\NN\14462666 (l_prep) in_6\IN\13603305 (l_pobj) alf_7\NNP\0
D010100_D062787 NONE oxygen_5\NN\14622893 (r_nmod) production_7\NN\30358 (l_amod) due_12\IN\5174653 (l_pobj) overdose_15\NN\84738
D006861_D017114 NONE peroxide_4\NN\14780040 (r_conj) superoxide_1\NN\14971519 (r_nmod) production_5\NN\30358 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) failure_11\NN\66216
D006861_D017114 NONE peroxide_5\NN\14780040 (r_compound) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) failure_22\NN\66216
D006861_D017114 NONE peroxide_5\NN\14780040 (r_compound) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) failure_22\NN\66216 (l_appos) alf_24\NNP\0
D006861_D017114 NONE peroxide_3\NN\14780040 (r_compound) production_4\NN\30358 (r_conj) superoxide_0\NN\14971519 (l_prep) by_5\IN\0 (l_pobj) neutrophils_7\NNS\5449959 (l_compound) alf_6\NNP\0
D006861_D017114 NONE peroxide_3\NN\14780040 (r_compound) production_4\NN\30358 (r_conj) superoxide_0\NN\14971519 (r_nsubj) stimulated_8\VBN\137313 (l_dobj) opsonized_11\VBN\126264 (l_prep) with_12\IN\0 (l_pobj) serum_14\NN\5397468 (l_compound) alf_13\NNP\0
D006861_D017114 NONE peroxide_3\NN\14780040 (r_compound) production_4\NN\30358 (r_conj) superoxide_0\NN\14971519 (l_prep) in_5\IN\13603305 (l_pobj) neutrophils_6\NNS\5449959 (l_acl) stimulated_7\VBN\137313 (l_prep) from_19\IN\0 (l_pobj) patients_24\NNS\9898892 (l_compound) alf_23\NNP\0
D013481_D017114 NONE superoxide_1\NN\14971519 (r_nmod) production_5\NN\30358 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_prep) with_8\IN\0 (l_pobj) failure_11\NN\66216
D013481_D017114 NONE superoxide_2\NN\14971519 (r_amod) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) failure_22\NN\66216
D013481_D017114 NONE superoxide_2\NN\14971519 (r_amod) production_6\NN\30358 (r_pobj) in_1\IN\13603305 (r_prep) defects_0\NNS\14462666 (r_nsubjpass) implicated_9\VBN\2677097 (l_prep) in_10\IN\13603305 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) infections_16\NNS\14052046 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) failure_22\NN\66216 (l_appos) alf_24\NNP\0
D013481_D017114 NONE superoxide_0\NN\14971519 (l_prep) by_5\IN\0 (l_pobj) neutrophils_7\NNS\5449959 (l_compound) alf_6\NNP\0
D013481_D017114 NONE superoxide_0\NN\14971519 (r_nsubj) stimulated_8\VBN\137313 (l_dobj) opsonized_11\VBN\126264 (l_prep) with_12\IN\0 (l_pobj) serum_14\NN\5397468 (l_compound) alf_13\NNP\0
D013481_D017114 NONE superoxide_0\NN\14971519 (l_prep) in_5\IN\13603305 (l_pobj) neutrophils_6\NNS\5449959 (l_acl) stimulated_7\VBN\137313 (l_prep) from_19\IN\0 (l_pobj) patients_24\NNS\9898892 (l_compound) alf_23\NNP\0
D000082_D062787 NONE paracetamol_14\JJ\0 (r_compound) overdose_15\NN\84738
D000082_D062787 NONE paracetamol_10\JJ\0 (r_compound) overdose_11\NN\84738
18483878
D003520_D001745 NONE cyp_22\NNP\0 (r_pobj) with_21\IN\0 (r_prep) wt_20\NNP\0 (r_pobj) in_19\IN\13603305 (r_prep) observed_18\VBD\2163746 (r_advcl) increased_15\VBN\169651 (l_advcl) mice_7\NNS\2329401 (l_prep) with_8\IN\0 (l_pobj) inflammation_10\NN\14299637
D003520_D003556 CID cyclophosphamide_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) mice_13\NNS\2329401 (r_appos) knockout_9\NN\10787470 (l_appos) cystitis_18\NN\14566129
D003520_D003556 CID cyp)-induced_17\VBN\0 (r_compound) cystitis_18\NN\14566129
D003520_D003556 CID cyclophosphamide_14\NN\0 (r_pobj) after_13\IN\0 (r_prep) altered_4\JJ\0 (l_dobj) cystitis_17\NN\14566129
D003520_D003556 CID cyp)-induced_16\VBN\0 (r_amod) cystitis_17\NN\14566129
D003520_D003556 CID cyp_32\NNP\0 (r_npadvmod) induced_34\VBN\1627355 (r_amod) cystitis_35\NN\14566129
19300240
D002395_D054549 NONE catecholamines_9\NNS\5407119 (r_pobj) of_7\IN\0 (r_prep) levels_6\NNS\4916342 (r_nsubj) contributed_24\VBN\126264 (l_dobj) development_26\NN\248977 (l_prep) of_27\IN\0 (l_pobj) abs_28\NN\14592610
D002395_D009369 NONE catecholamines_9\NNS\5407119 (r_pobj) of_7\IN\0 (r_prep) levels_6\NNS\4916342 (l_acl) caused_14\VBN\1617192 (l_agent) by_15\IN\0 (l_pobj) diagnosis_17\NN\152018 (l_compound) cancer_16\NN\14239425
D005472_D015179 NONE fluorouracil_5\NN\2722166 (r_pobj) with_4\IN\0 (r_prep) underwent_1\VBD\109660 (l_prep) for_6\IN\0 (l_pobj) cancer_9\NN\14239425
D005472_D054549 CID flourouracil_1\NN\0 (r_npadvmod) induced_3\VBN\1627355 (r_amod) syndrome_6\NN\5870365
11078231
D000109_D023921 NONE acetylcholine_8\NN\14807558 (r_pobj) of_7\IN\0 (r_prep) injection_6\NN\320852 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (l_conj) documented_17\VBN\1000214 (l_nsubjpass) stenosis_15\NN\14204950
D004280_D003329 CID dobutamine_8\NN\0 (r_compound) stress_9\NN\7083732 (r_compound) echocardiography_10\RB\177127 (r_pobj) during_7\IN\0 (r_prep) spasm_6\NN\14299637
D004280_D003329 CID dobutamine_19\NN\0 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (l_nsubjpass) ischemia_11\NN\14195315 (l_amod) due_12\IN\5174653 (l_pcomp) to_13\IN\0 (l_pobj) spasm_15\NN\14299637
D004280_D003329 CID dobutamine_4\NN\0 (r_nsubj) provoke_6\VB\1617192 (l_dobj) spasm_8\NN\14299637
D004280_D000788 CID dobutamine_4\NN\0 (r_nsubj) provoke_6\VB\1617192 (l_prep) in_9\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) angina_15\NN\14171682
D004280_D017202 NONE dobutamine_8\NN\0 (r_compound) stress_9\NN\7083732 (r_compound) echocardiography_10\RB\177127 (r_pobj) during_7\IN\0 (r_prep) spasm_6\NN\14299637 (r_pobj) due_2\IN\5174653 (r_amod) ischemia_1\NN\14195315
D004280_D017202 NONE dobutamine_0\NNP\0 (r_nsubj) stress_1\NN\7083732 (r_nsubj) is_6\VBZ\0 (l_attr) test_12\NN\5798043 (l_prep) for_13\IN\0 (l_pobj) ischemia_15\NN\14195315
D004280_D017202 NONE dobutamine_19\NN\0 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (l_nsubjpass) ischemia_11\NN\14195315
9630698
D006220_D009127 CID haloperidol_5\NN\3713736 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (l_nsubjpass) rigidity_1\NN\5023233
D006220_D009127 CID haloperidol_34\NN\3713736 (r_advmod) induced_36\VBN\1627355 (r_amod) rigidity_38\NN\5023233
C066192_D009127 NONE acid_1\NN\14818238 (r_nsubj) injected_12\VBN\81072 (l_conj) decreased_31\VBD\169651 (l_dobj) rigidity_38\NN\5023233
C066192_D009127 NONE 5,7-dcka_3\CD\0 (r_appos) acid_1\NN\14818238 (r_nsubj) injected_12\VBN\81072 (l_conj) decreased_31\VBD\169651 (l_dobj) rigidity_38\NN\5023233
D005998_D009127 NONE glycine_8\NN\14601829 (r_compound) site_9\NN\8673395 (r_compound) antagonist_10\NN\7846 (r_appos) acid_1\NN\14818238 (r_nsubj) injected_12\VBN\81072 (l_conj) decreased_31\VBD\169651 (l_dobj) rigidity_38\NN\5023233
12139551
D008787_D006323 CID metoclopramide_4\NN\0 (r_compound) case_7\NN\7283608 (r_pobj) after_2\IN\0 (r_prep) arrest_1\NN\88481
D008787_D006323 CID metoclopramide_4\NN\0 (r_compound) case_7\NN\7283608 (l_acl) causing_14\VBG\30358 (l_dobj) episodes_16\NNS\7283608 (l_prep) of_17\IN\0 (l_pobj) arrest_19\NN\88481
D008787_D006323 CID metoclopramide_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) injections_11\NNS\320852 (r_pobj) of_8\IN\0 (r_prep) case_7\NN\7283608 (r_pobj) after_2\IN\0 (r_prep) arrest_1\NN\88481
D008787_D006323 CID metoclopramide_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) injections_11\NNS\320852 (r_pobj) of_8\IN\0 (r_prep) case_7\NN\7283608 (l_acl) causing_14\VBG\30358 (l_dobj) episodes_16\NNS\7283608 (l_prep) of_17\IN\0 (l_pobj) arrest_19\NN\88481
D008787_D006323 CID metoclopramide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) injection_6\NN\320852 (r_nsubjpass) followed_11\VBN\1835496 (l_agent) by_12\IN\0 (l_pobj) asystole_13\NN\14204950
D008787_D006323 CID metoclopramide_3\JJ\0 (r_dobj) received_2\VBD\2210855 (r_ccomp) is_24\VBZ\0 (l_advcl) followed_37\VBN\1835496 (l_agent) by_38\IN\0 (l_pobj) asystole_39\NN\14204950
D008787_D006323 CID metoclopramide_30\NN\0 (r_pobj) of_29\IN\0 (r_prep) administration_28\NN\1133281 (r_nsubj) was_31\VBD\0 (r_ccomp) is_24\VBZ\0 (l_advcl) followed_37\VBN\1835496 (l_agent) by_38\IN\0 (l_pobj) asystole_39\NN\14204950
D008787_D006323 CID metoclopramide_10\NN\0 (r_pobj) by_9\IN\0 (r_agent) caused_8\VBN\1617192 (r_acl) episodes_4\NNS\7283608 (l_prep) of_5\IN\0 (l_pobj) arrest_7\NN\88481
11022397
D010862_D008569 NONE pilocarpine_10\NN\14712692 (r_conj) tropicamide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) after_5\IN\0 (r_prep) size_1\NN\5090441 (r_ccomp) impairment_15\NN\7296428 (l_prep) in_16\IN\13603305 (l_pobj) recall_18\NN\7185325
D014331_D008569 NONE tropicamide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) after_5\IN\0 (r_prep) size_1\NN\5090441 (r_ccomp) impairment_15\NN\7296428 (l_prep) in_16\IN\13603305 (l_pobj) recall_18\NN\7185325
D012601_D008569 CID scopolamine_12\NN\14712692 (r_npadvmod) induced_14\VBN\1627355 (r_amod) impairment_15\NN\7296428 (l_prep) in_16\IN\13603305 (l_pobj) recall_18\NN\7185325
D012601_D008569 CID scopolamine_11\NN\14712692 (r_npadvmod) induced_13\VBN\1627355 (r_amod) impairment_14\NN\7296428 (r_dobj) had_9\VBD\0 (l_dobj) recall_17\NN\7185325
16047871
D014859_D012871 NONE warfarin_11\NN\2718259 (r_dobj) receiving_10\VBG\2210855 (r_pcomp) after_9\IN\0 (r_prep) developed_8\VBD\1753788 (r_relcl) eruptions_6\NNS\7307754
D014859_D012871 NONE warfarin_21\NN\2718259 (r_nsubjpass) discontinued_23\VBN\0 (r_advcl) resolved_16\VBD\352826 (r_acl) lesions_15\NNS\14204950 (r_dobj) confirming_12\VBG\0 (r_advcl) were_6\VBD\0 (l_nsubj) results_1\NNS\34213 (l_prep) of_2\IN\0 (l_pobj) biopsies_5\NNS\5739043 (l_compound) lesion_4\NN\14204950
D014859_D018366 CID warfarin_21\NN\2718259 (r_nsubjpass) discontinued_23\VBN\0 (r_advcl) resolved_16\VBD\352826 (r_acl) lesions_15\NNS\14204950
D014859_C535509 NONE warfarin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) vasculitis_4\NN\14336539
D014859_C535509 NONE warfarin_12\NN\2718259 (r_pobj) due_10\JJ\5174653 (r_amod) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) lv_8\NNP\0
D014859_C535509 NONE warfarin_11\JJ\2718259 (r_compound) therapy_12\NN\657604 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) reaction_8\NN\13446390 (r_attr) be_2\VB\14625458 (l_nsubj) lv_0\NNP\0
16364460
D012601_D000647 CID scopolamine_10\NN\14712692 (r_npadvmod) induced_12\VBN\1627355 (r_amod) amnesia_13\NN\5669934
D012601_D000647 CID scopolamine_9\NN\14712692 (r_nmod) amnesia_14\NN\5669934
D012601_D000647 CID scopolamine_16\NN\14712692 (r_npadvmod) induced_18\VBN\1627355 (r_amod) amnesia_19\NN\5669934
D016713_D000647 NONE ritanserin_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) microinjection_0\NN\0 (r_nsubj) improves_9\VBZ\126264 (l_dobj) amnesia_13\NN\5669934
D016713_D000647 NONE ritanserin_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) on_8\IN\0 (l_pobj) amnesia_14\NN\5669934
D016713_D000647 NONE ritanserin_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) microinjection_4\NN\0 (r_nsubj) improves_14\VBZ\126264 (l_dobj) amnesia_19\NN\5669934
16418614
D011441_D014424 NONE ptu_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) vasculitis_3\NN\14336539 (l_prep) in_4\IN\13603305 (l_pobj) girl_6\NN\10787470 (l_prep) with_7\IN\0 (l_pobj) syndrome_9\NNP\5870365
D011441_D006111 NONE ptu_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) vasculitis_3\NN\14336539 (l_prep) in_4\IN\13603305 (l_pobj) girl_6\NN\10787470 (l_prep) with_7\IN\0 (l_pobj) syndrome_9\NNP\5870365 (l_conj) disease_13\NN\14061805
D011441_D014657 CID ptu_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) vasculitis_3\NN\14336539
D011441_D014657 CID propylthiouracil_3\NN\14727670 (r_pobj) of_2\IN\0 (r_prep) diagnosis_1\NN\152018 (r_nsubjpass) made_8\VBN\0 (l_nsubjpass) vasculitis_6\NN\14336539
D011441_D014657 CID ptu)-associated_5\VBN\0 (r_amod) vasculitis_6\NN\14336539
D011441_D014657 CID ptu_37\NNP\0 (r_pobj) of_36\IN\0 (r_prep) withdrawal_35\NN\7206096 (r_dobj) following_34\VBG\8180190 (r_acl) resolution_31\NN\6470073 (r_conj) detection_17\NN\5708432 (r_appos) made_8\VBN\0 (l_nsubjpass) vasculitis_6\NN\14336539
7263204
D000493_D000741 NONE allopurinol_14\NN\3740161 (r_pobj) than_13\IN\0 (r_prep) other_12\JJ\0 (r_amod) drugs_11\NNS\14778436 (r_nsubjpass) given_18\VBN\5892096 (r_relcl) described_7\VBN\1001294 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) anemia_5\NN\14189204
D007213_D000741 CID indomethacin_5\NN\3828465 (r_pobj) due_3\IN\5174653 (r_amod) anemia_2\NN\14189204
D007213_D000741 CID indomethacin_1\NN\3828465 (r_nsubjpass) implicated_4\VBN\2677097 (l_prep) as_5\IN\14622893 (l_pobj) cause_8\NN\7323922 (l_prep) of_9\IN\0 (l_pobj) anemia_11\NN\14189204
D007213_D000741 CID indomethacin_16\NN\3828465 (r_conj) allopurinol_14\NN\3740161 (r_pobj) than_13\IN\0 (r_prep) other_12\JJ\0 (r_amod) drugs_11\NNS\14778436 (r_nsubjpass) given_18\VBN\5892096 (r_relcl) described_7\VBN\1001294 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) anemia_5\NN\14189204
D007213_D000741 CID indomethacin_6\NN\3828465 (r_pobj) with_5\IN\0 (r_prep) test_4\NN\5798043 (r_nsubj) substantiates_10\VBZ\0 (l_dobj) role_13\NN\719494 (l_prep) in_17\IN\13603305 (l_pcomp) causing_18\VBG\30358 (l_dobj) anemia_20\NN\14189204
9545159
D001393_D016171 CID azole_22\JJ\0 (r_amod) agents_24\NNS\7347 (r_conj) erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_dobj) pointes_7\FW\831651
D001393_D008133 CID azole_22\JJ\0 (r_amod) agents_24\NNS\7347 (r_conj) erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_nsubj) prolongation_0\NN\1017987 (l_prep) of_1\IN\0 (l_pobj) interval_3\NN\33615
D004110_D008133 CID diltiazem_9\NN\2938514 (r_compound) interaction_10\NN\37396 (r_pobj) to_6\IN\0 (r_prep) related_5\VBN\628491 (r_acl) interval_4\NN\33615
D004110_D005764 NONE diltiazem_20\NN\2938514 (r_conj) disorder_18\NN\14034177
D004917_D008133 CID erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_nsubj) prolongation_0\NN\1017987 (l_prep) of_1\IN\0 (l_pobj) interval_3\NN\33615
D020117_D006973 NONE cisapride_14\NN\0 (r_dobj) taking_13\VBG\37396 (l_prep) for_31\IN\0 (l_pobj) hypertension_32\NN\14057371
D020117_D008133 CID cisapride_7\NN\0 (r_compound) diltiazem_9\NN\2938514 (r_compound) interaction_10\NN\37396 (r_pobj) to_6\IN\0 (r_prep) related_5\VBN\628491 (r_acl) interval_4\NN\33615
D020117_D005764 NONE cisapride_14\NN\0 (r_dobj) taking_13\VBG\37396 (l_prep) for_15\IN\0 (l_pobj) disorder_18\NN\14034177
D004110_D006973 NONE diltiazem_20\NN\2938514 (r_conj) disorder_18\NN\14034177 (r_pobj) for_15\IN\0 (r_prep) taking_13\VBG\37396 (l_prep) for_31\IN\0 (l_pobj) hypertension_32\NN\14057371
D004917_D016171 CID erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_dobj) pointes_7\FW\831651
D001393_D016757 CID azole_22\JJ\0 (r_amod) agents_24\NNS\7347 (r_conj) erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_dobj) pointes_7\FW\831651 (l_conj) death_12\NN\7296428
D020117_D015835 NONE cisapride_0\NNP\0 (r_nsubjpass) prescribed_13\VBN\748282 (l_prep) for_14\IN\0 (l_pobj) treatment_16\NN\654885 (l_prep) of_17\IN\0 (l_pobj) disorders_20\NNS\14034177
D004917_D016757 CID erythromycin_20\NNP\2716866 (r_pobj) with_19\IN\0 (r_prep) administration_18\NN\1133281 (r_pobj) after_16\IN\0 (r_prep) reported_15\VBN\831651 (l_nsubjpass) torsades_5\NNS\0 (l_dobj) pointes_7\FW\831651 (l_conj) death_12\NN\7296428
2320800
D007069_D051437 NONE ifosfamide_34\NN\0 (r_pobj) after_28\IN\0 (r_prep) day_27\NN\15154774 (r_npadvmod) developed_17\VBD\1753788 (l_dobj) failure_22\NN\66216
D007069_D001943 NONE ifosfamide_5\JJ\0 (r_compound) chemotherapy_6\NN\661091 (r_dobj) complicating_2\VBG\126264 (l_prep) in_7\IN\13603305 (l_pobj) patient_11\NN\9898892 (l_compound) cancer_10\NN\14239425
D007069_D001943 NONE ifosfamide_34\NN\0 (r_pobj) after_28\IN\0 (r_prep) day_27\NN\15154774 (r_npadvmod) developed_17\VBD\1753788 (l_nsubj) woman_6\NN\9605289 (l_prep) with_7\IN\0 (l_pobj) cancer_10\NN\14239425
D002945_D001002 NONE cisplatin_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) woman_6\NN\9605289 (r_nsubj) developed_17\VBD\1753788 (l_dobj) failure_22\NN\66216 (l_prep) with_23\IN\0 (l_pobj) anuria_24\NN\14061805
D002945_D001002 NONE cisplatin_20\NN\0 (r_amod) chemotherapy_21\NN\661091 (r_dobj) received_18\VBN\2210855 (r_advcl) occurring_13\VBG\0 (r_advcl) was_7\VBD\0 (l_nsubj) anuria_6\NN\14061805
D007069_D007022 NONE ifosfamide_11\NN\0 (r_xcomp) due_9\JJ\5174653 (r_acomp) was_7\VBD\0 (l_advcl) occurring_13\VBG\0 (l_advcl) received_18\VBN\2210855 (l_prep) with_23\IN\0 (l_pobj) perfusion_26\NN\320852 (l_prep) due_27\IN\5174653 (l_pcomp) to_28\IN\0 (l_pobj) hypotension_30\NN\14057371
D002945_D007022 NONE cisplatin_20\NN\0 (r_amod) chemotherapy_21\NN\661091 (r_dobj) received_18\VBN\2210855 (l_prep) with_23\IN\0 (l_pobj) perfusion_26\NN\320852 (l_prep) due_27\IN\5174653 (l_pcomp) to_28\IN\0 (l_pobj) hypotension_30\NN\14057371
D002945_D001943 NONE cisplatin_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) woman_6\NN\9605289 (l_prep) with_7\IN\0 (l_pobj) cancer_10\NN\14239425
D002945_D051437 NONE cisplatin_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) woman_6\NN\9605289 (r_nsubj) developed_17\VBD\1753788 (l_dobj) failure_22\NN\66216
D007069_D001002 CID ifosfamide_5\JJ\0 (r_compound) chemotherapy_6\NN\661091 (r_dobj) complicating_2\VBG\126264 (l_nsubj) anuria_1\NN\14061805
D007069_D001002 CID ifosfamide_34\NN\0 (r_pobj) after_28\IN\0 (r_prep) day_27\NN\15154774 (r_npadvmod) developed_17\VBD\1753788 (l_dobj) failure_22\NN\66216 (l_prep) with_23\IN\0 (l_pobj) anuria_24\NN\14061805
D007069_D001002 CID ifosfamide_11\NN\0 (r_xcomp) due_9\JJ\5174653 (r_acomp) was_7\VBD\0 (l_nsubj) anuria_6\NN\14061805
D007069_D007674 CID ifosfamide_5\JJ\0 (r_compound) chemotherapy_6\NN\661091 (r_dobj) complicating_2\VBG\126264 (l_prep) in_7\IN\13603305 (l_pobj) patient_11\NN\9898892 (l_prep) with_12\IN\0 (l_pobj) function_16\NN\13783581
D007069_D007674 CID ifosfamide_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) drug_5\NN\14778436 (l_amod) nephrotoxic_4\JJ\0
D007069_D007674 CID ifosfamide_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) drug_5\NN\14778436 (l_prep) with_6\IN\0 (l_pobj) tubulopathies_8\NNS\0
D007069_D007674 CID ifosfamide_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_acl) pretreated_8\VBN\0 (l_prep) with_9\IN\0 (l_pobj) chemotherapy_11\NN\661091 (l_amod) nephrotoxic_10\JJ\0
16586083
C109794_D002318 NONE peptide_10\NN\14724264 (r_pobj) as_3\IN\14622893 (r_prep) markers_1\NNS\21939 (r_nsubj) help_25\VB\407535 (l_advcl) avoiding_36\VBG\0 (l_dobj) occurrence_38\NN\29378 (l_prep) of_39\IN\0 (l_pobj) toxicity_42\NN\13576101
C109794_D002318 NONE probnp_14\NNP\0 (r_appos) peptide_10\NN\14724264 (r_pobj) as_3\IN\14622893 (r_prep) markers_1\NNS\21939 (r_nsubj) help_25\VB\407535 (l_advcl) avoiding_36\VBG\0 (l_dobj) occurrence_38\NN\29378 (l_prep) of_39\IN\0 (l_pobj) toxicity_42\NN\13576101
D016861_D006973 CID inhibitors_25\NNS\20090 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) stroke_15\NN\556313 (l_conj) hypertension_17\NN\14057371
D016861_D006333 CID inhibitors_25\NNS\20090 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) stroke_15\NN\556313 (l_conj) hypertension_17\NN\14057371 (l_conj) failure_20\NN\66216
D016861_D020521 CID inhibitors_25\NNS\20090 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) stroke_15\NN\556313
D016861_D009203 CID inhibitors_25\NNS\20090 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) during_21\IN\0 (r_prep) stroke_15\NN\556313 (r_conj) infarction_13\NN\14204950
6615052
D006493_D013927 NONE heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204 (l_conj) thrombosis_5\NN\14100769
D006493_D013921 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204
D006493_D013921 CID heparin_6\NN\2718259 (r_npadvmod) induced_8\VBN\1627355 (r_amod) thrombocytopenia_9\NN\14189204
D006493_D013923 CID heparin_17\VBN\2718259 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) in_14\IN\13603305 (r_prep) events_13\NNS\23100 (l_compound) thromboembolic_12\JJ\0
D006493_D001791 NONE heparin_12\NN\2718259 (r_pobj) to_11\IN\0 (r_prep) resistance_10\NN\37396 (r_dobj) increased_9\VBN\169651 (r_conj) revealed_3\VBN\2137132 (l_dobj) count_7\NN\13582013
D006493_D001791 NONE heparin_24\NN\2718259 (r_nsubjpass) added_26\VBN\156601 (r_conj) increased_9\VBN\169651 (r_conj) revealed_3\VBN\2137132 (l_dobj) count_7\NN\13582013
D006493_D001791 NONE heparin_15\JJ\2718259 (l_appos) testing_19\NN\639556 (l_compound) aggregation_18\NN\31264
D006493_D006470 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204 (l_conj) thrombosis_5\NN\14100769 (l_conj) hemorrhage_8\NN\14285662
D006493_D006470 CID heparin_17\VBN\2718259 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) in_14\IN\13603305 (r_prep) events_13\NNS\23100 (r_appos) hemorrhage_6\NN\14285662
14648024
D014212_D015473 NONE acid_4\NN\14818238 (r_npadvmod) induced_6\VBN\1627355 (r_amod) erythema_7\NN\14227218 (r_compound) nodosum_8\NN\0 (l_prep) in_9\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) leukemia_14\NN\14239918
D014212_D015473 NONE acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (l_prep) for_12\IN\0 (l_pobj) leukemia_15\NN\14239918
D014212_D015473 NONE acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (l_prep) for_12\IN\0 (l_pobj) leukemia_15\NN\14239918 (l_appos) apl_17\NNP\0
D014212_D015473 NONE atra_10\NNP\0 (r_appos) acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (l_prep) for_12\IN\0 (l_pobj) leukemia_15\NN\14239918
D014212_D015473 NONE atra_10\NNP\0 (r_appos) acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (l_prep) for_12\IN\0 (l_pobj) leukemia_15\NN\14239918 (l_appos) apl_17\NNP\0
D014212_D015473 NONE atra_12\NNP\0 (r_compound) therapy_13\NN\657604 (r_pobj) during_11\IN\0 (r_prep) developed_8\VBD\1753788 (r_relcl) apl_6\NNP\0
D014212_D010146 NONE atra_23\NNP\0 (r_compound) therapy_24\NN\657604 (r_pobj) after_22\IN\0 (r_prep) nodules_6\NNS\5264913 (l_amod) painful_4\JJ\0
D014212_D005334 CID atra_23\NNP\0 (r_compound) therapy_24\NN\657604 (r_pobj) after_22\IN\0 (r_prep) nodules_6\NNS\5264913 (r_conj) fever_0\NN\14299637
D013256_D004893 NONE steroid_5\NN\14727670 (r_pobj) of_4\IN\0 (r_prep) use_3\NN\407535 (r_nsubj) is_6\VBZ\0 (l_prep) in_9\IN\13603305 (l_pobj) nodosum_14\NN\0
D014212_D004893 CID acid_4\NN\14818238 (r_npadvmod) induced_6\VBN\1627355 (r_amod) erythema_7\NN\14227218 (r_compound) nodosum_8\NN\0
D014212_D004893 CID acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (r_acl) nodosum_1\NN\0
D014212_D004893 CID atra_10\NNP\0 (r_appos) acid_8\NN\14818238 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBD\628491 (r_acl) nodosum_1\NN\0
D014212_D004893 CID atra_12\NNP\0 (r_compound) therapy_13\NN\657604 (r_pobj) during_11\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) nodosum_10\NN\0
D014212_D004893 CID atra_23\NNP\0 (r_compound) therapy_24\NN\657604 (r_pobj) after_22\IN\0 (r_prep) nodules_6\NNS\5264913
D014212_D004893 CID atra_0\NNP\0 (r_nsubj) seemed_1\VBD\2604760 (l_xcomp) be_3\VB\14625458 (l_attr) etiology_7\NN\7326557 (l_prep) of_8\IN\0 (l_pobj) nodosum_10\NN\0
D014212_D004893 CID atra_10\NNP\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) nodosum_14\NN\0
17490864
D000661_D006948 CID amphetamine_0\NN\3248958 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hyperactivity_4\NN\14052403
21418164
D008130_D015620 NONE ccnu_0\NNP\0 (r_nsubjpass) used_2\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) lymphoma_9\NN\14239918 (l_conj) tumour_13\NN\14234074 (l_conj) tumour_16\NN\14234074 (l_conj) tumours_19\NNS\14234074
D008130_D056486 NONE 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea_19\JJ\0 (r_nmod) ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D056486 NONE ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D064420 NONE ccnu_0\NNP\0 (r_npadvmod) lomustine_2\NN\2722458 (l_dobj) toxicity_4\NN\13576101
D008130_D064420 NONE lomustine_2\NN\2722458 (l_dobj) toxicity_4\NN\13576101
D008130_D064420 NONE ccnu_6\NNP\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (r_acl) dogs_3\NNS\2083346 (r_pobj) of_0\IN\0 (r_prep) met_9\VBD\0 (l_dobj) criteria_12\NNS\13577171 (l_prep) for_13\IN\0 (l_pobj) class_17\NN\7951464 (l_prep) of_18\IN\0 (l_pobj) toxicity_19\NN\13576101
D008130_D064420 NONE ccnu_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) toxicity_3\NN\13576101
D008130_D008223 NONE ccnu_0\NNP\0 (r_nsubjpass) used_2\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) lymphoma_9\NN\14239918
D008130_D008223 NONE ccnu_0\NNP\0 (r_nsubjpass) used_2\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) lymphoma_9\NN\14239918 (l_conj) tumour_13\NN\14234074 (l_conj) tumour_16\NN\14234074 (l_conj) tumours_19\NNS\14234074 (l_conj) lymphoma_22\NN\14239918
D000409_D064420 NONE alanine_5\NN\14601829 (r_compound) transaminase_6\NN\15077571 (r_nmod) concentration_10\NN\4916342 (r_conj) toxicity_2\NN\13576101
D008130_D001932 NONE ccnu_0\NNP\0 (r_nsubjpass) used_2\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) lymphoma_9\NN\14239918 (l_conj) tumour_13\NN\14234074 (l_conj) tumour_16\NN\14234074
D008130_D034801 NONE ccnu_0\NNP\0 (r_nsubjpass) used_2\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) lymphoma_9\NN\14239918 (l_conj) tumour_13\NN\14234074
D008130_D007674 NONE 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea_19\JJ\0 (r_nmod) ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D007674 NONE ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D005767 NONE 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea_19\JJ\0 (r_nmod) ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D005767 NONE ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D006402 NONE 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea_19\JJ\0 (r_nmod) ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
D008130_D006402 NONE ccnu_21\NNP\0 (r_dobj) receiving_18\VBG\2210855 (r_acl) dogs_17\NNS\2083346 (r_pobj) in_13\IN\13603305 (r_prep) toxicities_12\NNS\13576101
9022662
D008774_D001289 NONE methylphenidate_14\NN\4320126 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (r_acl) disorder_10\NN\14034177
D010389_D001289 NONE pemoline_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) derivative_4\NN\5802185 (l_relcl) is_6\VBZ\0 (l_conj) used_12\VBN\0 (l_prep) in_13\IN\13603305 (l_pobj) treatment_15\NN\654885 (l_prep) of_16\IN\0 (l_pobj) disorder_19\NN\14034177
D001569_D001264 NONE benzodiazepines_10\NNS\3771443 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_conj) decontamination_4\NN\391599 (r_dobj) received_2\VBD\2210855 (l_prep) in_11\IN\13603305 (l_pobj) attempt_13\NN\407535 (l_acl) control_15\VB\5190804 (l_dobj) movements_18\NNS\191142 (l_compound) choreoathetoid_17\JJ\0
C064210_D001289 NONE oxazolidine_3\JJ\0 (r_compound) derivative_4\NN\5802185 (l_relcl) is_6\VBZ\0 (l_conj) used_12\VBN\0 (l_prep) in_13\IN\13603305 (l_pobj) treatment_15\NN\654885 (l_prep) of_16\IN\0 (l_pobj) disorder_19\NN\14034177
D010389_D001264 CID pemoline_0\NNP\0 (r_nsubj) induced_1\VBD\1627355 (l_dobj) choreoathetosis_3\NN\0
D010389_D001264 CID pemoline_9\NN\0 (l_relcl) experienced_11\VBD\2108377 (l_dobj) choreoathetosis_13\NN\0
D010389_D001264 CID pemoline_12\NN\0 (r_compound) overdose_13\NN\84738 (r_pobj) after_11\IN\0 (r_prep) presenting_10\VBG\2137132 (r_acl) patients_9\NNS\9898892 (r_pobj) in_8\IN\13603305 (r_prep) considered_7\VBN\689344 (l_nsubjpass) possibility_1\NN\5944958 (l_prep) of_2\IN\0 (l_pobj) movements_4\NNS\191142 (l_compound) choreoathetoid_3\JJ\0
D010389_D062787 CID pemoline_12\NN\0 (r_compound) overdose_13\NN\84738
D001569_D002819 NONE benzodiazepines_10\NNS\3771443 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_conj) decontamination_4\NN\391599 (r_dobj) received_2\VBD\2210855 (l_prep) in_11\IN\13603305 (l_pobj) attempt_13\NN\407535 (l_acl) control_15\VB\5190804 (l_dobj) movements_18\NNS\191142 (l_compound) choreoathetoid_17\JJ\0
D000662_D001289 NONE amphetamines_10\NNS\3248958 (r_pobj) from_9\IN\0 (r_prep) different_8\JJ\0 (r_acomp) is_6\VBZ\0 (l_conj) used_12\VBN\0 (l_prep) in_13\IN\13603305 (l_pobj) treatment_15\NN\654885 (l_prep) of_16\IN\0 (l_pobj) disorder_19\NN\14034177
D010389_D009069 NONE pemoline_0\NNP\0 (r_nsubjpass) associated_5\VBN\628491 (l_prep) as_9\IN\14622893 (l_pobj) cause_11\NN\7323922 (l_prep) of_12\IN\0 (l_pobj) disorders_15\NNS\14034177
D010389_D009069 NONE pemoline_0\NN\0 (r_nmod) disorder_3\NN\14034177
D010389_D002819 CID pemoline_0\NNP\0 (r_nsubj) induced_1\VBD\1627355 (l_dobj) choreoathetosis_3\NN\0
D010389_D002819 CID pemoline_9\NN\0 (l_relcl) experienced_11\VBD\2108377 (l_dobj) choreoathetosis_13\NN\0
D010389_D002819 CID pemoline_12\NN\0 (r_compound) overdose_13\NN\84738 (r_pobj) after_11\IN\0 (r_prep) presenting_10\VBG\2137132 (r_acl) patients_9\NNS\9898892 (r_pobj) in_8\IN\13603305 (r_prep) considered_7\VBN\689344 (l_nsubjpass) possibility_1\NN\5944958 (l_prep) of_2\IN\0 (l_pobj) movements_4\NNS\191142 (l_compound) choreoathetoid_3\JJ\0
839274
D003276_D020518 CID contraceptives_14\NNS\3183080 (r_pobj) on_12\IN\0 (r_prep) hyperplasia_5\NN\14365950
D003276_D020518 CID contraceptives_18\NNS\3183080 (r_pobj) of_16\IN\0 (r_prep) use_15\NN\407535 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBD\628491 (r_acl) one_6\CD\13741022 (l_prep) of_7\IN\0 (l_pobj) hyperplasia_10\NN\14365950
D003276_D000236 CID contraceptives_14\NNS\3183080 (r_pobj) on_12\IN\0 (r_prep) hyperplasia_5\NN\14365950 (r_conj) adenomas_1\NNS\14236226
D003276_D000236 CID contraceptives_18\NNS\3183080 (r_pobj) of_16\IN\0 (r_prep) use_15\NN\407535 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBD\628491 (r_acl) one_6\CD\13741022 (r_conj) cases_1\NNS\7283608 (l_prep) of_2\IN\0 (l_pobj) adenoma_4\NN\14236226
18177388
D000661_D054549 CID amphetamine_21\NN\3248958 (r_compound) use_22\NN\407535 (r_pobj) of_20\IN\0 (r_prep) setting_19\NN\8567235 (r_pobj) in_17\IN\13603305 (r_prep) woman_16\NN\9605289 (r_pobj) in_13\IN\13603305 (r_prep) left_3\VBN\8621598 (l_dobj) syndrome_7\NN\5870365
D000661_D054549 CID amphetamine_21\NN\3248958 (r_compound) use_22\NN\407535 (r_pobj) of_20\IN\0 (r_prep) setting_19\NN\8567235 (r_pobj) in_17\IN\13603305 (r_prep) woman_16\NN\9605289 (r_pobj) in_13\IN\13603305 (r_prep) left_3\VBN\8621598 (l_oprd) cardiomyopathy_11\NN\14103288
D000661_D054549 CID amphetamine_26\NN\3248958 (r_compound) use_27\NN\407535 (r_pobj) after_25\IN\0 (r_prep) occurring_24\VBG\0 (r_acl) type_18\NN\5839024 (l_prep) of_19\IN\0 (l_pobj) syndrome_23\NN\5870365
12851669
D016912_D054556 NONE levonorgestrel_42\NN\0 (r_npadvmod) containing_44\VBG\2632940 (r_amod) cocs_45\NNS\0 (r_pobj) on_41\IN\0 (r_prep) women_40\NNS\9605289 (r_pobj) among_39\IN\0 (r_prep) years_38\NNS\15144371 (r_pobj) per_34\IN\0 (r_prep) range_9\NN\5123416 (r_attr) was_6\VBD\0 (l_nsubj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) vte_5\NNP\0
D003277_D054556 CID contraceptives_30\NNS\3183080 (r_pobj) on_27\IN\0 (r_prep) women_26\NNS\9605289 (r_pobj) among_25\IN\0 (r_conj) achieve_1\VB\2524171 (l_dobj) estimates_4\NNS\5802185 (l_prep) of_5\IN\0 (l_pobj) thromboembolism_7\NN\14100769
D003277_D054556 CID contraceptives_30\NNS\3183080 (r_pobj) on_27\IN\0 (r_prep) women_26\NNS\9605289 (r_pobj) among_25\IN\0 (r_conj) achieve_1\VB\2524171 (l_dobj) estimates_4\NNS\5802185 (l_prep) of_5\IN\0 (l_pobj) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D003277_D054556 CID cocs_32\NNPS\0 (r_appos) contraceptives_30\NNS\3183080 (r_pobj) on_27\IN\0 (r_prep) women_26\NNS\9605289 (r_pobj) among_25\IN\0 (r_conj) achieve_1\VB\2524171 (l_dobj) estimates_4\NNS\5802185 (l_prep) of_5\IN\0 (l_pobj) thromboembolism_7\NN\14100769
D003277_D054556 CID cocs_32\NNPS\0 (r_appos) contraceptives_30\NNS\3183080 (r_pobj) on_27\IN\0 (r_prep) women_26\NNS\9605289 (r_pobj) among_25\IN\0 (r_conj) achieve_1\VB\2524171 (l_dobj) estimates_4\NNS\5802185 (l_prep) of_5\IN\0 (l_pobj) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D003277_D054556 CID cocs_19\NNS\0 (r_pobj) on_18\IN\0 (r_advcl) had_15\VBN\0 (l_dobj) vte_16\NNP\0
D003277_D054556 CID cocs_24\NNS\0 (r_pobj) on_23\IN\0 (r_prep) women_22\NNS\9605289 (r_pobj) among_20\IN\0 (r_prep) years_19\NNS\15144371 (r_pobj) per_15\IN\0 (r_prep) 3.1_11\CD\0 (r_npadvmod) range_28\NN\5123416 (r_appos) range_9\NN\5123416 (r_attr) was_6\VBD\0 (l_nsubj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) vte_5\NNP\0
D003277_D054556 CID cocs_45\NNS\0 (r_pobj) on_41\IN\0 (r_prep) women_40\NNS\9605289 (r_pobj) among_39\IN\0 (r_prep) years_38\NNS\15144371 (r_pobj) per_34\IN\0 (r_prep) range_9\NN\5123416 (r_attr) was_6\VBD\0 (l_nsubj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) vte_5\NNP\0
D003277_D054556 CID cocs_12\NNS\0 (r_pobj) on_11\IN\0 (r_prep) women_10\NNS\9605289 (r_pobj) among_8\IN\0 (r_prep) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) vte_7\NNP\0
D017373_D054556 NONE acetate_12\NN\15010703 (r_pobj) on_9\IN\0 (r_prep) women_8\NNS\9605289 (r_pobj) in_7\IN\13603305 (r_prep) thromboembolism_6\NN\14100769
D017373_D054556 NONE acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769
D017373_D054556 NONE acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D017373_D054556 NONE cpa_19\NNP\9761403 (r_nmod) ee_21\NNP\6125041 (r_appos) ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769
D017373_D054556 NONE cpa_19\NNP\9761403 (r_nmod) ee_21\NNP\6125041 (r_appos) ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D017373_D054556 NONE cpa_65\NNP\9761403 (r_nmod) ee_67\NNP\6125041 (r_pobj) on_64\IN\0 (r_prep) women_63\NNS\9605289 (r_pobj) among_61\IN\0 (r_prep) years_60\NNS\15144371 (r_pobj) per_56\IN\0 (r_prep) range_50\NN\5123416 (r_conj) range_9\NN\5123416 (r_attr) was_6\VBD\0 (l_nsubj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) vte_5\NNP\0
D017373_D054556 NONE cpa_20\NNP\9761403 (r_nmod) ee_22\NNP\6125041 (r_dobj) taking_19\VBG\37396 (r_acl) women_18\NNS\9605289 (r_pobj) among_17\IN\0 (r_prep) that_16\DT\0 (r_pobj) to_15\IN\0 (r_prep) similar_14\JJ\0 (r_acomp) is_13\VBZ\0 (r_ccomp) suggest_2\VBP\1010118 (l_dobj) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) vte_7\NNP\0
D004997_D054556 NONE ethinylestradiol_14\NN\0 (r_conj) acetate_12\NN\15010703 (r_pobj) on_9\IN\0 (r_prep) women_8\NNS\9605289 (r_pobj) in_7\IN\13603305 (r_prep) thromboembolism_6\NN\14100769
D004997_D054556 NONE ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769
D004997_D054556 NONE ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D004997_D054556 NONE ee_21\NNP\6125041 (r_appos) ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769
D004997_D054556 NONE ee_21\NNP\6125041 (r_appos) ethinylestradiol_17\NN\0 (r_conj) acetate_15\NN\15010703 (r_pobj) on_13\IN\0 (r_prep) women_12\NNS\9605289 (r_pobj) among_11\IN\0 (r_prep) thromboembolism_7\NN\14100769 (l_appos) vte_9\NNP\0
D004997_D054556 NONE ee_67\NNP\6125041 (r_pobj) on_64\IN\0 (r_prep) women_63\NNS\9605289 (r_pobj) among_61\IN\0 (r_prep) years_60\NNS\15144371 (r_pobj) per_56\IN\0 (r_prep) range_50\NN\5123416 (r_conj) range_9\NN\5123416 (r_attr) was_6\VBD\0 (l_nsubj) risk_3\NN\14541044 (l_prep) of_4\IN\0 (l_pobj) vte_5\NNP\0
D004997_D054556 NONE ee_22\NNP\6125041 (r_dobj) taking_19\VBG\37396 (r_acl) women_18\NNS\9605289 (r_pobj) among_17\IN\0 (r_prep) that_16\DT\0 (r_pobj) to_15\IN\0 (r_prep) similar_14\JJ\0 (r_acomp) is_13\VBZ\0 (r_ccomp) suggest_2\VBP\1010118 (l_dobj) risk_5\NN\14541044 (l_prep) of_6\IN\0 (l_pobj) vte_7\NNP\0
3670965
D001241_D012202 CID aspirin_16\JJ\2707683 (r_compound) ingestion_17\NN\13440063 (r_conj) salicylates_14\NNS\3828465 (r_pobj) with_13\IN\0 (r_prep) association_12\NN\8008335 (r_pobj) of_11\IN\0 (r_prep) lack_10\NN\14449126 (r_pobj) despite_7\IN\7501545 (r_prep) disappearing_4\VBG\42757 (l_nsubj) syndrome_1\NN\5870365
D012459_D012202 NONE salicylates_14\NNS\3828465 (r_pobj) with_13\IN\0 (r_prep) association_12\NN\8008335 (r_pobj) of_11\IN\0 (r_prep) lack_10\NN\14449126 (r_pobj) despite_7\IN\7501545 (r_prep) disappearing_4\VBG\42757 (l_nsubj) syndrome_1\NN\5870365
10692744
D000086_D003221 NONE acetazolamide_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) confusion_1\NN\13972797
D000086_D005862 CID acetazolamide_0\RB\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) syndrome_4\NN\5870365
D000086_D005862 CID acetazolamide_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) syndrome_9\NN\5870365
D000086_D007674 NONE acetazolamide_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) confusion_1\NN\13972797 (r_nsubj) is_5\VBZ\0 (l_attr) reaction_11\NN\13446390 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) impairment_16\NN\7296428
19940105
D006220_D002375 CID haloperidol_22\NN\3713736 (r_npadvmod) induced_24\VBN\1627355 (r_amod) catalepsy_25\NN\14023236
D006220_D002375 CID haloperidol_8\NN\3713736 (r_npadvmod) induced_10\VBN\1627355 (r_amod) catalepsy_11\NN\14023236
D018698_D010300 NONE glutamate_1\NN\15010703 (r_nmod) subtype_4\NN\0 (r_nsubj) modulates_5\VBZ\1724459 (l_prep) in_8\IN\13603305 (l_pobj) models_10\NNS\5888929 (l_prep) of_11\IN\0 (l_pobj) disease_14\NN\14061805
D018698_D010300 NONE glutamate_1\NN\15010703 (r_nmod) receptors_5\NNS\5225602 (r_nsubj) modulate_6\VBP\1724459 (l_conj) represent_15\VBP\2664769 (l_dobj) targets_18\NNS\7258332 (l_prep) for_19\IN\0 (l_pobj) treatment_21\NN\654885 (l_prep) of_22\IN\0 (l_pobj) disease_25\NN\14061805
D018698_D010300 NONE glutamate_1\NN\15010703 (r_nmod) receptors_5\NNS\5225602 (r_nsubj) modulate_6\VBP\1724459 (l_conj) represent_15\VBP\2664769 (l_dobj) targets_18\NNS\7258332 (l_prep) for_19\IN\0 (l_pobj) treatment_21\NN\654885 (l_prep) of_22\IN\0 (l_pobj) disease_25\NN\14061805 (l_appos) pd_27\NNP\14625458
C507346_D010300 NONE amn082_1\NNP\0 (r_nsubjpass) tested_15\VBN\670261 (l_prep) in_16\IN\13603305 (l_pobj) models_19\NNS\5888929 (l_prep) of_20\IN\0 (l_pobj) pd_21\NNP\14625458
C507346_D010300 NONE amn082_18\NNP\0 (r_nsubj) reverses_19\VBZ\13854649 (l_prep) in_0\IN\13603305 (l_pobj) task_4\NN\575741 (l_acl) used_6\VBN\0 (l_xcomp) evaluate_8\VB\670261 (l_dobj) symptoms_11\NNS\5823932 (l_prep) of_12\IN\0 (l_pobj) patients_14\NNS\9898892 (l_compound) pd_13\NNP\14625458
C507346_D010300 NONE amn082_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) have_11\VBP\7846 (l_dobj) effect_13\NN\34213 (l_prep) on_14\IN\0 (l_pobj) models_17\NNS\5888929 (l_prep) of_18\IN\0 (l_pobj) pd_19\NNP\14625458
C507346_D002375 NONE amn082_20\NNP\0 (r_pobj) of_19\IN\0 (r_prep) administration_12\NN\1133281 (r_dobj) intrastriatal_11\JJ\0 (r_csubj) reverses_21\VBZ\13854649 (l_dobj) catalepsy_25\NN\14023236
C507346_D002375 NONE amn082_3\NNP\0 (r_nsubj) reduces_4\VBZ\441445 (l_dobj) duration_6\NN\15113229 (l_prep) of_7\IN\0 (l_pobj) catalepsy_11\NN\14023236
C507346_D018476 NONE amn082_18\NNP\0 (r_nsubj) reverses_19\VBZ\13854649 (l_prep) in_0\IN\13603305 (l_pobj) task_4\NN\575741 (l_acl) used_6\VBN\0 (l_xcomp) evaluate_8\VB\670261 (l_dobj) symptoms_11\NNS\5823932 (l_amod) akinetic_10\JJ\0
D016627_D010300 NONE 6-ohda_31\CD\0 (r_advmod) lesioned_33\VBN\0 (r_amod) rats_34\NNS\2329401 (r_pobj) of_29\IN\0 (r_prep) cue_28\NN\7010821 (r_pobj) to_26\IN\0 (r_prep) respond_25\VB\2367363 (r_xcomp) reverses_19\VBZ\13854649 (l_prep) in_0\IN\13603305 (l_pobj) task_4\NN\575741 (l_acl) used_6\VBN\0 (l_xcomp) evaluate_8\VB\670261 (l_dobj) symptoms_11\NNS\5823932 (l_prep) of_12\IN\0 (l_pobj) patients_14\NNS\9898892 (l_compound) pd_13\NNP\14625458
D016627_D018476 NONE 6-ohda_31\CD\0 (r_advmod) lesioned_33\VBN\0 (r_amod) rats_34\NNS\2329401 (r_pobj) of_29\IN\0 (r_prep) cue_28\NN\7010821 (r_pobj) to_26\IN\0 (r_prep) respond_25\VB\2367363 (r_xcomp) reverses_19\VBZ\13854649 (l_prep) in_0\IN\13603305 (l_pobj) task_4\NN\575741 (l_acl) used_6\VBN\0 (l_xcomp) evaluate_8\VB\670261 (l_dobj) symptoms_11\NNS\5823932 (l_amod) akinetic_10\JJ\0
2980315
C053571_D014693 NONE iopentol_14\NN\0 (r_pobj) after_13\IN\0 (r_prep) 0.05_11\CD\0 (r_parataxis) were_4\VBD\0 (l_nsubj) frequencies_0\NNS\15286249 (l_prep) of_1\IN\0 (l_pobj) fibrillation_3\NN\14361664
D007472_D014693 NONE iohexol_20\NN\0 (r_conj) iopentol_14\NN\0 (r_pobj) after_13\IN\0 (r_prep) 0.05_11\CD\0 (r_parataxis) were_4\VBD\0 (l_nsubj) frequencies_0\NNS\15286249 (l_prep) of_1\IN\0 (l_pobj) fibrillation_3\NN\14361664
D008794_D014693 CID metrizoate_27\NN\0 (r_pobj) after_26\IN\0 (r_prep) than_25\IN\0 (r_prep) were_4\VBD\0 (l_nsubj) frequencies_0\NNS\15286249 (l_prep) of_1\IN\0 (l_pobj) fibrillation_3\NN\14361664
6433367
D011453_D012640 NONE prostaglandin_2\JJ\5414534 (r_amod) inhibitors_4\NNS\20090 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (l_prep) on_5\IN\0 (l_pobj) convulsions_8\NNS\14081375
D011453_D012640 NONE prostaglandins_5\NNS\5414534 (r_pobj) of_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D011453_D012640 NONE prostaglandins_5\NNS\5414534 (r_pobj) of_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) investigate_1\VB\644583 (r_advcl) evaluated_37\VBN\670261 (l_nsubjpass) effects_14\NNS\13245626 (l_prep) on_20\IN\0 (l_pobj) convulsions_21\NNS\14081375
D011453_D012640 NONE pgs_7\NNS\0 (r_appos) prostaglandins_5\NNS\5414534 (r_pobj) of_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D011453_D012640 NONE pgs_7\NNS\0 (r_appos) prostaglandins_5\NNS\5414534 (r_pobj) of_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) investigate_1\VB\644583 (r_advcl) evaluated_37\VBN\670261 (l_nsubjpass) effects_14\NNS\13245626 (l_prep) on_20\IN\0 (l_pobj) convulsions_21\NNS\14081375
D011453_D012640 NONE pgs_4\NNS\0 (r_nsubjpass) involved_6\VBN\2676054 (l_prep) in_7\IN\13603305 (l_pobj) fluorthyl-_12\NNS\0 (l_conj) convulsions_17\NNS\14081375
D011453_D012640 NONE pgs_4\NNS\0 (r_nsubjpass) involved_6\VBN\2676054 (l_conj) picrotoxin-_21\XX\0 (l_pobj) convulsions_29\NNS\14081375
D010433_D012640 CID pentetrazol_28\NNP\0 (r_nmod) ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375 (r_pobj) on_20\IN\0 (r_prep) effects_14\NNS\13245626 (r_nsubjpass) evaluated_37\VBN\670261 (l_advcl) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D010433_D012640 CID pentetrazol_28\NNP\0 (r_nmod) ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375
D010433_D012640 CID ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375 (r_pobj) on_20\IN\0 (r_prep) effects_14\NNS\13245626 (r_nsubjpass) evaluated_37\VBN\670261 (l_advcl) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D010433_D012640 CID ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375
D010433_D012640 CID ptz_14\NNP\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) convulsions_17\NNS\14081375
D010433_D012640 CID ptz_14\NNP\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) convulsions_17\NNS\14081375 (r_conj) fluorthyl-_12\NNS\0 (r_pobj) in_7\IN\13603305 (r_prep) involved_6\VBN\2676054 (l_conj) picrotoxin-_21\XX\0 (l_pobj) convulsions_29\NNS\14081375
D001640_D012640 CID bicuculline_35\NN\0 (r_conj) electroshock_33\NN\662681 (r_conj) ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375 (r_pobj) on_20\IN\0 (r_prep) effects_14\NNS\13245626 (r_nsubjpass) evaluated_37\VBN\670261 (l_advcl) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D001640_D012640 CID bicuculline_35\NN\0 (r_conj) electroshock_33\NN\662681 (r_conj) ptz_30\NNP\0 (r_conj) picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375
D001640_D012640 CID bicuculline_26\NN\0 (r_advmod) induced_28\VBN\1627355 (r_conj) electroshock-_23\XX\0 (r_conj) picrotoxin-_21\XX\0 (r_conj) involved_6\VBN\2676054 (l_prep) in_7\IN\13603305 (l_pobj) fluorthyl-_12\NNS\0 (l_conj) convulsions_17\NNS\14081375
D001640_D012640 CID bicuculline_26\NN\0 (r_advmod) induced_28\VBN\1627355 (r_conj) electroshock-_23\XX\0 (r_conj) picrotoxin-_21\XX\0 (l_pobj) convulsions_29\NNS\14081375
D010852_D012640 CID picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375 (r_pobj) on_20\IN\0 (r_prep) effects_14\NNS\13245626 (r_nsubjpass) evaluated_37\VBN\670261 (l_advcl) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D010852_D012640 CID picrotoxin_26\JJ\0 (r_conj) flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375
D010852_D012640 CID picrotoxin-_21\XX\0 (r_conj) involved_6\VBN\2676054 (l_prep) in_7\IN\13603305 (l_pobj) fluorthyl-_12\NNS\0 (l_conj) convulsions_17\NNS\14081375
D010852_D012640 CID picrotoxin-_21\XX\0 (l_pobj) convulsions_29\NNS\14081375
D005481_D012640 CID flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375 (r_pobj) on_20\IN\0 (r_prep) effects_14\NNS\13245626 (r_nsubjpass) evaluated_37\VBN\670261 (l_advcl) investigate_1\VB\644583 (l_prep) to_9\TO\0 (l_pobj) induction_11\NN\7450842 (l_compound) seizure_10\NN\14081375
D005481_D012640 CID flurothyl_24\JJ\0 (r_pobj) by_23\IN\0 (r_agent) induced_22\VBN\1627355 (r_acl) convulsions_21\NNS\14081375
D005481_D012640 CID fluorthyl-_12\NNS\0 (l_conj) convulsions_17\NNS\14081375
D005481_D012640 CID fluorthyl-_12\NNS\0 (r_pobj) in_7\IN\13603305 (r_prep) involved_6\VBN\2676054 (l_conj) picrotoxin-_21\XX\0 (l_pobj) convulsions_29\NNS\14081375
16600756
D011453_D053201 NONE prostaglandins_4\NNS\5414534 (r_conj) factor_2\NN\7326557 (l_prep) in_5\IN\13603305 (l_pobj) urine_7\NN\14853947 (l_prep) of_8\IN\0 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) bladder_13\NN\5515670
D011453_D053201 NONE pgs_7\NNS\0 (l_prep) in_8\IN\13603305 (l_pobj) women_9\NNS\9605289 (l_prep) with_10\IN\0 (l_pobj) oab_11\NNP\0
D011453_D053201 NONE pg_8\NNP\0 (r_conj) ngf_6\NNP\14734348 (r_pobj) between_4\IN\0 (r_prep) correlations_3\NNS\13841213 (l_conj) parameters_12\NNS\5858936 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) oab_16\NNP\0
D011453_D053201 NONE pgs_2\NNS\0 (r_conj) ngf_0\NNP\14734348 (r_nsubj) have_3\VBP\7846 (l_dobj) roles_5\NNS\719494 (l_prep) in_6\IN\13603305 (l_pobj) development_8\NN\248977 (l_prep) of_9\IN\0 (l_pobj) symptoms_11\NNS\5823932 (l_compound) oab_10\NNP\0
D011464_D053201 NONE pgi2_3\NNP\0 (r_nsubj) was_4\VBD\0 (l_acomp) different_6\JJ\0 (l_prep) between_7\IN\0 (l_pobj) controls_8\NNS\5190804 (l_prep) with_11\IN\0 (l_pobj) oab_12\NNP\0
D011464_D053201 NONE pgi2_5\NNP\0 (r_conj) pgf2alpha_3\NNP\0 (r_appos) ngf_1\NNP\14734348 (r_nsubj) correlate_8\VB\5857459 (l_prep) with_9\IN\0 (l_pobj) parameters_11\NNS\5858936 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) oab_15\NNP\0
D015232_D053201 CID pge2_3\NNP\0 (r_conj) ngf_1\NNP\14734348 (r_nsubjpass) increased_8\VBN\169651 (l_prep) in_9\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) oab_12\NNP\0
D015232_D053201 CID pge2_5\NNP\0 (l_compound) oab_3\NNP\0
D015237_D053201 CID pgf2alpha_5\NNP\0 (r_conj) pge2_3\NNP\0 (r_conj) ngf_1\NNP\14734348 (r_nsubjpass) increased_8\VBN\169651 (l_prep) in_9\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) oab_12\NNP\0
D015237_D053201 CID pgf2alpha_3\NNP\0 (r_appos) ngf_1\NNP\14734348 (r_nsubj) correlate_8\VB\5857459 (l_prep) with_9\IN\0 (l_pobj) parameters_11\NNS\5858936 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) oab_15\NNP\0
8410199
D010862_D012640 CID pilocarpine_14\NN\14712692 (r_npadvmod) induced_16\VBN\1627355 (r_amod) seizures_17\NNS\14081375
D010862_D012640 CID pilocarpine_8\NN\14712692 (r_pobj) with_7\IN\0 (r_prep) injected_5\VBN\81072 (l_conj) studied_15\VBN\0 (l_conj) intervals_27\NNS\33615 (l_prep) after_28\IN\0 (l_pobj) seizures_32\NNS\14081375
D010862_D012640 CID pilocarpine_29\NN\14712692 (r_npadvmod) induced_31\VBN\1627355 (r_amod) seizures_32\NNS\14081375
D018698_D012640 NONE glutamate_2\NN\15010703 (r_compound) decarboxylase_3\NN\14732946 (r_nmod) neurons_7\NNS\5430628 (r_pobj) of_1\IN\0 (r_prep) loss_0\NN\13252973 (l_prep) following_13\VBG\8180190 (l_pobj) seizures_17\NNS\14081375
D018698_D012640 NONE acid_10\NN\14818238 (r_compound) decarboxylase_11\NN\14732946 (r_nsubj) are_26\VBP\13600404 (l_acomp) vulnerable_27\JJ\0 (l_prep) to_28\IN\0 (l_pobj) damage_32\NN\7296428 (l_amod) induced_31\VBN\1627355 (l_npadvmod) seizure_29\NN\14081375
D018698_D012640 NONE acid_10\NN\14818238 (r_compound) decarboxylase_11\NN\14732946 (r_nsubj) are_26\VBP\13600404 (l_acomp) vulnerable_27\JJ\0 (l_prep) to_28\IN\0 (l_pobj) damage_32\NN\7296428 (l_prep) in_33\IN\13603305 (l_pobj) model_35\NN\5888929 (l_prep) of_36\IN\0 (l_pobj) seizures_38\NNS\14081375
C028911_D009410 NONE violet_6\NN\12387633 (r_compound) staining_7\NN\275424 (l_conj) methods_11\NNS\5616786 (l_compound) degeneration_10\NN\29677
C028911_D009410 NONE violet_6\NN\12387633 (r_compound) staining_7\NN\275424 (r_pobj) including_4\VBG\0 (r_prep) studies_2\NNS\635850 (r_nsubj) suggested_22\VBD\1010118 (l_ccomp) related_36\VBN\628491 (l_prep) to_37\IN\0 (l_pobj) loss_39\NN\13252973
1636026
D014527_D007674 NONE acid_39\NN\14818238 (r_pobj) of_37\IN\0 (r_prep) dl_36\NN\13616054 (r_pobj) of_32\IN\0 (r_prep) addition_31\NN\3081021 (r_pobj) without_29\IN\0 (r_conj) with_27\IN\0 (r_prep) buffer_26\NN\14818238 (r_pobj) with_22\IN\0 (r_prep) perfused_21\VBN\454868 (r_acl) kidney_20\NN\5333259 (r_pobj) in_15\IN\13603305 (r_prep) compared_14\VBN\644583 (l_nsubjpass) effects_3\NNS\13245626 (l_amod) nephrotoxic_2\JJ\0
D013496_D058186 CID suprofen_1\NN\0 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) development_7\NN\248977 (l_prep) of_8\IN\0 (l_pobj) failure_11\NN\66216
D013496_D058186 CID suprofen_3\VB\0 (r_nsubj) causes_4\VBZ\7323922 (l_dobj) declines_6\NNS\13458571 (l_prep) in_7\IN\13603305 (l_pobj) function_9\NN\13783581
D013496_D007674 NONE suprofen_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) mg_10\NN\13717155 (r_nsubjpass) compared_14\VBN\644583 (l_nsubjpass) effects_3\NNS\13245626 (l_amod) nephrotoxic_2\JJ\0
D014527_D058186 NONE acid_21\NN\14818238 (r_pobj) of_19\IN\0 (r_prep) distribution_18\NN\5726596 (r_dobj) altering_15\VBG\692130 (r_pcomp) by_13\IN\0 (r_prep) likely_12\JJ\0 (r_advcl) causes_4\VBZ\7323922 (l_dobj) declines_6\NNS\13458571 (l_prep) in_7\IN\13603305 (l_pobj) function_9\NN\13783581
6637851
D000638_D064420 NONE amiodarone_10\NN\2715941 (r_compound) therapy_11\NN\657604 (r_pobj) of_6\IN\0 (r_prep) toxicity_5\NN\13576101
D000638_D064420 NONE amiodarone_4\NN\2715941 (r_nsubj) is_5\VBZ\0 (r_advcl) causes_25\VBZ\7323922 (l_dobj) toxicity_27\NN\13576101
D000638_D006323 NONE amiodarone_0\NNP\2715941 (r_nsubjpass) administered_2\VBN\2436349 (l_prep) to_3\IN\0 (l_pobj) patients_5\NNS\9898892 (l_conj) arrest_24\NN\88481
D000638_D014693 NONE amiodarone_10\NN\2715941 (r_compound) therapy_11\NN\657604 (r_pobj) of_6\IN\0 (r_prep) toxicity_5\NN\13576101 (r_conj) efficacy_3\NN\5199286 (l_prep) for_12\IN\0 (l_pobj) tachycardia_14\NN\14110674 (l_conj) fibrillation_17\NN\14361664
D000638_D014693 NONE amiodarone_9\NN\2715941 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_dobj) continued_6\VBD\2367363 (l_conj) had_11\VBD\0 (l_dobj) recurrence_13\NN\7342049 (l_prep) of_14\IN\0 (l_pobj) vt_16\NNP\0 (l_conj) fibrillation_19\NN\14361664
D000638_D014693 NONE amiodarone_9\NN\2715941 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_dobj) continued_6\VBD\2367363 (l_conj) had_11\VBD\0 (l_dobj) recurrence_13\NN\7342049 (l_prep) of_14\IN\0 (l_pobj) vt_16\NNP\0 (l_appos) vf_21\NNP\0
D000638_D014693 NONE amiodarone_4\NN\2715941 (r_nsubj) is_5\VBZ\0 (l_prep) in_8\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) vt_15\NNP\0 (l_conj) refractory_18\NN\3673767 (l_compound) vf_17\NNP\0
D000638_D014693 NONE amiodarone_31\NN\2715941 (r_pobj) with_30\IN\0 (r_prep) managed_29\VBN\2524171 (l_nsubjpass) %_19\NN\0 (l_prep) of_20\IN\0 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) vt_23\NNP\0 (l_conj) vf_25\NNP\0
D000638_D017180 NONE amiodarone_10\NN\2715941 (r_compound) therapy_11\NN\657604 (r_pobj) of_6\IN\0 (r_prep) toxicity_5\NN\13576101 (r_conj) efficacy_3\NN\5199286 (l_prep) for_12\IN\0 (l_pobj) tachycardia_14\NN\14110674
D000638_D017180 NONE amiodarone_0\NNP\2715941 (r_nsubjpass) administered_2\VBN\2436349 (l_prep) to_3\IN\0 (l_pobj) patients_5\NNS\9898892 (l_relcl) sustained_8\VBN\2679899 (l_dobj) tachycardia_12\NN\14110674
D000638_D017180 NONE amiodarone_0\NNP\2715941 (r_nsubjpass) administered_2\VBN\2436349 (l_prep) to_3\IN\0 (l_pobj) patients_5\NNS\9898892 (l_relcl) sustained_8\VBN\2679899 (l_dobj) tachycardia_12\NN\14110674 (l_appos) vt_14\NNP\0
D000638_D017180 NONE amiodarone_9\NN\2715941 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_dobj) continued_6\VBD\2367363 (l_conj) had_11\VBD\0 (l_dobj) recurrence_13\NN\7342049 (l_prep) of_14\IN\0 (l_pobj) vt_16\NNP\0
D000638_D017180 NONE amiodarone_17\NN\2715941 (r_pobj) by_15\IN\0 (r_agent) managed_14\VBN\2524171 (r_conj) had_5\VBD\0 (l_dobj) recurrence_8\NN\7342049 (l_prep) of_9\IN\0 (l_pobj) vt_10\NNP\0
D000638_D017180 NONE amiodarone_4\NN\2715941 (r_nsubj) is_5\VBZ\0 (l_prep) in_8\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) vt_15\NNP\0
D000638_D017180 NONE amiodarone_31\NN\2715941 (r_pobj) with_30\IN\0 (r_prep) managed_29\VBN\2524171 (l_nsubjpass) %_19\NN\0 (l_prep) of_20\IN\0 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) vt_23\NNP\0
12734532
D010665_D009202 NONE ppa_7\NNP\0 (r_pobj) of_6\IN\0 (r_prep) abuse_5\NN\418025 (l_prep) with_8\IN\0 (l_pobj) injury_10\NN\14052046
D010665_D009202 NONE dexatrim_7\NNP\0 (r_nmod) injury_11\NN\14052046
D010665_D009202 NONE ppa)-induced_9\VBN\0 (r_amod) injury_11\NN\14052046
D010665_D009202 NONE ppa_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) cases_8\NNS\7283608 (l_acl) related_11\VBN\628491 (l_dobj) injury_13\NN\14052046
D010665_D009203 CID dexatrim_3\NNP\0 (l_prep) as_7\IN\14622893 (l_pobj) cause_9\NN\7323922 (l_prep) of_10\IN\0 (l_pobj) infarction_12\NN\14204950
D010665_D009203 CID phenylpropanolamine_5\NNP\2682038 (r_appos) dexatrim_3\NNP\0 (l_prep) as_7\IN\14622893 (l_pobj) cause_9\NN\7323922 (l_prep) of_10\IN\0 (l_pobj) infarction_12\NN\14204950
D010665_D062787 NONE ppa_7\NNP\0 (r_pobj) of_6\IN\0 (r_prep) abuse_5\NN\418025 (r_dobj) linked_3\VBN\628491 (l_advcl) involved_16\VBN\2676054 (l_nsubjpass) overdose_14\NN\84738
3535719
D014031_D064420 NONE tobramycin_7\JJ\2716866 (l_nsubj) efficacy_1\NN\5199286 (l_conj) toxicity_3\NN\13576101
D009428_D007239 NONE sulfate_9\NN\15010703 (r_pobj) of_7\IN\0 (r_prep) efficacy_4\NN\5199286 (r_dobj) compared_2\VBD\644583 (l_prep) in_13\IN\13603305 (l_pobj) conjunction_14\NN\5048123 (l_prep) in_18\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) infections_25\NNS\14052046
D010878_D006311 CID piperacillin_12\VB\3910033 (r_conj) netilmicin_10\NNS\0 (r_pobj) of_8\IN\0 (r_prep) %_6\NN\0 (r_pobj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) ototoxicity_0\NN\0
D010878_D006311 CID piperacillin_24\NN\3910033 (r_npadvmod) treated_26\VBN\2376958 (r_amod) patients_27\NNS\9898892 (r_conj) tobramycin_22\NNS\2716866 (r_pobj) of_20\IN\0 (r_prep) %_18\NN\0 (r_pobj) in_14\IN\13603305 (r_conj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) ototoxicity_0\NN\0
D014031_D006311 CID tobramycin_22\NNS\2716866 (r_pobj) of_20\IN\0 (r_prep) %_18\NN\0 (r_pobj) in_14\IN\13603305 (r_conj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) ototoxicity_0\NN\0
D014031_D006311 CID tobramycin_18\NNS\2716866 (r_pobj) with_17\IN\0 (r_prep) than_16\IN\0 (r_prep) reversible_13\JJ\3419014 (r_conj) severe_9\JJ\0 (r_acomp) was_7\VBD\0 (l_nsubj) ototoxicity_6\NN\0
D009428_D006311 CID netilmicin_10\NNS\0 (r_pobj) of_8\IN\0 (r_prep) %_6\NN\0 (r_pobj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) ototoxicity_0\NN\0
D009428_D006311 CID netilmicin_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) reversible_13\JJ\3419014 (r_conj) severe_9\JJ\0 (r_acomp) was_7\VBD\0 (l_nsubj) ototoxicity_6\NN\0
D009428_D007674 CID netilmicin_10\NNS\0 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) patients_7\NNS\9898892 (r_pobj) in_6\IN\13603305 (r_prep) proportion_5\NN\13824815 (r_pobj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) nephrotoxicity_0\NN\0
D000617_D006311 NONE aminoglycoside_3\NN\0 (r_npadvmod) associated_5\VBN\628491 (r_amod) ototoxicity_6\NN\0
D010878_D007239 NONE sodium_17\NN\14625458 (r_pobj) with_15\IN\0 (r_prep) conjunction_14\NN\5048123 (l_prep) in_18\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) infections_25\NNS\14052046
D014031_D007674 CID tobramycin_12\JJ\2716866 (r_conj) netilmicin_10\NNS\0 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) patients_7\NNS\9898892 (r_pobj) in_6\IN\13603305 (r_prep) proportion_5\NN\13824815 (r_pobj) in_2\IN\13603305 (r_prep) occurred_1\VBD\0 (l_nsubj) nephrotoxicity_0\NN\0
D009428_D064420 NONE netilmicin_5\NNS\0 (r_pobj) of_4\IN\0 (r_prep) toxicity_3\NN\13576101
D014031_D007239 NONE sulfate_12\NN\15010703 (r_conj) sulfate_9\NN\15010703 (r_pobj) of_7\IN\0 (r_prep) efficacy_4\NN\5199286 (r_dobj) compared_2\VBD\644583 (l_prep) in_13\IN\13603305 (l_pobj) conjunction_14\NN\5048123 (l_prep) in_18\IN\13603305 (l_pobj) patients_21\NNS\9898892 (l_prep) with_22\IN\0 (l_pobj) infections_25\NNS\14052046
6115999
D011433_D003316 NONE propranolol_10\NN\0 (r_amod) group_11\NN\2137 (r_pobj) in_8\IN\13603305 (r_prep) occurred_7\VBN\0 (r_xcomp) known_4\VBN\0 (l_nsubjpass) disease_2\NN\14061805
D011433_D011928 CID propranolol_37\NN\0 (r_dobj) taking_36\VBG\37396 (r_acl) men_33\NNS\8208016 (r_pobj) in_32\IN\13603305 (r_prep) phenomenon_29\NN\29677
D001539_D007172 CID bendrofluazide_6\JJ\0 (r_amod) treatment_7\NN\654885 (l_conj) impotence_9\NN\4723816
D001539_D007172 CID bendrofluazide_6\JJ\0 (r_amod) treatment_7\NN\654885 (r_pobj) between_5\IN\0 (r_prep) association_4\NN\8008335 (r_dobj) show_2\VBP\429048 (l_conj) occurred_14\VBD\0 (l_nsubj) impotence_12\NN\4723816
D001539_D006973 NONE bendrofluazide_3\VB\0 (l_conj) propranolol_5\NN\0 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) hypertension_11\NN\14057371
D001539_D006973 NONE bendrofluazide_21\NN\0 (r_amod) groups_19\NNS\2137 (r_pobj) of_16\IN\0 (r_prep) one_15\CD\13741022 (r_pobj) to_14\IN\0 (r_prep) allocated_13\VBN\2228698 (l_nsubjpass) participants_0\NNS\9816771 (l_prep) in_1\IN\13603305 (l_pobj) trial_7\NN\786195 (l_prep) for_8\IN\0 (l_pobj) hypertension_10\NN\14057371
D001539_D018149 CID bendrofluazide_23\NN\0 (r_amod) treatment_24\NN\654885 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_acl) tolerance_11\NN\5032565
D001539_D004417 NONE bendrofluazide_23\NN\0 (r_amod) treatment_24\NN\654885 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_acl) tolerance_11\NN\5032565 (l_conj) phenomenon_29\NN\29677 (l_conj) dyspnoea_31\NN\14299637
D001539_D011928 NONE bendrofluazide_23\NN\0 (r_amod) treatment_24\NN\654885 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_acl) tolerance_11\NN\5032565 (l_conj) phenomenon_29\NN\29677
D011433_D004417 CID propranolol_37\NN\0 (r_dobj) taking_36\VBG\37396 (r_acl) men_33\NNS\8208016 (r_pobj) in_32\IN\13603305 (r_prep) phenomenon_29\NN\29677 (l_conj) dyspnoea_31\NN\14299637
D011433_D007172 CID propranolol_20\RB\0 (r_dobj) taking_19\VBG\37396 (r_acl) patients_18\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) occurred_14\VBD\0 (r_conj) show_2\VBP\429048 (l_dobj) association_4\NN\8008335 (l_prep) between_5\IN\0 (l_pobj) treatment_7\NN\654885 (l_conj) impotence_9\NN\4723816
D011433_D007172 CID propranolol_20\RB\0 (r_dobj) taking_19\VBG\37396 (r_acl) patients_18\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) occurred_14\VBD\0 (l_nsubj) impotence_12\NN\4723816
D011433_D006973 NONE propranolol_5\NN\0 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) hypertension_11\NN\14057371
D011433_D006973 NONE propranolol_23\NN\0 (r_conj) bendrofluazide_21\NN\0 (r_amod) groups_19\NNS\2137 (r_pobj) of_16\IN\0 (r_prep) one_15\CD\13741022 (r_pobj) to_14\IN\0 (r_prep) allocated_13\VBN\2228698 (l_nsubjpass) participants_0\NNS\9816771 (l_prep) in_1\IN\13603305 (l_pobj) trial_7\NN\786195 (l_prep) for_8\IN\0 (l_pobj) hypertension_10\NN\14057371
D001539_D006073 CID bendrofluazide_23\NN\0 (r_amod) treatment_24\NN\654885 (r_pobj) with_22\IN\0 (r_prep) associated_21\VBN\628491 (r_acl) tolerance_11\NN\5032565 (l_prep) in_12\IN\13603305 (l_pobj) men_13\NNS\8208016 (l_conj) women_15\NNS\9605289 (l_conj) gout_17\NN\14186541
D011433_D018149 NONE propranolol_37\NN\0 (r_dobj) taking_36\VBG\37396 (r_acl) men_33\NNS\8208016 (r_pobj) in_32\IN\13603305 (r_prep) phenomenon_29\NN\29677 (r_conj) tolerance_11\NN\5032565
D011433_D006073 NONE propranolol_37\NN\0 (r_dobj) taking_36\VBG\37396 (r_acl) men_33\NNS\8208016 (r_pobj) in_32\IN\13603305 (r_prep) phenomenon_29\NN\29677 (r_conj) tolerance_11\NN\5032565 (l_prep) in_12\IN\13603305 (l_pobj) men_13\NNS\8208016 (l_conj) women_15\NNS\9605289 (l_conj) gout_17\NN\14186541
11847945
D007530_D056486 CID isoflurane_6\RB\3570838 (r_pobj) to_5\IN\0 (r_prep) exposure_4\NN\5042871 (r_pobj) after_3\IN\0 (r_prep) hepatitis_2\NN\14127211
D007530_D056486 CID isoflurane_14\RB\3570838 (r_pobj) to_10\IN\0 (r_prep) exposure_9\NN\5042871 (r_pobj) following_8\VBG\8180190 (r_prep) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) hepatitis_7\NN\14127211
D007530_D056486 CID isoflurane_0\NNP\3570838 (r_nsubj) cause_8\VB\7323922 (l_dobj) hepatitis_11\NN\14127211
D004177_D000699 NONE dipyrone_7\NN\0 (l_prep) for_8\IN\0 (l_pobj) analgesia_9\NN\14034177
D007530_D002779 CID isoflurane_6\RB\3570838 (r_pobj) to_5\IN\0 (r_prep) exposure_4\NN\5042871 (r_pobj) after_3\IN\0 (r_prep) hepatitis_2\NN\14127211
D007530_D002779 CID isoflurane_14\RB\3570838 (r_pobj) to_10\IN\0 (r_prep) exposure_9\NN\5042871 (r_pobj) following_8\VBG\8180190 (r_prep) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) hepatitis_7\NN\14127211
D007530_D002779 CID isoflurane_0\NNP\3570838 (r_nsubj) cause_8\VB\7323922 (l_dobj) hepatitis_11\NN\14127211
12013711
D018967_D001480 NONE risperidone_26\NN\0 (r_pobj) with_25\IN\0 (r_prep) treated_24\VBN\2376958 (l_nsubjpass) patients_2\NNS\9898892 (l_relcl) had_5\VBD\0 (l_conj) developed_16\VBN\1753788 (l_dobj) eps_17\NNP\0
D008238_D010468 NONE lsd_16\NNP\3097890 (r_compound) abuse_17\NN\418025 (r_pobj) of_15\IN\0 (r_prep) history_14\NN\15120823 (r_pobj) with_11\IN\0 (r_prep) disturbances_7\NNS\407535
D008238_D010468 NONE lsd_14\NNP\3097890 (r_compound) consumption_15\NN\13440063 (r_pobj) to_12\IN\0 (r_prep) related_11\VBN\628491 (r_acl) flashbacks_9\NNS\6401328 (r_pobj) as_7\IN\14622893 (r_prep) experienced_6\VBN\2108377 (r_acl) disturbances_4\NNS\407535
D018967_D012559 NONE risperidone_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) disturbances_7\NNS\407535 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_amod) schizophrenic_9\JJ\10490141
D018967_D012559 NONE risperidone_26\NN\0 (r_pobj) with_25\IN\0 (r_prep) treated_24\VBN\2376958 (l_nsubjpass) patients_2\NNS\9898892 (l_amod) schizophrenic_1\JJ\10490141
D008238_D001480 NONE lsd_10\NNP\3097890 (r_compound) abuse_11\NN\418025 (r_pobj) of_9\IN\0 (r_prep) history_8\NN\15120823 (r_dobj) had_5\VBD\0 (l_conj) developed_16\VBN\1753788 (l_dobj) eps_17\NNP\0
D008238_D012559 NONE lsd_16\NNP\3097890 (r_compound) abuse_17\NN\418025 (r_pobj) of_15\IN\0 (r_prep) history_14\NN\15120823 (r_pobj) with_11\IN\0 (r_prep) disturbances_7\NNS\407535 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_amod) schizophrenic_9\JJ\10490141
D008238_D012559 NONE lsd_10\NNP\3097890 (r_compound) abuse_11\NN\418025 (r_pobj) of_9\IN\0 (r_prep) history_8\NN\15120823 (r_dobj) had_5\VBD\0 (r_relcl) patients_2\NNS\9898892 (l_amod) schizophrenic_1\JJ\10490141
D018967_D010468 CID risperidone_0\NNP\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) disturbances_7\NNS\407535
D018967_D010468 CID risperidone_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) treatment_15\NN\654885 (r_dobj) starting_14\VBG\457382 (r_pcomp) after_13\IN\0 (r_prep) appeared_11\VBD\2604760 (r_relcl) disturbances_8\NNS\407535
D018967_D010468 CID risperidone_0\NNP\0 (r_compound) administration_1\NN\1133281 (r_nsubjpass) continued_3\VBN\2367363 (l_conj) wore_9\VBD\0 (l_nsubj) disturbances_7\NNS\407535
19923525
D009553_D008569 NONE nimodipine_0\NNP\0 (r_nsubj) prevents_1\VBZ\0 (l_dobj) impairment_3\NN\7296428
D002118_D007022 NONE calcium_13\NN\14625458 (r_compound) homeostasis_14\NN\13934900 (r_pobj) of_12\IN\0 (r_prep) preservation_11\NN\817680 (l_prep) during_15\IN\0 (l_pobj) hypotension_16\NN\14057371
D005996_D008569 CID nitroglycerin_6\NN\15015501 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypotension_9\NN\14057371 (r_pobj) by_5\IN\0 (r_agent) caused_4\VBN\1617192 (r_acl) impairment_3\NN\7296428
D009553_D007022 NONE nimodipine_0\NNP\0 (r_nsubj) prevents_1\VBZ\0 (l_dobj) impairment_3\NN\7296428 (l_acl) caused_4\VBN\1617192 (l_agent) by_5\IN\0 (l_pobj) hypotension_9\NN\14057371
D009553_D007022 NONE nimodipine_5\NN\0 (r_nsubj) administered_9\VBN\2436349 (r_acl) hypothesis_3\NN\7162194 (r_dobj) tested_1\VBD\670261 (r_ccomp) preserve_19\VB\14514039 (l_nsubj) hypotension_17\NN\14057371
D009553_D007022 NONE nimo_7\NNP\0 (r_appos) nimodipine_5\NN\0 (r_nsubj) administered_9\VBN\2436349 (r_acl) hypothesis_3\NN\7162194 (r_dobj) tested_1\VBD\670261 (r_ccomp) preserve_19\VB\14514039 (l_nsubj) hypotension_17\NN\14057371
D009553_D007022 NONE nimo_27\NN\0 (r_conj) ntg_25\NNP\0 (r_appos) saline_23\NN\14849367 (r_pobj) with_22\IN\0 (r_prep) injected_21\VBN\81072 (r_acl) those_20\DT\0 (r_pobj) with_19\IN\0 (r_prep) compared_18\VBN\644583 (r_prep) showed_5\VBD\2137132 (r_conj) subjected_1\VBN\137313 (l_prep) to_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) hypotensive_3\JJ\10405694
D009553_D007022 NONE nimo_0\NN\0 (r_advmod) attenuated_1\VBD\224901 (l_conj) improve_17\VB\126264 (l_prep) in_19\IN\13603305 (l_pobj) absence_21\NN\14449405 (l_prep) of_22\IN\0 (l_pobj) hypotension_23\NN\14057371
D009553_D007022 NONE nimo_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubj) been_7\VBN\0 (l_acomp) attributable_8\JJ\0 (l_prep) to_9\IN\0 (l_pobj) preservation_11\NN\817680 (l_prep) during_15\IN\0 (l_pobj) hypotension_16\NN\14057371
D005996_D007022 CID nitroglycerin_6\NN\15015501 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypotension_9\NN\14057371
D005996_D007022 CID nitroglycerin_14\NN\15015501 (r_pobj) of_13\IN\0 (r_prep) onset_12\NN\7325190 (r_pobj) at_10\IN\14622893 (r_prep) administered_9\VBN\2436349 (r_acl) hypothesis_3\NN\7162194 (r_dobj) tested_1\VBD\670261 (r_ccomp) preserve_19\VB\14514039 (l_nsubj) hypotension_17\NN\14057371
D005996_D007022 CID ntg)-induced_16\JJ\0 (r_amod) hypotension_17\NN\14057371
D005996_D007022 CID ntg_25\NNP\0 (r_appos) saline_23\NN\14849367 (r_pobj) with_22\IN\0 (r_prep) injected_21\VBN\81072 (r_acl) those_20\DT\0 (r_pobj) with_19\IN\0 (r_prep) compared_18\VBN\644583 (r_prep) showed_5\VBD\2137132 (r_conj) subjected_1\VBN\137313 (l_prep) to_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) hypotensive_3\JJ\10405694
D005996_D007022 CID ntg_31\NNP\0 (r_dobj) delayed_30\VBN\439958 (r_conj) showed_5\VBD\2137132 (r_conj) subjected_1\VBN\137313 (l_prep) to_2\IN\0 (l_pobj) episodes_4\NNS\7283608 (l_amod) hypotensive_3\JJ\10405694
D005996_D007022 CID ntg_9\NNP\0 (r_pobj) of_8\IN\0 (r_prep) injection_7\NN\320852 (r_nsubj) produced_13\VBD\1617192 (l_conj) had_30\VBD\0 (l_advcl) delayed_27\VBN\439958 (l_dobj) hypotension_29\NN\14057371
D005996_D007022 CID ntg_13\NNP\0 (r_pobj) by_12\IN\0 (r_agent) caused_11\VBN\1617192 (r_acl) memory_10\NN\5926676 (r_pobj) of_6\IN\0 (r_prep) consolidation_5\NN\7373803 (r_pobj) in_4\IN\13603305 (r_prep) disruption_3\NN\1066163 (r_dobj) attenuated_1\VBD\224901 (l_conj) improve_17\VB\126264 (l_prep) in_19\IN\13603305 (l_pobj) absence_21\NN\14449405 (l_prep) of_22\IN\0 (l_pobj) hypotension_23\NN\14057371
6436733
D000641_D006970 CID ammonia_0\NN\14940386 (r_nsubj) was_4\VBD\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_relcl) complained_14\VBD\0 (l_prep) of_15\IN\0 (l_pobj) drowsiness_16\NN\14015731
D000641_D006970 CID nh3_2\NNP\0 (r_appos) ammonia_0\NN\14940386 (r_nsubj) was_4\VBD\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_relcl) complained_14\VBD\0 (l_prep) of_15\IN\0 (l_pobj) drowsiness_16\NN\14015731
D014635_D006970 CID vpa_35\NNP\0 (r_compound) levels_37\NNS\4916342 (r_nsubj) were_38\VBD\0 (r_advcl) was_4\VBD\0 (l_prep) in_6\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_relcl) complained_14\VBD\0 (l_prep) of_15\IN\0 (l_pobj) drowsiness_16\NN\14015731
D014635_D004827 NONE acid_1\NN\14818238 (r_nsubjpass) given_6\VBN\5892096 (l_dative) to_7\IN\0 (l_pobj) patients_10\NNS\9898892 (l_amod) epileptic_9\JJ\10595647
D014635_D004827 NONE vpa_3\NNP\0 (r_appos) acid_1\NN\14818238 (r_nsubjpass) given_6\VBN\5892096 (l_dative) to_7\IN\0 (l_pobj) patients_10\NNS\9898892 (l_amod) epileptic_9\JJ\10595647
20533999
D004298_D020258 NONE dopamine_0\NN\14807737 (r_nsubj) is_1\VBZ\0 (l_acomp) essential_3\JJ\2452 (l_prep) for_4\IN\0 (l_pobj) development_6\NN\248977 (l_prep) of_7\IN\0 (l_pobj) neurotoxicity_11\NN\0
D004298_D020258 NONE da_29\NNP\10484858 (r_compound) neurotoxicity_30\NN\0
D004298_D020258 NONE da_13\NN\10484858 (r_pobj) in_11\IN\13603305 (r_prep) deficient_10\JJ\0 (r_acomp) be_9\VB\14625458 (r_xcomp) engineered_7\VBN\1639714 (l_conj) develop_14\VBP\1753788 (l_dobj) neurotoxicity_16\NN\0
D004298_D020258 NONE da_7\NNP\10484858 (r_nsubj) is_8\VBZ\0 (l_acomp) essential_10\JJ\2452 (l_prep) for_11\IN\0 (l_pobj) development_13\NN\248977 (l_prep) of_14\IN\0 (l_pobj) neurotoxicity_19\NN\0
D004298_D020258 NONE da_26\JJ\10484858 (r_pobj) of_25\IN\0 (r_prep) independent_24\JJ\9619824 (r_amod) mechanisms_23\NNS\13446390 (r_nsubj) warrant_27\NN\6552984 (r_ccomp) suggest_21\VBP\1010118 (r_conj) is_8\VBZ\0 (l_acomp) essential_10\JJ\2452 (l_prep) for_11\IN\0 (l_pobj) development_13\NN\248977 (l_prep) of_14\IN\0 (l_pobj) neurotoxicity_19\NN\0
D004298_D009461 NONE da_13\NNP\10484858 (r_compound) deficits_14\NNS\5113133 (r_dobj) have_10\VB\7846 (r_xcomp) engineered_8\VBN\1639714 (l_conj) develop_15\VBP\1753788 (l_dobj) deficits_20\NNS\5113133
D019805_D020258 NONE tyrosine_24\NN\14601829 (l_prep) on_25\IN\0 (l_pobj) neurotoxicity_30\NN\0
D008694_D020258 CID methamphetamine_8\NN\2704153 (r_npadvmod) induced_10\VBN\1627355 (r_amod) neurotoxicity_11\NN\0
D008694_D020258 CID meth_26\NNP\2704153 (r_npadvmod) induced_28\VBN\1627355 (r_amod) neurotoxicity_30\NN\0
D008694_D020258 CID meth_15\NNP\2704153 (r_compound) neurotoxicity_16\NN\0
D008694_D020258 CID meth_25\NNP\2704153 (r_pobj) of_24\IN\0 (r_prep) effects_23\NNS\13245626 (r_nsubjpass) preserved_27\VBN\2681795 (r_advcl) long_19\RB\1825237 (r_advmod) develop_14\VBP\1753788 (l_dobj) neurotoxicity_16\NN\0
D008694_D020258 CID meth_15\NNP\2704153 (r_npadvmod) induced_17\VBN\1627355 (r_amod) neurotoxicity_19\NN\0
D007980_D020258 NONE dihydroxyphenylalanine_11\NN\14601829 (r_pobj) of_8\IN\0 (r_prep) ability_7\NN\4723816 (l_acl) reverse_13\VB\13854649 (l_dobj) effect_16\NN\34213 (l_prep) of_17\IN\0 (l_pobj) tyrosine_24\NN\14601829 (l_prep) on_25\IN\0 (l_pobj) neurotoxicity_30\NN\0
D008694_D009461 NONE meth_16\NN\2704153 (r_npadvmod) induced_18\VBN\1627355 (r_amod) deficits_20\NNS\5113133
D004298_D064420 NONE dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_dobj) methamphetamine_10\NN\2704153 (l_acl) meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D004298_D064420 NONE dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D004298_D064420 NONE dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_advcl) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
D004298_D064420 NONE da_7\NNP\10484858 (r_appos) dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_dobj) methamphetamine_10\NN\2704153 (l_acl) meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D004298_D064420 NONE da_7\NNP\10484858 (r_appos) dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D004298_D064420 NONE da_7\NNP\10484858 (r_appos) dopamine_5\NN\14807737 (r_nsubj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_advcl) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
D004298_D064420 NONE da_24\NNP\10484858 (r_compound) neurotransmission_25\NN\0 (r_pobj) with_23\IN\0 (r_prep) interfere_22\VBP\2451370 (r_relcl) drugs_20\NNS\14778436 (r_nsubj) decrease_26\NN\7296428 (r_advcl) mediates_9\VBZ\761713 (l_dobj) methamphetamine_10\NN\2704153 (l_acl) meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D004298_D064420 NONE da_24\NNP\10484858 (r_compound) neurotransmission_25\NN\0 (r_pobj) with_23\IN\0 (r_prep) interfere_22\VBP\2451370 (r_relcl) drugs_20\NNS\14778436 (r_nsubj) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D004298_D064420 NONE da_24\NNP\10484858 (r_compound) neurotransmission_25\NN\0 (r_pobj) with_23\IN\0 (r_prep) interfere_22\VBP\2451370 (r_relcl) drugs_20\NNS\14778436 (r_nsubj) decrease_26\NN\7296428 (l_advcl) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
D004298_D064420 NONE da_33\NNP\10484858 (r_compound) neurotransmission_34\NN\0 (r_dobj) increase_32\VBP\13576355 (r_relcl) drugs_30\NNS\14778436 (r_nsubj) enhance_35\VB\227165 (r_advcl) decrease_26\NN\7296428 (r_advcl) mediates_9\VBZ\761713 (l_dobj) methamphetamine_10\NN\2704153 (l_acl) meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D004298_D064420 NONE da_33\NNP\10484858 (r_compound) neurotransmission_34\NN\0 (r_dobj) increase_32\VBP\13576355 (r_relcl) drugs_30\NNS\14778436 (r_nsubj) enhance_35\VB\227165 (r_advcl) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D004298_D064420 NONE da_33\NNP\10484858 (r_compound) neurotransmission_34\NN\0 (r_dobj) increase_32\VBP\13576355 (r_relcl) drugs_30\NNS\14778436 (r_nsubj) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
D008694_D064420 NONE methamphetamine_10\NN\2704153 (l_acl) meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D008694_D064420 NONE methamphetamine_10\NN\2704153 (r_dobj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D008694_D064420 NONE methamphetamine_10\NN\2704153 (r_dobj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_advcl) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
D008694_D064420 NONE meth)-induced_12\JJ\0 (l_dobj) toxicity_13\NN\13576101
D008694_D064420 NONE meth)-induced_12\JJ\0 (r_acl) methamphetamine_10\NN\2704153 (r_dobj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_dobj) toxicity_27\NN\13576101
D008694_D064420 NONE meth)-induced_12\JJ\0 (r_acl) methamphetamine_10\NN\2704153 (r_dobj) mediates_9\VBZ\761713 (l_advcl) decrease_26\NN\7296428 (l_advcl) enhance_35\VB\227165 (l_dobj) toxicity_36\NN\13576101
15517007
D018943_D006331 NONE anthracyclines_8\NNS\0 (r_conj) cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) damage_21\NN\7296428
D008942_D012595 NONE mitoxantrone_11\NN\0 (r_pobj) as_10\IN\14622893 (r_prep) anthracyclines_8\NNS\0 (r_conj) cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_dobj) patients_28\NNS\9898892 (l_compound) sclerosis_27\NN\14204950
D003520_D006331 CID cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) damage_21\NN\7296428
D018943_D012595 NONE anthracyclines_8\NNS\0 (r_conj) cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_dobj) patients_28\NNS\9898892 (l_compound) sclerosis_27\NN\14204950
D008942_D006331 CID mitoxantrone_11\NN\0 (r_pobj) as_10\IN\14622893 (r_prep) anthracyclines_8\NNS\0 (r_conj) cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) damage_21\NN\7296428
D003520_D012595 NONE cyclophosphamide_6\NN\0 (r_nsubjpass) used_13\VBN\0 (l_dobj) patients_28\NNS\9898892 (l_compound) sclerosis_27\NN\14204950
16157917
C047781_C562694 NONE lamotrigine_0\NNP\0 (l_acl) associated_1\VBD\628491 (l_prep) with_2\IN\0 (l_pobj) exacerbation_3\NN\374224 (l_prep) in_8\IN\13603305 (l_pobj) epilepsies_11\NNS\14085708
C047781_C562694 NONE lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) epilepsies_5\NNS\14085708
C047781_C562694 NONE lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) epilepsies_5\NNS\14085708 (l_appos) ige_7\NNP\15030481
C047781_C562694 NONE ltg_13\NNP\0 (r_appos) lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) epilepsies_5\NNS\14085708
C047781_C562694 NONE ltg_13\NNP\0 (r_appos) lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) epilepsies_5\NNS\14085708 (l_appos) ige_7\NNP\15030481
C047781_D009207 CID lamotrigine_0\NNP\0 (l_acl) associated_1\VBD\628491 (l_prep) with_2\IN\0 (l_pobj) exacerbation_3\NN\374224 (l_conj) myoclonus_7\NN\14360459
C047781_D009207 CID lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_advcl) experienced_15\VBD\2108377 (l_dobj) exacerbation_16\NN\374224 (l_conj) appearance_20\NN\4723816 (l_prep) of_21\IN\0 (l_pobj) jerks_23\NNS\10322238
C047781_D009207 CID lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_advcl) experienced_15\VBD\2108377 (l_dobj) exacerbation_16\NN\374224 (l_conj) appearance_20\NN\4723816 (l_prep) of_21\IN\0 (l_pobj) jerks_23\NNS\10322238 (l_appos) mj_25\NNP\0
C047781_D009207 CID ltg_13\NNP\0 (r_appos) lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_advcl) experienced_15\VBD\2108377 (l_dobj) exacerbation_16\NN\374224 (l_conj) appearance_20\NN\4723816 (l_prep) of_21\IN\0 (l_pobj) jerks_23\NNS\10322238
C047781_D009207 CID ltg_13\NNP\0 (r_appos) lamotrigine_11\NNP\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_advcl) experienced_15\VBD\2108377 (l_dobj) exacerbation_16\NN\374224 (l_conj) appearance_20\NN\4723816 (l_prep) of_21\IN\0 (l_pobj) jerks_23\NNS\10322238 (l_appos) mj_25\NNP\0
C047781_D009207 CID ltg_4\NNP\0 (r_nsubj) exacerbated_5\VBD\126264 (l_dobj) mj_6\NNP\0
C047781_D009207 CID ltg_3\NNP\0 (r_compound) dose_4\NN\3740161 (r_nsubjpass) decreased_6\VBN\169651 (r_advcl) disappeared_1\VBD\0 (l_nsubj) mj_0\NNP\0
C047781_D009207 CID ltg_4\NNP\0 (r_nsubj) exacerbated_5\VBD\126264 (l_prep) with_15\IN\0 (l_pobj) status_17\NN\24720
C047781_D009207 CID ltg_22\NNP\0 (r_compound) withdrawal_23\NN\7206096 (r_pobj) after_21\IN\0 (r_prep) ceased_20\VBD\0 (r_relcl) status_17\NN\24720 (r_pobj) with_15\IN\0 (r_prep) exacerbated_5\VBD\126264 (l_dobj) mj_6\NNP\0
C047781_D009207 CID ltg_22\NNP\0 (r_compound) withdrawal_23\NN\7206096 (r_pobj) after_21\IN\0 (r_prep) ceased_20\VBD\0 (r_relcl) status_17\NN\24720
12911170
D002939_D000744 NONE ciprofloxacin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) nephritis_5\NN\14113228 (l_conj) anemia_9\NN\14189204
D002939_D000744 NONE ciprofloxacin_9\NNS\2716866 (r_npadvmod) induced_11\VBN\1627355 (r_amod) nephritis_13\NN\14113228 (l_conj) anemia_17\NN\14189204
D002939_D000743 CID ciprofloxacin_0\NNP\2716866 (r_nsubjpass) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) effects_7\NNS\13245626 (l_prep) including_8\VBG\0 (l_pobj) nephritis_10\NN\14113228 (l_conj) anemia_13\NN\14189204
D002939_D009395 CID ciprofloxacin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) nephritis_5\NN\14113228
D002939_D009395 CID ciprofloxacin_0\NNP\2716866 (r_nsubjpass) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) effects_7\NNS\13245626 (l_prep) including_8\VBG\0 (l_pobj) nephritis_10\NN\14113228
D002939_D009395 CID ciprofloxacin_9\NNS\2716866 (r_npadvmod) induced_11\VBN\1627355 (r_amod) nephritis_13\NN\14113228
D013256_D000743 NONE steroid_10\NN\14727670 (r_compound) therapy_11\NN\657604 (r_pobj) of_9\IN\0 (r_prep) initiation_8\NN\7450842 (r_conj) drug_6\NN\14778436 (r_dobj) stopping_4\VBG\3323703 (r_pcomp) after_3\IN\0 (r_prep) improved_2\VBD\126264 (l_nsubj) anemia_1\NN\14189204
2886572
D004837_D006973 CID epinephrine_7\NN\14807929 (r_npadvmod) induced_9\VBN\1627355 (r_amod) rats_11\NNS\2329401 (l_amod) hypertensive_10\JJ\10405694
2322844
D015232_D006930 CID e2_1\NNP\0 (r_nsubj) showed_2\VBD\2137132 (l_dobj) effect_5\NN\34213 (l_amod) hyperalgesic_4\JJ\0
D015232_D006930 CID e2-induced_3\NNP\0 (r_amod) hyperalgesia_4\NN\0
D015232_D006930 CID e2_9\NNP\0 (r_conj) d2_6\NN\0 (r_nsubj) exert_10\VBP\1158872 (l_dobj) hyperalgesia_11\NN\0
C053876_D006930 NONE ah6809_28\NN\0 (r_pobj) by_27\IN\0 (r_agent) blocked_7\VBN\1476483 (l_nsubjpass) effect_2\NN\34213 (l_amod) hyperalgesic_1\JJ\0
C053876_D006930 NONE ah6809_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) blocked_6\VBN\1476483 (l_nsubjpass) hyperalgesia_4\NN\0
D011453_D006930 NONE pg_10\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) at_6\IN\14622893 (r_prep) effect_5\NN\34213 (l_amod) hyperalgesic_4\JJ\0
D015237_D010146 NONE alpha_2\NN\6828818 (r_nsubj) had_3\VBD\0 (l_dobj) effect_5\NN\34213 (l_prep) on_6\IN\0 (l_pobj) responses_8\NNS\11410625 (l_compound) pain_7\NN\14299637
D019342_D010146 NONE acid_21\NN\14818238 (r_conj) plate_18\NN\2797881 (r_dobj) using_16\VBG\418025 (r_pcomp) by_15\IN\0 (r_prep) evaluated_14\VBN\670261 (l_nsubjpass) effects_1\NNS\13245626 (l_prep) on_7\IN\0 (l_pobj) responses_9\NNS\11410625 (l_compound) pain_8\NN\14299637
D011453_D010146 NONE prostaglandins_6\NNS\5414534 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) on_7\IN\0 (l_pobj) responses_9\NNS\11410625 (l_compound) pain_8\NN\14299637
D015230_D006930 CID d2_1\NN\0 (r_nsubj) had_10\VBD\0 (l_dobj) action_13\NN\30358 (l_amod) hyperalgesic_12\JJ\0
D015230_D006930 CID d2_32\NN\0 (r_pobj) of_30\IN\0 (r_prep) that_29\DT\0 (r_pobj) than_28\IN\0 (r_prep) min_26\NN\15154774 (r_dobj) lasted_20\VBD\2704349 (r_conj) showed_2\VBD\2137132 (l_dobj) effect_5\NN\34213 (l_amod) hyperalgesic_4\JJ\0
D015230_D006930 CID d2_5\NN\0 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_amod) hyperalgesic_1\JJ\0
D015230_D006930 CID d2_6\NN\0 (r_nsubj) exert_10\VBP\1158872 (l_dobj) hyperalgesia_11\NN\0
6150641
D002927_D006402 NONE cimetidine_5\NN\14778019 (r_pobj) of_4\IN\0 (r_prep) doses_3\NNS\3740161 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubjpass) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D002927_D006402 NONE cimetidine_60\NN\14778019 (r_compound) therapy_61\NN\657604 (r_pobj) with_59\IN\0 (r_prep) seen_58\VBN\2106506 (r_advcl) level_56\NN\4916342 (r_pobj) with_50\IN\0 (r_prep) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D002927_D007172 CID cimetidine_12\NN\14778019 (r_dobj) taking_11\VBG\37396 (r_advcl) developed_5\VBD\1753788 (l_dobj) changes_7\NNS\7283608 (l_conj) impotence_9\NN\4723816
D002927_D007172 CID cimetidine_21\NN\14778019 (r_nsubjpass) replaced_23\VBN\1631072 (r_advcl) disappeared_19\VBD\0 (r_conj) taking_11\VBG\37396 (r_advcl) developed_5\VBD\1753788 (l_dobj) changes_7\NNS\7283608 (l_conj) impotence_9\NN\4723816
D002927_D056486 NONE cimetidine_5\NN\14778019 (r_pobj) of_4\IN\0 (r_prep) doses_3\NNS\3740161 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubjpass) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D002927_D056486 NONE cimetidine_60\NN\14778019 (r_compound) therapy_61\NN\657604 (r_pobj) with_59\IN\0 (r_prep) seen_58\VBN\2106506 (r_advcl) level_56\NN\4916342 (r_pobj) with_50\IN\0 (r_prep) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D003404_D006402 NONE creatinine_55\NN\0 (r_compound) level_56\NN\4916342 (r_pobj) with_50\IN\0 (r_prep) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D003404_D056486 NONE creatinine_55\NN\0 (r_compound) level_56\NN\4916342 (r_pobj) with_50\IN\0 (r_prep) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D011899_D056486 NONE ranitidine_18\NN\14778019 (r_conj) median_12\NN\6021761 (r_conj) cimetidine_5\NN\14778019 (r_pobj) of_4\IN\0 (r_prep) doses_3\NNS\3740161 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubjpass) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D011899_D056486 NONE ranitidine_46\NN\14778019 (r_compound) therapy_47\NN\657604 (r_nsubjpass) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D011899_D007172 NONE ranitidine_25\NN\14778019 (r_pobj) by_24\IN\0 (r_agent) replaced_23\VBN\1631072 (r_advcl) disappeared_19\VBD\0 (r_conj) taking_11\VBG\37396 (r_advcl) developed_5\VBD\1753788 (l_dobj) changes_7\NNS\7283608 (l_conj) impotence_9\NN\4723816
D011899_D006402 NONE ranitidine_18\NN\14778019 (r_conj) median_12\NN\6021761 (r_conj) cimetidine_5\NN\14778019 (r_pobj) of_4\IN\0 (r_prep) doses_3\NNS\3740161 (r_pobj) with_1\IN\0 (r_prep) treatment_0\NN\654885 (r_nsubjpass) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
D011899_D006402 NONE ranitidine_46\NN\14778019 (r_compound) therapy_47\NN\657604 (r_nsubjpass) associated_49\VBN\628491 (r_conj) associated_32\VBN\628491 (l_prep) with_33\IN\0 (l_pobj) toxicity_37\NN\13576101
15075188
D011692_D001201 CID pan_4\NNP\3101986 (r_compound) treatment_5\NN\654885 (r_nsubj) induced_6\VBD\1627355 (r_advcl) decreased_12\VBD\169651 (l_dobj) excretion_15\NN\13466586 (l_conj) ascites_19\NNS\14204950
D012964_D001201 NONE sodium_14\NN\14625458 (r_compound) excretion_15\NN\13466586 (l_conj) ascites_19\NNS\14204950
D012964_D004487 NONE sodium_6\NN\14625458 (r_compound) retention_7\NN\809465 (l_conj) edema_10\NN\14315192
D012964_D009404 NONE sodium_6\NN\14625458 (r_compound) retention_7\NN\809465 (r_pobj) by_5\IN\0 (r_agent) accompanied_4\VBN\0 (l_nsubjpass) syndrome_1\NN\5870365
D012964_D009404 NONE sodium_34\NN\14625458 (r_compound) retention_35\NN\809465 (l_acl) associated_36\VBN\628491 (l_prep) with_37\IN\0 (l_pobj) syndrome_42\NN\5870365
D011692_D034141 CID pan_4\NNP\3101986 (r_compound) treatment_5\NN\654885 (r_nsubj) induced_6\VBD\1627355 (l_dobj) proteinuria_8\NN\14299637 (l_appos) hypoalbuminemia_10\NN\0
D012964_D011507 NONE sodium_14\NN\14625458 (r_compound) excretion_15\NN\13466586 (r_dobj) decreased_12\VBD\169651 (l_advcl) induced_6\VBD\1627355 (l_dobj) proteinuria_8\NN\14299637
D012964_D034141 NONE sodium_14\NN\14625458 (r_compound) excretion_15\NN\13466586 (r_dobj) decreased_12\VBD\169651 (l_advcl) induced_6\VBD\1627355 (l_dobj) proteinuria_8\NN\14299637 (l_appos) hypoalbuminemia_10\NN\0
D011692_D009404 CID aminonucleoside_11\RB\0 (r_advmod) induced_13\VBN\1627355 (r_amod) syndrome_15\NN\5870365
D011692_D009404 CID pan_38\NNP\3101986 (r_npadvmod) induced_40\VBN\1627355 (r_amod) syndrome_42\NN\5870365
D011692_D011507 CID pan_4\NNP\3101986 (r_compound) treatment_5\NN\654885 (r_nsubj) induced_6\VBD\1627355 (l_dobj) proteinuria_8\NN\14299637
16006300
C019248_D006934 NONE pamidronate_0\JJ\0 (r_compound) treatment_1\NN\654885 (r_nsubjpass) associated_3\VBN\628491 (l_prep) in_11\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) of_13\IN\0 (l_pobj) hypercalcemia_16\NN\14299637
D002118_D006934 NONE calcium_18\NN\14625458 (r_dobj) corrected_16\VBN\138508 (r_parataxis) report_1\VBP\6470073 (l_dobj) data_6\NNS\7951464 (l_prep) in_7\IN\13603305 (l_pobj) patients_9\NNS\9898892 (l_relcl) presented_11\VBD\2137132 (l_prep) with_12\IN\0 (l_pobj) hypercalcemia_14\NN\14299637
D002118_D006934 NONE calcium_18\NN\14625458 (r_dobj) corrected_16\VBN\138508 (l_conj) review_28\VB\5733583 (l_dobj) literature_31\NN\6362953 (l_prep) on_32\IN\0 (l_pobj) syndrome_36\NN\5870365
D002119_D064420 NONE carbonate_1\NN\15010703 (r_compound) toxicity_2\NN\13576101
C019248_D006996 CID pamidronate_10\JJ\0 (l_relcl) caused_22\VBD\1617192 (l_dobj) hypocalcemia_24\NN\14299637
C019248_D006996 CID pamidronate_0\JJ\0 (r_compound) treatment_1\NN\654885 (r_nsubjpass) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) risk_6\NN\14541044 (l_prep) for_7\IN\0 (l_pobj) hypocalcemia_8\NN\14299637
D002119_D006934 CID carbonate_1\NN\15010703 (r_compound) toxicity_2\NN\13576101 (l_appos) syndrome_9\NN\5870365
D002119_D006934 CID carbonate_6\NN\15010703 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypercalcemia_9\NN\14299637
D002119_D006934 CID carbonate_6\NN\15010703 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hypercalcemia_9\NN\14299637 (r_pobj) with_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_dobj) describe_1\VB\1001294 (l_conj) gain_11\VB\13576355 (l_dobj) insights_12\NNS\5710020 (l_prep) into_13\IN\0 (l_pobj) cause_15\NN\7323922 (l_prep) of_18\IN\0 (l_pobj) syndrome_23\NN\5870365
D002119_D006934 CID carbonate_23\NN\15010703 (r_pobj) of_19\IN\0 (r_prep) amounts_18\NNS\13329641 (r_pobj) by_16\IN\0 (r_agent) precipitated_15\VBN\1642924 (r_conj) be_5\VB\14625458 (l_nsubj) syndrome_3\NN\5870365
D002119_D006934 CID carbonate_23\NN\15010703 (r_pobj) of_19\IN\0 (r_prep) amounts_18\NNS\13329641 (r_pobj) by_16\IN\0 (r_agent) precipitated_15\VBN\1642924 (r_conj) be_5\VB\14625458 (l_attr) cause_8\NN\7323922 (l_prep) of_9\IN\0 (l_pobj) hypercalcemia_11\NN\14299637
D002118_D006996 NONE calcium_7\NN\14625458 (r_compound) concentrations_8\NNS\4916342 (r_pobj) with_3\IN\0 (r_prep) patients_2\NNS\9898892 (r_nsubj) pamidronate_10\JJ\0 (l_relcl) caused_22\VBD\1617192 (l_dobj) hypocalcemia_24\NN\14299637
C097949_D000471 NONE d_27\JJ\15089472 (r_compound) concentrations_28\NNS\4916342 (r_conj) peptide_23\NN\14724264 (r_conj) hormone_15\NN\5404728 (r_conj) alkalosis_10\NN\14204950
C097949_D058186 NONE d_27\JJ\15089472 (r_compound) concentrations_28\NNS\4916342 (r_conj) peptide_23\NN\14724264 (r_conj) hormone_15\NN\5404728 (r_conj) alkalosis_10\NN\14204950 (r_conj) insufficiency_6\NN\14462946
3115150
D015760_D009127 CID alfentanil_3\NN\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) rigidity_7\NN\5023233
D015760_D009127 CID alfentanil_29\NN\0 (r_advcl) attenuated_14\VBD\224901 (l_dobj) rigidity_17\NN\5023233
D015760_D009127 CID alfentanil_15\NNS\0 (r_pobj) by_14\IN\0 (r_agent) produced_13\VBN\1617192 (r_acl) rigidity_12\NN\5023233
D015760_D009127 CID alfentanil_19\NNS\0 (r_pobj) by_18\IN\0 (r_agent) followed_17\VBN\1835496 (l_prep) despite_0\IN\7501545 (l_pobj) absence_2\NN\14449405 (l_prep) of_3\IN\0 (l_pobj) rigidity_4\NN\5023233
D015760_D009127 CID alfentanil_35\NN\0 (r_advmod) receiving_34\VBG\2210855 (r_acl) animals_33\NNS\4475 (r_nsubj) were_32\VBD\0 (r_advcl) responsive_27\JJ\0 (r_conj) flaccid_23\JJ\0 (r_conj) motionless_21\JJ\0 (r_acomp) were_20\VBD\0 (l_csubj) followed_17\VBN\1835496 (l_prep) despite_0\IN\7501545 (l_pobj) absence_2\NN\14449405 (l_prep) of_3\IN\0 (l_pobj) rigidity_4\NN\5023233
D007650_D009127 NONE ketanserin_0\JJ\0 (r_compound) pretreatment_1\NN\0 (r_nsubj) reverses_2\VBZ\13854649 (l_dobj) rigidity_7\NN\5023233
D007650_D009127 NONE ketanserin_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) pretreatment_1\NN\0 (r_nsubj) attenuated_14\VBD\224901 (l_dobj) rigidity_17\NN\5023233
D007650_D009127 NONE ketanserin_9\JJ\0 (r_dobj) received_8\VBD\2210855 (r_relcl) animals_6\NNS\4475 (r_nsubj) followed_17\VBN\1835496 (l_prep) despite_0\IN\7501545 (l_pobj) absence_2\NN\14449405 (l_prep) of_3\IN\0 (l_pobj) rigidity_4\NN\5023233
D012701_D002318 NONE serotonin_3\NN\14807737 (r_compound) antagonists_4\NNS\7846 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) be_6\VB\14625458 (l_advcl) be_20\VB\14625458 (l_xcomp) assess_23\VB\5220461 (l_dobj) interaction_25\NN\37396 (l_prep) of_26\IN\0 (l_pobj) cns_29\NNP\5237227 (l_conj) cardiovascular_31\JJ\0 (l_conj) depression_35\NN\14373582
D002707_D009127 NONE chlordiazepoxide_0\VB\2830852 (r_nsubj) failed_7\VBD\0 (l_xcomp) influence_10\VB\5190804 (l_dobj) rigidity_12\NN\5023233
D012701_D009127 NONE serotonin_9\NN\14807737 (r_compound) antagonist_11\NN\7846 (r_appos) pretreatment_1\NN\0 (r_nsubj) attenuated_14\VBD\224901 (l_dobj) rigidity_17\NN\5023233
D012701_D009127 NONE serotonin_3\NN\14807737 (r_compound) antagonists_4\NNS\7846 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) be_6\VB\14625458 (l_acomp) useful_8\JJ\0 (l_prep) in_9\IN\13603305 (l_pcomp) attenuating_10\VBG\224901 (l_dobj) rigidity_14\NN\5023233
D012701_D012131 NONE serotonin_3\NN\14807737 (r_compound) antagonists_4\NNS\7846 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) be_6\VB\14625458 (l_advcl) be_20\VB\14625458 (l_xcomp) assess_23\VB\5220461 (l_dobj) interaction_25\NN\37396 (l_prep) of_26\IN\0 (l_pobj) cns_29\NNP\5237227 (l_conj) cardiovascular_31\JJ\0 (l_conj) depression_35\NN\14373582
18513945
D010121_D007022 CID oxytocin_0\NN\5407119 (r_nsubj) is_1\VBZ\0 (l_attr) uterotonic_5\NN\0 (l_relcl) cause_8\VB\7323922 (l_dobj) hypotension_13\NN\14057371
D010121_D007022 CID oxytocin_0\NN\5407119 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371
D010121_D007022 CID oxytocin_4\NN\5407119 (r_pobj) to_3\IN\0 (r_prep) response_2\NN\11410625 (r_pobj) in_1\IN\13603305 (r_prep) hypotension_0\NN\14057371
D010121_D020521 NONE oxytocin_4\NN\5407119 (r_pobj) to_3\IN\0 (r_prep) response_2\NN\11410625 (r_pobj) in_1\IN\13603305 (r_prep) hypotension_0\NN\14057371 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) decrease_9\NN\7296428 (l_conj) increase_17\NN\13576355 (l_prep) in_18\IN\13603305 (l_pobj) volume_20\NN\33615 (l_compound) stroke_19\NN\556313
D010121_D006473 NONE oxytocin_0\NN\5407119 (r_npadvmod) induced_2\VBN\1627355 (r_amod) hypotension_3\NN\14057371 (r_nsubjpass) attributed_10\VBN\670261 (l_prep) to_11\IN\0 (l_pobj) loss_13\NN\13252973
2722224
D006854_D006973 CID hydrocortisone_0\NNP\14751417 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) hypertension_3\NN\14057371
D006854_D006973 CID hydrocortisone_7\NN\14751417 (r_pobj) with_6\IN\0 (r_prep) pressure_5\NN\11419404
D006854_D016534 NONE hydrocortisone_7\NN\14751417 (r_pobj) with_6\IN\0 (r_prep) pressure_5\NN\11419404 (r_dobj) resting_3\VBG\2604760 (r_pcomp) in_2\IN\13603305 (r_prep) rise_1\NN\7324673 (r_nsubjpass) associated_9\VBN\628491 (l_prep) with_10\IN\0 (l_pobj) output_14\NN\4007894
16720068
D000525_D014202 NONE alprazolam_7\NN\2830852 (r_compound) treatment_8\NN\654885 (r_conj) paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428 (l_conj) disorientation_17\NN\5896733 (l_conj) rigidity_22\NN\5023233 (l_prep) with_23\IN\0 (l_pobj) tremors_24\NNS\345926
D000525_D009127 NONE alprazolam_7\NN\2830852 (r_compound) treatment_8\NN\654885 (r_conj) paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428 (l_conj) disorientation_17\NN\5896733 (l_conj) rigidity_22\NN\5023233
D017374_D009127 NONE paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428 (l_conj) disorientation_17\NN\5896733 (l_conj) rigidity_22\NN\5023233
D017374_D009459 CID paroxetine_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_pobj) to_5\IN\0 (r_prep) related_4\VBN\628491 (r_acl) syndrome_3\NN\5870365
D017374_D009459 CID paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (r_ccomp) demonstrating_14\VBG\2137132 (r_advcl) presented_2\VBN\2137132 (l_prep) with_3\IN\0 (l_pobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) syndrome_8\NN\5870365
D017374_D009459 CID paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (r_ccomp) demonstrating_14\VBG\2137132 (r_advcl) presented_2\VBN\2137132 (l_prep) with_3\IN\0 (l_pobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) syndrome_8\NN\5870365 (l_appos) nms_10\NNP\13649268
D017374_D009459 CID paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (l_nsubj) symptoms_19\NNS\5823932 (l_amod) like_18\JJ\5839024 (l_npadvmod) nms_16\NNP\13649268
D000525_D009459 CID alprazolam_11\NN\2830852 (r_conj) paroxetine_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) treatment_7\NN\654885 (r_pobj) to_5\IN\0 (r_prep) related_4\VBN\628491 (r_acl) syndrome_3\NN\5870365
D000525_D009459 CID alprazolam_26\NN\2830852 (r_compound) treatment_27\NN\654885 (r_conj) paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (r_ccomp) demonstrating_14\VBG\2137132 (r_advcl) presented_2\VBN\2137132 (l_prep) with_3\IN\0 (l_pobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) syndrome_8\NN\5870365
D000525_D009459 CID alprazolam_26\NN\2830852 (r_compound) treatment_27\NN\654885 (r_conj) paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (r_ccomp) demonstrating_14\VBG\2137132 (r_advcl) presented_2\VBN\2137132 (l_prep) with_3\IN\0 (l_pobj) symptoms_4\NNS\5823932 (l_prep) of_5\IN\0 (l_pobj) syndrome_8\NN\5870365 (l_appos) nms_10\NNP\13649268
D000525_D009459 CID alprazolam_26\NN\2830852 (r_compound) treatment_27\NN\654885 (r_conj) paroxetine_24\NN\0 (r_pobj) after_22\IN\0 (r_prep) occur_21\VB\0 (l_nsubj) symptoms_19\NNS\5823932 (l_amod) like_18\JJ\5839024 (l_npadvmod) nms_16\NNP\13649268
D017374_D011596 NONE paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428
D017374_D014202 NONE paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428 (l_conj) disorientation_17\NN\5896733 (l_conj) rigidity_22\NN\5023233 (l_prep) with_23\IN\0 (l_pobj) tremors_24\NNS\345926
D000525_D011596 NONE alprazolam_7\NN\2830852 (r_compound) treatment_8\NN\654885 (r_conj) paroxetine_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) day_3\NN\15154774 (r_pobj) on_0\IN\0 (r_prep) exhibited_12\VBD\2632167 (l_dobj) retardation_15\NN\7296428
19721134
D010862_D001145 NONE pilocarpine_9\NN\14712692 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (r_dobj) evaluate_5\VB\670261 (l_conj) explore_11\VB\789138 (l_conj) using_17\VBG\418025 (l_dobj) rat_22\NN\2329401 (l_conj) models_30\NNS\5888929 (l_compound) arrhythmia_29\NN\14103288
D010862_D001145 NONE pilocarpine_5\NN\14712692 (r_amod) onset_8\NN\7325190 (l_prep) of_9\IN\0 (l_pobj) arrhythmias_10\NNS\14103288
D010862_D001145 NONE pilocarpine_5\NN\14712692 (r_amod) onset_8\NN\7325190 (r_dobj) showed_3\VBD\2137132 (r_ccomp) decreased_12\VBD\169651 (l_npadvmod) score_24\NN\5736149 (l_compound) arrhythmia_23\NN\14103288
D010862_D001145 NONE pilocarpine_5\NN\14712692 (r_amod) onset_8\NN\7325190 (r_dobj) showed_3\VBD\2137132 (r_ccomp) decreased_12\VBD\169651 (l_npadvmod) score_24\NN\5736149 (l_conj) increased_27\VBD\169651 (l_dobj) time_30\NN\7308889 (l_prep) of_31\IN\0 (l_pobj) rats_33\NNS\2329401 (l_amod) arrhythmic_32\JJ\0
D010862_D001145 NONE pilocarpine_4\NN\14712692 (r_nsubj) produced_5\VBD\1617192 (l_dobj) actions_7\NNS\30358 (l_prep) on_8\IN\0 (l_pobj) models_14\NNS\5888929 (l_nmod) rat_10\NN\2329401 (l_amod) arrhythmic_9\JJ\0
D010042_D001145 CID ouabain_24\NN\0 (r_npadvmod) induced_26\VBN\1627355 (r_amod) models_30\NNS\5888929 (l_compound) arrhythmia_29\NN\14103288
D010042_D001145 CID ouabain_19\RB\0 (r_conj) aconitine_17\NN\0 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) models_14\NNS\5888929 (l_nmod) rat_10\NN\2329401 (l_amod) arrhythmic_9\JJ\0
D010862_D014693 NONE pilocarpine_5\NN\14712692 (r_amod) onset_8\NN\7325190 (r_dobj) showed_3\VBD\2137132 (r_ccomp) decreased_12\VBD\169651 (l_dobj) course_15\NN\883297 (l_prep) of_16\IN\0 (l_pobj) tachycardia_18\NN\14110674 (l_conj) fibrillation_20\NN\14361664
D010862_D017180 NONE pilocarpine_5\NN\14712692 (r_amod) onset_8\NN\7325190 (r_dobj) showed_3\VBD\2137132 (r_ccomp) decreased_12\VBD\169651 (l_dobj) course_15\NN\883297 (l_prep) of_16\IN\0 (l_pobj) tachycardia_18\NN\14110674 (l_conj) fibrillation_20\NN\14361664
D000157_D001145 CID aconitine_19\NN\0 (r_npadvmod) induced_21\VBN\1627355 (r_amod) rat_22\NN\2329401 (l_conj) models_30\NNS\5888929 (l_compound) arrhythmia_29\NN\14103288
D000157_D001145 CID aconitine_17\NN\0 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) models_14\NNS\5888929 (l_nmod) rat_10\NN\2329401 (l_amod) arrhythmic_9\JJ\0
D002118_D001145 NONE ca(2_34\NNP\0 (r_pobj) of_33\IN\0 (r_prep) improvement_32\NN\7359599 (r_pobj) to_30\IN\0 (r_prep) related_29\VBN\628491 (r_relcl) cardiac_23\JJ\0 (r_dobj) stimulating_21\VBG\137313 (r_pcomp) via_20\IN\0 (r_prep) ouabain_19\RB\0 (r_conj) aconitine_17\NN\0 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) models_14\NNS\5888929 (l_nmod) rat_10\NN\2329401 (l_amod) arrhythmic_9\JJ\0
21294084
D010406_D004827 NONE penicillin_12\NN\2716866 (r_npadvmod) induced_14\VBN\1627355 (r_amod) model_16\NN\5888929 (r_pobj) in_11\IN\13603305 (r_prep) discharges_10\NNS\7283608 (l_amod) epileptic_9\JJ\10595647
D010406_D004827 NONE penicillin_12\NN\2716866 (r_npadvmod) induced_14\VBN\1627355 (r_amod) model_16\NN\5888929 (l_compound) epilepsy_15\NN\14085708
D010406_D004827 NONE penicillin_17\NN\2716866 (r_npadvmod) induced_19\VBN\1627355 (r_amod) model_21\NN\5888929 (r_pobj) in_16\IN\13603305 (r_prep) activity_15\NN\30358 (l_amod) epileptic_14\JJ\10595647
D010406_D004827 NONE penicillin_17\NN\2716866 (r_npadvmod) induced_19\VBN\1627355 (r_amod) model_21\NN\5888929 (l_compound) epilepsy_20\NN\14085708
D010406_D004827 NONE penicillin_7\NN\2716866 (r_npadvmod) induced_9\VBN\1627355 (r_amod) activity_12\NN\30358 (l_amod) epileptic_11\JJ\10595647
14742097
D020280_D020018 CID sertraline_8\NN\4169152 (r_conj) fluoxetine_6\NN\4169152 (r_dobj) receiving_4\VBG\2210855 (r_acl) women_3\NNS\9605289 (l_amod) dysfunctional_2\JJ\0
D004809_D020018 NONE ephedrine_10\NN\14712692 (r_pobj) of_9\IN\0 (r_prep) study_8\NN\635850 (l_prep) for_11\IN\0 (l_pobj) dysfunction_17\NN\14204950
D004809_D020018 NONE ephedrine_9\NN\14712692 (r_nsubj) has_28\VBZ\13888491 (l_dobj) effects_30\NNS\13245626 (l_prep) in_31\IN\13603305 (l_pcomp) reversing_32\VBG\109660 (l_dobj) dysfunction_37\NN\14204950
D004809_D020018 NONE ephedrine_35\NN\14712692 (r_pobj) of_34\IN\0 (r_prep) effects_33\NNS\13245626 (r_pobj) of_31\IN\0 (r_prep) study_30\NN\635850 (r_pobj) in_13\IN\13603305 (r_prep) participated_12\VBD\2367363 (l_nsubj) women_3\NNS\9605289 (l_amod) dysfunctional_2\JJ\0
D005473_D020018 CID fluoxetine_6\NN\4169152 (r_dobj) receiving_4\VBG\2210855 (r_acl) women_3\NNS\9605289 (l_amod) dysfunctional_2\JJ\0
D017374_D020018 CID paroxetine_11\NN\0 (r_conj) sertraline_8\NN\4169152 (r_conj) fluoxetine_6\NN\4169152 (r_dobj) receiving_4\VBG\2210855 (r_acl) women_3\NNS\9605289 (l_amod) dysfunctional_2\JJ\0
11868798
D013148_D009503 NONE spironolactone_9\NN\2721160 (r_pobj) of_8\IN\0 (r_prep) ability_7\NN\4723816 (l_acl) reduce_11\VB\441445 (l_conj) prevent_16\VB\0 (l_dobj) hypokalemia_17\NN\14299637 (l_prep) in_18\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_amod) neutropenic_19\JJ\0
D013148_D009503 NONE spironolactone_4\NN\2721160 (r_nsubj) reduce_6\VB\441445 (l_conj) prevent_10\VBP\0 (l_prep) by_12\IN\0 (l_pcomp) reducing_13\VBG\13447361 (l_dobj) loss_16\NN\13252973 (l_prep) in_17\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_amod) neutropenic_18\JJ\0
D011188_D007008 NONE potassium_12\NN\14625458 (r_compound) requirements_13\NNS\1129920 (r_dobj) reduce_11\VB\441445 (l_conj) prevent_16\VB\0 (l_dobj) hypokalemia_17\NN\14299637
D011188_D007008 NONE potassium_7\NN\14625458 (r_compound) requirements_8\NNS\1129920 (r_dobj) reduce_6\VB\441445 (l_conj) prevent_10\VBP\0 (l_dobj) hypokalemia_11\NN\14299637
D011188_D007008 NONE potassium_15\NN\14625458 (r_compound) loss_16\NN\13252973 (r_dobj) reducing_13\VBG\13447361 (r_pcomp) by_12\IN\0 (r_prep) prevent_10\VBP\0 (l_dobj) hypokalemia_11\NN\14299637
D013148_D007008 NONE spironolactone_0\NNP\2721160 (r_npadvmod) is_2\VBZ\0 (l_attr) drug_6\NN\14778436 (l_prep) for_7\IN\0 (l_pobj) prevention_9\NN\1073995 (l_prep) of_10\IN\0 (l_pobj) hypokalemia_15\NN\14299637
D013148_D007008 NONE spironolactone_9\NN\2721160 (r_pobj) of_8\IN\0 (r_prep) ability_7\NN\4723816 (l_acl) reduce_11\VB\441445 (l_conj) prevent_16\VB\0 (l_dobj) hypokalemia_17\NN\14299637
D013148_D007008 NONE spironolactone_4\NN\2721160 (r_nsubj) reduce_6\VB\441445 (l_conj) prevent_10\VBP\0 (l_dobj) hypokalemia_11\NN\14299637
D000666_D009369 NONE b_12\NN\1355326 (r_npadvmod) related_14\VBN\628491 (r_amod) hypokalemia_15\NN\14299637 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_compound) cancer_17\NN\14239425
D000666_D009503 NONE amb_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) on_21\IN\0 (r_prep) patients_20\NNS\9898892 (l_amod) neutropenic_19\JJ\0
D000666_D009503 NONE amb_21\JJ\0 (r_compound) treatment_22\NN\654885 (r_pobj) on_20\IN\0 (r_prep) patients_19\NNS\9898892 (l_amod) neutropenic_18\JJ\0
D013148_D006402 NONE spironolactone_21\NN\2721160 (r_conj) amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (r_xcomp) randomized_10\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disorders_8\NNS\14034177
D013148_D009369 NONE spironolactone_0\NNP\2721160 (r_npadvmod) is_2\VBZ\0 (l_attr) drug_6\NN\14778436 (l_prep) for_7\IN\0 (l_pobj) prevention_9\NN\1073995 (l_prep) of_10\IN\0 (l_pobj) hypokalemia_15\NN\14299637 (l_prep) in_16\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_compound) cancer_17\NN\14239425
D000666_D007674 NONE b_9\NNP\1355326 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) nephrotoxicity_1\NN\0
D000666_D007674 NONE amb_11\NNP\0 (r_appos) b_9\NNP\1355326 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_attr) is_2\VBZ\0 (l_nsubj) nephrotoxicity_1\NN\0
D000666_D064420 NONE amb._24\NNP\0 (r_compound) potassium_25\NN\14625458 (r_compound) depletion_26\NN\351638 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) effect_20\NN\34213 (r_attr) is_15\VBZ\0 (r_relcl) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_nsubj) toxicity_4\NN\13576101
D000666_D064420 NONE amb._24\NNP\0 (r_compound) potassium_25\NN\14625458 (r_compound) depletion_26\NN\351638 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) effect_20\NN\34213 (r_attr) is_15\VBZ\0 (r_relcl) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_conj) potentiates_28\VBZ\229605 (l_dobj) toxicity_31\NN\13576101
D000666_D064420 NONE amb._33\NN\0 (r_pobj) of_32\IN\0 (r_prep) toxicity_31\NN\13576101 (r_dobj) potentiates_28\VBZ\229605 (r_conj) seems_5\VBZ\2604760 (l_nsubj) toxicity_4\NN\13576101
D000666_D064420 NONE amb._33\NN\0 (r_pobj) of_32\IN\0 (r_prep) toxicity_31\NN\13576101
D000666_D007008 CID b_12\NN\1355326 (r_npadvmod) related_14\VBN\628491 (r_amod) hypokalemia_15\NN\14299637
D000666_D007008 CID amb_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) on_21\IN\0 (r_prep) patients_20\NNS\9898892 (r_pobj) in_18\IN\13603305 (r_prep) hypokalemia_17\NN\14299637
D000666_D007008 CID amb_21\JJ\0 (r_compound) treatment_22\NN\654885 (r_pobj) on_20\IN\0 (r_prep) patients_19\NNS\9898892 (r_pobj) in_17\IN\13603305 (r_prep) loss_16\NN\13252973 (r_dobj) reducing_13\VBG\13447361 (r_pcomp) by_12\IN\0 (r_prep) prevent_10\VBP\0 (l_dobj) hypokalemia_11\NN\14299637
D000666_D006402 NONE amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (r_xcomp) randomized_10\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disorders_8\NNS\14034177
D000666_D006402 NONE amb_18\JJ\0 (r_conj) amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (r_xcomp) randomized_10\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disorders_8\NNS\14034177
D011188_D009503 NONE potassium_12\NN\14625458 (r_compound) requirements_13\NNS\1129920 (r_dobj) reduce_11\VB\441445 (l_conj) prevent_16\VB\0 (l_dobj) hypokalemia_17\NN\14299637 (l_prep) in_18\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_amod) neutropenic_19\JJ\0
D011188_D009503 NONE potassium_7\NN\14625458 (r_compound) requirements_8\NNS\1129920 (r_dobj) reduce_6\VB\441445 (l_conj) prevent_10\VBP\0 (l_prep) by_12\IN\0 (l_pcomp) reducing_13\VBG\13447361 (l_dobj) loss_16\NN\13252973 (l_prep) in_17\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_amod) neutropenic_18\JJ\0
D011188_D009503 NONE potassium_15\NN\14625458 (r_compound) loss_16\NN\13252973 (l_prep) in_17\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_amod) neutropenic_18\JJ\0
D000666_D009181 NONE amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (l_advcl) developing_27\VBG\13541167 (l_dobj) infection_33\NN\14052046
D000666_D009181 NONE amb_18\JJ\0 (r_conj) amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (l_advcl) developing_27\VBG\13541167 (l_dobj) infection_33\NN\14052046
D013148_D009181 NONE spironolactone_21\NN\2721160 (r_conj) amb_15\VB\0 (r_dobj) receive_12\VB\2210855 (l_advcl) developing_27\VBG\13541167 (l_dobj) infection_33\NN\14052046
D011188_D064420 NONE potassium_12\NN\14625458 (r_compound) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_nsubj) toxicity_4\NN\13576101
D011188_D064420 NONE potassium_12\NN\14625458 (r_compound) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_conj) potentiates_28\VBZ\229605 (l_dobj) toxicity_31\NN\13576101
D011188_D064420 NONE potassium_25\NN\14625458 (r_compound) depletion_26\NN\351638 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) effect_20\NN\34213 (r_attr) is_15\VBZ\0 (r_relcl) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_nsubj) toxicity_4\NN\13576101
D011188_D064420 NONE potassium_25\NN\14625458 (r_compound) depletion_26\NN\351638 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) effect_20\NN\34213 (r_attr) is_15\VBZ\0 (r_relcl) wasting_13\VBG\14547643 (r_pobj) for_9\IN\0 (r_prep) responsible_8\JJ\0 (r_acomp) be_7\VB\14625458 (r_xcomp) seems_5\VBZ\2604760 (l_conj) potentiates_28\VBZ\229605 (l_dobj) toxicity_31\NN\13576101
12549952
D016642_D017114 CID bupropion_5\NN\0 (r_pobj) with_3\IN\0 (r_prep) failure_2\NN\66216
D016642_D017114 CID bupropion_9\NN\0 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) evidence_4\NN\5816287 (r_dobj) increasing_3\VBG\169651 (r_advcl) is_12\VBZ\0 (l_attr) case_15\NN\7283608 (l_relcl) resulted_21\VBN\2633881 (l_prep) from_22\IN\0 (l_pobj) failure_25\NN\66216
D016642_D017114 CID bupropion_30\NN\0 (r_dobj) receiving_29\VBG\2210855 (r_acl) patient_28\JJ\9898892 (r_pobj) in_26\IN\13603305 (r_prep) failure_25\NN\66216
D016642_D017114 CID bupropion_13\NN\0 (r_pobj) by_12\IN\0 (r_agent) induced_11\VBN\1627355 (r_acl) insult_10\NN\6714976
D016642_D056486 CID bupropion_3\NN\0 (r_nsubj) induced_4\VBD\1627355 (l_dobj) hepatotoxicity_5\NN\0
D016642_D056486 CID bupropion_9\NN\0 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) evidence_4\NN\5816287 (l_prep) of_5\IN\0 (l_pobj) hepatotoxicity_6\NN\0
D016642_D056486 CID bupropion_30\NN\0 (r_dobj) receiving_29\VBG\2210855 (r_acl) patient_28\JJ\9898892 (r_pobj) in_26\IN\13603305 (r_prep) failure_25\NN\66216 (r_pobj) from_22\IN\0 (r_prep) resulted_21\VBN\2633881 (r_relcl) case_15\NN\7283608 (r_attr) is_12\VBZ\0 (l_advcl) increasing_3\VBG\169651 (l_dobj) evidence_4\NN\5816287 (l_prep) of_5\IN\0 (l_pobj) hepatotoxicity_6\NN\0
D016642_D056486 CID bupropion_13\NN\0 (l_acl) given_14\VBN\5892096 (l_prep) with_16\IN\0 (l_pobj) drugs_19\NNS\14778436 (l_amod) hepatotoxic_18\JJ\0
D002231_D017093 NONE carbimazole_16\NN\0 (r_conj) bupropion_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) failure_7\NN\66216
D011433_D006980 NONE propranolol_17\NN\0 (r_conj) treated_13\VBN\2376958 (l_nsubjpass) man_5\NN\9605289 (l_prep) with_6\IN\0 (l_pobj) history_8\NN\15120823 (l_prep) of_9\IN\0 (l_pobj) hyperthyroidism_10\NN\14059928
D002231_D017114 CID carbimazole_7\NN\0 (r_compound) therapy_8\NN\657604 (r_conj) bupropion_5\NN\0 (r_pobj) with_3\IN\0 (r_prep) failure_2\NN\66216
D002231_D017114 CID carbimazole_36\NN\0 (r_pobj) with_35\IN\0 (r_prep) treatment_34\NN\654885 (r_pobj) on_32\IN\0 (r_prep) resulted_21\VBN\2633881 (l_prep) from_22\IN\0 (l_pobj) failure_25\NN\66216
D002231_D006980 NONE carbimazole_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (l_nsubjpass) man_5\NN\9605289 (l_prep) with_6\IN\0 (l_pobj) history_8\NN\15120823 (l_prep) of_9\IN\0 (l_pobj) hyperthyroidism_10\NN\14059928
D016642_D017093 NONE bupropion_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (r_pobj) with_10\IN\0 (r_prep) associated_9\VBN\628491 (r_acl) failure_7\NN\66216
D002231_D056486 CID carbimazole_36\NN\0 (r_pobj) with_35\IN\0 (r_prep) treatment_34\NN\654885 (r_pobj) on_32\IN\0 (r_prep) resulted_21\VBN\2633881 (r_relcl) case_15\NN\7283608 (r_attr) is_12\VBZ\0 (l_advcl) increasing_3\VBG\169651 (l_dobj) evidence_4\NN\5816287 (l_prep) of_5\IN\0 (l_pobj) hepatotoxicity_6\NN\0
7197363
D011814_D009069 CID quipazine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) head_18\NN\5225090 (r_compound) twitches_19\NNS\14360459
D011814_D009069 CID quipazine_31\NN\0 (r_pobj) of_28\IN\0 (r_prep) completing_27\VBG\352826 (r_pcomp) after_26\IN\0 (r_prep) increased_22\VBN\169651 (r_conj) reduced_13\VBN\441445 (r_conj) increased_6\VBD\169651 (l_conj) twitches_35\NNS\14360459
D001058_D009069 NONE apomorphine_10\NN\3786417 (r_npadvmod) induced_12\VBN\1627355 (r_amod) aggressiveness_13\NN\4835724 (l_conj) twitches_19\NNS\14360459
D001058_D009069 NONE apomorphine_7\NN\3786417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) aggressiveness_10\NN\4835724 (r_dobj) increased_6\VBD\169651 (l_conj) twitches_35\NNS\14360459
D011814_D012892 NONE quipazine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) head_18\NN\5225090 (r_compound) twitches_19\NNS\14360459 (r_conj) aggressiveness_13\NN\4835724 (r_pobj) on_9\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) deprivation_5\NN\14493145
D011814_D012892 NONE quipazine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) head_18\NN\5225090 (r_compound) twitches_19\NNS\14360459 (r_conj) aggressiveness_13\NN\4835724 (r_pobj) on_9\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) deprivation_5\NN\14493145 (l_appos) remd_7\NNP\0
D011814_D012892 NONE quipazine_31\NN\0 (r_pobj) of_28\IN\0 (r_prep) completing_27\VBG\352826 (r_pcomp) after_26\IN\0 (r_prep) increased_22\VBN\169651 (r_conj) reduced_13\VBN\441445 (r_conj) increased_6\VBD\169651 (l_nsubj) hr_3\NN\15154774 (l_prep) of_4\IN\0 (l_pobj) remd_5\NNP\0
D011814_D012892 NONE quipazine_31\NN\0 (r_pobj) of_28\IN\0 (r_prep) completing_27\VBG\352826 (r_pcomp) after_26\IN\0 (r_prep) increased_22\VBN\169651 (r_conj) reduced_13\VBN\441445 (l_prep) after_16\IN\0 (l_pcomp) completing_17\VBG\352826 (l_prep) of_18\IN\0 (l_pobj) remd_19\NNP\0
D011814_D012892 NONE quipazine_31\NN\0 (l_nmod) remd_29\NNP\0
D011814_D001523 NONE quipazine_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) head_18\NN\5225090 (r_compound) twitches_19\NNS\14360459 (r_conj) aggressiveness_13\NN\4835724
D011814_D001523 NONE quipazine_31\NN\0 (r_pobj) of_28\IN\0 (r_prep) completing_27\VBG\352826 (r_pcomp) after_26\IN\0 (r_prep) increased_22\VBN\169651 (r_conj) reduced_13\VBN\441445 (r_conj) increased_6\VBD\169651 (l_dobj) aggressiveness_10\NN\4835724
D001058_D001523 CID apomorphine_10\NN\3786417 (r_npadvmod) induced_12\VBN\1627355 (r_amod) aggressiveness_13\NN\4835724
D001058_D001523 CID apomorphine_7\NN\3786417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) aggressiveness_10\NN\4835724
D001058_D012892 NONE apomorphine_10\NN\3786417 (r_npadvmod) induced_12\VBN\1627355 (r_amod) aggressiveness_13\NN\4835724 (r_pobj) on_9\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) deprivation_5\NN\14493145
D001058_D012892 NONE apomorphine_10\NN\3786417 (r_npadvmod) induced_12\VBN\1627355 (r_amod) aggressiveness_13\NN\4835724 (r_pobj) on_9\IN\0 (r_prep) effects_1\NNS\13245626 (l_prep) of_2\IN\0 (l_pobj) deprivation_5\NN\14493145 (l_appos) remd_7\NNP\0
D001058_D012892 NONE apomorphine_7\NN\3786417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) aggressiveness_10\NN\4835724 (r_dobj) increased_6\VBD\169651 (l_nsubj) hr_3\NN\15154774 (l_prep) of_4\IN\0 (l_pobj) remd_5\NNP\0
D001058_D012892 NONE apomorphine_7\NN\3786417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) aggressiveness_10\NN\4835724 (r_dobj) increased_6\VBD\169651 (l_conj) reduced_13\VBN\441445 (l_prep) after_16\IN\0 (l_pcomp) completing_17\VBG\352826 (l_prep) of_18\IN\0 (l_pobj) remd_19\NNP\0
D001058_D012892 NONE apomorphine_7\NN\3786417 (r_npadvmod) induced_9\VBN\1627355 (r_amod) aggressiveness_10\NN\4835724 (r_dobj) increased_6\VBD\169651 (l_conj) reduced_13\VBN\441445 (l_conj) increased_22\VBN\169651 (l_prep) after_26\IN\0 (l_pcomp) completing_27\VBG\352826 (l_prep) of_28\IN\0 (l_pobj) quipazine_31\NN\0 (l_nmod) remd_29\NNP\0
8665051
D013256_D009336 NONE steroid_18\NN\14727670 (r_compound) groups_19\NNS\2137 (r_pobj) in_16\IN\13603305 (r_prep) atrophy_15\NN\14299637 (r_dobj) showed_11\VBD\2137132 (l_advcl) revealed_32\VBD\2137132 (l_dobj) pattern_36\NN\5726345 (l_prep) with_37\IN\0 (l_pobj) absence_38\NN\14449405 (l_prep) of_39\IN\0 (l_pobj) necrosis_40\NN\11444117
D013256_D009336 NONE steroids_14\NNS\14727670 (r_pobj) of_13\IN\0 (r_prep) doses_12\NNS\3740161 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_nsubj) induced_15\VBD\1627355 (r_ccomp) conclude_1\VBP\628491 (r_ccomp) induced_30\VBD\1627355 (r_ccomp) caused_51\VBD\1617192 (l_dobj) necrosis_53\NN\11444117
D013256_D009336 NONE steroids_29\NNS\14727670 (r_pobj) of_28\IN\0 (r_prep) types_27\NNS\5839024 (r_nsubj) induced_30\VBD\1627355 (r_ccomp) caused_51\VBD\1617192 (l_dobj) necrosis_53\NN\11444117
D013256_D009336 NONE steroid_50\NN\14727670 (r_nsubj) caused_51\VBD\1617192 (l_dobj) necrosis_53\NN\11444117
D013256_D013746 NONE steroid_8\NN\14727670 (r_compound) groups_9\NNS\2137 (r_pobj) in_6\IN\13603305 (r_prep) prolonged_5\VBN\317700 (l_conj) was_16\VBD\0 (l_advcl) were_24\VBD\0 (l_nsubj) tensions_23\NNS\14375890 (l_compound) tetanic_22\JJ\0
D013256_D009133 NONE steroid_18\NN\14727670 (r_compound) groups_19\NNS\2137 (r_pobj) in_16\IN\13603305 (r_prep) atrophy_15\NN\14299637
D013256_D009133 NONE steroid_18\NN\14727670 (r_compound) groups_19\NNS\2137 (r_pobj) in_16\IN\13603305 (r_prep) atrophy_15\NN\14299637 (l_conj) atrophy_25\NN\14299637
D013256_D009133 NONE steroids_14\NNS\14727670 (r_pobj) of_13\IN\0 (r_prep) doses_12\NNS\3740161 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_nsubj) induced_15\VBD\1627355 (r_ccomp) conclude_1\VBP\628491 (r_ccomp) induced_30\VBD\1627355 (r_ccomp) caused_51\VBD\1617192 (r_ccomp) caused_63\VBN\1617192 (l_nsubjpass) atrophy_60\NN\14299637
D013256_D009133 NONE steroids_29\NNS\14727670 (r_pobj) of_28\IN\0 (r_prep) types_27\NNS\5839024 (r_nsubj) induced_30\VBD\1627355 (r_ccomp) caused_51\VBD\1617192 (r_ccomp) caused_63\VBN\1617192 (l_nsubjpass) atrophy_60\NN\14299637
D013256_D009133 NONE steroid_50\NN\14727670 (r_nsubj) caused_51\VBD\1617192 (r_ccomp) caused_63\VBN\1617192 (l_nsubjpass) atrophy_60\NN\14299637
D014221_D000855 CID triamcinolone_24\NN\14751417 (r_conj) methylprednisolone_18\NN\0 (r_appos) c_15\NNP\13714184 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_dobj) receive_9\VB\2210855 (r_xcomp) assigned_7\VBN\2475922 (l_conj) showed_46\VBD\2137132 (l_dobj) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D014221_D000855 CID t_26\NNP\14999913 (r_appos) triamcinolone_24\NN\14751417 (r_conj) methylprednisolone_18\NN\0 (r_appos) c_15\NNP\13714184 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_dobj) receive_9\VB\2210855 (r_xcomp) assigned_7\VBN\2475922 (l_conj) showed_46\VBD\2137132 (l_dobj) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D014221_D000855 CID t_67\NNP\14999913 (r_conj) m_65\NNP\13649268 (r_pobj) in_64\IN\13603305 (r_prep) %_63\NN\0 (r_appos) groups_58\NNS\2137 (r_pobj) in_53\IN\13603305 (r_prep) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D008775_D000855 CID methylprednisolone_18\NN\0 (r_appos) c_15\NNP\13714184 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_dobj) receive_9\VB\2210855 (r_xcomp) assigned_7\VBN\2475922 (l_conj) showed_46\VBD\2137132 (l_dobj) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D008775_D000855 CID m_20\NNP\13649268 (r_appos) methylprednisolone_18\NN\0 (r_appos) c_15\NNP\13714184 (r_pobj) of_12\IN\0 (r_prep) injection_11\NN\320852 (r_dobj) receive_9\VB\2210855 (r_xcomp) assigned_7\VBN\2475922 (l_conj) showed_46\VBD\2137132 (l_dobj) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D008775_D000855 CID m_65\NNP\13649268 (r_pobj) in_64\IN\13603305 (r_prep) %_63\NN\0 (r_appos) groups_58\NNS\2137 (r_pobj) in_53\IN\13603305 (r_prep) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D013256_D001284 NONE steroids_14\NNS\14727670 (r_pobj) of_13\IN\0 (r_prep) doses_12\NNS\3740161 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_nsubj) induced_15\VBD\1627355 (r_ccomp) conclude_1\VBP\628491 (r_ccomp) induced_30\VBD\1627355 (l_dobj) atrophy_34\NN\14299637
D013256_D001284 NONE steroids_29\NNS\14727670 (r_pobj) of_28\IN\0 (r_prep) types_27\NNS\5839024 (r_nsubj) induced_30\VBD\1627355 (l_dobj) atrophy_34\NN\14299637
D013256_D001284 NONE steroid_50\NN\14727670 (r_nsubj) caused_51\VBD\1617192 (l_ccomp) induced_30\VBD\1627355 (l_dobj) atrophy_34\NN\14299637
D014221_D009133 CID t_27\NNP\14999913 (r_pobj) with_26\IN\0 (r_prep) atrophy_25\NN\14299637 (r_conj) atrophy_15\NN\14299637
D014221_D009133 CID t_27\NNP\14999913 (r_pobj) with_26\IN\0 (r_prep) atrophy_25\NN\14299637
D014221_D009133 CID t_18\NNP\14999913 (r_conj) c_16\NNP\13714184 (r_appos) rats_14\NNS\2329401 (r_pobj) in_12\IN\13603305 (r_prep) performed_11\VBN\0 (r_acl) study_9\NN\635850 (r_nsubj) showed_24\VBD\2137132 (l_ccomp) was_28\VBD\0 (l_nsubj) atrophy_27\NN\14299637
D014221_D009133 CID t_37\NNP\14999913 (r_npadvmod) treated_39\VBN\2376958 (r_amod) animals_40\NNS\4475 (r_pobj) in_36\IN\13603305 (r_prep) than_35\IN\0 (r_prep) pronounced_31\VBN\0 (r_acomp) was_28\VBD\0 (l_nsubj) atrophy_27\NN\14299637
D013256_D000855 NONE steroid_55\NN\14727670 (r_npadvmod) treated_57\VBN\2376958 (r_amod) groups_58\NNS\2137 (r_pobj) in_53\IN\13603305 (r_prep) reduction_49\NN\351485 (l_prep) of_50\IN\0 (l_pobj) intake_52\NN\13440063
D008775_D013746 NONE m_19\NNP\13649268 (r_pobj) with_18\IN\0 (r_prep) was_16\VBD\0 (l_advcl) were_24\VBD\0 (l_nsubj) tensions_23\NNS\14375890 (l_compound) tetanic_22\JJ\0
D014221_D009336 NONE t_27\NNP\14999913 (r_pobj) with_26\IN\0 (r_prep) atrophy_25\NN\14299637 (r_conj) atrophy_15\NN\14299637 (r_dobj) showed_11\VBD\2137132 (l_advcl) revealed_32\VBD\2137132 (l_dobj) pattern_36\NN\5726345 (l_prep) with_37\IN\0 (l_pobj) absence_38\NN\14449405 (l_prep) of_39\IN\0 (l_pobj) necrosis_40\NN\11444117
D000305_D009135 NONE corticosteroids_17\NNS\14745635 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) with_13\IN\0 (r_prep) treated_12\VBN\2376958 (r_acl) patients_11\NNS\9898892 (r_pobj) in_10\IN\13603305 (r_prep) occur_9\VB\0 (l_nsubj) myopathy_7\NN\14204950
2709684
D005839_D058186 CID gentamicin_41\NN\2716866 (r_npadvmod) induced_43\VBN\1627355 (r_amod) failure_46\NN\66216
D005839_D058186 CID gentamicin_41\NN\2716866 (r_npadvmod) induced_43\VBN\1627355 (r_amod) failure_46\NN\66216 (l_appos) arf_48\NNP\0
D005839_D058186 CID gentamicin_8\NN\2716866 (r_compound) arf_10\NNP\0
D013311_D003920 CID streptozotocin_3\NNS\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) diabetes_6\NN\14075199 (r_compound) mellitus_7\NN\0
D013311_D003920 CID streptozotocin_3\NNS\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) diabetes_6\NN\14075199 (r_compound) mellitus_7\NN\0 (l_appos) dm_9\NNP\14117805
D010695_D006029 NONE phlorizin_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) glycosuria_3\NN\14299637
D010695_D006029 NONE p_13\NN\14622893 (r_nmod) animals_15\NNS\4475 (r_pobj) of_11\IN\0 (r_prep) that_10\DT\0 (r_pobj) to_9\IN\0 (r_prep) degree_8\NN\4916342 (r_pobj) in_7\IN\13603305 (r_prep) similar_6\JJ\0 (r_amod) glycosuria_4\NN\14299637
D010695_D006029 NONE p_4\NN\14622893 (r_nsubj) induced_5\VBD\1627355 (l_dobj) glycosuria_10\NN\14299637
D005839_D007674 NONE gentamicin_7\NN\2716866 (r_compound) nephrotoxicity_8\NN\0
D005839_D007674 NONE gentamicin_3\NN\2716866 (r_amod) nephrotoxicity_4\NN\0
D005839_D007674 NONE gentamicin_11\NN\2716866 (r_pobj) of_10\IN\0 (r_prep) doses_1\NNS\3740161 (l_amod) nephrotoxic_0\JJ\0
D013311_D006029 NONE streptozotocin_3\NNS\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) diabetes_6\NN\14075199 (r_compound) mellitus_7\NN\0 (r_pobj) with_2\IN\0 (r_prep) rats_1\NNS\2329401 (r_nsubj) have_11\VBP\7846 (l_dobj) diuresis_15\NN\14299637 (l_appos) glycosuria_17\NN\14299637
D005839_D009956 NONE gentamicin_8\NN\2716866 (r_compound) arf_10\NNP\0 (r_dobj) prevent_7\VB\0 (l_conj) day_34\NN\15154774 (l_conj) score_39\NN\5736149 (l_compound) necrosis_38\NN\11444117
D005947_D003920 NONE glucose_21\NN\14710501 (r_compound) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (l_amod) diabetic_10\JJ\10595647
D010695_D007674 NONE phlorizin_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) glycosuria_3\NN\14299637 (r_nsubj) prevent_6\VB\0 (l_dobj) nephrotoxicity_8\NN\0
D010695_D007674 NONE phlorizin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) studied_6\VBN\0 (l_nsubjpass) protection_1\NN\407535 (l_prep) from_2\IN\0 (l_pobj) nephrotoxicity_4\NN\0
D010695_D007674 NONE p_26\NN\14622893 (r_appos) phlorizin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) studied_6\VBN\0 (l_nsubjpass) protection_1\NN\407535 (l_prep) from_2\IN\0 (l_pobj) nephrotoxicity_4\NN\0
D010695_D007674 NONE p_4\NN\14622893 (r_nsubj) induced_5\VBD\1627355 (l_conj) ccr_33\IN\0 (l_nsubj) evidence_27\NN\5816287 (l_prep) of_28\IN\0 (l_pobj) dysfunction_30\NN\14204950
D010695_D003920 NONE phlorizin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (l_amod) diabetic_10\JJ\10595647
D010695_D003920 NONE p_26\NN\14622893 (r_appos) phlorizin_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (l_amod) diabetic_10\JJ\10595647
D010695_D003920 NONE p_13\NN\14622893 (r_nmod) animals_15\NNS\4475 (r_pobj) of_11\IN\0 (r_prep) that_10\DT\0 (r_pobj) to_9\IN\0 (r_prep) degree_8\NN\4916342 (r_pobj) in_7\IN\13603305 (r_prep) similar_6\JJ\0 (r_amod) glycosuria_4\NN\14299637 (r_pobj) with_2\IN\0 (r_prep) rats_1\NNS\2329401 (l_compound) dm_0\NNP\14117805
D010695_D003920 NONE p_3\NN\14622893 (r_nsubj) received_6\VBD\2210855 (l_conj) ii_19\NNP\13741022 (l_conj) iii_27\NNP\13741022 (l_acl) gentamicin_29\NN\2716866 (l_conj) iv_34\NNP\13741022 (l_appos) dm_37\NNP\14117805
D010695_D003920 NONE p_7\NN\14622893 (r_dobj) received_6\VBD\2210855 (l_conj) ii_19\NNP\13741022 (l_conj) iii_27\NNP\13741022 (l_acl) gentamicin_29\NN\2716866 (l_conj) iv_34\NNP\13741022 (l_appos) dm_37\NNP\14117805
D010695_D003920 NONE p_21\NN\14622893 (r_appos) ii_19\NNP\13741022 (l_conj) iii_27\NNP\13741022 (l_acl) gentamicin_29\NN\2716866 (l_conj) iv_34\NNP\13741022 (l_appos) dm_37\NNP\14117805
D010695_D058186 NONE p_4\NN\14622893 (r_nsubj) prevent_7\VB\0 (l_dobj) arf_10\NNP\0
D010695_D058186 NONE p_21\NN\14622893 (r_appos) arf_10\NNP\0
D005839_D006029 NONE gentamicin_7\NN\2716866 (r_compound) nephrotoxicity_8\NN\0 (r_dobj) prevent_6\VB\0 (l_nsubj) glycosuria_3\NN\14299637
D005839_D006029 NONE gentamicin_41\NN\2716866 (r_npadvmod) induced_43\VBN\1627355 (r_amod) failure_46\NN\66216 (r_pobj) to_40\IN\0 (r_prep) resistance_39\NN\37396 (r_pobj) for_37\IN\0 (r_prep) responsible_36\JJ\0 (r_acomp) be_35\VB\14625458 (r_ccomp) suggested_29\VBN\1010118 (l_advcl) have_11\VBP\7846 (l_dobj) diuresis_15\NN\14299637 (l_appos) glycosuria_17\NN\14299637
D005839_D003920 NONE gentamicin_41\NN\2716866 (r_npadvmod) induced_43\VBN\1627355 (r_amod) failure_46\NN\66216 (r_pobj) to_40\IN\0 (r_prep) resistance_39\NN\37396 (r_pobj) for_37\IN\0 (r_prep) responsible_36\JJ\0 (r_acomp) be_35\VB\14625458 (r_ccomp) suggested_29\VBN\1010118 (l_advcl) have_11\VBP\7846 (l_nsubj) rats_1\NNS\2329401 (l_prep) with_2\IN\0 (l_pobj) mellitus_7\NN\0
D005839_D003920 NONE gentamicin_41\NN\2716866 (r_npadvmod) induced_43\VBN\1627355 (r_amod) failure_46\NN\66216 (r_pobj) to_40\IN\0 (r_prep) resistance_39\NN\37396 (r_pobj) for_37\IN\0 (r_prep) responsible_36\JJ\0 (r_acomp) be_35\VB\14625458 (r_ccomp) suggested_29\VBN\1010118 (l_advcl) have_11\VBP\7846 (l_nsubj) rats_1\NNS\2329401 (l_prep) with_2\IN\0 (l_pobj) mellitus_7\NN\0 (l_appos) dm_9\NNP\14117805
D005839_D003920 NONE gentamicin_3\NN\2716866 (r_amod) nephrotoxicity_4\NN\0 (r_pobj) from_2\IN\0 (r_prep) protection_1\NN\407535 (r_nsubjpass) studied_6\VBN\0 (l_prep) in_7\IN\13603305 (l_pobj) rats_11\NNS\2329401 (l_amod) diabetic_10\JJ\10595647
D005839_D003920 NONE gentamicin_23\NN\2716866 (r_conj) p_21\NN\14622893 (r_appos) ii_19\NNP\13741022 (l_conj) iii_27\NNP\13741022 (l_acl) gentamicin_29\NN\2716866 (l_conj) iv_34\NNP\13741022 (l_appos) dm_37\NNP\14117805
D005839_D003920 NONE gentamicin_29\NN\2716866 (l_conj) iv_34\NNP\13741022 (l_appos) dm_37\NNP\14117805
D005839_D003920 NONE gentamicin_39\NN\2716866 (r_conj) dm_37\NNP\14117805
D013311_D058186 NONE streptozotocin_3\NNS\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) diabetes_6\NN\14075199 (r_compound) mellitus_7\NN\0 (r_pobj) with_2\IN\0 (r_prep) rats_1\NNS\2329401 (r_nsubj) have_11\VBP\7846 (r_advcl) suggested_29\VBN\1010118 (l_ccomp) be_35\VB\14625458 (l_acomp) responsible_36\JJ\0 (l_prep) for_37\IN\0 (l_pobj) resistance_39\NN\37396 (l_prep) to_40\IN\0 (l_pobj) failure_46\NN\66216
D013311_D058186 NONE streptozotocin_3\NNS\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) diabetes_6\NN\14075199 (r_compound) mellitus_7\NN\0 (r_pobj) with_2\IN\0 (r_prep) rats_1\NNS\2329401 (r_nsubj) have_11\VBP\7846 (r_advcl) suggested_29\VBN\1010118 (l_ccomp) be_35\VB\14625458 (l_acomp) responsible_36\JJ\0 (l_prep) for_37\IN\0 (l_pobj) resistance_39\NN\37396 (l_prep) to_40\IN\0 (l_pobj) failure_46\NN\66216 (l_appos) arf_48\NNP\0
D010695_D009956 NONE p_4\NN\14622893 (r_nsubj) induced_5\VBD\1627355 (l_conj) ccr_33\IN\0 (l_dobj) score_49\NN\5736149 (l_compound) necrosis_48\NN\11444117
D010695_D009956 NONE p_4\NN\14622893 (r_nsubj) prevent_7\VB\0 (l_conj) day_34\NN\15154774 (l_conj) score_39\NN\5736149 (l_compound) necrosis_38\NN\11444117
D010695_D009956 NONE p_21\NN\14622893 (r_appos) arf_10\NNP\0 (r_dobj) prevent_7\VB\0 (l_conj) day_34\NN\15154774 (l_conj) score_39\NN\5736149 (l_compound) necrosis_38\NN\11444117
D005947_D007674 NONE glucose_21\NN\14710501 (r_compound) reabsorption_22\NN\13526110 (r_pobj) of_19\IN\0 (r_prep) blockage_18\NN\14034177 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) rats_11\NNS\2329401 (r_pobj) in_7\IN\13603305 (r_prep) studied_6\VBN\0 (l_nsubjpass) protection_1\NN\407535 (l_prep) from_2\IN\0 (l_pobj) nephrotoxicity_4\NN\0
15531665
D001205_D050197 NONE c_12\NN\13714184 (r_pobj) of_10\IN\0 (r_prep) intake_9\NN\13440063 (r_nsubj) promote_17\VB\2556126 (l_dobj) atherosclerosis_18\NN\14108324
D005492_D002318 NONE folate_21\NN\15090742 (r_nmod) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (r_appos) factors_6\NNS\7326557 (l_compound) risk_5\NN\14541044 (l_compound) disease_4\NN\14061805
D005492_D002318 NONE folate_21\NN\15090742 (r_nmod) e_24\NN\14724645 (l_conj) carotene_29\NN\15090379 (l_appos) risks_34\NNS\14541044 (l_prep) of_35\IN\0 (l_pobj) mortality_39\NN\5054863 (l_compound) disease_38\NN\14061805
D014810_D002318 NONE e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (r_appos) factors_6\NNS\7326557 (l_compound) risk_5\NN\14541044 (l_compound) disease_4\NN\14061805
D014810_D002318 NONE e_24\NN\14724645 (l_conj) carotene_29\NN\15090379 (l_appos) risks_34\NNS\14541044 (l_prep) of_35\IN\0 (l_pobj) mortality_39\NN\5054863 (l_compound) disease_38\NN\14061805
D019207_D003920 NONE carotene_29\NN\15090379 (r_conj) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (l_prep) of_9\IN\0 (l_pobj) medication_11\NN\3247620 (l_compound) diabetes_10\NN\14075199
D019207_D003920 NONE carotene_29\NN\15090379 (r_conj) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (l_prep) of_15\IN\0 (l_pobj) diabetes_16\NNS\14075199
D019207_D002318 NONE carotene_29\NN\15090379 (r_conj) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (r_appos) factors_6\NNS\7326557 (l_compound) risk_5\NN\14541044 (l_compound) disease_4\NN\14061805
D019207_D002318 NONE carotene_29\NN\15090379 (l_appos) risks_34\NNS\14541044 (l_prep) of_35\IN\0 (l_pobj) mortality_39\NN\5054863 (l_compound) disease_38\NN\14061805
D001205_D003324 NONE c_6\NN\13714184 (r_compound) intake_7\NN\13440063 (r_pobj) between_4\IN\0 (r_prep) relation_3\NN\2137 (r_dobj) studied_1\VBD\0 (l_dep) disease_22\NN\14061805
D001205_D002318 CID c_3\NN\13714184 (r_nsubj) increase_4\VB\13576355 (l_dobj) risk_7\NN\14541044 (l_compound) disease_6\NN\14061805
D001205_D002318 CID c_10\NN\13714184 (r_compound) intake_11\NN\13440063 (l_prep) from_14\IN\0 (l_pobj) disease_16\NN\14061805
D001205_D002318 CID c_6\NN\13714184 (r_compound) intake_7\NN\13440063 (l_prep) from_10\IN\0 (l_pobj) disease_13\NN\14061805
D001205_D002318 CID c_63\NN\13714184 (r_compound) intake_64\NN\13440063 (r_pobj) of_60\IN\0 (r_prep) quintiles_59\NNS\0 (r_pobj) across_58\IN\0 (r_prep) 1.0_41\CD\0 (r_attr) were_40\VBD\0 (l_nsubj) adjustment_1\NN\7357388 (l_prep) for_2\IN\0 (l_pobj) factors_6\NNS\7326557 (l_compound) risk_5\NN\14541044 (l_compound) disease_4\NN\14061805
D001205_D002318 CID c_63\NN\13714184 (r_compound) intake_64\NN\13440063 (r_pobj) of_60\IN\0 (r_prep) quintiles_59\NNS\0 (r_pobj) across_58\IN\0 (r_prep) 1.0_41\CD\0 (r_attr) were_40\VBD\0 (l_nsubj) adjustment_1\NN\7357388 (l_prep) for_2\IN\0 (l_pobj) factors_6\NNS\7326557 (l_appos) type_8\NN\5839024 (l_conj) duration_14\NN\15113229 (l_conj) intakes_19\NNS\13440063 (l_prep) of_20\IN\0 (l_pobj) e_24\NN\14724645 (l_conj) carotene_29\NN\15090379 (l_appos) risks_34\NNS\14541044 (l_prep) of_35\IN\0 (l_pobj) mortality_39\NN\5054863 (l_compound) disease_38\NN\14061805
D001205_D002318 CID c_1\NN\13714184 (r_compound) intake_2\NN\13440063 (r_nsubj) was_3\VBD\0 (l_acomp) unrelated_4\JJ\0 (l_prep) to_5\IN\0 (l_pobj) mortality_6\NN\5054863 (l_prep) from_7\IN\0 (l_pobj) disease_9\NN\14061805
D001205_D002318 CID c_3\NN\13714184 (r_compound) intake_4\NN\13440063 (r_nsubjpass) associated_8\VBN\628491 (l_prep) with_9\IN\0 (l_pobj) risk_12\NN\14541044 (l_prep) of_13\IN\0 (l_pobj) mortality_16\NN\5054863 (l_compound) disease_15\NN\14061805
D005492_D003920 NONE folate_21\NN\15090742 (r_nmod) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (l_prep) of_9\IN\0 (l_pobj) medication_11\NN\3247620 (l_compound) diabetes_10\NN\14075199
D005492_D003920 NONE folate_21\NN\15090742 (r_nmod) e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (l_prep) of_15\IN\0 (l_pobj) diabetes_16\NNS\14075199
D001205_D020521 NONE c_6\NN\13714184 (r_compound) intake_7\NN\13440063 (r_pobj) between_4\IN\0 (r_prep) relation_3\NN\2137 (r_dobj) studied_1\VBD\0 (l_dep) disease_22\NN\14061805 (l_conj) stroke_30\NN\556313
D014810_D003920 NONE e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (r_conj) type_8\NN\5839024 (l_prep) of_9\IN\0 (l_pobj) medication_11\NN\3247620 (l_compound) diabetes_10\NN\14075199
D014810_D003920 NONE e_24\NN\14724645 (r_pobj) of_20\IN\0 (r_prep) intakes_19\NNS\13440063 (r_conj) duration_14\NN\15113229 (l_prep) of_15\IN\0 (l_pobj) diabetes_16\NNS\14075199
D001205_D003920 NONE c_3\NN\13714184 (r_nsubj) increase_4\VB\13576355 (l_dobj) risk_7\NN\14541044 (l_prep) in_8\IN\13603305 (l_pobj) women_9\NNS\9605289 (l_prep) with_10\IN\0 (l_pobj) diabetes_11\NNS\14075199
D001205_D003920 NONE c_12\NN\13714184 (r_pobj) of_10\IN\0 (r_prep) intake_9\NN\13440063 (l_prep) in_13\IN\13603305 (l_pobj) persons_15\NNS\7347 (l_amod) diabetic_14\JJ\10595647
D001205_D003920 NONE c_6\NN\13714184 (r_compound) intake_7\NN\13440063 (r_pobj) between_4\IN\0 (r_prep) relation_3\NN\2137 (r_dobj) studied_1\VBD\0 (l_dep) disease_22\NN\14061805 (l_conj) stroke_30\NN\556313 (l_prep) in_36\IN\13603305 (l_pobj) women_39\NNS\9605289 (l_relcl) reported_41\VBD\831651 (l_xcomp) being_42\VBG\24720 (l_acomp) diabetic_43\JJ\10595647
D001205_D003920 NONE c_63\NN\13714184 (r_compound) intake_64\NN\13440063 (r_pobj) of_60\IN\0 (r_prep) quintiles_59\NNS\0 (r_pobj) across_58\IN\0 (r_prep) 1.0_41\CD\0 (r_attr) were_40\VBD\0 (l_nsubj) adjustment_1\NN\7357388 (l_prep) for_2\IN\0 (l_pobj) factors_6\NNS\7326557 (l_appos) type_8\NN\5839024 (l_prep) of_9\IN\0 (l_pobj) medication_11\NN\3247620 (l_compound) diabetes_10\NN\14075199
D001205_D003920 NONE c_63\NN\13714184 (r_compound) intake_64\NN\13440063 (r_pobj) of_60\IN\0 (r_prep) quintiles_59\NNS\0 (r_pobj) across_58\IN\0 (r_prep) 1.0_41\CD\0 (r_attr) were_40\VBD\0 (l_nsubj) adjustment_1\NN\7357388 (l_prep) for_2\IN\0 (l_pobj) factors_6\NNS\7326557 (l_appos) type_8\NN\5839024 (l_conj) duration_14\NN\15113229 (l_prep) of_15\IN\0 (l_pobj) diabetes_16\NNS\14075199
D001205_D003920 NONE c_3\NN\13714184 (r_compound) intake_4\NN\13440063 (r_nsubjpass) associated_8\VBN\628491 (l_prep) with_9\IN\0 (l_pobj) risk_12\NN\14541044 (l_prep) of_13\IN\0 (l_pobj) mortality_16\NN\5054863 (l_prep) in_17\IN\13603305 (l_pobj) women_19\NNS\9605289 (l_prep) with_20\IN\0 (l_pobj) diabetes_21\NNS\14075199
16563323
D005045_D011537 NONE etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637 (l_conj) nausea_21\NN\14299637 (l_conj) pruritus_24\NN\5723563
C071741_D001049 NONE remifentanil_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637
D005045_D001049 NONE etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637
C071741_D011537 NONE remifentanil_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637 (l_conj) nausea_21\NN\14299637 (l_conj) pruritus_24\NN\5723563
C071741_D009325 NONE remifentanil_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (r_nsubj) etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637 (l_conj) nausea_21\NN\14299637
D005045_D009325 NONE etomidate_10\NN\0 (l_prep) without_12\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) as_16\IN\14622893 (l_pobj) sedation_17\NN\14034177 (l_conj) apnea_19\NN\14299637 (l_conj) nausea_21\NN\14299637
D005045_D009207 CID etomidate_5\NN\0 (r_advcl) reduces_2\VBZ\441445 (l_dobj) myoclonus_3\NN\14360459
D005045_D009207 CID etomidate_32\NN\0 (r_pobj) with_31\IN\0 (r_prep) induction_30\NN\7450842 (r_amod) anesthesia_29\NN\14034177 (r_pobj) after_28\IN\0 (r_prep) effect_20\NN\34213 (l_prep) on_23\IN\0 (l_pobj) incidence_25\NN\13821570 (l_prep) of_26\IN\0 (l_pobj) myoclonus_27\NN\14360459
D005045_D009207 CID etomidate_16\NN\0 (r_advcl) associated_8\VBN\628491 (l_prep) with_9\IN\0 (l_pobj) incidence_12\NN\13821570 (l_prep) of_13\IN\0 (l_pobj) myoclonus_14\NN\14360459
D005045_D009207 CID etomidate_10\NN\0 (l_nsubj) pretreatment_0\NN\0 (l_appos) myoclonus_8\NN\14360459
D005045_D009207 CID etomidate_9\NN\0 (r_advcl) increased_2\VBD\169651 (l_dobj) incidence_3\NN\13821570 (l_prep) of_4\IN\0 (l_pobj) myoclonus_5\NN\14360459
C071741_D009207 NONE remifentanil_0\NNP\0 (r_compound) pretreatment_1\NN\0 (r_nsubj) reduces_2\VBZ\441445 (l_dobj) myoclonus_3\NN\14360459
C071741_D009207 NONE remifentanil_13\NN\0 (r_nmod) kg_17\NNS\13717155 (r_pobj) with_12\IN\0 (r_prep) pretreatment_11\NN\0 (l_conj) effect_20\NN\34213 (l_prep) on_23\IN\0 (l_pobj) incidence_25\NN\13821570 (l_prep) of_26\IN\0 (l_pobj) myoclonus_27\NN\14360459
C071741_D009207 NONE remifentanil_9\NN\0 (r_compound) group_10\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) lower_6\JJR\2831724 (r_acomp) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) myoclonus_3\NN\14360459
C071741_D009207 NONE remifentanil_2\NN\0 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (l_appos) myoclonus_8\NN\14360459
16584858
C009591_D017202 NONE chloride_10\NN\14818238 (r_nmod) test_14\NN\5798043 (l_acl) used_15\VBN\0 (l_prep) for_16\IN\0 (l_pobj) assay_20\NN\5733583 (l_prep) of_21\IN\0 (l_pobj) myocardium_24\NN\5389939
C009591_D017202 NONE ttc_12\NNP\0 (r_nmod) test_14\NN\5798043 (l_acl) used_15\VBN\0 (l_prep) for_16\IN\0 (l_pobj) assay_20\NN\5733583 (l_prep) of_21\IN\0 (l_pobj) myocardium_24\NN\5389939
D007501_D009202 NONE iron_58\NN\14625458 (r_nmod) capacity_60\NN\5202497 (r_conj) level_54\NN\4916342 (r_dobj) increased_51\VBN\169651 (l_ccomp) caused_20\VBD\1617192 (l_dobj) damage_22\NN\7296428
C013592_D017202 NONE mangiferin_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) role_2\NN\719494 (r_nsubjpass) analyzed_6\VBN\0 (l_agent) by_7\IN\0 (l_pobj) test_14\NN\5798043 (l_acl) used_15\VBN\0 (l_prep) for_16\IN\0 (l_pobj) assay_20\NN\5733583 (l_prep) of_21\IN\0 (l_pobj) myocardium_24\NN\5389939
C013592_D009203 NONE mangiferin_2\NN\0 (l_prep) on_3\IN\0 (l_pobj) alterations_5\NNS\7283608 (l_prep) in_9\IN\13603305 (l_pobj) infarction_14\NN\14204950
C013592_D009203 NONE mangiferin_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) pretreatment_1\NN\0 (r_pobj) upon_0\IN\0 (r_prep) suspended_9\VBN\1481360 (l_prep) given_17\VBN\5892096 (l_prep) to_22\IN\0 (l_pobj) rats_24\NNS\2329401 (l_compound) mi_23\NNP\14207561
C013592_D009203 NONE mangiferin_16\JJ\0 (r_compound) administration_17\NN\1133281 (r_pobj) upon_15\IN\0 (r_prep) rose_13\VBD\13112664 (l_prep) compared_19\VBN\644583 (l_prep) to_20\IN\0 (l_pobj) rats_25\NNS\2329401 (l_compound) mi_24\NNP\14207561
C013592_D009203 NONE mangiferin_8\NN\0 (r_nsubj) exerts_9\VBZ\1158872 (l_dobj) effect_12\NN\34213 (l_prep) against_13\IN\0 (l_pobj) mi_17\NNP\14207561
D014527_D009202 NONE acid_53\NN\14818238 (r_compound) level_54\NN\4916342 (r_dobj) increased_51\VBN\169651 (l_ccomp) caused_20\VBD\1617192 (l_dobj) damage_22\NN\7296428
C013592_D006331 NONE mangiferin_8\NN\0 (r_nsubj) exerts_9\VBZ\1158872 (l_prep) due_18\IN\5174653 (l_pcomp) to_19\IN\0 (l_pobj) potential_22\NN\14481929 (l_relcl) regulated_25\VBD\296178 (l_prep) against_30\IN\0 (l_pobj) damage_32\NN\7296428
D001205_D009203 NONE c_31\NN\13714184 (r_conj) cerruloplasmin_28\NN\0 (r_pobj) as_27\IN\14622893 (r_prep) antioxidants_25\NNS\14724436 (r_appos) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D019344_D009202 NONE lactate_36\NN\14850483 (r_compound) dehydrogenase_37\NN\0 (r_pobj) of_34\IN\0 (r_prep) activity_33\NN\30358 (r_pobj) by_30\IN\0 (r_agent) determined_29\VBN\0 (r_relcl) heart_25\NN\5919034 (r_pobj) in_23\IN\13603305 (r_prep) damage_22\NN\7296428
D005978_D009203 NONE glutathione_12\NN\0 (r_compound) peroxidase_13\NN\14971234 (r_conj) catalase_10\NNP\14732946 (r_conj) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D005978_D009203 NONE glutathione_15\NN\0 (r_compound) transferase_16\NN\14732946 (r_conj) peroxidase_13\NN\14971234 (r_conj) catalase_10\NNP\14732946 (r_conj) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D005978_D009203 NONE glutathione_18\NN\0 (r_compound) reductase_19\NN\14732946 (r_compound) activities_20\NNS\30358 (r_conj) transferase_16\NN\14732946 (r_conj) peroxidase_13\NN\14971234 (r_conj) catalase_10\NNP\14732946 (r_conj) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D005978_D009203 NONE glutathione_36\NN\0 (r_conj) e_34\NN\14724645 (r_conj) c_31\NN\13714184 (r_conj) cerruloplasmin_28\NN\0 (r_pobj) as_27\IN\14622893 (r_prep) antioxidants_25\NNS\14724436 (r_appos) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D007545_D009202 NONE isph_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) injection_1\NN\320852 (r_nsubj) caused_20\VBD\1617192 (l_dobj) damage_22\NN\7296428
D003401_D009202 NONE creatine_42\NN\14601829 (r_conj) caused_20\VBD\1617192 (l_dobj) damage_22\NN\7296428
D014810_D009203 NONE e_34\NN\14724645 (r_conj) c_31\NN\13714184 (r_conj) cerruloplasmin_28\NN\0 (r_pobj) as_27\IN\14622893 (r_prep) antioxidants_25\NNS\14724436 (r_appos) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D004121_D009203 NONE sulphoxide_15\RB\0 (r_pobj) of_13\IN\0 (r_prep) ml_12\NNS\13616054 (r_pobj) in_10\IN\13603305 (r_prep) suspended_9\VBN\1481360 (l_prep) given_17\VBN\5892096 (l_prep) to_22\IN\0 (l_pobj) rats_24\NNS\2329401 (l_compound) mi_23\NNP\14207561
D013481_D009203 NONE superoxide_7\JJ\14971519 (r_amod) dismutase_8\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) enzymes_4\NNS\14723628 (r_dobj) tissue_2\NN\5220461 (r_nsubjpass) altered_39\VBN\0 (l_prep) in_40\IN\13603305 (l_pobj) rats_42\NNS\2329401 (l_compound) mi_41\NNP\14207561
D007545_D006331 NONE isph_14\NNP\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) mi_17\NNP\14207561 (r_pobj) against_13\IN\0 (r_prep) effect_12\NN\34213 (r_dobj) exerts_9\VBZ\1158872 (l_prep) due_18\IN\5174653 (l_pcomp) to_19\IN\0 (l_pobj) potential_22\NN\14481929 (l_relcl) regulated_25\VBD\296178 (l_prep) against_30\IN\0 (l_pobj) damage_32\NN\7296428
D007545_D009203 CID isoproterenol_10\NN\3740161 (r_npadvmod) induced_12\VBN\1627355 (r_amod) infarction_14\NN\14204950
D007545_D009203 CID isoproterenol_5\NN\3740161 (r_pobj) on_4\IN\0 (r_prep) infarction_9\NN\14204950
D007545_D009203 CID isoproterenol_5\NN\3740161 (r_pobj) on_4\IN\0 (r_prep) infarction_9\NN\14204950 (l_appos) mi_11\NNP\14207561
D007545_D009203 CID isph)-induced_7\JJ\0 (r_amod) infarction_9\NN\14204950
D007545_D009203 CID isph)-induced_7\JJ\0 (r_amod) infarction_9\NN\14204950 (l_appos) mi_11\NNP\14207561
D007545_D009203 CID isph_21\NNP\0 (r_npadvmod) induced_23\VBN\1627355 (r_amod) rats_25\NNS\2329401 (l_compound) mi_24\NNP\14207561
D007545_D009203 CID isph_14\NNP\0 (r_npadvmod) induced_16\VBN\1627355 (r_amod) mi_17\NNP\14207561
2004
D000639_D002037 CID elavil_5\NNP\4482543 (r_conj) aventyl_0\NNP\0 (r_nsubj) block_14\NN\21939
D000639_D002037 CID amitriptyline_7\FW\4482543 (r_appos) elavil_5\NNP\4482543 (r_conj) aventyl_0\NNP\0 (r_nsubj) block_14\NN\21939
D013881_D017180 CID mellaril_8\NNP\3713736 (r_nsubj) appeared_12\VBD\2604760 (l_xcomp) be_14\VB\14625458 (l_acomp) responsible_15\JJ\0 (l_prep) for_16\IN\0 (l_pobj) cases_18\NNS\7283608 (l_prep) of_19\IN\0 (l_pobj) tachycardia_21\NN\14110674
D013881_D017180 CID thioridazine_10\NNP\3713736 (r_appos) mellaril_8\NNP\3713736 (r_nsubj) appeared_12\VBD\2604760 (l_xcomp) be_14\VB\14625458 (l_acomp) responsible_15\JJ\0 (l_prep) for_16\IN\0 (l_pobj) cases_18\NNS\7283608 (l_prep) of_19\IN\0 (l_pobj) tachycardia_21\NN\14110674
D010640_D005117 NONE phenothiazines_16\NNS\14771088 (r_dobj) receiving_15\VBG\2210855 (r_acl) patients_14\NNS\9898892 (r_pobj) to_13\IN\0 (r_prep) complications_12\NNS\1073995
D008012_D001145 NONE lidocaine_8\NN\3681148 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) to_4\IN\0 (r_prep) responded_3\VBD\2367363 (l_nsubj) arrhythmias_2\NNS\14103288
D011433_D001145 NONE propranolol_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) instances_22\NNS\7283608 (r_pobj) in_20\IN\13603305 (r_prep) required_19\VBN\0 (l_ccomp) responded_3\VBD\2367363 (l_nsubj) arrhythmias_2\NNS\14103288
D002746_D013617 NONE thorazine_7\NN\3713736 (r_dobj) receiving_6\VBG\2210855 (r_acl) patient_5\NN\9898892 (r_pobj) in_3\IN\13603305 (r_prep) developed_2\VBN\1753788 (l_nsubj) tachycardia_1\NN\14110674
D002746_D013617 NONE chlorpromazine_9\NN\3713736 (r_appos) thorazine_7\NN\3713736 (r_dobj) receiving_6\VBG\2210855 (r_acl) patient_5\NN\9898892 (r_pobj) in_3\IN\13603305 (r_prep) developed_2\VBN\1753788 (l_nsubj) tachycardia_1\NN\14110674
D009661_D002037 CID aventyl_0\NNP\0 (r_nsubj) block_14\NN\21939
D009661_D002037 CID nortriptyline_2\NN\4482543 (r_appos) aventyl_0\NNP\0 (r_nsubj) block_14\NN\21939
12745515
D016642_D012892 NONE bupropion_9\NN\0 (r_conj) deprivation_4\NN\14493145
D016642_D012892 NONE bupropion_12\NN\0 (r_compound) use_13\NN\407535 (l_conj) deprivation_16\NN\14493145
D016642_D012892 NONE bupropion_11\NN\0 (r_npadvmod) associated_13\VBN\628491 (r_amod) seizures_14\NNS\14081375 (r_pobj) of_10\IN\0 (r_prep) risk_9\NN\14541044 (r_pobj) to_7\IN\0 (r_prep) add_6\VB\14304060 (l_nsubj) deprivation_4\NN\14493145
D016642_D012640 CID bupropion_9\NN\0 (r_conj) deprivation_4\NN\14493145 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) seizure_0\NN\14081375
D016642_D012640 CID bupropion_12\NN\0 (r_compound) use_13\NN\407535 (r_pobj) with_8\IN\0 (r_prep) associated_7\VBN\628491 (r_acl) seizure_6\NN\14081375
D016642_D012640 CID bupropion_4\NN\0 (r_compound) use_5\NN\407535 (r_pobj) of_3\IN\0 (r_prep) weeks_2\NNS\15113229 (r_pobj) after_0\IN\0 (r_prep) experienced_9\VBD\2108377 (l_dobj) seizure_14\NN\14081375
D016642_D012640 CID bupropion_11\NN\0 (r_npadvmod) associated_13\VBN\628491 (r_amod) seizures_14\NNS\14081375
3708922
D000666_D007674 NONE b_24\NN\1355326 (r_conj) gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (l_amod) nephrotoxic_11\JJ\0
D000666_D064420 NONE b_24\NN\1355326 (r_conj) gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (r_pobj) with_9\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) aggravate_38\VB\126264 (l_ccomp) induced_41\VBN\1627355 (l_dobj) toxicity_42\NN\13576101
D007654_D007674 NONE ketoconazole_26\NN\0 (r_conj) b_24\NN\1355326 (r_conj) gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (l_amod) nephrotoxic_11\JJ\0
D016572_D064420 NONE csa_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) aggravate_38\VB\126264 (l_ccomp) induced_41\VBN\1627355 (l_dobj) toxicity_42\NN\13576101
D016572_D064420 NONE csa_40\NNP\0 (r_dobj) aggravate_38\VB\126264 (l_ccomp) induced_41\VBN\1627355 (l_dobj) toxicity_42\NN\13576101
D007654_D064420 NONE ketoconazole_26\NN\0 (r_conj) b_24\NN\1355326 (r_conj) gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (r_pobj) with_9\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) aggravate_38\VB\126264 (l_ccomp) induced_41\VBN\1627355 (l_dobj) toxicity_42\NN\13576101
D005839_D007674 NONE gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (l_amod) nephrotoxic_11\JJ\0
D005839_D007674 NONE gentamicin_0\NNP\2716866 (r_nsubj) increased_7\VBD\169651 (l_dobj) nephrotoxicity_9\NN\0
D016572_D007674 CID cyclosporine_1\NN\0 (r_compound) nephrotoxicity_2\NN\0
D016572_D007674 CID cyclosporine_3\NN\0 (r_pobj) of_2\IN\0 (l_conj) in_9\IN\13603305 (l_pobj) combination_10\NN\7951464 (l_prep) with_11\IN\0 (l_pobj) chemotherapeutics_13\NNS\0 (l_prep) in_14\IN\13603305 (l_pobj) development_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) toxicity_19\NN\13576101
D016572_D007674 CID csa_5\NNP\0 (r_appos) cyclosporine_3\NN\0 (r_pobj) of_2\IN\0 (l_conj) in_9\IN\13603305 (l_pobj) combination_10\NN\7951464 (l_prep) with_11\IN\0 (l_pobj) chemotherapeutics_13\NNS\0 (l_prep) in_14\IN\13603305 (l_pobj) development_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) toxicity_19\NN\13576101
D016572_D007674 CID csa_4\NNP\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (l_prep) with_9\IN\0 (l_pobj) potential_12\NN\14481929 (l_amod) nephrotoxic_11\JJ\0
D016572_D007674 CID csa_40\NNP\0 (r_dobj) aggravate_38\VB\126264 (l_nsubj) administration_2\NN\1133281 (l_prep) with_9\IN\0 (l_pobj) potential_12\NN\14481929 (l_amod) nephrotoxic_11\JJ\0
D016572_D007674 CID csa_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0
D016572_D007674 CID csa_6\NNP\0 (r_pobj) by_5\IN\0 (r_agent) induced_4\VBN\1627355 (r_acl) nephrotoxicity_3\NN\0
D005839_D064420 NONE gentamicin_16\NN\2716866 (r_pobj) as_15\IN\14622893 (r_prep) potential_12\NN\14481929 (r_pobj) with_9\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) aggravate_38\VB\126264 (l_ccomp) induced_41\VBN\1627355 (l_dobj) toxicity_42\NN\13576101
15266215
C406224_D001168 NONE valdecoxib_6\NNS\3124700 (l_prep) versus_7\IN\0 (l_pobj) agents_10\NNS\7347 (l_conj) placebo_12\NN\3740161 (l_prep) on_13\IN\0 (l_pobj) events_16\NNS\23100 (l_prep) in_17\IN\13603305 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) arthritis_20\NN\14171682
D009288_D013927 NONE naproxen_46\NN\3828465 (r_conj) ibuprofen_40\VBD\3828465 (r_npadvmod) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_amod) thrombotic_4\JJ\0
D009288_D013927 NONE naproxen_46\NN\3828465 (r_conj) ibuprofen_40\VBD\3828465 (r_npadvmod) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_appos) thrombotic_16\JJ\0
D009288_D010003 NONE naproxen_46\NN\3828465 (r_conj) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_nmod) osteoarthritis_57\NN\14186541
D007052_D010003 NONE ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_nmod) osteoarthritis_57\NN\14186541
C406224_D010003 NONE valdecoxib_6\NNS\3124700 (r_pobj) for_5\IN\0 (r_prep) data_4\NNS\7951464 (l_appos) inhibitor_11\NN\20090 (l_prep) in_12\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) osteoarthritis_17\NN\14186541
C406224_D010003 NONE valdecoxib_23\NNS\3124700 (r_dobj) analyzing_21\VBG\0 (r_pcomp) by_20\IN\0 (r_prep) determined_19\VBN\0 (l_appos) nsaid_33\NNP\2721538 (l_npadvmod) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_nmod) osteoarthritis_57\NN\14186541
C406224_D010003 NONE valdecoxib_24\NN\3124700 (r_compound) doses_25\NNS\3740161 (r_conj) treatment_5\NN\654885 (r_nsubjpass) associated_28\VBN\628491 (l_prep) with_29\IN\0 (l_pobj) incidence_32\NN\13821570 (l_prep) of_33\IN\0 (l_pobj) events_35\NNS\23100 (l_amod) relative_36\JJ\7846 (l_prep) to_37\IN\0 (l_pobj) nsaids_39\NNPS\2721538 (l_prep) in_42\IN\13603305 (l_pobj) patients_47\NNS\9898892 (l_nmod) osteoarthritis_43\NN\14186541
D004008_D013927 NONE diclofenac_35\NN\0 (r_nmod) bid_38\NN\7160883 (r_appos) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_amod) thrombotic_4\JJ\0
D004008_D013927 NONE diclofenac_35\NN\0 (r_nmod) bid_38\NN\7160883 (r_appos) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_appos) thrombotic_16\JJ\0
D004008_D001172 NONE diclofenac_35\NN\0 (r_nmod) bid_38\NN\7160883 (r_appos) nsaid_33\NNP\2721538 (l_npadvmod) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_compound) arthritis_60\NN\14171682
C406224_D001172 NONE valdecoxib_6\NNS\3124700 (r_pobj) for_5\IN\0 (r_prep) data_4\NNS\7951464 (l_appos) inhibitor_11\NN\20090 (l_prep) in_12\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) osteoarthritis_17\NN\14186541 (l_conj) arthritis_20\NN\14171682
C406224_D001172 NONE valdecoxib_23\NNS\3124700 (r_dobj) analyzing_21\VBG\0 (r_pcomp) by_20\IN\0 (r_prep) determined_19\VBN\0 (l_appos) nsaid_33\NNP\2721538 (l_npadvmod) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_compound) arthritis_60\NN\14171682
C406224_D001172 NONE valdecoxib_24\NN\3124700 (r_compound) doses_25\NNS\3740161 (r_conj) treatment_5\NN\654885 (r_nsubjpass) associated_28\VBN\628491 (l_prep) with_29\IN\0 (l_pobj) incidence_32\NN\13821570 (l_prep) of_33\IN\0 (l_pobj) events_35\NNS\23100 (l_amod) relative_36\JJ\7846 (l_prep) to_37\IN\0 (l_pobj) nsaids_39\NNPS\2721538 (l_prep) in_42\IN\13603305 (l_pobj) patients_47\NNS\9898892 (l_compound) arthritis_46\NN\14171682
C406224_D013927 NONE valdecoxib_6\NNS\3124700 (l_prep) versus_7\IN\0 (l_pobj) agents_10\NNS\7347 (l_conj) placebo_12\NN\3740161 (l_prep) on_13\IN\0 (l_pobj) events_16\NNS\23100 (l_amod) thrombotic_15\JJ\0
C406224_D013927 NONE valdecoxib_23\NNS\3124700 (r_dobj) analyzing_21\VBG\0 (r_pcomp) by_20\IN\0 (r_prep) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_amod) thrombotic_4\JJ\0
C406224_D013927 NONE valdecoxib_23\NNS\3124700 (r_dobj) analyzing_21\VBG\0 (r_pcomp) by_20\IN\0 (r_prep) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_appos) thrombotic_16\JJ\0
C406224_D013927 NONE valdecoxib_12\NNS\3124700 (r_pobj) for_11\IN\0 (r_prep) similar_10\JJ\0 (r_acomp) were_9\VBD\0 (l_nsubj) incidences_5\NNS\13821570 (l_prep) of_6\IN\0 (l_pobj) events_8\NNS\23100 (l_amod) thrombotic_7\JJ\0
C406224_D013927 NONE valdecoxib_11\NN\3124700 (r_compound) dose_12\NN\3740161 (r_pobj) for_9\IN\0 (r_prep) similar_8\JJ\0 (r_acomp) was_6\VBD\0 (l_nsubj) risk_1\NN\14541044 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_amod) thrombotic_4\JJ\0
C406224_D013927 NONE valdecoxib_23\NN\3124700 (r_conj) placebo_15\NN\3740161 (r_appos) nonusers_11\NNS\0 (r_pobj) than_10\IN\0 (r_prep) users_9\NNS\7846 (r_pobj) of_7\IN\0 (r_prep) users_6\NNS\7846 (r_pobj) for_5\IN\0 (r_prep) was_2\VBD\0 (l_nsubj) risk_1\NN\14541044 (l_amod) thrombotic_0\JJ\0
C406224_D013927 NONE valdecoxib_24\NN\3124700 (r_compound) doses_25\NNS\3740161 (r_conj) treatment_5\NN\654885 (r_nsubjpass) associated_28\VBN\628491 (l_prep) with_29\IN\0 (l_pobj) incidence_32\NN\13821570 (l_prep) of_33\IN\0 (l_pobj) events_35\NNS\23100 (l_amod) thrombotic_34\JJ\0
D007052_D013927 NONE ibuprofen_40\VBD\3828465 (r_npadvmod) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_amod) thrombotic_4\JJ\0
D007052_D013927 NONE ibuprofen_40\VBD\3828465 (r_npadvmod) nsaid_33\NNP\2721538 (r_appos) determined_19\VBN\0 (l_nsubjpass) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_5\NNS\23100 (l_appos) thrombotic_16\JJ\0
D001241_D013927 CID aspirin_8\NN\2707683 (r_compound) users_9\NNS\7846 (r_pobj) of_7\IN\0 (r_prep) users_6\NNS\7846 (r_pobj) for_5\IN\0 (r_prep) was_2\VBD\0 (l_nsubj) risk_1\NN\14541044 (l_amod) thrombotic_0\JJ\0
D001241_D013927 CID aspirin_13\NN\2707683 (r_pobj) of_12\IN\0 (r_prep) nonusers_11\NNS\0 (r_pobj) than_10\IN\0 (r_prep) users_9\NNS\7846 (r_pobj) of_7\IN\0 (r_prep) users_6\NNS\7846 (r_pobj) for_5\IN\0 (r_prep) was_2\VBD\0 (l_nsubj) risk_1\NN\14541044 (l_amod) thrombotic_0\JJ\0
D009288_D001172 NONE naproxen_46\NN\3828465 (r_conj) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_compound) arthritis_60\NN\14171682
D007052_D001172 NONE ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_compound) arthritis_60\NN\14171682
D004008_D010003 NONE diclofenac_35\NN\0 (r_nmod) bid_38\NN\7160883 (r_appos) nsaid_33\NNP\2721538 (l_npadvmod) ibuprofen_40\VBD\3828465 (l_conj) data_53\NNS\7951464 (l_prep) from_54\IN\0 (l_pobj) trials_61\NNS\786195 (l_nmod) osteoarthritis_57\NN\14186541
3311455
D016572_D007674 CID cyclosporine_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) therapy_15\NN\657604 (r_pobj) to_11\IN\0 (r_prep) secondary_10\JJ\8426461 (r_amod) nephrotoxicity_9\NN\0
D016572_D007674 CID cyclosporine_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) dosages_6\NNS\13576355 (r_nsubj) cause_10\VB\7323922 (l_dobj) nephrotoxicity_12\NN\0
20635749
D000638_D009230 CID amiodarone_6\NN\2715941 (r_pobj) on_5\IN\0 (l_pcomp) presenting_7\VBG\2137132 (l_prep) with_8\IN\0 (l_pobj) coma_10\NN\5678932
D000638_D009230 CID amiodarone_10\NN\2715941 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypothyroidism_13\NN\14059928 (r_pobj) to_9\IN\0 (r_prep) coma_7\NN\5678932
D000638_D009230 CID amiodarone_19\NN\2715941 (r_compound) therapy_20\NN\657604 (r_pobj) during_16\IN\0 (r_prep) report_12\NN\6470073 (l_prep) of_13\IN\0 (l_pobj) coma_15\NN\5678932
D000638_D003128 CID amiodarone_6\NN\2715941 (r_pobj) on_5\IN\0 (l_pcomp) presenting_7\VBG\2137132 (l_prep) with_8\IN\0 (l_pobj) coma_10\NN\5678932
D000638_D003128 CID amiodarone_10\NN\2715941 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypothyroidism_13\NN\14059928 (r_pobj) to_9\IN\0 (r_prep) coma_7\NN\5678932
D000638_D003128 CID amiodarone_19\NN\2715941 (r_compound) therapy_20\NN\657604 (r_pobj) during_16\IN\0 (r_prep) report_12\NN\6470073 (l_prep) of_13\IN\0 (l_pobj) coma_15\NN\5678932
D000638_D006333 NONE amiodarone_6\NN\2715941 (r_pobj) on_5\IN\0 (r_prep) patient_4\NN\9898892 (l_compound) failure_3\NN\66216
D000638_D006333 NONE amiodarone_10\NN\2715941 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypothyroidism_13\NN\14059928 (r_pobj) to_9\IN\0 (r_prep) coma_7\NN\5678932 (l_prep) in_14\IN\13603305 (l_pobj) patient_16\NN\9898892 (l_prep) with_17\IN\0 (l_pobj) failure_21\NN\66216
D000638_D006333 NONE amiodarone_10\NN\2715941 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypothyroidism_13\NN\14059928 (r_pobj) to_9\IN\0 (r_prep) coma_7\NN\5678932 (l_prep) in_14\IN\13603305 (l_pobj) patient_16\NN\9898892 (l_prep) with_17\IN\0 (l_pobj) failure_21\NN\66216 (l_appos) chf_23\NNP\0
D000638_D006333 NONE amiodarone_4\NN\2715941 (r_pobj) on_3\IN\0 (r_prep) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) chf_2\NNP\0
D000638_D006333 NONE amiodarone_13\NN\2715941 (l_prep) among_14\IN\0 (l_pobj) patients_16\NNS\9898892 (l_compound) chf_15\NNP\0
D000638_D007037 CID amiodarone_10\NN\2715941 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypothyroidism_13\NN\14059928
D000638_D007037 CID amiodarone_4\NN\2715941 (r_pobj) on_3\IN\0 (r_prep) patients_0\NNS\9898892 (r_nsubj) suffer_6\VB\2110220 (l_dobj) morbidity_8\NN\13826959 (l_prep) from_11\IN\0 (l_pobj) hypothyroidism_12\NN\14059928
17042884
C069541_D017109 NONE quetiapine_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) including_10\VBG\0 (l_pobj) akathisia_11\NN\0
C069541_D017109 NONE quetiapine_16\NN\0 (r_amod) monotherapy_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) different_14\JJ\0 (r_acomp) was_12\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) including_9\VBG\0 (l_pobj) akathisia_10\NN\0
C069541_D017109 NONE quetiapine_9\NN\0 (r_amod) monotherapy_10\NN\0 (r_pobj) with_8\IN\0 (r_prep) similar_7\JJ\0 (r_conj) low_5\JJ\14520518 (r_acomp) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
C069541_D017109 NONE qtp_24\NNP\0 (r_pobj) with_23\IN\0 (r_conj) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
C069541_D017109 NONE quetiapine_41\NN\0 (r_pcomp) than_40\IN\0 (r_prep) tremor_21\NN\345926 (r_npadvmod) induced_1\VBD\1627355 (l_dobj) incidence_5\NN\13821570 (l_appos) 0.001_9\CD\0 (l_prep) of_11\IN\0 (l_pobj) akathisia_12\NN\0
C069541_D017109 NONE quetiapine_13\NN\0 (r_amod) therapy_14\NN\657604 (r_nsubj) is_15\VBZ\0 (l_nsubj) incidence_5\NN\13821570 (l_prep) including_9\VBG\0 (l_pobj) akathisia_10\NN\0
D006220_D017109 CID haloperidol_0\NNP\3713736 (r_nsubj) induced_1\VBD\1627355 (l_dobj) incidence_5\NN\13821570 (l_appos) 0.001_9\CD\0 (l_prep) of_11\IN\0 (l_pobj) akathisia_12\NN\0
D006220_D014202 CID haloperidol_0\NNP\3713736 (r_nsubj) induced_1\VBD\1627355 (l_npadvmod) tremor_21\NN\345926
C069541_D014202 NONE quetiapine_20\NN\0 (r_pobj) than_19\IN\0 (r_prep) incidence_7\NN\13821570 (l_appos) 0.05_11\CD\0 (l_prep) of_13\IN\0 (l_pobj) tremor_14\NN\345926
C069541_D014202 NONE quetiapine_20\NN\0 (r_pobj) than_19\IN\0 (r_prep) incidence_7\NN\13821570 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_ccomp) contributed_40\VBN\126264 (l_nsubj) tremor_27\NN\345926
C069541_D014202 NONE quetiapine_20\NN\0 (r_pobj) than_19\IN\0 (r_prep) incidence_7\NN\13821570 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_ccomp) contributed_40\VBN\126264 (l_prep) to_41\IN\0 (l_pobj) rate_44\NN\13815152 (l_prep) of_45\IN\0 (l_pobj) tremor_46\NN\345926
C069541_D014202 NONE quetiapine_41\NN\0 (r_pcomp) than_40\IN\0 (r_prep) tremor_21\NN\345926
D006220_D001480 CID haloperidol_13\NN\3713736 (r_pobj) with_12\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) patients_10\NNS\9898892 (r_pobj) of_9\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_nsubj) events_1\NNS\23100 (l_acl) related_2\VBN\628491 (l_prep) to_3\IN\0 (l_pobj) eps_4\NNP\0
D006220_D001480 CID haloperidol_0\NNP\3713736 (r_nsubj) induced_1\VBD\1627355 (l_npadvmod) tremor_21\NN\345926 (l_conj) syndrome_32\NN\5870365
C069541_D001480 NONE quetiapine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) incidence_3\NN\13821570 (l_prep) of_4\IN\0 (l_pobj) symptoms_6\NNS\5823932
C069541_D001480 NONE quetiapine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) incidence_3\NN\13821570 (l_prep) of_4\IN\0 (l_pobj) symptoms_6\NNS\5823932 (l_appos) eps_8\NNP\0
C069541_D001480 NONE quetiapine_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) including_10\VBG\0 (r_prep) evaluate_3\VB\670261 (l_dobj) symptoms_5\NNS\5823932
C069541_D001480 NONE quetiapine_14\NN\0 (r_pobj) with_13\IN\0 (r_prep) including_10\VBG\0 (r_prep) evaluate_3\VB\670261 (l_dobj) symptoms_5\NNS\5823932 (l_appos) eps_7\NNP\0
C069541_D001480 NONE quetiapine_16\NN\0 (r_amod) monotherapy_17\NN\0 (r_pobj) with_15\IN\0 (r_prep) different_14\JJ\0 (r_acomp) was_12\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) events_7\NNS\23100 (l_amod) related_5\VBN\628491 (l_npadvmod) eps_3\NNP\0
C069541_D001480 NONE qtp_8\NNP\0 (r_pobj) with_7\IN\0 (r_prep) events_6\NNS\23100 (l_amod) related_4\VBN\628491 (l_npadvmod) eps_2\NNP\0
C069541_D001480 NONE quetiapine_41\NN\0 (r_pcomp) than_40\IN\0 (r_prep) tremor_21\NN\345926 (l_conj) syndrome_32\NN\5870365
C069541_D001480 NONE quetiapine_13\NN\0 (r_amod) therapy_14\NN\657604 (r_nsubj) is_15\VBZ\0 (l_nsubj) incidence_5\NN\13821570 (l_prep) of_6\IN\0 (l_pobj) eps_7\NNP\0
C069541_D001714 NONE quetiapine_11\NN\0 (l_prep) in_12\IN\13603305 (l_pobj) studies_14\NNS\635850 (l_prep) of_15\IN\0 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) mania_19\NN\9180259
C069541_D001714 NONE quetiapine_14\NN\0 (l_prep) in_15\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) mania_19\NN\9180259
C069541_D001714 NONE quetiapine_13\NN\0 (r_amod) therapy_14\NN\657604 (r_nsubj) is_15\VBZ\0 (l_prep) in_0\IN\13603305 (l_pobj) mania_2\NN\9180259
D008094_D001480 CID li_10\NNP\14625458 (r_nmod) dvp_12\NNP\0 (r_conj) qtp_8\NNP\0 (r_pobj) with_7\IN\0 (r_prep) events_6\NNS\23100 (l_amod) related_4\VBN\628491 (l_npadvmod) eps_2\NNP\0
D008094_D001480 CID li_24\NNP\14625458 (r_nmod) dvp_26\NNP\0 (r_conj) pbo_22\NNP\0 (r_pobj) with_21\IN\0 (r_prep) than_20\IN\0 (r_prep) different_19\JJ\0 (r_acomp) were_17\VBD\0 (l_nsubj) events_6\NNS\23100 (l_amod) related_4\VBN\628491 (l_npadvmod) eps_2\NNP\0
D008094_D001480 CID lithium_28\NN\14625458 (r_pobj) with_27\IN\0 (r_prep) treated_26\VBN\2376958 (r_acl) patients_25\NNS\9898892 (r_pobj) of_24\IN\0 (r_prep) %_23\NN\0 (r_pobj) whereas_21\IN\0 (r_prep) treated_11\VBN\2376958 (r_acl) patients_10\NNS\9898892 (r_pobj) of_9\IN\0 (r_prep) %_8\NN\0 (r_pobj) in_6\IN\13603305 (r_prep) occurred_5\VBD\0 (l_nsubj) events_1\NNS\23100 (l_acl) related_2\VBN\628491 (l_prep) to_3\IN\0 (l_pobj) eps_4\NNP\0
D008094_D017109 NONE li_26\NNP\14625458 (r_nmod) dvp_28\NNP\0 (r_conj) qtp_24\NNP\0 (r_pobj) with_23\IN\0 (r_conj) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
D008094_D017109 NONE li_36\NNP\14625458 (r_compound) dvp_38\NNP\0 (r_conj) pbo_34\NNP\0 (r_conj) dvp_28\NNP\0 (r_conj) qtp_24\NNP\0 (r_pobj) with_23\IN\0 (r_conj) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
D008094_D014202 CID lithium_0\NN\14625458 (r_nsubjpass) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) incidence_7\NN\13821570 (l_appos) 0.05_11\CD\0 (l_prep) of_13\IN\0 (l_pobj) tremor_14\NN\345926
D008094_D014202 CID lithium_0\NN\14625458 (r_nsubjpass) associated_2\VBN\628491 (r_ccomp) contributed_40\VBN\126264 (l_nsubj) tremor_27\NN\345926
D008094_D014202 CID lithium_0\NN\14625458 (r_nsubjpass) associated_2\VBN\628491 (r_ccomp) contributed_40\VBN\126264 (l_prep) to_41\IN\0 (l_pobj) rate_44\NN\13815152 (l_prep) of_45\IN\0 (l_pobj) tremor_46\NN\345926
D008094_D014202 CID lithium_36\NN\14625458 (r_pobj) of_35\IN\0 (r_prep) effect_34\NN\34213 (r_attr) is_30\VBZ\0 (r_relcl) tremor_27\NN\345926 (r_nsubj) contributed_40\VBN\126264 (l_ccomp) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) incidence_7\NN\13821570 (l_appos) 0.05_11\CD\0 (l_prep) of_13\IN\0 (l_pobj) tremor_14\NN\345926
D008094_D014202 CID lithium_36\NN\14625458 (r_pobj) of_35\IN\0 (r_prep) effect_34\NN\34213 (r_attr) is_30\VBZ\0 (r_relcl) tremor_27\NN\345926
D008094_D014202 CID lithium_36\NN\14625458 (r_pobj) of_35\IN\0 (r_prep) effect_34\NN\34213 (r_attr) is_30\VBZ\0 (r_relcl) tremor_27\NN\345926 (r_nsubj) contributed_40\VBN\126264 (l_prep) to_41\IN\0 (l_pobj) rate_44\NN\13815152 (l_prep) of_45\IN\0 (l_pobj) tremor_46\NN\345926
D008094_D014202 CID lithium_50\NN\14625458 (r_compound) therapy_51\NN\657604 (r_dobj) receiving_49\VBG\2210855 (r_acl) patients_48\NNS\9898892 (r_pobj) in_47\IN\13603305 (r_prep) rate_44\NN\13815152 (r_pobj) to_41\IN\0 (r_prep) contributed_40\VBN\126264 (l_ccomp) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) incidence_7\NN\13821570 (l_appos) 0.05_11\CD\0 (l_prep) of_13\IN\0 (l_pobj) tremor_14\NN\345926
D008094_D014202 CID lithium_50\NN\14625458 (r_compound) therapy_51\NN\657604 (r_dobj) receiving_49\VBG\2210855 (r_acl) patients_48\NNS\9898892 (r_pobj) in_47\IN\13603305 (r_prep) rate_44\NN\13815152 (r_pobj) to_41\IN\0 (r_prep) contributed_40\VBN\126264 (l_nsubj) tremor_27\NN\345926
D008094_D014202 CID lithium_50\NN\14625458 (r_compound) therapy_51\NN\657604 (r_dobj) receiving_49\VBG\2210855 (r_acl) patients_48\NNS\9898892 (r_pobj) in_47\IN\13603305 (r_prep) rate_44\NN\13815152 (l_prep) of_45\IN\0 (l_pobj) tremor_46\NN\345926
D014635_D001480 NONE dvp_12\NNP\0 (r_conj) qtp_8\NNP\0 (r_pobj) with_7\IN\0 (r_prep) events_6\NNS\23100 (l_amod) related_4\VBN\628491 (l_npadvmod) eps_2\NNP\0
D014635_D001480 NONE dvp_26\NNP\0 (r_conj) pbo_22\NNP\0 (r_pobj) with_21\IN\0 (r_prep) than_20\IN\0 (r_prep) different_19\JJ\0 (r_acomp) were_17\VBD\0 (l_nsubj) events_6\NNS\23100 (l_amod) related_4\VBN\628491 (l_npadvmod) eps_2\NNP\0
D014635_D017109 NONE dvp_28\NNP\0 (r_conj) qtp_24\NNP\0 (r_pobj) with_23\IN\0 (r_conj) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
D014635_D017109 NONE dvp_38\NNP\0 (r_conj) pbo_34\NNP\0 (r_conj) dvp_28\NNP\0 (r_conj) qtp_24\NNP\0 (r_pobj) with_23\IN\0 (r_conj) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) akathisia_3\NN\0
85485
D001556_D006528 CID hexachloride_15\NN\0 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) changes_0\NNS\7283608 (l_prep) in_1\IN\13603305 (l_pobj) peroxisomes_2\NNS\0 (l_prep) in_3\IN\13603305 (l_pobj) liver_5\NN\5298729 (l_conj) hepatoma_7\NN\14242337
D001556_D006528 CID hexachloride_17\NN\0 (r_pobj) by_11\IN\0 (r_prep) induced_8\VBN\1627355 (l_nsubj) peroxisomes_0\NNS\0 (l_prep) in_1\IN\13603305 (l_pobj) hepatomas_2\NNS\14242337
D001556_D017093 NONE hexachloride_17\NN\0 (r_pobj) by_11\IN\0 (r_prep) induced_8\VBN\1627355 (l_nsubj) peroxisomes_0\NNS\0 (l_prep) in_1\IN\13603305 (l_pobj) lesions_7\NNS\14204950
C012282_D009369 NONE chlorophenoxyisobutyrate_31\NN\0 (r_appos) alpha_27\NN\6828818 (r_appos) ethyl_25\NN\14617189 (r_pobj) to_24\IN\0 (r_prep) respond_23\VB\2367363 (l_advcl) were_5\VBD\0 (l_attr) tumors_9\NNS\14234074
C012282_D009369 NONE chlorophenoxyisobutyrate_31\NN\0 (r_appos) alpha_27\NN\6828818 (r_appos) ethyl_25\NN\14617189 (r_pobj) to_24\IN\0 (r_prep) respond_23\VB\2367363 (l_nsubj) cells_20\NNS\3080309 (l_compound) tumor_19\NN\14234074
C012282_D006528 NONE chlorophenoxyisobutyrate_31\NN\0 (r_appos) alpha_27\NN\6828818 (r_appos) ethyl_25\NN\14617189 (r_pobj) to_24\IN\0 (r_prep) respond_23\VB\2367363 (l_advcl) were_5\VBD\0 (l_nsubj) most_1\JJS\0 (l_prep) of_2\IN\0 (l_pobj) hepatomas_4\NNS\14242337
14975762
D004317_D006333 CID doxorubicin_11\RB\2716866 (r_compound) induced_13\VBN\1627355 (r_pobj) from_10\IN\0 (r_prep) myocytes_9\NNS\0 (r_pobj) of_5\IN\0 (r_prep) overexpression_4\NN\0 (r_nsubj) apoptosis_14\NN\11486178 (l_conj) reduces_16\VBZ\441445 (l_dobj) extent_18\NN\13939892 (l_prep) of_19\IN\0 (l_pobj) failure_22\NN\66216
D004317_D009369 NONE doxorubicin_0\NNP\2716866 (r_nsubj) is_1\VBZ\0 (l_attr) agent_6\NN\7347 (l_compound) tumor_5\NN\14234074
15930398
D015742_D000647 CID propofol_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) sedation_10\NN\14034177 (r_pobj) during_8\IN\0 (r_prep) onset_3\NN\7325190 (l_prep) of_6\IN\0 (l_pobj) amnesia_7\NN\5669934
18201582
C084178_D006973 NONE telmisartan_32\NN\0 (r_pobj) of_31\IN\0 (r_prep) combination_30\NN\7951464 (l_prep) with_41\IN\0 (l_pobj) hypertension_44\NN\14057371
C084178_D006973 NONE telmisartan_23\NNP\0 (r_pobj) of_22\IN\0 (r_prep) combination_18\NN\7951464 (r_pobj) of_12\IN\0 (r_prep) efficacy_9\NN\5199286 (r_dobj) evaluate_7\VB\670261 (l_conj) amlodipine_27\NN\0 (l_prep) compared_33\VBN\644583 (l_prep) with_34\IN\0 (l_pobj) amlodipine_35\NN\0 (l_appos) monotherapy_37\NN\0 (l_prep) in_41\IN\13603305 (l_pobj) patients_44\NNS\9898892 (l_prep) with_45\IN\0 (l_pobj) hypertension_48\NN\14057371
D017311_D006973 NONE amlodipine_34\NN\0 (r_conj) telmisartan_32\NN\0 (r_pobj) of_31\IN\0 (r_prep) combination_30\NN\7951464 (l_prep) with_41\IN\0 (l_pobj) hypertension_44\NN\14057371
D017311_D006973 NONE amlodipine_36\NN\0 (r_pobj) versus_35\IN\0 (r_prep) telmisartan_32\NN\0 (r_pobj) of_31\IN\0 (r_prep) combination_30\NN\7951464 (l_prep) with_41\IN\0 (l_pobj) hypertension_44\NN\14057371
D017311_D006973 NONE amlodipine_27\NN\0 (l_prep) compared_33\VBN\644583 (l_prep) with_34\IN\0 (l_pobj) amlodipine_35\NN\0 (l_appos) monotherapy_37\NN\0 (l_prep) in_41\IN\13603305 (l_pobj) patients_44\NNS\9898892 (l_prep) with_45\IN\0 (l_pobj) hypertension_48\NN\14057371
D017311_D006973 NONE amlodipine_35\NN\0 (l_appos) monotherapy_37\NN\0 (l_prep) in_41\IN\13603305 (l_pobj) patients_44\NNS\9898892 (l_prep) with_45\IN\0 (l_pobj) hypertension_48\NN\14057371
19917396
D016559_D006332 CID tacrolimus_5\NNS\0 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (r_acl) hypertrophy_2\NN\14365950
D016559_D006332 CID tacrolimus_8\NNS\0 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) hypertrophy_5\NN\14365950
D016559_D006332 CID tacrolimus_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) concentration_8\NN\4916342 (r_dobj) reducing_5\VBG\13447361 (r_pcomp) upon_4\IN\0 (r_prep) resolved_3\VBN\352826 (l_nsubj) hypertrophy_1\NN\14365950
D016559_D006332 CID tacrolimus_5\NN\0 (r_nsubj) induces_6\VBZ\1627355 (l_dobj) hypertrophy_9\NN\14365950
10074612
D008775_D007022 CID methylprednisolone_11\NN\0 (r_pobj) after_6\IN\0 (r_prep) asystole_5\NN\14204950 (r_conj) bradycardia_2\NNP\14110674 (r_conj) hypotension_0\NN\14057371
D008775_D007022 CID methylprednisolone_18\NN\0 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) asystole_10\NN\14204950 (r_conj) bradycardia_7\NNP\14110674 (r_conj) hypotension_5\NN\14057371
D008775_D003645 NONE methylprednisolone_16\NN\0 (r_pobj) of_14\IN\0 (r_prep) dose_13\NN\3740161 (r_pobj) after_10\IN\0 (r_prep) reviews_2\VBZ\5733583 (l_dobj) mechanisms_6\NNS\13446390 (l_prep) of_7\IN\0 (l_pobj) death_9\NN\7296428
D008775_D003645 NONE ivmp_18\NN\0 (r_appos) methylprednisolone_16\NN\0 (r_pobj) of_14\IN\0 (r_prep) dose_13\NN\3740161 (r_pobj) after_10\IN\0 (r_prep) reviews_2\VBZ\5733583 (l_dobj) mechanisms_6\NNS\13446390 (l_prep) of_7\IN\0 (l_pobj) death_9\NN\7296428
D008775_D006323 CID methylprednisolone_11\NN\0 (r_pobj) after_6\IN\0 (r_prep) asystole_5\NN\14204950
D008775_D006323 CID methylprednisolone_18\NN\0 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) asystole_10\NN\14204950
D008775_D001919 CID methylprednisolone_11\NN\0 (r_pobj) after_6\IN\0 (r_prep) asystole_5\NN\14204950 (r_conj) bradycardia_2\NNP\14110674
D008775_D001919 CID methylprednisolone_18\NN\0 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) asystole_10\NN\14204950 (r_conj) bradycardia_7\NNP\14110674
11704023
D013999_D005901 NONE timolol_6\NN\2832168 (l_prep) on_9\IN\0 (l_pobj) response_14\NN\11410625 (l_prep) in_15\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_prep) on_17\IN\0 (l_pobj) treatment_18\NN\654885 (l_prep) for_19\IN\0 (l_pobj) glaucoma_20\NN\14252864
D013999_D005901 NONE timolol_11\NN\2832168 (l_conj) suspension_21\NN\14586258 (l_relcl) forms_23\VBZ\6286395 (l_prep) on_26\IN\0 (l_pobj) application_27\NN\947128 (l_prep) on_35\IN\0 (l_pobj) rate_39\NN\13815152 (l_prep) in_40\IN\13603305 (l_pobj) patients_41\NNS\9898892 (l_acl) treated_44\VBN\2376958 (l_prep) for_45\IN\0 (l_pobj) glaucoma_46\NN\14252864
D013999_D005901 NONE timolol_13\NN\2832168 (r_compound) solution_14\NN\14586258 (r_appos) timolol_11\NN\2832168 (l_conj) suspension_21\NN\14586258 (l_relcl) forms_23\VBZ\6286395 (l_prep) on_26\IN\0 (l_pobj) application_27\NN\947128 (l_prep) on_35\IN\0 (l_pobj) rate_39\NN\13815152 (l_prep) in_40\IN\13603305 (l_pobj) patients_41\NNS\9898892 (l_acl) treated_44\VBN\2376958 (l_prep) for_45\IN\0 (l_pobj) glaucoma_46\NN\14252864
D013999_D005901 NONE timolol_20\NN\2832168 (r_compound) suspension_21\NN\14586258 (l_relcl) forms_23\VBZ\6286395 (l_prep) on_26\IN\0 (l_pobj) application_27\NN\947128 (l_prep) on_35\IN\0 (l_pobj) rate_39\NN\13815152 (l_prep) in_40\IN\13603305 (l_pobj) patients_41\NNS\9898892 (l_acl) treated_44\VBN\2376958 (l_prep) for_45\IN\0 (l_pobj) glaucoma_46\NN\14252864
D013999_D005901 NONE timolol_32\NN\2832168 (r_compound) gellan_33\NN\0 (r_appos) conjunctiva_30\NN\5327134 (r_pobj) to_28\IN\0 (r_prep) application_27\NN\947128 (l_prep) on_35\IN\0 (l_pobj) rate_39\NN\13815152 (l_prep) in_40\IN\13603305 (l_pobj) patients_41\NNS\9898892 (l_acl) treated_44\VBN\2376958 (l_prep) for_45\IN\0 (l_pobj) glaucoma_46\NN\14252864
D013999_D009798 NONE timolol_56\NN\2832168 (r_compound) solution_57\NN\14586258 (r_conj) crossed_32\VBN\2050132 (r_conj) randomized_30\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) glaucoma_10\NN\14252864 (l_conj) hypertension_13\NN\14057371
D013999_D009798 NONE timolol_68\NN\2832168 (r_compound) gellan_69\NN\0 (r_conj) solution_57\NN\14586258 (r_conj) crossed_32\VBN\2050132 (r_conj) randomized_30\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) glaucoma_10\NN\14252864 (l_conj) hypertension_13\NN\14057371
D013999_D005902 NONE timolol_56\NN\2832168 (r_compound) solution_57\NN\14586258 (r_conj) crossed_32\VBN\2050132 (r_conj) randomized_30\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) glaucoma_10\NN\14252864
D013999_D005902 NONE timolol_68\NN\2832168 (r_compound) gellan_69\NN\0 (r_conj) solution_57\NN\14586258 (r_conj) crossed_32\VBN\2050132 (r_conj) randomized_30\VBN\278117 (l_nsubjpass) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) glaucoma_10\NN\14252864
19135948
C107135_D009190 NONE everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365
C107135_D009190 NONE everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918 (l_nmod) mds_24\NNP\14622893
D016559_D006504 CID tacrolimus_10\NN\0 (r_conj) everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (r_nsubjpass) associated_12\VBN\628491 (l_prep) with_13\IN\0 (l_pobj) incidence_16\NN\13821570 (l_prep) of_17\IN\0 (l_pobj) syndrome_20\NN\5870365
C107135_D015470 NONE everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918
C107135_D015470 NONE everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918 (l_appos) aml_35\NNP\0
D016559_D006086 NONE tacrolimus_10\NN\0 (r_conj) everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (l_compound) disease_5\NN\14061805
D016559_D015470 NONE tacrolimus_8\NN\0 (r_conj) everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918
D016559_D015470 NONE tacrolimus_8\NN\0 (r_conj) everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918 (l_appos) aml_35\NNP\0
C107135_D006504 CID everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (r_nsubjpass) associated_12\VBN\628491 (l_prep) with_13\IN\0 (l_pobj) incidence_16\NN\13821570 (l_prep) of_17\IN\0 (l_pobj) syndrome_20\NN\5870365
D008727_D006086 NONE methotrexate_5\NNP\2722166 (r_pobj) with_4\IN\0 (r_prep) combined_3\VBN\2630189 (r_acl) inhibitor_2\NN\20090 (r_nsubj) is_6\VBZ\0 (l_attr) prophylaxis_9\NN\1077350 (l_prep) for_10\IN\0 (l_pobj) disease_16\NN\14061805
D008727_D006086 NONE methotrexate_5\NNP\2722166 (r_pobj) with_4\IN\0 (r_prep) combined_3\VBN\2630189 (r_acl) inhibitor_2\NN\20090 (r_nsubj) is_6\VBZ\0 (l_attr) prophylaxis_9\NN\1077350 (l_prep) for_10\IN\0 (l_pobj) disease_16\NN\14061805 (l_appos) gvhd_18\NNP\0
D016559_D009190 NONE tacrolimus_8\NN\0 (r_conj) everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365
D016559_D009190 NONE tacrolimus_8\NN\0 (r_conj) everolimus_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) combination_4\NN\7951464 (l_prep) with_19\IN\0 (l_pobj) syndrome_22\NN\5870365 (l_appos) leukemia_33\NN\14239918 (l_nmod) mds_24\NNP\14622893
C107135_D006086 NONE everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (l_compound) disease_5\NN\14061805
D016559_D014652 CID tacrolimus_10\NN\0 (r_conj) everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (r_nsubjpass) associated_12\VBN\628491 (l_conj) microangiopathy_22\NN\0
C107135_D014652 CID everolimus_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) prophylaxis_6\VBN\1077350 (r_nsubjpass) associated_12\VBN\628491 (l_conj) microangiopathy_22\NN\0
10091616
D007980_D004409 CID levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880
D001058_D004409 CID apomorphine_69\NN\3786417 (r_pobj) of_68\IN\0 (r_prep) dose_67\NN\3740161 (r_pobj) of_63\IN\0 (r_prep) administration_62\NN\1133281 (r_pobj) following_61\VBG\8180190 (r_prep) worsening_55\VBG\13457378 (r_pobj) on_53\IN\0 (r_prep) tasks_52\NNS\575741 (r_dobj) speaking_49\VBG\7109847 (r_dep) evaluate_16\VB\670261 (r_advcl) included_11\VBN\0 (l_nsubjpass) patients_1\NNS\9898892 (l_relcl) had_3\VBD\0 (l_prep) with_7\IN\0 (l_pcomp) disabling_8\VBG\126264 (l_dobj) dyskinesia_9\NN\14084880
D001058_D004409 CID apomorphine_69\NN\3786417 (r_pobj) of_68\IN\0 (r_prep) dose_67\NN\3740161 (r_pobj) of_63\IN\0 (r_prep) administration_62\NN\1133281 (r_pobj) following_61\VBG\8180190 (r_prep) worsening_55\VBG\13457378 (l_prep) of_56\IN\0 (l_pobj) dyskinesia_60\JJ\14084880
D001058_D010300 NONE apomorphine_69\NN\3786417 (r_pobj) of_68\IN\0 (r_prep) dose_67\NN\3740161 (r_pobj) of_63\IN\0 (r_prep) administration_62\NN\1133281 (r_pobj) following_61\VBG\8180190 (r_prep) worsening_55\VBG\13457378 (r_pobj) on_53\IN\0 (r_prep) tasks_52\NNS\575741 (r_dobj) speaking_49\VBG\7109847 (r_dep) evaluate_16\VB\670261 (r_advcl) included_11\VBN\0 (l_nsubjpass) patients_1\NNS\9898892 (l_relcl) had_3\VBD\0 (l_dobj) disease_6\NN\14061805
950631
D010396_D007674 CID penicillamine_2\NN\3740161 (r_npadvmod) induced_4\VBN\1627355 (r_amod) disease_6\NN\14061805
D010396_D001172 NONE penicillamine_18\NN\3740161 (r_pobj) with_15\IN\0 (r_prep) treatment_14\NN\654885 (r_pobj) of_13\IN\0 (r_prep) months_12\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) developed_5\VBD\1753788 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) arthritis_4\NN\14171682
D010396_D011507 CID penicillamine_18\NN\3740161 (r_pobj) with_15\IN\0 (r_prep) treatment_14\NN\654885 (r_pobj) of_13\IN\0 (r_prep) months_12\NNS\15113229 (r_pobj) after_8\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) proteinuria_7\NN\14299637
7803371
D003915_D003072 CID dextromethorphan_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) abuse_6\NN\418025 (r_pobj) from_2\IN\0 (r_prep) deterioration_1\NN\14560612
D003915_D003072 CID dm_13\NN\14117805 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) from_9\IN\0 (r_prep) resulting_8\VBG\2633881 (r_acl) deterioration_7\NN\14560612
9105126
D013256_D018658 CID steroid_9\NN\14727670 (r_compound) therapy_10\NN\657604 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) defect_3\NN\14462666
D013256_D018658 CID steroid_13\NN\14727670 (r_compound) therapy_14\NN\657604 (r_pobj) on_9\IN\0 (r_prep) patients_8\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) rupture_6\NN\14285662
D013256_D018658 CID steroid_4\NN\14727670 (r_compound) therapy_5\NN\657604 (l_conj) rupture_10\NN\14285662
15276120
D014859_D006470 CID warfarin_3\RB\2718259 (r_npadvmod) associated_5\VBN\628491 (r_amod) hemorrhage_6\NN\14285662
D014859_D006470 CID warfarin_4\RB\2718259 (r_npadvmod) related_6\VBN\628491 (r_amod) bleeding_7\NN\14285662
11694026
D000082_D014581 NONE paracetamol_4\NN\0 (r_conj) nimesulide_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) tolerability_0\DT\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) angioedema_13\NN\14316714 (l_nmod) urticaria_11\NN\14533203
D000082_D014581 NONE paracetamol_11\NN\0 (r_conj) nimesulide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) tolerability_5\NN\0 (r_dobj) investigated_4\VBD\644583 (l_prep) in_12\IN\13603305 (l_pobj) number_16\NN\5107765 (l_prep) of_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) history_25\NN\15120823 (l_prep) of_26\IN\0 (l_pobj) angioedema_32\NN\14316714 (l_nmod) urticaria_30\NN\14533203
D000082_D014581 NONE paracetamol_12\NNP\0 (r_conj) nimesulide_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) procedure_8\NN\407535 (r_nsubjpass) applied_14\VBN\0 (l_prep) with_18\IN\0 (l_pobj) history_20\NN\15120823 (l_prep) of_21\IN\0 (l_pobj) angioedema_27\NN\14316714 (l_nmod) urticaria_25\NN\14533203
D000082_D014581 NONE paracetamol_12\NN\0 (r_conj) nimesulide_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) tolerability_8\NN\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_relcl) experienced_16\VBD\2108377 (l_dobj) angioedema_19\NNP\14316714 (l_nmod) urticaria_17\NN\14533203
D000894_D014581 NONE nsaid_8\NNP\2721538 (r_npadvmod) induced_10\VBN\1627355 (r_amod) urticaria_11\NN\14533203
D000894_D014581 NONE nsaid_27\NNP\2721538 (r_npadvmod) induced_29\VBN\1627355 (r_amod) urticaria_30\NN\14533203
D000894_D014581 NONE nsaid_22\NNP\2721538 (r_npadvmod) induced_24\VBN\1627355 (r_amod) urticaria_25\NN\14533203
D000894_D014581 NONE nsaid_21\NNP\2721538 (r_npadvmod) induced_23\VBN\1627355 (r_amod) urticaria_24\NN\14533203 (r_nmod) angioedema_26\NN\14316714 (r_pobj) of_20\IN\0 (r_prep) history_19\NN\15120823 (r_pobj) with_17\IN\0 (r_prep) subjects_16\NNS\6598915 (r_pobj) of_15\IN\0 (r_prep) %_14\NN\0 (r_conj) history_8\NN\15120823 (l_prep) of_9\IN\0 (l_pobj) urticaria_11\NN\14533203
D000894_D014581 NONE nsaid_21\NNP\2721538 (r_npadvmod) induced_23\VBN\1627355 (r_amod) urticaria_24\NN\14533203
D000894_D014581 NONE nsaid_21\NNP\2721538 (r_npadvmod) induced_23\VBN\1627355 (r_amod) urticaria_24\NN\14533203 (r_nmod) angioedema_26\NN\14316714 (r_pobj) of_20\IN\0 (r_prep) history_19\NN\15120823 (l_prep) with_31\IN\0 (l_conj) without_33\IN\0 (l_pobj) urticaria_35\NN\14533203
D000894_D014581 NONE nsaids_22\NNS\2721538 (r_pobj) by_21\IN\0 (r_agent) caused_20\VBN\1617192 (r_acl) angioedema_19\NNP\14316714 (l_nmod) urticaria_17\NN\14533203
D000894_D014581 NONE nsaid_29\NNP\2721538 (r_npadvmod) induced_31\VBN\1627355 (r_amod) angioedema_32\NN\14316714 (r_pobj) of_28\IN\0 (r_prep) history_27\NN\15120823 (r_pobj) by_25\IN\0 (r_prep) increased_13\VBN\169651 (l_agent) by_14\IN\0 (l_pobj) history_16\NN\15120823 (l_prep) of_17\IN\0 (l_pobj) urticaria_19\NN\14533203
D000082_D000799 CID paracetamol_4\NN\0 (r_conj) nimesulide_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) tolerability_0\DT\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) angioedema_13\NN\14316714
D000082_D000799 CID paracetamol_11\NN\0 (r_conj) nimesulide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) tolerability_5\NN\0 (r_dobj) investigated_4\VBD\644583 (l_prep) in_12\IN\13603305 (l_pobj) number_16\NN\5107765 (l_prep) of_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) history_25\NN\15120823 (l_prep) of_26\IN\0 (l_pobj) angioedema_32\NN\14316714
D000082_D000799 CID paracetamol_12\NNP\0 (r_conj) nimesulide_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) procedure_8\NN\407535 (r_nsubjpass) applied_14\VBN\0 (l_prep) with_18\IN\0 (l_pobj) history_20\NN\15120823 (l_prep) of_21\IN\0 (l_pobj) angioedema_27\NN\14316714
D000082_D000799 CID paracetamol_12\NN\0 (r_conj) nimesulide_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) tolerability_8\NN\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_relcl) experienced_16\VBD\2108377 (l_dobj) angioedema_19\NNP\14316714
C012655_D000799 CID nimesulide_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) tolerability_0\DT\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) angioedema_13\NN\14316714
C012655_D000799 CID nimesulide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) tolerability_5\NN\0 (r_dobj) investigated_4\VBD\644583 (l_prep) in_12\IN\13603305 (l_pobj) number_16\NN\5107765 (l_prep) of_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) history_25\NN\15120823 (l_prep) of_26\IN\0 (l_pobj) angioedema_32\NN\14316714
C012655_D000799 CID nimesulide_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) procedure_8\NN\407535 (r_nsubjpass) applied_14\VBN\0 (l_prep) with_18\IN\0 (l_pobj) history_20\NN\15120823 (l_prep) of_21\IN\0 (l_pobj) angioedema_27\NN\14316714
C012655_D000799 CID nimesulide_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) tolerability_8\NN\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_relcl) experienced_16\VBD\2108377 (l_dobj) angioedema_19\NNP\14316714
C012655_D014581 NONE nimesulide_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) tolerability_0\DT\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) angioedema_13\NN\14316714 (l_nmod) urticaria_11\NN\14533203
C012655_D014581 NONE nimesulide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) tolerability_5\NN\0 (r_dobj) investigated_4\VBD\644583 (l_prep) in_12\IN\13603305 (l_pobj) number_16\NN\5107765 (l_prep) of_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) history_25\NN\15120823 (l_prep) of_26\IN\0 (l_pobj) angioedema_32\NN\14316714 (l_nmod) urticaria_30\NN\14533203
C012655_D014581 NONE nimesulide_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) procedure_8\NN\407535 (r_nsubjpass) applied_14\VBN\0 (l_prep) with_18\IN\0 (l_pobj) history_20\NN\15120823 (l_prep) of_21\IN\0 (l_pobj) angioedema_27\NN\14316714 (l_nmod) urticaria_25\NN\14533203
C012655_D014581 NONE nimesulide_10\NN\0 (r_pobj) of_9\IN\0 (r_prep) tolerability_8\NN\0 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_relcl) experienced_16\VBD\2108377 (l_dobj) angioedema_19\NNP\14316714 (l_nmod) urticaria_17\NN\14533203
D000894_D000799 CID nsaid_8\NNP\2721538 (r_npadvmod) induced_10\VBN\1627355 (r_amod) urticaria_11\NN\14533203 (r_nmod) angioedema_13\NN\14316714
D000894_D000799 CID nsaid_27\NNP\2721538 (r_npadvmod) induced_29\VBN\1627355 (r_amod) urticaria_30\NN\14533203 (r_nmod) angioedema_32\NN\14316714
D000894_D000799 CID nsaid_22\NNP\2721538 (r_npadvmod) induced_24\VBN\1627355 (r_amod) urticaria_25\NN\14533203 (r_nmod) angioedema_27\NN\14316714
D000894_D000799 CID nsaid_21\NNP\2721538 (r_npadvmod) induced_23\VBN\1627355 (r_amod) urticaria_24\NN\14533203 (r_nmod) angioedema_26\NN\14316714
D000894_D000799 CID nsaid_21\NNP\2721538 (r_npadvmod) induced_23\VBN\1627355 (r_amod) urticaria_24\NN\14533203 (r_nmod) angioedema_26\NN\14316714 (l_conj) angioedema_28\NN\14316714
D000894_D000799 CID nsaids_22\NNS\2721538 (r_pobj) by_21\IN\0 (r_agent) caused_20\VBN\1617192 (r_acl) angioedema_19\NNP\14316714
D000894_D000799 CID nsaid_29\NNP\2721538 (r_npadvmod) induced_31\VBN\1627355 (r_amod) angioedema_32\NN\14316714
19707748
D064704_D012640 CID levofloxacin_3\NNS\0 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) seizures_0\NNS\14081375
D064704_D012640 CID levofloxacin_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) treatment_13\NN\654885 (r_dobj) initiating_12\VBG\1617192 (r_pcomp) after_11\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) seizures_9\NNS\14081375
D064704_D012640 CID levofloxacin_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) treatment_13\NN\654885 (r_dobj) initiating_12\VBG\1617192 (r_pcomp) after_11\IN\0 (r_prep) developed_8\VBD\1753788 (r_relcl) patient_6\NN\9898892 (l_prep) of_47\IN\0 (l_pobj) seizures_51\NNS\14081375
D064704_D012640 CID levofloxacin_48\NN\0 (r_npadvmod) induced_50\VBN\1627355 (r_amod) seizures_51\NNS\14081375 (r_pobj) of_47\IN\0 (r_prep) patient_6\NN\9898892 (l_relcl) developed_8\VBD\1753788 (l_dobj) seizures_9\NNS\14081375
D064704_D012640 CID levofloxacin_48\NN\0 (r_npadvmod) induced_50\VBN\1627355 (r_amod) seizures_51\NNS\14081375
D064704_D012640 CID levofloxacin_3\NN\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) seizures_6\NNS\14081375
15811908
C037689_D010673 NONE benzamide_14\JJ\0 (r_amod) drugs_15\NNS\14778436 (r_pobj) of_12\IN\0 (r_prep) use_11\NN\407535 (r_pobj) with_9\IN\0 (r_prep) associated_8\VBN\628491 (l_nsubjpass) symptoms_3\NNS\5823932 (l_prep) of_4\IN\0 (l_pobj) pheochromocytoma_5\NN\14235200
D063325_D006973 CID tiapride_21\NN\0 (r_compound) therapy_22\NN\657604 (r_conj) amisulpride_19\NN\0 (r_conj) crisis_17\NN\14411243 (l_amod) hypertensive_16\JJ\10405694
D063325_D006973 CID tiapride_16\NN\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) crisis_20\NN\14411243 (l_amod) hypertensive_19\JJ\10405694
D063325_D010673 NONE tiapride_5\NN\0 (r_conj) amisulpride_3\NN\0 (r_pobj) by_2\IN\0 (r_prep) unmasked_1\VBD\853195 (l_nsubj) pheochromocytoma_0\NNP\14235200
D063325_D010673 NONE tiapride_13\NN\0 (r_conj) amisulpride_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) patient_8\NN\9898892 (r_pobj) in_6\IN\13603305 (r_prep) unmasking_3\NN\7215377 (l_prep) of_4\IN\0 (l_pobj) pheochromocytoma_5\NN\14235200
D063325_D010673 NONE tiapride_16\NN\0 (r_npadvmod) induced_18\VBN\1627355 (r_amod) crisis_20\NN\14411243 (r_conj) amisulpride-_14\JJ\0 (r_pobj) of_13\IN\0 (r_prep) case_12\NN\7283608 (l_prep) in_21\IN\13603305 (l_pobj) patient_23\NN\9898892 (l_prep) with_24\IN\0 (l_pobj) pheochromocytoma_25\NN\14235200
C012052_D014839 CID amisulpride_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) after_16\IN\0 (r_prep) vomiting_13\NN\116687
C012052_D006261 CID amisulpride_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) after_16\IN\0 (r_prep) vomiting_13\NN\116687 (r_conj) developed_6\VBD\1753788 (l_dobj) hypertension_8\NN\14057371 (l_prep) with_9\IN\0 (l_pobj) headache_11\NN\5829480
C012052_D010673 NONE amisulpride_3\NN\0 (r_pobj) by_2\IN\0 (r_prep) unmasked_1\VBD\853195 (l_nsubj) pheochromocytoma_0\NNP\14235200
C012052_D010673 NONE amisulpride_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (r_acl) patient_8\NN\9898892 (r_pobj) in_6\IN\13603305 (r_prep) unmasking_3\NN\7215377 (l_prep) of_4\IN\0 (l_pobj) pheochromocytoma_5\NN\14235200
C012052_D010673 NONE amisulpride-_14\JJ\0 (r_pobj) of_13\IN\0 (r_prep) case_12\NN\7283608 (l_prep) in_21\IN\13603305 (l_pobj) patient_23\NN\9898892 (l_prep) with_24\IN\0 (l_pobj) pheochromocytoma_25\NN\14235200
C012052_D006973 CID amisulpride_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) doses_19\NNS\3740161 (r_pobj) after_16\IN\0 (r_prep) vomiting_13\NN\116687 (r_conj) developed_6\VBD\1753788 (l_dobj) hypertension_8\NN\14057371
C012052_D006973 CID amisulpride_19\NN\0 (r_conj) crisis_17\NN\14411243 (l_amod) hypertensive_16\JJ\10405694
C012052_D006973 CID amisulpride-_14\JJ\0 (l_conj) crisis_20\NN\14411243 (l_amod) hypertensive_19\JJ\10405694
19719056
D002351_D010146 CID carrageenan_17\NN\14898470 (r_npadvmod) induced_19\VBN\1627355 (r_amod) model_23\NN\5888929 (r_conj) mice_14\NNS\2329401 (r_appos) model_12\NN\5888929 (r_attr) writhing_11\VBG\1831531
D019342_D010146 NONE acid_9\NN\14818238 (r_dobj) using_7\VBG\418025 (r_advcl) ascertained_6\VBN\0 (l_conj) induced_10\VBD\1627355 (l_xcomp) writhing_11\VBG\1831531
D019342_D004487 NONE acid_9\NN\14818238 (r_dobj) using_7\VBG\418025 (r_advcl) ascertained_6\VBN\0 (l_conj) induced_10\VBD\1627355 (l_xcomp) writhing_11\VBG\1831531 (l_attr) model_12\NN\5888929 (l_appos) mice_14\NNS\2329401 (l_conj) model_23\NN\5888929 (l_compound) edema_22\NN\14315192
D002351_D004487 CID carrageenan_17\NN\14898470 (r_npadvmod) induced_19\VBN\1627355 (r_amod) model_23\NN\5888929 (l_compound) edema_22\NN\14315192
7707116
D015474_D064420 NONE ra_24\NNP\14625458 (r_pobj) of_21\IN\0 (r_prep) toxicities_17\NNS\13576101
D015474_D064420 NONE ra_6\NNP\14625458 (r_nsubjpass) discontinued_8\VBN\0 (r_advcl) resolved_2\VBD\352826 (l_nsubj) toxicities_1\NNS\13576101
D015474_D009447 NONE acid_7\NN\14818238 (r_pobj) of_3\IN\0 (r_prep) trial_2\NN\786195 (l_prep) in_8\IN\13603305 (l_pobj) children_9\NNS\9622049 (l_prep) with_10\IN\0 (l_pobj) neuroblastoma_11\NN\14239425
D015474_D009447 NONE acid_11\NN\14818238 (r_pobj) with_7\IN\0 (r_prep) lines_6\NNS\8426461 (l_compound) neuroblastoma_4\NN\14239425
D015474_D009447 NONE ra_15\NNP\14625458 (r_appos) acid_11\NN\14818238 (r_pobj) with_7\IN\0 (r_prep) lines_6\NNS\8426461 (l_compound) neuroblastoma_4\NN\14239425
D015474_D009447 NONE ra_3\NNP\14625458 (r_nsubj) demonstrated_5\VBN\2137132 (l_dobj) responses_7\NNS\11410625 (l_prep) in_8\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_compound) neuroblastoma_9\NN\14239425
D015474_D009447 NONE ra_24\NNP\14625458 (r_pobj) of_21\IN\0 (r_prep) toxicities_17\NNS\13576101 (l_acl) administered_25\VBD\2436349 (l_prep) on_26\IN\0 (l_pobj) schedule_29\NN\5898568 (l_prep) in_30\IN\13603305 (l_pobj) children_31\NNS\9622049 (l_prep) with_32\IN\0 (l_pobj) neuroblastoma_33\NN\14239425
D015474_D006934 CID ra_13\NNP\14625458 (r_compound) levels_14\NNS\4916342 (r_pobj) by_9\IN\0 (r_agent) predicted_8\VBN\916909 (r_conj) included_2\VBD\0 (l_dobj) hypercalcemia_3\NN\14299637
11858397
D008787_D002037 NONE metoclopramide_5\NN\0 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (l_prep) with_10\IN\0 (l_pobj) block_16\NN\21939
D008787_D002037 NONE metoclopramide_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) administration_24\NN\1133281 (r_pobj) after_20\IN\0 (r_prep) developed_16\VBD\1753788 (r_relcl) woman_7\NN\9605289 (l_prep) with_8\IN\0 (l_pobj) block_14\NN\21939
D020117_D016171 CID cisapride_8\RB\0 (r_nsubjpass) given_12\VBN\5892096 (r_advcl) developed_3\VBD\1753788 (l_dobj) pointes_6\FW\831651
D008787_D016171 CID metoclopramide_5\NN\0 (r_pobj) by_4\IN\0 (r_agent) induced_3\VBN\1627355 (r_acl) pointes_2\NNS\831651
D008787_D016171 CID metoclopramide_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) administration_24\NN\1133281 (r_pobj) after_20\IN\0 (r_prep) developed_16\VBD\1753788 (l_dobj) pointes_19\NNS\831651
D008787_D016171 CID metoclopramide_6\NN\0 (r_nsubj) provokes_7\VBZ\1617192 (l_dobj) pointes_10\FW\831651
D008787_D016171 CID metoclopramide_0\NNP\0 (r_nsubjpass) used_3\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) risk_9\NN\14541044 (l_prep) of_10\IN\0 (l_pobj) pointes_13\FW\831651
D004917_D016171 CID erythromycin_10\NNP\2716866 (r_conj) cisapride_8\RB\0 (r_nsubjpass) given_12\VBN\5892096 (r_advcl) developed_3\VBD\1753788 (l_dobj) pointes_6\FW\831651
7007443
D000082_D017114 CID paracetamol_26\JJ\0 (r_compound) overdose_27\NN\84738 (r_pobj) after_25\IN\0 (r_prep) survived_21\VBD\0 (l_dobj) failure_24\NN\66216
D000082_D017114 CID paracetamol_26\JJ\0 (r_compound) overdose_27\NN\84738 (r_pobj) after_25\IN\0 (r_prep) survived_21\VBD\0 (r_relcl) those_19\DT\0 (r_pobj) in_18\IN\13603305 (r_prep) fourfold_17\RB\0 (r_conj) died_14\VBD\146138 (r_relcl) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) increased_8\VBN\169651 (l_advcl) increased_32\VBN\169651 (l_prep) in_34\IN\13603305 (l_pobj) patients_35\NNS\9898892 (l_prep) with_36\IN\0 (l_pobj) failure_39\NN\66216
D000082_D006525 NONE paracetamol_26\JJ\0 (r_compound) overdose_27\NN\84738 (r_pobj) after_25\IN\0 (r_prep) survived_21\VBD\0 (r_relcl) those_19\DT\0 (r_pobj) in_18\IN\13603305 (r_prep) fourfold_17\RB\0 (r_conj) died_14\VBD\146138 (r_relcl) patients_12\NNS\9898892 (r_pobj) in_11\IN\13603305 (r_prep) increased_8\VBN\169651 (l_advcl) increased_32\VBN\169651 (l_prep) in_34\IN\13603305 (l_pobj) patients_35\NNS\9898892 (l_prep) with_36\IN\0 (l_pobj) failure_39\NN\66216 (l_amod) due_40\IN\5174653 (l_pcomp) to_41\IN\0 (l_pobj) hepatitis_43\NN\14127211
D000082_D062787 NONE paracetamol_26\JJ\0 (r_compound) overdose_27\NN\84738
3653576
C001335_D007674 NONE hcbd_4\NNP\0 (r_pobj) by_3\IN\0 (r_agent) produced_2\VBN\1617192 (r_acl) damage_1\NN\7296428 (r_nsubjpass) discriminated_8\VBN\650353 (l_prep) from_13\IN\0 (l_pobj) damage_15\NN\7296428
C004504_D058186 CID 2-bromoethylamine_36\NN\0 (r_punct) ._42\.\0 (r_punct) puromycin_29\NNS\0 (l_ccomp) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
C004504_D058186 CID bea_38\NNP\0 (r_nmod) 2-bromoethylamine_36\NN\0 (r_punct) ._42\.\0 (r_punct) puromycin_29\NNS\0 (l_ccomp) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
C004504_D007674 NONE bea_6\NNP\0 (r_conj) hcbd_4\NNP\0 (r_pobj) by_3\IN\0 (r_agent) produced_2\VBN\1617192 (r_acl) damage_1\NN\7296428 (r_nsubjpass) discriminated_8\VBN\650353 (l_prep) from_13\IN\0 (l_pobj) damage_15\NN\7296428
D011692_D058186 CID aminonucleoside_30\NN\0 (r_nmod) pan_32\NNP\3101986 (r_npadvmod) puromycin_29\NNS\0 (l_ccomp) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
D011692_D058186 CID pan_32\NNP\3101986 (r_npadvmod) puromycin_29\NNS\0 (l_ccomp) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
C001335_D058186 CID hexachloro-1:3-butadiene_24\,\0 (r_pobj) of_23\IN\0 (r_prep) administration_22\NN\1133281 (r_pobj) by_21\IN\0 (r_agent) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
C001335_D058186 CID hcbd_26\NNP\0 (r_appos) hexachloro-1:3-butadiene_24\,\0 (r_pobj) of_23\IN\0 (r_prep) administration_22\NN\1133281 (r_pobj) by_21\IN\0 (r_agent) produced_20\VBN\1617192 (l_nsubjpass) models_2\NNS\5888929 (l_prep) of_3\IN\0 (l_pobj) damage_5\NN\7296428
D011692_D007674 NONE pan_18\NNP\3101986 (r_pobj) by_17\IN\0 (r_agent) produced_16\VBN\1617192 (r_acl) damage_15\NN\7296428
3084782
D008625_D003872 CID tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228 (l_conj) dermatitis_9\NN\14226056
D008625_D003872 CID tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_28\IN\0 (l_pobj) dermatitis_29\NN\14226056
D006046_D009393 NONE gold_32\NN\13371489 (r_compound) thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228
-1_D009393 NONE thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228
D006046_D003872 CID gold_32\NN\13371489 (r_compound) thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228 (l_conj) dermatitis_9\NN\14226056
D006046_D003872 CID gold_32\NN\13371489 (r_compound) thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (l_pobj) dermatitis_29\NN\14226056
D008625_D009393 CID tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228
D008625_D009393 CID tiopronin_17\NNP\0 (r_npadvmod) related_18\VBN\628491 (r_amod) group_20\NN\2137 (l_compound) nephritis_19\NN\14113228
D008625_D001172 NONE tiopronin_17\NNP\0 (r_npadvmod) related_18\VBN\628491 (r_amod) group_20\NN\2137 (r_pobj) for_15\IN\0 (r_prep) except_14\IN\807461 (r_prep) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) ra_13\NNP\14625458
D010396_D003872 NONE penicillamine_17\NN\3740161 (r_appos) tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228 (l_conj) dermatitis_9\NN\14226056
D010396_D003872 NONE penicillamine_17\NN\3740161 (r_appos) tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_28\IN\0 (l_pobj) dermatitis_29\NN\14226056
D010396_D009393 NONE penicillamine_17\NN\3740161 (r_appos) tiopronin_12\NNP\0 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228
-1_D003872 NONE thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (r_prep) found_5\VBN\13279262 (l_prep) between_6\IN\0 (l_pobj) nephritis_7\NN\14113228 (l_conj) dermatitis_9\NN\14226056
-1_D003872 NONE thiosulphate_33\NN\0 (r_pobj) due_30\IN\5174653 (r_prep) between_28\IN\0 (l_pobj) dermatitis_29\NN\14226056
3703509
D011241_D011141 NONE prednisone_5\NN\2721538 (r_pobj) to_3\IN\0 (r_prep) exposure_2\NN\5042871 (r_pobj) following_0\VBG\8180190 (r_prep) developed_9\VBD\1753788 (l_advcl) increasing_12\VBG\169651 (l_dobj) somnolence_13\NN\14015731 (l_conj) polydipsia_15\NN\14040660 (l_conj) polyphagia_17\NN\0 (l_conj) polyuria_20\NN\14113228
D019344_D007662 NONE lactate_13\NN\14850483 (r_compound) level_14\NN\4916342 (r_pobj) without_9\IN\0 (r_prep) present_4\JJ\28270 (l_prep) in_5\IN\13603305 (l_pobj) one_6\CD\13741022 (l_conj) ketosis_8\NN\14299637
D011241_D006963 NONE prednisone_5\NN\2721538 (r_pobj) to_3\IN\0 (r_prep) exposure_2\NN\5042871 (r_pobj) following_0\VBG\8180190 (r_prep) developed_9\VBD\1753788 (l_advcl) increasing_12\VBG\169651 (l_dobj) somnolence_13\NN\14015731 (l_conj) polydipsia_15\NN\14040660 (l_conj) polyphagia_17\NN\0
D011241_D053609 NONE prednisone_5\NN\2721538 (r_pobj) to_3\IN\0 (r_prep) exposure_2\NN\5042871 (r_pobj) following_0\VBG\8180190 (r_prep) developed_9\VBD\1753788 (l_dobj) lethargy_10\NN\14014621
D011241_D059606 NONE prednisone_5\NN\2721538 (r_pobj) to_3\IN\0 (r_prep) exposure_2\NN\5042871 (r_pobj) following_0\VBG\8180190 (r_prep) developed_9\VBD\1753788 (l_advcl) increasing_12\VBG\169651 (l_dobj) somnolence_13\NN\14015731 (l_conj) polydipsia_15\NN\14040660
D011241_D006970 NONE prednisone_5\NN\2721538 (r_pobj) to_3\IN\0 (r_prep) exposure_2\NN\5042871 (r_pobj) following_0\VBG\8180190 (r_prep) developed_9\VBD\1753788 (l_advcl) increasing_12\VBG\169651 (l_dobj) somnolence_13\NN\14015731
D019344_D000140 NONE lactate_13\NN\14850483 (r_compound) level_14\NN\4916342 (r_pobj) without_9\IN\0 (r_prep) present_4\JJ\28270 (r_acomp) was_3\VBD\0 (l_nsubj) acidosis_2\NN\14204950
1687392
D015647_D002375 NONE 38393_5\CD\0 (r_nummod) skf_4\NNP\0 (r_nmod) quinpirole_9\NN\0 (r_nsubj) decreased_10\VBD\169651 (l_dobj) catalepsy_12\NN\14023236
D015647_D002375 NONE 38393_3\CD\0 (r_nummod) skf_2\NNP\0 (r_pobj) of_1\IN\0 (r_prep) combination_0\NN\7951464 (r_nsubj) cause_8\VB\7323922 (l_ccomp) potentiated_9\VBN\229605 (l_dobj) effect_11\NN\34213 (l_prep) on_12\IN\0 (l_pobj) catalepsy_13\NN\14023236
D005476_D002375 CID fluphenazine_2\NN\3713736 (r_nsubj) induced_12\VBD\1627355 (l_dobj) catalepsy_13\NN\14023236
D005476_D002375 CID fluphenazine_15\NN\3713736 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) catalepsy_12\NN\14023236
C534628_D002375 CID 23390_7\CD\0 (r_nummod) sch_6\NNP\0 (r_appos) fluphenazine_2\NN\3713736 (r_nsubj) induced_12\VBD\1627355 (l_dobj) catalepsy_13\NN\14023236
C534628_D002375 CID 23390_3\CD\0 (r_nummod) sch_2\NNP\0 (r_pobj) of_1\IN\0 (r_prep) combination_0\NN\7951464 (r_nsubj) induce_8\VB\1627355 (l_dobj) potentiation_10\NN\13564910 (l_compound) catalepsy_9\NN\14023236
C534628_D002375 CID 23390_18\CD\0 (r_nummod) sch_17\NNP\0 (r_appos) fluphenazine_15\NN\3713736 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) catalepsy_12\NN\14023236
D019257_D002375 NONE quinpirole_9\NN\0 (r_nsubj) decreased_10\VBD\169651 (l_dobj) catalepsy_12\NN\14023236
D019257_D002375 NONE quinpirole_5\NN\0 (r_pobj) with_4\IN\0 (r_prep) combination_0\NN\7951464 (r_nsubj) cause_8\VB\7323922 (l_ccomp) potentiated_9\VBN\229605 (l_dobj) effect_11\NN\34213 (l_prep) on_12\IN\0 (l_pobj) catalepsy_13\NN\14023236
D004298_D002375 NONE dopamine_6\NN\14807737 (r_compound) receptors_7\NNS\5225602 (r_pobj) of_1\IN\0 (r_prep) blockade_0\NN\952963 (r_nsubj) induce_9\VB\1627355 (l_dobj) catalepsy_10\NN\14023236
D004298_D002375 NONE dopamine_4\NN\14807737 (r_compound) antagonists_5\NNS\7846 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) catalepsy_1\NN\14023236
D004298_D002375 NONE dopamine_4\NN\14807737 (r_compound) antagonists_5\NNS\7846 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) catalepsy_1\NN\14023236 (r_nsubjpass) tested_8\VBN\670261 (l_conj) determined_18\VBN\0 (l_nsubjpass) subtypes_13\NNS\0 (l_acl) involved_14\VBN\2676054 (l_prep) in_15\IN\13603305 (l_pobj) catalepsy_16\NN\14023236
D004298_D002375 NONE dopamine_12\NN\14807737 (r_compound) subtypes_13\NNS\0 (r_nsubjpass) determined_18\VBN\0 (r_conj) tested_8\VBN\670261 (l_nsubjpass) catalepsy_1\NN\14023236
D004298_D002375 NONE dopamine_12\NN\14807737 (r_compound) subtypes_13\NNS\0 (l_acl) involved_14\VBN\2676054 (l_prep) in_15\IN\13603305 (l_pobj) catalepsy_16\NN\14023236
D004298_D002375 NONE dopamine_0\NN\14807737 (r_compound) fluphenazine_2\NN\3713736 (r_nsubj) induced_12\VBD\1627355 (l_dobj) catalepsy_13\NN\14023236
D004298_D002375 NONE dopamine_16\NN\14807737 (r_compound) antagonists_17\NNS\7846 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) effect_11\NN\34213 (l_prep) on_12\IN\0 (l_pobj) catalepsy_13\NN\14023236
D013469_D002375 CID sulpiride_11\NN\0 (r_npadvmod) induced_12\VBD\1627355 (l_dobj) catalepsy_13\NN\14023236
D013469_D002375 CID sulpiride_5\NN\0 (r_pobj) with_4\IN\0 (r_prep) combination_0\NN\7951464 (r_nsubj) induce_8\VB\1627355 (l_dobj) potentiation_10\NN\13564910 (l_compound) catalepsy_9\NN\14023236
D013469_D002375 CID sulpiride_20\NN\0 (r_conj) sch_17\NNP\0 (r_appos) fluphenazine_15\NN\3713736 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) catalepsy_12\NN\14023236
4090988
D000082_D008113 CID paracetamol_2\NN\0 (l_prep) of_3\IN\0 (l_pobj) tumours_7\NNS\14234074
D000082_D008113 CID paracetamol_8\NN\0 (r_npadvmod) treated_10\VBN\2376958 (r_amod) rats_11\NNS\2329401 (r_pobj) of_7\IN\0 (r_prep) livers_6\NNS\5298729 (r_pobj) of_4\IN\0 (r_prep) study_3\NN\635850 (r_nsubj) revealed_12\VBD\2137132 (l_dobj) changes_14\NNS\7283608 (l_relcl) resemble_19\VBP\2657219 (l_dobj) those_20\DT\0 (l_relcl) result_22\NN\34213 (l_prep) from_23\IN\0 (l_pobj) exposure_24\NN\5042871 (l_prep) to_25\IN\0 (l_pobj) variety_27\NN\7951464 (l_prep) of_28\IN\0 (l_pobj) hepatocarcinogens_30\NNS\0
D000082_D009369 NONE paracetamol_12\JJ\0 (r_compound) feeding_13\NN\838098 (r_dobj) following_11\VBG\8180190 (r_prep) arose_10\VBD\2623529 (l_nsubj) yield_2\NN\913705 (l_prep) of_3\IN\0 (l_pobj) tumours_4\NNS\14234074
D000082_D001749 CID paracetamol_2\NN\0 (l_prep) of_3\IN\0 (l_pobj) tumours_7\NNS\14234074
D000082_D001749 CID paracetamol_11\RB\0 (r_npadvmod) treated_13\VBN\2376958 (r_amod) groups_14\NNS\2137 (r_pobj) in_9\IN\13603305 (r_prep) developed_8\VBN\1753788 (l_conj) bore_19\VBD\9631463 (l_dobj) carcinomas_21\NNS\14239918
D000082_D006965 CID paracetamol_7\NN\0 (r_npadvmod) treated_9\VBN\2376958 (r_amod) rats_10\NNS\2329401 (r_pobj) of_6\IN\0 (r_prep) %_5\NN\0 (r_nsubj) developed_11\VBD\1753788 (l_dobj) hyperplasia_12\NN\14365950
D000082_D001744 NONE paracetamol_7\NN\0 (r_npadvmod) treated_9\VBN\2376958 (r_amod) rats_10\NNS\2329401 (r_pobj) of_6\IN\0 (r_prep) %_5\NN\0 (r_nsubj) developed_11\VBD\1753788 (l_dobj) hyperplasia_12\NN\14365950 (l_prep) of_13\IN\0 (l_pobj) epithelium_16\NN\5267548 (l_relcl) was_19\VBD\0 (l_acomp) coincident_21\JJ\0 (l_prep) with_22\IN\0 (l_pobj) presence_24\NN\13954253 (l_prep) of_25\IN\0 (l_pobj) calculi_27\NNS\9416076
D000082_D010212 NONE paracetamol_11\RB\0 (r_npadvmod) treated_13\VBN\2376958 (r_amod) groups_14\NNS\2137 (r_pobj) in_9\IN\13603305 (r_prep) developed_8\VBN\1753788 (l_nsubj) papillomas_0\NNP\14236226
11524350
C037663_D012640 CID ropivacaine_6\VBP\0 (r_conj) levobupivacaine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (r_nsubj) were_10\VBD\0 (l_nsubj) seizures_9\NNS\14081375
D002045_D064420 NONE bupivacaine-_5\DT\0 (r_nmod) rats_13\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) toxicity_1\NN\13576101
D002045_D064420 NONE bupivacaine_6\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101
D002045_D064420 NONE bupivacaine_15\NN\0 (r_conj) ropivacaine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) that_11\DT\0 (r_pobj) between_10\IN\0 (r_prep) intermediate_9\JJ\14806838 (r_acomp) is_8\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
D002045_D064420 NONE bupivacaine_40\NN\0 (r_pobj) by_39\IN\0 (r_agent) induced_38\VBN\1627355 (r_acl) that_37\DT\0 (r_pobj) than_36\IN\0 (r_prep) susceptible_33\JJ\0 (r_acomp) be_31\VB\14625458 (r_xcomp) appears_29\VBZ\2604760 (r_conj) administered_17\VBN\2436349 (r_advcl) is_8\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
C476513_D001145 CID levobupivacaine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0
D002045_D012640 NONE bupivacaine_18\NN\0 (r_pobj) of_17\IN\0 (r_prep) those_16\DT\0 (r_pobj) than_15\IN\0 (r_prep) larger_14\JJR\0 (r_acomp) were_13\VBD\0 (r_conj) were_10\VBD\0 (l_nsubj) seizures_9\NNS\14081375
C476513_D006323 CID levobupivacaine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0 (l_conj) asystole_9\NN\14204950
C476513_D006323 CID levobupivacaine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) toxicity_5\NN\13576101 (r_nsubj) is_8\VBZ\0 (l_advcl) administered_17\VBN\2436349 (l_conj) appears_29\VBZ\2604760 (l_nsubj) arrest_28\NN\88481
C476513_D006323 CID levobupivacaine_42\NN\0 (r_conj) bupivacaine_40\NN\0 (r_pobj) by_39\IN\0 (r_agent) induced_38\VBN\1627355 (r_acl) that_37\DT\0 (r_pobj) than_36\IN\0 (r_prep) susceptible_33\JJ\0 (r_acomp) be_31\VB\14625458 (r_xcomp) appears_29\VBZ\2604760 (l_nsubj) arrest_28\NN\88481
D002045_D001145 NONE bupivacaine_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) those_24\DT\0 (r_pobj) than_23\IN\0 (r_prep) larger_22\JJR\0 (r_acomp) were_21\VBD\0 (r_conj) were_10\VBD\0 (l_nsubj) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0
C476513_D064420 NONE levobupivacaine-_7\JJ\0 (r_conj) bupivacaine-_5\DT\0 (r_nmod) rats_13\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) toxicity_1\NN\13576101
C476513_D064420 NONE levobupivacaine_8\NN\0 (r_conj) toxicity_4\NN\13576101
C476513_D064420 NONE levobupivacaine_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) toxicity_5\NN\13576101
C476513_D064420 NONE levobupivacaine_42\NN\0 (r_conj) bupivacaine_40\NN\0 (r_pobj) by_39\IN\0 (r_agent) induced_38\VBN\1627355 (r_acl) that_37\DT\0 (r_pobj) than_36\IN\0 (r_prep) susceptible_33\JJ\0 (r_acomp) be_31\VB\14625458 (r_xcomp) appears_29\VBZ\2604760 (r_conj) administered_17\VBN\2436349 (r_advcl) is_8\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
C476513_D012640 CID levobupivacaine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) doses_2\NNS\3740161 (r_nsubj) were_10\VBD\0 (l_nsubj) seizures_9\NNS\14081375
C037663_D064420 NONE ropivacaine_10\NN\0 (r_npadvmod) infused_12\VBN\606335 (r_conj) levobupivacaine-_7\JJ\0 (r_conj) bupivacaine-_5\DT\0 (r_nmod) rats_13\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) toxicity_1\NN\13576101
C037663_D064420 NONE ropivacaine_11\NN\0 (r_conj) levobupivacaine_8\NN\0 (r_conj) toxicity_4\NN\13576101
C037663_D064420 NONE ropivacaine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) that_11\DT\0 (r_pobj) between_10\IN\0 (r_prep) intermediate_9\JJ\14806838 (r_acomp) is_8\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
C037663_D064420 NONE ropivacaine_24\NN\0 (r_npadvmod) induced_26\VBN\1627355 (r_amod) arrest_28\NN\88481 (r_nsubj) appears_29\VBZ\2604760 (r_conj) administered_17\VBN\2436349 (r_advcl) is_8\VBZ\0 (l_nsubj) toxicity_5\NN\13576101
C037663_D006323 CID ropivacaine_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) than_12\IN\0 (r_prep) smaller_11\JJR\0 (r_acomp) were_10\VBD\0 (l_nsubj) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0 (l_conj) asystole_9\NN\14204950
C037663_D006323 CID ropivacaine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) that_11\DT\0 (r_pobj) between_10\IN\0 (r_prep) intermediate_9\JJ\14806838 (r_acomp) is_8\VBZ\0 (l_advcl) administered_17\VBN\2436349 (l_conj) appears_29\VBZ\2604760 (l_nsubj) arrest_28\NN\88481
C037663_D006323 CID ropivacaine_24\NN\0 (r_npadvmod) induced_26\VBN\1627355 (r_amod) arrest_28\NN\88481
C037663_D001145 CID ropivacaine_17\NN\0 (r_pobj) of_16\IN\0 (r_prep) doses_15\NNS\3740161 (r_pobj) than_12\IN\0 (r_prep) smaller_11\JJR\0 (r_acomp) were_10\VBD\0 (l_nsubj) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0
D002045_D006323 NONE bupivacaine_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) those_24\DT\0 (r_pobj) than_23\IN\0 (r_prep) larger_22\JJR\0 (r_acomp) were_21\VBD\0 (r_conj) were_10\VBD\0 (l_nsubj) doses_2\NNS\3740161 (l_relcl) produced_6\VBD\1617192 (l_dobj) dysrhythmias_7\NNS\0 (l_conj) asystole_9\NN\14204950
D002045_D006323 NONE bupivacaine_15\NN\0 (r_conj) ropivacaine_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) that_11\DT\0 (r_pobj) between_10\IN\0 (r_prep) intermediate_9\JJ\14806838 (r_acomp) is_8\VBZ\0 (l_advcl) administered_17\VBN\2436349 (l_conj) appears_29\VBZ\2604760 (l_nsubj) arrest_28\NN\88481
D002045_D006323 NONE bupivacaine_40\NN\0 (r_pobj) by_39\IN\0 (r_agent) induced_38\VBN\1627355 (r_acl) that_37\DT\0 (r_pobj) than_36\IN\0 (r_prep) susceptible_33\JJ\0 (r_acomp) be_31\VB\14625458 (r_xcomp) appears_29\VBZ\2604760 (l_nsubj) arrest_28\NN\88481
8106150
D016291_D004409 NONE mk-801_15\NNP\0 (r_punct) ,_16\,\0 (r_punct) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D015632_D004409 NONE mptp_12\NNP\0 (r_npadvmod) treated_14\VBN\2376958 (r_amod) monkeys_15\NNS\2469914 (r_pobj) in_11\IN\13603305 (r_prep) dyskinesias_10\NNS\14084880
D010830_D004409 NONE physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D008614_D004409 NONE meperidine_4\RB\3808564 (r_conj) yohimbine_2\NN\0 (r_nsubj) reduced_5\VBN\441445 (l_dobj) movements_9\NNS\191142 (l_amod) dyskinetic_8\JJ\0
D003000_D020734 NONE clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
D001418_D004409 NONE baclofen_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) useful_3\JJ\0 (l_prep) against_7\IN\0 (l_pobj) form_11\NN\6286395 (l_prep) of_12\IN\0 (l_pobj) dyskinesia_13\NN\14084880
D001418_D020821 NONE baclofen_0\NNP\0 (r_nsubj) was_1\VBD\0 (l_acomp) useful_3\JJ\0 (l_prep) against_7\IN\0 (l_pobj) form_11\NN\6286395 (l_amod) dystonic_10\JJ\0
D001285_D002819 NONE atropine_0\NNP\14712692 (r_nsubj) converted_1\VBD\126264 (l_prep) into_5\IN\0 (l_pobj) chorea_6\NN\14253124
D011433_D004409 NONE propranolol_12\NN\0 (r_conj) methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D016291_D020734 NONE mk-801_15\NNP\0 (r_punct) ,_16\,\0 (r_punct) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
D008784_D020734 NONE methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
D008784_D004409 NONE methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D007980_D004409 NONE dopa_7\NN\14601829 (r_npadvmod) induced_9\VBN\1627355 (r_amod) dyskinesias_10\NNS\14084880
D007980_D004409 NONE dopa_19\NNP\14601829 (r_pobj) with_16\IN\0 (r_prep) combination_15\NN\7951464 (r_pobj) in_14\IN\13603305 (r_prep) tested_13\VBN\670261 (l_advcl) see_21\VB\8647945 (l_ccomp) modified_28\VBN\109660 (l_nsubjpass) movements_25\NNS\191142 (l_amod) dyskinetic_24\JJ\0
D003000_D004409 NONE clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D011433_D020734 NONE propranolol_12\NN\0 (r_conj) methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
-1_D020734 NONE 5-mdot_10\CD\0 (r_conj) methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
D015632_D020734 CID mptp_11\NNP\0 (r_pobj) with_8\IN\0 (r_prep) parkinsonian_7\NN\0
D001285_D020821 NONE atropine_0\NNP\14712692 (r_nsubj) converted_1\VBD\126264 (l_dobj) movements_4\NNS\191142 (l_amod) dystonic_3\JJ\0
D015016_D004409 NONE yohimbine_2\NN\0 (r_nsubj) reduced_5\VBN\441445 (l_dobj) movements_9\NNS\191142 (l_amod) dyskinetic_8\JJ\0
-1_D004409 NONE 5-mdot_10\CD\0 (r_conj) methysergide_8\NN\0 (r_conj) physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_dobj) movements_21\NNS\191142 (l_amod) dyskinetic_20\JJ\0
D004298_D004409 NONE dopamine_10\NN\14807737 (r_pobj) than_9\IN\0 (r_prep) other_8\JJ\0 (r_amod) neurotransmitters_7\NNS\14807410 (r_pobj) on_6\IN\0 (r_prep) acting_4\VBG\407535 (r_acl) agents_3\NNS\7347 (r_pobj) of_2\IN\0 (r_prep) series_1\NN\8456993 (r_nsubjpass) tested_13\VBN\670261 (l_advcl) see_21\VB\8647945 (l_ccomp) modified_28\VBN\109660 (l_nsubjpass) movements_25\NNS\191142 (l_amod) dyskinetic_24\JJ\0
D010830_D020734 NONE physostigmine_6\NN\14712692 (r_conj) clonidine_4\NN\2721160 (r_pobj) including_3\VBG\0 (r_prep) drugs_1\NNS\14778436 (r_nsubj) reduced_18\VBD\441445 (l_conj) at_23\IN\14622893 (l_pobj) cost_25\NN\13275288 (l_prep) of_26\IN\0 (l_pobj) return_28\NN\6479665 (l_prep) of_29\IN\0 (l_pobj) symptomatology_31\NN\0 (l_amod) parkinsonian_30\JJ\0
3431591
C031662_D064420 NONE 3717_1\CD\0 (r_nummod) cb_0\NN\0 (r_nsubj) is_6\VBZ\0 (l_attr) inhibitor_11\NN\20090 (l_relcl) mediated_21\VBN\761713 (l_nsubjpass) cytotoxicity_19\NN\13583478
C031662_D064420 NONE acid_4\NN\14818238 (r_appos) cb_0\NN\0 (r_nsubj) is_6\VBZ\0 (l_attr) inhibitor_11\NN\20090 (l_relcl) mediated_21\VBN\761713 (l_nsubjpass) cytotoxicity_19\NN\13583478
C031662_D064420 NONE 3717_28\CD\0 (r_nummod) cb_27\NNP\0 (r_pobj) than_26\IN\0 (r_prep) potent_25\JJ\0 (r_amod) 26-_17\NNPS\0 (r_attr) are_16\VBP\13600404 (l_conj) be_39\VB\14625458 (l_attr) determinant_42\NN\5686481 (l_prep) of_43\IN\0 (l_pobj) cytotoxicity_46\NN\13583478
C031662_D064420 NONE 3717_45\CD\0 (r_nummod) cytotoxicity_46\NN\13583478
C031662_D010051 NONE 3717_6\CD\0 (r_nummod) cb_5\NNP\0 (r_pobj) with_4\IN\0 (r_prep) studies_3\NNS\635850 (r_pobj) in_0\IN\13603305 (r_prep) seen_11\VBN\2106506 (l_prep) in_12\IN\13603305 (l_pobj) cancer_14\NN\14239425 (l_conj) cancer_17\NN\14239425
C031662_D001943 NONE 3717_6\CD\0 (r_nummod) cb_5\NNP\0 (r_pobj) with_4\IN\0 (r_prep) studies_3\NNS\635850 (r_pobj) in_0\IN\13603305 (r_prep) seen_11\VBN\2106506 (l_prep) in_12\IN\13603305 (l_pobj) cancer_14\NN\14239425
C031662_D008654 NONE 3717_6\CD\0 (r_nummod) cb_5\NNP\0 (r_pobj) with_4\IN\0 (r_prep) studies_3\NNS\635850 (r_pobj) in_0\IN\13603305 (r_prep) seen_11\VBN\2106506 (l_prep) in_12\IN\13603305 (l_pobj) cancer_14\NN\14239425 (l_conj) cancer_17\NN\14239425 (l_conj) hepatoma_19\NN\14242337 (l_conj) mesothelioma_22\NN\14242337
C031662_D006528 NONE 3717_6\CD\0 (r_nummod) cb_5\NNP\0 (r_pobj) with_4\IN\0 (r_prep) studies_3\NNS\635850 (r_pobj) in_0\IN\13603305 (r_prep) seen_11\VBN\2106506 (l_prep) in_12\IN\13603305 (l_pobj) cancer_14\NN\14239425 (l_conj) cancer_17\NN\14239425 (l_conj) hepatoma_19\NN\14242337
18589141
D006493_D013927 NONE sodium_2\NN\14625458 (r_nsubjpass) used_16\VBN\0 (l_xcomp) prevent_24\VB\0 (l_dobj) thrombosis_25\NN\14100769
D006493_D013927 NONE ufh_4\NNP\0 (r_appos) sodium_2\NN\14625458 (r_nsubjpass) used_16\VBN\0 (l_xcomp) prevent_24\VB\0 (l_dobj) thrombosis_25\NN\14100769
D006493_D013921 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204
D006493_D013921 CID heparin_0\NNP\2718259 (r_npadvmod) induced_2\VBN\1627355 (r_amod) thrombocytopenia_3\NN\14189204 (l_appos) hit_5\NNP\36762
D006493_D013921 CID heparin_15\NN\2718259 (r_pobj) to_14\IN\0 (r_prep) reaction_13\NN\13446390 (r_attr) is_7\VBZ\0 (l_nsubj) thrombocytopenia_3\NN\14189204
D006493_D013921 CID heparin_15\NN\2718259 (r_pobj) to_14\IN\0 (r_prep) reaction_13\NN\13446390 (r_attr) is_7\VBZ\0 (l_nsubj) thrombocytopenia_3\NN\14189204 (l_appos) hit_5\NNP\36762
D006493_D013921 CID 4/heparin_10\NN\0 (r_nummod) reactive_12\JJ\0 (r_amod) antibody_13\NN\14728724 (r_nmod) positivity_18\NN\13856574 (r_conj) frequencies_1\NNS\15286249 (l_prep) of_2\IN\0 (l_pobj) hit_3\NN\36762
D006493_D013921 CID 4/heparin_10\NN\0 (r_nummod) reactive_12\JJ\0 (r_amod) antibody_13\NN\14728724 (r_nmod) positivity_18\NN\13856574 (l_nmod) antibody_16\NN\14728724 (l_nmod) hit_15\NNP\36762
D006493_D013921 CID ufh_7\NN\0 (r_npadvmod) related_9\VBN\628491 (r_amod) hit_10\NN\36762
D006493_D001791 NONE heparin_1\NN\2718259 (r_npadvmod) induced_3\VBN\1627355 (r_amod) test_6\NN\5798043 (l_compound) aggregation_5\NN\31264
D006495_D013927 NONE heparin_11\NN\2718259 (r_conj) sodium_2\NN\14625458 (r_nsubjpass) used_16\VBN\0 (l_xcomp) prevent_24\VB\0 (l_dobj) thrombosis_25\NN\14100769
7337133
D000082_D017093 CID acetaminophen_9\NN\2707683 (r_compound) overdose_10\NN\84738 (r_pobj) in_8\IN\13603305 (r_prep) failure_7\NN\66216
D000082_D017093 CID acetaminophen_6\RB\2707683 (r_advmod) induced_8\VBN\1627355 (r_amod) failure_11\NN\66216
D000082_D001929 CID acetaminophen_9\NN\2707683 (r_compound) overdose_10\NN\84738 (r_pobj) in_8\IN\13603305 (r_prep) failure_7\NN\66216 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) edema_2\NN\14315192
D000082_D001929 CID acetaminophen_6\RB\2707683 (r_advmod) induced_8\VBN\1627355 (r_amod) failure_11\NN\66216 (r_pobj) with_4\IN\0 (r_prep) patient_3\NN\9898892 (r_dobj) present_1\VBP\28270 (l_prep) with_13\IN\0 (l_pobj) signs_14\NNS\6643763 (l_prep) of_17\IN\0 (l_pobj) edema_19\NN\14315192
D000082_D062787 NONE acetaminophen_9\NN\2707683 (r_compound) overdose_10\NN\84738
10539815
D004232_D003920 NONE diuretic_49\JJ\3247620 (r_conj) antiplatelet_47\JJ\0 (r_pobj) of_46\IN\0 (r_prep) use_45\NN\407535 (r_conj) diabetes_42\NNS\14075199
D004232_D003920 NONE diuretic_14\JJ\3247620 (r_amod) therapy_15\NN\657604 (l_conj) diabetes_18\NNS\14075199
D004656_D018487 NONE enalapril_26\NN\2673637 (r_pobj) of_25\IN\0 (r_prep) trial_24\NN\786195 (r_appos) dysfunction_9\NNP\14204950
D003404_D051437 NONE creatinine_10\NN\0 (r_pobj) in_8\IN\13603305 (r_prep) rise_7\NN\7324673 (r_pobj) as_5\IN\14622893 (r_prep) defined_4\VBN\2604760 (l_nsubjpass) function_2\NN\13783581
D003404_D003920 NONE creatinine_25\NN\0 (r_conj) fraction_22\NN\14806838 (r_conj) age_18\NN\4916342 (l_appos) history_38\NN\15120823 (l_prep) of_39\IN\0 (l_pobj) hypertension_40\NN\14057371 (l_conj) diabetes_42\NNS\14075199
D004656_D051437 CID enalapril_4\NN\2673637 (r_pobj) to_3\IN\0 (r_prep) assigned_2\VBN\2475922 (r_acl) patients_0\NNS\9898892 (r_nsubj) had_5\VBD\0 (l_dobj) likelihood_10\NN\4756172 (l_prep) of_11\IN\0 (l_pobj) function_14\NN\13783581
D004656_D051437 CID enalapril_9\NN\2673637 (r_compound) groups_10\NNS\2137 (r_conj) placebo_7\NN\3740161 (r_pobj) in_4\IN\13603305 (r_prep) associated_20\VBN\628491 (l_prep) with_21\IN\0 (l_pobj) function_24\NN\13783581
D004656_D051437 CID enalapril_23\JJ\2673637 (r_compound) group_24\NN\2137 (r_pobj) in_21\IN\13603305 (r_prep) more_19\RBR\0 (r_conj) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) risk_7\NN\14541044 (l_prep) of_8\IN\0 (l_pcomp) developing_9\VBG\13541167 (l_dobj) function_12\NN\13783581
D004656_D051437 CID enalapril_26\NN\2673637 (r_dep) ratio_29\NN\13815152 (r_appos) group_24\NN\2137 (r_pobj) in_21\IN\13603305 (r_prep) more_19\RBR\0 (r_conj) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) risk_7\NN\14541044 (l_prep) of_8\IN\0 (l_pcomp) developing_9\VBG\13541167 (l_dobj) function_12\NN\13783581
D004656_D051437 CID enalapril_15\JJ\2673637 (r_compound) group_16\NN\2137 (r_pobj) in_13\IN\13603305 (r_prep) function_12\NN\13783581
D004656_D051437 CID enalapril_0\NNP\2673637 (r_compound) use_1\NN\407535 (r_nsubj) caused_2\VBD\1617192 (l_dobj) increase_6\NN\13576355 (l_prep) in_7\IN\13603305 (l_pobj) risk_9\NN\14541044 (l_prep) of_10\IN\0 (l_pobj) function_13\NN\13783581
D004656_D051437 CID enalapril_23\JJ\2673637 (r_compound) group_24\NN\2137 (r_pobj) in_21\IN\13603305 (r_prep) reduced_20\VBN\441445 (r_conj) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) impairment_9\NN\7296428
D004232_D051437 CID diuretic_14\JJ\3247620 (r_amod) therapy_15\NN\657604 (r_conj) age_12\NN\4916342 (r_conj) placebo_7\NN\3740161 (r_pobj) in_4\IN\13603305 (r_prep) associated_20\VBN\628491 (l_prep) with_21\IN\0 (l_pobj) function_24\NN\13783581
D004232_D051437 CID diuretic_0\JJ\3247620 (r_compound) therapy_1\NN\657604 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) risk_8\NN\14541044 (l_prep) of_9\IN\0 (l_pobj) function_12\NN\13783581
D004656_D006333 NONE enalapril_26\NN\2673637 (r_pobj) of_25\IN\0 (r_prep) trial_24\NN\786195 (l_prep) for_27\IN\0 (l_pobj) treatment_29\NN\654885 (l_prep) of_30\IN\0 (l_pobj) chf_31\NNP\0
D004656_D006333 NONE enalapril_0\NNP\2673637 (r_compound) use_1\NN\407535 (r_nsubj) caused_2\VBD\1617192 (l_dobj) increase_6\NN\13576355 (l_prep) in_7\IN\13603305 (l_pobj) risk_9\NN\14541044 (l_prep) of_10\IN\0 (l_pobj) function_13\NN\13783581 (l_prep) in_14\IN\13603305 (l_pobj) patients_15\NNS\9898892 (l_prep) with_16\IN\0 (l_pobj) chf_17\NNP\0
D004656_D006333 NONE enalapril_23\JJ\2673637 (r_compound) group_24\NN\2137 (r_pobj) in_21\IN\13603305 (r_prep) reduced_20\VBN\441445 (r_conj) associated_2\VBN\628491 (l_prep) with_3\IN\0 (l_pobj) risk_6\NN\14541044 (l_prep) of_7\IN\0 (l_pobj) impairment_9\NN\7296428 (l_prep) in_10\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) chf_14\NNP\0
D003404_D006973 NONE creatinine_25\NN\0 (r_conj) fraction_22\NN\14806838 (r_conj) age_18\NN\4916342 (l_appos) history_38\NN\15120823 (l_prep) of_39\IN\0 (l_pobj) hypertension_40\NN\14057371
D000809_D051437 NONE angiotensin_11\NN\4522421 (r_npadvmod) converting_13\VBG\126264 (r_amod) enzyme_14\NN\14723628 (r_compound) therapy_16\NN\657604 (r_pobj) during_10\IN\0 (r_prep) patients_6\NNS\9898892 (r_pobj) in_5\IN\13603305 (r_prep) function_4\NN\13783581
D000809_D051437 NONE angiotensin_1\NN\4522421 (r_npadvmod) converting_3\VBG\126264 (r_amod) enzyme_4\NN\14723628 (r_compound) therapy_6\NN\657604 (r_nsubj) reduces_7\VBZ\441445 (r_advcl) cause_23\VB\7323922 (l_dobj) function_26\NN\13783581
D000809_D051437 NONE angiotensin_17\NN\4522421 (r_npadvmod) converting_19\VBG\126264 (r_amod) enzyme_20\NN\14723628 (r_compound) therapy_22\NN\657604 (r_dobj) prescribed_16\VBN\748282 (r_relcl) chf_13\NNP\0 (r_pobj) with_12\IN\0 (r_prep) patients_11\NNS\9898892 (r_pobj) in_10\IN\13603305 (r_prep) reduction_6\NN\351485 (l_prep) in_7\IN\13603305 (l_pobj) function_9\NN\13783581
D000809_D018487 NONE angiotensin_11\NN\4522421 (r_npadvmod) converting_13\VBG\126264 (r_amod) enzyme_14\NN\14723628 (r_compound) therapy_16\NN\657604 (r_pobj) during_10\IN\0 (r_prep) patients_6\NNS\9898892 (r_pobj) in_5\IN\13603305 (r_prep) function_4\NN\13783581 (r_pobj) of_1\IN\0 (r_prep) predictors_0\NNS\10756433 (r_dep) results_18\NNS\34213 (l_prep) from_19\IN\0 (l_pobj) studies_21\NNS\635850 (l_prep) of_22\IN\0 (l_pobj) dysfunction_25\NN\14204950
D004232_D006973 NONE diuretic_49\JJ\3247620 (r_conj) antiplatelet_47\JJ\0 (r_pobj) of_46\IN\0 (r_prep) use_45\NN\407535 (r_conj) diabetes_42\NNS\14075199 (r_conj) hypertension_40\NN\14057371
D004656_D003920 NONE enalapril_9\NN\2673637 (r_compound) groups_10\NNS\2137 (r_conj) placebo_7\NN\3740161 (l_conj) age_12\NN\4916342 (l_conj) therapy_15\NN\657604 (l_conj) diabetes_18\NNS\14075199
D004656_D003920 NONE enalapril_2\NN\2673637 (r_nsubj) had_3\VBD\0 (l_npadvmod) rr_9\NN\0 (l_nummod) 1.33_10\CD\0 (l_prep) compared_19\VBN\644583 (l_prep) with_20\IN\0 (l_pobj) placebo_21\NN\3740161 (l_appos) ci_28\NNP\13635336 (l_prep) in_33\IN\13603305 (l_pobj) patients_34\NNS\9898892 (l_prep) with_35\IN\0 (l_pobj) diabetes_36\NNS\14075199
D004656_D003920 NONE enalapril_23\JJ\2673637 (r_compound) group_24\NN\2137 (r_pobj) in_21\IN\13603305 (r_prep) reduced_20\VBN\441445 (r_conj) associated_2\VBN\628491 (l_nsubjpass) diabetes_0\NN\14075199
D000809_D006333 NONE angiotensin_11\NN\4522421 (r_npadvmod) converting_13\VBG\126264 (r_amod) enzyme_14\NN\14723628 (r_compound) therapy_16\NN\657604 (r_pobj) during_10\IN\0 (r_prep) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) failure_9\NN\66216
D000809_D006333 NONE angiotensin_1\NN\4522421 (r_npadvmod) converting_3\VBG\126264 (r_amod) enzyme_4\NN\14723628 (r_compound) therapy_6\NN\657604 (r_nsubj) reduces_7\VBZ\441445 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) failure_15\NN\66216
D000809_D006333 NONE angiotensin_1\NN\4522421 (r_npadvmod) converting_3\VBG\126264 (r_amod) enzyme_4\NN\14723628 (r_compound) therapy_6\NN\657604 (r_nsubj) reduces_7\VBZ\441445 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) failure_15\NN\66216 (l_appos) chf_17\NNP\0
D000809_D006333 NONE angiotensin_17\NN\4522421 (r_npadvmod) converting_19\VBG\126264 (r_amod) enzyme_20\NN\14723628 (r_compound) therapy_22\NN\657604 (r_dobj) prescribed_16\VBN\748282 (r_relcl) chf_13\NNP\0
18441470
D008094_D012804 CID lithium_14\NN\14625458 (r_pobj) of_13\IN\0 (r_prep) effects_12\NNS\13245626 (r_pobj) among_8\IN\0 (r_prep) reported_5\VBN\831651 (l_nsubjpass) dysfunction_2\NN\14204950
D008094_D013575 NONE lithium_17\NN\14625458 (r_compound) therapy_18\NN\657604 (r_pobj) to_16\IN\0 (r_prep) developed_14\VBD\1753788 (l_nsubj) block_10\NN\21939 (l_prep) with_11\IN\0 (l_pobj) attacks_13\NNS\955060
D008094_D013575 NONE lithium_1\NN\14625458 (r_compound) levels_2\NNS\4916342 (r_nsubj) remained_3\VBD\2604760 (l_prep) during_10\IN\0 (l_pobj) attacks_13\NNS\955060
D008094_D054537 CID lithium_5\NN\14625458 (r_compound) therapy_6\NN\657604 (r_pobj) to_4\IN\0 (r_prep) secondary_3\JJ\8426461 (r_amod) block_2\NN\21939
D008094_D054537 CID lithium_17\NN\14625458 (r_compound) therapy_18\NN\657604 (r_pobj) to_16\IN\0 (r_prep) developed_14\VBD\1753788 (l_nsubj) block_10\NN\21939
11230490
D003520_D001943 NONE cyclophosphamide_12\NN\0 (r_conj) doxorubicin_10\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) efficacy_5\NN\5199286 (r_conj) cardiotoxicity_1\NN\0 (l_prep) compared_13\VBN\644583 (l_prep) in_19\IN\13603305 (l_pobj) trial_24\NN\786195 (l_prep) of_25\IN\0 (l_pobj) cancer_28\NN\14239425
D003520_D001943 NONE cyclophosphamide_18\NN\0 (r_conj) doxorubicin_16\NN\2716866 (r_pobj) with_14\IN\0 (r_prep) compared_13\VBN\644583 (l_prep) in_19\IN\13603305 (l_pobj) trial_24\NN\786195 (l_prep) of_25\IN\0 (l_pobj) cancer_28\NN\14239425
D003520_D001943 NONE cyclophosphamide_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) combination_22\NN\7951464 (r_pobj) in_21\IN\13603305 (r_prep) company_12\NNP\8053576 (r_nsubj) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425
D003520_D001943 NONE cyclophosphamide_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) combination_22\NN\7951464 (r_pobj) in_21\IN\13603305 (r_prep) company_12\NNP\8053576 (r_nsubj) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425 (l_appos) mbc_44\NNP\0
D003520_D001943 NONE cyclophosphamide_46\NN\0 (r_pobj) of_45\IN\0 (r_prep) combination_38\NN\7951464 (r_pobj) in_37\IN\13603305 (r_prep) receive_18\VB\2210855 (r_xcomp) randomized_16\VBN\278117 (l_nsubjpass) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) mbc_7\NNP\0
D003520_D001943 NONE cyclophosphamide_26\NN\0 (r_pobj) with_25\IN\0 (r_prep) combination_24\NN\7951464 (r_pobj) in_23\IN\13603305 (r_prep) used_22\VBN\0 (l_prep) as_27\IN\14622893 (l_pobj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) mbc_33\NNP\0
D003520_D064420 NONE cyclophosphamide_46\NN\0 (r_pobj) of_45\IN\0 (r_prep) combination_38\NN\7951464 (r_pobj) in_37\IN\13603305 (r_prep) receive_18\VB\2210855 (l_npadvmod) weeks_53\NNS\15113229 (l_prep) until_54\IN\0 (l_pobj) progression_56\NN\8457976 (l_conj) toxicity_59\NN\13576101
D003520_D009503 CID cyclophosphamide_26\NN\0 (r_pobj) with_25\IN\0 (r_prep) combination_24\NN\7951464 (r_pobj) in_23\IN\13603305 (r_prep) used_22\VBN\0 (r_advcl) provides_16\VBZ\2199590 (r_conj) improves_1\VBZ\126264 (l_dobj) neutropenia_14\NN\14196405
D004317_D066126 NONE doxorubicin_10\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) efficacy_5\NN\5199286 (r_conj) cardiotoxicity_1\NN\0
D004317_D066126 NONE doxorubicin_16\NN\2716866 (r_pobj) with_14\IN\0 (r_prep) compared_13\VBN\644583 (r_prep) cardiotoxicity_1\NN\0
D004317_D066126 NONE myocet_3\NNP\0 (r_nmod) doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_dobj) cardiotoxicity_28\NN\0
D004317_D066126 NONE doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_dobj) cardiotoxicity_28\NN\0
D004317_D066126 NONE doxorubicin_27\NN\2716866 (r_compound) cardiotoxicity_28\NN\0
D004317_D066126 NONE myocet_0\NNP\0 (r_nsubj) improves_1\VBZ\126264 (l_prep) by_7\IN\0 (l_pcomp) reducing_9\VBG\13447361 (l_dobj) cardiotoxicity_10\NN\0
D004317_D066126 NONE doxorubicin_6\NN\2716866 (r_pobj) of_5\IN\0 (r_prep) index_4\NN\13850304 (r_dobj) improves_1\VBZ\126264 (l_prep) by_7\IN\0 (l_pcomp) reducing_9\VBG\13447361 (l_dobj) cardiotoxicity_10\NN\0
D004317_D001943 NONE doxorubicin_10\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) efficacy_5\NN\5199286 (r_conj) cardiotoxicity_1\NN\0 (l_prep) compared_13\VBN\644583 (l_prep) in_19\IN\13603305 (l_pobj) trial_24\NN\786195 (l_prep) of_25\IN\0 (l_pobj) cancer_28\NN\14239425
D004317_D001943 NONE doxorubicin_16\NN\2716866 (r_pobj) with_14\IN\0 (r_prep) compared_13\VBN\644583 (l_prep) in_19\IN\13603305 (l_pobj) trial_24\NN\786195 (l_prep) of_25\IN\0 (l_pobj) cancer_28\NN\14239425
D004317_D001943 NONE myocet_3\NNP\0 (r_nmod) doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425
D004317_D001943 NONE myocet_3\NNP\0 (r_nmod) doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425 (l_appos) mbc_44\NNP\0
D004317_D001943 NONE doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425
D004317_D001943 NONE doxorubicin_8\NN\2716866 (r_dobj) determine_1\VB\0 (r_advcl) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425 (l_appos) mbc_44\NNP\0
D004317_D001943 NONE doxorubicin_27\NN\2716866 (r_compound) cardiotoxicity_28\NN\0 (r_dobj) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425
D004317_D001943 NONE doxorubicin_27\NN\2716866 (r_compound) cardiotoxicity_28\NN\0 (r_dobj) reduces_26\VBZ\441445 (l_advcl) providing_30\VBG\2199590 (l_prep) in_34\IN\13603305 (l_pobj) treatment_38\NN\654885 (l_prep) of_39\IN\0 (l_pobj) cancer_42\NN\14239425 (l_appos) mbc_44\NNP\0
D004317_D001943 NONE myocet_26\NNP\0 (r_nmod) m_28\NNP\13649268 (r_pobj) of_25\IN\0 (r_prep) m(2_23\NN\0 (r_dobj) receive_18\VB\2210855 (r_xcomp) randomized_16\VBN\278117 (l_nsubjpass) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) mbc_7\NNP\0
D004317_D001943 NONE doxorubicin_32\NN\2716866 (r_dobj) receive_18\VB\2210855 (r_xcomp) randomized_16\VBN\278117 (l_nsubjpass) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) mbc_7\NNP\0
D004317_D001943 NONE myocet_0\NNP\0 (r_nsubj) improves_1\VBZ\126264 (l_conj) provides_16\VBZ\2199590 (l_advcl) used_22\VBN\0 (l_prep) as_27\IN\14622893 (l_pobj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) mbc_33\NNP\0
D004317_D001943 NONE doxorubicin_6\NN\2716866 (r_pobj) of_5\IN\0 (r_prep) index_4\NN\13850304 (r_dobj) improves_1\VBZ\126264 (l_conj) provides_16\VBZ\2199590 (l_advcl) used_22\VBN\0 (l_prep) as_27\IN\14622893 (l_pobj) therapy_31\NN\657604 (l_prep) for_32\IN\0 (l_pobj) mbc_33\NNP\0
D004317_D009503 CID myocet_0\NNP\0 (r_nsubj) improves_1\VBZ\126264 (l_dobj) neutropenia_14\NN\14196405
D004317_D009503 CID doxorubicin_6\NN\2716866 (r_pobj) of_5\IN\0 (r_prep) index_4\NN\13850304 (r_dobj) improves_1\VBZ\126264 (l_dobj) neutropenia_14\NN\14196405
D003520_D066126 NONE cyclophosphamide_12\NN\0 (r_conj) doxorubicin_10\NN\2716866 (r_pobj) of_6\IN\0 (r_prep) efficacy_5\NN\5199286 (r_conj) cardiotoxicity_1\NN\0
D003520_D066126 NONE cyclophosphamide_18\NN\0 (r_conj) doxorubicin_16\NN\2716866 (r_pobj) with_14\IN\0 (r_prep) compared_13\VBN\644583 (r_prep) cardiotoxicity_1\NN\0
D003520_D066126 NONE cyclophosphamide_24\NN\0 (r_pobj) with_23\IN\0 (r_prep) combination_22\NN\7951464 (r_pobj) in_21\IN\13603305 (r_prep) company_12\NNP\8053576 (r_nsubj) reduces_26\VBZ\441445 (l_dobj) cardiotoxicity_28\NN\0
D003520_D066126 NONE cyclophosphamide_26\NN\0 (r_pobj) with_25\IN\0 (r_prep) combination_24\NN\7951464 (r_pobj) in_23\IN\13603305 (r_prep) used_22\VBN\0 (r_advcl) provides_16\VBZ\2199590 (r_conj) improves_1\VBZ\126264 (l_prep) by_7\IN\0 (l_pcomp) reducing_9\VBG\13447361 (l_dobj) cardiotoxicity_10\NN\0
D004317_D064420 NONE myocet_26\NNP\0 (r_nmod) m_28\NNP\13649268 (r_pobj) of_25\IN\0 (r_prep) m(2_23\NN\0 (r_dobj) receive_18\VB\2210855 (l_npadvmod) weeks_53\NNS\15113229 (l_prep) until_54\IN\0 (l_pobj) progression_56\NN\8457976 (l_conj) toxicity_59\NN\13576101
D004317_D064420 NONE doxorubicin_32\NN\2716866 (r_dobj) receive_18\VB\2210855 (l_npadvmod) weeks_53\NNS\15113229 (l_prep) until_54\IN\0 (l_pobj) progression_56\NN\8457976 (l_conj) toxicity_59\NN\13576101
11467664
D008687_D056486 NONE metformin_12\NN\2719105 (r_pobj) of_11\IN\0 (r_prep) initiation_10\NN\7450842 (r_pobj) after_8\IN\0 (r_prep) onset_2\NN\7325190 (r_pobj) given_0\VBN\5892096 (r_prep) believe_15\VBP\686447 (l_ccomp) represents_19\VBZ\2664769 (l_dobj) example_21\NN\5816287 (l_prep) of_22\IN\0 (l_pobj) hepatotoxicity_26\NN\0
D008687_D056486 NONE metformin_23\NN\2719105 (r_npadvmod) associated_25\VBN\628491 (r_amod) hepatotoxicity_26\NN\0
D008687_D041781 CID metformin_7\NN\2719105 (r_pobj) of_6\IN\0 (r_prep) use_5\NN\407535 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) jaundice_1\NN\14299637
D008687_D041781 CID hydrochloride_15\NN\14817592 (r_pobj) with_13\IN\0 (r_prep) treatment_12\NN\654885 (r_pobj) of_11\IN\0 (r_prep) initiation_10\NN\7450842 (r_pobj) after_9\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) jaundice_7\NN\14299637
D008687_D007565 NONE hydrochloride_1\NN\14817592 (r_nsubjpass) discontinued_3\VBN\0 (l_conj) resolved_10\VBN\352826 (l_nsubj) jaundice_9\NN\14299637
D008687_D007565 NONE metformin_12\NN\2719105 (r_pobj) of_11\IN\0 (r_prep) initiation_10\NN\7450842 (r_pobj) after_8\IN\0 (r_prep) onset_2\NN\7325190 (l_prep) of_3\IN\0 (l_pobj) jaundice_5\NN\14299637
D008687_D007565 NONE metformin_23\NN\2719105 (r_npadvmod) associated_25\VBN\628491 (r_amod) hepatotoxicity_26\NN\0 (r_pobj) of_22\IN\0 (r_prep) example_21\NN\5816287 (r_dobj) represents_19\VBZ\2664769 (r_ccomp) believe_15\VBP\686447 (l_prep) given_0\VBN\5892096 (l_pobj) onset_2\NN\7325190 (l_prep) of_3\IN\0 (l_pobj) jaundice_5\NN\14299637
19319147
D014859_D006470 NONE warfarin_12\RB\2718259 (r_npadvmod) associated_14\VBN\628491 (r_amod) hemorrhage_16\NN\14285662 (r_pobj) of_11\IN\0 (r_prep) model_10\NN\5888929 (r_pobj) in_7\IN\13603305 (r_prep) reduces_4\VBZ\441445 (l_dobj) volume_6\NN\33615 (l_compound) hemorrhage_5\NN\14285662
C025667_D002543 NONE pcc_5\NNP\0 (r_nsubj) be_7\VB\14625458 (l_attr) treatment_11\NN\654885 (l_prep) for_12\IN\0 (l_pobj) ich_15\NNP\0
D014859_D002543 CID warfarin_12\RB\2718259 (r_npadvmod) associated_14\VBN\628491 (r_amod) hemorrhage_16\NN\14285662
D014859_D002543 CID warfarin_0\NNP\2718259 (r_npadvmod) associated_2\VBN\628491 (r_amod) hemorrhage_4\NN\14285662
D014859_D002543 CID warfarin_0\NNP\2718259 (r_npadvmod) associated_2\VBN\628491 (r_amod) hemorrhage_4\NN\14285662 (l_appos) ich_8\NNP\0
D014859_D020521 NONE warfarin_0\NNP\2718259 (r_npadvmod) associated_2\VBN\628491 (r_amod) hemorrhage_4\NN\14285662 (r_nsubj) is_10\VBZ\0 (l_attr) type_13\NN\5839024 (l_prep) of_14\IN\0 (l_pobj) stroke_15\NN\556313
2557556
D009020_D006930 NONE morphine_0\NNP\2707683 (r_nsubj) alter_6\VB\0 (l_dobj) hyperalgesia_8\NN\0
D015232_D006930 CID e2-induced_23\VBN\0 (r_amod) hyperalgesia_24\NN\0
D015124_D006930 CID monophosphate_14\NN\0 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) hyperalgesia_8\NN\0
4069770
D005839_D058186 CID gentamicin_18\NN\2716866 (r_pobj) with_17\IN\0 (r_prep) therapy_16\NN\657604 (r_pobj) after_15\IN\0 (r_prep) died_10\VBD\146138 (l_prep) of_11\IN\0 (l_pobj) failure_14\NN\66216
D005839_D007674 NONE gentamicin_0\NNP\2716866 (r_amod) nephropathy_1\NN\14573196
D010406_D058186 NONE penicillin_28\NN\2716866 (r_conj) therapy_16\NN\657604 (r_pobj) after_15\IN\0 (r_prep) died_10\VBD\146138 (l_prep) of_11\IN\0 (l_pobj) failure_14\NN\66216
D005839_D001002 NONE gentamicin_2\NN\2716866 (r_compound) concentration_3\NN\4916342 (r_nsubj) reached_5\VBN\0 (l_advcl) developed_10\VBD\1753788 (l_nsubj) anuria_9\NN\14061805
2840807
D000324_D004421 CID acth_10\NNP\5407119 (r_nmod) stimulation_12\NN\242808 (r_pobj) after_5\IN\0 (r_prep) syndrome_4\NN\5870365 (l_amod) like_3\JJ\5839024 (l_npadvmod) dystonia_1\NN\0
D009074_D004421 CID msh_8\NNP\5407119 (r_nmod) acth_10\NNP\5407119 (r_nmod) stimulation_12\NN\242808 (r_pobj) after_5\IN\0 (r_prep) syndrome_4\NN\5870365 (l_amod) like_3\JJ\5839024 (l_npadvmod) dystonia_1\NN\0
D000324_D009069 NONE acth_20\NNP\5407119 (r_compound) terminal_23\NN\4306080 (r_compound) fragments_24\NNS\9385911 (r_pobj) by_18\IN\0 (r_agent) stimulated_17\VBN\137313 (r_ccomp) is_3\VBZ\0 (l_conj) cause_57\VB\7323922 (l_ccomp) resulted_94\VBD\2633881 (l_nsubj) depression_62\NN\14373582 (l_relcl) resulted_74\VBD\2633881 (l_prep) in_75\IN\13603305 (l_pobj) duration_78\NN\15113229 (l_prep) of_79\IN\0 (l_pobj) disorder_82\NN\14034177
D000324_D003866 NONE acth_20\NNP\5407119 (r_compound) terminal_23\NN\4306080 (r_compound) fragments_24\NNS\9385911 (r_pobj) by_18\IN\0 (r_agent) stimulated_17\VBN\137313 (r_ccomp) is_3\VBZ\0 (l_conj) cause_57\VB\7323922 (l_ccomp) resulted_94\VBD\2633881 (l_nsubj) depression_62\NN\14373582
2533791
D017325_D006509 NONE vaccine_25\NN\3562739 (r_dobj) derived_22\VBN\634472 (r_conj) treated_3\VBN\2376958 (l_prep) with_4\IN\0 (l_pobj) injections_6\NNS\320852 (l_prep) of_7\IN\0 (l_pobj) globulin_11\NN\14736972 (l_compound) b_9\NNP\1355326
18808529
D007545_D007022 NONE isoproterenol_3\NN\3740161 (r_npadvmod) induced_5\VBN\1627355 (r_amod) damage_7\NN\7296428 (r_pobj) of_2\IN\0 (r_prep) mechanism_1\NN\13446390 (r_nsubj) is_8\VBZ\0 (l_conj) is_25\VBZ\0 (l_nsubj) mismatch_13\NN\5695806 (l_prep) vs._17\IN\0 (l_pobj) demand_18\NN\6513366 (l_prep) following_19\VBG\8180190 (l_pobj) hyperactivity_24\NN\14052403 (l_nmod) hypotension_21\NN\14057371
D010100_D007022 NONE oxygen_15\NN\14622893 (r_compound) supply_16\NN\13576355 (r_pobj) of_14\IN\0 (r_prep) mismatch_13\NN\5695806 (l_prep) vs._17\IN\0 (l_pobj) demand_18\NN\6513366 (l_prep) following_19\VBG\8180190 (l_pobj) hyperactivity_24\NN\14052403 (l_nmod) hypotension_21\NN\14057371
D010100_D009202 NONE oxygen_15\NN\14622893 (r_compound) supply_16\NN\13576355 (r_pobj) of_14\IN\0 (r_prep) mismatch_13\NN\5695806 (r_nsubj) is_25\VBZ\0 (r_conj) is_8\VBZ\0 (l_nsubj) mechanism_1\NN\13446390 (l_prep) of_2\IN\0 (l_pobj) damage_7\NN\7296428
D010100_D009202 NONE oxygen_15\NN\14622893 (r_compound) supply_16\NN\13576355 (r_pobj) of_14\IN\0 (r_prep) mismatch_13\NN\5695806 (l_prep) vs._17\IN\0 (l_pobj) demand_18\NN\6513366 (l_prep) following_19\VBG\8180190 (l_pobj) hyperactivity_24\NN\14052403
D007545_D009202 CID isoproterenol_0\NN\3740161 (r_nsubj) induces_1\VBZ\1627355 (l_dobj) correlation_10\NN\13841213 (l_prep) with_11\IN\0 (l_pobj) injury_13\NN\14052046
D007545_D009202 CID isoproterenol_3\NN\3740161 (r_npadvmod) induced_5\VBN\1627355 (r_amod) damage_7\NN\7296428
D007545_D009202 CID isoproterenol_3\NN\3740161 (r_npadvmod) induced_5\VBN\1627355 (r_amod) damage_7\NN\7296428 (r_pobj) of_2\IN\0 (r_prep) mechanism_1\NN\13446390 (r_nsubj) is_8\VBZ\0 (l_conj) is_25\VBZ\0 (l_nsubj) mismatch_13\NN\5695806 (l_prep) vs._17\IN\0 (l_pobj) demand_18\NN\6513366 (l_prep) following_19\VBG\8180190 (l_pobj) hyperactivity_24\NN\14052403
D007545_D007511 CID isoproterenol_29\NN\3740161 (r_pobj) by_28\IN\0 (r_agent) induced_27\VBN\1627355 (r_acl) alterations_11\NNS\7283608 (r_dobj) explain_8\VBP\831651 (l_nsubj) changes_1\NNS\7283608 (l_acl) related_3\VBN\628491 (l_prep) to_4\IN\0 (l_pobj) injury_6\NN\14052046
9952311
D004317_D009202 NONE adriamycin_7\NNS\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) cardiomyopathy_10\NN\14103288
D004317_D028361 CID adriamycin_7\NNS\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) cardiomyopathy_10\NN\14103288 (r_pobj) in_6\IN\13603305 (r_prep) impairment_3\NN\7296428 (l_prep) of_4\IN\0 (l_pobj) mitochondria_5\NN\5445668
D004317_D028361 CID adr_21\NNP\0 (r_pobj) of_20\IN\0 (r_prep) effects_19\NNS\13245626 (r_nsubj) involve_25\VBP\2676054 (l_dobj) impairment_30\NN\7296428
D004317_D009369 NONE adriamycin_3\NNS\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (l_prep) in_7\IN\13603305 (l_pobj) chemotherapy_9\NN\661091 (l_compound) cancer_8\NN\14239425
D004317_D009369 NONE adr_5\NNP\0 (r_appos) adriamycin_3\NNS\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (l_prep) in_7\IN\13603305 (l_pobj) chemotherapy_9\NN\661091 (l_compound) cancer_8\NN\14239425
D004317_D002318 NONE adriamycin_3\NNS\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_12\VBN\4019101 (l_prep) due_13\IN\5174653 (l_pcomp) to_14\IN\0 (l_pobj) toxicity_18\NN\13576101
D004317_D002318 NONE adr_5\NNP\0 (r_appos) adriamycin_3\NNS\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_12\VBN\4019101 (l_prep) due_13\IN\5174653 (l_pcomp) to_14\IN\0 (l_pobj) toxicity_18\NN\13576101
D004317_D001145 NONE adr_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) mice_8\NNS\2329401 (r_pobj) of_7\IN\0 (r_prep) treatment_6\NN\654885 (r_nsubj) caused_11\VBD\1617192 (l_dobj) arrhythmias_13\NNS\14103288
D004317_D004487 NONE adr_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) mice_8\NNS\2329401 (r_pobj) of_7\IN\0 (r_prep) treatment_6\NN\654885 (r_nsubj) caused_11\VBD\1617192 (l_ccomp) swelling_51\NN\14315071
D004317_D001919 CID adr_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) mice_8\NNS\2329401 (r_pobj) of_7\IN\0 (r_prep) treatment_6\NN\654885 (r_nsubj) caused_11\VBD\1617192 (l_dobj) arrhythmias_13\NNS\14103288 (l_acl) characterized_14\VBN\609683 (l_agent) by_15\IN\0 (l_pobj) bradycardia_16\NNP\14110674
10523326
D009569_D006973 NONE oxide_1\NN\14818238 (r_compound) synthase_2\NN\0 (r_compound) expression_3\NN\4679549 (l_prep) in_4\IN\13603305 (l_pobj) course_6\NN\883297 (l_prep) of_7\IN\0 (l_pobj) hypertension_11\NN\14057371
D009569_D006973 NONE no_15\DT\7204911 (r_det) metabolites_16\NNS\20090 (r_pobj) of_14\IN\0 (r_prep) excretion_13\NN\13466586 (r_dobj) showed_2\VBD\2137132 (l_conj) increased_22\VBD\169651 (l_dobj) sequestration_24\NN\1201021 (l_prep) as_25\IN\14622893 (l_pobj) nitrotyrosine_26\JJ\0 (l_prep) in_27\IN\13603305 (l_pobj) tissues_29\NNS\5220461 (l_prep) in_30\IN\13603305 (l_pobj) rats_31\NNS\2329401 (l_prep) with_32\IN\0 (l_pobj) hypertension_36\NN\14057371
D009569_D006973 NONE no_23\DT\7204911 (r_det) sequestration_24\NN\1201021 (l_prep) as_25\IN\14622893 (l_pobj) nitrotyrosine_26\JJ\0 (l_prep) in_27\IN\13603305 (l_pobj) tissues_29\NNS\5220461 (l_prep) in_30\IN\13603305 (l_pobj) rats_31\NNS\2329401 (l_prep) with_32\IN\0 (l_pobj) hypertension_36\NN\14057371
D009569_D006973 NONE no_25\DT\7204911 (r_det) synthase_26\NN\0 (r_nmod) expression_30\NN\4679549 (r_pobj) due_22\IN\5174653 (r_prep) is_17\VBZ\0 (l_nsubj) reduction_8\NN\351485 (l_prep) in_12\IN\13603305 (l_pobj) hypertension_16\NN\14057371
D009569_D006973 NONE no_11\DT\7204911 (r_compound) inactivation_12\NN\13518963 (l_appos) inhibition_17\NN\1068773 (l_conj) actions_25\NNS\30358 (l_prep) of_26\IN\0 (l_pobj) stress_29\NN\7083732 (l_acl) associated_30\VBN\628491 (l_prep) with_31\IN\0 (l_pobj) hypertension_32\NN\14057371
C002744_D006973 NONE nitrotyrosine_26\JJ\0 (l_prep) in_27\IN\13603305 (l_pobj) tissues_29\NNS\5220461 (l_prep) in_30\IN\13603305 (l_pobj) rats_31\NNS\2329401 (l_prep) with_32\IN\0 (l_pobj) hypertension_36\NN\14057371
D007854_D006973 CID lead_8\NN\5155821 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hypertension_11\NN\14057371
D007854_D006973 CID lead_33\NN\5155821 (r_npadvmod) induced_35\VBN\1627355 (r_amod) hypertension_36\NN\14057371
D007854_D006973 CID lead_13\NN\5155821 (r_npadvmod) induced_15\VBN\1627355 (r_amod) hypertension_16\NN\14057371
D007854_D006973 CID lead_3\NN\5155821 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hypertension_6\NN\14057371
D007854_D006973 CID lead_14\NN\5155821 (r_npadvmod) associated_16\VBN\628491 (r_amod) inhibition_17\NN\1068773 (l_conj) actions_25\NNS\30358 (l_prep) of_26\IN\0 (l_pobj) stress_29\NN\7083732 (l_acl) associated_30\VBN\628491 (l_prep) with_31\IN\0 (l_pobj) hypertension_32\NN\14057371
D010100_D006973 NONE oxygen_5\NN\14622893 (r_compound) species_6\NNS\7992450 (r_dobj) showed_2\VBD\2137132 (l_conj) increased_22\VBD\169651 (l_dobj) sequestration_24\NN\1201021 (l_prep) as_25\IN\14622893 (l_pobj) nitrotyrosine_26\JJ\0 (l_prep) in_27\IN\13603305 (l_pobj) tissues_29\NNS\5220461 (l_prep) in_30\IN\13603305 (l_pobj) rats_31\NNS\2329401 (l_prep) with_32\IN\0 (l_pobj) hypertension_36\NN\14057371
D014810_D006973 NONE e_1\NN\14724645 (r_compound) supplementation_2\NN\5108947 (r_nsubj) ameliorated_3\VBD\126264 (l_dobj) hypertension_4\NN\14057371
D008315_D006973 NONE mda_8\NNP\0 (r_compound) concentration_9\NN\4916342 (r_dobj) lowered_6\VBD\1850315 (r_conj) ameliorated_3\VBD\126264 (l_dobj) hypertension_4\NN\14057371
1610717
D003042_D012640 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) seizures_4\NNS\14081375
783197
D010042_D006333 NONE ouabain_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_prep) on_12\IN\0 (l_pobj) parameters_19\NNS\5858936 (l_prep) without_29\IN\0 (l_pobj) failure_33\NN\66216
D010042_D006333 NONE ouabain_26\JJ\0 (r_compound) administration_27\NN\1133281 (r_pobj) after_25\IN\0 (r_prep) falls_24\VBZ\11692265 (r_conj) conclude_1\VBP\628491 (l_ccomp) left_18\VBD\8621598 (l_nsubj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disease_9\NN\14061805 (l_relcl) are_11\VBP\13600404 (l_prep) in_13\IN\13603305 (l_pobj) failure_17\NN\66216
D010042_D003324 NONE ouabain_2\NN\0 (l_prep) on_3\IN\0 (l_pobj) supply_6\NN\13576355 (l_conj) demand_8\NN\6513366 (l_prep) in_9\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) disease_15\NN\14061805
D010042_D003324 NONE ouabain_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_prep) on_12\IN\0 (l_pobj) parameters_19\NNS\5858936 (l_prep) in_20\IN\13603305 (l_pobj) patients_22\NNS\9898892 (l_prep) with_23\IN\0 (l_pobj) disease_28\NN\14061805
D010042_D003324 NONE ouabain_26\JJ\0 (r_compound) administration_27\NN\1133281 (r_pobj) after_25\IN\0 (r_prep) falls_24\VBZ\11692265 (r_conj) conclude_1\VBP\628491 (l_ccomp) left_18\VBD\8621598 (l_nsubj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) disease_9\NN\14061805
D010100_D003324 NONE oxygen_5\NN\14622893 (r_compound) supply_6\NN\13576355 (l_conj) demand_8\NN\6513366 (l_prep) in_9\IN\13603305 (l_pobj) patients_10\NNS\9898892 (l_prep) with_11\IN\0 (l_pobj) disease_15\NN\14061805
D010100_D003324 NONE oxygen_7\NN\14622893 (r_compound) supply_8\NN\13576355 (r_pobj) on_5\IN\0 (r_prep) glycosides_4\NNS\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubj) are_11\VBP\13600404 (l_prep) of_12\IN\0 (l_pobj) interest_14\NN\5682570 (l_prep) in_15\IN\13603305 (l_pobj) presence_17\NN\13954253 (l_prep) of_18\IN\0 (l_pobj) disease_22\NN\14061805
D004071_D003324 NONE glycosides_4\NNS\14727670 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubj) are_11\VBP\13600404 (l_prep) of_12\IN\0 (l_pobj) interest_14\NN\5682570 (l_prep) in_15\IN\13603305 (l_pobj) presence_17\NN\13954253 (l_prep) of_18\IN\0 (l_pobj) disease_22\NN\14061805
D010042_D002303 CID ouabain_26\JJ\0 (r_compound) administration_27\NN\1133281 (r_pobj) after_25\IN\0 (r_prep) falls_24\VBZ\11692265
2893236
D018698_D012133 NONE glutamate_11\NN\15010703 (r_conj) paralysis_9\NN\14557898
D005680_D012133 NONE gaba_0\NNP\14601829 (r_compound) involvement_1\NN\1080366 (r_nsubj) induced_4\VBN\1627355 (l_dobj) reversal_5\NN\199130 (l_prep) of_6\IN\0 (l_pobj) paralysis_8\NN\14557898
D005680_D012133 NONE gaba_13\NNP\14601829 (r_conj) glutamate_11\NN\15010703 (r_conj) paralysis_9\NN\14557898
D005680_D012133 NONE gaba_12\NNP\14601829 (r_dobj) involves_11\VBZ\2676054 (r_conj) reverses_4\VBZ\13854649 (l_dobj) paralysis_6\NN\14557898
D005680_D012131 NONE gaba_12\NNP\14601829 (r_pobj) in_11\IN\13603305 (r_prep) increase_10\NN\13576355 (r_pobj) with_8\IN\0 (r_prep) arrest_7\NN\88481
D018698_D012131 NONE glutamate_16\NN\15010703 (r_pobj) in_15\IN\13603305 (r_prep) decrease_14\NN\7296428 (r_conj) increase_10\NN\13576355 (r_pobj) with_8\IN\0 (r_prep) arrest_7\NN\88481
D009270_D012133 NONE naloxone_3\NN\3808977 (r_pobj) in_2\IN\13603305 (r_prep) involvement_1\NN\1080366 (r_nsubj) induced_4\VBN\1627355 (l_dobj) reversal_5\NN\199130 (l_prep) of_6\IN\0 (l_pobj) paralysis_8\NN\14557898
D009270_D012133 NONE naloxone_3\NN\3808977 (r_nsubj) reversed_4\VBD\109660 (l_dobj) paralysis_6\NN\14557898
D009270_D012133 NONE naloxone_0\NN\3808977 (r_nsubj) reversed_7\VBD\109660 (l_dobj) paralysis_9\NN\14557898
D009270_D012133 NONE naloxone_3\NN\3808977 (r_nsubj) reverses_4\VBZ\13854649 (l_dobj) paralysis_6\NN\14557898
D013874_D012133 CID thiopental_11\NN\2792049 (r_pobj) by_10\IN\0 (r_agent) produced_9\VBN\1617192 (r_acl) paralysis_8\NN\14557898
D013874_D012133 CID thiopental_9\NN\2792049 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) paralysis_6\NN\14557898
D013874_D012133 CID thiopental_9\NN\2792049 (r_pobj) by_8\IN\0 (r_agent) produced_7\VBN\1617192 (r_acl) paralysis_6\NN\14557898
D000596_D012131 NONE acids_29\NNS\14818238 (r_pobj) of_26\IN\0 (r_prep) any_25\DT\0 (r_dobj) affecting_24\VBG\126264 (r_pcomp) without_23\IN\0 (r_prep) stem_22\NN\6290637 (l_nsubj) arrest_7\NN\88481
D013874_D012131 NONE thiopental_4\NN\2792049 (r_npadvmod) produced_5\VBD\1617192 (r_amod) arrest_7\NN\88481
8677458
D015080_D064420 NONE mesna_15\NN\0 (r_dobj) administering_14\VBG\2436349 (r_pcomp) by_13\IN\0 (r_agent) prevented_12\VBN\0 (r_relcl) toxicity_6\NN\13576101
D007069_D006470 CID ifosfamide_7\RB\0 (r_advmod) induced_9\VBN\1627355 (r_amod) cystitis_11\NN\14566129
D007069_D006470 CID ifosfamide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D015080_D003556 CID mesna_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (l_relcl) prevent_6\VB\0 (l_dobj) cystitis_11\NN\14566129
D015080_D003556 CID mesna_15\NN\0 (r_dobj) administering_14\VBG\2436349 (r_pcomp) by_13\IN\0 (r_agent) prevented_12\VBN\0 (r_relcl) toxicity_6\NN\13576101 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D007069_D003556 CID ifosfamide_7\RB\0 (r_advmod) induced_9\VBN\1627355 (r_amod) cystitis_11\NN\14566129
D007069_D003556 CID ifosfamide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D015080_D006470 CID mesna_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (l_relcl) prevent_6\VB\0 (l_dobj) cystitis_11\NN\14566129
D015080_D006470 CID mesna_15\NN\0 (r_dobj) administering_14\VBG\2436349 (r_pcomp) by_13\IN\0 (r_agent) prevented_12\VBN\0 (r_relcl) toxicity_6\NN\13576101 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D007069_D064420 NONE ifosfamide_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101
D007069_D014839 NONE ifosfamide_33\RB\0 (r_advmod) induced_35\VBN\1627355 (r_amod) emesis_36\NN\116687
D015080_D014839 NONE mesna_19\NN\0 (r_compound) concentrations_20\NNS\4916342 (l_prep) as_23\IN\14622893 (l_prep) in_24\IN\13603305 (l_pobj) patient_26\NN\9898892 (l_relcl) experiences_31\VBZ\5984287 (l_dobj) emesis_36\NN\116687
D015080_D014839 NONE mesna_29\NN\0 (r_dobj) taking_27\VBG\37396 (r_acl) patient_26\NN\9898892 (l_relcl) experiences_31\VBZ\5984287 (l_dobj) emesis_36\NN\116687
3411101
D011802_D056486 NONE quinidine_0\NN\2715941 (r_nsubj) be_5\VB\14625458 (l_acomp) responsible_6\JJ\0 (l_prep) for_7\IN\0 (l_pobj) hepatitis_9\NN\14127211
C033457_D056486 CID phenylethylbarbiturate_1\NN\0 (r_npadvmod) induced_3\VBN\1627355 (l_dobj) hepatitis_5\NN\14127211
C033457_D056486 CID phenylethylbarbiturate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) administration_25\NN\1133281 (r_pobj) after_22\IN\0 (r_prep) affected_11\VBN\126264 (l_agent) by_12\IN\0 (l_pobj) hepatitis_14\NN\14127211
C033457_D056486 CID phenylethylbarbiturate_3\NN\0 (r_conj) quinidine_0\NN\2715941 (r_nsubj) be_5\VB\14625458 (l_acomp) responsible_6\JJ\0 (l_prep) for_7\IN\0 (l_pobj) hepatitis_9\NN\14127211
17943461
D015215_D002311 CID zidovudine_12\NNP\3834836 (r_appos) component_11\NN\5867413 (r_nsubj) triggers_18\VBZ\3659292 (l_conj) cause_28\VB\7323922 (l_dobj) disruption_30\NN\1066163 (l_prep) in_31\IN\13603305 (l_pobj) model_34\NN\5888929 (l_prep) of_35\IN\0 (l_pobj) dcm_36\NNP\0
D015215_D002311 CID 3'-azido-2',3'-deoxythymidine_14\CD\0 (r_appos) zidovudine_12\NNP\3834836 (r_appos) component_11\NN\5867413 (r_nsubj) triggers_18\VBZ\3659292 (l_conj) cause_28\VB\7323922 (l_dobj) disruption_30\NN\1066163 (l_prep) in_31\IN\13603305 (l_pobj) model_34\NN\5888929 (l_prep) of_35\IN\0 (l_pobj) dcm_36\NNP\0
D015215_D002311 CID azt_16\NNP\3834836 (r_appos) component_11\NN\5867413 (r_nsubj) triggers_18\VBZ\3659292 (l_conj) cause_28\VB\7323922 (l_dobj) disruption_30\NN\1066163 (l_prep) in_31\IN\13603305 (l_pobj) model_34\NN\5888929 (l_prep) of_35\IN\0 (l_pobj) dcm_36\NNP\0
D015215_D002311 CID azt_69\NNP\3834836 (r_pobj) of_68\IN\0 (r_prep) concentrations_67\NNS\4916342 (r_dobj) containing_65\VBG\2632940 (r_acl) libitum_64\NN\0 (r_dobj) received_61\VBD\2210855 (l_prep) in_4\IN\13603305 (l_pobj) order_5\NN\7168131 (l_acl) investigate_7\VB\644583 (l_ccomp) triggers_18\VBZ\3659292 (l_conj) cause_28\VB\7323922 (l_dobj) disruption_30\NN\1066163 (l_prep) in_31\IN\13603305 (l_pobj) model_34\NN\5888929 (l_prep) of_35\IN\0 (l_pobj) dcm_36\NNP\0
D015215_D002311 CID azt_3\NNP\3834836 (r_npadvmod) treated_5\VBN\2376958 (r_amod) fasl_6\NNPS\0 (r_compound) mice_8\NNS\2329401 (r_nsubj) developed_9\VBD\1753788 (l_dobj) dilation_11\NN\7138085
D015215_D009202 CID azt_7\NNP\3834836 (r_npadvmod) induced_9\VBN\1627355 (r_amod) cardiomyopathy_10\NN\14103288
11027904
D020910_D010146 NONE ketorolac_48\RB\3828465 (r_nmod) agents_53\NNS\7347 (r_conj) examined_23\VBN\0 (l_prep) by_0\IN\0 (l_pcomp) using_1\VBG\418025 (l_dobj) tolerance_13\NN\5032565 (l_prep) to_14\IN\0 (l_pobj) pain_21\NN\14299637
D008691_D010146 NONE methadone_3\NN\3808564 (r_npadvmod) maintained_5\VBN\0 (r_amod) abusers_7\NNS\9633969 (r_pobj) in_2\IN\13603305 (r_prep) responses_1\NNS\11410625 (l_compound) pain_0\NN\14299637
D008691_D010146 NONE methadone_19\NN\3808564 (r_compound) maintenance_21\NN\266806 (r_nmod) treatment_25\NN\654885 (r_pobj) in_18\IN\13603305 (r_prep) stabilized_17\VBD\126264 (r_acl) sample_13\NN\5820620 (r_pobj) in_11\IN\13603305 (r_prep) tolerance_7\NN\5032565 (l_compound) pain_6\NN\14299637
D004091_D010146 NONE hydromorphone_38\NN\2707683 (r_parataxis) opioid_36\NN\0 (r_pobj) of_34\IN\0 (r_prep) doses_33\NNS\3740161 (r_pobj) of_31\IN\0 (r_prep) administration_30\NN\1133281 (r_pobj) after_28\IN\0 (r_conj) before_26\IN\0 (r_advmod) examined_23\VBN\0 (l_prep) by_0\IN\0 (l_pcomp) using_1\VBG\418025 (l_dobj) tolerance_13\NN\5032565 (l_prep) to_14\IN\0 (l_pobj) pain_21\NN\14299637
D008691_D009293 NONE methadone_19\NN\3808564 (r_compound) maintenance_21\NN\266806 (r_nmod) treatment_25\NN\654885 (r_pobj) in_18\IN\13603305 (r_prep) stabilized_17\VBD\126264 (r_acl) sample_13\NN\5820620 (l_prep) of_14\IN\0 (l_pobj) addicts_16\NNS\10059582
11705128
D012254_D019698 NONE ribavirin_19\RB\2725367 (r_conj) interferon_15\NN\2725367 (r_pobj) with_14\IN\0 (r_prep) therapy_13\NN\657604 (r_pobj) of_11\IN\0 (r_prep) efficacy_6\NN\5199286 (r_dobj) demonstrated_4\VBN\2137132 (l_prep) compared_20\VBN\644583 (l_prep) with_21\IN\0 (l_pobj) monotherapy_25\NN\0 (l_prep) in_26\IN\13603305 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) c_32\NNP\13714184
D012254_D019698 NONE ribavirin_19\RB\2725367 (r_conj) interferon_15\NN\2725367 (r_pobj) with_14\IN\0 (r_prep) therapy_13\NN\657604 (r_pobj) of_11\IN\0 (r_prep) efficacy_6\NN\5199286 (r_dobj) demonstrated_4\VBN\2137132 (l_prep) compared_20\VBN\644583 (l_prep) with_21\IN\0 (l_pobj) monotherapy_25\NN\0 (l_prep) in_26\IN\13603305 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) c_32\NNP\13714184 (l_appos) chc_34\NNP\0
D012254_D000743 CID ribavirin_3\RB\2725367 (r_npadvmod) induced_5\VBN\1627355 (r_amod) anemia_7\NN\14189204
D012254_D000743 CID ribavirin_11\RB\2725367 (r_npadvmod) induced_13\VBN\1627355 (l_dobj) anemia_15\NN\14189204
D012254_D000743 CID ribavirin_11\RB\2725367 (r_npadvmod) induced_13\VBN\1627355 (l_dobj) anemia_15\NN\14189204 (l_appos) riha_17\NNP\0
D012254_D000743 CID ribavirin_14\JJ\2725367 (r_compound) dosage_15\NN\13576355 (r_pobj) of_12\IN\0 (r_prep) reduction_9\NN\351485 (r_attr) is_8\VBZ\0 (l_nsubj) standard_1\NN\13577171 (l_prep) for_4\IN\0 (l_pobj) management_5\NN\1123598 (l_prep) of_6\IN\0 (l_pobj) riha_7\NNP\0
D012254_D000743 CID ribavirin_7\NN\2725367 (r_pobj) of_6\IN\0 (r_prep) dose_5\NN\3740161 (l_conj) incidence_10\NN\13821570 (l_prep) of_11\IN\0 (l_pobj) riha_12\NNP\0
D012254_D006526 NONE ribavirin_3\RB\2725367 (r_npadvmod) induced_5\VBN\1627355 (r_amod) anemia_7\NN\14189204 (l_prep) in_8\IN\13603305 (l_pobj) treatment_10\NN\654885 (l_prep) of_11\IN\0 (l_pobj) c_13\NNP\13714184
D016898_D019698 NONE alpha_24\NN\6828818 (r_compound) monotherapy_25\NN\0 (l_prep) in_26\IN\13603305 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) c_32\NNP\13714184
D016898_D019698 NONE alpha_24\NN\6828818 (r_compound) monotherapy_25\NN\0 (l_prep) in_26\IN\13603305 (l_pobj) treatment_28\NN\654885 (l_prep) of_29\IN\0 (l_pobj) c_32\NNP\13714184 (l_appos) chc_34\NNP\0
17975693
D002939_D001008 CID ciprofloxacin-_5\JJ\0 (r_nmod) rats_10\NNS\2329401 (r_nsubj) showed_11\VBD\2137132 (l_dobj) behaviour_13\NN\14006945
D009643_D001008 CID norfloxacin_7\NNS\0 (r_npadvmod) treated_9\VBN\2376958 (r_conj) ciprofloxacin-_5\JJ\0 (r_nmod) rats_10\NNS\2329401 (r_nsubj) showed_11\VBD\2137132 (l_dobj) behaviour_13\NN\14006945
18627295
D004317_D009202 CID doxorubicin_0\NNP\2716866 (l_dobj) inflammation_4\NN\14299637 (l_amod) induced_3\VBN\1627355 (l_npadvmod) cardiomyopathy_1\NN\14103288
D004317_D009202 CID dox_17\NNP\0 (r_compound) cardiomyopathy_18\NN\14103288
D004317_D009202 CID dox_17\NNP\0 (r_compound) cardiomyopathy_18\NN\14103288 (r_pobj) of_16\IN\0 (r_prep) development_15\NN\248977 (r_pobj) during_13\IN\0 (r_prep) elucidate_1\VB\939277 (r_advcl) studied_21\VBD\0 (l_prep) by_29\IN\0 (l_pcomp) investigating_30\VBG\575741 (l_conj) apoptosis_34\NN\11486178 (l_prep) after_35\IN\0 (l_pobj) induction_36\NN\7450842 (l_prep) of_37\IN\0 (l_pobj) cardiomyopathy_41\NN\14103288
D004317_D009202 CID dox_38\NNP\0 (r_npadvmod) induced_40\VBN\1627355 (r_amod) cardiomyopathy_41\NN\14103288 (r_pobj) of_37\IN\0 (r_prep) induction_36\NN\7450842 (r_pobj) after_35\IN\0 (r_prep) apoptosis_34\NN\11486178 (r_conj) investigating_30\VBG\575741 (r_pcomp) by_29\IN\0 (r_prep) studied_21\VBD\0 (l_advcl) elucidate_1\VB\939277 (l_prep) during_13\IN\0 (l_pobj) development_15\NN\248977 (l_prep) of_16\IN\0 (l_pobj) cardiomyopathy_18\NN\14103288
D004317_D009202 CID dox_38\NNP\0 (r_npadvmod) induced_40\VBN\1627355 (r_amod) cardiomyopathy_41\NN\14103288
D004317_D009202 CID dox_8\NNP\0 (r_pobj) in_7\IN\13603305 (r_prep) is_5\VBZ\0 (l_acl) cardiomyopathy_9\NN\14103288
D004317_D009202 CID dox_16\NNP\0 (r_compound) cardiomyopathy_17\NN\14103288
D004317_D007249 NONE doxorubicin_0\NNP\2716866 (l_dobj) inflammation_4\NN\14299637
D004317_D007249 NONE dox_17\NNP\0 (r_compound) cardiomyopathy_18\NN\14103288 (r_pobj) of_16\IN\0 (r_prep) development_15\NN\248977 (r_pobj) during_13\IN\0 (r_prep) elucidate_1\VB\939277 (r_advcl) studied_21\VBD\0 (l_prep) by_29\IN\0 (l_pcomp) investigating_30\VBG\575741 (l_dobj) inflammation_32\NN\14299637
D004317_D007249 NONE dox_38\NNP\0 (r_npadvmod) induced_40\VBN\1627355 (r_amod) cardiomyopathy_41\NN\14103288 (r_pobj) of_37\IN\0 (r_prep) induction_36\NN\7450842 (r_pobj) after_35\IN\0 (r_prep) apoptosis_34\NN\11486178 (r_conj) investigating_30\VBG\575741 (l_dobj) inflammation_32\NN\14299637
D004317_D066126 NONE doxorubicin_5\NN\2716866 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_10\VBN\4019101 (l_agent) by_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_amod) cardiotoxic_13\JJ\0
D004317_D066126 NONE dox_7\NNP\0 (r_appos) doxorubicin_5\NN\2716866 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_10\VBN\4019101 (l_agent) by_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_amod) cardiotoxic_13\JJ\0
D004317_D006331 NONE dox_0\NN\0 (r_compound) control_1\NN\5190804 (r_compound) mice_2\NNS\2329401 (r_nsubj) showed_3\VBD\2137132 (l_dobj) dysfunction_5\NN\14204950
D004317_D006331 NONE dox_1\NNP\0 (r_nmod) mice_4\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) improved_9\VBN\126264 (l_nsubjpass) dysfunction_7\NN\14204950
D004317_D006331 NONE dox_12\NNP\0 (r_compound) mice_14\NNS\2329401 (r_pobj) to_11\IN\0 (r_prep) compared_10\VBN\644583 (r_prep) improved_9\VBN\126264 (l_nsubjpass) dysfunction_7\NN\14204950
D018943_D066126 NONE anthracycline_4\NN\0 (r_amod) doxorubicin_5\NN\2716866 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_10\VBN\4019101 (l_agent) by_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_amod) cardiotoxic_13\JJ\0
2564649
D011224_D009127 NONE prazosin_32\NN\2698769 (r_pobj) with_25\IN\0 (r_prep) lesions_18\NNS\14204950 (r_pobj) by_15\IN\0 (r_agent) reduced_14\VBN\441445 (r_conj) antagonized_11\VBN\1787955 (l_nsubjpass) rigidity_4\NN\5023233
D005283_D009127 CID fentanyl_8\NN\2707683 (r_npadvmod) induced_10\VBN\1627355 (r_amod) rigidity_12\NN\5023233
D005283_D009127 CID fentanyl_17\NN\2707683 (r_compound) anesthesia_18\NN\14034177 (r_pobj) with_13\IN\0 (r_prep) associated_12\VBN\628491 (r_relcl) effect_9\NN\34213 (r_attr) is_3\VBZ\0 (l_nsubj) rigidity_2\NN\5023233
D005283_D009127 CID fentanyl_10\NN\2707683 (r_pobj) by_9\IN\0 (r_prep) rigidity_8\NN\5023233
7542793
D016559_D007674 CID fk506_5\NNP\0 (r_conj) nephrotoxicity_0\NN\0
D016559_D007674 CID fk506_10\NNP\0 (r_nsubjpass) mediated_13\VBN\761713 (l_nsubjpass) effects_6\NNS\13245626 (l_amod) nephrotoxic_5\JJ\0
D016572_D064420 NONE csa_4\NNP\0 (l_conj) toxicity_7\NN\13576101
D018942_D006984 NONE macrolide_21\NN\0 (r_amod) rapamycin_23\NNS\0 (r_conj) fujimycine_9\NNP\0 (r_conj) mg/kg_6\NN\0 (r_appos) a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
D016572_D006984 NONE a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
D016572_D006984 NONE csa_3\NNP\0 (r_appos) a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
D016572_D007674 CID a_3\NNP\13649268 (r_pobj) of_1\IN\0 (r_prep) nephrotoxicity_0\NN\0
D016572_D007674 CID csa_8\NNP\0 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (l_amod) nephrotoxic_5\JJ\0
D016559_D064420 NONE fk506_6\NNP\0 (r_compound) toxicity_7\NN\13576101
D016559_D006984 NONE fujimycine_9\NNP\0 (r_conj) mg/kg_6\NN\0 (r_appos) a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
D016559_D006984 NONE fk506_11\NNP\0 (r_appos) fujimycine_9\NNP\0 (r_conj) mg/kg_6\NN\0 (r_appos) a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
D020123_D006984 NONE rapamycin_23\NNS\0 (r_conj) fujimycine_9\NNP\0 (r_conj) mg/kg_6\NN\0 (r_appos) a_1\NNP\13649268 (r_nsubj) caused_29\VBD\1617192 (l_dobj) reduction_31\NN\351485 (l_prep) of_32\IN\0 (l_pobj) rate_35\NN\13815152 (l_appos) changes_38\NNS\7283608 (l_conj) hypertrophy_45\NN\14365950
1300436
D003404_D058186 NONE creatinine_46\NN\0 (r_pobj) in_44\IN\13603305 (r_prep) rise_43\NN\7324673 (r_pobj) with_41\IN\0 (r_prep) deteriorated_26\VBD\208836
D005665_D007674 NONE furosemide_4\NN\3214670 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) in_5\IN\13603305 (l_pobj) nephropathy_7\NN\14573196
D005665_D007674 NONE furosemide_11\NN\3214670 (r_pobj) of_10\IN\0 (r_prep) efficacy_9\NN\5199286 (r_dobj) determine_7\VB\0 (l_prep) in_12\IN\13603305 (l_pobj) addition_13\NN\3081021 (l_prep) in_17\IN\13603305 (l_pobj) prevention_19\NN\1073995 (l_prep) of_20\IN\0 (l_pobj) nephropathy_22\NN\14573196
D005665_D007674 NONE furosemide_0\NNP\3214670 (r_nsubj) be_2\VB\14625458 (l_prep) in_4\IN\13603305 (l_pobj) prevention_6\NN\1073995 (l_prep) of_7\IN\0 (l_pobj) nephropathy_9\NN\14573196
D005665_D015431 NONE furosemide_9\NN\3214670 (r_npadvmod) treated_11\VBN\2376958 (r_amod) group_12\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) loss_6\NN\13252973
D005665_D051437 NONE furosemide_9\NN\3214670 (r_npadvmod) treated_11\VBN\2376958 (r_amod) group_12\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) loss_6\NN\13252973 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (l_nsubjpass) failure_1\NN\66216
D005665_D058186 CID furosemide_32\NN\3214670 (r_pobj) with_31\IN\0 (r_prep) pretreated_30\VBN\0 (r_acl) group_29\NN\2137 (r_pobj) in_27\IN\13603305 (r_prep) deteriorated_26\VBD\208836
12101159
D002118_D006323 NONE calcium_13\NN\14625458 (r_pobj) with_9\IN\0 (r_prep) resuscitation_8\NN\1047338 (r_dep) delayed_0\VBN\439958 (l_dobj) arrest_3\NN\88481 (l_amod) asystolic_1\JJ\0
D002118_D006323 NONE calcium_13\NN\14625458 (r_pobj) with_9\IN\0 (r_prep) resuscitation_8\NN\1047338 (r_dep) delayed_0\VBN\439958 (l_dobj) arrest_3\NN\88481
D002118_D006323 NONE calcium_12\NN\14625458 (r_compound) therapy_13\NN\657604 (r_pobj) for_7\IN\0 (r_prep) role_6\NN\719494 (l_prep) with_20\IN\0 (l_pobj) onset_22\NN\7325190 (l_prep) of_23\IN\0 (l_pobj) asystole_24\NN\14204950
D004110_D062787 CID diltiazem_5\NN\2938514 (r_compound) overdose_6\NN\84738
D004110_D062787 CID diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
D004110_D062787 CID diltiazem_16\NN\2938514 (r_compound) overdose_17\NN\84738
D004110_D062787 CID diltiazem_11\NN\2938514 (r_compound) overdose_12\NN\84738
D000431_D062787 NONE alcohol_25\NN\7881800 (r_conj) nitrate_22\NN\14818238 (r_conj) aspirin_19\NN\2707683 (r_conj) paracetamol_17\JJ\0 (r_conj) diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
D002118_D062787 NONE calcium_13\NN\14625458 (r_pobj) with_9\IN\0 (r_prep) resuscitation_8\NN\1047338 (r_dep) delayed_0\VBN\439958 (l_dobj) arrest_3\NN\88481 (l_prep) after_4\IN\0 (l_pobj) overdose_6\NN\84738
D002118_D062787 NONE calcium_12\NN\14625458 (r_compound) therapy_13\NN\657604 (l_prep) in_14\IN\13603305 (l_pobj) overdose_17\NN\84738
D004110_D006323 CID diltiazem_5\NN\2938514 (r_compound) overdose_6\NN\84738 (r_pobj) after_4\IN\0 (r_prep) arrest_3\NN\88481 (l_amod) asystolic_1\JJ\0
D004110_D006323 CID diltiazem_5\NN\2938514 (r_compound) overdose_6\NN\84738 (r_pobj) after_4\IN\0 (r_prep) arrest_3\NN\88481
D004110_D006323 CID diltiazem_16\NN\2938514 (r_compound) overdose_17\NN\84738 (r_pobj) in_14\IN\13603305 (r_prep) therapy_13\NN\657604 (r_pobj) for_7\IN\0 (r_prep) role_6\NN\719494 (l_prep) with_20\IN\0 (l_pobj) onset_22\NN\7325190 (l_prep) of_23\IN\0 (l_pobj) asystole_24\NN\14204950
D004110_D006323 CID diltiazem_11\NN\2938514 (r_compound) overdose_12\NN\84738 (r_pobj) after_10\IN\0 (r_prep) cases_6\NNS\7283608 (l_prep) of_7\IN\0 (l_pobj) arrest_9\NN\88481
D009566_D062787 NONE nitrate_22\NN\14818238 (r_conj) aspirin_19\NN\2707683 (r_conj) paracetamol_17\JJ\0 (r_conj) diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
D001241_D062787 NONE aspirin_19\NN\2707683 (r_conj) paracetamol_17\JJ\0 (r_conj) diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
D007547_D062787 NONE isosorbide_21\JJ\3740161 (r_compound) nitrate_22\NN\14818238 (r_conj) aspirin_19\NN\2707683 (r_conj) paracetamol_17\JJ\0 (r_conj) diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
D000082_D062787 NONE paracetamol_17\JJ\0 (r_conj) diltiazem_15\NN\2938514 (r_pobj) of_14\IN\0 (r_prep) g_13\NN\13717155 (r_pobj) including_9\VBG\0 (r_prep) overdose_8\NN\84738
11099450
D007980_D004409 CID levodopa_33\RB\14604959 (r_npadvmod) induced_35\VBN\1627355 (r_amod) dyskinesias_36\NNS\14084880
D007980_D004409 CID levodopa_33\RB\14604959 (r_npadvmod) induced_35\VBN\1627355 (r_amod) dyskinesias_36\NNS\14084880 (l_appos) lid_38\NNP\5313679
D007980_D004409 CID levodopa_8\JJ\14604959 (r_compound) responsiveness_9\NN\5652926 (r_pobj) between_5\IN\0 (r_prep) correlations_4\NNS\13841213 (r_dobj) found_1\VBD\13279262 (l_advcl) was_45\VBD\0 (l_attr) correlation_47\NN\13841213 (l_prep) with_48\IN\0 (l_pobj) improvement_50\NN\7359599 (l_prep) in_51\IN\13603305 (l_pobj) lid_52\NNP\5313679
D007980_D004409 CID levodopa_15\JJ\14604959 (r_compound) responsiveness_16\NN\5652926 (r_conj) responsiveness_9\NN\5652926 (r_pobj) between_5\IN\0 (r_prep) correlations_4\NNS\13841213 (r_dobj) found_1\VBD\13279262 (l_advcl) was_45\VBD\0 (l_attr) correlation_47\NN\13841213 (l_prep) with_48\IN\0 (l_pobj) improvement_50\NN\7359599 (l_prep) in_51\IN\13603305 (l_pobj) lid_52\NNP\5313679
D007980_D004409 CID levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (l_prep) for_7\IN\0 (l_pobj) outcome_9\NN\7291312 (l_prep) of_10\IN\0 (l_pobj) signs_15\NNS\6643763 (l_conj) lid_17\NNP\5313679
D007980_D004409 CID levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (l_prep) for_7\IN\0 (l_pobj) outcome_9\NN\7291312 (l_prep) of_10\IN\0 (l_pobj) signs_15\NNS\6643763 (l_conj) lid_17\NNP\5313679 (l_conj) correlations_21\NNS\13841213 (l_prep) of_22\IN\0 (l_pobj) volume_25\NN\33615 (l_prep) with_26\IN\0 (l_pobj) dyskinesias_27\NNS\14084880
D007980_D004409 CID levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (r_pobj) of_4\IN\0 (r_prep) value_3\NN\5856066 (r_nsubj) indicate_34\VBP\952524 (l_ccomp) be_42\VB\14625458 (l_acomp) responsible_43\JJ\0 (l_prep) for_44\IN\0 (l_pobj) signs_52\NNS\6643763 (l_conj) dyskinesias_54\NNS\14084880
D007980_D010300 NONE levodopa_33\RB\14604959 (r_npadvmod) induced_35\VBN\1627355 (r_amod) dyskinesias_36\NNS\14084880 (r_conj) signs_31\NNS\6643763 (l_poss) parkinsonian_27\NN\0
D007980_D010300 NONE levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (l_prep) for_7\IN\0 (l_pobj) outcome_9\NN\7291312 (l_prep) of_10\IN\0 (l_pobj) signs_15\NNS\6643763 (l_poss) parkinsonian_11\NN\0
D007980_D010300 NONE levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (l_prep) for_7\IN\0 (l_pobj) outcome_9\NN\7291312 (l_prep) of_10\IN\0 (l_pobj) signs_15\NNS\6643763 (l_conj) lid_17\NNP\5313679 (l_conj) correlations_21\NNS\13841213 (l_prep) of_22\IN\0 (l_pobj) volume_25\NN\33615 (l_prep) with_26\IN\0 (l_pobj) dyskinesias_27\NNS\14084880 (l_conj) parkinsonian_29\NN\0
D007980_D010300 NONE levodopa_5\JJ\14604959 (r_compound) responsiveness_6\NN\5652926 (r_pobj) of_4\IN\0 (r_prep) value_3\NN\5856066 (r_nsubj) indicate_34\VBP\952524 (l_ccomp) be_42\VB\14625458 (l_acomp) responsible_43\JJ\0 (l_prep) for_44\IN\0 (l_pobj) generation_46\NN\7942152 (l_prep) of_47\IN\0 (l_pobj) parkinsonian_48\NN\0
1079693
D002738_D012164 NONE chloroquine_2\NN\2721948 (r_xcomp) used_1\VBD\0 (l_conj) found_11\VBD\13279262 (l_dobj) case_14\NN\7283608 (l_prep) of_15\IN\0 (l_pobj) chorioretinopathy_16\JJ\0
D000305_D014605 NONE corticosteroids_27\NNS\14745635 (r_pobj) with_26\IN\0 (r_prep) treatment_25\NN\654885 (r_pobj) of_22\IN\0 (r_prep) months_21\NNS\15113229 (r_pobj) to_17\IN\0 (r_prep) respond_16\VB\2367363 (l_nsubj) %_9\NN\0 (l_prep) of_10\IN\0 (l_pobj) cases_11\NNS\7283608 (l_prep) of_12\IN\0 (l_pobj) uveitis_13\NN\14336539
D000305_D002386 NONE corticosteroids_2\NNS\14745635 (r_dobj) administered_1\VBN\2436349 (r_csubjpass) used_4\VBN\0 (r_ccomp) found_19\VBN\13279262 (l_nsubjpass) number_13\NN\5107765 (l_prep) of_14\IN\0 (l_pobj) cataracts_17\NNS\14252864
D006886_D012164 CID hydroxychloroquine_4\NN\2721538 (r_conj) chloroquine_2\NN\2721948 (r_xcomp) used_1\VBD\0 (l_conj) found_11\VBD\13279262 (l_dobj) case_14\NN\7283608 (l_prep) of_15\IN\0 (l_pobj) chorioretinopathy_16\JJ\0
11195262
D014635_D004830 NONE vpa_4\NNP\0 (r_dobj) taking_3\VBG\37396 (l_prep) for_5\IN\0 (l_pobj) treatment_6\NN\654885 (l_prep) of_7\IN\0 (l_pobj) convulsions_13\NNS\14081375
D014635_D007177 CID valproate_3\NN\0 (l_prep) to_4\IN\0 (l_pobj) syndrome_6\NN\5870365 (l_prep) of_7\IN\0 (l_pobj) secretion_9\NN\13526110 (l_prep) of_10\IN\0 (l_pobj) hormone_12\NN\5404728
D014635_D007177 CID valproate_14\NN\0 (l_conj) developed_21\VBD\1753788 (l_dobj) syndrome_23\NN\5870365 (l_prep) of_24\IN\0 (l_pobj) secretion_26\NN\13526110 (l_prep) of_27\IN\0 (l_pobj) hormone_29\NN\5404728
D014635_D007177 CID valproate_14\NN\0 (l_conj) developed_21\VBD\1753788 (l_dobj) syndrome_23\NN\5870365 (l_prep) of_24\IN\0 (l_pobj) secretion_26\NN\13526110 (l_prep) of_27\IN\0 (l_pobj) hormone_29\NN\5404728 (l_appos) siadh_31\NNP\0
D014635_D007177 CID vpa_16\NNP\0 (r_npadvmod) valproate_14\NN\0 (l_conj) developed_21\VBD\1753788 (l_dobj) syndrome_23\NN\5870365 (l_prep) of_24\IN\0 (l_pobj) secretion_26\NN\13526110 (l_prep) of_27\IN\0 (l_pobj) hormone_29\NN\5404728
D014635_D007177 CID vpa_16\NNP\0 (r_npadvmod) valproate_14\NN\0 (l_conj) developed_21\VBD\1753788 (l_dobj) syndrome_23\NN\5870365 (l_prep) of_24\IN\0 (l_pobj) secretion_26\NN\13526110 (l_prep) of_27\IN\0 (l_pobj) hormone_29\NN\5404728 (l_appos) siadh_31\NNP\0
D014635_D007177 CID vpa_30\NNP\0 (r_pobj) of_29\IN\0 (r_prep) administration_28\NN\1133281 (r_conj) weakness_17\NN\14462666 (r_pobj) including_15\VBG\0 (r_prep) factors_14\NNS\7326557 (r_pobj) of_13\IN\0 (r_prep) combination_12\NN\7951464 (r_pobj) of_10\IN\0 (r_prep) result_9\NN\34213 (r_attr) be_7\VB\14625458 (l_nsubj) episode_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) siadh_5\NNP\0
D014635_D002493 NONE vpa_30\NNP\0 (r_pobj) of_29\IN\0 (r_prep) administration_28\NN\1133281 (r_conj) weakness_17\NN\14462666 (l_prep) of_18\IN\0 (l_pobj) system_22\NN\3575240
2334179
D010396_D011507 CID penicillamine_2\NN\3740161 (r_nsubj) caused_3\VBD\1617192 (l_prep) in_6\IN\13603305 (l_pobj) patient_8\NN\9898892 (l_conj) proteinuria_12\NN\14299637
D010396_D012594 NONE penicillamine_2\NN\3740161 (l_prep) in_3\IN\13603305 (l_pobj) treatment_5\NN\654885 (l_prep) of_6\IN\0 (l_pobj) scleroderma_8\NN\14187378
D010396_D012594 NONE penicillamine_17\NN\3740161 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) scleroderma_10\NN\14187378
D010396_D012594 NONE penicillamine_6\NN\3740161 (r_nsubj) be_8\VB\14625458 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pobj) cases_12\NNS\7283608 (l_prep) of_13\IN\0 (l_pobj) scleroderma_15\NN\14187378
D010396_D009404 CID penicillamine_2\NN\3740161 (r_nsubj) caused_3\VBD\1617192 (l_dobj) syndrome_5\NN\5870365
D010396_D051437 NONE penicillamine_2\NN\3740161 (r_nsubj) caused_3\VBD\1617192 (r_ccomp) developed_19\VBD\1753788 (l_dobj) insufficiency_21\NN\14462946
18657397
D010400_D004827 CID potassium_20\NN\14625458 (r_dobj) injecting_14\VBG\81072 (r_pcomp) by_13\IN\0 (r_prep) induced_12\VBN\1627355 (l_nsubjpass) focus_10\NN\5704266 (l_amod) epileptic_9\JJ\10595647
D010406_D004827 NONE penicillin_5\NN\2716866 (r_npadvmod) induced_7\VBN\1627355 (r_amod) activity_9\NN\30358
D010406_D004827 NONE penicillin_0\NNP\2716866 (r_compound) model_1\NN\5888929 (r_nsubj) is_2\VBZ\0 (l_attr) model_7\NN\5888929 (l_prep) for_8\IN\0 (l_pobj) research_10\NN\633864 (l_compound) epilepsy_9\NN\14085708
D010406_D004827 NONE penicillin_13\NN\2716866 (r_npadvmod) induced_15\VBN\1627355 (r_amod) activity_17\NN\30358
D010406_D004827 NONE penicillin_7\NN\2716866 (r_npadvmod) induced_9\VBN\1627355 (r_amod) periods_12\NNS\13575869 (l_compound) activity_11\NN\30358
9270571
D004298_D010300 NONE dopamine_4\NN\14807737 (r_pobj) of_3\IN\0 (r_prep) utility_2\NN\8186047 (l_appos) agonists_10\NNS\0 (l_prep) in_11\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) disease_17\NN\14061805
D004298_D010300 NONE dopamine_4\NN\14807737 (r_pobj) of_3\IN\0 (r_prep) utility_2\NN\8186047 (l_appos) agonists_10\NNS\0 (l_prep) in_11\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) disease_17\NN\14061805 (l_appos) pd_19\NNP\14625458
D004298_D010300 NONE da_6\NNP\10484858 (r_nmod) agonists_10\NNS\0 (l_prep) in_11\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) disease_17\NN\14061805
D004298_D010300 NONE da_6\NNP\10484858 (r_nmod) agonists_10\NNS\0 (l_prep) in_11\IN\13603305 (l_pobj) treatment_13\NN\654885 (l_prep) of_14\IN\0 (l_pobj) disease_17\NN\14061805 (l_appos) pd_19\NNP\14625458
D004298_D010300 NONE da_1\NNP\10484858 (r_compound) d1_2\NN\0 (r_compound) agents_4\NNS\7347 (r_nsubj) are_23\VBP\13600404 (l_attr) tools_26\NNS\3563967 (l_prep) in_27\IN\13603305 (l_pobj) pd_28\NNP\14625458
D007980_D004409 CID levodopa_20\RB\14604959 (r_npadvmod) induced_22\VBN\1627355 (r_amod) dyskinesias_23\NNS\14084880
D007980_D004409 CID levodopa_20\RB\14604959 (r_npadvmod) induced_22\VBN\1627355 (r_amod) dyskinesias_23\NNS\14084880 (r_dobj) conducted_2\VBD\2436349 (l_advcl) evaluate_25\VB\670261 (l_dobj) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
D007980_D004409 CID levodopa_14\NN\14604959 (r_pobj) as_13\IN\14622893 (r_prep) alleviating_8\VBG\205885 (r_pcomp) in_7\IN\13603305 (r_prep) efficacious_6\JJ\0 (r_acomp) was_4\VBD\0 (l_conj) was_19\VBD\0 (l_acomp) likely_21\JJ\0 (l_xcomp) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
D007980_D004409 CID levodopa_25\RB\14604959 (r_npadvmod) induced_27\VBN\1627355 (r_amod) dyskinesias_28\NNS\14084880
D007980_D004409 CID levodopa_40\NN\14604959 (r_pobj) of_39\IN\0 (r_prep) challenge_38\NN\13927383 (r_pobj) with_33\IN\0 (r_prep) than_32\IN\0 (r_prep) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
D015632_D004409 NONE 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine_12\CD\0 (r_pobj) in_10\IN\13603305 (r_prep) study_9\NN\635850 (r_dobj) conducted_2\VBD\2436349 (l_dobj) dyskinesias_23\NNS\14084880
D015632_D004409 NONE 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine_12\CD\0 (r_pobj) in_10\IN\13603305 (r_prep) study_9\NN\635850 (r_dobj) conducted_2\VBD\2436349 (l_advcl) evaluate_25\VB\670261 (l_dobj) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
D015632_D004409 NONE mptp)-exposed_14\VBN\0 (r_amod) monkeys_16\NNS\2469914 (r_appos) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine_12\CD\0 (r_pobj) in_10\IN\13603305 (r_prep) study_9\NN\635850 (r_dobj) conducted_2\VBD\2436349 (l_dobj) dyskinesias_23\NNS\14084880
D015632_D004409 NONE mptp)-exposed_14\VBN\0 (r_amod) monkeys_16\NNS\2469914 (r_appos) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine_12\CD\0 (r_pobj) in_10\IN\13603305 (r_prep) study_9\NN\635850 (r_dobj) conducted_2\VBD\2436349 (l_advcl) evaluate_25\VB\670261 (l_dobj) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
D015632_D004409 NONE mptp_9\NNP\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) parkinsonism_12\NN\14085708 (r_dobj) alleviating_8\VBG\205885 (r_pcomp) in_7\IN\13603305 (r_prep) efficacious_6\JJ\0 (r_acomp) was_4\VBD\0 (l_conj) was_19\VBD\0 (l_acomp) likely_21\JJ\0 (l_xcomp) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
C095427_D010300 NONE a-86929_13\NNS\0 (r_punct) agents_4\NNS\7347 (r_nsubj) are_23\VBP\13600404 (l_attr) tools_26\NNS\3563967 (l_prep) in_27\IN\13603305 (l_pobj) pd_28\NNP\14625458
C095427_D020734 NONE a-86929_0\NNS\0 (l_dep) study_4\NN\635850 (l_prep) in_5\IN\13603305 (l_pobj) monkeys_10\NNS\2469914 (l_amod) parkinsonian_6\JJ\0
C095427_D020734 NONE a-86929_3\NNS\0 (r_punct) was_4\VBD\0 (l_acomp) efficacious_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
C095427_D004409 NONE a-86929_44\NNS\0 (r_punct) ,_57\,\0 (r_punct) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_dobj) evaluate_25\VB\670261 (r_advcl) conducted_2\VBD\2436349 (l_dobj) dyskinesias_23\NNS\14084880
C095427_D004409 NONE a-86929_44\NNS\0 (r_punct) ,_57\,\0 (r_punct) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
C095427_D004409 NONE 10-diol_55\JJ\0 (r_punct) )_56\-RRB-\0 (r_punct) ,_57\,\0 (r_punct) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_dobj) evaluate_25\VB\670261 (r_advcl) conducted_2\VBD\2436349 (l_dobj) dyskinesias_23\NNS\14084880
C095427_D004409 NONE 10-diol_55\JJ\0 (r_punct) )_56\-RRB-\0 (r_punct) ,_57\,\0 (r_punct) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
C095427_D004409 NONE a-86929_3\NNS\0 (r_punct) was_4\VBD\0 (l_conj) was_19\VBD\0 (l_acomp) likely_21\JJ\0 (l_xcomp) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
D007980_D020734 NONE levodopa_7\NN\14604959 (r_npadvmod) primed_9\VBN\406243 (r_amod) monkeys_10\NNS\2469914 (l_amod) parkinsonian_6\JJ\0
D007980_D020734 NONE levodopa_14\NN\14604959 (r_pobj) as_13\IN\14622893 (r_prep) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
D007980_D020734 NONE levodopa_25\RB\14604959 (r_npadvmod) induced_27\VBN\1627355 (r_amod) dyskinesias_28\NNS\14084880 (r_dobj) reproduce_23\VB\1621555 (r_xcomp) likely_21\JJ\0 (r_acomp) was_19\VBD\0 (r_conj) was_4\VBD\0 (l_acomp) efficacious_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
D007980_D020734 NONE levodopa_40\NN\14604959 (r_pobj) of_39\IN\0 (r_prep) challenge_38\NN\13927383 (r_pobj) with_33\IN\0 (r_prep) than_32\IN\0 (r_prep) reproduce_23\VB\1621555 (r_xcomp) likely_21\JJ\0 (r_acomp) was_19\VBD\0 (r_conj) was_4\VBD\0 (l_acomp) efficacious_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
D015632_D020734 CID mptp_9\NNP\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) parkinsonism_12\NN\14085708
D004298_D004409 NONE da_62\NNP\10484858 (r_compound) agonist_65\NN\0 (r_appos) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (r_dobj) evaluate_25\VB\670261 (r_advcl) conducted_2\VBD\2436349 (l_dobj) dyskinesias_23\NNS\14084880
D004298_D004409 NONE da_62\NNP\10484858 (r_compound) agonist_65\NN\0 (r_appos) doses_35\NNS\3740161 (r_pobj) with_33\IN\0 (r_prep) challenge_32\NN\13927383 (r_pobj) on_31\IN\0 (r_prep) effects_30\NNS\13245626 (l_amod) locomotor_27\NN\0 (l_conj) dyskinetic_29\JJ\0
C416545_D020734 NONE ly-171555_16\NNP\0 (r_conj) levodopa_14\NN\14604959 (r_pobj) as_13\IN\14622893 (r_prep) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
C416545_D020734 NONE ly-171555_35\NNP\0 (r_amod) challenge_38\NN\13927383 (r_pobj) with_33\IN\0 (r_prep) than_32\IN\0 (r_prep) reproduce_23\VB\1621555 (r_xcomp) likely_21\JJ\0 (r_acomp) was_19\VBD\0 (r_conj) was_4\VBD\0 (l_acomp) efficacious_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) alleviating_8\VBG\205885 (l_dobj) parkinsonism_12\NN\14085708
C416545_D004409 NONE ly-171555_16\NNP\0 (r_conj) levodopa_14\NN\14604959 (r_pobj) as_13\IN\14622893 (r_prep) alleviating_8\VBG\205885 (r_pcomp) in_7\IN\13603305 (r_prep) efficacious_6\JJ\0 (r_acomp) was_4\VBD\0 (l_conj) was_19\VBD\0 (l_acomp) likely_21\JJ\0 (l_xcomp) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
C416545_D004409 NONE ly-171555_35\NNP\0 (r_amod) challenge_38\NN\13927383 (r_pobj) with_33\IN\0 (r_prep) than_32\IN\0 (r_prep) reproduce_23\VB\1621555 (l_dobj) dyskinesias_28\NNS\14084880
8305357
D003630_D000163 NONE daunorubicin_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) safety_15\NN\13920835 (r_conj) efficacy_13\NN\5199286 (l_prep) in_22\IN\13603305 (l_pobj) treatment_24\NN\654885 (l_prep) of_25\IN\0 (l_pobj) aids_26\NNP\13974317
D003630_D012514 NONE daunorubicin_1\NN\0 (l_dobj) sarcoma_6\NN\14239918
D003630_D012514 NONE daunorubicin_18\NN\0 (r_pobj) of_16\IN\0 (r_prep) safety_15\NN\13920835 (r_conj) efficacy_13\NN\5199286 (r_dobj) assess_11\VB\5220461 (r_relcl) trial_9\NN\786195 (r_dobj) report_1\VBP\6470073 (l_ccomp) related_27\VBD\628491 (l_dobj) sarcoma_30\NN\14239918
D003630_D012514 NONE daunorubicin_7\NN\0 (r_nsubj) was_8\VBD\0 (l_attr) agent_14\NN\7347 (l_prep) in_15\IN\13603305 (l_pobj) treatment_17\NN\654885 (l_prep) of_18\IN\0 (l_pobj) sarcoma_21\NN\14239918
15985056
D003907_D006606 NONE dexamethasone_2\NN\2721538 (r_appos) corticosteroids_0\NNS\14745635 (r_nsubj) been_15\VBN\0 (l_attr) agents_18\NNS\7347 (l_acl) mentioned_19\VBD\730052 (l_prep) as_25\IN\14622893 (l_pcomp) associated_27\VBN\628491 (l_prep) with_28\IN\0 (l_pobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) hiccups_32\NNS\863513
D017963_D006606 CID azithromycin_1\RB\2716205 (r_advmod) associated_3\VBN\628491 (r_amod) hiccups_4\NNS\863513
D017963_D006606 CID azithromycin_9\CD\2716205 (r_amod) therapy_10\NN\657604 (r_pobj) by_8\IN\0 (r_agent) associated_7\VBN\628491 (r_acl) hiccups_6\NNS\863513
D017963_D006606 CID azithromycin_11\RB\2716205 (r_advmod) beginning_10\VBG\7283608 (r_pcomp) after_9\IN\0 (r_prep) presented_5\VBN\2137132 (l_prep) with_6\IN\0 (l_pobj) hiccups_8\NNS\863513
D017963_D006606 CID azithromycin_2\NNP\2716205 (r_pobj) of_1\IN\0 (r_prep) discontinuation_0\NN\209943 (r_nsubj) resolved_8\VBD\352826 (l_dobj) hiccups_9\NNS\863513
D017963_D006606 CID azithromycin_9\WP\2716205 (r_pobj) by_8\IN\0 (r_agent) mediated_7\VBN\761713 (r_acl) mechanism_6\NN\13446390 (r_nsubj) be_11\VB\14625458 (l_attr) pathogenesis_13\NN\13533470 (l_prep) of_14\IN\0 (l_pobj) hiccups_15\NNS\863513
D008775_D006606 NONE methylprednisolone_4\NN\0 (r_conj) dexamethasone_2\NN\2721538 (r_appos) corticosteroids_0\NNS\14745635 (r_nsubj) been_15\VBN\0 (l_attr) agents_18\NNS\7347 (l_acl) mentioned_19\VBD\730052 (l_prep) as_25\IN\14622893 (l_pcomp) associated_27\VBN\628491 (l_prep) with_28\IN\0 (l_pobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) hiccups_32\NNS\863513
D001569_D006606 NONE benzodiazepines_7\NNS\3771443 (r_appos) corticosteroids_0\NNS\14745635 (r_nsubj) been_15\VBN\0 (l_attr) agents_18\NNS\7347 (l_acl) mentioned_19\VBD\730052 (l_prep) as_25\IN\14622893 (l_pcomp) associated_27\VBN\628491 (l_prep) with_28\IN\0 (l_pobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) hiccups_32\NNS\863513
D001418_D006606 CID baclofen_6\NN\0 (r_pobj) with_5\IN\0 (r_prep) therapy_4\NN\657604 (r_conj) discontinuation_0\NN\209943 (r_nsubj) resolved_8\VBD\352826 (l_dobj) hiccups_9\NNS\863513
D018942_D006606 NONE macrolide_12\NN\0 (r_amod) antimicrobials_13\NNS\14778436 (r_pobj) to_11\IN\0 (r_prep) related_10\VBN\628491 (r_oprd) reported_9\VBN\831651 (l_nsubjpass) cases_1\NNS\7283608 (l_prep) of_2\IN\0 (l_pobj) hiccups_6\NNS\863513
D018942_D006606 NONE macrolides_36\NNS\0 (r_pobj) with_34\IN\0 (r_prep) reaction_33\NN\13446390 (l_conj) absence_39\NN\14449405 (l_prep) of_40\IN\0 (l_pobj) explanation_43\NN\6722453 (l_prep) for_44\IN\0 (l_pobj) hiccups_45\NNS\863513
D018942_D006606 NONE macrolide_2\NN\0 (r_amod) antimicrobials_3\NNS\14778436 (r_nsubjpass) reported_6\VBN\831651 (l_xcomp) associated_9\VBN\628491 (l_prep) with_10\IN\0 (l_pobj) mechanism_14\NN\13446390 (l_nmod) hiccups_11\NNS\863513
D017963_D010612 NONE azithromycin_11\RB\2716205 (r_advmod) beginning_10\VBG\7283608 (l_prep) for_12\IN\0 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) pharyngitis_16\NN\14171682
D008874_D006606 NONE midazolam_9\NN\2830852 (r_appos) benzodiazepines_7\NNS\3771443 (r_appos) corticosteroids_0\NNS\14745635 (r_nsubj) been_15\VBN\0 (l_attr) agents_18\NNS\7347 (l_acl) mentioned_19\VBD\730052 (l_prep) as_25\IN\14622893 (l_pcomp) associated_27\VBN\628491 (l_prep) with_28\IN\0 (l_pobj) development_30\NN\248977 (l_prep) of_31\IN\0 (l_pobj) hiccups_32\NNS\863513
6794356
D008094_D001282 NONE lithium_18\NN\14625458 (r_compound) level_19\NN\4916342 (r_conj) failure_12\NN\66216 (r_conj) flutter_8\JJ\331950
D008094_D001282 NONE lithium_26\NN\14625458 (r_compound) compounds_27\NNS\5869584 (r_pobj) to_25\IN\0 (r_prep) exposed_24\VBN\2110927 (r_acl) infants_23\NNS\9918248 (r_pobj) among_22\IN\0 (r_prep) disease_21\NN\14061805 (r_pobj) with_19\IN\0 (r_prep) patient_18\NN\9898892 (r_dobj) described_17\VBN\1001294 (r_conj) is_1\VBZ\0 (l_attr) patient_4\NN\9898892 (l_relcl) manifest_7\VB\6479665 (l_dobj) regurgitation_9\NN\7406350 (l_conj) flutter_12\NN\331950
D008094_D014262 NONE lithium_18\NN\14625458 (r_compound) level_19\NN\4916342 (r_conj) failure_12\NN\66216 (r_conj) flutter_8\JJ\331950 (r_conj) regurgitation_5\NN\7406350
D008094_D014262 NONE lithium_26\NN\14625458 (r_compound) compounds_27\NNS\5869584 (r_pobj) to_25\IN\0 (r_prep) exposed_24\VBN\2110927 (r_acl) infants_23\NNS\9918248 (r_pobj) among_22\IN\0 (r_prep) disease_21\NN\14061805 (r_pobj) with_19\IN\0 (r_prep) patient_18\NN\9898892 (r_dobj) described_17\VBN\1001294 (r_conj) is_1\VBZ\0 (l_attr) patient_4\NN\9898892 (l_relcl) manifest_7\VB\6479665 (l_dobj) regurgitation_9\NN\7406350
D008094_D006331 NONE lithium_26\NN\14625458 (r_compound) compounds_27\NNS\5869584 (r_pobj) to_25\IN\0 (r_prep) exposed_24\VBN\2110927 (r_acl) infants_23\NNS\9918248 (r_pobj) among_22\IN\0 (r_prep) disease_21\NN\14061805
D016651_D014262 NONE carbonate_5\NN\15010703 (r_compound) toxicity_6\NN\13576101 (r_conj) regurgitation_2\NN\7406350
D016651_D006331 NONE carbonate_1\NN\15010703 (r_nsubj) be_3\VB\14625458 (l_prep) in_6\IN\13603305 (l_pobj) incidence_9\NN\13821570 (l_prep) of_10\IN\0 (l_pobj) disease_13\NN\14061805
D016651_D064420 NONE carbonate_5\NN\15010703 (r_compound) toxicity_6\NN\13576101
D008094_D006333 NONE lithium_18\NN\14625458 (r_compound) level_19\NN\4916342 (r_conj) failure_12\NN\66216
11999899
D016291_D014202 NONE mk-801_16\NNP\0 (r_punct) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926
D016291_D014202 NONE mk-801_2\NNP\0 (r_punct) produced_4\VBD\1617192 (l_dobj) increase_7\NN\13576355 (l_prep) of_8\IN\0 (l_pobj) tremor_9\NN\345926
D016291_D014202 NONE mk-801_17\NNP\0 (r_punct) induced_6\VBN\1627355 (l_dobj) increases_7\NNS\13576355 (l_prep) in_8\IN\13603305 (l_pobj) tremor_9\NN\345926
D016291_D014202 NONE mk-801_33\NNP\0 (r_punct) injection_38\NN\320852 (r_nsubj) min_40\NN\15154774 (r_nsubj) reversed_44\VBD\109660 (r_advcl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926
D012110_D004409 CID reserpine_0\NN\2721160 (r_nsubj) produced_15\VBD\1617192 (l_dobj) increases_16\NNS\13576355 (l_prep) in_17\IN\13603305 (l_pobj) dyskinesia_19\NN\14084880 (l_relcl) are_30\VBP\13600404 (l_attr) signs_31\NNS\6643763 (l_amod) indicative_32\JJ\13801424 (l_prep) of_33\IN\0 (l_pobj) dyskinesia_35\NN\14084880
D012110_D004409 CID reserpine_4\NN\2721160 (r_nsubj) produces_5\VBZ\7555863 (l_dobj) movements_9\NNS\191142
D012110_D004409 CID reserpine_4\NN\2721160 (r_nsubj) produces_5\VBZ\7555863 (l_dobj) movements_9\NNS\191142 (l_relcl) related_13\VBN\628491 (l_conj) considered_22\VBN\689344 (l_prep) as_23\IN\14622893 (l_pobj) signs_30\NNS\6643763 (l_compound) dsykinesia_29\NN\0
D016202_D002375 NONE nmda_5\NNP\0 (r_pobj) by_4\IN\0 (r_agent) produced_3\VBN\1617192 (r_acl) blockage_2\NN\14034177 (r_nsubj) restore_7\VB\1631072 (l_dobj) signs_9\NNS\6643763 (l_prep) as_12\IN\14622893 (l_pobj) movements_15\NNS\191142 (l_conj) protrusions_18\NNS\13919685 (l_conj) catalepsy_20\NN\14023236
D016291_D002375 NONE mk-801_16\NNP\0 (r_punct) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926 (l_conj) catalepsy_5\NN\14023236
D016291_D002375 NONE mk-801_17\NNP\0 (r_punct) induced_6\VBN\1627355 (l_dobj) increases_7\NNS\13576355 (l_prep) in_8\IN\13603305 (l_pobj) tremor_9\NN\345926 (l_conj) catalepsy_11\NN\14023236
D016291_D002375 NONE mk-801_33\NNP\0 (r_punct) injection_38\NN\320852 (r_nsubj) min_40\NN\15154774 (r_nsubj) reversed_44\VBD\109660 (r_advcl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926 (l_conj) catalepsy_30\NN\14023236
D012110_D014202 CID reserpine_0\NN\2721160 (r_nsubj) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926
D012110_D014202 CID reserpine_11\NN\2721160 (r_npadvmod) treated_13\VBN\2376958 (r_amod) mice_14\NNS\2329401 (r_pobj) in_10\IN\13603305 (r_prep) increase_7\NN\13576355 (l_prep) of_8\IN\0 (l_pobj) tremor_9\NN\345926
D012110_D014202 CID reserpine_5\NN\2721160 (r_nsubj) induced_6\VBN\1627355 (l_dobj) increases_7\NNS\13576355 (l_prep) in_8\IN\13603305 (l_pobj) tremor_9\NN\345926
D012110_D014202 CID reserpine_12\NN\2721160 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) catalepsy_7\NN\14023236 (l_conj) tremor_9\NN\345926
D012110_D014202 CID reserpine_2\NN\2721160 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (l_acl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926
D012110_D014202 CID reserpine_48\NN\2721160 (r_pobj) of_47\IN\0 (r_prep) effects_46\NNS\13245626 (r_dobj) reversed_44\VBD\109660 (r_advcl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926
D012110_D009069 NONE reserpine_0\NN\2721160 (r_nsubj) produced_15\VBD\1617192 (l_dobj) increases_16\NNS\13576355 (l_prep) in_17\IN\13603305 (l_pobj) dyskinesia_19\NN\14084880
D012110_D009069 NONE reserpine_0\NN\2721160 (r_nsubj) administered_6\VBN\2436349 (r_ccomp) produce_29\VB\7555863 (l_dobj) dyskinesia_31\NN\14084880
D001058_D009069 NONE apomophine_15\JJ\0 (r_amod) injection_16\NN\320852 (r_pobj) by_14\IN\0 (r_agent) followed_13\VBN\1835496 (r_conj) administered_6\VBN\2436349 (r_ccomp) produce_29\VB\7555863 (l_dobj) dyskinesia_31\NN\14084880
D016202_D014202 NONE nmda_5\NNP\0 (r_pobj) by_4\IN\0 (r_agent) produced_3\VBN\1617192 (r_acl) blockage_2\NN\14034177 (r_nsubj) restore_7\VB\1631072 (l_dobj) signs_9\NNS\6643763 (l_prep) as_12\IN\14622893 (l_pobj) movements_15\NNS\191142 (l_conj) protrusions_18\NNS\13919685 (l_conj) catalepsy_20\NN\14023236 (l_conj) tremor_22\NN\345926
D016291_D010300 NONE mk-801_16\NNP\0 (r_punct) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926 (l_relcl) are_8\VBP\13600404 (l_attr) signs_9\NNS\6643763 (l_amod) suggestive_10\JJ\0 (l_prep) of_11\IN\0 (l_pobj) disease_14\NN\14061805
D012110_D010300 NONE reserpine_0\NN\2721160 (r_nsubj) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926 (l_relcl) are_8\VBP\13600404 (l_attr) signs_9\NNS\6643763 (l_amod) suggestive_10\JJ\0 (l_prep) of_11\IN\0 (l_pobj) disease_14\NN\14061805
D012110_D010300 NONE reserpine_4\NN\2721160 (r_nsubj) produces_5\VBZ\7555863 (l_dobj) movements_9\NNS\191142 (l_relcl) related_13\VBN\628491 (l_conj) considered_22\VBN\689344 (l_prep) as_23\IN\14622893 (l_pobj) signs_30\NNS\6643763 (l_amod) parkinsonian_24\JJ\0
D012110_D002375 CID reserpine_0\NN\2721160 (r_nsubj) produced_2\VBD\1617192 (l_dobj) tremor_3\NN\345926 (l_conj) catalepsy_5\NN\14023236
D012110_D002375 CID reserpine_25\NN\2721160 (r_pobj) by_24\IN\0 (r_agent) induced_23\VBN\1627355 (r_acl) movements_17\NNS\191142 (l_conj) protrusions_20\NNS\13919685 (l_conj) catalepsy_22\NN\14023236
D012110_D002375 CID reserpine_5\NN\2721160 (r_nsubj) induced_6\VBN\1627355 (l_dobj) increases_7\NNS\13576355 (l_prep) in_8\IN\13603305 (l_pobj) tremor_9\NN\345926 (l_conj) catalepsy_11\NN\14023236
D012110_D002375 CID reserpine_12\NN\2721160 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) catalepsy_7\NN\14023236
D012110_D002375 CID reserpine_2\NN\2721160 (r_pobj) with_1\IN\0 (r_prep) pretreatment_0\NN\0 (l_acl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926 (l_conj) catalepsy_30\NN\14023236
D012110_D002375 CID reserpine_48\NN\2721160 (r_pobj) of_47\IN\0 (r_prep) effects_46\NNS\13245626 (r_dobj) reversed_44\VBD\109660 (r_advcl) produced_13\VBD\1617192 (l_conj) increases_26\NNS\13576355 (l_prep) in_27\IN\13603305 (l_pobj) tremor_28\NN\345926 (l_conj) catalepsy_30\NN\14023236
9205462
D013629_D001943 NONE tamoxifen_9\NN\2714883 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (l_prep) for_10\IN\0 (l_pobj) carcinoma_18\NN\14239918
D013629_D017093 CID tamoxifen_2\NN\2714883 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dysfunction_6\NN\14204950
D013629_D017093 CID tamoxifen_20\NN\2714883 (r_compound) metabolism_21\NN\13526110 (r_pobj) in_19\IN\13603305 (r_prep) alterations_18\NNS\7283608 (r_pobj) because_16\IN\0 (r_prep) be_8\VB\14625458 (l_nsubj) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) dysfunction_6\NN\14204950
D013629_D009369 NONE tamoxifen_8\NN\2714883 (r_compound) use_9\NN\407535 (l_conj) tumors_12\NNS\14234074
D013629_C537296 CID tamoxifen_9\NN\2714883 (r_compound) use_10\NN\407535 (r_pobj) with_7\IN\0 (r_prep) associated_6\VBN\628491 (r_acl) ovary_5\NN\11675842
D004967_D001943 NONE estrogen_13\NN\14745635 (r_compound) carcinoma_18\NN\14239918
D013629_D006106 NONE tamoxifen_2\NN\2714883 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dysfunction_6\NN\14204950 (r_pobj) with_1\IN\0 (r_prep) patients_0\NNS\9898892 (r_nsubj) be_8\VB\14625458 (l_prep) at_9\IN\14622893 (l_pobj) risk_11\NN\14541044 (l_prep) for_12\IN\0 (l_pobj) tumors_15\NNS\14234074
D013629_D006106 NONE tamoxifen_20\NN\2714883 (r_compound) metabolism_21\NN\13526110 (r_pobj) in_19\IN\13603305 (r_prep) alterations_18\NNS\7283608 (r_pobj) because_16\IN\0 (r_prep) be_8\VB\14625458 (l_prep) at_9\IN\14622893 (l_pobj) risk_11\NN\14541044 (l_prep) for_12\IN\0 (l_pobj) tumors_15\NNS\14234074
19105845
D016642_D012640 CID hydrochloride_8\NN\14817592 (r_npadvmod) induced_10\VBN\1627355 (r_amod) seizures_11\NNS\14081375
D016642_D012640 CID bupropion_15\NN\0 (r_npadvmod) induced_17\VBN\1627355 (r_amod) seizures_18\NNS\14081375
D016642_D012640 CID hcl_12\NNP\0 (r_pobj) of_10\IN\0 (r_prep) rates_9\NNS\13308999 (r_dobj) varying_5\VBG\0 (r_pcomp) of_4\IN\0 (r_prep) effect_3\NN\34213 (l_appos) cd50_22\NNP\0 (l_amod) convulsive_18\JJ\0
D016642_D012640 CID hcl_12\NNP\0 (r_pobj) of_10\IN\0 (r_prep) rates_9\NNS\13308999 (r_dobj) varying_5\VBG\0 (r_pcomp) of_4\IN\0 (r_prep) effect_3\NN\34213 (r_dobj) investigated_1\VBD\644583 (l_prep) on_25\IN\0 (l_pobj) incidence_27\NN\13821570 (l_prep) of_30\IN\0 (l_pobj) convulsions_34\NNS\14081375
D016642_D012640 CID bupropion_31\NN\0 (r_npadvmod) induced_33\VBN\1627355 (r_amod) convulsions_34\NNS\14081375 (r_pobj) of_30\IN\0 (r_prep) incidence_27\NN\13821570 (r_pobj) on_25\IN\0 (r_prep) investigated_1\VBD\644583 (l_dobj) effect_3\NN\34213 (l_appos) cd50_22\NNP\0 (l_amod) convulsive_18\JJ\0
D016642_D012640 CID bupropion_31\NN\0 (r_npadvmod) induced_33\VBN\1627355 (r_amod) convulsions_34\NNS\14081375
D016642_D012640 CID hcl_9\NNP\0 (r_ccomp) showed_3\VBD\2137132 (l_advcl) induced_15\VBD\1627355 (l_dobj) convulsions_16\NNS\14081375
D016642_D012640 CID hcl_27\NNP\0 (r_pobj) of_25\IN\0 (r_prep) time_24\NN\7308889 (r_dobj) increasing_20\VBG\169651 (r_conj) ratio_15\NN\13815152 (r_nsubjpass) associated_31\VBN\628491 (l_prep) with_32\IN\0 (l_pobj) odds_37\NNS\4756635 (l_prep) of_38\IN\0 (l_pobj) convulsions_39\NNS\14081375
D016642_D012640 CID bupropion_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) dose_17\NN\3740161 (l_amod) fixed_14\JJ\205885 (l_conj) convulsive_16\JJ\0
D016642_D012640 CID bupropion_19\NN\0 (r_pobj) of_18\IN\0 (r_prep) dose_17\NN\3740161 (l_conj) risk_22\NN\14541044 (l_prep) of_23\IN\0 (l_pobj) convulsions_24\NNS\14081375
9067481
D002251_D064420 NONE tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
D000082_D066126 NONE acetaminophen_35\RB\2707683 (l_conj) against_39\IN\0 (l_pobj) lethal_41\JJ\0 (l_conj) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
D005688_D064420 NONE galactosamine_52\NN\0 (r_npadvmod) induced_54\VBN\1627355 (r_conj) chloroform-_50\JJ\0 (r_nmod) toxicity_55\NN\13576101
D004317_D066126 CID adriamycin_49\NNS\0 (r_amod) administration_50\NN\1133281 (r_pobj) of_48\IN\0 (r_prep) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
C103872_D064420 NONE acid_35\NN\14818238 (l_conj) salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
D002725_D064420 NONE chloroform-_50\JJ\0 (r_nmod) toxicity_55\NN\13576101
D004317_D056486 NONE adriamycin_49\NNS\0 (r_amod) administration_50\NN\1133281 (r_pobj) of_48\IN\0 (r_prep) effect_47\NN\34213 (r_conj) lethal_41\JJ\0 (r_pobj) against_39\IN\0 (r_conj) acetaminophen_35\RB\2707683 (r_conj) chcl3_33\NNP\0 (r_pobj) of_30\IN\0 (r_prep) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
D004317_D064420 NONE adriamycin-_45\JJ\0 (r_conj) acetaminophen-_43\NN\0 (r_nmod) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
D002251_D066126 NONE ccl4_31\NNP\0 (r_nmod) chcl3_33\NNP\0 (l_conj) acetaminophen_35\RB\2707683 (l_conj) against_39\IN\0 (l_pobj) lethal_41\JJ\0 (l_conj) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
D002725_D056486 CID chcl3_33\NNP\0 (r_pobj) of_30\IN\0 (r_prep) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
D005688_D056486 CID galactosamine_37\NN\0 (r_conj) acetaminophen_35\RB\2707683 (r_conj) chcl3_33\NNP\0 (r_pobj) of_30\IN\0 (r_prep) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
D005688_D056486 CID galactosamine_30\NN\0 (r_amod) hepatotoxicity_31\NN\0
D000082_D064420 NONE acetaminophen-_43\NN\0 (r_nmod) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
D002725_D066126 NONE chcl3_33\NNP\0 (l_conj) acetaminophen_35\RB\2707683 (l_conj) against_39\IN\0 (l_pobj) lethal_41\JJ\0 (l_conj) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
D002251_D056486 CID tetrachloride_35\NN\14818238 (r_advmod) effects_32\NNS\13245626 (l_amod) hepatotoxic_31\JJ\0
D002251_D056486 CID ccl4_37\NNP\0 (r_appos) effects_32\NNS\13245626 (l_amod) hepatotoxic_31\JJ\0
D002251_D056486 CID ccl4_31\NNP\0 (r_nmod) chcl3_33\NNP\0 (r_pobj) of_30\IN\0 (r_prep) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
-1_D056486 NONE salt_17\NN\14818238 (r_nmod) administration_21\NN\1133281 (r_conj) hemisuccinate_14\NN\0 (r_conj) rigidifier_9\NN\0 (r_pobj) as_5\IN\14622893 (r_prep) use_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) addition_1\NN\3081021 (r_pobj) in_0\IN\13603305 (r_prep) shown_25\VBN\2137132 (l_xcomp) protect_27\VB\1127795 (l_prep) from_29\IN\0 (l_pobj) effects_32\NNS\13245626 (l_amod) hepatotoxic_31\JJ\0
-1_D056486 NONE cs_19\NNP\14625458 (r_nmod) administration_21\NN\1133281 (r_conj) hemisuccinate_14\NN\0 (r_conj) rigidifier_9\NN\0 (r_pobj) as_5\IN\14622893 (r_prep) use_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) addition_1\NN\3081021 (r_pobj) in_0\IN\13603305 (r_prep) shown_25\VBN\2137132 (l_xcomp) protect_27\VB\1127795 (l_prep) from_29\IN\0 (l_pobj) effects_32\NNS\13245626 (l_amod) hepatotoxic_31\JJ\0
-1_D056486 NONE cs_13\NNP\14625458 (r_nmod) kg_17\NNS\13717155 (r_pobj) of_12\IN\0 (r_prep) dose_11\NN\3740161 (r_pobj) with_8\IN\0 (r_prep) pretreatment_2\NN\0 (r_nsubj) resulted_22\VBD\2633881 (l_prep) in_23\IN\13603305 (l_pobj) protection_25\NN\407535 (l_prep) against_26\IN\0 (l_pobj) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
-1_D056486 NONE cs_3\NNP\14625458 (r_compound) protection_4\NN\407535 (r_pobj) of_2\IN\0 (r_prep) mechanism_1\NN\13446390 (r_nsubj) appear_7\VB\2604760 (l_xcomp) be_9\VB\14625458 (l_acomp) dependent_10\JJ\9627906 (l_prep) on_11\IN\0 (l_pobj) inhibition_13\NN\1068773 (l_prep) to_17\IN\0 (l_pobj) in_23\IN\13603305 (l_pobj) light_24\NN\11421401 (l_prep) of_25\IN\0 (l_pobj) protection_27\NN\407535 (l_acl) observed_28\VBN\2163746 (l_prep) against_29\IN\0 (l_pobj) hepatotoxicity_31\NN\0
-1_D064420 NONE cs_8\NNP\14625458 (r_compound) cytoprotection_9\NN\0 (r_pobj) of_7\IN\0 (r_prep) mechanism_6\NN\13446390 (r_pobj) of_4\IN\0 (r_prep) understanding_3\NN\5804793 (r_dobj) further_1\VB\2554922 (r_advmod) examined_12\VBD\0 (l_conj) mice_16\NNS\2329401 (l_dobj) abilities_19\NNS\4723816 (l_prep) of_20\IN\0 (l_pobj) cs_21\NNP\14625458 (l_conj) form_28\NN\6286395 (l_prep) of_29\IN\0 (l_pobj) cs_30\NNP\14625458 (l_conj) acid_35\NN\14818238 (l_conj) salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
-1_D064420 NONE cs_21\NNP\14625458 (l_conj) form_28\NN\6286395 (l_prep) of_29\IN\0 (l_pobj) cs_30\NNP\14625458 (l_conj) acid_35\NN\14818238 (l_conj) salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
-1_D064420 NONE cs_30\NNP\14625458 (l_conj) acid_35\NN\14818238 (l_conj) salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
-1_D064420 NONE salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
-1_D064420 NONE cse_40\NNP\8342039 (r_appos) salt_38\NN\14818238 (l_prep) against_42\IN\0 (l_pobj) tetrachloride-_48\NN\0 (l_appos) toxicity_55\NN\13576101
D000082_D056486 CID acetaminophen_35\RB\2707683 (r_conj) chcl3_33\NNP\0 (r_pobj) of_30\IN\0 (r_prep) effects_29\NNS\13245626 (l_amod) hepatotoxic_28\JJ\0
C013440_D056486 NONE hemisuccinate_14\NN\0 (r_conj) rigidifier_9\NN\0 (r_pobj) as_5\IN\14622893 (r_prep) use_4\NN\407535 (r_pobj) to_2\IN\0 (r_prep) addition_1\NN\3081021 (r_pobj) in_0\IN\13603305 (r_prep) shown_25\VBN\2137132 (l_xcomp) protect_27\VB\1127795 (l_prep) from_29\IN\0 (l_pobj) effects_32\NNS\13245626 (l_amod) hepatotoxic_31\JJ\0
-1_D066126 NONE cs_13\NNP\14625458 (r_nmod) kg_17\NNS\13717155 (r_pobj) of_12\IN\0 (r_prep) dose_11\NN\3740161 (r_pobj) with_8\IN\0 (r_prep) pretreatment_2\NN\0 (r_nsubj) resulted_22\VBD\2633881 (l_prep) in_23\IN\13603305 (l_pobj) protection_25\NN\407535 (l_prep) against_26\IN\0 (l_pobj) effects_29\NNS\13245626 (l_prep) of_30\IN\0 (l_pobj) chcl3_33\NNP\0 (l_conj) acetaminophen_35\RB\2707683 (l_conj) against_39\IN\0 (l_pobj) lethal_41\JJ\0 (l_conj) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
D005688_D066126 NONE galactosamine_37\NN\0 (r_conj) acetaminophen_35\RB\2707683 (l_conj) against_39\IN\0 (l_pobj) lethal_41\JJ\0 (l_conj) effect_47\NN\34213 (l_amod) cardiotoxic_45\JJ\0
2422478
D012701_D006973 NONE serotonin_19\NN\14807737 (r_compound) group_21\NN\2137 (r_pobj) of_15\IN\0 (r_prep) area_14\NN\8630985 (r_pobj) into_12\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (l_amod) hypertensive_2\JJ\10405694
D012701_D006973 NONE serotonin_51\NN\14807737 (r_compound) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) hypertensive_2\JJ\10405694
D012701_D020521 NONE serotonin_19\NN\14807737 (r_compound) group_21\NN\2137 (r_pobj) of_15\IN\0 (r_prep) area_14\NN\8630985 (r_pobj) into_12\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (l_amod) prone_6\JJ\0 (l_npadvmod) stroke_4\NN\556313
D012701_D020521 NONE serotonin_51\NN\14807737 (r_compound) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) prone_6\JJ\0 (l_npadvmod) stroke_4\NN\556313
D015116_D020521 NONE 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) prone_6\JJ\0 (l_npadvmod) stroke_4\NN\556313
D015116_D020521 NONE 5,7-dht_55\NNP\0 (r_appos) 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) prone_6\JJ\0 (l_npadvmod) stroke_4\NN\556313
D008750_D007022 CID methyldopa_13\NN\2721160 (r_pobj) of_12\IN\0 (r_prep) effect_11\NN\34213 (l_amod) hypotensive_10\JJ\10405694
D008750_D007022 CID methyldopa_10\NN\2721160 (r_pobj) of_9\IN\0 (r_prep) microinjection_8\NN\0 (r_nsubj) elicits_23\VBZ\1617192 (l_dobj) response_26\NN\11410625 (l_amod) hypotensive_25\JJ\10405694
D008750_D007022 CID methyldopa_11\NN\2721160 (r_pobj) of_10\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) caused_26\VBD\1617192 (l_dobj) hypotension_29\NN\14057371
D008750_D007022 CID methyldopa_14\NN\2721160 (r_npadvmod) induced_16\VBN\1627355 (r_amod) hypotension_17\NN\14057371
D008750_D007022 CID methyldopa_14\NN\2721160 (r_npadvmod) induced_16\VBN\1627355 (r_amod) hypotension_17\NN\14057371 (r_dobj) mediate_12\VBP\761713 (r_relcl) cells_10\NNS\3080309 (r_pobj) unlike_6\IN\0 (r_prep) contribute_30\VB\126264 (l_prep) to_31\IN\0 (l_pobj) action_34\NN\30358 (l_amod) hypotensive_33\JJ\10405694
D008750_D007022 CID methyldopa_36\NN\2721160 (r_pobj) of_35\IN\0 (r_prep) action_34\NN\30358 (r_pobj) to_31\IN\0 (r_prep) contribute_30\VB\126264 (l_prep) unlike_6\IN\0 (l_pobj) cells_10\NNS\3080309 (l_relcl) mediate_12\VBP\761713 (l_dobj) hypotension_17\NN\14057371
D008750_D007022 CID methyldopa_36\NN\2721160 (r_pobj) of_35\IN\0 (r_prep) action_34\NN\30358 (l_amod) hypotensive_33\JJ\10405694
D008750_D006973 NONE methyldopa_11\NN\2721160 (r_pobj) of_10\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (l_amod) hypertensive_2\JJ\10405694
D008750_D020521 NONE methyldopa_11\NN\2721160 (r_pobj) of_10\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (l_amod) prone_6\JJ\0 (l_npadvmod) stroke_4\NN\556313
D015116_D006973 NONE 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) hypertensive_2\JJ\10405694
D015116_D006973 NONE 5,7-dht_55\NNP\0 (r_appos) 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_prep) in_0\IN\13603305 (l_pobj) rats_7\NNS\2329401 (l_amod) hypertensive_2\JJ\10405694
D012701_D007022 NONE serotonin_2\NN\14807737 (r_compound) nerves_3\NNS\14373582 (r_nsubjpass) involved_8\VBN\2676054 (l_prep) in_9\IN\13603305 (l_pobj) effect_11\NN\34213 (l_amod) hypotensive_10\JJ\10405694
D012701_D007022 NONE serotonin_18\NN\14807737 (r_compound) neurons_19\NNS\5430628 (r_pobj) of_15\IN\0 (r_prep) cells_14\NNS\3080309 (r_pobj) onto_11\IN\0 (r_prep) microinjection_8\NN\0 (r_nsubj) elicits_23\VBZ\1617192 (l_dobj) response_26\NN\11410625 (l_amod) hypotensive_25\JJ\10405694
D012701_D007022 NONE serotonin_19\NN\14807737 (r_compound) group_21\NN\2137 (r_pobj) of_15\IN\0 (r_prep) area_14\NN\8630985 (r_pobj) into_12\IN\0 (r_prep) microinjection_9\NN\0 (r_conj) rats_7\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) caused_26\VBD\1617192 (l_dobj) hypotension_29\NN\14057371
D012701_D007022 NONE serotonin_51\NN\14807737 (r_compound) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_dobj) hypotension_29\NN\14057371
D012701_D007022 NONE serotonin_15\NN\14807737 (r_compound) projections_16\NNS\5775081 (r_dobj) descending_14\VBG\1835496 (r_pcomp) of_12\IN\0 (r_prep) lesion_11\NN\14204950 (r_dobj) produce_7\VB\7555863 (r_relcl) injection_3\NN\320852 (r_nsubj) affect_23\VB\26192 (l_dobj) hypotension_25\NN\14057371
D012701_D007022 NONE serotonin_24\NN\14807737 (r_compound) cells_26\NNS\3080309 (r_nsubj) contribute_30\VB\126264 (l_prep) unlike_6\IN\0 (l_pobj) cells_10\NNS\3080309 (l_relcl) mediate_12\VBP\761713 (l_dobj) hypotension_17\NN\14057371
D012701_D007022 NONE serotonin_24\NN\14807737 (r_compound) cells_26\NNS\3080309 (r_nsubj) contribute_30\VB\126264 (l_prep) to_31\IN\0 (l_pobj) action_34\NN\30358 (l_amod) hypotensive_33\JJ\10405694
D015116_D007022 NONE 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_dobj) hypotension_29\NN\14057371
D015116_D007022 NONE 5,7-dht_55\NNP\0 (r_appos) 5,7-dihydroxytryptamine_53\CD\0 (r_appos) neurotoxin_52\NN\15034074 (r_pobj) by_49\IN\0 (r_agent) abolished_48\VBN\0 (r_conj) caused_26\VBD\1617192 (l_dobj) hypotension_29\NN\14057371
D015116_D007022 NONE 5,7-dht_5\CD\0 (r_pobj) of_4\IN\0 (r_prep) injection_3\NN\320852 (r_nsubj) affect_23\VB\26192 (l_dobj) hypotension_25\NN\14057371
7421734
D004967_D009369 NONE estrogens_4\NNS\14745635 (r_pobj) on_2\IN\0 (r_prep) women_1\NNS\9605289 (r_nsubj) increased_14\VBN\169651 (l_nsubj) therapy_10\NN\657604 (l_compound) cancer_9\NN\14239425
D004967_D016889 CID estrogens_16\NNS\14745635 (r_dobj) received_14\VBD\2210855 (l_npadvmod) treatment_19\NN\654885 (l_acl) implicated_20\VBN\2677097 (l_prep) in_21\IN\13603305 (l_pobj) development_23\NN\248977 (l_prep) of_24\IN\0 (l_pobj) cancer_26\NN\14239425
D004967_D016889 CID estrogens_4\NNS\14745635 (r_pobj) on_2\IN\0 (r_prep) women_1\NNS\9605289 (r_nsubj) increased_14\VBN\169651 (l_dobj) risk_15\NN\14541044 (l_prep) of_16\IN\0 (l_pobj) carcinoma_18\NN\14239918
D004967_D010049 NONE estrogens_16\NNS\14745635 (r_dobj) received_14\VBD\2210855 (r_conj) had_1\VBD\0 (l_dobj) failure_3\NN\66216
D004967_D010049 NONE estrogens_4\NNS\14745635 (l_prep) for_5\IN\0 (l_pobj) failure_7\NN\66216
D004967_D006689 NONE estrogens_16\NNS\14745635 (r_dobj) received_14\VBD\2210855 (r_conj) had_1\VBD\0 (l_dobj) failure_3\NN\66216 (l_prep) after_4\IN\0 (l_pobj) irradiation_6\NN\13920835 (l_prep) for_9\IN\0 (l_pobj) disease_11\NN\14061805
7843916
D013256_D005901 NONE steroid_0\NN\14727670 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_prep) in_3\IN\13603305 (l_pobj) changes_5\NNS\7283608 (l_prep) in_6\IN\13603305 (l_pobj) meshwork_9\NN\3309808 (l_amod) similar_10\JJ\0 (l_prep) to_11\IN\0 (l_pobj) those_12\DT\0 (l_acl) reported_13\VBN\831651 (l_prep) for_14\IN\0 (l_pobj) glaucoma_16\NN\14252864
D003907_D009798 CID dexamethasone_0\NN\2721538 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) hypertension_4\NN\14057371
D003907_D009798 CID dexamethasone_4\NN\2721538 (r_npadvmod) treated_6\VBN\2376958 (r_amod) eyes_8\NNS\5945642
D003907_D009798 CID dexamethasone_0\NN\2721538 (r_compound) treatment_1\NN\654885 (r_nsubj) led_10\VBD\3202760 (l_prep) to_11\IN\0 (l_pobj) generation_13\NN\7942152 (l_prep) of_14\IN\0 (l_pobj) hypertension_16\NN\14057371
D003907_D009798 CID dexamethasone_23\NN\2721538 (r_npadvmod) treated_25\VBN\2376958 (r_amod) eyes_26\NNS\5945642 (r_pobj) of_21\IN\0 (r_prep) %_20\NN\0 (r_pobj) in_17\IN\13603305 (r_prep) generation_13\NN\7942152 (l_prep) of_14\IN\0 (l_pobj) hypertension_16\NN\14057371
D013256_D005902 NONE steroid_0\NN\14727670 (r_compound) treatment_1\NN\654885 (r_nsubj) resulted_2\VBD\2633881 (l_prep) in_3\IN\13603305 (l_pobj) changes_5\NNS\7283608 (l_prep) in_6\IN\13603305 (l_pobj) meshwork_9\NN\3309808 (l_amod) similar_10\JJ\0 (l_prep) to_11\IN\0 (l_pobj) those_12\DT\0 (l_acl) reported_13\VBN\831651 (l_prep) for_14\IN\0 (l_pobj) glaucoma_16\NN\14252864 (l_conj) glaucoma_20\NN\14252864
6415512
D002220_D004831 CID carbamazepine_10\NN\0 (r_compound) therapy_11\NN\657604 (r_pobj) of_9\IN\0 (r_prep) institution_8\NN\8008335 (r_dobj) following_7\VBG\8180190 (r_prep) seizures_6\NNS\14081375
D002220_D004831 CID carbamazepine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_conj) had_15\VBD\0 (l_dobj) reaction_19\NN\13446390 (l_acl) characterized_20\VBN\609683 (l_agent) by_21\IN\0 (l_pobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) absence_28\NN\14449405 (l_conj) seizures_35\NNS\14081375
D002220_D004832 CID carbamazepine_10\NN\0 (r_compound) therapy_11\NN\657604 (r_pobj) of_9\IN\0 (r_prep) institution_8\NN\8008335 (r_dobj) following_7\VBG\8180190 (r_prep) seizures_6\NNS\14081375
D002220_D004832 CID carbamazepine_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_conj) had_15\VBD\0 (l_dobj) reaction_19\NN\13446390 (l_acl) characterized_20\VBN\609683 (l_agent) by_21\IN\0 (l_pobj) onset_23\NN\7325190 (l_prep) of_24\IN\0 (l_pobj) absence_28\NN\14449405 (l_conj) seizures_35\NNS\14081375
D002220_D012640 NONE carbamazepine_2\NN\0 (r_nsubjpass) discontinued_4\VBN\0 (r_advcl) returned_10\VBD\1835496 (r_ccomp) had_19\VBD\0 (l_ccomp) resolve_24\VBP\4616059 (l_nsubj) seizures_23\NNS\14081375
D002220_D012640 NONE carbamazepine_2\NN\0 (r_nsubjpass) discontinued_4\VBN\0 (r_advcl) returned_10\VBD\1835496 (r_ccomp) had_19\VBD\0 (l_conj) had_33\VBD\0 (l_ccomp) persist_36\VB\118523 (l_nsubj) seizures_35\NNS\14081375
D002220_D004827 NONE carbamazepine_11\NN\0 (l_prep) for_12\IN\0 (l_pobj) epilepsy_13\NN\14085708
1969772
D004298_D007022 NONE dopamine-1_4\NNS\0 (r_punct) agonist_9\NN\0 (l_relcl) causes_11\VBZ\7323922 (l_conj) preserves_23\VBZ\7597145 (l_prep) during_29\IN\0 (l_pobj) hypotension_31\NN\14057371
D012964_D007022 NONE sodium_25\NN\14625458 (r_amod) hypotension_29\NN\14057371 (r_pobj) during_24\IN\0 (r_prep) decreased_18\VBD\169651 (r_conj) increased_6\VBD\169651 (l_prep) during_7\IN\0 (l_pobj) hypotension_11\NN\14057371
D012964_D007022 NONE sodium_25\NN\14625458 (r_amod) hypotension_29\NN\14057371
D018818_D007022 CID fenoldopam_9\NN\0 (r_pobj) with_8\IN\0 (r_prep) induced_7\VBN\1627355 (l_nsubj) preservation_0\NN\817680 (l_prep) during_5\IN\0 (l_pobj) hypotension_6\NN\14057371
D018818_D007022 CID fenoldopam_3\NN\0 (r_relcl) hypothesis_1\NN\7162194 (r_nsubjpass) used_6\VBN\0 (l_xcomp) induce_8\VB\1627355 (l_dobj) hypotension_9\NN\14057371
D018818_D007022 CID fenoldopam_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hypotension_11\NN\14057371
D018818_D007022 CID fenoldopam_8\NN\0 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hypotension_11\NN\14057371 (r_pobj) during_7\IN\0 (r_prep) increased_6\VBD\169651 (l_conj) decreased_18\VBD\169651 (l_prep) during_24\IN\0 (l_pobj) hypotension_29\NN\14057371
D009599_D007022 CID nitroprusside_26\RB\0 (r_advmod) induced_28\VBN\1627355 (r_amod) hypotension_29\NN\14057371 (r_pobj) during_24\IN\0 (r_prep) decreased_18\VBD\169651 (r_conj) increased_6\VBD\169651 (l_prep) during_7\IN\0 (l_pobj) hypotension_11\NN\14057371
D009599_D007022 CID nitroprusside_26\RB\0 (r_advmod) induced_28\VBN\1627355 (r_amod) hypotension_29\NN\14057371
D009599_D007022 CID nitroprusside_1\NN\0 (r_nsubj) is_2\VBZ\0 (l_attr) vasodilator_10\NN\3198383 (l_relcl) produce_13\VB\7555863 (l_prep) during_22\IN\0 (l_pobj) hypotension_24\NN\14057371
3686155
D001971_D011605 CID bromocriptine_4\NN\0 (r_pobj) by_3\IN\0 (r_prep) induced_2\VBN\1627355 (l_nsubj) psychosis_1\NN\14380140
D001971_D011605 CID bromocriptine_16\NN\0 (r_dobj) received_15\VBN\2210855 (r_advcl) seen_9\VBN\2106506 (l_prep) with_10\IN\0 (l_pobj) psychosis_12\NN\14380140
D001971_D011605 CID bromocriptine_0\NNP\0 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) psychosis_9\NN\14380140
D001971_D011605 CID bromocriptine_4\NN\0 (r_nsubj) cause_6\VB\7323922 (l_dobj) psychosis_7\NN\14380140
D001971_D010300 NONE bromocriptine_0\NNP\0 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) psychosis_9\NN\14380140 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_acl) receiving_12\VBG\2210855 (l_dobj) drug_14\NN\14778436 (l_prep) for_15\IN\0 (l_pobj) disease_18\NN\14061805
D001971_D001523 NONE bromocriptine_16\NN\0 (r_dobj) received_15\VBN\2210855 (r_advcl) seen_9\VBN\2106506 (l_nsubjpass) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) history_7\NN\15120823 (l_amod) psychiatric_6\JJ\0
D001971_D007775 NONE bromocriptine_16\NN\0 (r_dobj) received_15\VBN\2210855 (l_prep) for_17\IN\0 (l_pobj) inhibition_18\NN\1068773 (l_prep) of_19\IN\0 (l_pobj) lactation_20\NN\15113229
982002
D012293_D058186 CID rifampicin_8\NNS\0 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) to_4\IN\0 (r_prep) subsequent_3\JJ\0 (r_amod) failure_2\NN\66216
D012293_D051437 NONE rifampicin_12\NNS\0 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (r_pobj) after_7\IN\0 (r_prep) developed_3\VBN\1753788 (l_dobj) failure_6\NN\66216
3950060
D000583_D007674 CID amikacin_10\JJ\0 (r_dobj) receiving_9\VBG\2210855 (r_acl) patients_8\NNS\9898892 (r_pobj) in_7\IN\13603305 (r_prep) nephrotoxicity_3\NN\0
D000583_D007674 CID amikacin_6\JJ\0 (r_pobj) with_5\IN\0 (r_prep) treated_4\VBN\2376958 (r_acl) patients_3\NNS\9898892 (r_pobj) from_1\IN\0 (r_prep) data_0\NNS\7951464 (r_nsubjpass) analyzed_8\VBN\0 (l_prep) for_9\IN\0 (l_pobj) factors_10\NNS\7326557 (l_acl) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) nephrotoxicity_13\NN\0
16574713
D018817_D008569 CID mdma_12\NNP\3054098 (r_compound) users_13\NNS\7846 (r_pobj) in_10\IN\13603305 (r_prep) observed_9\VBN\2163746 (l_nsubjpass) evidence_4\NN\5816287 (l_prep) of_5\IN\0 (l_pobj) impairment_7\NN\7296428
D018817_D008569 CID mdma_4\NNP\3054098 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (l_prep) in_5\IN\13603305 (l_pobj) quantities_6\NNS\2137 (l_relcl) considered_10\VBN\689344 (l_oprd) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) functioning_20\VBG\29677
D018817_D008569 CID mdma_4\NNP\3054098 (r_pobj) of_3\IN\0 (r_prep) use_2\NN\407535 (r_nsubj) lead_28\VB\5155821 (l_prep) to_29\IN\0 (l_pobj) impairments_33\NNS\7296428
D018817_D008569 CID mdma_25\NNP\3054098 (r_compound) use_26\NN\407535 (r_pobj) of_24\IN\0 (r_prep) use_23\NN\407535 (r_nsubj) lead_28\VB\5155821 (l_nsubj) use_2\NN\407535 (l_prep) in_5\IN\13603305 (l_pobj) quantities_6\NNS\2137 (l_relcl) considered_10\VBN\689344 (l_oprd) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) functioning_20\VBG\29677
D018817_D008569 CID mdma_25\NNP\3054098 (r_compound) use_26\NN\407535 (r_pobj) of_24\IN\0 (r_prep) use_23\NN\407535 (r_nsubj) lead_28\VB\5155821 (l_prep) to_29\IN\0 (l_pobj) impairments_33\NNS\7296428
D012701_D020258 NONE serotonin_13\NN\14807737 (r_dobj) damage_11\VB\7296428 (r_xcomp) shown_9\VBN\2137132 (r_advcl) known_26\VBN\0 (l_prep) about_27\IN\0 (l_pobj) consequences_32\NNS\34213 (l_prep) of_33\IN\0 (l_pobj) lesions_39\NNS\14204950
D012701_D020258 NONE 5-ht_15\CD\0 (r_nmod) neurons_17\NNS\5430628 (r_appos) serotonin_13\NN\14807737 (r_dobj) damage_11\VB\7296428 (r_xcomp) shown_9\VBN\2137132 (r_advcl) known_26\VBN\0 (l_prep) about_27\IN\0 (l_pobj) consequences_32\NNS\34213 (l_prep) of_33\IN\0 (l_pobj) lesions_39\NNS\14204950
D012701_D020258 NONE 5-ht_37\CD\0 (r_nummod) lesions_39\NNS\14204950
D012701_D020258 NONE 5-ht_44\CD\0 (r_nsubjpass) involved_46\VBN\2676054 (r_relcl) functions_41\NNS\13783581 (r_pobj) on_40\IN\0 (r_prep) lesions_39\NNS\14204950
D018817_D020258 NONE 3,4-methylenedioxymethamphetamine_1\CD\0 (r_nsubjpass) shown_9\VBN\2137132 (r_advcl) known_26\VBN\0 (l_prep) about_27\IN\0 (l_pobj) consequences_32\NNS\34213 (l_prep) of_33\IN\0 (l_pobj) lesions_39\NNS\14204950
D018817_D020258 NONE mdma_3\NNP\3054098 (r_nsubjpass) shown_9\VBN\2137132 (r_advcl) known_26\VBN\0 (l_prep) about_27\IN\0 (l_pobj) consequences_32\NNS\34213 (l_prep) of_33\IN\0 (l_pobj) lesions_39\NNS\14204950
D018817_D020258 NONE ecstasy_5\NN\13985818 (r_conj) mdma_3\NNP\3054098 (r_nsubjpass) shown_9\VBN\2137132 (r_advcl) known_26\VBN\0 (l_prep) about_27\IN\0 (l_pobj) consequences_32\NNS\34213 (l_prep) of_33\IN\0 (l_pobj) lesions_39\NNS\14204950
D018817_D020258 NONE mdma_34\NNP\3054098 (r_npadvmod) induced_36\VBN\1627355 (r_amod) lesions_39\NNS\14204950
4038130
D008619_D009135 CID mepivacaine_19\NN\0 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) seen_10\VBN\2106506 (l_prep) in_0\IN\13603305 (l_pobj) addition_1\NN\3081021 (l_prep) to_2\IN\0 (l_pobj) damage_4\NN\7296428
D008012_D009135 CID lidocaine_21\NN\3681148 (r_conj) mepivacaine_19\NN\0 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) seen_10\VBN\2106506 (l_prep) in_0\IN\13603305 (l_pobj) addition_1\NN\3081021 (l_prep) to_2\IN\0 (l_pobj) damage_4\NN\7296428
D004837_D009135 NONE epinephrine_23\NN\14807929 (r_conj) mepivacaine_19\NN\0 (r_pobj) to_18\IN\0 (r_prep) exposure_17\NN\5042871 (r_pobj) after_16\IN\0 (r_prep) seen_10\VBN\2106506 (l_prep) in_0\IN\13603305 (l_pobj) addition_1\NN\3081021 (l_prep) to_2\IN\0 (l_pobj) damage_4\NN\7296428
8800187
D003891_D064420 NONE desipramine_8\JJ\4482543 (r_amod) toxicity_9\NN\13576101
D015761_D064420 NONE 4-aminopyridine_5\CD\0 (r_compound) therapy_6\NN\657604 (l_prep) on_7\IN\0 (l_pobj) toxicity_9\NN\13576101
D002122_D007022 NONE cacl2_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) reverse_8\VB\13854649 (l_dobj) hypotension_13\NN\14057371
D003891_D001919 CID desipramine_6\NN\4482543 (r_compound) ip_7\NNP\5999797 (r_dobj) received_2\VBD\2210855 (l_advcl) produce_9\VB\7555863 (l_dobj) prolongation_13\NN\1017987 (l_conj) bradycardia_16\NN\14110674
D002118_D007022 NONE calcium_7\NN\14625458 (r_compound) channel_8\NN\6251781 (r_compound) blockade_9\NN\952963 (l_prep) in_10\IN\13603305 (l_pobj) hypotension_15\NN\14057371
D002118_D007022 NONE calcium_8\NN\14625458 (r_compound) channel_9\NN\6251781 (r_compound) inhibition_10\NN\1068773 (l_prep) in_11\IN\13603305 (l_pobj) pathogenesis_13\NN\13533470 (l_prep) of_14\IN\0 (l_pobj) hypotension_19\NN\14057371
D015761_D007022 NONE 4-aminopyridine_5\NN\0 (r_punct) did_6\VBD\0 (r_aux) reverse_8\VB\13854649 (l_dobj) hypotension_13\NN\14057371
D002122_D001145 CID cacl2_19\NNP\0 (r_compound) group_20\NN\2137 (r_pobj) in_17\IN\13603305 (r_prep) seizures_11\NNS\14081375 (r_conj) arrhythmias_4\NNS\14103288
D002122_D002318 NONE cacl2_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) worsen_4\VB\146138 (l_dobj) toxicity_11\NN\13576101
D002118_D062787 NONE calcium_14\NN\14625458 (r_compound) channel_15\NN\6251781 (r_compound) overdose_17\NN\84738
D002122_D002493 NONE cacl2_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) worsen_4\VB\146138 (l_dobj) toxicity_11\NN\13576101
D017693_D007022 NONE nahco3_0\NNP\0 (r_nsubj) reversed_6\VBD\109660 (l_dobj) hypotension_7\NN\14057371
D002122_D012640 NONE cacl2_19\NNP\0 (r_compound) group_20\NN\2137 (r_pobj) in_17\IN\13603305 (r_prep) seizures_11\NNS\14081375
D002122_D064420 NONE chloride_3\NN\14818238 (l_conj) therapy_6\NN\657604 (l_prep) on_7\IN\0 (l_pobj) toxicity_9\NN\13576101
D003891_D007022 CID desipramine_6\NN\4482543 (r_compound) ip_7\NNP\5999797 (r_dobj) received_2\VBD\2210855 (l_advcl) produce_9\VB\7555863 (l_dobj) hypotension_10\NN\14057371
8546130
D017291_D007676 NONE clarithromycin_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) hallucinations_4\NNS\14376855 (l_prep) in_5\IN\13603305 (l_pobj) patient_7\NN\9898892 (l_prep) with_8\IN\0 (l_pobj) failure_11\NN\66216
D017291_D007676 NONE clarithromycin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (l_prep) in_9\IN\13603305 (l_pobj) face_10\NN\5225090 (l_prep) of_11\IN\0 (l_pobj) failure_14\NN\66216
D017291_D020258 NONE clarithromycin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) of_2\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubj) facilitated_28\VBN\2547586 (l_dobj) appearance_30\NN\4723816 (l_prep) of_31\IN\0 (l_pobj) effect_35\NN\34213 (l_amod) neurotoxic_33\JJ\0
D018942_D006212 NONE macrolide_13\NN\0 (r_amod) antibiotic_14\NN\2716205 (r_pobj) with_10\IN\0 (r_prep) association_9\NN\8008335 (r_pobj) in_8\IN\13603305 (r_prep) occurring_7\VBG\0 (r_acl) hallucinations_6\NNS\14376855
D000535_D020258 NONE aluminum_23\NN\14625458 (r_compound) intoxication_24\NN\14034177 (r_pobj) with_21\IN\0 (r_prep) combination_1\NN\7951464 (r_nsubj) facilitated_28\VBN\2547586 (l_dobj) appearance_30\NN\4723816 (l_prep) of_31\IN\0 (l_pobj) effect_35\NN\34213 (l_amod) neurotoxic_33\JJ\0
D017291_D006212 CID clarithromycin_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) hallucinations_4\NNS\14376855
D017291_D006212 CID clarithromycin_16\NN\0 (r_appos) antibiotic_14\NN\2716205 (r_pobj) with_10\IN\0 (r_prep) association_9\NN\8008335 (r_pobj) in_8\IN\13603305 (r_prep) occurring_7\VBG\0 (r_acl) hallucinations_6\NNS\14376855
D000535_D007676 NONE aluminum_23\NN\14625458 (r_compound) intoxication_24\NN\14034177 (r_pobj) with_21\IN\0 (r_prep) combination_1\NN\7951464 (l_prep) of_2\IN\0 (l_pobj) dose_6\NN\3740161 (l_prep) in_9\IN\13603305 (l_pobj) face_10\NN\5225090 (l_prep) of_11\IN\0 (l_pobj) failure_14\NN\66216
9121607
D016202_D012640 NONE aspartate_6\NNP\0 (l_appos) seizures_9\NNS\14081375
D016202_D012640 NONE nmda)-induced_8\JJ\0 (r_amod) seizures_9\NNS\14081375
D016202_D012640 NONE nmda_10\NNP\0 (r_pobj) in_9\IN\13603305 (r_prep) delay_8\NN\15271008 (r_dobj) caused_3\VBD\1617192 (l_conj) protect_22\VB\1127795 (l_prep) against_23\IN\0 (l_pobj) seizures_25\NNS\14081375
D016202_D012640 NONE nmda_24\NNP\0 (r_compound) seizures_25\NNS\14081375
D007608_D013226 CID acid_7\NN\14818238 (r_npadvmod) induced_9\VBN\1627355 (r_amod) seizures_11\NNS\14081375 (r_pobj) against_3\IN\0 (r_prep) protect_2\VBP\1127795 (l_advcl) epilepticus_14\NN\0
D007608_D013226 CID acid_23\NN\14818238 (r_npadvmod) induced_25\VBN\1627355 (r_amod) seizures_27\NNS\14081375 (l_conj) epilepticus_30\NN\0
D007608_D013226 CID acid_14\NN\14818238 (r_npadvmod) induced_16\VBN\1627355 (r_amod) seizures_17\NNS\14081375 (r_pobj) against_10\IN\0 (r_prep) protecting_9\VBG\1127795 (r_pcomp) in_8\IN\13603305 (r_prep) effective_7\JJ\0 (r_acomp) are_5\VBP\13600404 (l_advcl) epilepticus_20\NN\0
D007608_D013226 CID acid_14\NN\14818238 (r_npadvmod) induced_16\VBN\1627355 (r_amod) seizures_17\NNS\14081375 (r_pobj) against_10\IN\0 (r_prep) protecting_9\VBG\1127795 (r_pcomp) in_8\IN\13603305 (r_prep) effective_7\JJ\0 (r_acomp) are_5\VBP\13600404 (l_conj) be_26\VB\14625458 (l_advmod) epilepticus_37\NN\0
D013256_D012640 NONE steroids_1\NNS\14727670 (r_nsubj) protect_2\VBP\1127795 (l_prep) against_3\IN\0 (l_pobj) seizures_11\NNS\14081375
D013256_D012640 NONE steroids_0\NNS\14727670 (r_nsubj) were_19\VBD\0 (l_parataxis) mg/kg_28\NNS\0 (l_conj) s.c.)-induced_30\VBN\0 (l_dobj) seizures_33\NNS\14081375
D013256_D012640 NONE steroids_3\NNS\14727670 (r_nsubj) were_4\VBD\0 (l_acomp) potent_7\JJ\0 (l_advcl) clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D013256_D012640 NONE steroids_3\NNS\14727670 (r_nsubj) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D013256_D012640 NONE steroids_18\NNS\14727670 (r_nsubj) had_26\VBD\0 (l_advcl) were_4\VBD\0 (l_acomp) potent_7\JJ\0 (l_advcl) clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D013256_D012640 NONE steroids_18\NNS\14727670 (r_nsubj) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D013256_D012640 NONE steroids_52\NNS\14727670 (r_nsubj) have_54\VB\7846 (r_ccomp) indicating_48\VBG\952524 (r_advcl) had_26\VBD\0 (l_advcl) were_4\VBD\0 (l_acomp) potent_7\JJ\0 (l_advcl) clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D013256_D012640 NONE steroids_52\NNS\14727670 (r_nsubj) have_54\VB\7846 (r_ccomp) indicating_48\VBG\952524 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D013256_D012640 NONE steroids_0\NNS\14727670 (r_nsubj) produced_13\VBD\1617192 (l_dobj) delay_18\NN\15271008 (l_prep) in_19\IN\13603305 (l_pobj) onset_21\NN\7325190 (l_prep) of_22\IN\0 (l_pobj) seizures_24\NNS\14081375
D013256_D012640 NONE steroids_0\NNS\14727670 (r_nsubj) produced_13\VBD\1617192 (l_conj) protect_40\VB\1127795 (l_prep) against_41\IN\0 (l_pobj) seizures_43\NNS\14081375
D013256_D012640 NONE steroid_8\NN\14727670 (r_pobj) of_6\IN\0 (r_prep) dose_5\NN\3740161 (r_nsubjpass) administered_10\VBN\2436349 (r_advcl) hr_12\NN\15154774 (r_nmod) protection_19\NN\407535 (l_prep) from_20\IN\0 (l_pobj) seizures_27\NNS\14081375
D013256_D012640 NONE steroids_1\NNS\14727670 (r_nsubj) caused_3\VBD\1617192 (l_conj) protect_22\VB\1127795 (l_prep) against_23\IN\0 (l_pobj) seizures_25\NNS\14081375
D013256_D012640 NONE steroids_4\NNS\14727670 (r_nsubj) are_5\VBP\13600404 (l_acomp) effective_7\JJ\0 (l_prep) in_8\IN\13603305 (l_pcomp) protecting_9\VBG\1127795 (l_prep) against_10\IN\0 (l_pobj) seizures_17\NNS\14081375
D001569_D012640 NONE benzodiazepine_10\JJ\3771443 (r_amod) clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D001569_D012640 NONE benzodiazepine_10\JJ\3771443 (r_amod) clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D013256_D013226 NONE steroids_1\NNS\14727670 (r_nsubj) protect_2\VBP\1127795 (l_advcl) epilepticus_14\NN\0
D013256_D013226 NONE steroids_0\NNS\14727670 (r_nsubj) were_19\VBD\0 (l_npadvmod) values_39\NNS\5941423 (l_amod) epilepticus_36\NN\0
D013256_D013226 NONE steroid_8\NN\14727670 (r_pobj) of_6\IN\0 (r_prep) dose_5\NN\3740161 (r_nsubjpass) administered_10\VBN\2436349 (r_advcl) hr_12\NN\15154774 (r_nmod) protection_19\NN\407535 (l_prep) from_20\IN\0 (l_pobj) seizures_27\NNS\14081375 (l_conj) epilepticus_30\NN\0
D013256_D013226 NONE steroids_4\NNS\14727670 (r_nsubj) are_5\VBP\13600404 (l_advcl) epilepticus_20\NN\0
D013256_D013226 NONE steroids_4\NNS\14727670 (r_nsubj) are_5\VBP\13600404 (l_conj) be_26\VB\14625458 (l_advmod) epilepticus_37\NN\0
D010862_D013226 CID pilocarpine-_4\NN\0 (r_nmod) seizures_11\NNS\14081375 (r_pobj) against_3\IN\0 (r_prep) protect_2\VBP\1127795 (l_advcl) epilepticus_14\NN\0
D010862_D013226 CID pilocarpine_25\NN\14712692 (r_pobj) against_24\IN\0 (r_prep) protecting_23\VBG\1127795 (r_pcomp) in_22\IN\13603305 (r_prep) effective_21\JJ\0 (r_acomp) were_19\VBD\0 (l_npadvmod) values_39\NNS\5941423 (l_amod) epilepticus_36\NN\0
D010862_D013226 CID pilocarpine-_11\NN\0 (r_nmod) seizures_17\NNS\14081375 (r_pobj) against_10\IN\0 (r_prep) protecting_9\VBG\1127795 (r_pcomp) in_8\IN\13603305 (r_prep) effective_7\JJ\0 (r_acomp) are_5\VBP\13600404 (l_advcl) epilepticus_20\NN\0
D010862_D013226 CID pilocarpine-_11\NN\0 (r_nmod) seizures_17\NNS\14081375 (r_pobj) against_10\IN\0 (r_prep) protecting_9\VBG\1127795 (r_pcomp) in_8\IN\13603305 (r_prep) effective_7\JJ\0 (r_acomp) are_5\VBP\13600404 (l_conj) be_26\VB\14625458 (l_advmod) epilepticus_37\NN\0
D001569_D064420 NONE benzodiazepine_10\JJ\3771443 (r_amod) clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D013256_D064420 NONE steroids_3\NNS\14727670 (r_nsubj) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D013256_D064420 NONE steroids_18\NNS\14727670 (r_nsubj) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D013256_D064420 NONE steroids_52\NNS\14727670 (r_nsubj) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D002998_D064420 NONE clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D002998_D064420 NONE clonazepam_46\NN\0 (r_advcl) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
D002998_D012640 NONE clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D002998_D012640 NONE clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D002998_D012640 NONE clonazepam_46\NN\0 (r_advcl) had_26\VBD\0 (l_advcl) were_4\VBD\0 (l_acomp) potent_7\JJ\0 (l_advcl) clonazepam_11\NN\0 (l_prep) in_12\IN\13603305 (l_pcomp) protecting_13\VBG\1127795 (l_prep) against_14\IN\0 (l_pobj) seizures_16\NNS\14081375
D002998_D012640 NONE clonazepam_46\NN\0 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D010862_D012640 CID pilocarpine-_4\NN\0 (r_nmod) seizures_11\NNS\14081375
D010862_D012640 CID pilocarpine_25\NN\14712692 (r_pobj) against_24\IN\0 (r_prep) protecting_23\VBG\1127795 (r_pcomp) in_22\IN\13603305 (r_prep) effective_21\JJ\0 (r_acomp) were_19\VBD\0 (l_parataxis) mg/kg_28\NNS\0 (l_conj) s.c.)-induced_30\VBN\0 (l_dobj) seizures_33\NNS\14081375
D010862_D012640 CID pilocarpine_15\NN\14712692 (r_amod) seizures_16\NNS\14081375
D010862_D012640 CID pilocarpine_15\NN\14712692 (r_amod) seizures_16\NNS\14081375 (r_pobj) against_14\IN\0 (r_prep) protecting_13\VBG\1127795 (r_pcomp) in_12\IN\13603305 (r_prep) clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_dobj) values_32\NNS\5941423 (l_appos) td50_34\NNP\0 (l_acl) divided_38\VBN\140123 (l_prep) for_41\IN\0 (l_pobj) protection_43\NN\407535 (l_compound) seizure_42\NN\14081375
D010862_D012640 CID pilocarpine-_11\NN\0 (r_nmod) seizures_17\NNS\14081375
D007608_D012640 CID acid_7\NN\14818238 (r_npadvmod) induced_9\VBN\1627355 (r_amod) seizures_11\NNS\14081375
D007608_D012640 CID acid_28\NN\14818238 (r_pobj) by_26\IN\0 (r_agent) induced_25\VBN\1627355 (r_acl) delay_18\NN\15271008 (l_prep) in_19\IN\13603305 (l_pobj) onset_21\NN\7325190 (l_prep) of_22\IN\0 (l_pobj) seizures_24\NNS\14081375
D007608_D012640 CID acid_28\NN\14818238 (r_pobj) by_26\IN\0 (r_agent) induced_25\VBN\1627355 (r_acl) delay_18\NN\15271008 (r_dobj) produced_13\VBD\1617192 (l_conj) protect_40\VB\1127795 (l_prep) against_41\IN\0 (l_pobj) seizures_43\NNS\14081375
D007608_D012640 CID acid_23\NN\14818238 (r_npadvmod) induced_25\VBN\1627355 (r_amod) seizures_27\NNS\14081375
D007608_D012640 CID acid_14\NN\14818238 (r_npadvmod) induced_16\VBN\1627355 (r_amod) seizures_17\NNS\14081375
D010862_D064420 NONE pilocarpine_15\NN\14712692 (r_amod) seizures_16\NNS\14081375 (r_pobj) against_14\IN\0 (r_prep) protecting_13\VBG\1127795 (r_pcomp) in_12\IN\13603305 (r_prep) clonazepam_11\NN\0 (r_advcl) potent_7\JJ\0 (r_acomp) were_4\VBD\0 (r_advcl) had_26\VBD\0 (l_advcl) indicating_48\VBG\952524 (l_ccomp) have_54\VB\7846 (l_dobj) toxicity_57\NN\13576101
9226773
D008094_D018500 CID lithium_5\NN\14625458 (r_compound) therapy_6\NN\657604 (r_dobj) following_4\VBG\8180190 (r_prep) insipidus_3\NN\0
D008094_D018500 CID lithium_9\NN\14625458 (r_npadvmod) induced_11\VBN\1627355 (r_amod) insipidus_14\NN\0
D008094_D018500 CID lithium_17\NN\14625458 (r_compound) therapy_18\NN\657604 (r_nsubjpass) discontinued_21\VBN\0 (r_conj) diagnosed_6\VBN\644583 (l_xcomp) have_8\VB\7846 (l_dobj) insipidus_14\NN\0
D008094_D018500 CID lithium_8\NN\14625458 (r_pobj) of_7\IN\0 (r_prep) cessation_6\NN\7365849 (r_pobj) despite_5\IN\7501545 (r_prep) polyuric_4\JJ\0 (r_conj) thirsty_2\JJ\0 (r_acomp) remained_1\VBD\2604760 (l_conj) showed_13\VBD\2137132 (l_ccomp) have_16\VB\7846 (l_prep) with_24\IN\0 (l_pobj) evidence_26\NN\5816287 (l_prep) of_27\IN\0 (l_pobj) insipidus_30\NN\0
D008094_D018500 CID lithium_0\NN\14625458 (r_nsubj) induced_1\VBD\1627355 (l_dobj) insipidus_4\NN\0
D008094_D018500 CID lithium_24\NN\14625458 (r_nsubjpass) stopped_26\VBN\0 (r_advcl) be_8\VB\14625458 (r_xcomp) considered_6\VBN\689344 (l_csubjpass) induced_1\VBD\1627355 (l_dobj) insipidus_4\NN\0
D008094_D018500 CID lithium_14\NN\14625458 (r_npadvmod) induced_16\VBN\1627355 (r_amod) insipidus_19\NN\0
D008094_D011141 CID lithium_8\NN\14625458 (r_pobj) of_7\IN\0 (r_prep) cessation_6\NN\7365849 (r_pobj) despite_5\IN\7501545 (r_prep) polyuric_4\JJ\0
D008094_D011141 CID lithium_0\NN\14625458 (r_nsubj) induced_1\VBD\1627355 (r_csubjpass) considered_6\VBN\689344 (l_xcomp) be_8\VB\14625458 (l_acomp) reversible_9\JJ\3419014 (l_prep) on_10\IN\0 (l_pobj) cessation_11\NN\7365849 (l_prep) of_12\IN\0 (l_pobj) therapy_13\NN\657604 (l_conj) polyuria_15\NN\14113228
D008094_D011141 CID lithium_24\NN\14625458 (r_nsubjpass) stopped_26\VBN\0 (r_advcl) be_8\VB\14625458 (l_acomp) reversible_9\JJ\3419014 (l_prep) on_10\IN\0 (l_pobj) cessation_11\NN\7365849 (l_prep) of_12\IN\0 (l_pobj) therapy_13\NN\657604 (l_conj) polyuria_15\NN\14113228
D014667_D011141 NONE vasopressin_21\NN\5407119 (r_compound) secretion_22\NN\13526110 (r_conj) thirst_19\NN\14035298 (r_dobj) have_16\VB\7846 (r_ccomp) showed_13\VBD\2137132 (r_conj) remained_1\VBD\2604760 (l_acomp) thirsty_2\JJ\0 (l_conj) polyuric_4\JJ\0
D014667_D018500 NONE vasopressin_21\NN\5407119 (r_compound) secretion_22\NN\13526110 (r_conj) thirst_19\NN\14035298 (r_dobj) have_16\VB\7846 (l_prep) with_24\IN\0 (l_pobj) evidence_26\NN\5816287 (l_prep) of_27\IN\0 (l_pobj) insipidus_30\NN\0
3780697
D005283_D009127 CID fentanyl_5\NN\2707683 (r_compound) administration_6\NN\1133281 (r_pobj) after_4\IN\0 (r_prep) rigidity_3\NN\5023233
D005283_D009127 CID fentanyl_29\NN\2707683 (r_pobj) of_28\IN\0 (r_prep) dose_27\NN\3740161 (r_dobj) received_24\VBD\2210855 (r_relcl) patient_22\NN\9898892 (r_pobj) in_19\IN\13603305 (r_prep) period_18\NN\13575869 (r_pobj) in_13\IN\13603305 (r_prep) described_12\VBN\1001294 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) rigidity_6\NN\5023233
D005283_D012131 NONE fentanyl_29\NN\2707683 (r_pobj) of_28\IN\0 (r_prep) dose_27\NN\3740161 (r_dobj) received_24\VBD\2210855 (r_relcl) patient_22\NN\9898892 (r_pobj) in_19\IN\13603305 (r_prep) period_18\NN\13575869 (r_pobj) in_13\IN\13603305 (r_prep) described_12\VBN\1001294 (l_nsubjpass) case_1\NN\7283608 (l_prep) of_2\IN\0 (l_pobj) rigidity_6\NN\5023233 (l_acl) leading_7\VBG\4339291 (l_prep) to_8\IN\0 (l_pobj) failure_10\NN\66216
19203554
D013256_D010996 NONE steroid_32\NN\14727670 (r_compound) therapy_33\NN\657604 (r_dobj) initiated_31\VBD\1617192 (l_advcl) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642 (l_conj) pain_15\NN\14299637 (l_conj) titer_17\NN\5038593 (l_prep) of_18\IN\0 (l_pobj) protein_22\NN\14944888 (l_prep) of_25\IN\0 (l_pobj) effusions_28\NNS\6880249
D013256_D010996 NONE steroid_32\NN\14727670 (r_compound) therapy_33\NN\657604 (r_dobj) initiated_31\VBD\1617192 (l_conj) increased_45\VBD\169651 (l_conj) remained_56\VBD\2604760 (l_nsubj) effusion_55\NN\6880249
D013256_D010996 NONE steroid_3\NN\14727670 (r_compound) therapy_4\NN\657604 (r_pobj) after_2\IN\0 (r_prep) disappeared_9\VBD\0 (l_nsubj) effusion_8\NN\6880249
D012460_D005334 CID sulphasalazine_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) cessation_1\NN\7365849 (r_nsubj) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637
D012460_D005921 NONE sulphasalazine_10\JJ\0 (r_compound) treatment_11\NN\654885 (r_dobj) restarting_9\VBG\1857717 (r_pcomp) after_8\IN\0 (r_prep) antibody-(pr3-anca_3\NNS\0 (l_appos) glomerulonephritis_7\NN\14113798
D012460_D005921 NONE sulphasalazine_4\NN\0 (r_nsubj) induce_6\VB\1627355 (l_dobj) glomerulonephritis_11\NN\14113798
D012460_D002637 NONE sulphasalazine_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) cessation_1\NN\7365849 (r_nsubj) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642 (l_conj) pain_15\NN\14299637
D013256_D005128 NONE steroid_32\NN\14727670 (r_compound) therapy_33\NN\657604 (r_dobj) initiated_31\VBD\1617192 (l_advcl) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642
D012460_D004802 NONE sulphasalazine_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) of_21\IN\0 (r_prep) restarting_20\VBG\1857717 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) eyes_10\NNS\5945642 (l_conj) effusion_13\NN\6880249 (l_conj) eosinophilia_15\NN\14299637
D012460_D003093 NONE sulphasalazine_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) of_21\IN\0 (r_prep) restarting_20\VBG\1857717 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_nsubj) woman_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) colitis_7\NN\14336539
D012460_D001745 NONE sulphasalazine_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) of_21\IN\0 (r_prep) restarting_20\VBG\1857717 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) eyes_10\NNS\5945642 (l_conj) effusion_13\NN\6880249 (l_conj) eosinophilia_15\NN\14299637 (l_conj) abnormalities_18\NNS\14034177
D012460_D005128 NONE sulphasalazine_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) of_21\IN\0 (r_prep) restarting_20\VBG\1857717 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) eyes_10\NNS\5945642
D012460_D005128 NONE sulphasalazine_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) cessation_1\NN\7365849 (r_nsubj) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642
D013256_D005334 NONE steroid_32\NN\14727670 (r_compound) therapy_33\NN\657604 (r_dobj) initiated_31\VBD\1617192 (l_advcl) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637
D012460_D010996 CID sulphasalazine_22\JJ\0 (r_compound) treatment_23\NN\654885 (r_pobj) of_21\IN\0 (r_prep) restarting_20\VBG\1857717 (r_pcomp) after_19\IN\0 (r_prep) developed_8\VBD\1753788 (l_dobj) eyes_10\NNS\5945642 (l_conj) effusion_13\NN\6880249
D012460_D010996 CID sulphasalazine_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) cessation_1\NN\7365849 (r_nsubj) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642 (l_conj) pain_15\NN\14299637 (l_conj) titer_17\NN\5038593 (l_prep) of_18\IN\0 (l_pobj) protein_22\NN\14944888 (l_prep) of_25\IN\0 (l_pobj) effusions_28\NNS\6880249
D012460_D010996 CID sulphasalazine_3\NN\0 (r_compound) treatment_4\NN\654885 (r_pobj) of_2\IN\0 (r_prep) cessation_1\NN\7365849 (r_nsubj) resulted_5\VBD\2633881 (r_advcl) initiated_31\VBD\1617192 (l_conj) increased_45\VBD\169651 (l_conj) remained_56\VBD\2604760 (l_nsubj) effusion_55\NN\6880249
D013256_D002637 NONE steroid_32\NN\14727670 (r_compound) therapy_33\NN\657604 (r_dobj) initiated_31\VBD\1617192 (l_advcl) resulted_5\VBD\2633881 (l_prep) in_6\IN\13603305 (l_pobj) improvements_7\NNS\7359599 (l_prep) in_8\IN\13603305 (l_pobj) fever_9\NN\14299637 (l_appos) eyes_12\NNS\5945642 (l_conj) pain_15\NN\14299637
12842176
D000431_D064420 NONE ethanol_35\NN\14708720 (r_conj) pb_33\NNP\14625458 (r_nmod) isoenzymes_38\NNS\0 (r_pobj) by_32\IN\0 (r_agent) formed_31\VBN\1617192 (r_acl) metabolites_30\NNS\20090 (r_conj) lindane_25\NN\14919948 (r_nsubjpass) involved_40\VBN\2676054 (l_prep) in_41\IN\13603305 (l_pobj) toxicity_44\NN\13576101
D001556_D064420 NONE lindane_7\NN\14919948 (r_pobj) of_6\IN\0 (r_prep) metabolism_5\NN\13526110 (r_nsubjpass) blocked_9\VBN\1476483 (r_advcl) increased_17\VBN\169651 (l_advcl) indicating_23\VBG\952524 (l_ccomp) involved_40\VBN\2676054 (l_prep) in_41\IN\13603305 (l_pobj) toxicity_44\NN\13576101
D001556_D064420 NONE lindane_22\NN\14919948 (r_pobj) with_21\IN\0 (r_prep) treated_20\VBN\2376958 (r_acl) animals_19\NNS\4475 (r_pobj) in_18\IN\13603305 (r_prep) increased_17\VBN\169651 (l_advcl) indicating_23\VBG\952524 (l_ccomp) involved_40\VBN\2676054 (l_prep) in_41\IN\13603305 (l_pobj) toxicity_44\NN\13576101
D001556_D064420 NONE lindane_25\NN\14919948 (r_nsubjpass) involved_40\VBN\2676054 (l_prep) in_41\IN\13603305 (l_pobj) toxicity_44\NN\13576101
D000431_D012640 NONE ethanol_46\NN\14708720 (r_conj) inducer_41\NN\14778436 (r_appos) phenobarbital_35\JJ\2792049 (r_pobj) with_34\IN\0 (r_prep) pretreatment_33\NN\0 (r_conj) convulsions_31\NNS\14081375
D000431_D012640 NONE ethanol_46\NN\14708720 (r_conj) inducer_41\NN\14778436 (r_appos) phenobarbital_35\JJ\2792049 (r_pobj) with_34\IN\0 (r_prep) pretreatment_33\NN\0 (r_conj) convulsions_31\NNS\14081375 (r_dobj) induced_30\VBN\1627355 (r_ccomp) shown_4\VBN\2137132 (r_ccomp) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D000431_D012640 NONE ethanol_35\NN\14708720 (r_conj) pb_33\NNP\14625458 (r_nmod) isoenzymes_38\NNS\0 (r_pobj) by_32\IN\0 (r_agent) formed_31\VBN\1617192 (r_acl) metabolites_30\NNS\20090 (r_conj) lindane_25\NN\14919948 (r_nsubjpass) involved_40\VBN\2676054 (r_ccomp) indicating_23\VBG\952524 (r_advcl) increased_17\VBN\169651 (l_advcl) blocked_9\VBN\1476483 (l_agent) by_10\IN\0 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) convulsions_15\NNS\14081375
C018021_D012640 NONE chloride_12\NN\14818238 (r_compound) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) convulsions_15\NNS\14081375
D008748_D012640 NONE 3-methylcholanthrene_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) pretreatment_7\NN\0 (r_nsubj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (l_dobj) convulsions_31\NNS\14081375
D008748_D012640 NONE 3-methylcholanthrene_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) pretreatment_7\NN\0 (r_nsubj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (r_ccomp) shown_4\VBN\2137132 (r_ccomp) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D008748_D012640 NONE mc_11\NNP\15286249 (r_pobj) of_8\IN\0 (r_prep) pretreatment_7\NN\0 (r_nsubj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (l_dobj) convulsions_31\NNS\14081375
D008748_D012640 NONE mc_11\NNP\15286249 (r_pobj) of_8\IN\0 (r_prep) pretreatment_7\NN\0 (r_nsubj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (r_ccomp) shown_4\VBN\2137132 (r_ccomp) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D010634_D012640 NONE phenobarbital_35\JJ\2792049 (r_pobj) with_34\IN\0 (r_prep) pretreatment_33\NN\0 (r_conj) convulsions_31\NNS\14081375
D010634_D012640 NONE phenobarbital_35\JJ\2792049 (r_pobj) with_34\IN\0 (r_prep) pretreatment_33\NN\0 (r_conj) convulsions_31\NNS\14081375 (r_dobj) induced_30\VBN\1627355 (r_ccomp) shown_4\VBN\2137132 (r_ccomp) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D001556_D020258 NONE lindane_2\NN\14919948 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubj) induced_16\VBN\1627355 (l_dobj) neurotoxicity_17\NN\0
D001556_D020258 NONE lindane_15\NN\14919948 (r_pobj) in_14\IN\13603305 (r_prep) modulation_13\NN\7044917 (r_pobj) of_11\IN\0 (r_prep) influence_10\NN\5190804 (r_nsubj) induced_16\VBN\1627355 (l_dobj) neurotoxicity_17\NN\0
C018021_D064420 NONE chloride_12\NN\14818238 (r_compound) incidence_13\NN\13821570 (r_pobj) by_10\IN\0 (r_agent) blocked_9\VBN\1476483 (r_advcl) increased_17\VBN\169651 (l_advcl) indicating_23\VBG\952524 (l_ccomp) involved_40\VBN\2676054 (l_prep) in_41\IN\13603305 (l_pobj) toxicity_44\NN\13576101
D001556_D012640 CID lindane_29\NN\14919948 (r_pobj) of_28\IN\0 (r_prep) incidence_27\NN\13821570 (r_pobj) in_25\IN\13603305 (r_prep) effect_24\NN\34213 (r_dobj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (l_dobj) convulsions_31\NNS\14081375
D001556_D012640 CID lindane_29\NN\14919948 (r_pobj) of_28\IN\0 (r_prep) incidence_27\NN\13821570 (r_pobj) in_25\IN\13603305 (r_prep) effect_24\NN\34213 (r_dobj) produce_21\VB\7555863 (r_advcl) induced_30\VBN\1627355 (r_ccomp) shown_4\VBN\2137132 (r_ccomp) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D001556_D012640 CID lindane_61\NN\14919948 (r_pobj) of_60\IN\0 (r_prep) incidence_59\NN\13821570 (r_dobj) increased_57\VBD\169651 (l_ccomp) shown_4\VBN\2137132 (l_ccomp) induced_30\VBN\1627355 (l_dobj) convulsions_31\NNS\14081375
D001556_D012640 CID lindane_61\NN\14919948 (r_pobj) of_60\IN\0 (r_prep) incidence_59\NN\13821570 (r_dobj) increased_57\VBD\169651 (l_advcl) induced_62\VBN\1627355 (l_dobj) convulsions_63\NNS\14081375
D001556_D012640 CID lindane_7\NN\14919948 (r_pobj) of_6\IN\0 (r_prep) metabolism_5\NN\13526110 (r_nsubjpass) blocked_9\VBN\1476483 (l_agent) by_10\IN\0 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) convulsions_15\NNS\14081375
D001556_D012640 CID lindane_22\NN\14919948 (r_pobj) with_21\IN\0 (r_prep) treated_20\VBN\2376958 (r_acl) animals_19\NNS\4475 (r_pobj) in_18\IN\13603305 (r_prep) increased_17\VBN\169651 (l_advcl) blocked_9\VBN\1476483 (l_agent) by_10\IN\0 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) convulsions_15\NNS\14081375
D001556_D012640 CID lindane_25\NN\14919948 (r_nsubjpass) involved_40\VBN\2676054 (r_ccomp) indicating_23\VBG\952524 (r_advcl) increased_17\VBN\169651 (l_advcl) blocked_9\VBN\1476483 (l_agent) by_10\IN\0 (l_pobj) incidence_13\NN\13821570 (l_prep) of_14\IN\0 (l_pobj) convulsions_15\NNS\14081375
6699841
D012459_D007681 NONE salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117
D012459_D007681 NONE salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117 (l_appos) rpn_32\NNP\0
D013467_D007681 NONE sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117
D013467_D007681 NONE sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117 (l_appos) rpn_32\NNP\0
D013467_D007681 NONE sulindac_15\NN\3828465 (r_pobj) of_14\IN\0 (r_prep) advantages_13\NNS\5154517 (r_dobj) discuss_11\VB\7466557 (r_conj) linking_4\VBG\628491 (l_dobj) rpn_5\NNP\0
D009288_D001172 NONE naproxen_39\NN\3828465 (r_compound) therapy_40\NN\657604 (r_pobj) of_38\IN\0 (r_prep) institution_37\NN\8008335 (r_pobj) after_36\IN\0 (r_prep) developed_27\VBD\1753788 (l_nsubj) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
D006046_D001172 NONE gold_24\NN\13371489 (r_compound) salts_25\NNS\14818238 (r_conj) salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
D005279_D001172 NONE calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
D005279_D007681 NONE calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117
D005279_D007681 NONE calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117 (l_appos) rpn_32\NNP\0
D013467_D007674 NONE sulindac_15\NN\3828465 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_relcl) experienced_20\VBN\2108377 (l_dobj) toxicity_22\NN\13576101
D009288_D007681 CID naproxen_5\NN\3828465 (r_pobj) due_3\IN\5174653 (r_prep) necrosis_2\NN\11444117
D009288_D007681 CID naproxen_39\NN\3828465 (r_compound) therapy_40\NN\657604 (r_pobj) of_38\IN\0 (r_prep) institution_37\NN\8008335 (r_pobj) after_36\IN\0 (r_prep) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117
D009288_D007681 CID naproxen_39\NN\3828465 (r_compound) therapy_40\NN\657604 (r_pobj) of_38\IN\0 (r_prep) institution_37\NN\8008335 (r_pobj) after_36\IN\0 (r_prep) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117 (l_appos) rpn_32\NNP\0
D006046_D007681 NONE gold_24\NN\13371489 (r_compound) salts_25\NNS\14818238 (r_conj) salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117
D006046_D007681 NONE gold_24\NN\13371489 (r_compound) salts_25\NNS\14818238 (r_conj) salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (r_nsubj) developed_27\VBD\1753788 (l_dobj) necrosis_30\NN\11444117 (l_appos) rpn_32\NNP\0
D013467_D001172 NONE sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
D012459_D001172 NONE salicylates_22\NNS\3828465 (r_conj) calcium_18\NN\14625458 (r_conj) sulindac_15\NN\3828465 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_relcl) man_4\NN\9605289 (l_prep) with_5\IN\0 (l_pobj) arthritis_7\NN\14171682
1545575
D015080_D006470 NONE mesna_19\NN\0 (r_pobj) with_18\IN\0 (r_prep) trial_15\NN\786195 (l_relcl) neutralizes_22\VBZ\126264 (l_dobj) metabolite_25\NN\20090 (l_relcl) causes_29\VBZ\7323922 (l_dobj) cystitis_31\NN\14566129
D015080_D006470 NONE mesna_10\JJ\0 (r_amod) uroprophylaxis_11\NNS\0 (r_dobj) received_9\VBD\2210855 (r_relcl) patients_7\NNS\9898892 (r_nsubj) had_17\VBD\0 (l_dobj) cystitis_20\NN\14566129
D003520_D006470 CID cyclophosphamide_11\NN\0 (r_compound) therapy_12\NN\657604 (r_pobj) of_7\IN\0 (r_prep) complication_6\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D003520_D006470 CID cyclophosphamide_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) metabolite_25\NN\20090 (l_relcl) causes_29\VBZ\7323922 (l_dobj) cystitis_31\NN\14566129
D015080_D003556 NONE mesna_19\NN\0 (r_pobj) with_18\IN\0 (r_prep) trial_15\NN\786195 (l_relcl) neutralizes_22\VBZ\126264 (l_dobj) metabolite_25\NN\20090 (l_relcl) causes_29\VBZ\7323922 (l_dobj) cystitis_31\NN\14566129
D015080_D003556 NONE mesna_10\JJ\0 (r_amod) uroprophylaxis_11\NNS\0 (r_dobj) received_9\VBD\2210855 (r_relcl) patients_7\NNS\9898892 (r_nsubj) had_17\VBD\0 (l_dobj) cystitis_20\NN\14566129
D003520_D003556 CID cyclophosphamide_11\NN\0 (r_compound) therapy_12\NN\657604 (r_pobj) of_7\IN\0 (r_prep) complication_6\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) cystitis_1\NN\14566129
D003520_D003556 CID cyclophosphamide_27\NN\0 (r_pobj) of_26\IN\0 (r_prep) metabolite_25\NN\20090 (l_relcl) causes_29\VBZ\7323922 (l_dobj) cystitis_31\NN\14566129
12452237
D008012_D063806 NONE lidocaine_9\JJ\3681148 (r_compound) pretreatment_10\NN\0 (l_prep) on_11\IN\0 (l_pobj) reduction_12\NN\351485 (l_prep) of_13\IN\0 (l_pobj) myalgia_17\NN\14322699
D013390_D010149 CID succinylcholine_3\NN\3800001 (r_dobj) reduce_2\VB\441445 (l_conj) induced_4\VBD\1627355 (l_dobj) myalgia_6\NN\14322699
D013390_D010149 CID succinylcholine_4\NN\3800001 (r_nsubjpass) used_6\VBN\0 (r_advcl) proven_10\VBN\2604760 (l_xcomp) be_12\VB\14625458 (l_attr) agent_16\NN\7347 (l_prep) for_17\IN\0 (l_pobj) reduction_19\NN\351485 (l_prep) of_20\IN\0 (l_pobj) myalgia_22\NN\14322699
D008012_D010149 NONE lidocaine_1\RB\3681148 (r_nsubj) reduce_2\VB\441445 (l_conj) induced_4\VBD\1627355 (l_dobj) myalgia_6\NN\14322699
D008012_D010149 NONE lidocaine_8\NN\3681148 (r_nsubjpass) proven_10\VBN\2604760 (l_xcomp) be_12\VB\14625458 (l_attr) agent_16\NN\7347 (l_prep) for_17\IN\0 (l_pobj) reduction_19\NN\351485 (l_prep) of_20\IN\0 (l_pobj) myalgia_22\NN\14322699
D013390_D063806 NONE succinylcholine_14\NN\3800001 (r_npadvmod) induced_16\VBN\1627355 (r_amod) myalgia_17\NN\14322699
16826348
D003561_D010523 CID arabinoside_8\NN\0 (r_amod) treatment_9\NN\654885 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) neuropathy_1\NNS\14204950
D003561_D010523 CID arabinoside_14\NN\0 (r_nsubj) is_15\VBZ\0 (l_advcl) are_6\VBP\13600404 (l_nsubj) mechanisms_2\NNS\13446390 (l_prep) of_3\IN\0 (l_pobj) neuropathy_5\NN\14204950
D003561_D015470 NONE arabinoside_8\NN\0 (r_amod) treatment_9\NN\654885 (l_prep) in_10\IN\13603305 (l_pobj) patient_12\NN\9898892 (l_prep) with_13\IN\0 (l_pobj) leukemia_16\NN\14239918
D003561_D006987 NONE arabinoside_8\NN\0 (r_pobj) of_3\IN\0 (r_prep) course_2\NN\883297 (r_nsubj) resulted_9\VBD\2633881 (l_conj) complained_28\VBD\0 (l_prep) of_29\IN\0 (l_pobj) numbness_30\NN\14299637
D008775_D006086 NONE methylprednisolone_38\NN\0 (r_pobj) to_37\IN\0 (r_prep) responded_36\VBD\2367363 (r_conj) worsened_19\VBD\146138 (l_prep) with_21\IN\0 (l_pobj) development_23\NN\248977 (l_prep) of_24\IN\0 (l_pobj) disease_30\NN\14061805
D003561_D064420 NONE arabinoside_10\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101
D003561_D064420 NONE arabinoside_10\NN\0 (r_pobj) of_5\IN\0 (r_prep) toxicity_4\NN\13576101 (r_nsubjpass) recognized_13\VBN\686447 (l_conj) reported_29\VBN\831651 (l_nsubjpass) toxicity_17\NN\13576101
D003561_D064420 NONE arabinoside_20\NN\0 (r_pobj) of_18\IN\0 (r_prep) toxicity_17\NN\13576101 (r_nsubjpass) reported_29\VBN\831651 (r_conj) recognized_13\VBN\686447 (l_nsubjpass) toxicity_4\NN\13576101
D003561_D064420 NONE arabinoside_20\NN\0 (r_pobj) of_18\IN\0 (r_prep) toxicity_17\NN\13576101
D008775_D009422 NONE methylprednisolone_38\NN\0 (r_pobj) to_37\IN\0 (r_prep) responded_36\VBD\2367363 (r_conj) worsened_19\VBD\146138 (l_ccomp) received_11\VBD\2210855 (l_ccomp) resolving_4\VBG\5781800 (l_nsubj) neuropathy_1\NN\14204950
3123611
D003276_D002819 CID contraception_4\NN\851994 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) chorea_0\NNP\14253124
D003276_D002819 CID contraceptives_7\NNS\3183080 (r_dobj) receiving_5\VBG\2210855 (r_advcl) developed_2\VBD\1753788 (l_dobj) chorea_3\NN\14253124
D003276_D002819 CID contraception_12\NN\851994 (r_pobj) after_9\IN\0 (r_prep) had_3\VBD\0 (l_dobj) chorea_8\NN\14253124
D000661_D002819 CID amphetamine_5\NN\3248958 (r_npadvmod) induced_7\VBN\1627355 (r_amod) chorea_8\NN\14253124
10411803
D015313_D000743 CID cefotetan_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) use_7\NN\407535 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) anemia_3\NN\14189204
D015313_D000743 CID cefotetan_8\JJ\0 (r_appos) cephalosporins_5\NNS\2716866 (r_conj) second-_0\NNP\0 (r_nsubjpass) associated_12\VBN\628491 (l_prep) with_13\IN\0 (l_pobj) anemia_20\NN\14189204
D015313_D000743 CID cefotetan_9\NN\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) anemias_13\NNS\14189204
D015313_D000743 CID cefotetan_20\JJ\0 (r_dobj) received_19\VBN\2210855 (r_relcl) patients_16\NNS\9898892 (r_pobj) in_15\IN\13603305 (r_prep) were_14\VBD\0 (l_nsubj) 10_3\CD\13745420 (l_prep) of_4\IN\0 (l_pobj) cases_7\NNS\7283608 (l_prep) of_8\IN\0 (l_pobj) anemias_13\NNS\14189204
D002511_D000743 NONE cephalosporins_5\NNS\2716866 (r_conj) second-_0\NNP\0 (r_nsubjpass) associated_12\VBN\628491 (l_prep) with_13\IN\0 (l_pobj) anemia_20\NN\14189204
16596970
D010862_D012640 NONE pilocarpine_0\NNP\14712692 (r_amod) seizures_1\NNS\14081375
D010862_D012640 NONE pilocarpine_0\NN\14712692 (r_nsubj) induced_4\VBN\1627355 (r_ccomp) resulted_12\VBD\2633881 (l_prep) in_13\IN\13603305 (l_pobj) loss_16\NN\13252973 (l_conj) seizures_19\NNS\14081375
D010862_D012640 NONE pilocarpine_0\NN\14712692 (r_nsubj) induced_4\VBN\1627355 (r_ccomp) resulted_12\VBD\2633881 (l_advcl) had_24\VBD\0 (l_dobj) loss_27\NN\13252973 (l_conj) seizures_30\NNS\14081375
D010862_D001308 CID pilocarpine_0\NNP\14712692 (r_amod) seizures_1\NNS\14081375 (r_nsubj) cause_2\IN\7323922 (l_dobj) impairment_6\NN\7296428 (l_prep) in_7\IN\13603305 (l_pobj) discrimination_10\NN\1123598
D010862_D013226 CID pilocarpine_0\NN\14712692 (r_nsubj) induced_4\VBN\1627355 (l_advmod) epilepticus_6\NN\0
D010862_D013226 CID pilocarpine_0\NN\14712692 (r_nsubj) induced_4\VBN\1627355 (r_ccomp) resulted_12\VBD\2633881 (l_nsubj) epilepticus_9\NN\0
2576810
D009627_D006948 CID nomifensine_4\NN\0 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (r_acl) hyperactivity_1\NN\14052403
D016666_D006948 CID fluvoxamine_4\NNP\0 (r_pobj) with_3\IN\0 (r_prep) treatment_2\NN\654885 (r_nsubj) potentiated_12\VBN\229605 (l_dobj) hyperactivity_25\NN\14052403
D016666_D006948 CID fluvoxamine_10\NN\0 (r_pobj) by_9\IN\0 (r_prep) unaffected_8\JJ\0 (r_acomp) remained_7\VBD\2604760 (l_nsubj) hyperactivity_1\NN\14052403
D000661_D006948 CID amphetamine_22\NN\3248958 (r_npadvmod) induced_24\VBN\1627355 (r_amod) hyperactivity_25\NN\14052403
12091028
D003975_D006212 NONE diazepam_0\NNP\2830852 (r_nsubj) remains_7\VBZ\2684 (l_attr) drug_12\NN\14778436 (l_relcl) ketamine_14\NN\3054098 (l_advcl) buffers_17\VBZ\14818238 (l_conj) decreases_22\VBZ\7296428 (l_dobj) duration_24\NN\15113229 (l_prep) of_27\IN\0 (l_pobj) hallucinations_31\NNS\14376855
D007649_D006212 CID ketamine_14\NN\3054098 (l_advcl) buffers_17\VBZ\14818238 (l_conj) decreases_22\VBZ\7296428 (l_dobj) duration_24\NN\15113229 (l_prep) of_27\IN\0 (l_pobj) hallucinations_31\NNS\14376855
11245434
D016190_D000740 CID carboplatin_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_dobj) using_3\VBG\418025 (r_xcomp) induced_2\VBN\1627355 (l_nsubjpass) anemia_0\NN\14189204
D016190_D000740 CID carboplatin_29\NN\0 (r_amod) application_30\NN\947128 (r_pobj) before_28\IN\0 (r_prep) days_27\NNS\15140892 (r_dobj) starting_25\VBG\457382 (r_advcl) administered_19\VBN\2436349 (r_conj) prevented_10\VBN\0 (l_nsubjpass) development_6\NN\248977 (l_prep) of_7\IN\0 (l_pobj) anemia_8\NN\14189204
D003520_D064420 NONE cyclophosphamide_8\NN\0 (r_compound) cytotoxicity_9\NN\13583478
D003520_D064420 NONE cyclophosphamide_25\NN\0 (r_pobj) of_24\IN\0 (r_prep) cytotoxicity_23\NN\13583478
D003520_D064420 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) cytotoxicity_9\NN\13583478
D010100_D064420 NONE oxygen_37\NN\14622893 (r_compound) supply_38\NN\13576355 (r_pobj) of_34\IN\0 (r_prep) result_33\NN\34213 (r_pobj) as_31\IN\14622893 (r_prep) increases_26\VBZ\13576355 (r_advcl) reduces_8\VBZ\441445 (l_dobj) cytotoxicity_9\NN\13583478
D016190_D009369 NONE carboplatin_3\NN\0 (r_amod) treatment_4\NN\654885 (r_pobj) after_2\IN\0 (r_prep) implanted_16\VBN\1421622 (l_nsubjpass) tumors_6\NNS\14234074
D016190_D009369 NONE carboplatin_1\NN\0 (l_conj) influenced_5\VBN\137313 (l_dobj) rate_8\NN\13815152 (l_compound) tumor_6\NN\14234074
D010100_D000740 NONE oxygen_37\NN\14622893 (r_compound) supply_38\NN\13576355 (r_pobj) of_34\IN\0 (r_prep) result_33\NN\34213 (r_pobj) as_31\IN\14622893 (r_prep) increases_26\VBZ\13576355 (r_advcl) reduces_8\VBZ\441445 (l_nsubj) anemia_7\NN\14189204
D010100_D000740 NONE oxygen_37\NN\14622893 (r_compound) supply_38\NN\13576355 (r_pobj) of_34\IN\0 (r_prep) result_33\NN\34213 (r_pobj) as_31\IN\14622893 (r_prep) increases_26\VBZ\13576355 (l_nsubj) correction_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) anemia_18\NN\14189204
D010100_D009369 NONE oxygen_37\NN\14622893 (r_compound) supply_38\NN\13576355 (r_pobj) of_34\IN\0 (r_prep) result_33\NN\34213 (r_pobj) as_31\IN\14622893 (r_prep) increases_26\VBZ\13576355 (r_advcl) reduces_8\VBZ\441445 (l_dobj) cytotoxicity_9\NN\13583478 (l_prep) in_12\IN\13603305 (l_pobj) tumors_13\NNS\14234074
D010100_D009369 NONE oxygen_37\NN\14622893 (r_compound) supply_38\NN\13576355 (l_prep) to_39\IN\0 (l_pobj) tissue_41\NN\5220461 (l_compound) tumor_40\NN\14234074
D016190_D012509 NONE carboplatin_3\NN\0 (r_amod) treatment_4\NN\654885 (r_pobj) after_2\IN\0 (r_prep) implanted_16\VBN\1421622 (l_nsubjpass) tumors_6\NNS\14234074 (l_appos) sarcoma_10\NN\14239918
D003520_D009369 NONE cyclophosphamide_8\NN\0 (r_compound) cytotoxicity_9\NN\13583478 (l_prep) in_10\IN\13603305 (l_pobj) tumors_12\NNS\14234074
D003520_D009369 NONE cyclophosphamide_25\NN\0 (r_pobj) of_24\IN\0 (r_prep) cytotoxicity_23\NN\13583478 (l_prep) in_26\IN\13603305 (l_pobj) tumors_29\NNS\14234074
D003520_D009369 NONE cyclophosphamide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_pobj) with_4\IN\0 (r_prep) treated_3\VBN\2376958 (l_nsubjpass) tumors_1\NNS\14234074
D003520_D009369 NONE cyclophosphamide_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) dose_7\NN\3740161 (r_pobj) with_4\IN\0 (r_prep) treated_3\VBN\2376958 (r_advcl) observed_31\VBN\2163746 (l_nsubjpass) delay_22\NN\15271008 (l_prep) with_23\IN\0 (l_pobj) regrowth_26\NN\0 (l_prep) of_27\IN\0 (l_pobj) tumors_29\NNS\14234074
D003520_D009369 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) cytotoxicity_9\NN\13583478 (l_prep) in_12\IN\13603305 (l_pobj) tumors_13\NNS\14234074
D003520_D009369 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) cytotoxicity_9\NN\13583478 (r_dobj) reduces_8\VBZ\441445 (l_advcl) increases_26\VBZ\13576355 (l_prep) as_31\IN\14622893 (l_pobj) result_33\NN\34213 (l_prep) of_34\IN\0 (l_pobj) supply_38\NN\13576355 (l_prep) to_39\IN\0 (l_pobj) tissue_41\NN\5220461 (l_compound) tumor_40\NN\14234074
D003520_D000740 NONE cyclophosphamide_8\NN\0 (r_compound) cytotoxicity_9\NN\13583478 (r_pobj) in_7\IN\13603305 (r_prep) reduction_6\NN\351485 (l_amod) induced_5\VBN\1627355 (l_npadvmod) anemia_3\NN\14189204
D003520_D000740 NONE cyclophosphamide_25\NN\0 (r_pobj) of_24\IN\0 (r_prep) cytotoxicity_23\NN\13583478 (r_pobj) on_21\IN\0 (r_prep) treatment_20\NN\654885 (r_pobj) by_13\IN\0 (r_prep) impact_9\NN\7339329 (l_prep) of_10\IN\0 (l_pobj) prevention_12\NN\1073995 (l_compound) anemia_11\NN\14189204
D003520_D000740 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) cytotoxicity_9\NN\13583478 (r_dobj) reduces_8\VBZ\441445 (l_nsubj) anemia_7\NN\14189204
D003520_D000740 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) cytotoxicity_9\NN\13583478 (r_dobj) reduces_8\VBZ\441445 (l_advcl) increases_26\VBZ\13576355 (l_nsubj) correction_16\NN\248977 (l_prep) of_17\IN\0 (l_pobj) anemia_18\NN\14189204
6203632
D007545_D006332 CID isoproterenol_2\NN\3740161 (r_npadvmod) induced_4\VBN\1627355 (r_amod) hypertrophy_6\NN\14365950
D007545_D006332 CID isoproterenol_17\NN\3740161 (r_pobj) of_16\IN\0 (r_prep) injections_15\NNS\320852 (r_pobj) following_12\VBG\8180190 (r_prep) studied_6\VBN\0 (l_nsubjpass) development_1\NN\248977 (l_prep) of_2\IN\0 (l_pobj) hypertrophy_4\NN\14365950
D007545_D006332 CID iso_19\NN\0 (r_appos) injections_15\NNS\320852 (r_pobj) following_12\VBG\8180190 (r_prep) studied_6\VBN\0 (l_nsubjpass) development_1\NN\248977 (l_prep) of_2\IN\0 (l_pobj) hypertrophy_4\NN\14365950
D007545_D006984 NONE iso_8\NN\0 (r_pobj) to_7\IN\0 (r_prep) response_6\NN\11410625 (r_nsubj) shows_9\VBZ\429048 (l_dobj) phase_13\NN\15113229 (l_amod) hypertrophic_12\JJ\0
8607407
D002110_D006973 CID caffeine_5\NN\14712692 (r_pobj) with_4\IN\0 (r_prep) elevations_3\NNS\7445480 (l_prep) in_6\IN\13603305 (l_pobj) men_7\NNS\8208016 (l_prep) with_8\IN\0 (l_pobj) hypertension_11\NN\14057371
D002110_D006973 CID caffeine_5\NN\14712692 (r_pobj) of_4\IN\0 (r_prep) actions_3\NNS\30358 (r_nsubjpass) enhanced_7\VBN\227165 (l_prep) in_8\IN\13603305 (l_pobj) persons_10\NNS\7347 (l_amod) hypertensive_9\JJ\10405694
D002110_D006973 CID caffeine_24\NN\14712692 (r_compound) ingestion_25\NN\13440063 (r_pobj) after_23\IN\0 (r_prep) achieved_19\VBD\2524171 (l_dobj) levels_22\NNS\4916342 (l_amod) hypertensive_20\JJ\10405694
D002110_D006973 CID caffeine_10\NN\14712692 (r_pobj) to_9\IN\0 (r_prep) responses_8\NNS\11410625 (r_nsubj) were_11\VBD\0 (l_prep) in_2\IN\13603305 (l_pobj) men_5\NNS\8208016 (l_amod) hypertensive_4\JJ\10405694
D002110_D006973 CID caffeine_10\NN\14712692 (r_pobj) to_9\IN\0 (r_prep) responses_8\NNS\11410625 (r_nsubj) were_11\VBD\0 (l_advcl) replicated_23\VBN\2035919 (l_conj) representative_29\NN\10351874 (l_prep) of_30\IN\0 (l_pobj) hypertensives_34\NNS\10405694
8473723
D016666_D012640 CID fluvoxamine_6\NN\0 (r_compound) treatment_7\NN\654885 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D016666_D012640 CID fluvoxamine_8\NN\0 (r_nmod) seizures_12\NNS\14081375
D008728_D012640 CID levomepromazine_4\JJ\0 (r_amod) fluvoxamine_6\NN\0 (r_compound) treatment_7\NN\654885 (r_pobj) by_2\IN\0 (r_agent) induced_1\VBN\1627355 (l_nsubj) seizures_0\NNS\14081375
D008728_D012640 CID levomepromazine_6\JJ\0 (r_amod) fluvoxamine_8\NN\0 (r_nmod) seizures_12\NNS\14081375
17194457
D012701_D001523 NONE 5-ht_16\CD\0 (r_pobj) with_13\IN\0 (r_prep) users_12\NNS\7846 (r_nsubj) be_18\VB\14625458 (l_acomp) prone_20\JJ\0 (l_xcomp) exhibit_22\VB\6733939 (l_dobj) behavior_24\NN\407535
D013739_D001523 CID t_0\NNP\14999913 (r_nsubj) had_2\VBD\0 (l_dobj) effect_4\NN\34213 (l_prep) on_5\IN\0 (l_pobj) locomotion_6\NN\4773351 (l_conj) irritability_8\NN\7552087
D013739_D001523 CID t_0\NNP\14999913 (r_nsubj) had_2\VBD\0 (l_conj) preference_16\NN\7497473 (l_conj) aggression_18\NN\4657876
-1_D001523 NONE pcpa_3\NNP\0 (r_pobj) to_2\IN\0 (r_prep) exposure_1\NN\5042871 (r_nsubj) decreased_6\VBD\169651 (l_conj) increased_10\VBN\169651 (l_dobj) irritability_11\NN\7552087
-1_D001523 NONE pcpa_3\NNP\0 (r_pobj) to_2\IN\0 (r_prep) exposure_1\NN\5042871 (r_nsubj) decreased_6\VBD\169651 (l_conj) had_13\VBD\0 (l_dobj) effect_15\NN\34213 (l_prep) on_16\IN\0 (l_pobj) behavior_18\NN\407535 (l_conj) preference_21\NN\7497473 (l_conj) aggression_24\NN\4657876
20394767
C015068_D012021 CID mcpp_12\NNS\0 (r_advcl) increased_3\VBN\169651 (l_dobj) startle_5\NN\863513
C015068_D012021 CID mcpp_12\NNS\0 (r_advcl) increased_3\VBN\169651 (l_conj) suppressed_13\VBD\2510337 (l_dobj) startle_15\NN\863513
C015068_D012021 CID mcpp_12\NNS\0 (r_advcl) increased_3\VBN\169651 (l_conj) suppressed_13\VBD\2510337 (l_conj) suppressed_24\VBD\2510337 (l_dobj) startle_26\NN\863513
D015016_D012021 CID yohimbine_2\NN\0 (r_nsubj) increased_3\VBN\169651 (l_dobj) startle_5\NN\863513
D015016_D012021 CID yohimbine_2\NN\0 (r_nsubj) increased_3\VBN\169651 (l_conj) suppressed_13\VBD\2510337 (l_dobj) startle_15\NN\863513
D015016_D012021 CID yohimbine_2\NN\0 (r_nsubj) increased_3\VBN\169651 (l_conj) suppressed_13\VBD\2510337 (l_conj) suppressed_24\VBD\2510337 (l_dobj) startle_26\NN\863513
D010433_D012021 CID ptz_23\NNP\0 (r_nsubj) suppressed_24\VBD\2510337 (r_conj) suppressed_13\VBD\2510337 (r_conj) increased_3\VBN\169651 (l_dobj) startle_5\NN\863513
D010433_D012021 CID ptz_23\NNP\0 (r_nsubj) suppressed_24\VBD\2510337 (r_conj) suppressed_13\VBD\2510337 (l_dobj) startle_15\NN\863513
D010433_D012021 CID ptz_23\NNP\0 (r_nsubj) suppressed_24\VBD\2510337 (l_dobj) startle_26\NN\863513
9228650
D012601_D000647 CID scopolamine_6\NN\14712692 (r_npadvmod) induced_8\VBN\1627355 (r_amod) amnesia_9\NN\5669934
D012601_D000647 CID scopolamine_7\NN\14712692 (r_npadvmod) induced_9\VBN\1627355 (r_amod) amnesia_10\NN\5669934
D012601_D000647 CID scopolamine_14\NN\14712692 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) amnesia_11\NN\5669934
D012601_D000647 CID scopolamine_17\NN\14712692 (r_npadvmod) induced_19\VBN\1627355 (r_amod) amnesia_20\NN\5669934
C049860_D000647 CID nik-247_2\NNP\0 (l_prep) on_3\IN\0 (l_pobj) cholinesterase_4\NN\14732946 (l_conj) amnesia_9\NN\5669934
C049860_D000647 CID nik-247_3\NNP\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubjpass) examined_15\VBN\0 (l_nsubjpass) amnesia_10\NN\5669934
C049860_D000647 CID nik-247_4\NNP\0 (r_nsubj) improves_16\VBZ\126264 (l_dobj) amnesia_20\NN\5669934
C076946_D000647 CID e-2020_29\NNS\0 (r_conj) tacrine_27\NN\0 (r_appos) inhibitors_26\NNS\20090 (r_pobj) of_20\IN\0 (r_prep) those_19\DT\0 (r_pobj) with_18\IN\0 (r_prep) compared_17\VBN\644583 (r_conj) examined_15\VBN\0 (l_nsubjpass) amnesia_10\NN\5669934
C049860_D000544 NONE nik-247_4\NNP\0 (r_nsubj) be_6\VB\14625458 (l_attr) drug_9\NN\14778436 (l_prep) for_10\IN\0 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) disease_16\NN\14061805
D013619_D000647 CID tacrine_27\NN\0 (r_appos) inhibitors_26\NNS\20090 (r_pobj) of_20\IN\0 (r_prep) those_19\DT\0 (r_pobj) with_18\IN\0 (r_prep) compared_17\VBN\644583 (r_conj) examined_15\VBN\0 (l_nsubjpass) amnesia_10\NN\5669934
17702969
D005473_D006976 CID fluoxetine_3\NN\4169152 (r_advmod) induces_4\VBZ\1627355 (l_dobj) hypertension_7\NN\14057371
D005473_D006976 CID fluoxetine_4\NN\4169152 (r_amod) exposure_5\NN\5042871 (r_nsubj) increases_7\VBZ\13576355 (l_dobj) prevalence_9\NN\4764412 (l_prep) of_10\IN\0 (l_pobj) syndrome_14\NN\5870365
D005473_D006976 CID fluoxetine_20\NN\4169152 (r_amod) effect_21\NN\34213 (r_appos) evidence_14\NN\5816287 (l_prep) of_15\IN\0 (l_pobj) hypertension_18\NN\14057371
D005473_D006976 CID fluoxetine_5\NN\4169152 (r_amod) exposure_6\NN\5042871 (r_nsubj) resulted_7\VBD\2633881 (l_prep) in_8\IN\13603305 (l_pobj) hypertension_11\NN\14057371
D005473_D006976 CID fluoxetine_6\NN\4169152 (r_amod) exposure_7\NN\5042871 (r_nsubj) induces_10\VBZ\1627355 (l_dobj) hypertension_12\NN\14057371
D005473_D005315 CID fluoxetine_3\NN\4169152 (r_advmod) induces_4\VBZ\1627355 (l_dobj) hypertension_7\NN\14057371
D005473_D005315 CID fluoxetine_5\NN\4169152 (r_amod) exposure_6\NN\5042871 (r_nsubj) resulted_7\VBD\2633881 (l_prep) in_8\IN\13603305 (l_pobj) hypertension_11\NN\14057371
17490790
D007501_D009410 NONE iron_6\NN\14625458 (r_compound) overload_7\NN\3679986 (r_pobj) between_4\IN\0 (r_prep) relationship_3\NN\31921 (r_dobj) demonstrate_1\VB\2137132 (r_advcl) used_25\VBD\0 (l_dobj) voltammetry_28\NN\0 (l_conj) immunohistochemistry_35\NN\791527 (l_conj) staining_40\NN\275424 (l_conj) detection_49\NN\5708432 (l_acl) study_51\VB\635850 (l_dobj) degeneration_53\NN\29677 (l_prep) of_54\IN\0 (l_pobj) neurons_56\NNS\5430628
D007501_D009410 NONE iron_39\NN\14625458 (r_compound) staining_40\NN\275424 (l_conj) detection_49\NN\5708432 (l_acl) study_51\VB\635850 (l_dobj) degeneration_53\NN\29677 (l_prep) of_54\IN\0 (l_pobj) neurons_56\NNS\5430628
D007501_D009410 NONE iron_59\NN\14625458 (r_compound) content_60\NN\7951464 (r_conj) staining_40\NN\275424 (l_conj) detection_49\NN\5708432 (l_acl) study_51\VB\635850 (l_dobj) degeneration_53\NN\29677 (l_prep) of_54\IN\0 (l_pobj) neurons_56\NNS\5430628
D007501_D009410 NONE iron_10\NN\14625458 (r_compound) level_11\NN\4916342 (l_relcl) causes_19\VBZ\7323922 (l_dobj) degeneration_21\NN\29677 (l_prep) of_22\IN\0 (l_pobj) neurons_24\NNS\5430628
D007501_D009410 NONE iron_18\NN\14625458 (r_nsubj) causes_19\VBZ\7323922 (l_dobj) degeneration_21\NN\29677 (l_prep) of_22\IN\0 (l_pobj) neurons_24\NNS\5430628
D014443_D009410 NONE tyrosine_30\NN\14601829 (r_det) immunohistochemistry_35\NN\791527 (l_conj) staining_40\NN\275424 (l_conj) detection_49\NN\5708432 (l_acl) study_51\VB\635850 (l_dobj) degeneration_53\NN\29677 (l_prep) of_54\IN\0 (l_pobj) neurons_56\NNS\5430628
D007501_D010300 NONE iron_0\NN\14625458 (r_compound) accumulation_1\NN\13497135 (r_nsubjpass) considered_3\VBN\689344 (l_xcomp) involved_6\VBN\2676054 (l_prep) in_7\IN\13603305 (l_pobj) pathogenesis_9\NN\13533470 (l_prep) of_10\IN\0 (l_pobj) disease_13\NN\14061805
D007505_D009410 CID dextran_2\NN\0 (r_nsubj) induced_3\VBD\1627355 (l_dobj) degeneration_4\NN\29677 (l_prep) of_5\IN\0 (l_pobj) neurons_7\NNS\5430628
D007505_D009410 CID dextran_66\NN\0 (r_amod) animals_68\NNS\4475 (r_pobj) of_64\IN\0 (r_prep) sn_63\NN\14625458 (r_pobj) in_61\IN\13603305 (r_prep) content_60\NN\7951464 (r_conj) staining_40\NN\275424 (l_conj) detection_49\NN\5708432 (l_acl) study_51\VB\635850 (l_dobj) degeneration_53\NN\29677 (l_prep) of_54\IN\0 (l_pobj) neurons_56\NNS\5430628
D007505_D009410 CID dextran_6\NN\0 (r_nsubj) increase_8\VB\13576355 (l_dobj) level_11\NN\4916342 (l_relcl) causes_19\VBZ\7323922 (l_dobj) degeneration_21\NN\29677 (l_prep) of_22\IN\0 (l_pobj) neurons_24\NNS\5430628
11752998
D002211_D004342 NONE capsaicin_27\NN\15032661 (r_npadvmod) evoked_29\VBN\1617192 (r_amod) hypersensitivity_31\NN\14531772
D002211_D004342 NONE capsaicin_20\NN\15032661 (r_compound) injection_21\NN\320852 (r_pobj) after_18\IN\0 (r_prep) reflect_13\VB\923793 (r_xcomp) presumed_11\VBN\719734 (r_advcl) show_2\VBP\429048 (l_dobj) inhibition_4\NN\1068773 (l_prep) by_5\IN\0 (l_pobj) adenosine_7\NN\14964367 (l_prep) of_8\IN\0 (l_pobj) hypersensitivity_9\NN\14531772
D002211_D010146 NONE capsaicin_82\NN\15032661 (r_compound) injection_83\NN\320852 (r_pobj) after_80\IN\0 (r_prep) stimuli_72\NNS\5816287 (r_pobj) to_69\IN\0 (r_prep) response_68\NN\11410625 (r_pobj) in_67\IN\13603305 (r_prep) ratings_66\NNS\5733583 (l_compound) pain_65\NN\14299637
D002211_D010146 NONE capsaicin_22\NN\15032661 (r_compound) injection_23\NN\320852 (r_pobj) from_20\IN\0 (r_prep) allodynia_19\NN\0 (r_conj) hyperalgesia_17\NN\0 (r_conj) stimulation_13\NN\242808 (r_pobj) to_7\IN\0 (r_prep) produced_1\VBD\1617192 (l_dobj) effect_3\NN\34213 (l_prep) on_4\IN\0 (l_pobj) report_6\NN\6470073 (l_compound) pain_5\NN\14299637
D000241_D059787 NONE adenosine_4\NN\14964367 (r_pobj) of_2\IN\0 (r_prep) studies_1\NNS\635850 (r_nsubj) suggest_5\VBP\1010118 (l_ccomp) be_8\VB\14625458 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) pain_17\NN\14299637
D000241_D059787 NONE adenosine_33\NN\14964367 (r_pobj) of_32\IN\0 (r_prep) formulation_31\NN\14818238 (r_pobj) with_28\IN\0 (r_prep) volunteers_25\NNS\10582746 (r_pobj) in_24\IN\13603305 (r_prep) studies_23\NNS\635850 (r_nsubj) suggests_34\VBZ\1010118 (r_conj) suggest_5\VBP\1010118 (l_ccomp) be_8\VB\14625458 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) pain_17\NN\14299637
D000241_D006930 NONE adenosine_34\NN\14964367 (r_amod) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_prep) in_67\IN\13603305 (l_pobj) response_68\NN\11410625 (l_prep) to_69\IN\0 (l_pobj) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0
D000241_D006930 NONE adenosine_34\NN\14964367 (r_amod) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_prep) in_67\IN\13603305 (l_pobj) response_68\NN\11410625 (l_prep) to_69\IN\0 (l_pobj) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0 (l_conj) allodynia_79\NN\0
D000241_D006930 NONE adenosine_52\NN\14964367 (r_pobj) of_51\IN\0 (r_prep) trial_50\NN\786195 (r_conj) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_prep) in_67\IN\13603305 (l_pobj) response_68\NN\11410625 (l_prep) to_69\IN\0 (l_pobj) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0
D000241_D006930 NONE adenosine_52\NN\14964367 (r_pobj) of_51\IN\0 (r_prep) trial_50\NN\786195 (r_conj) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_prep) in_67\IN\13603305 (l_pobj) response_68\NN\11410625 (l_prep) to_69\IN\0 (l_pobj) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0 (l_conj) allodynia_79\NN\0
D000241_D006930 NONE adenosine_0\NNP\14964367 (r_nsubj) produced_1\VBD\1617192 (l_prep) to_7\IN\0 (l_pobj) stimulation_13\NN\242808 (l_conj) hyperalgesia_17\NN\0
D000241_D006930 NONE adenosine_0\NNP\14964367 (r_nsubj) produced_1\VBD\1617192 (l_prep) to_7\IN\0 (l_pobj) stimulation_13\NN\242808 (l_conj) hyperalgesia_17\NN\0 (l_conj) allodynia_19\NN\0
D000241_D009437 NONE adenosine_27\NN\14964367 (r_pobj) of_26\IN\0 (r_prep) residence_25\NN\8491027 (r_pobj) due_22\JJ\5174653 (r_acomp) is_20\VBZ\0 (r_conj) is_5\VBZ\0 (l_acomp) consistent_6\JJ\0 (l_prep) with_7\IN\0 (l_pcomp) observed_9\VBN\2163746 (l_prep) in_10\IN\13603305 (l_pobj) reports_12\NNS\6470073 (l_prep) of_13\IN\0 (l_pobj) patients_14\NNS\9898892 (l_prep) with_15\IN\0 (l_pobj) pain_18\NN\14299637
D000241_D004342 NONE adenosine_4\NN\14964367 (r_pobj) of_2\IN\0 (r_prep) studies_1\NNS\635850 (r_nsubj) suggest_5\VBP\1010118 (l_conj) suggests_34\VBZ\1010118 (l_ccomp) be_37\VB\14625458 (l_acomp) effective_38\JJ\0 (l_prep) in_39\IN\13603305 (l_pobj) states_41\NNS\8491826 (l_compound) hypersensitivity_40\NN\14531772
D000241_D004342 NONE adenosine_33\NN\14964367 (r_pobj) of_32\IN\0 (r_prep) formulation_31\NN\14818238 (r_pobj) with_28\IN\0 (r_prep) volunteers_25\NNS\10582746 (r_pobj) in_24\IN\13603305 (r_prep) studies_23\NNS\635850 (r_nsubj) suggests_34\VBZ\1010118 (l_ccomp) be_37\VB\14625458 (l_acomp) effective_38\JJ\0 (l_prep) in_39\IN\13603305 (l_pobj) states_41\NNS\8491826 (l_compound) hypersensitivity_40\NN\14531772
D000241_D004342 NONE adenosine_15\NN\14964367 (r_pobj) of_14\IN\0 (r_prep) formulation_13\NN\14818238 (r_pobj) of_10\IN\0 (r_prep) efficacy_9\NN\5199286 (r_pobj) for_8\IN\0 (r_prep) screen_7\VB\4362025 (l_advcl) using_21\VBG\418025 (l_dobj) stimulation_25\NN\242808 (l_conj) hypersensitivity_31\NN\14531772
D000241_D004342 NONE adenosine_7\NN\14964367 (l_prep) of_8\IN\0 (l_pobj) hypersensitivity_9\NN\14531772
D000241_D059350 NONE adenosine_4\NN\14964367 (r_pobj) of_2\IN\0 (r_prep) studies_1\NNS\635850 (r_nsubj) suggest_5\VBP\1010118 (l_ccomp) be_8\VB\14625458 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) pain_17\NN\14299637
D000241_D059350 NONE adenosine_33\NN\14964367 (r_pobj) of_32\IN\0 (r_prep) formulation_31\NN\14818238 (r_pobj) with_28\IN\0 (r_prep) volunteers_25\NNS\10582746 (r_pobj) in_24\IN\13603305 (r_prep) studies_23\NNS\635850 (r_nsubj) suggests_34\VBZ\1010118 (r_conj) suggest_5\VBP\1010118 (l_ccomp) be_8\VB\14625458 (l_acomp) effective_9\JJ\0 (l_prep) in_10\IN\13603305 (l_pobj) treatment_12\NN\654885 (l_prep) of_13\IN\0 (l_pobj) pain_17\NN\14299637
D000241_D010146 NONE adenosine_34\NN\14964367 (r_amod) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_compound) pain_65\NN\14299637
D000241_D010146 NONE adenosine_52\NN\14964367 (r_pobj) of_51\IN\0 (r_prep) trial_50\NN\786195 (r_conj) doses_35\NNS\3740161 (r_pobj) with_32\IN\0 (r_prep) trial_31\NN\786195 (r_appos) trials_21\NNS\786195 (r_pobj) in_19\IN\13603305 (r_prep) studied_18\VBN\0 (l_conj) obtained_59\VBN\2210855 (l_conj) determined_85\VBN\0 (l_nsubjpass) ratings_66\NNS\5733583 (l_compound) pain_65\NN\14299637
D000241_D010146 NONE adenosine_0\NNP\14964367 (r_nsubj) produced_1\VBD\1617192 (l_dobj) effect_3\NN\34213 (l_prep) on_4\IN\0 (l_pobj) report_6\NN\6470073 (l_compound) pain_5\NN\14299637
D002211_D006930 CID capsaicin_82\NN\15032661 (r_compound) injection_83\NN\320852 (r_pobj) after_80\IN\0 (r_prep) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0
D002211_D006930 CID capsaicin_82\NN\15032661 (r_compound) injection_83\NN\320852 (r_pobj) after_80\IN\0 (r_prep) stimuli_72\NNS\5816287 (l_conj) areas_74\NNS\8630985 (l_prep) of_75\IN\0 (l_pobj) hyperalgesia_77\NN\0 (l_conj) allodynia_79\NN\0
D002211_D006930 CID capsaicin_22\NN\15032661 (r_compound) injection_23\NN\320852 (r_pobj) from_20\IN\0 (r_prep) allodynia_19\NN\0 (r_conj) hyperalgesia_17\NN\0
D002211_D006930 CID capsaicin_22\NN\15032661 (r_compound) injection_23\NN\320852 (r_pobj) from_20\IN\0 (r_prep) allodynia_19\NN\0
11079278
D004280_D017202 CID dobutamine_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) ischemia_14\NN\14195315
D004280_D017202 CID dobutamine_1\NN\0 (r_pcomp) during_0\IN\0 (r_prep) attenuates_6\VBZ\224901 (l_conj) eliminates_8\VBZ\1619929 (l_dobj) evidence_9\NN\5816287 (l_prep) of_10\IN\0 (l_pobj) ischemia_12\NN\14195315
D008790_D017202 NONE metoprolol_3\NN\2832168 (l_conj) metoprolol_6\NN\2832168 (l_conj) glucagon_8\NN\5407119 (l_prep) on_9\IN\0 (l_pobj) ischemia_14\NN\14195315
D008790_D017202 NONE metoprolol_6\NN\2832168 (l_conj) glucagon_8\NN\5407119 (l_prep) on_9\IN\0 (l_pobj) ischemia_14\NN\14195315
D008790_D017202 NONE metoprolol_5\FW\2832168 (r_nsubj) attenuates_6\VBZ\224901 (l_conj) eliminates_8\VBZ\1619929 (l_dobj) evidence_9\NN\5816287 (l_prep) of_10\IN\0 (l_pobj) ischemia_12\NN\14195315
7416947
D004077_D020018 CID digoxin_13\NN\15060131 (r_pobj) of_12\IN\0 (r_prep) administration_11\NN\1133281 (r_pobj) on_7\IN\0 (r_prep) patients_6\NNS\9898892 (r_pobj) of_5\IN\0 (r_prep) dysfunction_4\NN\14204950
D004077_D012214 NONE digoxin_10\NN\15060131 (r_pobj) without_9\IN\0 (r_prep) group_7\NN\2137 (r_pobj) of_2\IN\0 (r_prep) patients_1\NNS\9898892 (r_nsubj) were_12\VBD\0 (l_conj) selected_29\VBN\697589 (l_prep) from_30\IN\0 (l_pobj) patients_35\NNS\9898892 (l_compound) disease_34\NN\14061805
19761039
D010936_D004409 NONE sinensis_7\NN\0 (r_pobj) of_4\IN\0 (r_prep) extract_3\NN\14589223 (r_pobj) of_1\IN\0 (r_prep) effect_0\NN\34213 (r_nsubjpass) studied_15\VBN\0 (l_prep) on_16\IN\0 (l_pobj) dyskinesia_21\JJ\14084880
D010936_D004409 NONE sinensis_10\NN\0 (r_nsubj) had_11\VBD\0 (l_dobj) role_14\NN\719494 (l_prep) against_15\IN\0 (l_pobj) dyskinesia_20\JJ\14084880
D012110_D004409 CID reserpine_17\NN\2721160 (r_npadvmod) induced_19\VBN\1627355 (r_amod) dyskinesia_21\JJ\14084880
D012110_D004409 CID reserpine_16\NN\2721160 (r_npadvmod) induced_18\VBN\1627355 (r_amod) dyskinesia_20\JJ\14084880
12852481
D001241_D005767 NONE asa_20\NNP\0 (r_nsubjpass) administered_22\VBN\2436349 (r_advcl) compare_7\VB\4744814 (r_xcomp) were_5\VBD\0 (l_nsubj) objectives_0\NNS\5980875 (l_acl) compare_33\VB\4744814 (l_conj) test_50\VB\5798043 (l_dobj) hypothesis_52\NN\7162194 (l_acl) confounds_57\VBZ\2604760 (l_nsubj) toxicity_56\NN\13576101
D001241_D005767 NONE asa_65\NNP\0 (r_pobj) with_64\IN\0 (r_prep) malformations_63\NNS\14213199 (r_pobj) of_60\IN\0 (r_prep) detection_59\NN\5708432 (r_dobj) confounds_57\VBZ\2604760 (l_nsubj) toxicity_56\NN\13576101
D001241_D000014 CID aspirin_0\NNP\2707683 (r_nsubj) acetylsalicylic_2\JJ\0 (l_conj) induces_17\VBZ\1627355 (l_dobj) anomalies_19\NNS\14501726
D001241_D000014 CID acid_3\NN\14818238 (r_npadvmod) acetylsalicylic_2\JJ\0 (l_conj) induces_17\VBZ\1627355 (l_dobj) anomalies_19\NNS\14501726
D001241_D000014 CID asa_5\NNP\0 (r_appos) acid_3\NN\14818238 (r_npadvmod) acetylsalicylic_2\JJ\0 (l_conj) induces_17\VBZ\1627355 (l_dobj) anomalies_19\NNS\14501726
D001241_D000014 CID asa_20\NNP\0 (r_nsubjpass) administered_22\VBN\2436349 (r_advcl) compare_7\VB\4744814 (r_xcomp) were_5\VBD\0 (l_nsubj) objectives_0\NNS\5980875 (l_acl) compare_33\VB\4744814 (l_conj) test_50\VB\5798043 (l_dobj) hypothesis_52\NN\7162194 (l_acl) confounds_57\VBZ\2604760 (l_dobj) detection_59\NN\5708432 (l_prep) of_60\IN\0 (l_pobj) malformations_63\NNS\14213199
D001241_D000014 CID asa_65\NNP\0 (r_pobj) with_64\IN\0 (r_prep) malformations_63\NNS\14213199
D001241_D000014 CID asa_16\NNP\0 (r_nsubj) induces_17\VBZ\1627355 (r_advcl) focused_9\VBD\628491 (l_prep) on_10\IN\0 (l_pobj) malformations_12\NNS\14213199
D001241_D000014 CID asa_16\NNP\0 (r_nsubj) induces_17\VBZ\1627355 (l_dobj) malformations_23\NNS\14213199
D001241_D000014 CID asa_6\NNP\0 (r_nsubjpass) administered_8\VBN\2436349 (r_advcl) were_3\VBD\0 (l_nsubj) variations_0\NNS\7296428 (l_conj) malformations_2\NNS\14213199
D001241_D000014 CID asa_38\NNP\0 (r_pobj) with_37\IN\0 (r_prep) induced_36\VBN\1627355 (l_nsubjpass) malformations_17\NNS\14213199
19058474
D014859_D006470 NONE warfarin_26\NN\2718259 (r_pobj) of_25\IN\0 (r_prep) dosage_24\NN\13576355 (r_dobj) maintaining_21\VBG\0 (r_advcl) consumed_13\VBD\1168468 (r_relcl) man_11\NN\9605289 (r_pobj) in_8\IN\13603305 (r_prep) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) haemorrhage_7\NN\14285662
D014859_D010490 NONE warfarin_13\NN\2718259 (r_pobj) with_12\IN\0 (r_prep) interaction_8\NN\37396 (r_pobj) due_5\IN\5174653 (r_prep) haemorrhage_4\NN\14285662 (l_nmod) haemopericardium_1\NN\0
D014859_D006471 CID warfarin_13\NN\2718259 (r_pobj) with_12\IN\0 (r_prep) interaction_8\NN\37396 (r_pobj) due_5\IN\5174653 (r_prep) haemorrhage_4\NN\14285662
11009181
D001058_D004409 NONE apomorphine_13\NN\3786417 (r_compound) infusions_14\NNS\14589223 (r_pobj) with_10\IN\0 (r_prep) monotherapy_9\NN\0 (r_nsubjpass) associated_16\VBN\628491 (l_prep) with_17\IN\0 (l_pobj) reductions_19\NNS\351485 (l_prep) of_20\IN\0 (l_pobj) dyskinesias_25\NNS\14084880
D007980_D004409 CID levodopa_22\NN\14604959 (r_npadvmod) induced_24\VBN\1627355 (r_amod) dyskinesias_25\NNS\14084880
D001058_D001523 NONE apomorphine_6\NN\3786417 (r_compound) treatment_7\NN\654885 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (r_nsubjpass) related_9\VBN\628491 (l_advcl) play_20\VBP\7007684 (l_nsubj) sedation_16\NN\14034177 (l_conj) complications_19\NNS\1073995 (l_amod) psychiatric_18\JJ\0
D001058_D010300 NONE apomorphine_0\NNP\3786417 (l_appos) therapy_4\NN\657604 (l_prep) for_5\IN\0 (l_pobj) disease_8\NN\14061805
D001058_D010300 NONE apomorphine_0\NNP\3786417 (r_nsubj) was_1\VBD\0 (l_attr) drug_5\NN\14778436 (l_acl) used_7\VBN\0 (l_xcomp) treat_9\VB\7570720 (l_dobj) symptoms_10\NNS\5823932 (l_prep) of_11\IN\0 (l_pobj) disease_14\NN\14061805
D001058_D010300 NONE apomorphine_24\NN\3786417 (r_pobj) of_23\IN\0 (r_prep) administration_22\NN\1133281 (r_pobj) by_20\IN\0 (r_prep) treating_15\VBG\2376958 (l_dobj) disease_19\NN\14061805
D001058_D010300 NONE apomorphine_8\NN\3786417 (r_compound) treatment_9\NN\654885 (l_prep) in_10\IN\13603305 (l_pobj) disease_14\NN\14061805
15897593
D005047_D015431 CID etoposide_12\RB\0 (r_conj) daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0 (l_conj) loss_8\NN\13252973
D005047_D015431 CID etoposide_12\RB\0 (r_conj) daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973
D018943_D066126 NONE anthracyclines_1\NNS\0 (r_nsubj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0 (l_conj) toxicity_29\NN\13576101
D018943_D066126 NONE anthracycline_9\NN\0 (r_advmod) induced_11\VBN\1627355 (r_amod) cardiotoxicity_12\NN\0
D003630_D064420 NONE daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973 (l_conj) cytotoxicity_39\NN\13583478
D005047_D006402 CID etoposide_33\VB\0 (r_pobj) to_32\TO\0 (r_prep) sensitivity_24\NN\5651971 (r_nsubjpass) determined_42\VBN\0 (l_advcl) investigated_22\VBN\644583 (l_nsubjpass) toxicity_8\NN\13576101
D005047_D006402 CID etoposide_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) doses_11\NNS\3740161 (r_dobj) combining_7\VBG\7373277 (r_acl) metastases_6\NNS\13533470 (r_pobj) with_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_pobj) in_2\IN\13603305 (r_prep) trials_1\NNS\786195 (r_nsubj) is_14\VBZ\0 (l_acomp) ongoing_15\JJ\0 (l_prep) with_16\IN\0 (l_pobj) aim_18\NN\5980875 (l_prep) of_19\IN\0 (l_pcomp) improving_20\VBG\126264 (l_prep) without_22\IN\0 (l_pcomp) aggravating_23\VBG\126264 (l_dobj) toxicity_25\NN\13576101
D064730_D006402 NONE dexrazoxane_12\NN\0 (r_pobj) of_11\IN\0 (r_prep) coadministration_10\NN\0 (r_pobj) following_9\VBG\8180190 (r_prep) toxicity_8\NN\13576101
D064730_D006402 NONE dexrazoxane_40\NN\0 (r_dobj) doxorubicin_38\NN\2716866 (r_conj) daunorubicin_35\NNS\0 (r_conj) etoposide_33\VB\0 (r_pobj) to_32\TO\0 (r_prep) sensitivity_24\NN\5651971 (r_nsubjpass) determined_42\VBN\0 (l_advcl) investigated_22\VBN\644583 (l_nsubjpass) toxicity_8\NN\13576101
D064730_D006402 NONE dexrazoxane_8\NN\0 (r_nmod) doses_11\NNS\3740161 (r_dobj) combining_7\VBG\7373277 (r_acl) metastases_6\NNS\13533470 (r_pobj) with_4\IN\0 (r_prep) patients_3\NNS\9898892 (r_pobj) in_2\IN\13603305 (r_prep) trials_1\NNS\786195 (r_nsubj) is_14\VBZ\0 (l_acomp) ongoing_15\JJ\0 (l_prep) with_16\IN\0 (l_pobj) aim_18\NN\5980875 (l_prep) of_19\IN\0 (l_pcomp) improving_20\VBG\126264 (l_prep) without_22\IN\0 (l_pcomp) aggravating_23\VBG\126264 (l_dobj) toxicity_25\NN\13576101
D011034_D001855 NONE epipodophyllotoxin_7\NN\0 (r_conj) doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0
D011034_D066126 NONE epipodophyllotoxin_7\NN\0 (r_conj) doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0 (l_conj) toxicity_29\NN\13576101
D003630_D001855 NONE daunorubicin_13\NNS\0 (r_conj) etoposide_11\NN\0 (r_advmod) protects_1\VBZ\1127795 (l_prep) against_2\IN\0 (l_pobj) myelosuppression_3\NN\0
D003630_D001855 NONE daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0
D003630_D001855 NONE daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0
D003630_D001855 NONE daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0
D064730_D064420 NONE dexrazoxane_3\NN\0 (r_npadvmod) reduced_4\VBN\441445 (r_amod) myelosuppression_5\NN\0 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973 (l_conj) cytotoxicity_39\NN\13583478
D064730_D064420 NONE dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973 (l_conj) cytotoxicity_39\NN\13583478
D004317_D006402 CID doxorubicin_38\NN\2716866 (r_conj) daunorubicin_35\NNS\0 (r_conj) etoposide_33\VB\0 (r_pobj) to_32\TO\0 (r_prep) sensitivity_24\NN\5651971 (r_nsubjpass) determined_42\VBN\0 (l_advcl) investigated_22\VBN\644583 (l_nsubjpass) toxicity_8\NN\13576101
D064730_D015431 NONE dexrazoxane_3\NN\0 (r_npadvmod) reduced_4\VBN\441445 (r_amod) myelosuppression_5\NN\0 (l_conj) loss_8\NN\13252973
D064730_D015431 NONE dexrazoxane_3\NN\0 (r_npadvmod) reduced_4\VBN\441445 (r_amod) myelosuppression_5\NN\0 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973
D064730_D015431 NONE dexrazoxane_27\NN\0 (l_nsubj) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0 (l_conj) loss_8\NN\13252973
D064730_D015431 NONE dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973
D064730_D066126 NONE dexrazoxane_0\NNP\0 (r_nsubjpass) recommended_5\VBN\875394 (l_prep) for_6\IN\0 (l_pobj) protection_7\NN\407535 (l_prep) against_8\IN\0 (l_pobj) cardiotoxicity_12\NN\0
D064730_D066126 NONE icrf-187_2\NN\0 (r_appos) dexrazoxane_0\NNP\0 (r_nsubjpass) recommended_5\VBN\875394 (l_prep) for_6\IN\0 (l_pobj) protection_7\NN\407535 (l_prep) against_8\IN\0 (l_pobj) cardiotoxicity_12\NN\0
D005047_D066126 NONE etoposide_8\NN\0 (r_appos) epipodophyllotoxin_7\NN\0 (r_conj) doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0 (l_conj) toxicity_29\NN\13576101
D004317_D066126 NONE doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0 (l_conj) toxicity_29\NN\13576101
D064730_D001855 NONE dexrazoxane_0\NNP\0 (r_nsubj) protects_1\VBZ\1127795 (l_prep) against_2\IN\0 (l_pobj) myelosuppression_3\NN\0
D064730_D001855 NONE dexrazoxane_3\NN\0 (r_npadvmod) reduced_4\VBN\441445 (r_amod) myelosuppression_5\NN\0
D064730_D001855 NONE dexrazoxane_3\NN\0 (r_npadvmod) reduced_4\VBN\441445 (r_amod) myelosuppression_5\NN\0 (r_pobj) of_2\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0
D064730_D001855 NONE dexrazoxane_27\NN\0 (l_nsubj) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0
D064730_D001855 NONE dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0
D005047_D064420 NONE etoposide_12\RB\0 (r_conj) daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973 (l_conj) cytotoxicity_39\NN\13583478
D064730_D009362 NONE dexrazoxane_8\NN\0 (r_nmod) doses_11\NNS\3740161 (r_dobj) combining_7\VBG\7373277 (r_acl) metastases_6\NNS\13533470
D005047_D001855 NONE etoposide_11\NN\0 (r_advmod) protects_1\VBZ\1127795 (l_prep) against_2\IN\0 (l_pobj) myelosuppression_3\NN\0
D005047_D001855 NONE etoposide_8\NN\0 (r_appos) epipodophyllotoxin_7\NN\0 (r_conj) doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0
D005047_D001855 NONE etoposide_12\RB\0 (r_conj) daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0
D005047_D001855 NONE etoposide_12\RB\0 (r_conj) daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0
D004317_D064420 NONE doxorubicin_41\NN\2716866 (r_pobj) from_40\IN\0 (r_prep) cytotoxicity_39\NN\13583478
D005047_D009362 NONE etoposide_13\NN\0 (r_pobj) of_12\IN\0 (r_prep) doses_11\NNS\3740161 (r_dobj) combining_7\VBG\7373277 (r_acl) metastases_6\NNS\13533470
D004317_D015431 CID doxorubicin_41\NN\2716866 (r_pobj) from_40\IN\0 (r_prep) cytotoxicity_39\NN\13583478 (r_conj) loss_33\NN\13252973 (r_conj) myelosuppression_30\NN\0 (r_dobj) dexrazoxane_27\NN\0 (l_nsubj) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0 (l_conj) loss_8\NN\13252973
D004317_D015431 CID doxorubicin_41\NN\2716866 (r_pobj) from_40\IN\0 (r_prep) cytotoxicity_39\NN\13583478 (r_conj) loss_33\NN\13252973
D018943_D001855 NONE anthracyclines_1\NNS\0 (r_nsubj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0
D003630_D006402 CID daunorubicin_35\NNS\0 (r_conj) etoposide_33\VB\0 (r_pobj) to_32\TO\0 (r_prep) sensitivity_24\NN\5651971 (r_nsubjpass) determined_42\VBN\0 (l_advcl) investigated_22\VBN\644583 (l_nsubjpass) toxicity_8\NN\13576101
D003630_D066126 NONE daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0 (l_conj) toxicity_29\NN\13576101
D004317_D001855 NONE doxorubicin_16\RB\2716866 (r_conj) etoposide_11\NN\0 (r_advmod) protects_1\VBZ\1127795 (l_prep) against_2\IN\0 (l_pobj) myelosuppression_3\NN\0
D004317_D001855 NONE doxorubicin_4\NN\2716866 (r_conj) daunorubicin_2\NN\0 (r_ccomp) limit_30\VBP\5123416 (l_nsubj) myelosuppression_26\NN\0
D004317_D001855 NONE doxorubicin_41\NN\2716866 (r_pobj) from_40\IN\0 (r_prep) cytotoxicity_39\NN\13583478 (r_conj) loss_33\NN\13252973 (r_conj) myelosuppression_30\NN\0 (r_dobj) dexrazoxane_27\NN\0 (l_nsubj) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0
D004317_D001855 NONE doxorubicin_41\NN\2716866 (r_pobj) from_40\IN\0 (r_prep) cytotoxicity_39\NN\13583478 (r_conj) loss_33\NN\13252973 (r_conj) myelosuppression_30\NN\0
D003630_D015431 CID daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (l_prep) of_2\IN\0 (l_pobj) myelosuppression_5\NN\0 (l_conj) loss_8\NN\13252973
D003630_D015431 CID daunorubicin_10\NN\0 (r_pobj) from_9\IN\0 (r_prep) doses_1\NNS\3740161 (r_nsubj) dexrazoxane_27\NN\0 (l_dobj) myelosuppression_30\NN\0 (l_conj) loss_33\NN\13252973
1595783
D000638_D011014 CID amiodarone_0\NN\2715941 (r_nsubj) is_1\VBZ\0 (l_attr) agent_5\NN\7347 (l_appos) being_19\VBG\24720 (l_attr) pneumonitis_20\NN\14336539
D000638_D008171 NONE amiodarone_0\NN\2715941 (r_amod) toxicity_2\NN\13576101
D000638_D008171 NONE amiodarone_4\NN\2715941 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101
D000638_D008171 NONE amiodarone_6\NN\2715941 (r_npadvmod) induced_8\VBN\1627355 (r_amod) toxicity_10\NN\13576101
D000638_D004342 NONE amiodarone_4\NN\2715941 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101 (r_nsubjpass) thought_6\VBN\5809192 (l_xcomp) result_8\VB\34213 (l_prep) from_9\IN\0 (l_pobj) injury_11\NN\14052046 (l_acl) related_12\VBN\628491 (l_prep) to_13\IN\0 (l_pobj) accumulation_16\NN\13497135 (l_prep) of_17\IN\0 (l_pobj) pneumonitis_25\NN\14336539
D000638_D000542 NONE amiodarone_4\NN\2715941 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101 (r_nsubjpass) thought_6\VBN\5809192 (l_xcomp) result_8\VB\34213 (l_prep) from_9\IN\0 (l_pobj) injury_11\NN\14052046 (l_acl) related_12\VBN\628491 (l_prep) to_13\IN\0 (l_pobj) accumulation_16\NN\13497135 (l_prep) of_17\IN\0 (l_pobj) pneumonitis_25\NN\14336539
3952818
D005472_D066126 NONE 5-fluorouracil_3\CD\0 (r_punct) ._4\.\0 (r_punct) toxicity_1\NN\13576101
D005472_D066126 NONE 5-fu_14\CD\0 (r_pobj) to_13\IN\0 (r_pcomp) due_12\JJ\5174653 (r_prep) be_7\VB\14625458 (l_attr) cause_9\NN\7323922 (l_prep) of_10\IN\0 (l_pobj) cardiotoxicity_11\NN\0
D005472_D066126 NONE 5-fu_14\CD\0 (r_pobj) to_13\IN\0 (r_pcomp) due_12\JJ\5174653 (r_prep) be_7\VB\14625458 (l_conj) used_23\VBN\0 (l_prep) in_24\IN\13603305 (l_pobj) prevention_26\NN\1073995 (l_prep) of_29\IN\0 (l_pobj) cardiotoxicity_31\NN\0
D005472_D066126 NONE 5-fu_30\CD\0 (r_compound) cardiotoxicity_31\NN\0 (r_pobj) of_29\IN\0 (r_prep) prevention_26\NN\1073995 (r_pobj) in_24\IN\13603305 (r_prep) used_23\VBN\0 (r_conj) be_7\VB\14625458 (l_attr) cause_9\NN\7323922 (l_prep) of_10\IN\0 (l_pobj) cardiotoxicity_11\NN\0
D005472_D066126 NONE 5-fu_30\CD\0 (r_compound) cardiotoxicity_31\NN\0
D009543_D000788 NONE nifedipine_19\NN\2938514 (r_pobj) with_18\IN\0 (r_prep) resolved_17\VBD\352826 (r_conj) was_3\VBD\0 (l_acomp) similar_4\JJ\0 (l_prep) to_5\IN\0 (l_pobj) that_6\DT\0 (l_acl) observed_7\VBN\2163746 (l_prep) in_8\IN\13603305 (l_pobj) angina_11\NN\14171682
D005472_D002637 CID 5-fluorouracil_18\CD\0 (r_punct) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (l_dobj) pain_16\NN\14299637
D005472_D002637 CID 5-fu_20\CD\0 (r_nmod) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (l_dobj) pain_16\NN\14299637
D009543_D002637 NONE nifedipine_19\NN\2938514 (r_pobj) with_18\IN\0 (r_prep) resolved_17\VBD\352826 (l_nsubj) pain_15\NN\14299637
D005472_D009362 NONE 5-fluorouracil_18\CD\0 (r_punct) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (r_relcl) patient_6\NN\9898892 (l_prep) with_7\IN\0 (l_pobj) carcinoma_9\NN\14239918 (l_conj) metastasis_12\NN\13533470
D005472_D009362 NONE 5-fu_20\CD\0 (r_nmod) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (r_relcl) patient_6\NN\9898892 (l_prep) with_7\IN\0 (l_pobj) carcinoma_9\NN\14239918 (l_conj) metastasis_12\NN\13533470
D005472_D003329 NONE 5-fu_14\CD\0 (r_pobj) to_13\IN\0 (r_pcomp) due_12\JJ\5174653 (r_prep) be_7\VB\14625458 (l_nsubj) spasm_5\NN\14299637
D005472_D003329 NONE 5-fu_30\CD\0 (r_compound) cardiotoxicity_31\NN\0 (r_pobj) of_29\IN\0 (r_prep) prevention_26\NN\1073995 (r_pobj) in_24\IN\13603305 (r_prep) used_23\VBN\0 (r_conj) be_7\VB\14625458 (l_nsubj) spasm_5\NN\14299637
D005472_D003110 NONE 5-fluorouracil_18\CD\0 (r_punct) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (r_relcl) patient_6\NN\9898892 (l_prep) with_7\IN\0 (l_pobj) carcinoma_9\NN\14239918
D005472_D003110 NONE 5-fu_20\CD\0 (r_nmod) administration_22\NN\1133281 (r_pobj) after_17\IN\0 (r_prep) presented_14\VBD\2137132 (r_relcl) patient_6\NN\9898892 (l_prep) with_7\IN\0 (l_pobj) carcinoma_9\NN\14239918
D002118_D066126 NONE calcium_18\NN\14625458 (r_compound) antagonists_19\NNS\7846 (r_nsubjpass) used_23\VBN\0 (r_conj) be_7\VB\14625458 (l_attr) cause_9\NN\7323922 (l_prep) of_10\IN\0 (l_pobj) cardiotoxicity_11\NN\0
D002118_D066126 NONE calcium_18\NN\14625458 (r_compound) antagonists_19\NNS\7846 (r_nsubjpass) used_23\VBN\0 (l_prep) in_24\IN\13603305 (l_pobj) prevention_26\NN\1073995 (l_prep) of_29\IN\0 (l_pobj) cardiotoxicity_31\NN\0
D002118_D003329 NONE calcium_18\NN\14625458 (r_compound) antagonists_19\NNS\7846 (r_nsubjpass) used_23\VBN\0 (r_conj) be_7\VB\14625458 (l_nsubj) spasm_5\NN\14299637
8475949
D008274_C537153 NONE magnesium_11\NN\14625458 (r_compound) levels_12\NNS\4916342 (l_conj) hypomagnesemia_14\NN\0
D008274_D008133 NONE magnesium_8\NN\14625458 (r_compound) supplementation_9\NN\5108947 (r_nsubjpass) advocated_11\VBN\875394 (l_advcl) observed_5\VBN\2163746 (l_nsubjpass) prolongation_3\NN\1017987
D008274_D016171 NONE magnesium_11\NN\14625458 (r_compound) levels_12\NNS\4916342 (r_pobj) to_9\IN\0 (r_prep) related_8\VBN\628491 (l_nsubjpass) pointes_5\FW\831651
D010419_D017180 NONE pentamidine_3\NN\0 (l_conj) tachycardia_7\NN\14110674
D010419_D017180 NONE isethionate_1\NN\0 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) tachyarrhythmias_7\NNS\0
D010419_D016171 CID isethionate_1\NN\0 (r_nsubjpass) associated_4\VBN\628491 (l_prep) with_5\IN\0 (l_pobj) tachyarrhythmias_7\NNS\0 (l_prep) including_9\VBG\0 (l_pobj) pointes_12\FW\831651
D010419_D016171 CID pentamidine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) torsade_3\NN\0 (r_nmod) pointes_5\FW\831651
D010419_D016171 CID pentamidine_13\NN\0 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_pobj) of_10\IN\0 (r_prep) days_9\NNS\15140892 (r_pobj) of_7\IN\0 (r_prep) average_6\NN\6021499 (r_pobj) after_4\IN\0 (r_prep) occurred_3\VBD\0 (l_nsubj) pointes_2\NNS\831651
D010419_D016171 CID pentamidine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) discontinuation_12\NN\209943 (r_pobj) without_11\IN\0 (r_prep) recognized_7\VBN\686447 (r_advcl) treated_5\VBN\2376958 (l_nsubjpass) pointes_2\FW\831651
D010419_C537153 NONE pentamidine_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) torsade_3\NN\0 (r_nmod) pointes_5\FW\831651 (r_nsubjpass) related_8\VBN\628491 (l_prep) to_9\IN\0 (l_pobj) levels_12\NNS\4916342 (l_conj) hypomagnesemia_14\NN\0
11860495
D012601_D000647 CID scopolamine_21\NN\14712692 (r_npadvmod) induced_23\VBN\1627355 (r_amod) amnesia_24\NN\5669934
D012601_D000647 CID scopolamine_25\NN\14712692 (r_npadvmod) induced_27\VBN\1627355 (r_amod) amnesia_28\NN\5669934
D005680_D000647 NONE gaba(a)r_15\NNP\0 (r_compound) ligands_16\NNS\20090 (r_conj) nmdar_13\NNP\0 (r_pobj) of_12\IN\0 (r_prep) effects_11\NNS\13245626 (l_amod) like_10\JJ\5839024 (l_amod) amnesic_8\JJ\10158756
C018370_D000647 NONE sulphate_13\NN\15010703 (r_pobj) of_11\IN\0 (r_prep) effects_10\NNS\13245626 (l_amod) amnesic_9\JJ\10158756
C018370_D000647 NONE pregs_2\NNP\0 (r_nsubj) is_3\VBZ\0 (l_acomp) able_4\JJ\0 (l_xcomp) reverse_6\VB\13854649 (l_dobj) effects_11\NNS\13245626 (l_amod) like_10\JJ\5839024 (l_amod) amnesic_8\JJ\10158756
C018370_D000647 NONE pregs_6\NNP\0 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (r_nsubjpass) tested_11\VBN\670261 (l_prep) in_12\IN\13603305 (l_pobj) task_16\NN\575741 (l_acl) using_17\VBG\418025 (l_dobj) model_19\NN\5888929 (l_prep) of_20\IN\0 (l_pobj) amnesia_24\NN\5669934
C018370_D000647 NONE pregs_10\NNP\0 (r_pobj) of_8\IN\0 (r_prep) ability_7\NN\4723816 (l_acl) be_12\VB\14625458 (l_attr) order_14\NN\7168131 (l_amod) effective_18\JJ\0 (l_prep) than_19\IN\0 (l_pobj) enantiomer_22\NN\14818238 (l_prep) in_23\IN\13603305 (l_pcomp) reversing_24\VBG\109660 (l_dobj) amnesia_28\NN\5669934
D013256_D000647 NONE steroid_0\NN\14727670 (r_compound) structure_1\NN\21939 (r_nsubj) determine_5\VBP\0 (l_dobj) effects_10\NNS\13245626 (l_amod) amnesic_9\JJ\10158756
2257294
C034753_D001855 NONE benzylacyclouridine_0\NN\0 (r_nsubj) reverses_1\VBZ\13854649 (l_dobj) suppression_6\NN\13489037
C034753_D001855 NONE bau_11\NNP\0 (r_nsubj) reduced_12\VBD\441445 (l_dobj) toxicity_17\NN\13576101
C034753_D064420 NONE benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_prep) because_0\IN\0 (l_pobj) toxicities_4\NNS\13576101
C034753_D064420 NONE bau_16\NNP\0 (r_appos) benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_prep) because_0\IN\0 (l_pobj) toxicities_4\NNS\13576101
D014529_D000740 NONE urd_8\NNP\0 (r_compound) administration_9\NN\1133281 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) toxicities_4\NNS\13576101 (r_pobj) because_0\IN\0 (r_prep) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204
D014529_D064420 NONE urd_8\NNP\0 (r_compound) administration_9\NN\1133281 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) toxicities_4\NNS\13576101
D014529_D064420 NONE urd_3\NNP\0 (r_compound) catabolism_4\NN\13526110 (r_dobj) inhibits_2\VBZ\2510337 (l_conj) increases_10\VBZ\13576355 (l_prep) without_23\IN\0 (l_pobj) toxicity_27\NN\13576101
D014529_D064420 NONE urd_15\NNP\0 (r_pobj) of_14\IN\0 (r_prep) concentration_13\NN\4916342 (r_dobj) increases_10\VBZ\13576355 (l_prep) without_23\IN\0 (l_pobj) toxicity_27\NN\13576101
D014529_D064420 NONE urd_24\NNP\0 (r_npadvmod) related_26\VBN\628491 (r_amod) toxicity_27\NN\13576101
C034753_-1 NONE bau_31\NNP\0 (r_conj) azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_conj) increased_67\VBN\169651 (l_conj) improved_74\VBN\126264 (l_dobj) megaloblastosis_75\NN\0
D014529_D007970 NONE urd_8\NNP\0 (r_compound) administration_9\NN\1133281 (r_pobj) with_6\IN\0 (r_prep) associated_5\VBN\628491 (r_acl) toxicities_4\NNS\13576101 (r_pobj) because_0\IN\0 (r_prep) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204 (l_conj) leukopenia_29\NN\14189204
D015215_D064420 NONE azt_24\NNP\3834836 (r_npadvmod) induced_26\VBN\1627355 (r_amod) anemia_27\NN\14189204 (r_nsubjpass) assessed_31\VBN\670261 (l_prep) because_0\IN\0 (l_pobj) toxicities_4\NNS\13576101
D015215_D001855 CID azidothymidine_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) suppression_6\NN\13489037
D015215_D001855 CID azt_3\NNP\3834836 (r_pobj) with_2\IN\0 (r_prep) coadministered_1\VBN\0 (r_advcl) reduced_12\VBD\441445 (l_dobj) toxicity_17\NN\13576101
D015215_D001855 CID azt_13\NNP\3834836 (r_npadvmod) induced_15\VBN\1627355 (r_amod) toxicity_17\NN\13576101
D014529_D007153 NONE uridine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_nsubjpass) reported_10\VBN\831651 (l_xcomp) reduce_12\VB\441445 (l_dobj) inhibition_20\NN\1068773 (l_prep) without_28\IN\0 (l_pobj) impairment_29\NN\7296428 (l_prep) of_30\IN\0 (l_pobj) virus_34\NN\9312843 (l_compound) immunodeficiency_33\NN\13973990
D014529_D007153 NONE urd_6\NNP\0 (r_appos) uridine_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) concentrations_2\NNS\4916342 (r_nsubjpass) reported_10\VBN\831651 (l_xcomp) reduce_12\VB\441445 (l_dobj) inhibition_20\NN\1068773 (l_prep) without_28\IN\0 (l_pobj) impairment_29\NN\7296428 (l_prep) of_30\IN\0 (l_pobj) virus_34\NN\9312843 (l_compound) immunodeficiency_33\NN\13973990
D015215_D007970 CID azt_24\NNP\3834836 (r_npadvmod) induced_26\VBN\1627355 (r_amod) anemia_27\NN\14189204 (l_conj) leukopenia_29\NN\14189204
D015215_D007970 CID azt_10\NNP\3834836 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_pobj) by_6\IN\0 (r_prep) leukopenic_5\JJ\0
D015215_D007970 CID azt_10\NNP\3834836 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_pobj) by_6\IN\0 (r_prep) leukopenic_5\JJ\0 (r_conj) rendered_2\VBD\120316 (r_acl) mice_1\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204 (l_conj) leukopenia_45\NN\14189204
D015215_D007970 CID azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_conj) leukopenic_5\JJ\0
D015215_D007970 CID azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204 (l_conj) leukopenia_45\NN\14189204
D015215_D007970 CID azt_40\NNP\3834836 (r_npadvmod) induced_42\VBN\1627355 (r_amod) anemia_43\NN\14189204 (r_dobj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_conj) leukopenic_5\JJ\0
D015215_D007970 CID azt_40\NNP\3834836 (r_npadvmod) induced_42\VBN\1627355 (r_amod) anemia_43\NN\14189204 (l_conj) leukopenia_45\NN\14189204
C034753_D000740 NONE benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204
C034753_D000740 NONE bau_16\NNP\0 (r_appos) benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204
C034753_D000740 NONE bau_31\NNP\0 (r_conj) azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_oprd) anemic_3\JJ\0
C034753_D000740 NONE bau_31\NNP\0 (r_conj) azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204
C034753_D007153 NONE benzylacyclouridine_0\NN\0 (r_nsubj) reverses_1\VBZ\13854649 (l_prep) without_7\IN\0 (l_pobj) impairment_8\NN\7296428 (l_prep) of_9\IN\0 (l_pobj) activity_15\NN\30358 (l_compound) virus_14\NN\9312843 (l_compound) immunodeficiency_13\NN\13973990
D015215_D000740 CID azt_24\NNP\3834836 (r_npadvmod) induced_26\VBN\1627355 (r_amod) anemia_27\NN\14189204
D015215_D000740 CID azt_10\NNP\3834836 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_pobj) by_6\IN\0 (r_prep) leukopenic_5\JJ\0 (r_conj) rendered_2\VBD\120316 (l_oprd) anemic_3\JJ\0
D015215_D000740 CID azt_10\NNP\3834836 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_pobj) by_6\IN\0 (r_prep) leukopenic_5\JJ\0 (r_conj) rendered_2\VBD\120316 (r_acl) mice_1\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204
D015215_D000740 CID azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_oprd) anemic_3\JJ\0
D015215_D000740 CID azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204
D015215_D000740 CID azt_40\NNP\3834836 (r_npadvmod) induced_42\VBN\1627355 (r_amod) anemia_43\NN\14189204 (r_dobj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_oprd) anemic_3\JJ\0
D015215_D000740 CID azt_40\NNP\3834836 (r_npadvmod) induced_42\VBN\1627355 (r_amod) anemia_43\NN\14189204
C034753_D007970 NONE benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204 (l_conj) leukopenia_29\NN\14189204
C034753_D007970 NONE bau_16\NNP\0 (r_appos) benzylacyclouridine_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) ability_12\NN\4723816 (r_nsubjpass) assessed_31\VBN\670261 (l_nsubjpass) anemia_27\NN\14189204 (l_conj) leukopenia_29\NN\14189204
C034753_D007970 NONE bau_31\NNP\0 (r_conj) azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_prep) in_0\IN\13603305 (l_pobj) mice_1\NNS\2329401 (l_acl) rendered_2\VBD\120316 (l_conj) leukopenic_5\JJ\0
C034753_D007970 NONE bau_31\NNP\0 (r_conj) azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_dobj) anemia_43\NN\14189204 (l_conj) leukopenia_45\NN\14189204
D015215_-1 NONE azt_10\NNP\3834836 (r_pobj) of_9\IN\0 (r_prep) administration_8\NN\1133281 (r_pobj) by_6\IN\0 (r_prep) leukopenic_5\JJ\0 (r_conj) rendered_2\VBD\120316 (r_acl) mice_1\NNS\2329401 (r_pobj) in_0\IN\13603305 (r_prep) reversed_39\VBD\109660 (l_conj) increased_67\VBN\169651 (l_conj) improved_74\VBN\126264 (l_dobj) megaloblastosis_75\NN\0
D015215_-1 NONE azt_28\NNP\3834836 (r_pobj) of_27\IN\0 (r_prep) administration_26\NN\1133281 (r_nsubj) reversed_39\VBD\109660 (l_conj) increased_67\VBN\169651 (l_conj) improved_74\VBN\126264 (l_dobj) megaloblastosis_75\NN\0
D015215_-1 NONE azt_40\NNP\3834836 (r_npadvmod) induced_42\VBN\1627355 (r_amod) anemia_43\NN\14189204 (r_dobj) reversed_39\VBD\109660 (l_conj) increased_67\VBN\169651 (l_conj) improved_74\VBN\126264 (l_dobj) megaloblastosis_75\NN\0
D015215_D007153 NONE azidothymidine_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) suppression_6\NN\13489037 (r_dobj) reverses_1\VBZ\13854649 (l_prep) without_7\IN\0 (l_pobj) impairment_8\NN\7296428 (l_prep) of_9\IN\0 (l_pobj) activity_15\NN\30358 (l_compound) virus_14\NN\9312843 (l_compound) immunodeficiency_13\NN\13973990
D015215_D007153 NONE azidothymidine_17\NN\0 (r_advmod) vitro_15\FW\0 (r_amod) in_14\IN\13603305 (r_prep) reduce_12\VB\441445 (l_dobj) inhibition_20\NN\1068773 (l_prep) without_28\IN\0 (l_pobj) impairment_29\NN\7296428 (l_prep) of_30\IN\0 (l_pobj) virus_34\NN\9312843 (l_compound) immunodeficiency_33\NN\13973990
D015215_D007153 NONE azt)-induced_19\JJ\0 (r_compound) inhibition_20\NN\1068773 (l_prep) without_28\IN\0 (l_pobj) impairment_29\NN\7296428 (l_prep) of_30\IN\0 (l_pobj) virus_34\NN\9312843 (l_compound) immunodeficiency_33\NN\13973990
20103708
D010100_D003928 NONE oxygen_20\NN\14622893 (r_compound) species_21\NNS\7992450 (r_pobj) of_18\IN\0 (r_prep) production_17\NN\30358 (r_pobj) by_15\IN\0 (r_agent) accompanied_14\VBN\0 (r_relcl) causes_7\NNS\7323922 (r_pobj) of_4\IN\0 (r_prep) one_3\CD\13741022 (r_attr) is_2\VBZ\0 (l_nsubj) nephropathy_1\NN\14573196
D013311_D058186 NONE streptozotocin_13\RB\0 (r_npadvmod) induced_15\VBN\1627355 (r_amod) damage_17\NN\7296428
D010100_D051437 NONE oxygen_20\NN\14622893 (r_compound) species_21\NNS\7992450 (r_pobj) of_18\IN\0 (r_prep) production_17\NN\30358 (r_pobj) by_15\IN\0 (r_agent) accompanied_14\VBN\0 (r_relcl) causes_7\NNS\7323922 (l_prep) of_8\IN\0 (l_pobj) failure_10\NN\66216
D013311_D003928 CID streptozotocin_6\JJ\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) nephropathy_10\NN\14573196
D013311_D003928 CID streptozotocin_22\RB\0 (r_npadvmod) induced_24\VBN\1627355 (r_amod) model_27\NN\5888929 (l_ccomp) explore_2\VBP\789138 (l_dobj) role_5\NN\719494 (l_prep) against_8\IN\0 (l_pobj) nephropathy_10\NN\14573196
D013311_D003928 CID streptozotocin_22\RB\0 (r_npadvmod) induced_24\VBN\1627355 (r_amod) model_27\NN\5888929 (l_ccomp) explore_2\VBP\789138 (l_dobj) role_5\NN\719494 (l_prep) against_8\IN\0 (l_pobj) nephropathy_10\NN\14573196 (l_acl) using_11\VBG\418025 (l_prep) from_16\IN\0 (l_pobj) patients_19\NNS\9898892 (l_compound) nephropathy_18\NN\14573196
D013311_D003928 CID streptozotocin_22\RB\0 (r_npadvmod) induced_24\VBN\1627355 (r_amod) model_27\NN\5888929 (l_compound) nephropathy_26\NN\14573196
18997632
D002110_D018879 CID caffeine_1\NN\14712692 (r_nsubjpass) used_4\VBN\0 (l_conj) tolerated_18\VBN\802318 (l_prep) from_20\IN\0 (l_pobj) reports_22\NNS\6470073 (l_prep) of_23\IN\0 (l_pobj) ectopy_27\NN\0
D002110_D006331 NONE caffeine_25\NN\14712692 (r_compound) administration_26\NN\1133281 (r_pobj) after_24\IN\0 (r_prep) developed_14\VBD\1753788 (r_relcl) disease_10\NN\14061805
D002110_D012640 CID caffeine_1\NN\14712692 (r_nsubjpass) used_4\VBN\0 (l_xcomp) improve_6\VB\126264 (l_dobj) duration_8\NN\15113229 (l_compound) seizure_7\NN\14081375
D002110_D017180 CID caffeine_7\NN\14712692 (r_compound) pretreatment_8\NN\0 (r_pobj) to_6\IN\0 (r_prep) related_5\VBN\628491 (r_acl) tachycardia_4\NN\14110674
D002110_D017180 CID caffeine_25\NN\14712692 (r_compound) administration_26\NN\1133281 (r_pobj) after_24\IN\0 (r_prep) developed_14\VBD\1753788 (l_dobj) bigeminy_16\JJ\0 (l_conj) runs_20\NNS\186634 (l_prep) of_21\IN\0 (l_pobj) tachycardia_23\NN\14110674
D002110_D001145 NONE caffeine_25\NN\14712692 (r_compound) administration_26\NN\1133281 (r_pobj) after_24\IN\0 (r_prep) developed_14\VBD\1753788 (r_relcl) disease_10\NN\14061805 (l_conj) arrhythmia_12\NN\14103288
D002110_D001145 NONE caffeine_2\NN\14712692 (r_nsubjpass) tolerated_6\VBN\802318 (r_advcl) be_11\VB\14625458 (l_acomp) aware_12\JJ\0 (l_prep) of_13\IN\0 (l_pobj) potential_15\NN\14481929 (l_prep) for_16\IN\0 (l_pobj) arrhythmias_21\NNS\14103288
14633084
D015080_D006470 NONE mesna_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) use_0\NN\407535 (l_prep) for_5\IN\0 (l_pobj) prevention_7\NN\1073995 (l_prep) of_8\IN\0 (l_pobj) cystitis_13\NN\14566129
D015080_D006470 NONE mesna_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) use_9\NN\407535 (l_prep) for_16\IN\0 (l_pobj) prevention_18\NN\1073995 (l_prep) of_19\IN\0 (l_pobj) hc_23\NN\0
D015080_D006470 NONE mesna_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) combination_2\NN\7951464 (r_pobj) in_1\IN\13603305 (r_prep) dexamethasone_0\NN\2721538 (r_nsubj) was_5\VBD\0 (l_acomp) efficient_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) blocking_8\VBG\562280 (l_dobj) hc_12\NN\0
D015080_D006470 NONE mesna_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
D015080_D006470 NONE mesna_16\JJ\0 (r_amod) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) all_13\DT\0 (r_conj) saline_11\NN\14849367 (r_pobj) with_10\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
D015080_D003556 NONE mesna_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) use_0\NN\407535 (l_prep) for_5\IN\0 (l_pobj) prevention_7\NN\1073995 (l_prep) of_8\IN\0 (l_pobj) cystitis_13\NN\14566129
D015080_D003556 NONE mesna_15\NN\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) use_9\NN\407535 (l_prep) for_16\IN\0 (l_pobj) prevention_18\NN\1073995 (l_prep) of_19\IN\0 (l_pobj) hc_23\NN\0
D015080_D003556 NONE mesna_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) combination_2\NN\7951464 (r_pobj) in_1\IN\13603305 (r_prep) dexamethasone_0\NN\2721538 (r_nsubj) was_5\VBD\0 (l_acomp) efficient_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) blocking_8\VBG\562280 (l_dobj) hc_12\NN\0
D015080_D003556 NONE mesna_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
D015080_D003556 NONE mesna_16\JJ\0 (r_amod) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) all_13\DT\0 (r_conj) saline_11\NN\14849367 (r_pobj) with_10\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
D007069_D003556 CID ifosfamide_9\RB\0 (r_advmod) induced_11\VBN\1627355 (r_amod) cystitis_13\NN\14566129
D007069_D003556 CID ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129
D007069_D003556 CID ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129 (l_appos) hc_5\NNP\0
D007069_D003556 CID ifs_18\NNP\0 (r_appos) ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129
D007069_D003556 CID ifs_18\NNP\0 (r_appos) ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129 (l_appos) hc_5\NNP\0
D007069_D003556 CID ifs_20\NNP\0 (r_npadvmod) induced_22\VBN\1627355 (r_amod) hc_23\NN\0
D007069_D003556 CID ifs_9\NNP\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) hc_12\NN\0
D007069_D006470 CID ifosfamide_9\RB\0 (r_advmod) induced_11\VBN\1627355 (r_amod) cystitis_13\NN\14566129
D007069_D006470 CID ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129
D007069_D006470 CID ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129 (l_appos) hc_5\NNP\0
D007069_D006470 CID ifs_18\NNP\0 (r_appos) ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129
D007069_D006470 CID ifs_18\NNP\0 (r_appos) ifosfamide_16\NN\0 (r_pobj) with_15\IN\0 (r_prep) effect_12\NN\34213 (r_attr) is_7\VBZ\0 (l_nsubj) aim_0\VB\5980875 (l_appos) cystitis_3\NN\14566129 (l_appos) hc_5\NNP\0
D007069_D006470 CID ifs_20\NNP\0 (r_npadvmod) induced_22\VBN\1627355 (r_amod) hc_23\NN\0
D007069_D006470 CID ifs_9\NNP\0 (r_npadvmod) induced_11\VBN\1627355 (r_amod) hc_12\NN\0
D003907_D006470 NONE dexamethasone_2\NN\2721538 (r_pobj) of_1\IN\0 (r_prep) use_0\NN\407535 (l_prep) for_5\IN\0 (l_pobj) prevention_7\NN\1073995 (l_prep) of_8\IN\0 (l_pobj) cystitis_13\NN\14566129
D003907_D006470 NONE dexamethasone_11\NN\2721538 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (l_prep) for_16\IN\0 (l_pobj) prevention_18\NN\1073995 (l_prep) of_19\IN\0 (l_pobj) hc_23\NN\0
D003907_D006470 NONE dexamethasone_0\NN\2721538 (r_nsubj) was_5\VBD\0 (l_acomp) efficient_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) blocking_8\VBG\562280 (l_dobj) hc_12\NN\0
D003907_D006470 NONE dexamethasone_19\NN\2721538 (r_pobj) with_18\IN\0 (r_prep) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) all_13\DT\0 (r_conj) saline_11\NN\14849367 (r_pobj) with_10\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
D003907_D003556 NONE dexamethasone_2\NN\2721538 (r_pobj) of_1\IN\0 (r_prep) use_0\NN\407535 (l_prep) for_5\IN\0 (l_pobj) prevention_7\NN\1073995 (l_prep) of_8\IN\0 (l_pobj) cystitis_13\NN\14566129
D003907_D003556 NONE dexamethasone_11\NN\2721538 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (l_prep) for_16\IN\0 (l_pobj) prevention_18\NN\1073995 (l_prep) of_19\IN\0 (l_pobj) hc_23\NN\0
D003907_D003556 NONE dexamethasone_0\NN\2721538 (r_nsubj) was_5\VBD\0 (l_acomp) efficient_6\JJ\0 (l_prep) in_7\IN\13603305 (l_pcomp) blocking_8\VBG\562280 (l_dobj) hc_12\NN\0
D003907_D003556 NONE dexamethasone_19\NN\2721538 (r_pobj) with_18\IN\0 (r_prep) doses_17\NNS\3740161 (r_pobj) of_14\IN\0 (r_prep) all_13\DT\0 (r_conj) saline_11\NN\14849367 (r_pobj) with_10\IN\0 (r_prep) doses_7\NNS\3740161 (r_pobj) of_4\IN\0 (r_prep) replacement_3\NN\196485 (r_nsubj) prevent_22\VB\0 (l_dobj) hc_23\NN\0
19274460
D003907_D009101 NONE dexamethasone_14\NN\2721538 (r_pobj) with_11\IN\0 (r_prep) combination_10\NN\7951464 (r_pobj) in_9\IN\13603305 (r_prep) definition_5\NN\6738281 (l_prep) for_15\IN\0 (l_pobj) induction_17\NN\7450842 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) myeloma_23\NN\14239425
D003907_D009101 NONE dexamethasone_17\NN\2721538 (r_conj) bortezomib_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425
D003907_D009101 NONE dexamethasone_17\NN\2721538 (r_conj) bortezomib_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425 (l_appos) mm_34\NNP\13649268
D003907_D009101 NONE dexamethasone_16\NN\2721538 (r_nsubj) is_17\VBZ\0 (l_attr) treatment_21\NN\654885 (l_prep) for_22\IN\0 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) mm_27\NNP\13649268
C400082_D009101 NONE bortezomib_12\NNS\0 (r_amod) dexamethasone_14\NN\2721538 (r_pobj) with_11\IN\0 (r_prep) combination_10\NN\7951464 (r_pobj) in_9\IN\13603305 (r_prep) definition_5\NN\6738281 (l_prep) for_15\IN\0 (l_pobj) induction_17\NN\7450842 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) myeloma_23\NN\14239425
C400082_D009101 NONE bortezomib_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425
C400082_D009101 NONE bortezomib_15\NNS\0 (r_pobj) with_14\IN\0 (r_prep) combination_13\NN\7951464 (r_pobj) in_12\IN\13603305 (r_prep) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425 (l_appos) mm_34\NNP\13649268
C400082_D009101 NONE bortezomib_4\NNS\0 (r_nsubj) is_17\VBZ\0 (l_attr) treatment_21\NN\654885 (l_prep) for_22\IN\0 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) mm_27\NNP\13649268
D003520_D009101 NONE cyclophosphamide_8\NN\0 (r_pobj) for_6\IN\0 (r_prep) definition_5\NN\6738281 (l_prep) for_15\IN\0 (l_pobj) induction_17\NN\7450842 (l_prep) in_18\IN\13603305 (l_pobj) patients_19\NNS\9898892 (l_prep) with_20\IN\0 (l_pobj) myeloma_23\NN\14239425
D003520_D009101 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) dose_9\NN\3740161 (r_dobj) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425
D003520_D009101 NONE cyclophosphamide_11\NN\0 (r_pobj) of_10\IN\0 (r_prep) dose_9\NN\3740161 (r_dobj) evaluate_6\VB\670261 (l_prep) as_18\IN\14622893 (l_pobj) treatment_20\NN\654885 (l_prep) before_21\IN\0 (l_pobj) transplantation_24\NN\671351 (l_prep) for_25\IN\0 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) myeloma_32\NN\14239425 (l_appos) mm_34\NNP\13649268
D003520_D009101 NONE cyclophosphamide_8\NN\0 (r_pobj) with_7\IN\0 (r_prep) combination_6\NN\7951464 (r_pobj) in_5\IN\13603305 (r_prep) bortezomib_4\NNS\0 (r_nsubj) is_17\VBZ\0 (l_attr) treatment_21\NN\654885 (l_prep) for_22\IN\0 (l_pobj) patients_23\NNS\9898892 (l_prep) with_24\IN\0 (l_pobj) mm_27\NNP\13649268
6769133
D004317_D006333 CID adriamycin_13\NNS\0 (r_compound) dose_14\NN\3740161 (r_pobj) at_9\IN\14622893 (r_prep) developed_5\VBD\1753788 (l_dobj) failure_8\NN\66216
D018943_D009202 NONE anthracycline_10\NN\0 (r_amod) induced_12\VBN\1627355 (r_amod) cardiomyopathy_13\NN\14103288
D004317_D066126 NONE adriamycin_6\NNS\0 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (r_conj) cardiotoxic_0\NNP\0
D018943_D001768 NONE anthracycline_10\NN\0 (r_amod) induced_12\VBN\1627355 (r_amod) cardiomyopathy_13\NN\14103288 (r_pobj) in_8\IN\13603305 (r_prep) found_7\VBN\13279262 (r_acl) those_6\DT\0 (r_dobj) resembled_5\VBD\2657219 (l_nsubj) lesions_4\NNS\14204950
D004317_D015470 CID adriamycin_16\NNS\0 (r_pobj) of_15\IN\0 (r_prep) m2_14\CD\13357178 (r_dobj) receiving_10\VBG\2210855 (r_pcomp) after_9\IN\0 (r_prep) developed_5\VBD\1753788 (l_dobj) leukemia_8\NN\14239918
D004317_D007938 NONE adriamycin_4\NN\0 (r_nsubj) is_5\VBZ\0 (l_conj) be_20\VB\14625458 (l_nsubj) leukemia_18\NN\14239918
3762968
D013835_D014899 NONE pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (r_ccomp) delineate_29\VB\2137132 (r_acl) order_27\NN\7168131 (r_pobj) in_26\IN\13603305 (r_prep) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_relcl) developed_17\VBD\1753788 (l_dobj) encephalopathy_20\NN\14084880
D013835_D014899 NONE tpp_44\NNP\0 (r_appos) pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (r_ccomp) delineate_29\VB\2137132 (r_acl) order_27\NN\7168131 (r_pobj) in_26\IN\13603305 (r_prep) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_relcl) developed_17\VBD\1753788 (l_dobj) encephalopathy_20\NN\14084880
D013835_D014899 NONE tpp_30\NNP\0 (r_pobj) for_29\IN\0 (r_prep) km_28\NNP\13649268 (r_pobj) by_26\IN\0 (r_agent) determined_25\VBN\0 (r_advcl) had_21\VBD\0 (l_nsubj) patient_7\NN\9898892 (l_prep) with_14\IN\0 (l_pobj) history_16\NN\15120823 (l_prep) of_17\IN\0 (l_pobj) encephalopathy_20\NN\14084880
D014042_D020915 NONE tolazamide_24\NN\4353189 (r_pobj) with_23\IN\0 (r_prep) treated_22\VBN\2376958 (r_advcl) developed_17\VBD\1753788 (r_relcl) patient_15\NN\9898892 (r_pobj) of_12\IN\0 (r_prep) fibroblasts_11\NNS\5447757 (r_pobj) from_10\IN\0 (r_prep) studied_1\VBD\0 (l_prep) in_26\IN\13603305 (l_pobj) order_27\NN\7168131 (l_acl) delineate_29\VB\2137132 (l_ccomp) had_34\VBD\0 (l_advcl) reported_50\VBN\831651 (l_prep) in_51\IN\13603305 (l_pobj) syndrome_56\NN\5870365
D014042_D020915 NONE tolazamide_15\NN\4353189 (r_npadvmod) induced_17\VBN\1627355 (r_amod) encephalopathy_20\NN\14084880 (r_pobj) with_14\IN\0 (r_prep) patient_13\NN\9898892 (r_conj) syndrome_10\NN\5870365
D013831_D014899 NONE thiamine_3\NN\15090742 (r_npadvmod) dependent_5\JJ\9627906 (r_amod) enzyme_6\NN\14723628 (r_dobj) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_relcl) developed_17\VBD\1753788 (l_dobj) encephalopathy_20\NN\14084880
D013835_D003920 NONE pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (r_ccomp) delineate_29\VB\2137132 (r_acl) order_27\NN\7168131 (r_pobj) in_26\IN\13603305 (r_prep) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_amod) diabetic_14\JJ\10595647
D013835_D003920 NONE tpp_44\NNP\0 (r_appos) pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (r_ccomp) delineate_29\VB\2137132 (r_acl) order_27\NN\7168131 (r_pobj) in_26\IN\13603305 (r_prep) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_amod) diabetic_14\JJ\10595647
D013835_D003920 NONE tpp_30\NNP\0 (r_pobj) for_29\IN\0 (r_prep) km_28\NNP\13649268 (r_pobj) by_26\IN\0 (r_agent) determined_25\VBN\0 (r_advcl) had_21\VBD\0 (l_nsubj) patient_7\NN\9898892 (l_conj) one_9\CD\13741022 (l_prep) of_10\IN\0 (l_pobj) kindreds_13\NNS\7950920 (l_amod) diabetic_12\JJ\10595647
D013831_D020915 NONE thiamine_3\NN\15090742 (r_npadvmod) dependent_5\JJ\9627906 (r_amod) enzyme_6\NN\14723628 (r_dobj) studied_1\VBD\0 (l_prep) in_26\IN\13603305 (l_pobj) order_27\NN\7168131 (l_acl) delineate_29\VB\2137132 (l_ccomp) had_34\VBD\0 (l_advcl) reported_50\VBN\831651 (l_prep) in_51\IN\13603305 (l_pobj) syndrome_56\NN\5870365
D013835_D020915 NONE pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (l_advcl) reported_50\VBN\831651 (l_prep) in_51\IN\13603305 (l_pobj) syndrome_56\NN\5870365
D013835_D020915 NONE tpp_44\NNP\0 (r_appos) pyrophosphate_42\NN\15010703 (r_pobj) for_40\IN\0 (r_prep) km_39\NNP\13649268 (r_appos) abnormality_36\NN\14034177 (r_dobj) had_34\VBD\0 (l_advcl) reported_50\VBN\831651 (l_prep) in_51\IN\13603305 (l_pobj) syndrome_56\NN\5870365
D014042_D014899 CID tolazamide_3\NN\4353189 (r_npadvmod) induced_5\VBN\1627355 (r_amod) encephalopathy_8\NN\14084880
D014042_D014899 CID tolazamide_24\NN\4353189 (r_pobj) with_23\IN\0 (r_prep) treated_22\VBN\2376958 (r_advcl) developed_17\VBD\1753788 (l_dobj) encephalopathy_20\NN\14084880
D014042_D014899 CID tolazamide_15\NN\4353189 (r_npadvmod) induced_17\VBN\1627355 (r_amod) encephalopathy_20\NN\14084880
D014042_D003920 NONE tolazamide_24\NN\4353189 (r_pobj) with_23\IN\0 (r_prep) treated_22\VBN\2376958 (r_advcl) developed_17\VBD\1753788 (r_relcl) patient_15\NN\9898892 (l_amod) diabetic_14\JJ\10595647
D013831_D003920 NONE thiamine_3\NN\15090742 (r_npadvmod) dependent_5\JJ\9627906 (r_amod) enzyme_6\NN\14723628 (r_dobj) studied_1\VBD\0 (l_prep) from_10\IN\0 (l_pobj) fibroblasts_11\NNS\5447757 (l_prep) of_12\IN\0 (l_pobj) patient_15\NN\9898892 (l_amod) diabetic_14\JJ\10595647
3732088
D000584_D003324 NONE amiloride_30\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) weeks_20\NNS\15113229 (r_pobj) after_18\IN\0 (r_prep) known_14\VBN\0 (l_dobj) disease_17\NN\14061805
D011188_D001145 NONE potassium_2\NN\14625458 (l_conj) arrhythmias_4\NNS\14103288
D011188_D001145 NONE potassium_9\NN\14625458 (r_pobj) in_7\IN\13603305 (r_prep) changes_6\NNS\7283608 (r_nsubj) alter_11\VB\0 (l_dobj) tendency_13\NN\6193203 (l_prep) towards_14\IN\0 (l_pobj) arrhythmias_16\NNS\14103288
D002752_D006973 NONE chlorthalidone_43\NN\3214670 (r_pobj) on_36\IN\0 (r_prep) period_35\NN\13575869 (r_conj) measured_6\VBN\697589 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) hypertension_12\NN\14057371
D011188_D003324 NONE potassium_25\NN\14625458 (r_npadvmod) conserving_27\VBG\2681795 (r_amod) diuretic_28\JJ\3247620 (r_amod) amiloride_30\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) weeks_20\NNS\15113229 (r_pobj) after_18\IN\0 (r_prep) known_14\VBN\0 (l_dobj) disease_17\NN\14061805
D011188_D003324 NONE potassium_38\NN\14625458 (r_npadvmod) losing_40\VBG\0 (r_amod) chlorthalidone_43\NN\3214670 (r_pobj) on_36\IN\0 (r_prep) period_35\NN\13575869 (r_conj) measured_6\VBN\697589 (l_conj) known_14\VBN\0 (l_dobj) disease_17\NN\14061805
D002752_D018879 CID chlorthalidone_6\NN\3214670 (r_compound) phase_7\NN\15113229 (r_nsubjpass) associated_9\VBN\628491 (l_prep) with_10\IN\0 (l_pobj) frequency_13\NN\15286249 (l_prep) of_14\IN\0 (l_pobj) beats_17\NNS\8289449
D011188_D003327 NONE potassium_2\NN\14625458 (r_conj) diuretics_0\NNS\3247620 (l_prep) in_5\IN\13603305 (l_pobj) disease_8\NN\14061805
D000584_D006973 NONE amiloride_30\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) weeks_20\NNS\15113229 (r_pobj) after_18\IN\0 (r_prep) known_14\VBN\0 (r_conj) measured_6\VBN\697589 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) hypertension_12\NN\14057371
D011188_D006973 NONE potassium_2\NN\14625458 (r_conj) diuretics_0\NNS\3247620 (l_prep) in_5\IN\13603305 (l_pobj) disease_8\NN\14061805 (l_amod) hypertensive_6\JJ\10405694
D011188_D006973 NONE potassium_25\NN\14625458 (r_npadvmod) conserving_27\VBG\2681795 (r_amod) diuretic_28\JJ\3247620 (r_amod) amiloride_30\NN\0 (r_pobj) with_23\IN\0 (r_prep) treatment_22\NN\654885 (r_pobj) of_21\IN\0 (r_prep) weeks_20\NNS\15113229 (r_pobj) after_18\IN\0 (r_prep) known_14\VBN\0 (r_conj) measured_6\VBN\697589 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) hypertension_12\NN\14057371
D011188_D006973 NONE potassium_38\NN\14625458 (r_npadvmod) losing_40\VBG\0 (r_amod) chlorthalidone_43\NN\3214670 (r_pobj) on_36\IN\0 (r_prep) period_35\NN\13575869 (r_conj) measured_6\VBN\697589 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) hypertension_12\NN\14057371
D002752_D003324 NONE chlorthalidone_43\NN\3214670 (r_pobj) on_36\IN\0 (r_prep) period_35\NN\13575869 (r_conj) measured_6\VBN\697589 (l_conj) known_14\VBN\0 (l_dobj) disease_17\NN\14061805
D000584_D018879 NONE amiloride_2\NN\0 (r_compound) treatment_3\NN\654885 (r_pobj) to_1\IN\0 (r_prep) compared_0\VBN\644583 (r_prep) associated_9\VBN\628491 (l_prep) with_10\IN\0 (l_pobj) frequency_13\NN\15286249 (l_prep) of_14\IN\0 (l_pobj) beats_17\NNS\8289449
D011188_D017202 NONE potassium_6\NN\14625458 (r_npadvmod) losing_8\VBG\0 (r_amod) therapy_10\NN\657604 (r_nsubj) increase_12\VB\13576355 (l_dobj) excitability_15\NN\5653575 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805
D011188_D017202 NONE potassium_28\NN\14625458 (r_compound) concentrations_29\NNS\4916342 (r_pobj) in_26\IN\13603305 (r_prep) falls_25\VBZ\11692265 (l_advcl) increase_12\VB\13576355 (l_dobj) excitability_15\NN\5653575 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) disease_21\NN\14061805
3137399
D016685_D066126 NONE c._12\NNP\0 (r_pobj) by_10\IN\0 (r_agent) induced_9\VBN\1627355 (r_acl) study_2\NN\635850 (l_prep) on_3\IN\0 (l_pobj) dependency_6\NN\24720 (l_prep) of_7\IN\0 (l_pobj) cardiotoxicity_8\NN\0
D016685_D066126 NONE c_3\NNP\13714184 (r_nsubjpass) suggested_9\VBN\1010118 (l_xcomp) be_11\VB\14625458 (l_acomp) cardiotoxic_12\JJ\0
D016685_D066126 NONE mmc_5\NN\0 (r_appos) c_3\NNP\13714184 (r_nsubjpass) suggested_9\VBN\1010118 (l_xcomp) be_11\VB\14625458 (l_acomp) cardiotoxic_12\JJ\0
D016685_D066126 NONE mmc_16\NN\0 (r_npadvmod) related_18\VBN\628491 (r_amod) cardiotoxicity_19\NN\0
D016685_D006333 CID mmc_11\NNP\0 (r_pobj) after_7\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) failure_6\NN\66216
D004317_D006333 CID doxorubicin_17\NN\2716866 (r_conj) mmc_11\NNP\0 (r_pobj) after_7\IN\0 (r_prep) developed_4\VBD\1753788 (l_dobj) failure_6\NN\66216
D004317_D066126 NONE doxorubicin_21\NN\2716866 (r_dobj) following_20\VBG\8180190 (r_pcomp) given_19\VBN\5892096 (r_conj) combined_16\VBN\2630189 (r_advcl) suggested_9\VBN\1010118 (l_xcomp) be_11\VB\14625458 (l_acomp) cardiotoxic_12\JJ\0
D004317_D066126 NONE doxorubicin_47\NN\2716866 (r_pobj) with_46\IN\0 (r_prep) treated_45\VBN\2376958 (r_acl) patients_38\NNS\9898892 (r_pobj) in_37\IN\13603305 (r_prep) is_20\VBZ\0 (l_nsubj) cardiotoxicity_19\NN\0
761833
D000641_D003128 NONE ammonia_2\NN\14940386 (r_compound) coma_3\NN\5678932
D000641_D003128 NONE ammonia_0\NN\14940386 (r_compound) coma_1\NN\5678932
D000641_D003128 NONE ammonia_18\NN\14940386 (r_compound) coma_19\NN\5678932
D000641_D003128 NONE ammonia_26\NN\14940386 (r_compound) concentrations_27\NNS\4916342 (r_dobj) affect_21\VB\26192 (r_conj) prevent_16\VB\0 (l_dobj) coma_19\NN\5678932
D000641_D003128 NONE ammonia_14\NN\14940386 (r_pobj) on_10\IN\0 (r_prep) dopa_9\NN\14601829 (l_conj) coma_18\NN\5678932
D000641_D003128 NONE ammonia_17\NN\14940386 (r_compound) coma_18\NN\5678932
D000641_D003128 NONE ammonia_8\NN\14940386 (r_pobj) in_4\IN\13603305 (r_prep) reduction_3\NN\351485 (l_conj) prevention_11\NN\1073995 (l_prep) of_12\IN\0 (l_pobj) coma_14\NN\5678932
D000641_D003128 NONE ammonia_13\NN\14940386 (r_compound) coma_14\NN\5678932
D064751_D003128 NONE salt_19\NN\14818238 (r_compound) injection_20\NN\320852 (r_pobj) before_16\IN\0 (r_prep) prevented_3\VBN\0 (l_nsubjpass) coma_1\NN\5678932
D007980_D001927 NONE dopa_18\NNP\14601829 (r_dobj) receiving_15\VBG\2210855 (r_acl) patients_14\NNS\9898892 (l_amod) encephalopathic_13\JJ\0
D000643_D003128 CID nh4cl_17\NN\0 (r_pobj) of_14\IN\0 (r_prep) intraperitonealinjection_13\NN\0 (r_pobj) of_11\IN\0 (r_prep) minutes_10\NNS\6502378 (r_pobj) within_6\IN\0 (r_prep) rats_5\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) produced_3\VBN\1617192 (l_nsubjpass) coma_1\NN\5678932
D007980_D003128 NONE dopa_9\NNP\14601829 (r_pobj) by_6\IN\0 (r_prep) rats_5\NNS\2329401 (r_pobj) in_4\IN\13603305 (r_prep) coma_3\NN\5678932
D007980_D003128 NONE dopa_9\NN\14601829 (r_pobj) with_4\IN\0 (r_prep) prevented_3\VBN\0 (l_nsubjpass) coma_1\NN\5678932
D007980_D003128 NONE dopa_9\NN\14601829 (l_conj) coma_18\NN\5678932
D007980_D003128 NONE dopa_18\NNP\14601829 (r_pobj) after_15\IN\0 (r_prep) prevention_11\NN\1073995 (l_prep) of_12\IN\0 (l_pobj) coma_14\NN\5678932
D004298_D003128 NONE dopamine_3\NN\14807737 (r_pobj) of_2\IN\0 (r_prep) infusion_1\NN\14589223 (r_nsubj) sufficient_4\JJ\0 (l_conj) prevent_16\VB\0 (l_dobj) coma_19\NN\5678932
D004298_D003128 NONE dopamine_9\NN\14807737 (r_dobj) raise_6\VB\5108947 (r_xcomp) sufficient_4\JJ\0 (l_conj) prevent_16\VB\0 (l_dobj) coma_19\NN\5678932
D004298_D003128 NONE dopamine_29\NN\14807737 (r_pobj) of_28\IN\0 (r_prep) effect_27\NN\34213 (r_pobj) by_24\IN\0 (r_agent) accounted_22\VBN\2604760 (l_nsubjpass) reduction_3\NN\351485 (l_conj) prevention_11\NN\1073995 (l_prep) of_12\IN\0 (l_pobj) coma_14\NN\5678932
8278214
D009020_D006930 CID morphine_11\NN\2707683 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_acl) patients_6\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) myoclonus_2\NN\14360459 (r_conj) hyperalgesia_0\NNP\0
D009020_D006930 CID morphine_16\NN\2707683 (r_pobj) of_14\IN\0 (r_prep) doses_13\NNS\3740161 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (l_advcl) developed_17\VBN\1753788 (l_dobj) hyperalgesia_18\NN\0
D009020_D006930 CID morphine_16\NN\2707683 (r_pobj) of_15\IN\0 (r_prep) doses_14\NNS\3740161 (r_conj) myoclonus_11\NN\14360459 (l_nmod) hyperalgesia_9\NN\0
D009020_D006930 CID morphine_27\NN\2707683 (r_nsubj) plays_33\VBZ\7007684 (r_ccomp) indicates_25\VBZ\952524 (l_advcl) are_17\VBP\13600404 (l_nsubj) descriptions_4\NNS\6722453 (l_prep) of_5\IN\0 (l_pobj) relationship_7\NN\31921 (l_prep) between_8\IN\0 (l_pobj) myoclonus_11\NN\14360459 (l_nmod) hyperalgesia_9\NN\0
D009020_D009369 NONE morphine_11\NN\2707683 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_acl) patients_6\NNS\9898892 (l_compound) cancer_5\NN\14239425
D009020_D009369 NONE morphine_16\NN\2707683 (r_pobj) of_14\IN\0 (r_prep) doses_13\NNS\3740161 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (l_nsubj) patients_2\NNS\9898892 (l_compound) cancer_1\NN\14239425
D009020_D009207 CID morphine_11\NN\2707683 (r_pobj) with_8\IN\0 (r_prep) treated_7\VBN\2376958 (r_acl) patients_6\NNS\9898892 (r_pobj) in_3\IN\13603305 (r_prep) myoclonus_2\NN\14360459
D009020_D009207 CID morphine_16\NN\2707683 (r_pobj) of_15\IN\0 (r_prep) doses_14\NNS\3740161 (r_conj) myoclonus_11\NN\14360459
D009020_D009207 CID morphine_27\NN\2707683 (r_nsubj) plays_33\VBZ\7007684 (r_ccomp) indicates_25\VBZ\952524 (l_advcl) are_17\VBP\13600404 (l_nsubj) descriptions_4\NNS\6722453 (l_prep) of_5\IN\0 (l_pobj) relationship_7\NN\31921 (l_prep) between_8\IN\0 (l_pobj) myoclonus_11\NN\14360459
10728962
D014667_D006333 NONE vasopressin_0\NN\5407119 (l_prep) in_1\IN\13603305 (l_pobj) treatment_3\NN\654885 (l_prep) of_4\IN\0 (l_pobj) hypotension_8\NN\14057371 (l_prep) in_9\IN\13603305 (l_pobj) failure_12\NN\66216
D014667_D006333 NONE vasopressin_16\NN\5407119 (r_pobj) of_15\IN\0 (r_prep) doses_14\NNS\3740161 (r_nsubj) restored_17\VBD\1631072 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) failure_5\NN\66216
D020105_D006333 NONE milrinone_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hypotension_8\NN\14057371 (l_prep) in_9\IN\13603305 (l_pobj) failure_12\NN\66216
D020105_D006333 NONE milrinone_7\NN\0 (l_prep) in_8\IN\13603305 (l_pobj) treatment_10\NN\654885 (l_prep) of_11\IN\0 (l_pobj) failure_14\NN\66216
D020105_D006333 NONE milrinone_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_pobj) after_8\IN\0 (r_prep) hypotension_7\NN\14057371 (r_pobj) with_6\IN\0 (r_prep) failure_5\NN\66216
D020105_D006333 NONE milrinone_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (r_dobj) inhibiting_21\VBG\2510337 (r_pcomp) without_20\IN\0 (r_prep) restored_17\VBD\1631072 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) failure_5\NN\66216
D020105_D007022 CID milrinone_5\NN\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) hypotension_8\NN\14057371
D020105_D007022 CID milrinone_7\NN\0 (r_pobj) as_6\IN\14622893 (r_prep) inhibitors_4\NNS\20090 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) restricted_17\VBN\235368 (l_advcl) cause_20\VBP\7323922 (l_dobj) vasodilation_21\NN\365995 (l_conj) hypotension_23\NN\14057371
D020105_D007022 CID milrinone_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) treatment_9\NN\654885 (r_pobj) after_8\IN\0 (r_prep) hypotension_7\NN\14057371
D020105_D007022 CID milrinone_26\NN\0 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (r_dobj) inhibiting_21\VBG\2510337 (r_pcomp) without_20\IN\0 (r_prep) restored_17\VBD\1631072 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) failure_5\NN\66216 (l_prep) with_6\IN\0 (l_pobj) hypotension_7\NN\14057371
D014667_D007022 CID vasopressin_0\NN\5407119 (l_prep) in_1\IN\13603305 (l_pobj) treatment_3\NN\654885 (l_prep) of_4\IN\0 (l_pobj) hypotension_8\NN\14057371
D014667_D007022 CID vasopressin_16\NN\5407119 (r_pobj) of_15\IN\0 (r_prep) doses_14\NNS\3740161 (r_nsubj) restored_17\VBD\1631072 (l_prep) in_0\IN\13603305 (l_pobj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) failure_5\NN\66216 (l_prep) with_6\IN\0 (l_pobj) hypotension_7\NN\14057371
343678
D006514_D006509 NONE antigen_43\NN\20090 (r_nmod) donors_46\NNS\9608709 (r_pobj) to_39\IN\0 (r_prep) exposure_38\NN\5042871 (r_pobj) after_34\IN\0 (r_prep) preventing_30\VBG\0 (r_pcomp) in_29\IN\13603305 (r_prep) efficacies_28\NNS\5199286 (r_dobj) assess_25\VB\5220461 (r_advcl) examined_15\VBN\0 (l_nsubjpass) globulin_3\NN\14736972 (l_compound) b_1\NN\1355326
D006514_D006509 NONE antigen_43\NN\20090 (r_nmod) donors_46\NNS\9608709 (r_pobj) to_39\IN\0 (r_prep) exposure_38\NN\5042871 (r_pobj) after_34\IN\0 (r_prep) preventing_30\VBG\0 (l_dobj) hepatitis_33\NN\14127211
D006514_D006509 NONE hbsag)-positive_45\JJ\0 (r_compound) donors_46\NNS\9608709 (r_pobj) to_39\IN\0 (r_prep) exposure_38\NN\5042871 (r_pobj) after_34\IN\0 (r_prep) preventing_30\VBG\0 (r_pcomp) in_29\IN\13603305 (r_prep) efficacies_28\NNS\5199286 (r_dobj) assess_25\VB\5220461 (r_advcl) examined_15\VBN\0 (l_nsubjpass) globulin_3\NN\14736972 (l_compound) b_1\NN\1355326
D006514_D006509 NONE hbsag)-positive_45\JJ\0 (r_compound) donors_46\NNS\9608709 (r_pobj) to_39\IN\0 (r_prep) exposure_38\NN\5042871 (r_pobj) after_34\IN\0 (r_prep) preventing_30\VBG\0 (l_dobj) hepatitis_33\NN\14127211
430165
D010672_D064420 NONE diphenylhydantoin_7\JJ\3550533 (r_compound) toxicity_8\NN\13576101
D010672_D064420 NONE dph_13\NNP\6702458 (r_compound) toxicity_14\NN\13576101
D010672_D002526 CID diphenylhydantoin_6\NN\3550533 (r_nmod) overdose_10\NN\84738 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (r_pobj) among_0\IN\0 (r_prep) are_18\VBP\13600404 (l_nsubj) those_19\DT\0 (l_prep) of_20\IN\0 (l_pobj) dysfunction_22\NN\14204950
D010672_D002526 CID dph_8\NNP\6702458 (r_nmod) overdose_10\NN\84738 (r_pobj) of_5\IN\0 (r_prep) effects_4\NNS\13245626 (r_pobj) among_0\IN\0 (r_prep) are_18\VBP\13600404 (l_nsubj) those_19\DT\0 (l_prep) of_20\IN\0 (l_pobj) dysfunction_22\NN\14204950
D010672_D062787 CID diphenylhydantoin_6\NN\3550533 (r_nmod) overdose_10\NN\84738
D010672_D062787 CID dph_8\NNP\6702458 (r_nmod) overdose_10\NN\84738
D010672_D062787 CID dph_10\NNP\6702458 (r_compound) overdose_11\NN\84738
D010672_D010291 CID diphenylhydantoin_7\JJ\3550533 (r_compound) toxicity_8\NN\13576101 (r_pobj) of_6\IN\0 (r_prep) manifestation_5\NN\7321772 (r_appos) hemiparesis_1\NN\0
D010672_D010291 CID dph_10\NNP\6702458 (r_compound) overdose_11\NN\84738 (r_pobj) due_8\IN\5174653 (r_prep) suffered_5\VBD\2110220 (l_dobj) hemiparesis_7\NN\0
D010672_D001927 NONE dph_13\NNP\6702458 (r_compound) toxicity_14\NN\13576101 (r_dobj) manifest_12\VB\6479665 (r_xcomp) liable_10\JJ\0 (r_acomp) are_9\VBP\13600404 (l_nsubj) patients_4\NNS\9898892 (l_prep) with_5\IN\0 (l_pobj) damage_8\NN\7296428
1628552
D002738_D006327 NONE chloroquine_0\NNP\2721948 (r_nsubj) related_1\VBD\628491 (l_dobj) block_4\NN\21939
D002738_D006327 NONE chloroquine_5\NN\2721948 (r_amod) retinopathy_6\NN\14252864 (r_pobj) of_4\IN\0 (r_prep) features_3\NNS\5849040 (r_dobj) revealed_2\VBD\2137132 (r_ccomp) revealed_10\VBD\2137132 (l_dobj) features_11\NNS\5849040 (l_conj) block_19\NN\21939
D002738_D006327 NONE chloroquine_15\NN\2721948 (r_amod) discontinuation_16\NN\209943 (r_dobj) following_14\VBG\8180190 (r_prep) resolved_12\VBD\352826 (r_conj) treated_4\VBN\2376958 (l_nsubjpass) block_2\NN\21939
D002738_D015354 NONE chloroquine_9\NN\2721948 (r_amod) ingestion_10\NN\13440063 (r_pobj) of_7\IN\0 (r_prep) history_6\NN\15120823 (r_pobj) with_5\IN\0 (r_prep) woman_4\NN\9605289 (r_nsubj) presented_11\VBN\2137132 (l_prep) with_12\IN\0 (l_pobj) deterioration_14\NN\14560612 (l_prep) of_15\IN\0 (l_pobj) vision_16\NN\5767733
D002738_D013575 CID chloroquine_9\NN\2721948 (r_amod) ingestion_10\NN\13440063 (r_pobj) of_7\IN\0 (r_prep) history_6\NN\15120823 (r_pobj) with_5\IN\0 (r_prep) woman_4\NN\9605289 (r_nsubj) presented_11\VBN\2137132 (l_prep) with_12\IN\0 (l_pobj) deterioration_14\NN\14560612 (l_conj) fatiguability_19\NN\0 (l_conj) dyspnoea_21\NN\14299637 (l_conj) dizziness_23\NN\14299637 (l_acl) progressing_24\VBG\252019 (l_prep) to_25\IN\0 (l_pobj) attacks_27\NNS\955060
D002738_D004417 CID chloroquine_9\NN\2721948 (r_amod) ingestion_10\NN\13440063 (r_pobj) of_7\IN\0 (r_prep) history_6\NN\15120823 (r_pobj) with_5\IN\0 (r_prep) woman_4\NN\9605289 (r_nsubj) presented_11\VBN\2137132 (l_prep) with_12\IN\0 (l_pobj) deterioration_14\NN\14560612 (l_conj) fatiguability_19\NN\0 (l_conj) dyspnoea_21\NN\14299637
D002738_D004244 CID chloroquine_9\NN\2721948 (r_amod) ingestion_10\NN\13440063 (r_pobj) of_7\IN\0 (r_prep) history_6\NN\15120823 (r_pobj) with_5\IN\0 (r_prep) woman_4\NN\9605289 (r_nsubj) presented_11\VBN\2137132 (l_prep) with_12\IN\0 (l_pobj) deterioration_14\NN\14560612 (l_conj) fatiguability_19\NN\0 (l_conj) dyspnoea_21\NN\14299637 (l_conj) dizziness_23\NN\14299637
D002738_D005221 CID chloroquine_9\NN\2721948 (r_amod) ingestion_10\NN\13440063 (r_pobj) of_7\IN\0 (r_prep) history_6\NN\15120823 (r_pobj) with_5\IN\0 (r_prep) woman_4\NN\9605289 (r_nsubj) presented_11\VBN\2137132 (l_prep) with_12\IN\0 (l_pobj) deterioration_14\NN\14560612 (l_conj) fatiguability_19\NN\0
D002738_D001766 CID chloroquine_0\NNP\2721948 (r_nsubj) related_1\VBD\628491 (l_dobj) block_4\NN\21939 (l_prep) with_5\IN\0 (l_pobj) blindness_6\NN\14552802
D002738_D006333 CID chloroquine_5\NN\2721948 (r_amod) retinopathy_6\NN\14252864 (r_pobj) of_4\IN\0 (r_prep) features_3\NNS\5849040 (r_dobj) revealed_2\VBD\2137132 (r_ccomp) revealed_10\VBD\2137132 (l_dobj) features_11\NNS\5849040 (l_prep) of_12\IN\0 (l_pobj) failure_14\NN\66216
D002738_D006333 CID chloroquine_15\NN\2721948 (r_amod) discontinuation_16\NN\209943 (r_dobj) following_14\VBG\8180190 (r_prep) resolved_12\VBD\352826 (l_nsubj) failure_11\NN\66216
D002738_D002037 CID chloroquine_5\NN\2721948 (r_amod) retinopathy_6\NN\14252864 (r_pobj) of_4\IN\0 (r_prep) features_3\NNS\5849040 (r_dobj) revealed_2\VBD\2137132 (r_ccomp) revealed_10\VBD\2137132 (l_dobj) features_11\NNS\5849040 (l_conj) block_19\NN\21939 (l_prep) with_20\IN\0 (l_pobj) pattern_25\NN\5726345 (l_compound) block_24\NN\21939
D002738_D012164 CID chloroquine_5\NN\2721948 (r_amod) retinopathy_6\NN\14252864
1445986
D015313_D000743 CID cefotetan_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) anemia_5\NN\14189204
D010406_D000743 NONE penicillins_17\NNS\2716866 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) in_14\IN\13603305 (r_prep) described_12\VBN\1001294 (l_nsubjpass) anemia_2\NN\14189204
D002511_D000743 NONE cephalosporins_22\NNS\2716866 (r_conj) penicillins_17\NNS\2716866 (r_dobj) receiving_16\VBG\2210855 (r_acl) patients_15\NNS\9898892 (r_pobj) in_14\IN\13603305 (r_prep) described_12\VBN\1001294 (l_nsubjpass) anemia_2\NN\14189204
D015313_D000740 NONE cefotetan_10\NN\0 (r_dobj) receiving_8\VBG\2210855 (r_advcl) developed_5\VBD\1753788 (l_dobj) anemia_6\NN\14189204
20042557
D015742_D011183 CID propofol_4\NN\0 (r_amod) sedation_5\NN\14034177 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubj) decreased_6\VBD\169651 (l_dobj) prevalence_8\NN\4764412 (l_prep) of_9\IN\0 (l_pobj) delirium_11\NN\14391660
D015742_D003704 NONE propofol_39\NN\0 (r_amod) sedation_40\NN\14034177 (r_pobj) with_38\IN\0 (r_prep) anesthesia_37\NN\14034177 (r_pobj) under_35\IN\0 (r_prep) repair_34\NN\248977 (r_dobj) underwent_31\VBD\109660 (r_relcl) delirium_26\NN\14391660 (l_conj) dementia_29\NN\14395018
D015742_D006620 NONE propofol_39\NN\0 (r_amod) sedation_40\NN\14034177 (r_pobj) with_38\IN\0 (r_prep) anesthesia_37\NN\14034177 (r_pobj) under_35\IN\0 (r_prep) repair_34\NN\248977 (l_compound) fracture_33\NN\14285662
D015742_D003693 CID propofol_39\NN\0 (r_amod) sedation_40\NN\14034177 (r_pobj) with_38\IN\0 (r_prep) anesthesia_37\NN\14034177 (r_pobj) under_35\IN\0 (r_prep) repair_34\NN\248977 (r_dobj) underwent_31\VBD\109660 (r_relcl) delirium_26\NN\14391660
D015742_D003693 CID propofol_4\NN\0 (r_amod) sedation_5\NN\14034177 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubj) decreased_6\VBD\169651 (l_dobj) prevalence_8\NN\4764412 (l_prep) of_9\IN\0 (l_pobj) delirium_11\NN\14391660
10840460
D009020_D001523 NONE morphine_0\NNP\2707683 (r_nsubj) reversed_4\VBD\109660 (l_dobj) disorders_7\NNS\14034177
D009020_D004487 NONE morphine_6\NN\2707683 (r_pobj) of_5\IN\0 (r_prep) administration_4\NN\1133281 (l_appos) modifications_9\NNS\191142 (l_prep) as_16\IN\14622893 (l_pobj) edema_21\NN\14315192
D003520_D059265 NONE cyclophosphamide_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cystitis_3\NN\14566129 (l_appos) approach_12\NN\940842 (l_prep) to_13\IN\0 (l_pobj) model_16\NN\5888929 (l_prep) of_17\IN\0 (l_pobj) pain_19\NN\14299637
D003520_D059265 NONE cp_10\NNP\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) cystitis_13\NN\14566129 (r_pobj) of_9\IN\0 (r_prep) model_8\NN\5888929 (r_nsubj) be_15\VB\14625458 (l_attr) model_20\NN\5888929 (l_prep) of_21\IN\0 (l_pobj) pain_24\NN\14299637
D003520_D010146 CID cp_10\NNP\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) cystitis_13\NN\14566129 (r_pobj) of_9\IN\0 (r_prep) model_8\NN\5888929 (r_nsubj) be_15\VB\14625458 (l_advcl) allowing_26\VBG\0 (l_dobj) understanding_29\NN\5804793 (l_prep) of_30\IN\0 (l_pobj) syndromes_33\NNS\5870365
D000171_D003556 NONE acrolein_22\NN\14584765 (r_pobj) through_17\IN\0 (r_prep) produce_10\VB\7555863 (r_xcomp) known_8\VBN\0 (r_acl) agent_7\NN\7347 (r_appos) cyclophosphamide_0\NNP\0 (r_nsubjpass) used_25\VBN\0 (l_xcomp) induce_27\VB\1627355 (l_dobj) cystitis_28\NN\14566129
D003520_D003556 CID cyclophosphamide_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) cystitis_3\NN\14566129
D003520_D003556 CID cyclophosphamide_0\NNP\0 (r_nsubjpass) used_25\VBN\0 (l_xcomp) induce_27\VB\1627355 (l_dobj) cystitis_28\NN\14566129
D003520_D003556 CID cp_2\NNP\0 (r_appos) cyclophosphamide_0\NNP\0 (r_nsubjpass) used_25\VBN\0 (l_xcomp) induce_27\VB\1627355 (l_dobj) cystitis_28\NN\14566129
D003520_D003556 CID cp_10\NNP\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) cystitis_13\NN\14566129
11860278
D004298_D004827 NONE dopamine_0\NNP\14807737 (r_nsubj) plays_12\VBZ\7007684 (l_prep) in_16\IN\13603305 (l_pobj) control_18\NN\5190804 (l_prep) of_19\IN\0 (l_pobj) seizures_21\NNS\14081375
D004298_D004827 NONE da_2\NNP\10484858 (r_appos) dopamine_0\NNP\14807737 (r_nsubj) plays_12\VBZ\7007684 (l_prep) in_16\IN\13603305 (l_pobj) control_18\NN\5190804 (l_prep) of_19\IN\0 (l_pobj) seizures_21\NNS\14081375
D004298_D004827 NONE da_11\NNP\10484858 (r_compound) receptors_12\NNS\5225602 (r_pobj) of_10\IN\0 (r_prep) role_9\NN\719494 (l_prep) in_13\IN\13603305 (l_pobj) occurrence_15\NN\29378 (l_prep) of_16\IN\0 (l_pobj) death_22\NN\7296428 (l_amod) induced_19\VBN\1627355 (l_npadvmod) epilepsy_17\NN\14085708
D000109_D012640 NONE acetylcholine_16\NN\14807558 (r_conj) glutamate_14\NN\15010703 (r_pobj) by_12\IN\0 (r_agent) induced_11\VBN\1627355 (r_acl) seizures_10\NNS\14081375
D010862_D020258 NONE pilocarpine_18\NN\14712692 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) mice_12\NNS\2329401 (r_pobj) in_9\IN\13603305 (r_prep) seizures_6\NNS\14081375 (l_conj) neurotoxicity_8\NN\0
D010862_D012640 CID pilocarpine_18\NN\14712692 (r_pobj) with_14\IN\0 (r_prep) treated_13\VBN\2376958 (r_acl) mice_12\NNS\2329401 (r_pobj) in_9\IN\13603305 (r_prep) seizures_6\NNS\14081375
D010862_D012640 CID pilocarpine_2\NN\14712692 (r_npadvmod) induced_4\VBN\1627355 (r_amod) seizures_5\NNS\14081375
D018698_D012640 NONE glutamate_14\NN\15010703 (r_pobj) by_12\IN\0 (r_agent) induced_11\VBN\1627355 (r_acl) seizures_10\NNS\14081375
D007608_D012640 CID ka_23\NNP\0 (r_pobj) to_22\IN\0 (r_prep) comparison_21\NN\635850 (r_pobj) in_20\IN\13603305 (r_prep) death_12\NN\7296428 (r_pobj) in_7\IN\13603305 (r_prep) result_6\VBP\34213 (l_nsubj) seizures_5\NNS\14081375
11302406
D015725_D017180 NONE fluconazole_4\NN\0 (r_nsubjpass) discontinued_6\VBN\0 (r_advcl) resolved_2\VBD\352826 (r_ccomp) continued_12\VBD\2367363 (l_conj) tachycardia_21\NN\14110674
D015725_D017180 NONE fluconazole_4\NN\0 (r_nsubjpass) discontinued_6\VBN\0 (r_advcl) resolved_2\VBD\352826 (r_ccomp) continued_12\VBD\2367363 (l_conj) tachycardia_21\NN\14110674 (l_appos) nsvt_23\NNP\0
D015725_D017180 NONE fluconazole_22\NN\0 (r_dobj) suggests_21\VBZ\1010118 (l_csubj) followed_9\VBN\1835496 (l_nsubj) disappearance_2\NN\42757 (l_prep) of_3\IN\0 (l_pobj) nsvt_4\NNP\0
D011188_D003866 NONE potassium_10\NN\14625458 (r_compound) currents_11\NNS\11449002 (r_dobj) activating_7\VBG\407535 (r_pcomp) of_5\IN\0 (r_prep) depression_4\NN\14373582
D015725_D016171 CID fluconazole_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) torsade_3\NN\0 (r_nmod) pointes_5\FW\831651
D015725_D016171 CID fluconazole_5\NN\0 (r_advmod) associated_7\VBN\628491 (r_amod) pointes_10\FW\831651
D015725_D016171 CID fluconazole_5\NN\0 (r_advmod) associated_7\VBN\628491 (r_amod) pointes_10\FW\831651 (l_appos) tdp_12\NNP\0
D015725_D016171 CID fluconazole_5\NN\0 (r_advmod) associated_7\VBN\628491 (r_amod) pointes_10\FW\831651 (r_pobj) of_4\IN\0 (r_prep) case_3\NN\7283608 (r_dobj) present_1\VB\28270 (l_conj) discuss_15\VB\7466557 (l_dobj) role_18\NN\719494 (l_prep) in_19\IN\13603305 (l_pcomp) causing_20\VBG\30358 (l_dobj) tdp_21\NNP\0
D015725_D016171 CID fluconazole_16\NN\0 (r_poss) role_18\NN\719494 (r_dobj) discuss_15\VB\7466557 (r_conj) present_1\VB\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) pointes_10\FW\831651
D015725_D016171 CID fluconazole_16\NN\0 (r_poss) role_18\NN\719494 (r_dobj) discuss_15\VB\7466557 (r_conj) present_1\VB\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) pointes_10\FW\831651 (l_appos) tdp_12\NNP\0
D015725_D016171 CID fluconazole_16\NN\0 (r_poss) role_18\NN\719494 (l_prep) in_19\IN\13603305 (l_pcomp) causing_20\VBG\30358 (l_dobj) tdp_21\NNP\0
D015725_D016171 CID fluconazole_21\NN\0 (r_dobj) commencing_19\VBG\0 (r_pcomp) after_18\IN\0 (r_prep) glabrata_8\NNS\0 (l_xcomp) isolated_9\VBN\2512305 (l_prep) from_10\IN\0 (l_pobj) abscess_13\NN\14299637 (l_acl) developed_14\VBD\1753788 (l_dobj) tdp_15\NNP\0
D015725_D016171 CID fluconazole_33\NN\0 (r_pobj) of_32\IN\0 (r_prep) initiation_31\NN\7450842 (r_pobj) between_29\IN\0 (r_prep) association_28\NN\8008335 (r_attr) was_25\VBD\0 (r_relcl) factors_6\NNS\7326557 (l_prep) for_7\IN\0 (l_pobj) tdp_8\NNP\0
D015725_D016171 CID fluconazole_33\NN\0 (l_conj) tdp_35\NNP\0
D015725_D016171 CID fluconazole_4\NN\0 (r_nsubjpass) discontinued_6\VBN\0 (r_advcl) resolved_2\VBD\352826 (l_nsubj) tdp_1\NNP\0
D015725_D016171 CID fluconazole_14\NN\0 (r_pobj) of_13\IN\0 (r_prep) use_12\NN\407535 (l_conj) development_17\NN\248977 (l_prep) of_18\IN\0 (l_pobj) tdp_19\NNP\0
D015725_D016171 CID fluconazole_5\NN\0 (r_ccomp) aware_3\JJ\0 (r_acomp) be_2\VB\14625458 (l_conj) cause_13\VB\7323922 (l_advcl) leading_20\VBG\4339291 (l_prep) to_21\IN\0 (l_pobj) tdp_22\NNP\0
D015725_D009202 NONE fluconazole_33\NN\0 (r_pobj) of_32\IN\0 (r_prep) initiation_31\NN\7450842 (r_pobj) between_29\IN\0 (r_prep) association_28\NN\8008335 (r_attr) was_25\VBD\0 (r_relcl) factors_6\NNS\7326557 (l_prep) including_10\VBG\0 (l_pobj) disease_13\NN\14061805 (l_amod) cardiomyopathy_15\NN\14103288
D015725_D006333 NONE fluconazole_33\NN\0 (r_pobj) of_32\IN\0 (r_prep) initiation_31\NN\7450842 (r_pobj) between_29\IN\0 (r_prep) association_28\NN\8008335 (r_attr) was_25\VBD\0 (r_relcl) factors_6\NNS\7326557 (l_prep) including_10\VBG\0 (l_pobj) disease_13\NN\14061805 (l_amod) cardiomyopathy_15\NN\14103288 (l_conj) failure_19\NN\66216
D015725_D008133 NONE fluconazole_5\NN\0 (r_ccomp) aware_3\JJ\0 (r_acomp) be_2\VB\14625458 (l_conj) cause_13\VB\7323922 (l_dobj) prolongation_14\NN\1017987 (l_prep) of_15\IN\0 (l_pobj) interval_18\NN\33615
D015725_D003324 NONE fluconazole_33\NN\0 (r_pobj) of_32\IN\0 (r_prep) initiation_31\NN\7450842 (r_pobj) between_29\IN\0 (r_prep) association_28\NN\8008335 (r_attr) was_25\VBD\0 (r_relcl) factors_6\NNS\7326557 (l_prep) including_10\VBG\0 (l_pobj) disease_13\NN\14061805
D015725_D018879 NONE fluconazole_4\NN\0 (r_nsubjpass) discontinued_6\VBN\0 (r_advcl) resolved_2\VBD\352826 (r_ccomp) continued_12\VBD\2367363 (l_xcomp) have_14\VB\7846 (l_dobj) contractions_17\NNS\358931
D015725_D018879 NONE fluconazole_22\NN\0 (r_dobj) suggests_21\VBZ\1010118 (l_csubj) followed_9\VBN\1835496 (l_nsubj) disappearance_2\NN\42757 (l_conj) contractions_8\NNS\358931
D015725_D001145 NONE fluconazole_7\NN\0 (r_nsubjpass) administered_9\VBN\2436349 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_relcl) are_13\VBP\13600404 (l_prep) at_14\IN\14622893 (l_pobj) risk_15\NN\14541044 (l_prep) for_16\IN\0 (l_pobj) arrhythmias_18\NNS\14103288
11271907
D003520_D009205 CID cyclophosphamide_5\NN\0 (r_compound) therapy_6\NN\657604 (r_pobj) to_4\IN\0 (r_prep) secondary_3\JJ\8426461 (l_amod) myocarditis_2\NN\14338942
D003520_D009205 CID cyclophosphamide_9\NN\0 (r_compound) therapy_10\NN\657604 (r_pobj) of_8\IN\0 (r_prep) complication_7\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) myocarditis_1\NN\14338942
D003520_D006470 CID cyclophosphamide_5\NN\0 (r_compound) therapy_6\NN\657604 (r_pobj) to_4\IN\0 (r_prep) secondary_3\JJ\8426461 (l_amod) myocarditis_2\NN\14338942
D003520_D006470 CID cyclophosphamide_9\NN\0 (r_compound) therapy_10\NN\657604 (r_pobj) of_8\IN\0 (r_prep) complication_7\NN\1073995 (r_attr) is_2\VBZ\0 (l_nsubj) myocarditis_1\NN\14338942
20304337
D003042_-1 NONE cocaine_8\NN\3492717 (r_pobj) to_7\IN\0 (r_prep) exposed_6\VBN\2110927 (l_nsubj) dysgenesis_1\NN\14045507
1255900
D006493_D013924 NONE heparin_8\JJ\2718259 (r_compound) therapy_9\NN\657604 (r_pobj) of_7\IN\0 (r_prep) initiation_6\NN\7450842 (l_prep) for_10\IN\0 (l_pobj) thrombophlebitis_13\NN\14352890
18405372
D012460_D001168 NONE sulfasalazine_3\NN\0 (l_prep) in_4\IN\13603305 (l_pobj) arthritis_6\NN\14171682
D012460_D056486 CID sulfasalazine_3\NN\0 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) hepatotoxicity_0\NN\0
D012460_D056486 CID sulfasalazine_7\NN\0 (r_pobj) on_6\IN\0 (r_prep) had_4\VBD\0 (l_dobj) hepatotoxicity_5\NN\0
D012460_D056486 CID sulfasalazine_6\NN\0 (r_pobj) with_5\IN\0 (r_prep) hepatotoxicity_4\NN\0
D012460_D056486 CID sulfasalazine_7\NN\0 (r_pobj) with_6\IN\0 (r_prep) hepatotoxicity_5\NN\0
D012460_D056486 CID sulfasalazine_4\NN\0 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) hepatotoxicity_1\NN\0
7565311
D016190_D018233 NONE carboplatin_15\NN\0 (r_pobj) with_11\IN\0 (r_prep) treated_10\VBN\2376958 (l_prep) for_16\IN\0 (l_pobj) rhabdomyosarcoma_20\NN\14246359
D016190_D058186 CID carboplatin_6\NN\0 (r_compound) chemotherapy_7\NN\661091 (r_pobj) in_3\IN\13603305 (r_prep) failure_2\NN\66216
D016190_D058186 CID carboplatin_0\NNP\0 (r_nsubjpass) reported_3\VBN\831651 (l_xcomp) cause_5\VB\7323922 (l_dobj) failure_8\NN\66216
6695415
D010665_D002543 CID phenylpropanolamine_4\NN\2682038 (r_pobj) with_3\IN\0 (r_prep) associated_2\VBN\628491 (r_acl) hemorrhage_1\NN\14285662
D010665_D002543 CID ppa_4\NNP\0 (r_nmod) caffeine_6\NN\14712692 (r_nsubj) lead_8\VB\5155821 (l_prep) to_9\IN\0 (l_pobj) hemorrhage_11\NN\14285662
D002110_D006973 CID caffeine_7\NN\14712692 (r_nsubj) lead_9\VB\5155821 (l_prep) in_12\IN\13603305 (l_pobj) rats_16\NNS\2329401 (l_amod) normotensive_13\NN\0 (l_conj) hypertensive_15\JJ\10405694
D002110_D006973 CID caffeine_4\NN\14712692 (r_compound) administration_5\NN\1133281 (r_nsubj) lead_10\NN\5155821 (l_prep) to_11\IN\0 (l_pobj) hypertension_13\NN\14057371
D002110_D006973 CID caffeine_4\NN\14712692 (r_compound) administration_5\NN\1133281 (r_nsubj) lead_10\NN\5155821 (l_prep) to_11\IN\0 (l_pobj) hypertension_13\NN\14057371 (l_prep) in_14\IN\13603305 (l_pobj) animals_20\NNS\4475 (l_amod) normotensive_17\NN\0 (l_conj) hypertensive_19\JJ\10405694
D002110_D006973 CID caffeine_6\NN\14712692 (r_nsubj) lead_8\VB\5155821 (l_prep) to_9\IN\0 (l_pobj) hemorrhage_11\NN\14285662 (l_prep) in_12\IN\13603305 (l_pobj) animals_15\NNS\4475 (l_amod) hypertensive_14\JJ\10405694
D002110_D002543 CID caffeine_8\NN\14712692 (r_pobj) with_7\IN\0 (r_prep) combination_6\NN\7951464 (r_pobj) in_5\IN\13603305 (r_prep) associated_2\VBN\628491 (r_acl) hemorrhage_1\NN\14285662
D002110_D002543 CID caffeine_6\NN\14712692 (r_nsubj) lead_8\VB\5155821 (l_prep) to_9\IN\0 (l_pobj) hemorrhage_11\NN\14285662
D010665_D006973 CID ppa_5\NNP\0 (r_nmod) caffeine_7\NN\14712692 (r_nsubj) lead_9\VB\5155821 (l_prep) in_12\IN\13603305 (l_pobj) rats_16\NNS\2329401 (l_amod) normotensive_13\NN\0 (l_conj) hypertensive_15\JJ\10405694
D010665_D006973 CID ppa_2\NNP\0 (r_nmod) caffeine_4\NN\14712692 (r_compound) administration_5\NN\1133281 (r_nsubj) lead_10\NN\5155821 (l_prep) to_11\IN\0 (l_pobj) hypertension_13\NN\14057371
D010665_D006973 CID ppa_2\NNP\0 (r_nmod) caffeine_4\NN\14712692 (r_compound) administration_5\NN\1133281 (r_nsubj) lead_10\NN\5155821 (l_prep) to_11\IN\0 (l_pobj) hypertension_13\NN\14057371 (l_prep) in_14\IN\13603305 (l_pobj) animals_20\NNS\4475 (l_amod) normotensive_17\NN\0 (l_conj) hypertensive_19\JJ\10405694
D010665_D006973 CID ppa_4\NNP\0 (r_nmod) caffeine_6\NN\14712692 (r_nsubj) lead_8\VB\5155821 (l_prep) to_9\IN\0 (l_pobj) hemorrhage_11\NN\14285662 (l_prep) in_12\IN\13603305 (l_pobj) animals_15\NNS\4475 (l_amod) hypertensive_14\JJ\10405694
D002110_D020521 NONE caffeine_7\NN\14712692 (r_nsubj) lead_9\VB\5155821 (l_prep) to_10\IN\0 (l_pobj) stroke_11\NN\556313
D010665_D020521 CID phenylpropanolamine_0\NNP\2682038 (r_nsubj) is_4\VBZ\0 (l_attr) drug_6\NN\14778436 (l_relcl) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) including_15\VBG\0 (l_pobj) stroke_16\NN\556313
D010665_D020521 CID ppa_2\NNP\0 (r_appos) phenylpropanolamine_0\NNP\2682038 (r_nsubj) is_4\VBZ\0 (l_attr) drug_6\NN\14778436 (l_relcl) associated_10\VBN\628491 (l_prep) with_11\IN\0 (l_pobj) effects_14\NNS\13245626 (l_prep) including_15\VBG\0 (l_pobj) stroke_16\NN\556313
D010665_D020521 CID ppa_5\NNP\0 (r_nmod) caffeine_7\NN\14712692 (r_nsubj) lead_9\VB\5155821 (l_prep) to_10\IN\0 (l_pobj) stroke_11\NN\556313
7596955
D000242_D001791 NONE camp_19\NNS\3763727 (r_pobj) of_17\IN\0 (r_prep) determination_16\NN\43195 (r_conj) aggregation_14\NN\31264
C045645_D005483 CID clz_25\NNP\0 (r_pobj) of_24\IN\0 (r_prep) ingestion_23\NN\13440063 (r_pobj) after_22\IN\0 (r_prep) accompanying_11\VBG\0 (l_dobj) flush_13\NN\15113229
C045645_D006261 CID clz_25\NNP\0 (r_pobj) of_24\IN\0 (r_prep) ingestion_23\NN\13440063 (r_pobj) after_22\IN\0 (r_prep) accompanying_11\VBG\0 (r_acl) duration_10\NN\15113229 (r_pobj) of_7\IN\0 (r_prep) headache_6\NN\5829480
C045645_D009325 CID clz_25\NNP\0 (r_pobj) of_24\IN\0 (r_prep) ingestion_23\NN\13440063 (r_pobj) after_22\IN\0 (r_prep) accompanying_11\VBG\0 (l_dobj) flush_13\NN\15113229 (l_prep) in_14\IN\13603305 (l_pobj) one_15\CD\13741022 (l_conj) nausea_17\NN\14299637
20510337
C024989_D058186 NONE q10_5\NNP\0 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) investigated_7\VBN\644583 (l_prep) in_8\IN\13603305 (l_pobj) mice_9\NNS\2329401 (l_prep) with_10\IN\0 (l_pobj) injury_13\NN\14052046
D002945_D009369 NONE cisplatin_55\JJ\0 (r_amod) administration_56\NN\1133281 (r_pobj) from_54\IN\0 (r_prep) resulted_53\VBD\2633881 (r_advcl) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D002945_D007674 NONE cisplatin_5\NN\0 (r_amod) nephrotoxicity_6\NN\0
D002945_D007674 NONE cisplatin_8\NN\0 (r_pobj) by_7\IN\0 (r_agent) mediated_6\VBN\761713 (r_acl) damage_5\NN\7296428
D002945_D007674 NONE cisplatin_15\NN\0 (r_amod) nephrotoxicity_16\NN\0
C024989_D009336 NONE q10_1\NNP\0 (r_nsubj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D005978_D009369 NONE glutathione_12\NN\0 (r_compound) level_13\NN\4916342 (r_dobj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D013481_D009336 NONE superoxide_15\NN\14971519 (r_amod) activity_17\NN\30358 (r_conj) level_13\NN\4916342 (r_dobj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D012643_D009336 NONE selenium_46\NN\14724645 (r_nmod) ions_49\NNS\9386422 (r_pobj) of_45\IN\0 (r_prep) reductions_44\NNS\351485 (r_dobj) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D010984_D009369 NONE platinum_37\NN\14627081 (r_compound) ion_38\NN\9386422 (r_compound) concentration_39\NN\4916342 (r_conj) oxide_35\NN\14818238 (r_conj) alpha_32\NN\6828818 (r_appos) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
C024989_D009369 NONE q10_1\NNP\0 (r_nsubj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D010984_D009336 NONE platinum_37\NN\14627081 (r_compound) ion_38\NN\9386422 (r_compound) concentration_39\NN\4916342 (r_conj) oxide_35\NN\14818238 (r_conj) alpha_32\NN\6828818 (r_appos) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
C024989_D007674 NONE q10_1\NNP\0 (r_compound) treatment_2\NN\654885 (r_nsubj) ameliorates_3\VBZ\126264 (l_dobj) nephrotoxicity_6\NN\0
C024989_D007674 NONE q10_13\NNP\0 (r_compound) treatment_14\NN\654885 (r_pobj) by_11\IN\0 (r_agent) ameliorated_10\VBN\126264 (l_nsubjpass) damage_5\NN\7296428
C024989_D007674 NONE q10_5\NNP\0 (r_nsubj) represents_6\VBZ\2664769 (l_dobj) option_10\NN\6480506 (l_acl) protect_12\VB\1127795 (l_prep) against_13\IN\0 (l_pobj) nephrotoxicity_16\NN\0
D009569_D009336 NONE oxide_35\NN\14818238 (r_conj) alpha_32\NN\6828818 (r_appos) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D015032_D009369 NONE zinc_48\NN\14625458 (r_conj) selenium_46\NN\14724645 (r_nmod) ions_49\NNS\9386422 (r_pobj) of_45\IN\0 (r_prep) reductions_44\NNS\351485 (r_dobj) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D005978_D009336 NONE glutathione_12\NN\0 (r_compound) level_13\NN\4916342 (r_dobj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D013481_D009369 NONE superoxide_15\NN\14971519 (r_amod) activity_17\NN\30358 (r_conj) level_13\NN\4916342 (r_dobj) compensated_3\VBD\2673134 (l_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D015032_D009336 NONE zinc_48\NN\14625458 (r_conj) selenium_46\NN\14724645 (r_nmod) ions_49\NNS\9386422 (r_pobj) of_45\IN\0 (r_prep) reductions_44\NNS\351485 (r_dobj) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D002945_D058186 CID cisplatin_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) injection_19\NN\320852 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_advcl) investigated_7\VBN\644583 (l_prep) in_8\IN\13603305 (l_pobj) mice_9\NNS\2329401 (l_prep) with_10\IN\0 (l_pobj) injury_13\NN\14052046
D012643_D009369 NONE selenium_46\NN\14724645 (r_nmod) ions_49\NNS\9386422 (r_pobj) of_45\IN\0 (r_prep) reductions_44\NNS\351485 (r_dobj) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
D002945_D009336 NONE cisplatin_55\JJ\0 (r_amod) administration_56\NN\1133281 (r_pobj) from_54\IN\0 (r_prep) resulted_53\VBD\2633881 (r_advcl) attenuated_42\VBD\224901 (r_conj) decreased_24\VBD\169651 (l_dobj) elevations_26\NNS\7445480 (l_prep) of_27\IN\0 (l_pobj) factor_30\NN\7326557 (l_compound) necrosis_29\NN\11444117
D009569_D009369 NONE oxide_35\NN\14818238 (r_conj) alpha_32\NN\6828818 (r_appos) factor_30\NN\7326557 (l_compound) tumor_28\NN\14234074
17511042
C417083_D063726 CID alpha-2b_16\NN\0 (r_pobj) during_13\IN\0 (r_prep) parasitosis_6\NN\0
C417083_D063726 CID alpha-2b_17\CD\0 (r_prep) present_1\VBP\28270 (l_dobj) woman_6\NN\9605289 (l_relcl) developed_8\VBD\1753788 (l_dobj) parasitosis_11\NN\0
D012254_D019698 NONE ribavirin_18\JJ\2725367 (r_compound) treatment_19\NN\654885 (r_conj) alpha-2b_16\NN\0 (r_pobj) during_13\IN\0 (r_prep) parasitosis_6\NN\0 (l_prep) in_7\IN\13603305 (l_pobj) patient_12\NN\9898892 (l_compound) c_11\NN\13714184
D012254_D019698 NONE ribavirin_10\RB\2725367 (r_conj) interferon_8\NN\2725367 (r_pobj) with_7\IN\0 (r_prep) patients_6\NNS\9898892 (l_compound) c_5\NNP\13714184
D012254_D063726 CID ribavirin_18\JJ\2725367 (r_compound) treatment_19\NN\654885 (r_conj) alpha-2b_16\NN\0 (r_pobj) during_13\IN\0 (r_prep) parasitosis_6\NN\0
D012254_D063726 CID ribavirin_20\RB\2725367 (r_conj) weekly_18\RB\6593803 (r_amod) alpha-2b_17\CD\0 (r_prep) present_1\VBP\28270 (l_dobj) woman_6\NN\9605289 (l_relcl) developed_8\VBD\1753788 (l_dobj) parasitosis_11\NN\0
C417083_D019698 NONE alpha-2b_16\NN\0 (r_pobj) during_13\IN\0 (r_prep) parasitosis_6\NN\0 (l_prep) in_7\IN\13603305 (l_pobj) patient_12\NN\9898892 (l_compound) c_11\NN\13714184
1928887
D009270_D062787 NONE naloxone_0\NN\3808977 (r_compound) reversal_1\NN\199130 (l_prep) due_4\IN\5174653 (l_pobj) overdose_7\NN\84738
D009270_D062787 NONE naloxone_22\NN\3808977 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) with_18\IN\0 (r_prep) resolved_16\VBD\352826 (r_ccomp) report_1\VBP\6470073 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) overdose_8\NN\84738
D002216_D062787 NONE captopril_6\NN\2673637 (r_compound) overdose_7\NN\84738
D002216_D062787 NONE captopril_7\NN\2673637 (r_compound) overdose_8\NN\84738
D002216_D007022 NONE captopril_6\NN\2673637 (r_compound) overdose_7\NN\84738 (r_pobj) due_4\IN\5174653 (r_prep) reversal_1\NN\199130 (l_prep) of_2\IN\0 (l_pobj) hypotension_3\NN\14057371
D002216_D007022 NONE captopril_15\NN\2673637 (r_pobj) of_14\IN\0 (r_prep) actions_13\NNS\30358 (l_amod) hypotensive_12\JJ\10405694
D002216_D007022 NONE captopril_7\NN\2673637 (r_compound) overdose_8\NN\84738 (r_pobj) of_4\IN\0 (r_prep) case_3\NN\7283608 (r_dobj) report_1\VBP\6470073 (l_advcl) manifested_10\VBN\1015244 (l_agent) by_11\IN\0 (l_pobj) hypotension_13\NN\14057371
D002216_D007022 NONE captopril_11\NN\2673637 (r_npadvmod) induced_13\VBN\1627355 (r_amod) hypotension_14\NN\14057371
D002216_D007022 NONE captopril_15\NN\2673637 (r_pobj) from_14\IN\0 (r_prep) resulting_13\VBG\2633881 (r_acl) hypotension_12\NN\14057371
D009270_D007022 NONE naloxone_0\NN\3808977 (r_compound) reversal_1\NN\199130 (l_prep) of_2\IN\0 (l_pobj) hypotension_3\NN\14057371
D009270_D007022 NONE naloxone_3\NN\3808977 (r_appos) antagonist_2\NN\7846 (r_nsubjpass) shown_6\VBN\2137132 (l_xcomp) block_8\VB\21939 (l_conj) reverse_10\VB\13854649 (l_dobj) actions_13\NNS\30358 (l_amod) hypotensive_12\JJ\10405694
D009270_D007022 NONE naloxone_22\NN\3808977 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) with_18\IN\0 (r_prep) resolved_16\VBD\352826 (r_ccomp) report_1\VBP\6470073 (l_advcl) manifested_10\VBN\1015244 (l_agent) by_11\IN\0 (l_pobj) hypotension_13\NN\14057371
D009270_D007022 NONE naloxone_17\NN\3808977 (r_pobj) with_16\IN\0 (r_prep) treated_15\VBN\2376958 (r_acl) hypotension_14\NN\14057371
D009270_D007022 NONE naloxone_7\NN\3808977 (l_prep) in_8\IN\13603305 (l_pobj) reversal_10\NN\199130 (l_prep) of_11\IN\0 (l_pobj) hypotension_12\NN\14057371
10354657
D008094_D007037 CID lithium_22\NN\14625458 (r_compound) therapy_23\NN\657604 (r_pobj) of_21\IN\0 (r_prep) onset_20\NN\7325190 (r_pobj) after_19\IN\0 (r_prep) accelerated_12\VBN\226566 (l_dobj) onset_13\NN\7325190 (l_prep) of_14\IN\0 (l_pobj) hypothyroidism_15\NN\14059928
D008094_D007037 CID lithium_38\NN\14625458 (r_compound) therapy_39\NN\657604 (r_pobj) of_37\IN\0 (r_prep) onset_36\NN\7325190 (r_pobj) after_35\IN\0 (r_prep) accelerated_12\VBN\226566 (l_dobj) onset_13\NN\7325190 (l_prep) of_14\IN\0 (l_pobj) hypothyroidism_15\NN\14059928
D008094_D007037 CID lithium_12\NN\14625458 (r_compound) therapy_13\NN\657604 (r_pobj) during_11\IN\0 (r_prep) factor_6\NN\7326557 (l_prep) for_7\IN\0 (l_pobj) hypothyroidism_8\NN\14059928
D008094_D006934 NONE lithium_12\NN\14625458 (r_compound) therapy_13\NN\657604 (r_pobj) during_11\IN\0 (r_prep) factor_6\NN\7326557 (l_prep) for_7\IN\0 (l_pobj) hypothyroidism_8\NN\14059928 (l_conj) hypercalcemia_10\NN\14299637
D008094_D013959 NONE lithium_9\NN\14625458 (r_compound) therapy_10\NN\657604 (r_pobj) of_8\IN\0 (r_prep) duration_7\NN\15113229 (r_pobj) to_5\IN\0 (r_prep) respect_4\NN\5817845 (r_pobj) with_3\IN\0 (r_prep) evaluated_2\VBN\670261 (l_parataxis) had_25\VBD\0 (l_dobj) relative_30\NN\7846 (l_prep) with_31\IN\0 (l_pobj) disease_33\NN\14061805
D008094_D013959 NONE lithium_22\NN\14625458 (r_compound) therapy_23\NN\657604 (r_pobj) of_21\IN\0 (r_prep) onset_20\NN\7325190 (r_pobj) after_19\IN\0 (r_prep) accelerated_12\VBN\226566 (l_nsubj) patients_1\NNS\9898892 (l_acl) having_2\VBG\0 (l_dobj) relatives_6\NNS\7846 (l_acl) affected_7\VBN\126264 (l_agent) by_8\IN\0 (l_pobj) illness_10\NN\14052046
D008094_D013959 NONE lithium_38\NN\14625458 (r_compound) therapy_39\NN\657604 (r_pobj) of_37\IN\0 (r_prep) onset_36\NN\7325190 (r_pobj) after_35\IN\0 (r_prep) accelerated_12\VBN\226566 (l_nsubj) patients_1\NNS\9898892 (l_acl) having_2\VBG\0 (l_dobj) relatives_6\NNS\7846 (l_acl) affected_7\VBN\126264 (l_agent) by_8\IN\0 (l_pobj) illness_10\NN\14052046
D008094_D013959 NONE lithium_12\NN\14625458 (r_compound) therapy_13\NN\657604 (r_pobj) during_11\IN\0 (r_prep) factor_6\NN\7326557 (r_attr) is_3\VBZ\0 (l_nsubj) illness_2\NN\14052046
D008094_D001714 NONE lithium_16\NN\14625458 (r_compound) therapy_18\NN\657604 (r_dobj) receiving_15\VBG\2210855 (l_nsubj) disorder_14\NN\14034177
18086064
D020927_D009203 NONE dexmedetomidine_0\NNP\0 (r_nsubjpass) associated_2\VBN\628491 (r_ccomp) mortality_14\NN\5054863 (l_appos) infarction_35\NN\14204950
1899352
D015080_D006417 NONE mesna_22\NNP\0 (r_dobj) adding_21\VBG\156601 (r_advcl) is_18\VBZ\0 (r_conj) are_6\VBP\13600404 (l_nsubj) frequency_1\NN\15286249 (l_conj) predictability_3\NN\4753455 (l_prep) of_4\IN\0 (l_pobj) hematuria_5\NN\14299637
D015080_D006417 NONE mesna_22\NNP\0 (r_dobj) adding_21\VBG\156601 (l_prep) to_23\IN\0 (l_pobj) infusate_25\NN\0 (l_prep) in_26\IN\13603305 (l_pobj) patients_27\NNS\9898892 (l_prep) with_28\IN\0 (l_pobj) hematuria_30\NN\14299637
16725121
D003891_D012640 NONE desipramine_12\NN\4482543 (r_pobj) of_11\IN\0 (r_prep) administration_10\NN\1133281 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (l_xcomp) linking_13\VBG\628491 (l_prep) to_14\IN\0 (l_pobj) alteration_16\NN\7283608 (l_prep) of_17\IN\0 (l_pobj) sensitivity_18\NN\5651971 (l_prep) of_19\IN\0 (l_pobj) convulsions_25\NNS\14081375
D003891_D012640 NONE desipramine_3\NN\4482543 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) increased_4\VBD\169651 (l_dobj) incidence_6\NN\13821570 (l_prep) of_7\IN\0 (l_pobj) appearance_8\NN\4723816 (l_prep) of_9\IN\0 (l_pobj) convulsions_13\NNS\14081375
D003891_D012640 NONE desipramine_3\NN\4482543 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (r_nsubj) increased_4\VBD\169651 (l_conj) decreased_15\VBD\169651 (l_dobj) that_16\DT\0 (l_prep) of_17\IN\0 (l_pobj) convulsions_21\NNS\14081375
D003891_D012640 NONE desipramine_6\NN\4482543 (r_pobj) with_5\IN\0 (r_prep) lidocaine_4\NN\3681148 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) reversed_7\VBD\109660 (l_dobj) changes_9\NNS\7283608 (l_prep) of_10\IN\0 (l_pobj) activity_12\NN\30358 (l_amod) convulsive_11\JJ\0
D003891_D012640 NONE desipramine_22\NN\4482543 (r_pobj) of_21\IN\0 (r_prep) administration_20\NN\1133281 (r_pobj) by_18\IN\0 (r_agent) induced_17\VBN\1627355 (r_acl) changes_9\NNS\7283608 (l_prep) of_10\IN\0 (l_pobj) activity_12\NN\30358 (l_amod) convulsive_11\JJ\0
D003891_D012640 NONE desipramine_15\NN\4482543 (r_pobj) of_14\IN\0 (r_prep) administration_13\NN\1133281 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) regulation_6\NN\6652242 (r_nsubj) be_17\VB\14625458 (l_acomp) relevant_18\JJ\0 (l_prep) to_19\IN\0 (l_pobj) sensitization_23\NN\14531772 (l_prep) of_24\IN\0 (l_pobj) convulsions_26\NNS\14081375
D003891_D012640 NONE desipramine_20\NN\4482543 (r_advmod) induced_22\VBN\1627355 (r_amod) sensitization_23\NN\14531772 (l_prep) of_24\IN\0 (l_pobj) convulsions_26\NNS\14081375
D003891_D012640 NONE desipramine_0\NN\4482543 (r_nsubj) induced_2\VBN\1627355 (r_amod) sensitization_3\NN\14531772 (l_prep) of_4\IN\0 (l_pobj) seizures_6\NNS\14081375
D009638_D012640 NONE norepinephrine_4\NN\14807929 (r_amod) function_6\NN\13783581 (r_pobj) of_3\IN\0 (r_prep) regulation_2\NN\6652242 (l_acl) induced_7\VBN\1627355 (l_xcomp) linking_13\VBG\628491 (l_prep) to_14\IN\0 (l_pobj) alteration_16\NN\7283608 (l_prep) of_17\IN\0 (l_pobj) sensitivity_18\NN\5651971 (l_prep) of_19\IN\0 (l_pobj) convulsions_25\NNS\14081375
D009638_D012640 NONE norepinephrine_2\NN\14807929 (r_compound) transporter_3\NN\4490091 (r_nmod) function_7\NN\13783581 (l_prep) by_8\IN\0 (l_pobj) inhibition_10\NN\1068773 (l_prep) in_13\IN\13603305 (l_pobj) relation_14\NN\2137 (l_prep) to_15\IN\0 (l_pobj) sensitization_16\NN\14531772 (l_prep) to_17\IN\0 (l_pobj) seizures_18\NNS\14081375
D003042_D012640 CID cocaine_21\NN\3492717 (r_pobj) by_20\IN\0 (r_agent) induce_19\VB\1627355 (r_acl) seizures_18\NNS\14081375
D003042_D012640 CID cocaine_18\NN\3492717 (r_npadvmod) induced_20\VBN\1627355 (r_amod) convulsions_21\NNS\14081375 (r_pobj) of_17\IN\0 (r_prep) that_16\DT\0 (r_dobj) decreased_15\VBD\169651 (r_conj) increased_4\VBD\169651 (l_dobj) incidence_6\NN\13821570 (l_prep) of_7\IN\0 (l_pobj) appearance_8\NN\4723816 (l_prep) of_9\IN\0 (l_pobj) convulsions_13\NNS\14081375
D003042_D012640 CID cocaine_18\NN\3492717 (r_npadvmod) induced_20\VBN\1627355 (r_amod) convulsions_21\NNS\14081375
D003042_D012640 CID cocaine_16\NN\3492717 (r_conj) lidocaine_14\NN\3681148 (r_pobj) of_13\IN\0 (r_prep) activity_12\NN\30358 (l_amod) convulsive_11\JJ\0
D003042_D012640 CID cocaine_19\NN\3492717 (r_pobj) of_18\IN\0 (r_prep) administration_17\NN\1133281 (r_pobj) from_15\IN\0 (r_prep) resulting_14\VBG\2633881 (r_acl) kindling_13\VBG\15101361 (r_pobj) from_12\IN\0 (r_prep) distinct_11\JJ\0 (r_amod) mechanism_10\NN\13446390 (r_dobj) have_8\VB\7846 (l_nsubj) sensitization_3\NN\14531772 (l_prep) of_4\IN\0 (l_pobj) seizures_6\NNS\14081375
D008012_D012640 CID lidocaine_10\NN\3681148 (r_npadvmod) induced_12\VBN\1627355 (r_amod) convulsions_13\NNS\14081375
D008012_D012640 CID lidocaine_10\NN\3681148 (r_npadvmod) induced_12\VBN\1627355 (r_amod) convulsions_13\NNS\14081375 (r_pobj) of_9\IN\0 (r_prep) appearance_8\NN\4723816 (r_pobj) of_7\IN\0 (r_prep) incidence_6\NN\13821570 (r_dobj) increased_4\VBD\169651 (l_conj) decreased_15\VBD\169651 (l_dobj) that_16\DT\0 (l_prep) of_17\IN\0 (l_pobj) convulsions_21\NNS\14081375
D008012_D012640 CID lidocaine_4\NN\3681148 (r_pobj) of_3\IN\0 (r_prep) administration_2\NN\1133281 (r_nsubj) reversed_7\VBD\109660 (l_dobj) changes_9\NNS\7283608 (l_prep) of_10\IN\0 (l_pobj) activity_12\NN\30358 (l_amod) convulsive_11\JJ\0
D008012_D012640 CID lidocaine_14\NN\3681148 (r_pobj) of_13\IN\0 (r_prep) activity_12\NN\30358 (l_amod) convulsive_11\JJ\0
D008012_D012640 CID lidocaine_25\NN\3681148 (r_compound) convulsions_26\NNS\14081375
D008012_D012640 CID lidocaine_5\NN\3681148 (r_compound) seizures_6\NNS\14081375
2917114
D004491_D001919 CID edrophonium_17\NN\0 (r_pobj) before_15\IN\0 (r_prep) min_14\NN\15154774 (r_dobj) given_12\VBN\5892096 (l_conj) was_19\VBD\0 (l_acomp) sufficient_20\JJ\0 (l_xcomp) minimize_22\VB\441445 (l_dobj) bradycardias_28\NNS\14110674
D004491_D001919 CID edrophonium_25\NN\0 (r_npadvmod) induced_27\VBN\1627355 (r_amod) bradycardias_28\NNS\14110674
D006024_D001919 NONE glycopyrronium_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) use_0\NN\407535 (l_acl) given_12\VBN\5892096 (l_conj) was_19\VBD\0 (l_acomp) sufficient_20\JJ\0 (l_xcomp) minimize_22\VB\441445 (l_dobj) bradycardias_28\NNS\14110674
19139001
D013467_D034381 CID sulindac_14\NN\3828465 (r_compound) group_15\NN\2137 (l_relcl) experienced_17\VBD\2108377 (l_dobj) loss_21\NN\13252973
D013467_D015179 NONE sulindac_15\NN\3828465 (l_prep) for_16\IN\0 (l_pobj) prevention_17\NN\1073995 (l_prep) of_18\IN\0 (l_pobj) adenomas_21\NNS\14236226
D000518_D015179 NONE difluoromethylornithine_13\NN\0 (l_conj) sulindac_15\NN\3828465 (l_prep) for_16\IN\0 (l_pobj) prevention_17\NN\1073995 (l_prep) of_18\IN\0 (l_pobj) adenomas_21\NNS\14236226
D000518_D064420 NONE dfmo_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) treatment_8\NN\654885 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101
D000518_D034381 NONE dfmo_10\NN\0 (r_pobj) with_9\IN\0 (r_prep) treatment_8\NN\654885 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101 (r_attr) is_3\VBZ\0 (l_nsubj) loss_2\NN\13252973
D000518_D034381 NONE dfmo_12\NN\0 (r_nmod) group_15\NN\2137 (l_relcl) experienced_17\VBD\2108377 (l_dobj) loss_21\NN\13252973
D013467_D018256 NONE sulindac_22\NN\3828465 (r_conj) difluoromethylornithine_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) months_15\NNS\15113229 (r_pobj) for_13\IN\0 (r_prep) treatment_12\NN\654885 (r_pobj) after_11\IN\0 (r_prep) polyps_10\NNS\14234074
D000518_D018256 NONE difluoromethylornithine_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) months_15\NNS\15113229 (r_pobj) for_13\IN\0 (r_prep) treatment_12\NN\654885 (r_pobj) after_11\IN\0 (r_prep) polyps_10\NNS\14234074
D000518_D018256 NONE dfmo_19\NN\0 (r_appos) difluoromethylornithine_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) months_15\NNS\15113229 (r_pobj) for_13\IN\0 (r_prep) treatment_12\NN\654885 (r_pobj) after_11\IN\0 (r_prep) polyps_10\NNS\14234074
8854309
D003042_D010259 CID cocaine_9\NN\3492717 (r_npadvmod) induced_11\VBN\1627355 (r_amod) paranoia_12\NN\14398067
D003042_D010259 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) paranoia_3\NN\14398067
D003042_D010259 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) paranoia_3\NN\14398067 (l_appos) cip_5\NNP\0
D003042_D010259 CID cocaine_0\NN\3492717 (r_npadvmod) induced_2\VBN\1627355 (r_amod) paranoia_3\NN\14398067 (r_nsubj) remains_7\VBZ\2684 (l_attr) model_13\NN\5888929 (l_prep) of_14\IN\0 (l_pobj) paranoia_16\NN\14398067
D016578_D010259 NONE cocaine_14\NN\3492717 (r_compound) abusers_15\NNS\9633969 (l_acl) endorsing_16\VBG\806502 (l_prep) past_17\IN\28270 (l_pobj) cip_18\NNP\0
D016578_D010259 NONE cocaine_14\NN\3492717 (r_compound) abusers_15\NNS\9633969 (l_acl) endorsing_16\VBG\806502 (l_prep) from_24\IN\0 (l_pobj) group_26\NN\2137 (l_relcl) denied_31\VBD\823436 (l_prep) past_32\IN\28270 (l_pobj) cip_33\NNP\0
D016578_D010259 NONE crack_28\NN\9379111 (r_compound) addicts_29\NNS\10059582 (r_pobj) of_27\IN\0 (r_prep) group_26\NN\2137 (r_pobj) from_24\IN\0 (r_prep) endorsing_16\VBG\806502 (l_prep) past_17\IN\28270 (l_pobj) cip_18\NNP\0
D016578_D010259 NONE crack_28\NN\9379111 (r_compound) addicts_29\NNS\10059582 (r_pobj) of_27\IN\0 (r_prep) group_26\NN\2137 (l_relcl) denied_31\VBD\823436 (l_prep) past_32\IN\28270 (l_pobj) cip_33\NNP\0
D016578_D011681 NONE cocaine_14\NN\3492717 (r_compound) abusers_15\NNS\9633969 (r_pobj) of_11\IN\0 (r_prep) group_10\NN\2137 (r_dobj) distinguish_8\VB\618878 (r_xcomp) able_5\JJ\0 (r_acomp) were_4\VBD\0 (l_nsubj) measures_0\NNS\168237 (l_prep) of_1\IN\0 (l_pobj) oscillation_3\NN\13518963
D016578_D011681 NONE crack_28\NN\9379111 (r_compound) addicts_29\NNS\10059582 (r_pobj) of_27\IN\0 (r_prep) group_26\NN\2137 (r_pobj) from_24\IN\0 (r_prep) endorsing_16\VBG\806502 (r_acl) abusers_15\NNS\9633969 (r_pobj) of_11\IN\0 (r_prep) group_10\NN\2137 (r_dobj) distinguish_8\VB\618878 (r_xcomp) able_5\JJ\0 (r_acomp) were_4\VBD\0 (l_nsubj) measures_0\NNS\168237 (l_prep) of_1\IN\0 (l_pobj) oscillation_3\NN\13518963
D003042_D011681 CID cocaine_9\NN\3492717 (r_npadvmod) induced_11\VBN\1627355 (r_amod) paranoia_12\NN\14398067 (r_pobj) of_8\IN\0 (r_prep) marker_7\NN\21939 (r_pobj) as_5\IN\14622893 (r_prep) measure_1\NN\168237 (l_prep) of_2\IN\0 (l_pobj) oscillation_4\NN\13518963
9321531
D007980_D004409 CID levodopa_11\RB\14604959 (r_npadvmod) induced_13\VBN\1627355 (r_amod) dyskinesias_14\NNS\14084880
D007980_D010300 NONE levodopa_11\RB\14604959 (r_npadvmod) induced_13\VBN\1627355 (r_amod) dyskinesias_14\NNS\14084880 (r_dobj) reduces_10\VBZ\441445 (l_prep) in_0\IN\13603305 (l_pobj) disease_6\NN\14061805
8617710
D020280_D003072 NONE sertraline_4\NN\4169152 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) on_5\IN\0 (l_pobj) sensitization_9\NN\14531772 (l_prep) of_10\IN\0 (l_pobj) impairment_12\NN\7296428
D020280_D003072 NONE sertraline_14\NN\4169152 (r_compound) administration_15\NN\1133281 (r_pobj) by_12\IN\0 (r_agent) worsened_11\VBN\146138 (r_relcl) profile_4\NN\6999802 (l_prep) of_5\IN\0 (l_pobj) impairment_7\NN\7296428
D006220_D003072 CID haloperidol_14\NN\3713736 (r_pobj) with_13\IN\0 (r_prep) impairment_12\NN\7296428
D006220_D003072 CID haloperidol_13\NN\3713736 (r_pobj) of_12\IN\0 (r_prep) administration_11\NN\1133281 (r_pobj) after_10\IN\0 (r_prep) observed_5\VBN\2163746 (l_nsubjpass) impairment_0\NN\7296428 (l_prep) of_1\IN\0 (l_pobj) function_3\NN\13783581
D006220_D003072 CID haloperidol_0\NNP\3713736 (r_nsubj) produced_1\VBD\1617192 (l_dobj) profile_4\NN\6999802 (l_prep) of_5\IN\0 (l_pobj) impairment_7\NN\7296428
384871
D004977_D064420 NONE ethambutol_8\NN\0 (r_pobj) due_6\IN\5174653 (r_amod) hazards_1\NNS\14541044 (l_prep) of_2\IN\0 (l_pobj) toxicity_5\NN\13576101
D004977_D009901 CID ethambutol_6\NN\0 (r_nmod) treatment_9\NN\654885 (r_pobj) due_3\IN\5174653 (r_prep) neuropathy_2\NN\14204950
D007538_D009901 CID isoniazid_8\NN\2716205 (r_conj) ethambutol_6\NN\0 (r_nmod) treatment_9\NN\654885 (r_pobj) due_3\IN\5174653 (r_prep) neuropathy_2\NN\14204950
16629641
C026956_D000743 NONE viramidine_0\NNP\0 (r_nsubj) has_10\VBZ\13888491 (l_dobj) potential_12\NN\14481929 (l_acl) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204
D012254_D007674 NONE ribavirin_8\RB\2725367 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hemolysis_11\NN\13509528 (r_pobj) of_7\IN\0 (r_prep) result_6\NN\34213 (r_pobj) as_4\IN\14622893 (r_prep) decrease_2\VBP\7296428 (l_conj) be_17\VB\14625458 (l_conj) comorbid_29\VBN\0 (l_dobj) disorders_33\NNS\14034177
D007372_D006526 NONE interferon_12\NN\2725367 (r_pobj) with_10\IN\0 (r_prep) therapy_9\NN\657604 (r_attr) is_7\VBZ\0 (l_nsubj) treatment_3\NN\654885 (l_prep) for_4\IN\0 (l_pobj) infection_6\NN\14052046
D012254_D002318 NONE ribavirin_8\RB\2725367 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hemolysis_11\NN\13509528 (r_pobj) of_7\IN\0 (r_prep) result_6\NN\34213 (r_pobj) as_4\IN\14622893 (r_prep) decrease_2\VBP\7296428 (l_conj) be_17\VB\14625458 (l_conj) comorbid_29\VBN\0 (l_dobj) disorders_33\NNS\14034177
D012254_D000740 NONE ribavirin_8\RB\2725367 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hemolysis_11\NN\13509528 (r_pobj) of_7\IN\0 (r_prep) result_6\NN\34213 (r_pobj) as_4\IN\14622893 (r_prep) decrease_2\VBP\7296428 (l_conj) be_17\VB\14625458 (l_nsubj) anemia_15\NN\14189204
D012254_D000740 NONE ribavirin_1\RB\2725367 (r_npadvmod) associated_3\VBN\628491 (r_amod) anemia_4\NN\14189204
D012254_D000740 NONE ribavirin_8\RB\2725367 (r_npadvmod) associated_10\VBN\628491 (r_amod) anemia_11\NN\14189204
D012254_D019698 NONE ribavirin_8\NN\2725367 (r_pobj) of_7\IN\0 (r_prep) prodrug_6\NN\0 (r_appos) viramidine_0\NNP\0 (r_nsubj) has_10\VBZ\13888491 (l_dobj) potential_12\NN\14481929 (l_acl) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204 (l_prep) in_27\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_prep) with_29\IN\0 (l_pobj) c._32\NNP\0
D012254_D019698 NONE ribavirin_19\RB\2725367 (r_pobj) of_18\IN\0 (r_prep) efficacy_17\NN\5199286 (r_dobj) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204 (l_prep) in_27\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_prep) with_29\IN\0 (l_pobj) c._32\NNP\0
D012254_D006461 NONE ribavirin_8\RB\2725367 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hemolysis_11\NN\13509528
D012254_D000743 CID ribavirin_8\NN\2725367 (r_pobj) of_7\IN\0 (r_prep) prodrug_6\NN\0 (r_appos) viramidine_0\NNP\0 (r_nsubj) has_10\VBZ\13888491 (l_dobj) potential_12\NN\14481929 (l_acl) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204
D012254_D000743 CID ribavirin_19\RB\2725367 (r_pobj) of_18\IN\0 (r_prep) efficacy_17\NN\5199286 (r_dobj) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204
D012254_D006526 NONE ribavirin_14\NN\2725367 (r_conj) interferon_12\NN\2725367 (r_pobj) with_10\IN\0 (r_prep) therapy_9\NN\657604 (r_attr) is_7\VBZ\0 (l_nsubj) treatment_3\NN\654885 (l_prep) for_4\IN\0 (l_pobj) infection_6\NN\14052046
D012254_D006526 NONE ribavirin_8\RB\2725367 (r_npadvmod) induced_10\VBN\1627355 (r_amod) hemolysis_11\NN\13509528 (r_pobj) of_7\IN\0 (r_prep) result_6\NN\34213 (r_pobj) as_4\IN\14622893 (r_prep) decrease_2\VBP\7296428 (l_conj) be_17\VB\14625458 (l_prep) in_19\IN\13603305 (l_pobj) patients_20\NNS\9898892 (l_prep) with_21\IN\0 (l_pobj) infection_23\NN\14052046
C026956_D019698 NONE viramidine_0\NNP\0 (r_nsubj) has_10\VBZ\13888491 (l_dobj) potential_12\NN\14481929 (l_acl) maintain_14\VB\0 (l_advcl) decreasing_21\VBG\169651 (l_dobj) risk_23\NN\14541044 (l_prep) of_24\IN\0 (l_pobj) anemia_26\NN\14189204 (l_prep) in_27\IN\13603305 (l_pobj) patients_28\NNS\9898892 (l_prep) with_29\IN\0 (l_pobj) c._32\NNP\0
16132524
D017239_D001929 CID paclitaxel_9\NN\0 (r_dobj) received_4\VBD\2210855 (l_conj) suffered_11\VBD\2110220 (l_prep) from_12\IN\0 (l_prep) to_14\TO\0 (l_pobj) edema_17\NN\14315192
D017239_D001929 CID paclitaxel_30\NN\0 (r_pobj) of_27\IN\0 (r_prep) total_26\NN\3553 (r_dobj) received_23\VBD\2210855 (r_advcl) suffered_11\VBD\2110220 (l_prep) from_12\IN\0 (l_prep) to_14\TO\0 (l_pobj) edema_17\NN\14315192
D017239_D005909 NONE paclitaxel_3\NN\0 (r_nmod) carboplatin_5\VB\0 (r_amod) phases_9\NNS\15113229 (l_prep) for_11\IN\0 (l_pobj) glioblastoma_13\NN\14236743
D017239_D005909 NONE paclitaxel_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) application_19\NN\947128 (r_pobj) of_15\IN\0 (r_prep) effects_14\NNS\13245626 (r_conj) safety_8\NN\13920835 (r_conj) feasibility_6\NN\5152150 (r_nsubjpass) examined_31\VBN\0 (l_prep) for_0\IN\0 (l_pobj) recurrences_3\NNS\7342049 (l_compound) glioblastoma_2\NN\14236743
D017239_D005909 NONE paclitaxel_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) application_20\NN\947128 (r_dobj) received_17\VBD\2210855 (r_conj) underwent_12\VBN\109660 (r_acl) multiforme_11\NN\0 (l_compound) glioblastoma_10\NN\14236743
D016190_D005909 NONE carboplatin_5\VB\0 (r_amod) phases_9\NNS\15113229 (l_prep) for_11\IN\0 (l_pobj) glioblastoma_13\NN\14236743
D016190_D005909 NONE carboplatin_23\NN\0 (r_advmod) encapsulated_24\VBN\1587062 (r_conj) effects_14\NNS\13245626 (r_conj) safety_8\NN\13920835 (r_conj) feasibility_6\NN\5152150 (r_nsubjpass) examined_31\VBN\0 (l_prep) for_0\IN\0 (l_pobj) recurrences_3\NNS\7342049 (l_compound) glioblastoma_2\NN\14236743
D016190_D005909 NONE carboplatin_24\VB\0 (r_amod) phases_26\NNS\15113229 (r_conj) received_17\VBD\2210855 (r_conj) underwent_12\VBN\109660 (r_acl) multiforme_11\NN\0 (l_compound) glioblastoma_10\NN\14236743
8841157
D000804_D006973 NONE ii_5\CD\13741022 (r_compound) antagonist_6\NN\7846 (l_prep) for_7\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) of_10\IN\0 (l_pobj) hypertension_12\NN\14057371
C081489_D006973 NONE valsartan_0\NNP\2712393 (l_appos) antagonist_6\NN\7846 (l_prep) for_7\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) of_10\IN\0 (l_pobj) hypertension_12\NN\14057371
C081489_D006973 NONE valsartan_27\NN\2712393 (r_dobj) receive_24\VB\2210855 (r_advcl) allocated_14\VBN\2228698 (l_nsubjpass) outpatients_6\NNS\10405694 (l_prep) with_7\IN\0 (l_pobj) hypertension_11\NN\14057371
C081489_D006973 NONE valsartan_4\NN\2712393 (r_nsubj) is_5\VBZ\0 (l_acomp) effective_9\JJ\0 (l_prep) as_10\IN\14622893 (l_pobj) amlodipine_11\NN\0 (l_prep) in_12\IN\13603305 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) hypertension_19\NN\14057371
D017311_D004487 CID amlodipine_13\NN\0 (r_compound) group_14\NN\2137 (r_pobj) in_11\IN\13603305 (r_prep) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
D017311_D004487 CID amlodipine_38\NN\0 (r_pobj) for_35\IN\0 (r_prep) %_34\NN\0 (r_npadvmod) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
D017311_D004487 CID amlodipine_47\NN\0 (r_conj) %_41\NN\0 (r_conj) %_34\NN\0 (r_npadvmod) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
D017311_D004487 CID amlodipine_54\NN\0 (r_pobj) for_51\IN\0 (r_prep) %_50\NN\0 (r_appos) %_34\NN\0 (r_npadvmod) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
D017311_D006973 NONE amlodipine_23\NN\0 (r_pobj) against_22\IN\0 (r_prep) safety_21\NN\13920835 (r_conj) efficacy_19\NN\5199286 (r_pobj) of_17\IN\0 (r_prep) study_16\NN\635850 (r_appos) valsartan_0\NNP\2712393 (l_appos) antagonist_6\NN\7846 (l_prep) for_7\IN\0 (l_pobj) treatment_9\NN\654885 (l_prep) of_10\IN\0 (l_pobj) hypertension_12\NN\14057371
D017311_D006973 NONE amlodipine_31\NN\0 (r_conj) valsartan_27\NN\2712393 (r_dobj) receive_24\VB\2210855 (r_advcl) allocated_14\VBN\2228698 (l_nsubjpass) outpatients_6\NNS\10405694 (l_prep) with_7\IN\0 (l_pobj) hypertension_11\NN\14057371
D017311_D006973 NONE amlodipine_11\NN\0 (l_prep) in_12\IN\13603305 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) hypertension_19\NN\14057371
C081489_D004487 CID valsartan_31\NN\2712393 (r_pobj) for_28\IN\0 (r_prep) %_27\NN\0 (r_appos) dose_19\NN\3740161 (r_pobj) at_17\IN\14622893 (r_prep) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
C081489_D004487 CID valsartan_43\NN\2712393 (r_pobj) for_42\IN\0 (r_prep) %_41\NN\0 (r_conj) %_34\NN\0 (r_npadvmod) was_8\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) edema_7\NN\14315192
12180796
D009569_D001167 NONE oxide_21\NN\14818238 (r_compound) synthase_22\NN\0 (r_pobj) of_19\IN\0 (r_prep) type_18\NN\5839024 (r_pobj) of_16\IN\0 (r_prep) expressions_15\NNS\4679549 (r_pobj) for_14\IN\0 (r_prep) examined_12\VBN\0 (r_conj) induced_1\VBN\1627355 (l_nsubj) arteritis_0\NNP\14336539
D018818_D001167 CID fenoldopam_12\NN\0 (r_pobj) by_11\IN\0 (r_prep) rats_10\NNS\2329401 (r_pobj) in_9\IN\13603305 (r_prep) induced_8\VBN\1627355 (l_nsubj) beta1_0\NNP\0 (l_prep) in_6\IN\13603305 (l_pobj) arteritis_7\NN\14336539
D018818_D001167 CID fenoldopam_7\NN\0 (r_npadvmod) induced_1\VBN\1627355 (l_nsubj) arteritis_0\NNP\14336539
D013806_D001167 CID theophylline_14\NN\2905612 (r_conj) fenoldopam_12\NN\0 (r_pobj) by_11\IN\0 (r_prep) rats_10\NNS\2329401 (r_pobj) in_9\IN\13603305 (r_prep) induced_8\VBN\1627355 (l_nsubj) beta1_0\NNP\0 (l_prep) in_6\IN\13603305 (l_pobj) arteritis_7\NN\14336539
D013806_D001167 CID theophylline_9\NN\2905612 (r_conj) fenoldopam_7\NN\0 (r_npadvmod) induced_1\VBN\1627355 (l_nsubj) arteritis_0\NNP\14336539
D013806_D009369 NONE theophylline_9\NN\2905612 (r_conj) fenoldopam_7\NN\0 (r_npadvmod) induced_1\VBN\1627355 (l_conj) examined_12\VBN\0 (l_prep) for_14\IN\0 (l_pobj) expressions_15\NNS\4679549 (l_prep) of_16\IN\0 (l_pobj) type_18\NN\5839024 (l_prep) of_19\IN\0 (l_pobj) synthase_22\NN\0 (l_appos) factor_30\NN\7326557 (l_conj) beta1_39\NNP\0 (l_compound) factor_37\NN\7326557 (l_compound) tumor_35\NN\14234074
D018818_D009369 NONE fenoldopam_7\NN\0 (r_npadvmod) induced_1\VBN\1627355 (l_conj) examined_12\VBN\0 (l_prep) for_14\IN\0 (l_pobj) expressions_15\NNS\4679549 (l_prep) of_16\IN\0 (l_pobj) type_18\NN\5839024 (l_prep) of_19\IN\0 (l_pobj) synthase_22\NN\0 (l_appos) factor_30\NN\7326557 (l_conj) beta1_39\NNP\0 (l_compound) factor_37\NN\7326557 (l_compound) tumor_35\NN\14234074
D009569_D009369 NONE oxide_7\NN\14818238 (l_appos) factor_15\NN\7326557 (l_conj) growth_21\NN\13526110 (l_compound) tumor_20\NN\14234074
D009569_D009369 NONE oxide_21\NN\14818238 (r_compound) synthase_22\NN\0 (l_appos) factor_30\NN\7326557 (l_conj) beta1_39\NNP\0 (l_compound) factor_37\NN\7326557 (l_compound) tumor_35\NN\14234074
9431903
D005996_D046628 NONE trinitrate_3\NN\0 (l_prep) on_4\IN\0 (l_pobj) sphincter_6\NN\5289297 (l_prep) of_7\IN\0 (l_pobj) spasm_9\NN\14299637
D005996_D046628 NONE trinitrate_9\NN\0 (l_prep) on_10\IN\0 (l_pobj) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D005996_D046628 NONE trinitrate_9\NN\0 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_nsubjpass) evaluated_22\VBN\670261 (l_prep) with_27\IN\0 (l_pobj) sphincter_28\NN\5289297 (l_prep) of_29\IN\0 (l_pobj) dyskinesia_31\NN\14084880
D005996_D046628 NONE trinitrate_11\NN\0 (l_prep) on_12\IN\0 (l_pobj) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D005996_D046628 NONE trinitrate_2\NN\0 (r_nsubj) is_3\VBZ\0 (r_advcl) be_16\VB\14625458 (l_prep) in_19\IN\13603305 (l_pobj) treatment_21\NN\654885 (l_prep) of_22\IN\0 (l_pobj) sphincter_23\NN\5289297 (l_prep) of_24\IN\0 (l_pobj) dyskinesia_26\NN\14084880
D009388_D013035 CID prostigmine_12\JJ\0 (r_compound) morphine_14\NN\2707683 (r_compound) administration_15\NN\1133281 (r_pobj) by_11\IN\0 (r_agent) evoked_10\VBN\1617192 (r_acl) spasm_9\NN\14299637
D009388_D013035 CID prostigmine_12\JJ\0 (r_compound) morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D009388_D013035 CID prostigmine_7\JJ\0 (r_compound) morphine_9\NN\2707683 (r_compound) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009388_D013035 CID prostigmine_14\NN\0 (r_parataxis) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009388_D013035 CID prostigmine_1\JJ\0 (r_compound) morphine_3\NN\2707683 (r_compound) provocation_4\NN\1221611 (r_nsubj) caused_5\VBD\1617192 (l_advcl) indicating_97\VBG\952524 (l_dobj) spasm_100\NN\14299637
D009388_D046628 CID prostigmine_12\JJ\0 (r_compound) morphine_14\NN\2707683 (r_compound) administration_15\NN\1133281 (r_pobj) by_11\IN\0 (r_agent) evoked_10\VBN\1617192 (r_acl) spasm_9\NN\14299637
D009388_D046628 CID prostigmine_12\JJ\0 (r_compound) morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D009388_D046628 CID prostigmine_12\JJ\0 (r_compound) morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (r_pobj) on_10\IN\0 (r_prep) trinitrate_9\NN\0 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_nsubjpass) evaluated_22\VBN\670261 (l_prep) with_27\IN\0 (l_pobj) sphincter_28\NN\5289297 (l_prep) of_29\IN\0 (l_pobj) dyskinesia_31\NN\14084880
D009388_D046628 CID prostigmine_7\JJ\0 (r_compound) morphine_9\NN\2707683 (r_compound) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009388_D046628 CID prostigmine_14\NN\0 (r_parataxis) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009020_D013035 CID morphine_14\NN\2707683 (r_compound) administration_15\NN\1133281 (r_pobj) by_11\IN\0 (r_agent) evoked_10\VBN\1617192 (r_acl) spasm_9\NN\14299637
D009020_D013035 CID morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D009020_D013035 CID morphine_9\NN\2707683 (r_compound) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009020_D013035 CID morphine_19\NN\2707683 (r_conj) prostigmine_14\NN\0 (r_parataxis) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009020_D013035 CID morphine_3\NN\2707683 (r_compound) provocation_4\NN\1221611 (r_nsubj) caused_5\VBD\1617192 (l_advcl) indicating_97\VBG\952524 (l_dobj) spasm_100\NN\14299637
D005996_D013035 NONE trinitrate_3\NN\0 (l_prep) on_4\IN\0 (l_pobj) sphincter_6\NN\5289297 (l_prep) of_7\IN\0 (l_pobj) spasm_9\NN\14299637
D005996_D013035 NONE trinitrate_9\NN\0 (l_prep) on_10\IN\0 (l_pobj) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D005996_D013035 NONE trinitrate_11\NN\0 (l_prep) on_12\IN\0 (l_pobj) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D009020_D046628 CID morphine_14\NN\2707683 (r_compound) administration_15\NN\1133281 (r_pobj) by_11\IN\0 (r_agent) evoked_10\VBN\1617192 (r_acl) spasm_9\NN\14299637
D009020_D046628 CID morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (l_prep) of_18\IN\0 (l_pobj) spasm_20\NN\14299637
D009020_D046628 CID morphine_14\NN\2707683 (r_npadvmod) induced_16\VBN\1627355 (r_amod) sphincter_17\NN\5289297 (r_pobj) on_10\IN\0 (r_prep) trinitrate_9\NN\0 (r_pobj) of_7\IN\0 (r_prep) effect_6\NN\34213 (r_nsubjpass) evaluated_22\VBN\670261 (l_prep) with_27\IN\0 (l_pobj) sphincter_28\NN\5289297 (l_prep) of_29\IN\0 (l_pobj) dyskinesia_31\NN\14084880
D009020_D046628 CID morphine_9\NN\2707683 (r_compound) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009020_D046628 CID morphine_19\NN\2707683 (r_conj) prostigmine_14\NN\0 (r_parataxis) administration_10\NN\1133281 (r_pobj) by_6\IN\0 (r_agent) induced_5\VBN\1627355 (l_nsubjpass) spasm_3\NN\14299637
D009020_D046628 CID morphine_12\NN\2707683 (r_pobj) of_11\IN\0 (r_prep) effect_10\NN\34213 (r_dobj) overcome_6\VB\0 (r_xcomp) able_4\JJ\0 (r_acomp) is_3\VBZ\0 (r_advcl) be_16\VB\14625458 (l_prep) in_19\IN\13603305 (l_pobj) treatment_21\NN\654885 (l_prep) of_22\IN\0 (l_pobj) sphincter_23\NN\5289297 (l_prep) of_24\IN\0 (l_pobj) dyskinesia_26\NN\14084880
3015327
D007538_D009422 CID isoniazid_6\NN\2716205 (r_compound) neuropathy_7\NN\14204950
D007538_D009422 CID isoniazid_8\NN\2716205 (r_pobj) of_7\IN\0 (r_prep) dose_6\NN\3740161 (r_pobj) by_3\IN\0 (r_agent) caused_2\VBN\1617192 (r_acl) neuropathy_1\NN\14204950
9201797
D002354_D002375 NONE hydrochloride_5\NN\14817592 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D002354_D002375 NONE carteolol_5\NN\0 (r_pobj) of_4\IN\0 (r_prep) effects_3\NNS\13245626 (l_appos) antagonist_11\NN\7846 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D002354_D002375 NONE carteolol_0\NNP\0 (l_conj) propranolol_5\NN\0 (l_conj) inhibited_9\VBD\2510337 (l_dobj) catalepsy_14\NN\14023236
D002354_D002375 NONE carteolol_5\NN\0 (r_nsubj) improves_6\VBZ\126264 (l_dobj) catalepsy_10\NN\14023236
D006220_D002375 CID haloperidol_14\NN\3713736 (r_npadvmod) induced_16\VBN\1627355 (r_amod) catalepsy_17\NN\14023236
D006220_D002375 CID haloperidol_11\NN\3713736 (r_npadvmod) induced_13\VBN\1627355 (r_amod) catalepsy_14\NN\14023236
D006220_D002375 CID haloperidol_7\NN\3713736 (r_npadvmod) induced_9\VBN\1627355 (r_amod) catalepsy_10\NN\14023236
D004298_D017109 NONE dopamine_40\NN\14807737 (r_nmod) receptor_41\NN\5225602 (r_nmod) activity_43\NN\30358 (r_pobj) to_37\IN\0 (r_pcomp) due_36\IN\5174653 (r_prep) attenuating_30\VBG\224901 (r_pcomp) without_29\IN\0 (r_prep) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) akathisia_28\NN\0
D002354_D009069 NONE carteolol_0\NNP\0 (r_nsubj) evoke_3\VB\1617192 (l_dobj) signs_10\NNS\6643763 (l_prep) as_12\IN\14622893 (l_pobj) stereotypy_13\NN\0 (l_conj) hyperlocomotion_15\NN\0
D004298_D009069 NONE dopamine_5\NN\14807737 (r_nmod) signs_10\NNS\6643763 (l_prep) as_12\IN\14622893 (l_pobj) stereotypy_13\NN\0 (l_conj) hyperlocomotion_15\NN\0
D004298_D002375 NONE dopamine_40\NN\14807737 (r_nmod) receptor_41\NN\5225602 (r_nmod) activity_43\NN\30358 (r_pobj) to_37\IN\0 (r_pcomp) due_36\IN\5174653 (r_prep) attenuating_30\VBG\224901 (r_pcomp) without_29\IN\0 (r_prep) treatment_26\NN\654885 (r_pobj) in_24\IN\13603305 (r_prep) effective_23\JJ\0 (r_acomp) be_22\VB\14625458 (r_xcomp) expected_20\VBN\670261 (r_conj) improves_6\VBZ\126264 (l_dobj) catalepsy_10\NN\14023236
D006220_D017109 NONE haloperidol_7\NN\3713736 (r_npadvmod) induced_9\VBN\1627355 (r_amod) catalepsy_10\NN\14023236 (r_dobj) improves_6\VBZ\126264 (l_conj) expected_20\VBN\670261 (l_xcomp) be_22\VB\14625458 (l_acomp) effective_23\JJ\0 (l_prep) in_24\IN\13603305 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) akathisia_28\NN\0
D001712_D002375 NONE biperiden_30\VBN\0 (r_conj) propranolol_28\NN\0 (r_pobj) of_27\IN\0 (r_prep) those_26\DT\0 (r_pobj) with_25\IN\0 (r_prep) compared_24\VBN\644583 (r_conj) studied_22\VBN\0 (l_nsubjpass) effects_3\NNS\13245626 (l_appos) antagonist_11\NN\7846 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D001712_D002375 NONE biperiden_7\RB\0 (r_conj) propranolol_5\NN\0 (l_conj) inhibited_9\VBD\2510337 (l_dobj) catalepsy_14\NN\14023236
D011433_D002375 NONE propranolol_28\NN\0 (r_pobj) of_27\IN\0 (r_prep) those_26\DT\0 (r_pobj) with_25\IN\0 (r_prep) compared_24\VBN\644583 (r_conj) studied_22\VBN\0 (l_nsubjpass) effects_3\NNS\13245626 (l_appos) antagonist_11\NN\7846 (l_prep) on_13\IN\0 (l_pobj) catalepsy_17\NN\14023236
D011433_D002375 NONE propranolol_5\NN\0 (l_conj) inhibited_9\VBD\2510337 (l_dobj) catalepsy_14\NN\14023236
D002354_D017109 NONE carteolol_5\NN\0 (r_nsubj) improves_6\VBZ\126264 (l_conj) expected_20\VBN\670261 (l_xcomp) be_22\VB\14625458 (l_acomp) effective_23\JJ\0 (l_prep) in_24\IN\13603305 (l_pobj) treatment_26\NN\654885 (l_prep) of_27\IN\0 (l_pobj) akathisia_28\NN\0
15042318
D004317_D009136 NONE doxorubicin_34\NN\2716866 (r_npadvmod) based_36\VBN\0 (r_amod) chemotherapy_37\NN\661091 (r_pobj) of_33\IN\0 (r_prep) cycle_32\NN\15269513 (r_pobj) following_30\VBG\8180190 (r_prep) fibrillation_29\NN\14361664 (r_conj) form_20\NN\6286395 (l_prep) of_21\IN\0 (l_pobj) dystrophy_24\NN\14151139
D004317_C535648 NONE doxorubicin_34\NN\2716866 (r_npadvmod) based_36\VBN\0 (r_amod) chemotherapy_37\NN\661091 (r_pobj) of_33\IN\0 (r_prep) cycle_32\NN\15269513 (r_pobj) following_30\VBG\8180190 (r_prep) fibrillation_29\NN\14361664 (r_conj) form_20\NN\6286395 (r_appos) dystrophy_15\NN\14151139 (l_nmod) lymphoma_12\NN\14239918
D004317_D009223 NONE doxorubicin_34\NN\2716866 (r_npadvmod) based_36\VBN\0 (r_amod) chemotherapy_37\NN\661091 (r_pobj) of_33\IN\0 (r_prep) cycle_32\NN\15269513 (r_pobj) following_30\VBG\8180190 (r_prep) fibrillation_29\NN\14361664 (r_conj) form_20\NN\6286395 (r_appos) dystrophy_15\NN\14151139
D004317_D001281 CID doxorubicin_34\NN\2716866 (r_npadvmod) based_36\VBN\0 (r_amod) chemotherapy_37\NN\661091 (r_pobj) of_33\IN\0 (r_prep) cycle_32\NN\15269513 (r_pobj) following_30\VBG\8180190 (r_prep) fibrillation_29\NN\14361664
8492347
D011188_D013746 NONE potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) spasms_14\NNS\14299637 (l_conj) tetany_16\NN\14304060
D008274_D013746 NONE magnesium_10\NN\14625458 (r_compound) supplementation_11\NN\5108947 (r_pobj) of_9\IN\0 (r_prep) importance_8\NN\5138488 (r_appos) tetany_0\NNP\14304060
D011188_D007008 NONE potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_advcl) cause_4\VB\7323922 (l_nsubj) hypokalemia_2\NN\14299637
D002118_C537153 NONE calcium_25\NN\14625458 (r_conj) potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_nsubjpass) hypomagnesemia_9\NN\0
D008274_D007008 NONE magnesium_27\NN\14625458 (r_compound) depletion_28\NN\351638 (r_pobj) of_26\IN\0 (r_prep) effects_25\NNS\13245626 (r_nsubjpass) noted_31\VBN\1009240 (r_conj) observed_19\VBN\2163746 (r_conj) reported_4\VBN\831651 (l_nsubjpass) hypokalemia_1\NN\14299637
D008274_D006996 NONE magnesium_27\NN\14625458 (r_compound) depletion_28\NN\351638 (r_pobj) of_26\IN\0 (r_prep) effects_25\NNS\13245626 (r_nsubjpass) noted_31\VBN\1009240 (r_conj) observed_19\VBN\2163746 (l_prep) in_14\IN\13603305 (l_pobj) hypocalcemia_17\NN\14299637
D011188_C537153 NONE potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_nsubjpass) hypomagnesemia_9\NN\0
D011188_D018908 NONE potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_advcl) cause_4\VB\7323922 (l_dobj) weakness_6\NN\14462666
D002118_D013746 NONE calcium_25\NN\14625458 (r_conj) potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) spasms_14\NNS\14299637 (l_conj) tetany_16\NN\14304060
D005665_D012206 CID furosemide_6\NN\3214670 (r_pobj) due_3\JJ\5174653 (r_prep) tetany_0\NNP\14304060 (l_conj) rhabdomyolysis_2\NN\0
D005665_D013746 CID furosemide_6\NN\3214670 (r_pobj) due_3\JJ\5174653 (r_prep) tetany_0\NNP\14304060
D008274_D012206 NONE magnesium_10\NN\14625458 (r_compound) supplementation_11\NN\5108947 (r_pobj) of_9\IN\0 (r_prep) importance_8\NN\5138488 (r_appos) tetany_0\NNP\14304060 (l_conj) rhabdomyolysis_2\NN\0
D002118_D007008 NONE calcium_25\NN\14625458 (r_conj) potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_advcl) cause_4\VB\7323922 (l_nsubj) hypokalemia_2\NN\14299637
D002118_D013035 NONE calcium_25\NN\14625458 (r_conj) potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) spasms_14\NNS\14299637
D002118_D018908 NONE calcium_25\NN\14625458 (r_conj) potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_advcl) cause_4\VB\7323922 (l_dobj) weakness_6\NN\14462666
D011188_D013035 NONE potassium_23\NN\14625458 (r_nmod) supplementation_26\NN\5108947 (r_pobj) by_22\IN\0 (r_agent) corrected_21\VBN\138508 (r_ccomp) associated_11\VBN\628491 (l_prep) with_12\IN\0 (l_pobj) spasms_14\NNS\14299637
10414674
D000082_D001791 NONE acetaminophen_9\NN\2707683 (r_compound) group_10\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) increased_6\VBD\169651 (l_nsubj) aggregation_5\NN\31264
D000082_D001791 NONE acetaminophen_9\NN\2707683 (r_compound) group_10\NN\2137 (r_pobj) in_7\IN\13603305 (r_prep) increased_6\VBD\169651 (l_advcl) compared_17\VBN\644583 (l_prep) with_18\IN\0 (l_pobj) results_23\NNS\34213 (l_compound) aggregation_22\NN\31264
D000082_D013345 NONE acetaminophen_35\RB\2707683 (r_advmod) nsaid_33\NNP\2721538 (r_conj) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_nsubjpass) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) hemorrhage_4\NN\14285662
D000082_D013345 NONE acetaminophen_35\RB\2707683 (r_advmod) nsaid_33\NNP\2721538 (r_conj) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_punct) (_5\-LRB-\0 (l_preconj) sah_6\NNP\0
D000082_D013345 NONE acetaminophen_35\RB\2707683 (r_advmod) nsaid_33\NNP\2721538 (r_conj) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0
D000082_D013345 NONE acetaminophen_45\NN\2707683 (r_compound) group_46\NN\2137 (r_nsubj) starting_52\VBG\457382 (r_parataxis) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_nsubjpass) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) hemorrhage_4\NN\14285662
D000082_D013345 NONE acetaminophen_45\NN\2707683 (r_compound) group_46\NN\2137 (r_nsubj) starting_52\VBG\457382 (r_parataxis) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_punct) (_5\-LRB-\0 (l_preconj) sah_6\NNP\0
D000082_D013345 NONE acetaminophen_45\NN\2707683 (r_compound) group_46\NN\2137 (r_nsubj) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0
D000082_D013345 NONE acetaminophen_3\RB\2707683 (l_dobj) function_6\NN\13783581 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) sah_10\NNP\0
D007660_D006470 NONE ketoprofen_1\NN\3828465 (r_nsubjpass) used_3\VBN\0 (r_advcl) pose_13\VB\4787763 (l_dobj) factor_17\NN\7326557 (l_prep) for_18\IN\0 (l_pobj) hemorrhage_19\NN\14285662
D007660_D001791 CID ketoprofen_14\NN\3828465 (r_pobj) of_13\IN\0 (r_prep) administration_12\NN\1133281 (r_pobj) after_11\IN\0 (r_prep) decreased_10\VBD\169651 (r_conj) induced_3\VBN\1627355 (l_nsubj) aggregation_2\NN\31264
D007660_D013345 NONE ketoprofen_13\JJ\3828465 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_nsubjpass) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) hemorrhage_4\NN\14285662
D007660_D013345 NONE ketoprofen_13\JJ\3828465 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_punct) (_5\-LRB-\0 (l_preconj) sah_6\NNP\0
D007660_D013345 NONE ketoprofen_13\JJ\3828465 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0
D007660_D013345 NONE ketoprofen_23\JJ\3828465 (r_compound) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_nsubjpass) patients_0\NNS\9898892 (l_prep) with_1\IN\0 (l_pobj) hemorrhage_4\NN\14285662
D007660_D013345 NONE ketoprofen_23\JJ\3828465 (r_compound) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (r_xcomp) randomized_9\VBN\278117 (l_punct) (_5\-LRB-\0 (l_preconj) sah_6\NNP\0
D007660_D013345 NONE ketoprofen_23\JJ\3828465 (r_compound) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0
D007660_D013345 NONE ketoprofen_0\NNP\3828465 (l_conj) acetaminophen_3\RB\2707683 (l_dobj) function_6\NN\13783581 (l_prep) in_7\IN\13603305 (l_pobj) patients_8\NNS\9898892 (l_prep) with_9\IN\0 (l_pobj) sah_10\NNP\0
D007660_D017542 NONE ketoprofen_13\JJ\3828465 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0 (l_amod) aneurysmal_58\JJ\0
D007660_D017542 NONE ketoprofen_23\JJ\3828465 (r_compound) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0 (l_amod) aneurysmal_58\JJ\0
D000082_D017542 NONE acetaminophen_35\RB\2707683 (r_advmod) nsaid_33\NNP\2721538 (r_conj) group_24\NN\2137 (r_dobj) receive_11\VB\2210855 (l_parataxis) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0 (l_amod) aneurysmal_58\JJ\0
D000082_D017542 NONE acetaminophen_45\NN\2707683 (r_compound) group_46\NN\2137 (r_nsubj) starting_52\VBG\457382 (l_prep) after_54\IN\0 (l_pobj) diagnosis_56\NN\152018 (l_prep) of_57\IN\0 (l_pobj) sah_59\NNP\0 (l_amod) aneurysmal_58\JJ\0
D007660_D006406 CID ketoprofen_4\JJ\3828465 (r_compound) group_5\NN\2137 (r_pobj) in_2\IN\13603305 (r_prep) patient_1\NN\9898892 (r_nsubj) developed_6\VBD\1753788 (l_dobj) hematoma_10\NN\14317720
D000244_D001791 NONE diphosphate_9\NN\0 (r_pobj) of_7\IN\0 (r_prep) microm_6\NNS\0 (r_pobj) by_4\IN\0 (r_prep) induced_3\VBN\1627355 (l_nsubj) aggregation_2\NN\31264
D007660_D002532 NONE ketoprofen_1\NN\3828465 (r_nsubjpass) used_3\VBN\0 (l_prep) on_6\IN\0 (l_pobj) aneurysms_9\NNS\14057371
8643966
D017239_D001943 NONE paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_appos) carcinoma_28\NN\14239918
D017239_D001943 NONE taxol_2\NNP\0 (r_appos) paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_appos) carcinoma_28\NN\14239918
D017239_D010051 NONE paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_appos) carcinoma_28\NN\14239918
D017239_D010051 NONE taxol_2\NNP\0 (r_appos) paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_appos) carcinoma_28\NN\14239918
D017239_D064420 NONE paclitaxel_9\NN\0 (r_compound) infusion_10\NN\14589223 (r_pobj) of_6\IN\0 (r_prep) efficacy_3\NN\5199286 (l_conj) toxicity_5\NN\13576101
D017239_D064420 NONE paclitaxel_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_prep) with_12\IN\0 (l_pobj) infusion_15\NN\14589223 (l_acl) proving_16\VBG\2604760 (l_oprd) effective_18\JJ\0 (l_prep) to_19\IN\0 (l_pobj) infusion_22\NN\14589223 (l_conj) superior_24\JJ\9623038 (l_prep) in_25\IN\13603305 (l_pobj) terms_26\NNS\13945919 (l_prep) of_27\IN\0 (l_pobj) incidence_29\NN\13821570 (l_prep) of_30\IN\0 (l_pobj) toxicity_34\NN\13576101
D017239_D002289 NONE paclitaxel_11\NN\0 (r_pobj) with_10\IN\0 (r_prep) cancer_9\NN\14239425
D017239_D002289 NONE paclitaxel_6\NN\0 (r_compound) infusions_7\NNS\14589223 (l_prep) in_8\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) iiib_15\NNS\0 (l_conj) cancer_23\NN\14239425
D017239_D002289 NONE paclitaxel_6\NN\0 (r_compound) infusions_7\NNS\14589223 (l_prep) in_8\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) iiib_15\NNS\0 (l_conj) cancer_23\NN\14239425 (l_appos) nsclc_25\NNP\0
D017239_D002289 NONE paclitaxel_9\NN\0 (r_compound) infusion_10\NN\14589223 (l_prep) in_11\IN\13603305 (l_pobj) trial_15\NN\786195 (l_prep) in_16\IN\13603305 (l_pobj) patients_17\NNS\9898892 (l_prep) with_18\IN\0 (l_pobj) iiib_21\NNS\0 (l_conj) nsclc_24\NNP\0
D017239_D002289 NONE paclitaxel_5\NN\0 (r_pobj) with_4\IN\0 (r_prep) studies_3\NNS\635850 (l_acl) combined_6\VBN\2630189 (l_prep) with_7\IN\0 (l_pobj) drugs_9\NNS\14778436 (l_amod) active_10\JJ\14779550 (l_prep) against_11\IN\0 (l_pobj) nsclc_12\NNP\0
D017239_D002289 NONE paclitaxel_21\NN\0 (r_dobj) comparing_20\VBG\635850 (r_acl) studies_19\NNS\635850 (r_dobj) phase_17\NN\15113229 (r_conj) indicated_14\VBN\952524 (l_nsubjpass) phase_1\NN\15113229 (l_dobj) studies_3\NNS\635850 (l_acl) combined_6\VBN\2630189 (l_prep) with_7\IN\0 (l_pobj) drugs_9\NNS\14778436 (l_amod) active_10\JJ\14779550 (l_prep) against_11\IN\0 (l_pobj) nsclc_12\NNP\0
D017239_D009369 NONE paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_compound) tumor_21\NN\14234074
D017239_D009369 NONE taxol_2\NNP\0 (r_appos) paclitaxel_0\NNP\0 (r_nsubj) demonstrated_15\VBN\2137132 (l_dobj) activity_18\NN\30358 (l_prep) against_19\IN\0 (l_pobj) types_22\NNS\5839024 (l_compound) tumor_21\NN\14234074
9041081
D013256_D009798 NONE steroid_13\NN\14727670 (r_npadvmod) induced_15\VBN\1627355 (r_amod) pressure_18\NN\11419404
D013256_D009798 NONE steroid_2\NN\14727670 (r_npadvmod) induced_4\VBN\1627355 (r_amod) rise_6\NN\7324673
D000305_D009798 CID corticosteroid_25\NN\14745635 (r_compound) therapy_26\NN\657604 (r_nsubjpass) discontinued_28\VBN\0 (r_advcl) resolved_23\VBD\352826 (r_relcl) iop_20\NNP\11495041 (r_appos) pressure_18\NN\11419404
16710500
D004977_D014376 NONE ethambutol_2\NNP\0 (r_nsubjpass) used_4\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) tuberculosis_9\NN\14127211
D004977_D009901 CID ethambutol_0\NN\0 (r_npadvmod) associated_2\VBN\628491 (r_amod) neuropathy_4\NN\14204950
D004977_D009901 CID ethambutol_3\NN\0 (r_npadvmod) associated_5\VBN\628491 (r_amod) neuropathy_8\NNS\14204950
D004977_D014786 CID ethambutol_2\NNP\0 (r_nsubjpass) used_4\VBN\0 (l_conj) associated_22\VBN\628491 (l_prep) with_23\IN\0 (l_pobj) loss_26\NN\13252973
D004977_D014786 CID ethambutol_0\NNP\0 (r_compound) usage_1\NN\407535 (r_nsubjpass) associated_3\VBN\628491 (l_prep) with_4\IN\0 (l_pobj) loss_7\NN\13252973
12093990
C059262_D009503 CID cidofovir_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) use_0\NN\407535 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) failure_11\NN\66216 (l_conj) neutropenia_13\NN\14196405
D012254_D000257 NONE ribavirin_1\JJ\2725367 (r_compound) treatment_2\NN\654885 (l_prep) for_3\IN\0 (l_pobj) disease_6\NN\14061805
D012254_D000257 NONE ribavirin_7\NN\2725367 (r_compound) therapy_8\NN\657604 (r_pobj) with_5\IN\0 (r_prep) experience_4\NN\5984287 (l_prep) for_9\IN\0 (l_pobj) disease_12\NN\14061805
D012254_D000257 NONE ribavirin_12\RB\2725367 (r_pobj) with_10\IN\0 (r_prep) treated_9\VBN\2376958 (l_prep) for_13\IN\0 (l_pobj) disease_17\NN\14061805
D012254_D000257 NONE ribavirin_2\NN\2725367 (r_nsubj) was_3\VBD\0 (l_acomp) effective_5\JJ\0 (l_prep) for_6\IN\0 (l_pobj) children_8\NNS\9622049 (l_prep) with_9\IN\0 (l_pobj) disease_12\NN\14061805
D012254_D000257 NONE ribavirin_11\RB\2725367 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (l_nsubj) children_3\NNS\9622049 (l_prep) with_4\IN\0 (l_pobj) disease_7\NN\14061805
D012254_D000257 NONE ribavirin_33\NN\2725367 (r_pobj) as_31\IN\14622893 (r_prep) therapies_28\NNS\657604 (r_pobj) of_22\IN\0 (r_prep) trial_21\NN\786195 (r_conj) children_14\NNS\9622049 (r_appos) hosts_11\NNS\9605289 (r_pobj) in_9\IN\13603305 (r_prep) prevalence_5\NN\4764412 (l_prep) of_6\IN\0 (l_pobj) disease_8\NN\14061805
C059262_D000257 NONE cidofovir_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (l_prep) in_4\IN\13603305 (l_pobj) infection_7\NN\14052046
D012254_D000740 NONE ribavirin_7\RB\2725367 (r_pobj) of_5\IN\0 (r_prep) effect_4\NN\34213 (r_nsubj) is_8\VBZ\0 (l_attr) anemia_11\NN\14189204
D012254_D006482 NONE ribavirin_0\NNP\2725367 (r_nsubjpass) licensed_2\VBN\803325 (l_conj) is_27\VBZ\0 (l_attr) treatment_29\NN\654885 (l_prep) for_32\IN\0 (l_pobj) infection_33\NN\14052046 (l_prep) with_34\IN\0 (l_pobj) viruses_37\NNS\9312843
D012254_D006482 NONE ribavirin_26\RB\2725367 (r_dobj) treat_22\VB\7570720 (r_conj) licensed_2\VBN\803325 (l_conj) is_27\VBZ\0 (l_attr) treatment_29\NN\654885 (l_prep) for_32\IN\0 (l_pobj) infection_33\NN\14052046 (l_prep) with_34\IN\0 (l_pobj) viruses_37\NNS\9312843
D012254_D007239 NONE ribavirin_2\NN\2725367 (r_nsubj) was_3\VBD\0 (r_advcl) is_22\VBZ\0 (l_advcl) begun_29\VBN\0 (l_prep) in_31\IN\13603305 (l_pobj) course_33\NN\883297 (l_prep) of_34\IN\0 (l_pobj) infection_36\NN\14052046
C059262_D058186 CID cidofovir_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) use_0\NN\407535 (r_nsubjpass) associated_7\VBN\628491 (l_prep) with_8\IN\0 (l_pobj) failure_11\NN\66216
D012254_D006526 NONE ribavirin_0\NNP\2725367 (r_nsubjpass) licensed_2\VBN\803325 (l_conj) treat_22\VB\7570720 (l_dobj) ribavirin_26\RB\2725367 (l_compound) intravenous_25\NNP\0 (l_compound) c._24\NNP\0
D012254_D006526 NONE ribavirin_26\RB\2725367 (l_compound) intravenous_25\NNP\0 (l_compound) c._24\NNP\0
D012254_D018357 NONE ribavirin_0\NNP\2725367 (r_nsubjpass) licensed_2\VBN\803325 (l_prep) in_3\IN\13603305 (l_pobj) form_5\NN\6286395 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) infection_13\NN\14052046
D012254_D018357 NONE ribavirin_26\RB\2725367 (r_dobj) treat_22\VB\7570720 (r_conj) licensed_2\VBN\803325 (l_prep) in_3\IN\13603305 (l_pobj) form_5\NN\6286395 (l_prep) for_6\IN\0 (l_pobj) treatment_8\NN\654885 (l_prep) of_9\IN\0 (l_pobj) infection_13\NN\14052046
C059262_D007674 NONE cidofovir_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) use_1\NN\407535 (r_nsubjpass) limited_10\VBN\4019101 (r_ccomp) is_20\VBZ\0 (l_attr) nephrotoxicity_21\NN\0
17049862
D010672_D001919 CID phenytoin_1\JJ\3550533 (r_compound) administration_2\NN\1133281 (r_pobj) following_0\VBG\8180190 (r_prep) developed_6\VBD\1753788 (l_dobj) bradycardia_9\NN\14110674
D001285_D001919 NONE atropine_13\NN\14712692 (r_pobj) to_12\IN\0 (r_prep) refractory_11\JJ\3673767 (r_advcl) developed_6\VBD\1753788 (l_dobj) bradycardia_9\NN\14110674
D010672_D012640 NONE phenytoin_1\NN\3550533 (r_nsubjpass) administered_3\VBN\2436349 (l_prep) during_4\IN\0 (l_pobj) part_7\NN\31921 (l_prep) of_8\IN\0 (l_pobj) surgery_10\NN\6045562 (l_prep) for_11\IN\0 (l_pobj) prophylaxis_13\NN\1077350 (l_compound) seizure_12\NN\14081375
D004837_D001919 NONE adrenaline_15\NN\14807929 (r_conj) atropine_13\NN\14712692 (r_pobj) to_12\IN\0 (r_prep) refractory_11\JJ\3673767 (r_advcl) developed_6\VBD\1753788 (l_dobj) bradycardia_9\NN\14110674
D010672_D007035 NONE phenytoin_1\JJ\3550533 (r_compound) administration_2\NN\1133281 (r_nsubj) is_0\VBZ\0 (l_acomp) safe_3\JJ\4340750 (l_prep) in_4\IN\13603305 (l_pobj) child_7\NN\9622049 (l_amod) hypothermic_6\JJ\0
D010672_D007035 NONE phenytoin_5\NN\3550533 (l_conj) hypothermia_7\NN\14034177
D010672_D007035 NONE phenytoin_2\NN\3550533 (r_pobj) of_1\IN\0 (r_prep) administration_0\NN\1133281 (l_prep) in_3\IN\13603305 (l_pobj) presence_5\NN\13954253 (l_prep) of_6\IN\0 (l_pobj) hypothermia_7\NN\14034177
11063349
D016572_D064420 NONE cyclosporine_16\NN\0 (l_appos) csa_18\NNP\0 (l_conj) toxicity_25\NN\13576101
D016572_D064420 NONE csa_18\NNP\0 (l_conj) toxicity_25\NN\13576101
D016572_D064420 NONE csa_6\NNP\0 (l_conj) nephrotoxicity_9\NN\0 (l_conj) csa_15\NNP\0 (l_conj) toxicity_18\NN\13576101
D016572_D064420 NONE csa_15\NNP\0 (l_conj) toxicity_18\NN\13576101
D003404_D007674 NONE creatinine_17\NN\0 (r_pobj) in_15\IN\13603305 (r_prep) decrease_14\NN\7296428 (r_attr) was_11\VBD\0 (l_prep) in_1\IN\13603305 (l_pobj) patients_4\NNS\9898892 (l_acl) switched_5\VBD\138508 (l_prep) because_6\IN\0 (l_pobj) nephrotoxicity_9\NN\0
D016572_D056486 NONE csa_6\NNP\0 (l_conj) hepatotoxicity_43\NN\0
D016572_D056486 NONE csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (r_conj) csa_6\NNP\0 (l_conj) hepatotoxicity_43\NN\0
D020123_D011014 NONE rapa_0\NNP\0 (r_nsubjpass) discontinued_2\VBN\0 (l_prep) because_7\IN\0 (l_pobj) pneumonia_9\NN\14145095
D016559_-1 NONE tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0 (l_conj) csa_15\NNP\0 (l_conj) dysmorphism_25\NN\0
D016559_-1 NONE tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101 (r_conj) csa_15\NNP\0 (l_conj) dysmorphism_25\NN\0
D016572_D007674 CID csa_6\NNP\0 (l_conj) nephrotoxicity_9\NN\0
D016572_D007674 CID csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0
D016572_D008232 NONE csa_6\NNP\0 (l_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177
D016572_D008232 NONE csa_6\NNP\0 (l_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177 (l_appos) ptld_34\NN\0
D016572_D008232 NONE csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177
D016572_D008232 NONE csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177 (l_appos) ptld_34\NN\0
D020123_D013281 NONE rapa_0\NNP\0 (r_nsubjpass) discontinued_2\VBN\0 (l_appos) ptld_13\NN\0 (l_conj) ulcers_20\NNS\14211294
D016572_-1 NONE csa_6\NNP\0 (l_conj) nephrotoxicity_9\NN\0 (l_conj) csa_15\NNP\0 (l_conj) dysmorphism_25\NN\0
D016572_-1 NONE csa_15\NNP\0 (l_conj) dysmorphism_25\NN\0
D016559_D007674 CID tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0
D016559_D007674 CID tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101 (r_conj) csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0
D016559_D008232 NONE tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177
D016559_D008232 NONE tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177 (l_appos) ptld_34\NN\0
D016559_D008232 NONE tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101 (r_conj) csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177
D016559_D008232 NONE tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101 (r_conj) csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (l_conj) disorder_32\NN\14034177 (l_appos) ptld_34\NN\0
D020123_D008232 NONE rapa_0\NNP\0 (r_nsubjpass) discontinued_2\VBN\0 (l_appos) ptld_13\NN\0
D020123_D011020 NONE rapa_6\NNP\0 (r_compound) levels_8\NNS\4916342 (r_pobj) to_5\IN\0 (r_prep) converting_3\VBG\126264 (r_csubjpass) monitored_11\VBN\2169352 (r_advcl) given_27\VBN\5892096 (l_nsubjpass) prophylaxis_24\NN\1077350 (l_compound) pneumonia_23\NN\14145095
D020123_D064420 NONE rapa_11\NNP\0 (r_compound) conversion_12\NN\7359599 (l_prep) in_13\IN\13603305 (l_pobj) patients_14\NNS\9898892 (l_acl) undergoing_15\VBG\109660 (l_dobj) cyclosporine_16\NN\0 (l_appos) csa_18\NNP\0 (l_conj) toxicity_25\NN\13576101
D016559_D064420 NONE tacrolimus_21\NN\0 (r_nmod) toxicity_25\NN\13576101
D016559_D064420 NONE tac_23\NN\0 (r_nmod) toxicity_25\NN\13576101
D016559_D064420 NONE tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0 (l_conj) csa_15\NNP\0 (l_conj) toxicity_18\NN\13576101
D016559_D064420 NONE tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101
D016559_D056486 NONE tac_8\NNP\0 (r_compound) nephrotoxicity_9\NN\0 (r_conj) csa_6\NNP\0 (l_conj) hepatotoxicity_43\NN\0
D016559_D056486 NONE tac_17\NNP\0 (r_compound) toxicity_18\NN\13576101 (r_conj) csa_15\NNP\0 (r_conj) nephrotoxicity_9\NN\0 (r_conj) csa_6\NNP\0 (l_conj) hepatotoxicity_43\NN\0
11900788
D018738_D002375 NONE hexamethonium_10\NN\0 (r_conj) mecamylamine_7\NN\0 (r_conj) naloxone_5\NN\3808977 (r_appos) administration_1\NN\1133281 (l_appos) catalepsy_14\NN\14023236
D018738_D002375 NONE hexamethonium_5\NN\0 (r_conj) atropine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) injection_1\NN\320852 (r_nsubj) decreased_10\VBD\169651 (l_dobj) catalepsy_11\NN\14023236
D001285_D002375 NONE atropine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) administration_1\NN\1133281 (l_appos) catalepsy_14\NN\14023236
D001285_D002375 NONE atropine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) injection_1\NN\320852 (r_nsubj) decreased_10\VBD\169651 (l_dobj) catalepsy_11\NN\14023236
D008464_D002375 NONE mecamylamine_7\NN\0 (r_conj) naloxone_5\NN\3808977 (r_appos) administration_1\NN\1133281 (l_appos) catalepsy_14\NN\14023236
D009538_D002375 CID nicotine_0\NN\14712692 (r_compound) potentiation_1\NN\13564910 (l_prep) of_2\IN\0 (l_pobj) catalepsy_6\NN\14023236
D009538_D002375 CID nicotine_7\NN\14712692 (r_pobj) of_6\IN\0 (r_prep) effects_5\NNS\13245626 (l_prep) on_8\IN\0 (l_pobj) catalepsy_9\NN\14023236
D009538_D002375 CID nicotine_3\NN\14712692 (r_conj) morphine_0\NNP\2707683 (r_nsubj) induced_4\VBD\1627355 (l_dobj) catalepsy_9\NN\14023236
D009538_D002375 CID nicotine_22\NN\14712692 (r_pobj) with_21\IN\0 (r_prep) combination_18\NN\7951464 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) catalepsy_14\NN\14023236
D009538_D002375 CID nicotine_16\NN\14712692 (r_conj) morphine_14\NN\2707683 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) catalepsy_11\NN\14023236
D009538_D002375 CID nicotine_22\NN\14712692 (r_pobj) by_21\IN\0 (r_agent) induced_20\VBN\1627355 (r_acl) potentiation_17\NN\13564910 (r_nsubjpass) mediated_26\VBN\761713 (r_conj) elicited_8\VBN\1617192 (l_nsubjpass) catalepsy_5\NN\14023236
D009020_D002375 CID morphine_3\NN\2707683 (r_npadvmod) induced_5\VBN\1627355 (r_amod) catalepsy_6\NN\14023236
D009020_D002375 CID morphine_12\NN\2707683 (r_pobj) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) effects_5\NNS\13245626 (l_prep) on_8\IN\0 (l_pobj) catalepsy_9\NN\14023236
D009020_D002375 CID morphine_0\NNP\2707683 (r_nsubj) induced_4\VBD\1627355 (l_dobj) catalepsy_9\NN\14023236
D009020_D002375 CID morphine_20\NN\2707683 (r_pobj) of_19\IN\0 (r_prep) combination_18\NN\7951464 (r_pobj) by_16\IN\0 (r_agent) induced_15\VBN\1627355 (r_acl) catalepsy_14\NN\14023236
D009020_D002375 CID morphine_14\NN\2707683 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) catalepsy_11\NN\14023236
D009020_D002375 CID morphine_4\NN\2707683 (r_compound) catalepsy_5\NN\14023236
D009020_D002375 CID morphine_19\NN\2707683 (r_pobj) of_18\IN\0 (r_prep) potentiation_17\NN\13564910 (r_nsubjpass) mediated_26\VBN\761713 (r_conj) elicited_8\VBN\1617192 (l_nsubjpass) catalepsy_5\NN\14023236
D009270_D002375 NONE naloxone_5\NN\3808977 (r_appos) administration_1\NN\1133281 (l_appos) catalepsy_14\NN\14023236
D009270_D002375 NONE naloxone_8\NN\3808977 (r_conj) hexamethonium_5\NN\0 (r_conj) atropine_3\NN\14712692 (r_pobj) of_2\IN\0 (r_prep) injection_1\NN\320852 (r_nsubj) decreased_10\VBD\169651 (l_dobj) catalepsy_11\NN\14023236
11583940
C063008_D007674 NONE mofetil_7\NNS\0 (r_dobj) mycophenolate_6\VB\0 (l_dep) have_14\VBP\7846 (l_dobj) nephrotoxicity_16\NN\0
D020123_D007674 NONE sirolimus_9\NN\0 (r_conj) mofetil_7\NNS\0 (r_dobj) mycophenolate_6\VB\0 (l_dep) have_14\VBP\7846 (l_dobj) nephrotoxicity_16\NN\0
D020123_D007674 NONE rapamycin_11\NNS\0 (r_appos) mofetil_7\NNS\0 (r_dobj) mycophenolate_6\VB\0 (l_dep) have_14\VBP\7846 (l_dobj) nephrotoxicity_16\NN\0
1700207
D006221_D001145 NONE halothane_17\NN\3570838 (r_npadvmod) anesthetized_19\VBN\84738 (r_amod) dogs_20\NNS\2083346 (r_pobj) in_16\IN\13603305 (r_prep) infusion_15\NN\14589223 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (l_nsubjpass) arrhythmia_1\NN\14103288
D012964_D001145 NONE na_7\NNP\14625458 (r_compound) blockers_9\NNS\10101634 (r_pobj) by_6\IN\0 (r_agent) suppressed_5\VBN\2510337 (r_relcl) arrhythmia_1\NN\14103288
D010042_D001145 CID ouabain_21\NN\0 (r_pobj) of_20\IN\0 (r_prep) injection_19\NN\320852 (r_appos) intravenous_15\JJ\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (l_nsubjpass) arrhythmia_1\NN\14103288
C032151_D001145 NONE cibenzoline_6\NN\0 (l_prep) on_7\IN\0 (l_pobj) arrhythmias_10\NNS\14103288
C032151_D001145 NONE -cibenzoline_6\:\0 (r_conj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (l_conj) examined_11\VBN\0 (l_advcl) using_12\VBG\418025 (l_dobj) models_17\NNS\5888929 (l_compound) arrhythmia_16\NN\14103288
C032151_D001145 NONE -)-cibenzoline_9\:\0 (r_nsubjpass) examined_11\VBN\0 (l_advcl) using_12\VBG\418025 (l_dobj) models_17\NNS\5888929 (l_compound) arrhythmia_16\NN\14103288
C032151_D001145 NONE -cibenzoline_8\,\0 (r_punct) suppressed_9\VBN\2510337 (r_amod) arrhythmias_15\NNS\14103288
C032151_D001145 NONE -cibenzoline_9\:\0 (r_punct) for_10\IN\0 (l_pobj) arrhythmias_16\NNS\14103288
C032151_D001145 NONE -)-cibenzoline_9\NNP\0 (r_nsubj) suppressed_10\VBD\2510337 (l_dobj) arrhythmia_15\NN\14103288
C032151_D001145 NONE -)-cibenzoline_9\NNP\0 (r_nsubj) suppressed_10\VBD\2510337 (r_pcomp) of_7\IN\0 (r_prep) i.v._6\NN\0 (r_appos) dose_2\NN\3740161 (r_nsubjpass) needed_22\VBN\0 (l_advcl) suppress_24\VB\2510337 (l_dobj) arrhythmias_28\NNS\14103288
C032151_D001145 NONE -)-cibenzoline_7\:\0 (l_prep) for_8\IN\0 (l_pobj) arrhythmia_14\NN\14103288
D004837_D001145 CID adrenaline_14\NN\14807929 (r_amod) infusion_15\NN\14589223 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (l_nsubjpass) arrhythmia_1\NN\14103288
D004837_D001145 CID adrenaline_12\NN\14807929 (r_npadvmod) induced_14\VBN\1627355 (r_conj) digitalis-_10\NN\0 (r_amod) arrhythmias_15\NNS\14103288
D004837_D001145 CID adrenaline_13\NN\14807929 (r_npadvmod) induced_15\VBN\1627355 (r_conj) digitalis-_11\NN\0 (r_amod) arrhythmias_16\NNS\14103288
D004837_D001145 CID adrenaline_25\NN\14807929 (r_npadvmod) induced_27\VBN\1627355 (r_amod) arrhythmias_28\NNS\14103288 (r_dobj) suppress_24\VB\2510337 (r_advcl) needed_22\VBN\0 (l_nsubjpass) dose_2\NN\3740161 (l_appos) i.v._6\NN\0 (l_prep) of_7\IN\0 (l_pcomp) suppressed_10\VBD\2510337 (l_dobj) arrhythmia_15\NN\14103288
D004837_D001145 CID adrenaline_25\NN\14807929 (r_npadvmod) induced_27\VBN\1627355 (r_amod) arrhythmias_28\NNS\14103288
D004837_D001145 CID adrenaline_11\NN\14807929 (r_npadvmod) induced_13\VBN\1627355 (r_conj) digitalis-_9\NN\0 (r_amod) arrhythmia_14\NN\14103288
D010424_D001145 NONE pentobarbital_23\NN\2792049 (r_npadvmod) anesthetized_25\VBN\84738 (r_amod) dogs_26\NNS\2083346 (r_pobj) in_22\IN\13603305 (r_prep) injection_19\NN\320852 (r_appos) intravenous_15\JJ\0 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (l_nsubjpass) arrhythmia_1\NN\14103288
D002118_D001145 NONE ca_7\NNP\14625458 (r_aux) channel_8\NN\6251781 (r_compound) blockers_9\NNS\10101634 (r_pobj) by_6\IN\0 (r_agent) suppressed_5\VBN\2510337 (r_relcl) arrhythmia_1\NN\14103288
D004070_D001145 NONE digitalis_0\NNP\15059939 (r_compound) arrhythmia_1\NN\14103288
D004070_D001145 NONE digitalis-_10\NN\0 (r_amod) arrhythmias_15\NNS\14103288
D004070_D001145 NONE digitalis-_11\NN\0 (r_amod) arrhythmias_16\NNS\14103288
D004070_D001145 NONE digitalis_12\NN\15059939 (r_npadvmod) induced_14\VBN\1627355 (r_amod) arrhythmia_15\NN\14103288
D004070_D001145 NONE digitalis_12\NN\15059939 (r_npadvmod) induced_14\VBN\1627355 (r_amod) arrhythmia_15\NN\14103288 (r_dobj) suppressed_10\VBD\2510337 (r_pcomp) of_7\IN\0 (r_prep) i.v._6\NN\0 (r_appos) dose_2\NN\3740161 (r_nsubjpass) needed_22\VBN\0 (l_advcl) suppress_24\VB\2510337 (l_dobj) arrhythmias_28\NNS\14103288
D004070_D001145 NONE digitalis-_9\NN\0 (r_amod) arrhythmia_14\NN\14103288
6118280
D002998_D009207 NONE clonazepam_4\NN\0 (r_nsubjpass) found_12\VBN\13279262 (l_xcomp) be_14\VB\14625458 (l_prep) in_27\IN\13603305 (l_pcomp) blocking_28\VBG\562280 (l_dobj) jerks_31\NNS\10322238
D009118_D009207 CID muscimol_7\NNS\0 (r_npadvmod) induced_9\VBN\1627355 (l_dobj) jerks_11\NNS\10322238
D009118_D009207 CID muscimol_5\NNS\0 (r_nsubj) produced_6\VBD\1617192 (l_dobj) jerks_8\NNS\10322238
D009118_D009207 CID muscimol_22\NN\0 (r_npadvmod) induced_24\VBN\1627355 (r_amod) myoclonus_25\NN\14360459 (r_appos) myoclonus_19\NN\14360459
D009118_D009207 CID muscimol_22\NN\0 (r_npadvmod) induced_24\VBN\1627355 (r_amod) myoclonus_25\NN\14360459
D001418_D009207 NONE baclofen_5\JJ\0 (r_compound) block_6\NN\21939 (r_conj) benzodiazepines_3\NNS\3771443 (r_conj) drugs_1\NNS\14778436 (r_nsubj) induced_9\VBN\1627355 (l_dobj) jerks_11\NNS\10322238
D001418_D009207 NONE -)-baclofen_11\:\0 (r_punct) in_12\IN\13603305 (l_pobj) management_14\NN\1123598 (l_prep) of_15\IN\0 (l_pobj) myoclonus_17\NN\14360459
D003975_D009207 NONE diazepam_20\NN\2830852 (r_pobj) than_19\IN\0 (r_prep) potent_18\JJ\0 (r_acomp) be_14\VB\14625458 (l_prep) in_27\IN\13603305 (l_pcomp) blocking_28\VBG\562280 (l_dobj) jerks_31\NNS\10322238
D001569_D009207 NONE benzodiazepines_3\NNS\3771443 (r_conj) drugs_1\NNS\14778436 (r_nsubj) induced_9\VBN\1627355 (l_dobj) jerks_11\NNS\10322238
D001569_D009207 NONE benzodiazepines_2\NNS\3771443 (r_pobj) of_0\IN\0 (r_prep) found_12\VBN\13279262 (l_xcomp) be_14\VB\14625458 (l_prep) in_27\IN\13603305 (l_pcomp) blocking_28\VBG\562280 (l_dobj) jerks_31\NNS\10322238
D001569_D009207 NONE benzodiazepines_7\NNS\3771443 (r_conj) 5-htp_4\NN\0 (r_nsubjpass) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_acomp) beneficial_13\JJ\0 (l_prep) in_14\IN\13603305 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) myoclonus_19\NN\14360459
D001569_D009207 NONE benzodiazepines_7\NNS\3771443 (r_conj) 5-htp_4\NN\0 (r_nsubjpass) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_acomp) beneficial_13\JJ\0 (l_prep) in_14\IN\13603305 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) myoclonus_19\NN\14360459 (l_appos) myoclonus_25\NN\14360459
D006916_D009207 NONE 5-htp_4\NN\0 (r_nsubjpass) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_acomp) beneficial_13\JJ\0 (l_prep) in_14\IN\13603305 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) myoclonus_19\NN\14360459
D006916_D009207 NONE 5-htp_4\NN\0 (r_nsubjpass) found_10\VBN\13279262 (l_xcomp) be_12\VB\14625458 (l_acomp) beneficial_13\JJ\0 (l_prep) in_14\IN\13603305 (l_pobj) management_16\NN\1123598 (l_prep) of_17\IN\0 (l_pobj) myoclonus_19\NN\14360459 (l_appos) myoclonus_25\NN\14360459
C014896_D009207 NONE mk-212_8\NNP\0 (r_punct) and_9\CC\0 (r_punct) -)-baclofen_11\:\0 (r_punct) in_12\IN\13603305 (l_pobj) management_14\NN\1123598 (l_prep) of_15\IN\0 (l_pobj) myoclonus_17\NN\14360459
20552622
D000420_D013617 CID salbutamol_7\NN\0 (r_pobj) by_6\IN\0 (r_agent) triggered_5\VBN\1641914 (r_acl) tachyarrhythmia_4\NN\0
D000420_D013617 CID salbutamol_0\NNP\0 (r_nsubjpass) presented_2\VBN\2137132 (l_prep) as_4\IN\14622893 (l_pobj) trigger_7\NN\3659292 (l_prep) for_8\IN\0 (l_pobj) siat_9\NNP\0
D001262_D013610 NONE atenolol_51\NN\2832168 (r_pobj) as_50\IN\14622893 (r_prep) blocker_48\NN\10101634 (r_nsubj) relieve_60\VB\205885 (r_conj) swallowing_42\VBG\1156834 (r_advcl) be_31\VB\14625458 (l_nsubj) agonist_21\NN\0 (l_acl) known_25\VBN\0 (l_xcomp) induce_27\VB\1627355 (l_dobj) tachycardia_28\NN\14110674
D001262_D001145 NONE atenolol_6\NN\2832168 (r_pobj) with_5\IN\0 (r_prep) resolved_2\VBD\352826 (l_nsubj) arrhythmia_1\NN\14103288
D001262_D001145 NONE atenolol_13\NN\2832168 (r_pobj) with_11\IN\0 (r_prep) week_10\NN\15113229 (r_pobj) after_8\IN\0 (r_prep) disappeared_17\VBD\0 (l_nsubj) arrhythmia_16\NN\14103288
D000420_D013610 NONE salbutamol_23\NN\0 (r_pobj) like_22\IN\5839024 (r_prep) agonist_21\NN\0 (l_acl) known_25\VBN\0 (l_xcomp) induce_27\VB\1627355 (l_dobj) tachycardia_28\NN\14110674
11282081
D002698_D001281 NONE chloralose_21\NN\0 (r_amod) dogs_23\NNS\2083346 (r_pobj) to_18\IN\0 (r_prep) administered_16\VBD\2436349 (l_advcl) evaluate_1\VB\670261 (l_dobj) mechanisms_4\NNS\13446390 (l_prep) of_5\IN\0 (l_pobj) promotion_7\NN\6598915 (l_compound) af_6\NNP\0
D004110_D001281 NONE diltiazem_0\NNP\2938514 (r_nsubj) affect_3\VB\26192 (l_dobj) erp_4\NNP\0 (l_conj) length_8\NN\5093581 (l_compound) af_6\NNP\0
D004110_D001281 NONE diltiazem_0\NNP\2938514 (r_nsubj) affect_3\VB\26192 (l_dobj) erp_4\NNP\0 (l_conj) length_8\NN\5093581 (l_conj) duration_11\NN\15113229 (l_compound) af_10\NNP\0
D004110_D001281 NONE diltiazem_23\NN\2938514 (r_pobj) by_22\IN\0 (r_agent) shared_21\VBN\2660631 (r_conj) effect_13\NN\34213 (r_dobj) promotes_1\VBZ\2556126 (l_dobj) af_2\NNP\0
D009020_D001281 NONE morphine_19\NN\2707683 (r_npadvmod) chloralose_21\NN\0 (r_amod) dogs_23\NNS\2083346 (r_pobj) to_18\IN\0 (r_prep) administered_16\VBD\2436349 (l_advcl) evaluate_1\VB\670261 (l_dobj) mechanisms_4\NNS\13446390 (l_prep) of_5\IN\0 (l_pobj) promotion_7\NN\6598915 (l_compound) af_6\NNP\0
D002118_D013617 NONE ca(2_23\NNP\0 (r_dobj) decreases_19\VBZ\7296428 (r_conj) promotes_7\VBZ\2556126 (l_nsubj) tachycardia_3\NN\14110674
D002118_D001281 NONE ca(2_23\NNP\0 (r_dobj) decreases_19\VBZ\7296428 (r_conj) promotes_7\VBZ\2556126 (l_dobj) occurrence_9\NN\29378 (l_prep) of_12\IN\0 (l_pobj) fibrillation_14\NN\14361664
D002118_D001281 NONE ca(2_23\NNP\0 (r_dobj) decreases_19\VBZ\7296428 (r_conj) promotes_7\VBZ\2556126 (l_dobj) occurrence_9\NN\29378 (l_prep) of_12\IN\0 (l_pobj) fibrillation_14\NN\14361664 (l_appos) af_16\NNP\0
D002118_D001281 NONE ca(2_11\NN\0 (r_nmod) channel_13\NN\6251781 (r_compound) blockade_14\NN\952963 (r_nsubj) promote_16\VB\2556126 (l_dobj) af_17\NNP\0
D002118_D001281 NONE ca(2_11\NN\0 (r_nmod) channel_13\NN\6251781 (r_compound) blockade_14\NN\952963 (r_nsubj) promote_16\VB\2556126 (l_advcl) consistent_19\JJ\0 (l_prep) with_20\IN\0 (l_pobj) effect_24\NN\34213 (l_compound) af_22\NNP\0
D002118_D001281 NONE ca(2_26\NNP\0 (r_nmod) inhibition_30\NN\1068773 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (r_pobj) with_20\IN\0 (r_prep) consistent_19\JJ\0 (r_advcl) promote_16\VB\2556126 (l_dobj) af_17\NNP\0
D002118_D001281 NONE ca(2_26\NNP\0 (r_nmod) inhibition_30\NN\1068773 (r_pobj) of_25\IN\0 (r_prep) effect_24\NN\34213 (l_compound) af_22\NNP\0
D002118_D001281 NONE ca(2_9\NNP\0 (r_nmod) blockers_13\NNS\10101634 (r_pobj) by_8\IN\0 (r_prep) promotion_7\NN\6598915 (l_compound) af_6\NNP\0
D014700_D001281 CID verapamil_2\NN\2938514 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_prep) on_3\IN\0 (l_pobj) fibrillation_5\NN\14361664
D014700_D001281 CID verapamil_17\NN\2938514 (r_dobj) administered_16\VBD\2436349 (l_advcl) evaluate_1\VB\670261 (l_dobj) mechanisms_4\NNS\13446390 (l_prep) of_5\IN\0 (l_pobj) promotion_7\NN\6598915 (l_compound) af_6\NNP\0
D014700_D001281 CID verapamil_1\NNP\2938514 (r_nsubj) caused_2\VBD\1617192 (l_dobj) promotion_4\NN\6598915 (l_compound) af_3\NNP\0
D014700_D001281 CID verapamil_1\NNP\2938514 (r_nsubj) caused_2\VBD\1617192 (l_advcl) increasing_9\VBG\169651 (l_dobj) duration_11\NN\15113229 (l_prep) of_12\IN\0 (l_pobj) af_13\NNP\0
D014700_D001281 CID verapamil_4\NN\2938514 (r_nsubj) shortened_5\VBN\429060 (l_conj) accelerated_43\VBN\226566 (l_conj) decreased_47\VBD\169651 (l_dobj) length_50\NN\5093581 (l_prep) of_51\IN\0 (l_pobj) 94+/-4_54\CD\0 (l_nmod) af_52\NNP\0
D014700_D001281 CID verapamil_22\NNP\2938514 (r_nmod) n=5_24\NNS\0 (r_pobj) by_21\IN\0 (r_agent) caused_20\VBN\1617192 (r_acl) that_19\DT\0 (r_pobj) to_18\IN\0 (r_prep) similar_17\JJ\0 (r_amod) acceleration_16\NN\7296428 (r_dobj) produced_14\VBD\1617192 (r_conj) affect_3\VB\26192 (l_dobj) erp_4\NNP\0 (l_conj) length_8\NN\5093581 (l_compound) af_6\NNP\0
D014700_D001281 CID verapamil_22\NNP\2938514 (r_nmod) n=5_24\NNS\0 (r_pobj) by_21\IN\0 (r_agent) caused_20\VBN\1617192 (r_acl) that_19\DT\0 (r_pobj) to_18\IN\0 (r_prep) similar_17\JJ\0 (r_amod) acceleration_16\NN\7296428 (r_dobj) produced_14\VBD\1617192 (r_conj) affect_3\VB\26192 (l_dobj) erp_4\NNP\0 (l_conj) length_8\NN\5093581 (l_conj) duration_11\NN\15113229 (l_compound) af_10\NNP\0
D014700_D001281 CID verapamil_7\NN\2938514 (r_nsubj) failed_8\VBD\0 (l_xcomp) promote_10\VB\2556126 (l_dobj) af_11\NNP\0
D014700_D001281 CID verapamil_4\NN\2938514 (r_nsubj) promoted_5\VBD\2556126 (l_dobj) af_6\NNP\0
D014700_D001281 CID verapamil_0\NNP\2938514 (r_nsubj) promotes_1\VBZ\2556126 (l_dobj) af_2\NNP\0
7650771
D004456_D064420 NONE iodide_8\NN\14904359 (r_compound) drops_10\VBZ\13899200 (r_pobj) of_6\IN\0 (r_prep) instillation_5\NN\320852 (r_pobj) from_3\IN\0 (r_prep) resulting_2\VBG\2633881 (r_acl) toxicity_1\NN\13576101
D004456_D018908 CID iodide_12\NN\14904359 (r_nmod) drops_14\NNS\13899200 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) from_7\IN\0 (r_prep) syndrome_6\NN\5870365 (r_dobj) developed_2\VBD\1753788 (l_conj) presented_16\VBN\2137132 (l_prep) with_17\IN\0 (l_pobj) weakness_20\NN\14462666
D004456_D009157 NONE iodide_12\NN\14904359 (r_nmod) drops_14\NNS\13899200 (r_pobj) of_10\IN\0 (r_prep) use_9\NN\407535 (r_pobj) from_7\IN\0 (r_prep) syndrome_6\NN\5870365 (r_dobj) developed_2\VBD\1753788 (l_conj) presented_16\VBN\2137132 (l_conj) given_24\VBN\5892096 (l_dobj) diagnosis_26\NN\152018 (l_prep) of_27\IN\0 (l_pobj) gravis_29\NN\0
19893084
D005839_D058186 CID gentamicin_12\NN\2716866 (r_pcomp) by_11\IN\0 (r_agent) induced_10\VBN\1627355 (r_acl) failure_9\NN\66216
7066357
D011692_D009404 CID aminonucleoside_18\RB\0 (r_advmod) induced_12\VBN\1627355 (l_nsubj) plasma_0\NN\5398023 (l_prep) during_6\IN\0 (l_pobj) development_8\NN\248977 (l_prep) of_9\IN\0 (l_pobj) syndrome_11\NN\5870365
D011692_D009404 CID aminonucleoside_19\NN\0 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) alterations_8\NNS\7283608 (l_prep) of_9\IN\0 (l_pobj) lipoproteins_11\NNS\14731135 (l_acl) found_12\VBN\13279262 (l_prep) in_13\IN\13603305 (l_pobj) syndrome_15\NN\5870365
D011692_D009404 CID aminonucleoside_19\NN\0 (r_pobj) by_17\IN\0 (r_agent) induced_16\VBN\1627355 (r_acl) alterations_8\NNS\7283608 (r_nsubj) were_20\VBD\0 (l_acomp) due_21\JJ\5174653 (l_prep) to_22\IN\0 (l_pobj) syndrome_24\NN\5870365
D011692_D009404 CID aminonucleoside_37\NN\0 (r_pobj) to_35\IN\0 (r_prep) were_20\VBD\0 (l_nsubj) alterations_8\NNS\7283608 (l_prep) of_9\IN\0 (l_pobj) lipoproteins_11\NNS\14731135 (l_acl) found_12\VBN\13279262 (l_prep) in_13\IN\13603305 (l_pobj) syndrome_15\NN\5870365
D011692_D009404 CID aminonucleoside_37\NN\0 (r_pobj) to_35\IN\0 (r_prep) were_20\VBD\0 (l_acomp) due_21\JJ\5174653 (l_prep) to_22\IN\0 (l_pobj) syndrome_24\NN\5870365
D011692_D009404 CID aminonucleoside_21\NN\0 (l_conj) development_32\NN\248977 (l_prep) of_33\IN\0 (l_pobj) syndrome_35\NN\5870365
D005227_D009404 NONE acids_10\NNS\14818238 (r_pobj) of_8\IN\0 (r_prep) level_7\NN\4916342 (r_nsubj) decreased_15\VBD\169651 (l_prep) in_0\IN\13603305 (l_pobj) stage_4\NN\15113229 (l_amod) nephrotic_3\JJ\0
D002788_D009404 NONE esters_22\NNS\14727670 (r_nsubj) remained_25\VBD\2604760 (r_advcl) decreased_15\VBD\169651 (l_prep) in_0\IN\13603305 (l_pobj) stage_4\NN\15113229 (l_amod) nephrotic_3\JJ\0
D014280_D009404 NONE triacylglycerol_12\NN\0 (r_conj) acids_10\NNS\14818238 (r_pobj) of_8\IN\0 (r_prep) level_7\NN\4916342 (r_nsubj) decreased_15\VBD\169651 (l_prep) in_0\IN\13603305 (l_pobj) stage_4\NN\15113229 (l_amod) nephrotic_3\JJ\0
3962737
D000638_D056486 CID amiodarone_2\NN\2715941 (r_pobj) of_1\IN\0 (r_prep) hepatotoxicity_0\NN\0
D000638_D056486 CID amiodarone_7\NN\2715941 (r_compound) treatment_8\NN\654885 (r_appos) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) hepatitis_4\NN\14127211
D000638_D056486 CID amiodarone_7\NN\2715941 (r_compound) treatment_8\NN\654885 (r_appos) patient_1\NN\9898892 (r_nsubjpass) presented_10\VBN\2137132 (l_conj) given_21\VBN\5892096 (l_nsubjpass) review_14\NN\5733583 (l_prep) of_15\IN\0 (l_pobj) hepatotoxicity_17\NN\0
D000638_D056486 CID amiodarone_19\NN\2715941 (r_pobj) of_18\IN\0 (r_prep) hepatotoxicity_17\NN\0 (r_pobj) of_15\IN\0 (r_prep) review_14\NN\5733583 (r_nsubjpass) given_21\VBN\5892096 (r_conj) presented_10\VBN\2137132 (l_nsubjpass) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) hepatitis_4\NN\14127211
D000638_D056486 CID amiodarone_19\NN\2715941 (r_pobj) of_18\IN\0 (r_prep) hepatotoxicity_17\NN\0
D000638_D056486 CID amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (r_prep) exists_6\VBZ\0 (l_prep) of_7\IN\0 (l_pobj) injury_9\NN\14052046
D000638_D056486 CID amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (l_pobj) alterations_18\NNS\7283608 (l_acl) resembling_19\VBG\2657219 (l_dobj) hepatitis_21\NN\14127211 (l_appos) cirrhosis_27\NN\14116321 (l_nmod) hepatitis_24\NN\14127211
D000638_D013610 NONE amiodarone_0\NNP\2715941 (r_nsubj) proved_2\VBN\2604760 (l_prep) in_5\IN\13603305 (l_pobj) treatment_7\NN\654885 (l_prep) of_8\IN\0 (l_pobj) tachyarrhythmias_12\NNS\0
D000638_D006519 NONE amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (l_pobj) alterations_18\NNS\7283608 (l_acl) resembling_19\VBG\2657219 (l_dobj) hepatitis_21\NN\14127211
D000638_D008103 CID amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (l_pobj) alterations_18\NNS\7283608 (l_acl) resembling_19\VBG\2657219 (l_dobj) hepatitis_21\NN\14127211 (l_appos) cirrhosis_27\NN\14116321 (l_prep) of_28\IN\0 (l_pobj) liver_30\NN\5298729
D000638_D002779 CID amiodarone_7\NN\2715941 (r_compound) treatment_8\NN\654885 (r_appos) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) hepatitis_4\NN\14127211
D000638_D002779 CID amiodarone_19\NN\2715941 (r_pobj) of_18\IN\0 (r_prep) hepatotoxicity_17\NN\0 (r_pobj) of_15\IN\0 (r_prep) review_14\NN\5733583 (r_nsubjpass) given_21\VBN\5892096 (r_conj) presented_10\VBN\2137132 (l_nsubjpass) patient_1\NN\9898892 (l_prep) with_2\IN\0 (l_pobj) hepatitis_4\NN\14127211
D000638_D002779 CID amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (r_pobj) to_11\IN\0 (r_pcomp) due_10\IN\5174653 (l_pobj) alterations_18\NNS\7283608 (l_acl) resembling_19\VBG\2657219 (l_dobj) hepatitis_21\NN\14127211 (l_appos) cirrhosis_27\NN\14116321 (l_nmod) hepatitis_24\NN\14127211
D000638_D005234 CID amiodarone_12\NN\2715941 (r_compound) treatment_13\NN\654885 (l_prep) including_15\VBG\0 (l_pobj) steatosis_16\NN\0
15096016
D007980_D018476 NONE levodopa_20\RB\14604959 (r_npadvmod) induced_22\VBN\1627355 (r_amod) dyskinesias_23\NNS\14084880 (r_dobj) improving_19\VBG\126264 (r_pcomp) in_18\IN\13603305 (r_prep) be_17\VB\14625458 (r_xcomp) seems_15\VBZ\2604760 (l_ccomp) improves_2\VBZ\126264 (l_dobj) bradykinesia_3\JJ\0
D007980_D009127 NONE levodopa_20\RB\14604959 (r_npadvmod) induced_22\VBN\1627355 (r_amod) dyskinesias_23\NNS\14084880 (r_dobj) improving_19\VBG\126264 (r_pcomp) in_18\IN\13603305 (r_prep) be_17\VB\14625458 (r_xcomp) seems_15\VBZ\2604760 (l_ccomp) improves_2\VBZ\126264 (l_dobj) bradykinesia_3\JJ\0 (l_conj) rigidity_5\NN\5023233
D007980_D004409 CID levodopa_20\RB\14604959 (r_npadvmod) induced_22\VBN\1627355 (r_amod) dyskinesias_23\NNS\14084880
8586822
D017673_D006973 CID chloride_31\NN\14818238 (r_compound) supplementation_32\NN\5108947 (r_pobj) of_28\IN\0 (r_prep) effect_27\NN\34213 (r_pobj) to_24\IN\0 (r_prep) contributes_22\VBZ\126264 (l_advcl) test_1\VB\5798043 (l_dobj) hypothesis_3\NN\7162194 (l_relcl) treated_10\VBN\2376958 (l_dobj) rats_13\NNS\2329401 (l_amod) hypertensive_12\JJ\10405694
D017673_D006973 CID chloride_31\NN\14818238 (r_compound) supplementation_32\NN\5108947 (r_pobj) of_28\IN\0 (r_prep) effect_27\NN\34213 (l_amod) hypertensive_26\JJ\10405694
D017673_D006973 CID chloride_19\NN\14818238 (r_npadvmod) induced_21\VBN\1627355 (r_amod) increase_22\NN\13576355 (l_prep) in_23\IN\13603305 (l_pobj) map_24\NNP\4076846
D002216_D006973 NONE captopril_12\FW\2673637 (r_npadvmod) treated_14\VBN\2376958 (l_dobj) rats_17\NNS\2329401 (l_amod) hypertensive_16\JJ\10405694
D002216_D006973 NONE captopril_8\FW\2673637 (r_npadvmod) treated_10\VBN\2376958 (l_dobj) rats_13\NNS\2329401 (l_amod) hypertensive_12\JJ\10405694
D002216_D006973 NONE captopril_8\FW\2673637 (r_npadvmod) treated_10\VBN\2376958 (r_relcl) hypothesis_3\NN\7162194 (r_dobj) test_1\VB\5798043 (r_advcl) contributes_22\VBZ\126264 (l_prep) to_24\IN\0 (l_pobj) effect_27\NN\34213 (l_amod) hypertensive_26\JJ\10405694
D018738_D006973 NONE hexamethonium_6\NN\0 (r_pobj) of_2\IN\0 (r_prep) infusion_1\NN\14589223 (r_nsubj) resulted_7\VBD\2633881 (l_prep) in_8\IN\13603305 (l_pobj) decline_11\NN\13458571 (l_relcl) eliminated_15\VBD\1619929 (l_dobj) increase_22\NN\13576355 (l_prep) in_23\IN\13603305 (l_pobj) map_24\NNP\4076846
7651879
D001569_D012131 NONE benzodiazepine_3\JJ\3771443 (r_amod) antagonist_5\NN\7846 (l_acl) used_6\VBD\0 (l_xcomp) reverse_8\VB\13854649 (l_dobj) sedation_9\NN\14034177 (l_conj) depression_12\NN\14373582
D001569_D012131 NONE benzodiazepines_15\NNS\3771443 (r_pobj) by_14\IN\0 (r_agent) induced_13\VBN\1627355 (r_acl) sedation_9\NN\14034177 (l_conj) depression_12\NN\14373582
D005442_D012131 NONE flumazenil_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) antagonist_5\NN\7846 (l_acl) used_6\VBD\0 (l_xcomp) reverse_8\VB\13854649 (l_dobj) sedation_9\NN\14034177 (l_conj) depression_12\NN\14373582
D005442_D012640 CID flumazenil_2\JJ\0 (r_compound) administration_3\NN\1133281 (r_pobj) after_1\IN\0 (r_prep) seizure_0\NN\14081375
D005442_D012640 CID flumazenil_19\JJ\0 (r_pobj) of_18\IN\0 (r_prep) administration_17\NN\1133281 (r_pobj) following_15\VBG\8180190 (r_acl) patient_14\NN\9898892 (r_pobj) in_11\IN\13603305 (r_prep) seizure_10\NN\14081375
6402369
D015080_D064420 NONE mesna_7\NNP\0 (r_compound) series_8\NN\8456993 (l_conj) series_13\NN\8456993 (l_prep) with_14\IN\0 (l_pobj) respect_15\NN\5817845 (l_prep) to_16\IN\0 (l_pobj) toxicity_21\NN\13576101
D015080_D008175 NONE sulphonate_13\JJ\0 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) by_7\IN\0 (r_prep) toxicity_6\NN\13576101 (r_pobj) of_1\IN\0 (r_prep) treatment_0\NN\654885 (l_prep) to_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) cancer_22\NN\14239425
D015080_D008175 NONE mesna_15\NNP\0 (r_appos) sulphonate_13\JJ\0 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) by_7\IN\0 (r_prep) toxicity_6\NN\13576101 (r_pobj) of_1\IN\0 (r_prep) treatment_0\NN\654885 (l_prep) to_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) cancer_22\NN\14239425
D015080_D008175 NONE sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) tested_26\VBN\670261 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) cancer_36\NN\14239425
D015080_D008175 NONE mesna_14\NNP\0 (r_appos) sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) tested_26\VBN\670261 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) cancer_36\NN\14239425
D013438_D001745 NONE thiol_8\JJ\0 (r_compound) sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) against_16\IN\0 (l_pobj) toxicity_18\NN\13576101
D013438_D008175 NONE thiol_8\JJ\0 (r_compound) sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) tested_26\VBN\670261 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) cancer_36\NN\14239425
D015080_D001745 NONE sulphonate_13\JJ\0 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) by_7\IN\0 (r_prep) toxicity_6\NN\13576101
D015080_D001745 NONE mesna_15\NNP\0 (r_appos) sulphonate_13\JJ\0 (r_pobj) of_10\IN\0 (r_prep) administration_9\NN\1133281 (r_pobj) by_7\IN\0 (r_prep) toxicity_6\NN\13576101
D015080_D001745 NONE sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) against_16\IN\0 (l_pobj) toxicity_18\NN\13576101
D015080_D001745 NONE mesna_14\NNP\0 (r_appos) sulphonate_12\JJ\0 (r_pobj) of_6\IN\0 (r_prep) administration_5\NN\1133281 (r_pobj) of_3\IN\0 (r_prep) effect_2\NN\34213 (l_prep) against_16\IN\0 (l_pobj) toxicity_18\NN\13576101
D007069_D001745 CID ifosfamide_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) toxicity_6\NN\13576101
D007069_D001745 CID ifosfamide_21\NN\0 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) toxicity_18\NN\13576101
D007069_D001745 CID if_23\IN\0 (r_mark) tested_26\VBN\670261 (l_nsubjpass) effect_2\NN\34213 (l_prep) against_16\IN\0 (l_pobj) toxicity_18\NN\13576101
D007069_D001745 CID if_40\IN\0 (r_mark) m2_45\NN\13357178 (r_pobj) with_39\IN\0 (r_prep) treatment_38\NN\654885 (r_pobj) under_37\IN\0 (r_prep) cancer_36\NN\14239425 (r_pobj) with_33\IN\0 (r_prep) patients_32\NNS\9898892 (r_pobj) of_30\IN\0 (r_prep) group_29\NN\2137 (r_pobj) in_27\IN\13603305 (r_prep) tested_26\VBN\670261 (l_nsubjpass) effect_2\NN\34213 (l_prep) against_16\IN\0 (l_pobj) toxicity_18\NN\13576101
D007069_D008175 NONE ifosfamide_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) toxicity_6\NN\13576101 (r_pobj) of_1\IN\0 (r_prep) treatment_0\NN\654885 (l_prep) to_17\IN\0 (l_pobj) patients_18\NNS\9898892 (l_prep) with_19\IN\0 (l_pobj) cancer_22\NN\14239425
D007069_D008175 NONE ifosfamide_21\NN\0 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) toxicity_18\NN\13576101 (r_pobj) against_16\IN\0 (r_prep) effect_2\NN\34213 (r_nsubjpass) tested_26\VBN\670261 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) cancer_36\NN\14239425
D007069_D008175 NONE if_23\IN\0 (r_mark) tested_26\VBN\670261 (l_prep) in_27\IN\13603305 (l_pobj) group_29\NN\2137 (l_prep) of_30\IN\0 (l_pobj) patients_32\NNS\9898892 (l_prep) with_33\IN\0 (l_pobj) cancer_36\NN\14239425
D007069_D008175 NONE if_40\IN\0 (r_mark) m2_45\NN\13357178 (r_pobj) with_39\IN\0 (r_prep) treatment_38\NN\654885 (r_pobj) under_37\IN\0 (r_prep) cancer_36\NN\14239425
8958188
C045894_D009369 NONE lometrexol_9\NN\0 (r_nsubj) has_10\VBZ\13888491 (l_dobj) activity_11\NN\30358 (l_prep) against_12\IN\0 (l_pobj) tumours_13\NNS\14234074
D005492_D064420 NONE acid_16\NN\14818238 (r_compound) administration_17\NN\1133281 (r_pobj) by_12\IN\0 (r_agent) prevented_11\VBN\0 (l_nsubjpass) toxicity_6\NN\13576101
D005492_D064420 NONE acid_13\NN\14818238 (r_compound) supplementation_14\NN\5108947 (l_relcl) confirmed_17\VBN\0 (l_ccomp) reduced_26\VBN\441445 (l_nsubjpass) toxicity_20\NN\13576101
D005492_D064420 NONE acid_29\NN\14818238 (r_compound) supplementation_30\NN\5108947 (r_pobj) by_27\IN\0 (r_agent) reduced_26\VBN\441445 (l_nsubjpass) toxicity_20\NN\13576101
D005492_D064420 NONE folate_13\JJ\15090742 (r_compound) elevation_14\NN\7445480 (r_pobj) of_11\IN\0 (r_prep) extent_10\NN\13939892 (r_conj) toxicity_7\NN\13576101
D005492_D064420 NONE acid_12\NN\14818238 (r_compound) administration_13\NN\1133281 (r_pobj) by_10\IN\0 (r_agent) altered_9\VBN\0 (l_advcl) indicating_14\VBG\952524 (l_ccomp) is_17\VBZ\0 (l_acomp) unlikely_18\JJ\0 (l_xcomp) reduce_20\VB\441445 (l_dobj) toxicity_21\NN\13576101
D008727_D009369 NONE methotrexate_22\NNP\2722166 (r_appos) drugs_19\NNS\14778436 (r_pobj) to_17\IN\0 (r_prep) refractory_16\JJ\3673767 (r_acomp) are_15\VBP\13600404 (r_relcl) tumours_13\NNS\14234074
C045894_D064420 NONE lometrexol_7\NN\0 (r_pobj) of_6\IN\0 (r_prep) development_5\NN\248977 (r_nsubjpass) curtailed_9\VBN\235368 (l_prep) because_10\IN\0 (l_pobj) toxicities_16\NNS\13576101
C045894_D064420 NONE lometrexol_8\NN\0 (r_pobj) of_7\IN\0 (r_prep) toxicity_6\NN\13576101
C045894_D064420 NONE lometrexol_9\NN\0 (r_pobj) of_8\IN\0 (r_prep) study_7\NN\635850 (l_acl) given_10\VBN\5892096 (l_prep) with_11\IN\0 (l_pobj) supplementation_14\NN\5108947 (l_relcl) confirmed_17\VBN\0 (l_ccomp) reduced_26\VBN\441445 (l_nsubjpass) toxicity_20\NN\13576101
C045894_D064420 NONE lometrexol_22\NN\0 (r_pobj) of_21\IN\0 (r_prep) toxicity_20\NN\13576101
C045894_D064420 NONE lometrexol_4\NN\0 (r_compound) plasma_5\NN\5398023 (r_compound) pharmacokinetics_6\NNS\6054892 (r_nsubjpass) altered_9\VBN\0 (l_advcl) indicating_14\VBG\952524 (l_ccomp) is_17\VBZ\0 (l_acomp) unlikely_18\JJ\0 (l_xcomp) reduce_20\VB\441445 (l_dobj) toxicity_21\NN\13576101
C045894_D064420 NONE lometrexol_24\NN\0 (r_compound) plasma_25\NN\5398023 (r_compound) clearance_26\NN\5089947 (r_dobj) enhancing_23\VBG\227165 (r_pcomp) by_22\IN\0 (r_prep) reduce_20\VB\441445 (l_dobj) toxicity_21\NN\13576101
1535072
D012701_D001008 NONE serotonin_23\NN\14807737 (r_compound) blockers_25\NNS\10101634 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) after_20\IN\0 (r_prep) suffered_16\VBD\2110220 (r_relcl) disorders_14\NNS\14034177 (r_conj) anxiety_10\NN\14373582
D015016_D020018 NONE yohimbine_0\NNP\0 (r_compound) treatment_1\NN\654885 (l_prep) of_2\IN\0 (l_pobj) effects_5\NNS\13245626
D015016_D020018 NONE yohimbine_6\NN\0 (r_nsubjpass) used_9\VBN\0 (l_xcomp) treat_11\VB\7570720 (l_dobj) effects_15\NNS\13245626
D015016_D020018 NONE yohimbine_3\NN\0 (r_dobj) evaluated_2\VBD\670261 (l_prep) as_4\IN\14622893 (l_pobj) treatment_6\NN\654885 (l_prep) for_7\IN\0 (l_pobj) effects_11\NNS\13245626
D015016_D020018 NONE yohimbine_28\NN\0 (r_dobj) given_27\VBN\5892096 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disorder_6\NN\14034177 (l_conj) trichotillomania_8\NN\9181557 (l_conj) anxiety_10\NN\14373582 (l_conj) disorders_14\NNS\14034177 (l_relcl) suffered_16\VBD\2110220 (l_dobj) effects_19\NNS\13245626
D015016_D020018 NONE yohimbine_7\NN\0 (r_nsubj) be_9\VB\14625458 (l_attr) treatment_12\NN\654885 (l_prep) for_13\IN\0 (l_pobj) effects_17\NNS\13245626
D012701_D020018 NONE serotonin_8\NN\14807737 (r_compound) blockers_10\NNS\10101634 (r_pobj) by_7\IN\0 (r_agent) induced_6\VBN\1627355 (r_acl) treatment_1\NN\654885 (l_prep) of_2\IN\0 (l_pobj) effects_5\NNS\13245626
D012701_D020018 NONE serotonin_14\NN\14807737 (r_compound) blockers_16\NNS\10101634 (r_pobj) by_13\IN\0 (r_agent) caused_12\VBN\1617192 (r_acl) effects_11\NNS\13245626
D012701_D020018 NONE serotonin_23\NN\14807737 (r_compound) blockers_25\NNS\10101634 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) after_20\IN\0 (r_prep) suffered_16\VBD\2110220 (l_dobj) effects_19\NNS\13245626
D012701_D020018 NONE serotonin_20\NN\14807737 (r_compound) blockers_22\NNS\10101634 (r_pobj) by_19\IN\0 (r_agent) caused_18\VBN\1617192 (r_acl) effects_17\NNS\13245626
D015016_D009771 NONE yohimbine_28\NN\0 (r_dobj) given_27\VBN\5892096 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disorder_6\NN\14034177
D012701_D019964 NONE serotonin_23\NN\14807737 (r_compound) blockers_25\NNS\10101634 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) after_20\IN\0 (r_prep) suffered_16\VBD\2110220 (r_relcl) disorders_14\NNS\14034177
D015016_D014256 NONE yohimbine_28\NN\0 (r_dobj) given_27\VBN\5892096 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disorder_6\NN\14034177 (l_conj) trichotillomania_8\NN\9181557
D015016_D007172 NONE yohimbine_6\NN\0 (r_nsubj) facilitates_7\VBZ\2547586 (l_conj) be_12\VB\14625458 (l_acomp) helpful_13\JJ\0 (l_prep) in_14\IN\13603305 (l_pobj) treatment_16\NN\654885 (l_prep) of_17\IN\0 (l_pobj) impotence_19\NN\4723816
D012701_D009771 NONE serotonin_23\NN\14807737 (r_compound) blockers_25\NNS\10101634 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) after_20\IN\0 (r_prep) suffered_16\VBD\2110220 (r_relcl) disorders_14\NNS\14034177 (r_conj) anxiety_10\NN\14373582 (r_conj) trichotillomania_8\NN\9181557 (r_conj) disorder_6\NN\14034177
D002997_D020018 CID clomipramine_17\NN\4482543 (r_pobj) of_16\IN\0 (r_prep) effects_15\NNS\13245626
D015016_D019964 NONE yohimbine_28\NN\0 (r_dobj) given_27\VBN\5892096 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disorder_6\NN\14034177 (l_conj) trichotillomania_8\NN\9181557 (l_conj) anxiety_10\NN\14373582 (l_conj) disorders_14\NNS\14034177
D012701_D014256 NONE serotonin_23\NN\14807737 (r_compound) blockers_25\NNS\10101634 (r_pobj) with_22\IN\0 (r_prep) treatment_21\NN\654885 (r_pobj) after_20\IN\0 (r_prep) suffered_16\VBD\2110220 (r_relcl) disorders_14\NNS\14034177 (r_conj) anxiety_10\NN\14373582 (r_conj) trichotillomania_8\NN\9181557
D015016_D001008 NONE yohimbine_28\NN\0 (r_dobj) given_27\VBN\5892096 (l_nsubjpass) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) disorder_6\NN\14034177 (l_conj) trichotillomania_8\NN\9181557 (l_conj) anxiety_10\NN\14373582
D015016_D001008 NONE yohimbine_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effects_1\NNS\13245626 (r_nsubj) included_4\VBD\0 (l_dobj) sweating_6\NN\13440063 (l_conj) anxiety_9\NN\14373582
7053705
D013866_D006504 CID 6-thioguanine_7\CD\0 (r_pobj) by_6\IN\0 (r_agent) caused_5\VBN\1617192 (r_acl) disease_4\NN\14061805
D013866_D006504 CID 6-thioguanine_27\CD\0 (r_punct) ._28\.\0 (r_punct) disease_5\NN\14061805 (l_prep) of_6\IN\0 (l_pobj) liver_8\NN\5298729
D013866_D006504 CID 6-thioguanine_35\CD\0 (r_pobj) to_34\IN\0 (r_prep) related_32\VBN\628491 (r_pobj) of_28\IN\0 (r_prep) case_27\NN\7283608 (r_attr) be_24\VB\14625458 (r_conj) presented_2\VBD\2137132 (l_dobj) opportunity_5\NN\14481929 (l_acl) observe_7\VB\2163746 (l_dobj) features_10\NNS\5849040 (l_prep) of_11\IN\0 (l_pobj) disease_18\NN\14061805
D013866_D054198 NONE 6-thioguanine_27\CD\0 (r_punct) ._28\.\0 (r_punct) disease_5\NN\14061805 (l_prep) of_6\IN\0 (l_pobj) liver_8\NN\5298729 (l_acl) developed_9\VBN\1753788 (l_prep) in_10\IN\13603305 (l_pobj) man_15\NN\9605289 (l_prep) with_16\IN\0 (l_pobj) leukemia_19\NN\14239918
8384253
D014750_D008228 NONE vincristine_10\NN\3917455 (r_pobj) with_9\IN\0 (r_prep) treated_8\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) lymphoma_7\NNP\14239918
D014750_D008228 NONE vincristine_37\NN\3917455 (r_pobj) of_36\IN\0 (r_prep) effects_35\NNS\13245626 (r_dobj) evaluate_31\VB\670261 (r_acl) order_29\NN\7168131 (r_pobj) in_28\IN\13603305 (r_prep) investigated_27\VBN\644583 (r_parataxis) treated_8\VBN\2376958 (l_nsubj) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) lymphoma_7\NNP\14239918
D014750_D009422 NONE vincristine_8\NN\3917455 (r_pobj) with_4\IN\0 (r_prep) are_17\VBP\13600404 (l_nsubj) signs_11\NNS\6643763 (l_conj) symptoms_13\NNS\5823932 (l_prep) of_14\IN\0 (l_pobj) neuropathy_16\NN\14204950
D014750_D009422 NONE vincristine_15\NN\3917455 (r_compound) neuropathy_16\NN\14204950
8111719
D007069_D006212 CID ifosfamide_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) neurotoxicity_5\NN\0 (r_conj) hallucinations_0\NNS\14376855
D007069_D006212 CID ifosfamide_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) effect_14\NN\34213 (r_attr) are_7\VBP\13600404 (l_nsubj) hallucinations_0\NNS\14376855
D007069_D006212 CID ifosfamide_3\RB\0 (r_npadvmod) induced_5\VBN\1627355 (r_amod) hallucinations_6\NNS\14376855
D007069_D006212 CID ifosfamide_6\RB\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hallucinations_9\NNS\14376855
D007069_D006212 CID ifosfamide_7\RB\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hallucinations_10\NNS\14376855
D007069_D020258 NONE ifosfamide_2\RB\0 (r_advmod) induced_4\VBN\1627355 (r_amod) neurotoxicity_5\NN\0
D007069_D020258 NONE ifosfamide_16\NN\0 (r_pobj) of_15\IN\0 (r_prep) effect_14\NN\34213 (r_attr) are_7\VBP\13600404 (l_nsubj) hallucinations_0\NNS\14376855 (l_prep) as_1\IN\14622893 (l_pobj) symptom_3\NN\5823932 (l_prep) of_4\IN\0 (l_pobj) neurotoxicity_6\NN\0
D007069_D020258 NONE ifosfamide_7\RB\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) hallucinations_10\NNS\14376855 (l_relcl) occur_14\VB\0 (l_prep) without_15\IN\0 (l_pobj) signs_17\NNS\6643763 (l_prep) of_18\IN\0 (l_pobj) neurotoxicity_19\NN\0
D006220_D011595 NONE haloperidol_12\NN\3713736 (r_appos) neuroleptics_8\NNS\4470232 (l_amod) marked_3\JJ\1296462 (l_auxpass) becomes_2\VBZ\146138 (l_nsubj) agitation_1\NN\14373582
9579567
D013629_D016889 CID tamoxifen_9\NN\2714883 (r_compound) use_10\NN\407535 (r_conj) cancer_7\NN\14239425
D013629_D016889 CID tamoxifen_4\NN\2714883 (r_dobj) received_3\VBN\2210855 (r_relcl) women_0\NNS\9605289 (r_nsubj) were_5\VBD\0 (l_acomp) likely_8\JJ\0 (l_xcomp) have_10\VB\7846 (l_dobj) cancer_12\NN\14239425
D013629_D016889 CID tamoxifen_8\NN\2714883 (r_advmod) received_7\VBN\2210855 (r_conj) had_2\VBD\0 (l_dobj) cancer_4\NN\14239425
D013629_D016889 CID tamoxifen_8\NN\2714883 (r_advmod) received_7\VBN\2210855 (r_conj) had_2\VBD\0 (r_relcl) women_0\NNS\9605289 (r_nsubj) had_9\VBD\0 (l_dobj) disease_12\NN\14061805 (l_conj) prognosis_15\NN\6748969 (l_prep) than_16\IN\0 (l_pobj) those_17\DT\0 (l_prep) with_18\IN\0 (l_pobj) cancer_20\NN\14239425
D013629_D016889 CID tamoxifen_7\NN\2714883 (r_pobj) of_6\IN\0 (r_prep) role_5\NN\719494 (l_prep) in_8\IN\13603305 (l_pobj) cancer_10\NN\14239425
D013629_D016889 CID tamoxifen_7\NN\2714883 (r_pobj) with_6\IN\0 (r_prep) treated_5\VBN\2376958 (r_acl) women_4\NNS\9605289 (r_pobj) in_3\IN\13603305 (r_prep) diagnosed_2\VBD\644583 (r_acl) cancers_1\NNS\14239425
D013629_D001943 NONE tamoxifen_1\NN\2714883 (r_nsubjpass) used_4\VBN\0 (l_prep) in_5\IN\13603305 (l_pobj) treatment_8\NN\654885 (l_compound) cancer_7\NN\14239425
D013629_D001943 NONE tamoxifen_1\NN\2714883 (r_nsubjpass) used_4\VBN\0 (l_conj) proposed_12\VBN\1010118 (l_prep) for_13\IN\0 (l_pobj) prevention_15\NN\1073995 (l_prep) of_16\IN\0 (l_pobj) cancer_18\NN\14239425
D013629_D001943 NONE tamoxifen_9\NN\2714883 (r_compound) use_10\NN\407535 (r_conj) cancer_7\NN\14239425 (r_pobj) between_5\IN\0 (r_prep) association_4\NN\8008335 (l_acl) treated_16\VBN\2376958 (l_prep) for_17\IN\0 (l_pobj) cancer_19\NN\14239425
D013629_D001943 NONE tamoxifen_7\NN\2714883 (r_pobj) of_6\IN\0 (r_prep) role_5\NN\719494 (r_dobj) suggest_2\VBP\1010118 (l_advcl) used_14\VBN\0 (l_xcomp) proposed_17\VBN\1010118 (l_prep) for_18\IN\0 (l_pobj) prevention_21\NN\1073995 (l_compound) cancer_20\NN\14239425
D013629_D001943 NONE tamoxifen_3\NN\2714883 (r_dobj) receive_2\VBP\2210855 (l_prep) for_4\IN\0 (l_pobj) cancer_6\NN\14239425
D013629_D001943 NONE tamoxifen_12\NN\2714883 (r_pobj) of_11\IN\0 (r_prep) ratio_10\NN\13815152 (r_pobj) of_5\IN\0 (r_prep) evaluation_4\NN\874067 (l_prep) as_13\IN\14622893 (l_pobj) treatment_16\NN\654885 (l_prep) for_17\IN\0 (l_pobj) cancer_19\NN\14239425
D013629_D020178 NONE tamoxifen_8\NN\2714883 (r_advmod) received_7\VBN\2210855 (r_conj) had_2\VBD\0 (r_relcl) women_0\NNS\9605289 (r_nsubj) had_9\VBD\0 (l_dobj) disease_12\NN\14061805
9669632
D020117_D010146 NONE cisapride_11\NN\0 (r_compound) therapy_12\NN\657604 (r_nmod) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_dobj) score_9\NN\5736149 (l_compound) pain_8\NN\14299637
D020117_D010146 NONE cisapride_25\NN\0 (r_conj) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_dobj) score_9\NN\5736149 (l_compound) pain_8\NN\14299637
D020117_D003248 NONE cisapride_36\NN\0 (r_conj) before_28\IN\0 (r_advmod) underwent_23\VBD\109660 (l_nsubj) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) ibs_5\NNP\0 (l_appos) predominant_9\JJ\0 (l_compound) constipation_7\NN\14299637
D020117_D003248 NONE cisapride_11\NN\0 (r_npadvmod) treated_13\VBN\2376958 (r_amod) patients_18\NNS\9898892 (r_pobj) in_10\IN\13603305 (r_prep) were_8\VBD\0 (l_nsubj) scores_1\NNS\13757724 (l_acl) relating_2\VBG\628491 (l_prep) to_3\IN\0 (l_pobj) severity_5\NN\5036394 (l_prep) of_6\IN\0 (l_pobj) constipation_7\NN\14299637
D020117_D003248 NONE cisapride_11\NN\0 (r_npadvmod) treated_13\VBN\2376958 (r_amod) patients_18\NNS\9898892 (l_amod) predominant_16\JJ\0 (l_compound) constipation_14\NN\14299637
D020117_D003967 NONE cisapride_36\NN\0 (r_conj) before_28\IN\0 (r_advmod) underwent_23\VBD\109660 (l_punct) ;_14\:\0 (l_preconj) predominant_17\JJ\0 (l_compound) diarrhoea_15\NN\14299637
D020117_D003967 NONE cisapride_14\NN\0 (r_nmod) groups_17\NNS\2137 (r_pobj) between_12\IN\0 (r_prep) observed_11\VBN\2163746 (l_prep) in_0\IN\13603305 (l_pobj) patients_4\NNS\9898892 (l_amod) predominant_3\JJ\0 (l_npadvmod) diarrhoea_1\NN\14299637
D020117_D003967 NONE cisapride_1\NN\0 (r_npadvmod) treated_3\VBN\2376958 (r_amod) patients_7\NNS\9898892 (l_amod) predominant_6\JJ\0 (l_npadvmod) diarrhoea_4\NN\14299637
D020117_D003967 NONE cisapride_11\NN\0 (r_compound) therapy_12\NN\657604 (r_nmod) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_amod) predominant_2\JJ\0 (l_npadvmod) diarrhoea_0\NN\14299637
D020117_D003967 NONE cisapride_25\NN\0 (r_conj) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_amod) predominant_2\JJ\0 (l_npadvmod) diarrhoea_0\NN\14299637
D020117_D043183 NONE cisapride_2\NN\0 (r_pobj) of_1\IN\0 (r_prep) effects_0\NNS\13245626 (l_conj) function_11\NN\13783581 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) syndrome_17\NN\5870365
D020117_D043183 NONE cisapride_17\NN\0 (l_prep) on_19\IN\0 (l_pobj) motility_22\NN\4773351 (l_prep) in_25\IN\13603305 (l_pobj) syndrome_29\NN\5870365
D020117_D043183 NONE cisapride_17\NN\0 (l_prep) on_19\IN\0 (l_pobj) motility_22\NN\4773351 (l_prep) in_25\IN\13603305 (l_pobj) syndrome_29\NN\5870365 (l_appos) ibs_31\NNP\0
D020117_D043183 NONE cisapride_36\NN\0 (r_conj) before_28\IN\0 (r_advmod) underwent_23\VBD\109660 (l_nsubj) patients_3\NNS\9898892 (l_prep) with_4\IN\0 (l_pobj) ibs_5\NNP\0
D020117_D043183 NONE cisapride_11\NN\0 (r_npadvmod) treated_13\VBN\2376958 (r_amod) patients_18\NNS\9898892 (l_compound) ibs_17\NNP\0
D020117_D043183 NONE cisapride_11\NN\0 (r_compound) therapy_12\NN\657604 (r_nmod) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_compound) ibs_3\NNP\0
D020117_D043183 NONE cisapride_25\NN\0 (r_conj) score_14\NN\5736149 (r_advcl) had_5\VBD\0 (l_nsubj) patients_4\NNS\9898892 (l_compound) ibs_3\NNP\0
D020117_D043183 NONE cisapride_0\NNP\0 (r_nsubj) affects_1\VBZ\26192 (l_dobj) characteristics_4\NNS\5849040 (l_conj) symptoms_7\NNS\5823932 (l_prep) in_8\IN\13603305 (l_pobj) ibs_9\NNP\0
873132
D004997_D002779 CID estradiol_12\NN\14749794 (r_npadvmod) induced_14\VBN\1627355 (r_amod) cholestasis_15\NN\14052403
D003840_D002779 NONE acid_9\NN\14818238 (r_pobj) of_7\IN\0 (r_prep) hydroxylation_6\NN\0 (r_dobj) decreased_3\VBD\169651 (l_dobj) cholestasis_15\NN\14052403
20973483
D006220_D002375 CID haloperidol_53\NN\3713736 (r_npadvmod) induced_55\VBN\1627355 (r_amod) catalepsy_56\NN\14023236
D015632_D002375 NONE mptp_80\NNP\0 (r_npadvmod) treated_82\VBN\2376958 (r_amod) model_87\NN\5888929 (r_conj) across_37\IN\0 (l_pobj) number_39\NN\5107765 (l_prep) of_40\IN\0 (l_pobj) models_42\NNS\5888929 (l_prep) of_43\IN\0 (l_pobj) disease_46\NN\14061805 (l_prep) including_47\VBG\0 (l_pobj) models_51\NNS\5888929 (l_prep) of_52\IN\0 (l_pobj) catalepsy_56\NN\14023236
D006220_D004409 NONE haloperidol_53\NN\3713736 (r_npadvmod) induced_55\VBN\1627355 (r_amod) catalepsy_56\NN\14023236 (l_appos) model_59\NN\5888929 (l_prep) of_60\IN\0 (l_pobj) akinesia_64\NN\14558226
D058915_D010300 NONE antagonist_11\NN\7846 (l_prep) in_12\IN\13603305 (l_pobj) models_14\NNS\5888929 (l_prep) of_15\IN\0 (l_pobj) disease_18\NN\14061805
D058915_D010300 NONE antagonist_11\NN\7846 (l_prep) in_12\IN\13603305 (l_pobj) models_15\NNS\5888929 (l_prep) of_16\IN\0 (l_pobj) disease_19\NN\14061805
D015632_D004409 NONE mptp_80\NNP\0 (r_npadvmod) treated_82\VBN\2376958 (r_amod) model_87\NN\5888929 (r_conj) across_37\IN\0 (l_pobj) number_39\NN\5107765 (l_prep) of_40\IN\0 (l_pobj) models_42\NNS\5888929 (l_prep) of_43\IN\0 (l_pobj) disease_46\NN\14061805 (l_prep) including_47\VBG\0 (l_pobj) models_51\NNS\5888929 (l_prep) of_52\IN\0 (l_pobj) catalepsy_56\NN\14023236 (l_appos) model_59\NN\5888929 (l_prep) of_60\IN\0 (l_pobj) akinesia_64\NN\14558226
D016627_D002375 NONE 6-hydroxydopamine_67\NN\0 (r_nmod) 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236
D016627_D002375 NONE 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236
D012110_D004409 CID reserpine_61\NN\2721160 (r_npadvmod) induced_63\VBN\1627355 (r_compound) akinesia_64\NN\14558226
D016627_D010300 NONE 6-hydroxydopamine_67\NN\0 (r_nmod) 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236 (r_pobj) of_52\IN\0 (r_prep) models_51\NNS\5888929 (r_pobj) including_47\VBG\0 (r_prep) disease_46\NN\14061805
D016627_D010300 NONE 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236 (r_pobj) of_52\IN\0 (r_prep) models_51\NNS\5888929 (r_pobj) including_47\VBG\0 (r_prep) disease_46\NN\14061805
D012110_D010300 NONE reserpine_61\NN\2721160 (r_npadvmod) induced_63\VBN\1627355 (r_compound) akinesia_64\NN\14558226 (r_pobj) of_60\IN\0 (r_prep) model_59\NN\5888929 (r_appos) catalepsy_56\NN\14023236 (r_pobj) of_52\IN\0 (r_prep) models_51\NNS\5888929 (r_pobj) including_47\VBG\0 (r_prep) disease_46\NN\14061805
D012110_D002375 NONE reserpine_61\NN\2721160 (r_npadvmod) induced_63\VBN\1627355 (r_compound) akinesia_64\NN\14558226 (r_pobj) of_60\IN\0 (r_prep) model_59\NN\5888929 (r_appos) catalepsy_56\NN\14023236
D006220_D010300 NONE haloperidol_53\NN\3713736 (r_npadvmod) induced_55\VBN\1627355 (r_amod) catalepsy_56\NN\14023236 (r_pobj) of_52\IN\0 (r_prep) models_51\NNS\5888929 (r_pobj) including_47\VBG\0 (r_prep) disease_46\NN\14061805
D016627_D004409 NONE 6-hydroxydopamine_67\NN\0 (r_nmod) 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236 (l_appos) model_59\NN\5888929 (l_prep) of_60\IN\0 (l_pobj) akinesia_64\NN\14558226
D016627_D004409 NONE 6-ohda_69\CD\0 (r_nummod) model_72\NN\5888929 (r_appos) catalepsy_56\NN\14023236 (l_appos) model_59\NN\5888929 (l_prep) of_60\IN\0 (l_pobj) akinesia_64\NN\14558226
D015632_D010300 NONE mptp_80\NNP\0 (r_npadvmod) treated_82\VBN\2376958 (r_amod) model_87\NN\5888929 (r_conj) across_37\IN\0 (l_pobj) number_39\NN\5107765 (l_prep) of_40\IN\0 (l_pobj) models_42\NNS\5888929 (l_prep) of_43\IN\0 (l_pobj) disease_46\NN\14061805
3183120
C033706_D001927 CID tiazofurin_5\NN\0 (r_compound) usage_6\NN\407535 (r_pobj) with_4\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) lesions_2\NNS\14204950
9549528
D007980_D020734 NONE dopa_9\NN\14601829 (r_npadvmod) induced_11\VBN\1627355 (r_amod) dyskinesia_15\NN\14084880 (r_pobj) with_6\IN\0 (r_prep) patients_5\NNS\9898892 (l_amod) parkinsonian_4\JJ\0
D007980_D020734 NONE dopa_42\NN\14601829 (r_compound) medication_43\NN\3247620 (r_pobj) on_39\IN\0 (r_prep) patients_38\NNS\9898892 (l_amod) parkinsonian_37\JJ\0
D007980_D020734 NONE dopa_51\NN\14601829 (r_pobj) without_48\IN\0 (r_prep) one_47\NN\13741022 (r_nsubj) induced_52\VBD\1627355 (r_conj) studied_2\VBN\0 (l_dobj) flow_7\NN\7311115 (l_conj) changes_11\NNS\7283608 (l_acl) induced_12\VBN\1627355 (l_agent) by_13\IN\0 (l_pobj) execution_15\NN\1161161 (l_prep) in_26\IN\13603305 (l_pobj) cortex_32\NN\5462674 (l_prep) of_33\IN\0 (l_pobj) groups_35\NNS\2137 (l_prep) of_36\IN\0 (l_pobj) patients_38\NNS\9898892 (l_amod) parkinsonian_37\JJ\0
D007980_D004409 CID dopa_9\NN\14601829 (r_npadvmod) induced_11\VBN\1627355 (r_amod) dyskinesia_15\NN\14084880
D007980_D004409 CID dopa_42\NN\14601829 (r_compound) medication_43\NN\3247620 (r_pobj) on_39\IN\0 (r_prep) patients_38\NNS\9898892 (r_pobj) of_36\IN\0 (r_prep) groups_35\NNS\2137 (r_pobj) of_33\IN\0 (r_prep) cortex_32\NN\5462674 (r_pobj) in_26\IN\13603305 (r_prep) execution_15\NN\1161161 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) changes_11\NNS\7283608 (r_conj) flow_7\NN\7311115 (r_dobj) studied_2\VBN\0 (l_conj) induced_52\VBD\1627355 (l_dobj) dyskinesia_53\NN\14084880
D007980_D004409 CID dopa_42\NN\14601829 (r_compound) medication_43\NN\3247620 (r_pobj) on_39\IN\0 (r_prep) patients_38\NNS\9898892 (r_pobj) of_36\IN\0 (r_prep) groups_35\NNS\2137 (r_pobj) of_33\IN\0 (r_prep) cortex_32\NN\5462674 (r_pobj) in_26\IN\13603305 (r_prep) execution_15\NN\1161161 (r_pobj) by_13\IN\0 (r_agent) induced_12\VBN\1627355 (r_acl) changes_11\NNS\7283608 (r_conj) flow_7\NN\7311115 (r_dobj) studied_2\VBN\0 (l_conj) induced_52\VBD\1627355 (l_dobj) dyskinesia_53\NN\14084880 (l_conj) other_61\JJ\0 (l_prep) with_62\IN\0 (l_pobj) dyskinesia_67\NN\14084880
D007980_D004409 CID dopa_51\NN\14601829 (r_pobj) without_48\IN\0 (r_prep) one_47\NN\13741022 (r_nsubj) induced_52\VBD\1627355 (l_dobj) dyskinesia_53\NN\14084880
D007980_D004409 CID dopa_51\NN\14601829 (r_pobj) without_48\IN\0 (r_prep) one_47\NN\13741022 (r_nsubj) induced_52\VBD\1627355 (l_dobj) dyskinesia_53\NN\14084880 (l_conj) other_61\JJ\0 (l_prep) with_62\IN\0 (l_pobj) dyskinesia_67\NN\14084880
D007980_D004409 CID dopa_17\NN\14601829 (r_npadvmod) induced_19\VBN\1627355 (r_amod) dyskinesia_22\NN\14084880 (r_pobj) like_14\IN\5839024 (r_prep) movement_12\NN\191142
D007980_D004409 CID dopa_17\NN\14601829 (r_npadvmod) induced_19\VBN\1627355 (r_amod) dyskinesia_22\NN\14084880
D007980_D006948 NONE dopa_17\NN\14601829 (r_npadvmod) induced_19\VBN\1627355 (r_amod) dyskinesia_22\NN\14084880 (r_pobj) like_14\IN\5839024 (r_prep) movement_12\NN\191142 (l_amod) hyperkinetic_9\JJ\0
18239197
D014282_D003072 CID trihexyphenidyl_10\JJ\0 (r_pcomp) after_9\IN\0 (r_prep) associated_3\VBN\628491 (r_acl) slowing_2\NN\7296428
D014282_D003072 CID trihexyphenidyl_5\JJ\0 (r_pobj) of_4\IN\0 (r_prep) dose_3\NN\3740161 (r_nsubj) resulted_6\VBD\2633881 (l_prep) in_7\IN\13603305 (l_pobj) ratings_10\NNS\5733583 (l_prep) of_11\IN\0 (l_pobj) slowness_13\NN\5648247
D014282_D003072 CID trihexyphenidyl_10\JJ\0 (r_pobj) between_7\IN\0 (r_prep) scores_6\NNS\13757724 (l_prep) on_13\IN\0 (l_pobj) ratings_14\NNS\5733583 (l_prep) of_15\IN\0 (l_pobj) slowness_17\NN\5648247
D014282_D003072 CID trihexyphenidyl_14\JJ\0 (r_amod) challenge_16\NN\13927383 (r_pobj) after_13\IN\0 (r_prep) slowing_12\NN\7296428
D014282_D003221 NONE trihexyphenidyl_19\NN\0 (l_prep) on_20\IN\0 (l_pobj) measures_21\NNS\168237 (l_acl) reflecting_22\VBG\923793 (l_dobj) sedation_23\NN\14034177 (l_conj) confusion_25\NN\13972797
D014282_D003221 NONE trihexyphenidyl_32\NN\0 (r_npadvmod) induced_34\VBN\1627355 (r_amod) effects_36\NNS\13245626 (r_pobj) between_31\IN\0 (r_prep) relationship_30\NN\31921 (r_dobj) investigate_28\VB\644583 (r_conj) examine_9\VB\0 (l_dobj) relationship_11\NN\31921 (l_conj) effects_17\NNS\13245626 (l_prep) of_18\IN\0 (l_pobj) trihexyphenidyl_19\NN\0 (l_prep) on_20\IN\0 (l_pobj) measures_21\NNS\168237 (l_acl) reflecting_22\VBG\923793 (l_dobj) sedation_23\NN\14034177 (l_conj) confusion_25\NN\13972797
17241657
C107044_D012640 NONE 21_15\CD\13745420 (r_nummod) /-)-sm_14\SYM\0 (r_conj) umb24_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) pretreatment_4\NN\0 (r_nsubj) attenuated_17\VBN\224901 (l_dobj) convulsions_21\NNS\14081375
C519696_D012640 NONE umb24_10\NNP\0 (r_pobj) with_9\IN\0 (r_prep) pretreatment_4\NN\0 (r_nsubj) attenuated_17\VBN\224901 (l_dobj) convulsions_21\NNS\14081375
D003042_D012640 CID cocaine_21\NN\3492717 (r_pobj) of_20\IN\0 (r_prep) actions_19\NNS\30358 (l_amod) convulsive_11\JJ\0
D003042_D012640 CID cocaine_18\NN\3492717 (r_npadvmod) induced_20\VBN\1627355 (r_amod) convulsions_21\NNS\14081375
20558148
D006220_D002375 CID haloperidol_12\NN\3713736 (r_npadvmod) induced_14\VBN\1627355 (r_amod) catalepsy_15\NN\14023236
D006220_D002375 CID haloperidol_25\NN\3713736 (r_appos) blocker_24\NN\10101634 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) catalepsy_18\NN\14023236
D006220_D002375 CID haloperidol_0\NN\3713736 (r_npadvmod) induced_2\VBN\1627355 (r_amod) catalepsy_3\NN\14023236
D006220_D002375 CID haloperidol_15\NN\3713736 (r_pobj) of_14\IN\0 (r_prep) injections_13\NNS\320852 (r_pobj) to_11\IN\0 (r_prep) previous_10\JJ\0 (r_amod) ap7_9\RB\0 (r_conj) microinjection_5\NN\0 (r_dobj) showed_2\VBD\2137132 (l_ccomp) attenuated_17\VBD\224901 (l_dobj) catalepsy_19\NN\14023236
D006220_D002375 CID haloperidol_17\NN\3713736 (r_npadvmod) induced_19\VBN\1627355 (r_amod) catalepsy_20\NN\14023236
D018698_D002375 NONE glutamate_11\NN\15010703 (r_compound) antagonists_14\NNS\7846 (r_pobj) of_10\IN\0 (r_prep) microinjections_9\NNS\0 (r_pobj) with_6\IN\0 (r_prep) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D018698_D002375 NONE glutamate_4\NN\15010703 (r_npadvmod) mediated_6\VBN\761713 (r_amod) mechanisms_7\NNS\13446390 (l_prep) in_8\IN\13603305 (l_pobj) circuits_11\NNS\3269401 (l_prep) at_12\IN\14622893 (l_pobj) catalepsy_20\NN\14023236
D016291_D002375 NONE mk-801_16\NNP\0 (r_punct) microl_22\NN\0 (r_dobj) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D016291_D002375 NONE mk-801_7\NNP\0 (r_punct) and_8\CC\0 (r_cc) microinjection_5\NN\0 (r_dobj) showed_2\VBD\2137132 (l_ccomp) attenuated_17\VBD\224901 (l_dobj) catalepsy_19\NN\14023236
C031231_D002375 NONE ap7_25\RB\0 (r_conj) microl_22\NN\0 (r_dobj) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
C031231_D002375 NONE ap7_9\RB\0 (r_conj) microinjection_5\NN\0 (r_dobj) showed_2\VBD\2137132 (l_ccomp) attenuated_17\VBD\224901 (l_dobj) catalepsy_19\NN\14023236
D004298_D002375 NONE dopamine_22\NN\14807737 (r_compound) receptor_23\NN\5225602 (r_compound) blocker_24\NN\10101634 (r_pobj) by_20\IN\0 (r_agent) induced_19\VBN\1627355 (r_acl) catalepsy_18\NN\14023236
D016202_D002375 NONE nmda_4\NNP\0 (r_compound) receptors_5\NNS\5225602 (r_pobj) by_3\IN\0 (r_agent) mediated_2\VBN\761713 (r_acl) neurotransmission_1\NN\0 (r_nsubj) modulate_11\VB\1724459 (l_dobj) catalepsy_15\NN\14023236
D016202_D002375 NONE nmda_12\NNP\0 (r_compound) receptor_13\NN\5225602 (r_compound) antagonists_14\NNS\7846 (r_pobj) of_10\IN\0 (r_prep) microinjections_9\NNS\0 (r_pobj) with_6\IN\0 (r_prep) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D016202_D002375 NONE nmda_37\NNP\0 (r_compound) receptor_38\NN\5225602 (r_pobj) of_35\IN\0 (r_prep) microl_22\NN\0 (r_dobj) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D016202_D002375 NONE aspartate_46\NNP\0 (r_nmod) nmda_48\NNP\0 (r_appos) receptor_38\NN\5225602 (r_pobj) of_35\IN\0 (r_prep) microl_22\NN\0 (r_dobj) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D016202_D002375 NONE nmda_48\NNP\0 (r_appos) receptor_38\NN\5225602 (r_pobj) of_35\IN\0 (r_prep) microl_22\NN\0 (r_dobj) challenged_5\VBN\869596 (l_nsubjpass) catalepsy_3\NN\14023236
D000596_D002375 NONE acid_9\NN\14818238 (r_npadvmod) mediated_11\VBN\761713 (r_amod) mechanisms_12\NNS\13446390 (r_pobj) of_6\IN\0 (r_prep) influence_5\NN\5190804 (l_prep) on_16\IN\0 (l_pobj) catalepsy_18\NN\14023236
10027919
D002117_D001851 CID calcitriol_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) suppresses_2\VBZ\2510337 (l_conj) has_17\VBZ\13888491 (l_dobj) drawbacks_19\NNS\5161614 (l_prep) including_21\VBG\0 (l_pobj) hypercalcemia_22\NN\14299637 (l_conj) suppression_25\NN\13489037 (l_prep) of_26\IN\0 (l_pobj) turnover_28\NN\13819207
D002117_D001851 CID calcitriol_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) suppresses_2\VBZ\2510337 (l_conj) has_17\VBZ\13888491 (l_dobj) drawbacks_19\NNS\5161614 (l_prep) including_21\VBG\0 (l_pobj) hypercalcemia_22\NN\14299637 (l_conj) suppression_25\NN\13489037 (l_prep) of_26\IN\0 (l_pobj) turnover_28\NN\13819207 (l_relcl) lead_32\VB\5155821 (l_prep) to_33\IN\0 (l_pobj) disease_36\NN\14061805
D002117_D006934 CID calcitriol_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) suppresses_2\VBZ\2510337 (l_conj) has_17\VBZ\13888491 (l_dobj) drawbacks_19\NNS\5161614 (l_prep) including_21\VBG\0 (l_pobj) hypercalcemia_22\NN\14299637
C051883_D001851 NONE 22-oxacalcitriol_0\JJ\0 (r_nsubj) suppresses_1\VBZ\2510337 (l_prep) without_4\IN\0 (l_pcomp) inducing_5\VBG\42311 (l_dobj) turnover_8\NN\13819207
C051883_D001851 NONE oct_6\NNP\15209706 (r_nsubj) prevent_10\VB\0 (r_advcl) be_24\VB\14625458 (l_advcl) induce_37\VB\1627355 (l_dobj) turnover_40\NN\13819207
C051883_D001851 NONE oct_6\NNP\15209706 (r_nsubj) prevent_10\VB\0 (r_advcl) be_24\VB\14625458 (l_advcl) induce_37\VB\1627355 (l_conj) increase_47\VB\13576355 (l_dobj) risk_49\NN\14541044 (l_prep) of_50\IN\0 (l_pobj) disease_53\NN\14061805
C051883_-1 NONE oct_4\NNP\15209706 (r_nsubj) reversed_5\VBD\109660 (l_dobj) formation_8\NN\7938773 (l_prep) as_11\IN\14622893 (l_pobj) osteoid_13\NN\0
C051883_D006934 CID oct_6\NNP\15209706 (r_nsubj) prevent_10\VB\0 (l_dobj) occurrence_12\NN\29378 (l_prep) of_13\IN\0 (l_pobj) hypercalcemia_14\NN\14299637
C051883_D005355 NONE oct_4\NNP\15209706 (r_nsubj) reversed_5\VBD\109660 (l_dobj) formation_8\NN\7938773 (l_prep) as_11\IN\14622893 (l_pobj) osteoid_13\NN\0 (l_conj) fibrosis_15\NN\14204950
C051883_D006962 NONE 22-oxacalcitriol_0\JJ\0 (r_nsubj) suppresses_1\VBZ\2510337 (l_dobj) hyperparathyroidism_3\NN\14059928
C051883_D006962 NONE oct_7\NNP\15209706 (r_nsubj) stabilized_14\VBD\126264 (l_prep) in_0\IN\13603305 (l_pobj) hyperparathyroidism_5\NN\14059928
C051883_D006962 NONE oct_6\NNP\15209706 (r_nsubj) prevent_10\VB\0 (r_advcl) be_24\VB\14625458 (l_prep) in_27\IN\13603305 (l_pobj) management_29\NN\1123598 (l_prep) of_30\IN\0 (l_pobj) hyperparathyroidism_32\NN\14059928
D002117_D051437 NONE calcitriol_0\NNP\0 (r_compound) therapy_1\NN\657604 (r_nsubj) suppresses_2\VBZ\2510337 (l_prep) in_11\IN\13603305 (l_pobj) patients_12\NNS\9898892 (l_prep) with_13\IN\0 (l_pobj) failure_15\NN\66216
C051883_D051437 NONE 22-oxacalcitriol_0\JJ\0 (r_nsubj) suppresses_1\VBZ\2510337 (l_prep) without_4\IN\0 (l_pcomp) inducing_5\VBG\42311 (l_dobj) turnover_8\NN\13819207 (l_prep) in_9\IN\13603305 (l_pobj) dogs_10\NNS\2083346 (l_prep) with_11\IN\0 (l_pobj) failure_13\NN\66216
C051883_D051437 NONE oct_4\NNP\15209706 (r_nsubj) decreased_6\VBD\169651 (l_prep) after_11\IN\0 (l_pobj) induction_13\NN\7450842 (l_prep) of_14\IN\0 (l_pobj) insufficiency_16\NN\14462946
C051883_D051437 NONE oct_6\NNP\15209706 (r_nsubj) prevent_10\VB\0 (l_dobj) occurrence_12\NN\29378 (l_prep) in_15\IN\13603305 (l_pobj) dogs_17\NNS\2083346 (l_prep) with_18\IN\0 (l_pobj) insufficiency_20\NN\14462946
C051883_D007674 NONE oct_9\NNP\15209706 (r_pobj) of_8\IN\0 (r_prep) effects_7\NNS\13245626 (l_prep) on_10\IN\0 (l_pobj) levels_13\NNS\4916342 (l_conj) turnover_16\NN\13819207 (l_prep) in_17\IN\13603305 (l_pobj) states_18\NNS\8491826 (l_prep) of_19\IN\0 (l_pobj) function_24\NN\13783581
7189975
C004616_D012640 CID chloroprocaine_31\NN\0 (r_compound) group_32\NN\2137 (r_pobj) of_29\IN\0 (r_prep) %_28\NN\0 (r_pobj) in_26\IN\13603305 (r_prep) was_15\VBD\0 (l_nsubj) dose_2\NN\3740161 (l_appos) convulsions_8\NNS\14081375
C004616_D012640 CID chloroprocaine_31\NN\0 (r_compound) group_32\NN\2137 (r_pobj) of_29\IN\0 (r_prep) %_28\NN\0 (r_pobj) in_26\IN\13603305 (r_prep) was_15\VBD\0 (l_prep) in_17\IN\13603305 (l_pobj) %_19\NN\0 (l_prep) of_20\IN\0 (l_pobj) seizures_24\NNS\14081375
D002045_D012640 CID bupivacaine_21\NN\0 (r_npadvmod) induced_23\VBN\1627355 (r_amod) seizures_24\NNS\14081375 (r_pobj) of_20\IN\0 (r_prep) %_19\NN\0 (r_pobj) in_17\IN\13603305 (r_prep) was_15\VBD\0 (l_nsubj) dose_2\NN\3740161 (l_appos) convulsions_8\NNS\14081375
D002045_D012640 CID bupivacaine_21\NN\0 (r_npadvmod) induced_23\VBN\1627355 (r_amod) seizures_24\NNS\14081375
D008012_D012640 CID lidocaine_40\NN\3681148 (r_compound) group_41\NN\2137 (r_pobj) of_38\IN\0 (r_prep) %_37\NN\0 (r_pobj) in_35\IN\13603305 (r_conj) in_26\IN\13603305 (r_prep) was_15\VBD\0 (l_nsubj) dose_2\NN\3740161 (l_appos) convulsions_8\NNS\14081375
D008012_D012640 CID lidocaine_40\NN\3681148 (r_compound) group_41\NN\2137 (r_pobj) of_38\IN\0 (r_prep) %_37\NN\0 (r_pobj) in_35\IN\13603305 (r_conj) in_26\IN\13603305 (r_prep) was_15\VBD\0 (l_prep) in_17\IN\13603305 (l_pobj) %_19\NN\0 (l_prep) of_20\IN\0 (l_pobj) seizures_24\NNS\14081375
7724492
D003487_D007674 NONE cyanoacrylate_7\JJ\0 (r_compound) nanoparticles_8\NNS\0 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101
D004317_D005921 NONE doxorubicin_1\NN\2716866 (r_npadvmod) loaded_3\VBN\452512 (r_amod) nanoparticle_4\NN\0 (r_nmod) toxicity_9\NN\13576101 (r_nsubjpass) explored_11\VBN\789138 (l_prep) in_12\IN\13603305 (l_pobj) rats_15\NNS\2329401 (l_conj) rats_17\NNS\2329401 (l_prep) with_18\IN\0 (l_pobj) glomerulonephritis_20\NN\14113798
D004317_D005921 NONE dx_10\NNP\0 (r_pobj) given_9\VBN\5892096 (r_prep) rats_8\NNS\2329401 (r_nsubj) died_11\VBD\146138 (l_prep) in_0\IN\13603305 (l_pobj) rats_1\NNS\2329401 (l_prep) with_2\IN\0 (l_pobj) glomerulonephritis_5\NN\14113798
D004317_D011507 CID dx_16\NNP\0 (r_pobj) with_15\IN\0 (r_prep) treated_14\VBN\2376958 (r_acl) those_13\DT\0 (r_pobj) in_12\IN\13603305 (r_prep) than_11\IN\0 (r_prep) treated_8\VBN\2376958 (r_acl) animals_7\NNS\4475 (r_pobj) in_6\IN\13603305 (r_prep) appeared_5\VBD\2604760 (l_nsubj) proteinuria_4\NN\14299637
D004317_D011507 CID doxorubicin_22\NN\2716866 (r_compound) treatment_23\NN\654885 (r_pobj) after_21\IN\0 (r_prep) prolonged_20\VBN\317700 (r_conj) intense_13\JJ\0 (r_acomp) was_7\VBD\0 (r_conj) appeared_1\VBD\2604760 (l_nsubj) proteinuria_0\NNP\14299637
D004317_D011507 CID dx_39\NNP\0 (r_conj) dxnp_37\NNP\0 (r_pobj) between_36\IN\0 (r_prep) difference_35\NN\4723816 (r_pobj) without_33\IN\0 (r_prep) was_7\VBD\0 (r_conj) appeared_1\VBD\2604760 (l_nsubj) proteinuria_0\NNP\14299637
D004317_D007674 NONE doxorubicin_4\NN\2716866 (r_nmod) nanoparticles_8\NNS\0 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101
D004317_D007674 NONE adriamycin)-loaded_6\VBN\0 (r_amod) nanoparticles_8\NNS\0 (r_pobj) of_3\IN\0 (r_prep) toxicity_2\NN\13576101
D004317_D007674 NONE doxorubicin_1\NN\2716866 (r_npadvmod) loaded_3\VBN\452512 (r_amod) nanoparticle_4\NN\0 (r_nmod) toxicity_9\NN\13576101
D004317_D007674 NONE dx_16\NNP\0 (r_pobj) than_14\IN\0 (r_prep) animals_13\NNS\4475 (r_dobj) killed_11\VBD\0 (l_prep) despite_18\IN\7501545 (l_prep) of_19\IN\0 (l_pobj) toxicity_23\NN\13576101
15565293
D004977_D051437 NONE emb_7\NNP\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) neuropathy_11\NN\14204950 (r_pobj) of_6\IN\0 (r_prep) management_5\NN\1123598 (r_pobj) of_4\IN\0 (r_prep) terms_3\NNS\13945919 (r_pobj) in_2\IN\13603305 (r_prep) is_14\VBZ\0 (l_acomp) important_15\JJ\0 (l_xcomp) manage_18\VB\2524171 (l_dobj) dosing_20\VBG\515154 (l_prep) in_21\IN\13603305 (l_pobj) patients_22\NNS\9898892 (l_prep) with_23\IN\0 (l_pobj) impairment_25\NN\7296428
D004977_D051437 NONE ethambutol_19\NN\0 (r_amod) dosing_20\VBG\515154 (l_prep) in_21\IN\13603305 (l_pobj) patients_22\NNS\9898892 (l_prep) with_23\IN\0 (l_pobj) impairment_25\NN\7296428
D004977_D014376 NONE ethambutol_0\NNP\0 (r_nsubj) is_1\VBZ\0 (l_attr) agent_4\NN\7347 (l_acl) used_6\VBD\0 (l_xcomp) treat_8\VB\7570720 (l_dobj) tuberculosis_9\NN\14127211
D004977_D009901 CID ethambutol_10\NN\0 (r_advmod) induced_12\VBN\1627355 (r_amod) neuropathy_14\NN\14204950
D004977_D009901 CID ethambutol_14\NN\0 (r_advmod) induced_16\VBN\1627355 (r_amod) neuropathy_18\NN\14204950
D004977_D009901 CID ethambutol_4\NN\0 (r_pobj) of_3\IN\0 (r_prep) complication_2\NN\1073995 (r_nsubj) is_5\VBZ\0 (l_attr) neuropathy_8\NN\14204950
D004977_D009901 CID ethambutol_6\NN\0 (r_amod) neuropathy_10\NN\14204950
D004977_D009901 CID emb)-induced_8\VBN\0 (r_amod) optic_9\JJ\5299178 (r_compound) neuropathy_10\NN\14204950
D004977_D009901 CID emb_6\NNP\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) neuropathy_10\NN\14204950
D004977_D009901 CID emb_7\NNP\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) neuropathy_11\NN\14204950
D004977_D009901 CID ethambutol_19\NN\0 (r_amod) dosing_20\VBG\515154 (r_dobj) manage_18\VB\2524171 (r_xcomp) important_15\JJ\0 (r_acomp) is_14\VBZ\0 (l_prep) in_2\IN\13603305 (l_pobj) terms_3\NNS\13945919 (l_prep) of_4\IN\0 (l_pobj) management_5\NN\1123598 (l_prep) of_6\IN\0 (l_pobj) neuropathy_11\NN\14204950
D004977_D009410 NONE ethambutol_14\NN\0 (r_advmod) induced_16\VBN\1627355 (r_amod) neuropathy_18\NN\14204950 (r_pobj) in_13\IN\13603305 (r_prep) degeneration_12\NN\29677
D004977_D014786 CID ethambutol_6\NN\0 (r_amod) neuropathy_10\NN\14204950 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) with_2\IN\0 (r_prep) subjects_1\NNS\6598915 (r_nsubjpass) administered_23\VBN\2436349 (l_nsubjpass) deficits_21\NNS\5113133
D004977_D014786 CID emb)-induced_8\VBN\0 (r_amod) optic_9\JJ\5299178 (r_compound) neuropathy_10\NN\14204950 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) with_2\IN\0 (r_prep) subjects_1\NNS\6598915 (r_nsubjpass) administered_23\VBN\2436349 (l_nsubjpass) deficits_21\NNS\5113133
D004977_D014786 CID emb_6\NNP\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) neuropathy_10\NN\14204950 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) with_3\IN\0 (r_prep) subjects_2\NNS\6598915 (r_pobj) in_0\IN\13603305 (r_prep) was_13\VBD\0 (l_attr) loss_16\NN\13252973 (l_prep) with_32\IN\0 (l_pobj) recovery_34\NN\7357388 (l_prep) with_48\IN\0 (l_pobj) deficits_51\NNS\5113133
D004977_D014786 CID emb_6\NNP\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) neuropathy_10\NN\14204950 (r_pobj) of_5\IN\0 (r_prep) history_4\NN\15120823 (r_pobj) with_3\IN\0 (r_prep) subjects_2\NNS\6598915 (r_pobj) in_0\IN\13603305 (r_prep) was_13\VBD\0 (l_attr) loss_16\NN\13252973 (l_conj) loss_55\NN\13252973 (l_conj) c_58\NN\13714184 (l_prep) with_60\IN\0 (l_pobj) deficits_63\NNS\5113133
17074608
D014635_D002819 CID valproate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) chorea_3\NN\14253124
D014635_D002819 CID valproate_32\NN\0 (r_amod) therapy_33\NN\657604 (r_pobj) of_31\IN\0 (r_prep) initiation_30\NN\7450842 (r_pobj) after_29\IN\0 (r_prep) presentation_22\NN\1027379 (l_prep) with_23\IN\0 (l_pobj) encephalopathy_25\NN\14084880 (l_conj) chorea_27\NN\14253124
D005998_D000592 NONE glycine_15\NN\14601829 (r_compound) system_17\NN\3575240 (r_pobj) in_13\IN\13603305 (r_prep) defect_12\NN\14462666 (r_nsubj) leads_18\VBZ\5155821 (r_relcl) metabolism_8\NN\13526110
D005998_D000592 NONE glycine_23\NN\14601829 (r_pobj) of_22\IN\0 (r_prep) accumulation_21\NN\13497135 (r_pobj) to_19\IN\0 (r_prep) leads_18\VBZ\5155821 (r_relcl) metabolism_8\NN\13526110
D005998_D020158 NONE glycine_15\NN\14601829 (r_compound) system_17\NN\3575240 (r_pobj) in_13\IN\13603305 (r_prep) defect_12\NN\14462666 (r_nsubj) leads_18\VBZ\5155821 (r_relcl) metabolism_8\NN\13526110 (r_pobj) of_5\IN\0 (r_prep) disorder_4\NN\14034177 (r_attr) is_2\VBZ\0 (l_nsubj) hyperglycinemia_1\NN\0
D005998_D020158 NONE glycine_23\NN\14601829 (r_pobj) of_22\IN\0 (r_prep) accumulation_21\NN\13497135 (r_pobj) to_19\IN\0 (r_prep) leads_18\VBZ\5155821 (r_relcl) metabolism_8\NN\13526110 (r_pobj) of_5\IN\0 (r_prep) disorder_4\NN\14034177 (r_attr) is_2\VBZ\0 (l_nsubj) hyperglycinemia_1\NN\0
D014635_D020158 NONE valproate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) chorea_3\NN\14253124 (l_conj) encephalopathy_5\JJ\14084880 (l_prep) in_6\IN\13603305 (l_pobj) hyperglycinemia_9\NN\0
D014635_D020158 NONE valproate_32\NN\0 (r_amod) therapy_33\NN\657604 (r_pobj) of_31\IN\0 (r_prep) initiation_30\NN\7450842 (r_pobj) after_29\IN\0 (r_prep) presentation_22\NN\1027379 (r_pobj) following_20\VBG\8180190 (r_prep) found_15\VBN\13279262 (l_xcomp) have_17\VB\7846 (l_dobj) hyperglycinemia_19\NN\0
D014635_D001927 CID valproate_0\NNP\0 (r_npadvmod) induced_2\VBN\1627355 (r_amod) chorea_3\NN\14253124 (l_conj) encephalopathy_5\JJ\14084880
D014635_D001927 CID valproate_32\NN\0 (r_amod) therapy_33\NN\657604 (r_pobj) of_31\IN\0 (r_prep) initiation_30\NN\7450842 (r_pobj) after_29\IN\0 (r_prep) presentation_22\NN\1027379 (l_prep) with_23\IN\0 (l_pobj) encephalopathy_25\NN\14084880
D014635_D008607 NONE valproate_32\NN\0 (r_amod) therapy_33\NN\657604 (r_pobj) of_31\IN\0 (r_prep) initiation_30\NN\7450842 (r_pobj) after_29\IN\0 (r_prep) presentation_22\NN\1027379 (r_pobj) following_20\VBG\8180190 (r_prep) found_15\VBN\13279262 (r_relcl) delay_8\NN\15271008 (l_conj) retardation_11\NN\7296428
D014635_D007805 NONE valproate_32\NN\0 (r_amod) therapy_33\NN\657604 (r_pobj) of_31\IN\0 (r_prep) initiation_30\NN\7450842 (r_pobj) after_29\IN\0 (r_prep) presentation_22\NN\1027379 (r_pobj) following_20\VBG\8180190 (r_prep) found_15\VBN\13279262 (r_relcl) delay_8\NN\15271008
15580403
D012254_D019698 NONE ribavirin_3\JJ\2725367 (r_compound) reduction_4\NN\351485 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) hemolysis_8\NN\13509528 (l_prep) during_9\IN\0 (l_pobj) therapy_11\NN\657604 (l_prep) for_16\IN\0 (l_pobj) c._19\NNP\0
D012254_D019698 NONE ribavirin_15\RB\2725367 (r_conj) interferon_13\NN\2725367 (r_pobj) of_12\IN\0 (r_prep) therapy_11\NN\657604 (l_prep) for_16\IN\0 (l_pobj) c._19\NNP\0
D007372_D000743 CID interferon_14\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) therapy_12\NN\657604 (r_pobj) of_9\IN\0 (r_prep) events_8\NNS\23100 (r_pobj) of_4\IN\0 (r_prep) one_3\CD\13741022 (r_attr) is_2\VBZ\0 (l_nsubj) anemia_1\NN\14189204
D012254_D000740 NONE ribavirin_9\NN\2725367 (r_pobj) of_8\IN\0 (r_prep) reduction_7\NN\351485 (r_pobj) with_6\IN\0 (r_prep) patients_5\NNS\9898892 (r_nsubj) continue_12\VB\2367363 (l_advcl) decreased_24\VBD\169651 (l_conj) occurred_33\VBD\0 (l_nsubj) effects_32\NNS\13245626 (l_amod) related_29\VBN\628491 (l_npadvmod) anemia_27\NN\14189204
D007372_D019698 NONE interferon_13\NN\2725367 (r_pobj) of_12\IN\0 (r_prep) therapy_11\NN\657604 (l_prep) for_16\IN\0 (l_pobj) c._19\NNP\0
D007372_D006461 NONE interferon_13\NN\2725367 (r_pobj) of_12\IN\0 (r_prep) therapy_11\NN\657604 (r_pobj) during_9\IN\0 (r_prep) hemolysis_8\NN\13509528
D012254_D006461 NONE ribavirin_3\JJ\2725367 (r_compound) reduction_4\NN\351485 (l_prep) in_5\IN\13603305 (l_pobj) patients_6\NNS\9898892 (l_prep) with_7\IN\0 (l_pobj) hemolysis_8\NN\13509528
D012254_D006461 NONE ribavirin_15\RB\2725367 (r_conj) interferon_13\NN\2725367 (r_pobj) of_12\IN\0 (r_prep) therapy_11\NN\657604 (r_pobj) during_9\IN\0 (r_prep) hemolysis_8\NN\13509528
D012254_D006461 NONE ribavirin_13\JJ\2725367 (r_compound) reduction_14\NN\351485 (l_prep) in_15\IN\13603305 (l_pobj) patients_16\NNS\9898892 (l_prep) with_17\IN\0 (l_pobj) hemolysis_18\NN\13509528
D012254_D000743 CID ribavirin_16\NN\2725367 (r_conj) interferon_14\NN\2725367 (r_pobj) of_13\IN\0 (r_prep) therapy_12\NN\657604 (r_pobj) of_9\IN\0 (r_prep) events_8\NNS\23100 (r_pobj) of_4\IN\0 (r_prep) one_3\CD\13741022 (r_attr) is_2\VBZ\0 (l_nsubj) anemia_1\NN\14189204
D012254_D000743 CID ribavirin_2\RB\2725367 (r_npadvmod) related_4\VBN\628491 (r_amod) anemia_6\NN\14189204
12600698
D013307_D015837 CID streptomycin_5\NN\2716866 (r_npadvmod) induced_7\VBN\1627355 (r_amod) vestibulotoxicity_8\NN\0
D013307_D015837 CID streptomycin_5\NNS\2716866 (r_npadvmod) induced_7\VBN\1627355 (r_amod) vestibulotoxicity_8\NN\0
D013307_D015837 CID streptomycin_6\NN\2716866 (r_npadvmod) induced_8\VBN\1627355 (r_amod) vestibulotoxicity_9\NN\0
C005435_D015837 NONE edaravone_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (l_prep) against_4\IN\0 (l_pobj) vestibulotoxicity_8\NN\0
C005435_D015837 NONE edaravone_10\NN\0 (r_pobj) by_9\IN\0 (r_prep) alleviation_3\NN\7492516 (l_prep) of_4\IN\0 (l_pobj) vestibulotoxicity_8\NN\0
C005435_D015837 NONE edaravone_4\NN\0 (r_nsubj) suppresses_5\VBZ\2510337 (l_dobj) vestibulotoxicity_9\NN\0
C005435_D002544 NONE edaravone_0\NNP\0 (r_nsubj) has_7\VBZ\13888491 (l_conj) used_15\VBN\0 (l_xcomp) treat_20\VB\7570720 (l_dobj) infarction_22\NN\14204950
18541230
D011692_D006402 NONE aminonucleoside_6\NN\0 (r_advmod) induced_8\VBN\1627355 (r_amod) abnormalities_10\NNS\14034177
D011692_D009404 NONE aminonucleoside_18\RB\0 (r_advmod) induced_20\VBN\1627355 (r_amod) nephrosis_21\NN\14304060 (l_relcl) is_24\VBZ\0 (l_attr) model_27\NN\5888929 (l_prep) of_28\IN\0 (l_pobj) syndrome_31\NN\5870365
D011692_D009404 NONE aminonucleoside_14\RB\0 (r_advmod) induced_16\VBN\1627355 (r_amod) syndrome_18\NN\5870365
D011692_D009401 CID aminonucleoside_6\JJ\0 (r_amod) nephrosis_7\NN\14304060
D011692_D009401 CID aminonucleoside_18\RB\0 (r_advmod) induced_20\VBN\1627355 (r_amod) nephrosis_21\NN\14304060
D011692_D006949 NONE aminonucleoside_1\RB\0 (r_advmod) induced_3\VBN\1627355 (r_amod) dysfunction_5\NN\14204950 (l_conj) hyperlipidemia_7\NN\14299637
D011692_D007674 NONE aminonucleoside_1\RB\0 (r_advmod) induced_3\VBN\1627355 (r_amod) dysfunction_5\NN\14204950
48362
D011802_D056486 CID quinidine_0\NN\2715941 (r_compound) hepatitis_1\NN\14127211
D011802_D056486 CID quinidine_6\VBN\2715941 (r_poss) hepatotoxicity_7\NN\0
17263743
D003000_D001008 NONE clonidine_16\NN\2721160 (r_pobj) of_15\IN\0 (r_prep) doses_14\NNS\3740161 (r_dobj) administered_12\VBD\2436349 (l_advcl) reduce_26\VB\441445 (l_dobj) anxiety_27\NN\14373582
D003000_D004827 NONE clonidine_18\NN\2721160 (r_dobj) receiving_17\VBG\2210855 (r_advcl) present_1\VBP\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) child_9\NN\9622049 (l_prep) with_10\IN\0 (l_pobj) disorder_15\NN\14034177
D001418_D002547 NONE baclofen_28\JJ\0 (r_compound) pump_29\NN\3736970 (r_pobj) of_26\IN\0 (r_prep) placement_25\NN\5074774 (r_pobj) for_24\IN\0 (r_prep) presented_23\VBD\2137132 (r_relcl) restlessness_20\NN\4773351 (r_pobj) for_19\IN\0 (r_prep) receiving_17\VBG\2210855 (r_advcl) present_1\VBP\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) child_9\NN\9622049 (l_prep) with_10\IN\0 (l_pobj) disorder_15\NN\14034177 (l_nmod) palsy_12\JJ\14557898
C009250_D006323 NONE sevoflurane_9\NN\0 (r_amod) induction_10\NN\7450842 (r_dobj) undergoing_8\VBG\109660 (r_acl) arrest_1\NN\88481
D003000_D011595 NONE clonidine_18\NN\2721160 (r_dobj) receiving_17\VBG\2210855 (l_prep) for_19\IN\0 (l_pobj) restlessness_20\NN\4773351
D003000_D006323 CID clonidine_15\NN\2721160 (r_pobj) after_13\IN\0 (r_prep) anesthesia_12\NN\14034177 (r_pobj) of_11\IN\0 (r_prep) induction_10\NN\7450842 (r_dobj) undergoing_8\VBG\109660 (r_acl) arrest_1\NN\88481
D003000_D006323 CID clonidine_6\NN\2721160 (r_npadvmod) associated_8\VBN\628491 (r_amod) arrest_10\NN\88481
C009250_D002547 NONE sevoflurane_9\NN\0 (r_amod) induction_10\NN\7450842 (r_dobj) undergoing_8\VBG\109660 (r_acl) arrest_1\NN\88481 (l_prep) in_2\IN\13603305 (l_pobj) child_4\NN\9622049 (l_prep) with_5\IN\0 (l_pobj) palsy_7\JJ\14557898
D003000_D002547 NONE clonidine_15\NN\2721160 (r_pobj) after_13\IN\0 (r_prep) anesthesia_12\NN\14034177 (r_pobj) of_11\IN\0 (r_prep) induction_10\NN\7450842 (r_dobj) undergoing_8\VBG\109660 (r_acl) arrest_1\NN\88481 (l_prep) in_2\IN\13603305 (l_pobj) child_4\NN\9622049 (l_prep) with_5\IN\0 (l_pobj) palsy_7\JJ\14557898
D003000_D002547 NONE clonidine_18\NN\2721160 (r_dobj) receiving_17\VBG\2210855 (r_advcl) present_1\VBP\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) child_9\NN\9622049 (l_prep) with_10\IN\0 (l_pobj) disorder_15\NN\14034177 (l_nmod) palsy_12\JJ\14557898
D001418_D011595 NONE baclofen_28\JJ\0 (r_compound) pump_29\NN\3736970 (r_pobj) of_26\IN\0 (r_prep) placement_25\NN\5074774 (r_pobj) for_24\IN\0 (r_prep) presented_23\VBD\2137132 (r_relcl) restlessness_20\NN\4773351
D001418_D004827 NONE baclofen_28\JJ\0 (r_compound) pump_29\NN\3736970 (r_pobj) of_26\IN\0 (r_prep) placement_25\NN\5074774 (r_pobj) for_24\IN\0 (r_prep) presented_23\VBD\2137132 (r_relcl) restlessness_20\NN\4773351 (r_pobj) for_19\IN\0 (r_prep) receiving_17\VBG\2210855 (r_advcl) present_1\VBP\28270 (l_dobj) case_3\NN\7283608 (l_prep) of_4\IN\0 (l_pobj) child_9\NN\9622049 (l_prep) with_10\IN\0 (l_pobj) disorder_15\NN\14034177
10910842
D011239_D009468 NONE prednisolone_8\NN\2721538 (r_pobj) after_7\IN\0 (r_prep) dysfunction_6\NN\14204950
D000109_D009133 NONE acetylcholine_22\NN\14807558 (r_compound) expression_24\NN\4679549 (r_pobj) in_21\IN\13603305 (r_prep) changes_20\NNS\7283608 (r_pobj) from_19\IN\0 (r_prep) less_18\JJR\14187378 (r_advmod) derive_17\VB\634472 (r_conj) derive_11\VBP\634472 (l_prep) from_13\IN\0 (l_pobj) atrophy_15\NN\14299637
D011239_D009133 CID prednisolone_8\NN\2721538 (r_pobj) after_7\IN\0 (r_prep) dysfunction_6\NN\14204950 (r_nsubj) is_9\VBZ\0 (l_conj) derives_15\VBZ\634472 (l_prep) from_17\IN\0 (l_pobj) atrophy_19\NN\14299637
D000109_D001284 NONE acetylcholine_13\NN\14807558 (r_compound) expression_15\NN\4679549 (r_pobj) by_11\IN\0 (r_prep) than_10\IN\0 (r_prep) atrophy_9\NN\14299637
D014403_D013746 NONE tubocurarine_27\NN\14712692 (r_pobj) of_24\IN\0 (r_prep) curves_23\NNS\13863771 (r_conj) fatigability_16\NN\5040275 (r_conj) tensions_13\NNS\14375890 (l_compound) tetanic_12\JJ\0
D011239_D018908 CID prednisolone_0\NNP\2721538 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dysfunction_4\NN\14204950
D000109_D018908 NONE acetylcholine_13\NN\14807558 (r_compound) expression_15\NN\4679549 (r_pobj) by_11\IN\0 (r_prep) than_10\IN\0 (r_prep) atrophy_9\NN\14299637 (r_pobj) by_8\IN\0 (r_agent) caused_6\VBN\1617192 (l_nsubjpass) dysfunction_4\NN\14204950
D011239_D001284 NONE prednisolone_0\NNP\2721538 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dysfunction_4\NN\14204950 (r_nsubjpass) caused_6\VBN\1617192 (l_agent) by_8\IN\0 (l_pobj) atrophy_9\NN\14299637
2750819
D008278_D020879 CID sulfate_4\NN\15010703 (r_pobj) with_2\IN\0 (r_prep) blockade_1\NN\952963
D008278_D020879 CID sulfate_15\NN\15010703 (r_pobj) of_13\IN\0 (r_prep) mg_12\NN\13717155 (r_nsubjpass) administered_17\VBN\2436349 (l_nsubjpass) patient_1\NN\9898892 (l_relcl) received_3\VBD\2210855 (l_dobj) tocolysis_4\NN\0 (l_prep) with_5\IN\0 (l_pobj) blockade_9\NN\952963
D008274_D064420 NONE magnesium_11\NN\14625458 (r_pobj) of_10\IN\0 (r_prep) toxicity_9\NN\13576101
D009543_D064420 NONE nifedipine_4\NN\2938514 (r_nsubj) potentiate_7\VB\229605 (l_dobj) toxicity_9\NN\13576101
D009543_D020879 CID nifedipine_6\NN\2938514 (r_conj) sulfate_4\NN\15010703 (r_pobj) with_2\IN\0 (r_prep) blockade_1\NN\952963
D009543_D020879 CID nifedipine_6\NN\2938514 (r_nmod) blockade_9\NN\952963
8494478
D002939_D007674 NONE ciprofloxacin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) nephrotoxicity_3\NN\0
D002939_D007674 NONE ciprofloxacin_3\NNS\2716866 (r_pobj) with_2\IN\0 (r_prep) associated_1\VBN\628491 (r_acl) nephrotoxicity_0\NN\0
D002939_D058186 CID ciprofloxacin_13\NNS\2716866 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_dobj) followed_10\VBD\1835496 (r_relcl) failure_8\NN\66216
D002939_D058186 CID ciprofloxacin_18\NNS\2716866 (r_npadvmod) induced_20\VBN\1627355 (r_amod) failure_23\NN\66216
D002939_D009369 NONE ciprofloxacin_0\NNP\2716866 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) nephrotoxicity_3\NN\0 (l_prep) in_4\IN\13603305 (l_pobj) patients_5\NNS\9898892 (l_prep) with_6\IN\0 (l_pobj) cancer_7\NN\14239425
D002939_D009369 NONE ciprofloxacin_13\NNS\2716866 (r_pobj) with_12\IN\0 (r_prep) treatment_11\NN\654885 (r_dobj) followed_10\VBD\1835496 (r_relcl) failure_8\NN\66216 (r_dobj) developed_5\VBD\1753788 (r_relcl) patients_1\NNS\9898892 (l_prep) with_2\IN\0 (l_pobj) cancer_3\NN\14239425
10524660
D005996_D008881 NONE gtn_14\NNP\0 (r_compound) infusion_15\NN\14589223 (r_advcl) was_1\VBD\0 (l_acomp) severe_3\JJ\0 (l_prep) in_4\IN\13603305 (l_pobj) migraineurs_5\NNS\0
D005996_D008881 NONE gtn_5\NNP\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) headache_8\NN\5829480 (r_nsubj) disappeared_10\VBD\0 (l_advcl) peak_15\JJ\13758296 (l_prep) in_13\IN\13603305 (l_pobj) migraineurs_14\NNS\0
D009569_D020325 NONE no_5\DT\7204911 (r_nsubjpass) involved_7\VBN\2676054 (l_prep) in_8\IN\13603305 (l_pobj) mechanisms_11\NNS\13446390 (l_prep) with_14\IN\0 (l_pobj) aura_15\NN\14299637
D009569_D020325 NONE no_9\DT\7204911 (r_intj) liberate_8\VB\146138 (r_xcomp) shown_6\VBN\2137132 (r_advcl) help_16\VB\407535 (l_dobj) understanding_18\NN\5804793 (l_prep) of_19\IN\0 (l_pobj) coupling_21\NN\3091374 (l_prep) between_22\IN\0 (l_pobj) depression_25\NN\14373582 (l_conj) headache_27\NN\5829480 (l_prep) with_30\IN\0 (l_pobj) aura_31\NN\14299637
D009569_D010146 NONE oxide_13\NN\14818238 (r_nsubjpass) involved_18\VBN\2676054 (l_prep) in_19\IN\13603305 (l_pobj) mechanisms_21\NNS\13446390 (l_compound) pain_20\NN\14299637
D009569_D010146 NONE no_15\NNP\7204911 (r_appos) oxide_13\NN\14818238 (r_nsubjpass) involved_18\VBN\2676054 (l_prep) in_19\IN\13603305 (l_pobj) mechanisms_21\NNS\13446390 (l_compound) pain_20\NN\14299637
D009569_D010146 NONE no_5\DT\7204911 (r_nsubjpass) involved_7\VBN\2676054 (l_prep) in_8\IN\13603305 (l_pobj) mechanisms_11\NNS\13446390 (l_compound) pain_10\NN\14299637
D005996_D020326 CID trinitrate_1\NN\0 (r_nsubj) induces_2\VBZ\1627355 (l_dobj) attacks_3\NNS\955060 (l_prep) without_6\IN\0 (l_pobj) aura_7\NN\14299637
D005996_D020325 NONE trinitrate_1\NN\0 (r_nsubj) induces_2\VBZ\1627355 (l_dobj) attacks_3\NNS\955060 (l_prep) without_6\IN\0 (l_pobj) aura_7\NN\14299637 (l_prep) in_8\IN\13603305 (l_pobj) sufferers_9\NNS\9630641 (l_prep) with_12\IN\0 (l_pobj) aura_13\NN\14299637
D005996_D020325 NONE trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (r_dobj) examined_19\VBD\0 (l_prep) in_0\IN\13603305 (l_pobj) order_1\NN\7168131 (l_acl) clarify_3\VB\939277 (l_ccomp) is_7\VBZ\0 (l_acomp) true_8\JJ\5077146 (l_prep) for_9\IN\0 (l_pobj) migraine_10\NN\14326607 (l_prep) with_11\IN\0 (l_pobj) aura_12\NN\14299637
D005996_D020325 NONE trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (r_dobj) examined_19\VBD\0 (l_parataxis) min_38\NN\15154774 (l_prep) in_43\IN\13603305 (l_pobj) sufferers_45\NNS\9630641 (l_prep) with_48\IN\0 (l_pobj) aura_49\NN\14299637
D005996_D020325 NONE gtn_30\NNP\0 (r_appos) trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (r_dobj) examined_19\VBD\0 (l_prep) in_0\IN\13603305 (l_pobj) order_1\NN\7168131 (l_acl) clarify_3\VB\939277 (l_ccomp) is_7\VBZ\0 (l_acomp) true_8\JJ\5077146 (l_prep) for_9\IN\0 (l_pobj) migraine_10\NN\14326607 (l_prep) with_11\IN\0 (l_pobj) aura_12\NN\14299637
D005996_D020325 NONE gtn_30\NNP\0 (r_appos) trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (r_dobj) examined_19\VBD\0 (l_parataxis) min_38\NN\15154774 (l_prep) in_43\IN\13603305 (l_pobj) sufferers_45\NNS\9630641 (l_prep) with_48\IN\0 (l_pobj) aura_49\NN\14299637
D009569_D003866 NONE no_9\DT\7204911 (r_intj) liberate_8\VB\146138 (r_xcomp) shown_6\VBN\2137132 (l_nsubjpass) depression_3\NN\14373582
D009569_D003866 NONE no_9\DT\7204911 (r_intj) liberate_8\VB\146138 (r_xcomp) shown_6\VBN\2137132 (r_advcl) help_16\VB\407535 (l_dobj) understanding_18\NN\5804793 (l_prep) of_19\IN\0 (l_pobj) coupling_21\NN\3091374 (l_prep) between_22\IN\0 (l_pobj) depression_25\NN\14373582
D009569_D020326 CID oxide_13\NN\14818238 (r_nsubjpass) involved_18\VBN\2676054 (l_prep) in_19\IN\13603305 (l_pobj) mechanisms_21\NNS\13446390 (l_prep) without_24\IN\0 (l_pobj) aura_25\NN\14299637
D009569_D020326 CID no_15\NNP\7204911 (r_appos) oxide_13\NN\14818238 (r_nsubjpass) involved_18\VBN\2676054 (l_prep) in_19\IN\13603305 (l_pobj) mechanisms_21\NNS\13446390 (l_prep) without_24\IN\0 (l_pobj) aura_25\NN\14299637
D009569_D006261 NONE no_9\DT\7204911 (r_intj) liberate_8\VB\146138 (r_xcomp) shown_6\VBN\2137132 (r_advcl) help_16\VB\407535 (l_dobj) understanding_18\NN\5804793 (l_prep) of_19\IN\0 (l_pobj) coupling_21\NN\3091374 (l_prep) between_22\IN\0 (l_pobj) depression_25\NN\14373582 (l_conj) headache_27\NN\5829480
D005996_D006261 NONE trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (l_compound) headache_21\NN\5829480
D005996_D006261 NONE gtn_30\NNP\0 (r_appos) trinitrate_28\NN\0 (r_pobj) of_26\IN\0 (r_prep) infusion_25\NN\14589223 (r_pobj) to_23\IN\0 (r_prep) response_22\NN\11410625 (l_compound) headache_21\NN\5829480
D005996_D006261 NONE gtn_14\NNP\0 (r_compound) infusion_15\NN\14589223 (r_advcl) was_1\VBD\0 (l_nsubj) headache_0\NNP\5829480
D005996_D006261 NONE gtn_5\NNP\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) headache_8\NN\5829480
D005996_D006261 NONE gtn_5\NNP\0 (r_npadvmod) induced_7\VBN\1627355 (r_amod) headache_8\NN\5829480 (r_nsubj) disappeared_10\VBD\0 (l_advcl) peak_15\JJ\13758296 (l_ccomp) occurred_18\VBD\0 (l_nsubj) intensity_17\NN\5090441 (l_compound) headache_16\NN\5829480
9154656
D000809_D009404 NONE angiotensin_9\NN\4522421 (r_compound) proteins_11\NNS\14944888 (r_pobj) of_5\IN\0 (r_prep) concentration_1\NN\4916342 (r_nsubjpass) altered_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) rats_15\NNS\2329401 (l_prep) with_16\IN\0 (l_pobj) syndrome_18\NN\5870365
D000809_D009404 NONE angiotensin_9\NN\4522421 (r_compound) proteins_11\NNS\14944888 (r_pobj) of_5\IN\0 (r_prep) concentration_1\NN\4916342 (r_nsubjpass) altered_13\VBN\0 (l_prep) in_14\IN\13603305 (l_pobj) rats_15\NNS\2329401 (l_prep) with_16\IN\0 (l_pobj) syndrome_18\NN\5870365 (l_appos) ns_20\NNP\14622893
D011692_D009404 CID nucleoside_11\NN\14887305 (r_nmod) pan_13\NNP\3101986 (r_pobj) of_7\IN\0 (r_prep) injection_6\NN\320852 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubjpass) ns_0\NNP\14622893
D011692_D009404 CID pan_13\NNP\3101986 (r_pobj) of_7\IN\0 (r_prep) injection_6\NN\320852 (r_pobj) by_3\IN\0 (r_agent) induced_2\VBN\1627355 (l_nsubjpass) ns_0\NNP\14622893
D011692_D009404 CID pan_19\NNP\3101986 (r_compound) injection_20\NN\320852 (r_pobj) after_18\IN\0 (r_prep) observed_14\VBN\2163746 (r_advcl) change_34\VB\7283608 (l_advcl) established_26\VBN\2426171 (l_nsubjpass) ns_23\NNP\14622893
D011692_D009404 CID pan_22\NNP\3101986 (r_pobj) by_21\IN\0 (r_agent) induced_20\VBN\1627355 (r_acl) development_15\NN\248977 (l_prep) of_16\IN\0 (l_pobj) ns_19\NNP\14622893
7619765
D005047_D009203 CID etoposide_0\RB\0 (r_npadvmod) related_2\VBN\628491 (r_amod) infarction_4\NN\14204950
D005047_D009203 CID etoposide_11\RB\0 (r_dobj) containing_10\VBG\2632940 (r_acl) chemotherapy_9\NN\661091 (r_pobj) after_8\IN\0 (r_prep) reported_7\VBN\831651 (l_nsubjpass) occurrence_1\NN\29378 (l_prep) of_2\IN\0 (l_pobj) infarction_5\NN\14204950
D005047_D003327 NONE etoposide_11\RB\0 (r_dobj) containing_10\VBG\2632940 (r_acl) chemotherapy_9\NN\661091 (r_pobj) after_8\IN\0 (r_prep) reported_7\VBN\831651 (l_prep) in_13\IN\13603305 (l_pobj) man_15\NN\9605289 (l_prep) with_16\IN\0 (l_pobj) factors_19\NNS\7326557 (l_prep) for_20\IN\0 (l_pobj) disease_23\NN\14061805
12571256
D007472_D007674 CID iohexol_45\NN\0 (r_pobj) of_33\IN\0 (r_prep) those_32\DT\0 (r_pobj) with_31\IN\0 (r_prep) effects_16\NNS\13245626 (l_amod) nephrotoxic_15\JJ\0
C044834_D007674 NONE iodixanol_29\NN\0 (r_appos) medium_27\NN\3575240 (r_pobj) of_17\IN\0 (r_prep) effects_16\NNS\13245626 (l_amod) nephrotoxic_15\JJ\0
C044834_D007674 NONE iodixanol_17\NN\0 (r_nsubjpass) used_19\VBN\0 (r_advcl) develop_10\VB\1753788 (r_xcomp) likely_8\JJ\0 (r_acomp) be_6\VB\14625458 (l_csubj) induced_1\VBN\1627355 (l_nsubj) nephropathy_0\NNP\14573196
D003404_D003920 NONE creatinine_9\JJ\0 (r_compound) concentrations_10\NNS\4916342 (r_pobj) with_7\IN\0 (r_prep) diabetes_6\NNS\14075199
1848636
D008790_D007008 NONE metoprolol_8\NN\2832168 (l_prep) of_9\IN\0 (l_pobj) hypokalemia_13\NN\14299637
D013726_D007008 CID terbutaline_10\NN\0 (r_npadvmod) induced_12\VBN\1627355 (r_amod) hypokalemia_13\NN\14299637
10225068
D008012_D011128 CID lignocaine_10\NN\0 (r_pobj) with_6\IN\0 (r_prep) anaesthesia_5\NN\14034177 (r_pobj) after_3\IN\0 (r_prep) syndrome_2\NN\5870365
D008012_D011128 CID lignocaine_10\NN\0 (r_pobj) with_6\IN\0 (r_prep) anaesthesia_5\NN\14034177 (r_pobj) after_3\IN\0 (r_prep) syndrome_2\NN\5870365 (l_appos) review_13\NN\5733583 (l_prep) of_14\IN\0 (l_pobj) cases_16\NNS\7283608 (l_prep) of_17\IN\0 (l_pobj) syndrome_20\NN\5870365
D008012_D020258 NONE lignocaine_6\NN\0 (r_pobj) of_2\IN\0 (r_prep) dose_1\NN\3740161 (r_nsubj) ranged_8\VBD\2604760 (r_ccomp) caused_21\VBN\1617192 (l_agent) by_22\IN\0 (l_pobj) neurotoxicity_24\NN\0
D008012_D020258 NONE lignocaine_29\NN\0 (r_pobj) of_25\IN\0 (r_prep) neurotoxicity_24\NN\0
11284996
D005996_D018781 NONE trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_prep) in_24\IN\13603305 (l_pobj) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) headache_32\NN\5829480
D005996_D018781 NONE gtn_22\NNP\0 (r_appos) trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_prep) in_24\IN\13603305 (l_pobj) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) headache_32\NN\5829480
D009569_D006261 CID oxide_8\NN\14818238 (r_npadvmod) induced_10\VBN\1627355 (r_amod) headache_11\NN\5829480
D009569_D006261 CID oxide_6\NN\14818238 (r_nsubj) induced_10\VBN\1627355 (l_ccomp) associated_17\VBN\628491 (l_nsubjpass) headache_11\NN\5829480
D009569_D006261 CID no_8\NNP\7204911 (r_intj) oxide_6\NN\14818238 (r_nsubj) induced_10\VBN\1627355 (l_ccomp) associated_17\VBN\628491 (l_nsubjpass) headache_11\NN\5829480
D009569_D006261 CID no_17\JJ\7204911 (r_det) trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) headache_13\NN\5829480
D009569_D006261 CID no_5\RB\7204911 (r_intj) induced_7\VBN\1627355 (r_amod) headache_9\NN\5829480
D009569_D051270 NONE oxide_6\NN\14818238 (r_nsubj) induced_10\VBN\1627355 (l_ccomp) associated_17\VBN\628491 (l_nsubjpass) headache_11\NN\5829480 (l_prep) in_12\IN\13603305 (l_pobj) headaches_14\NNS\5829480
D009569_D051270 NONE no_8\NNP\7204911 (r_intj) oxide_6\NN\14818238 (r_nsubj) induced_10\VBN\1627355 (l_ccomp) associated_17\VBN\628491 (l_nsubjpass) headache_11\NN\5829480 (l_prep) in_12\IN\13603305 (l_pobj) headaches_14\NNS\5829480
D009569_D018781 NONE oxide_8\NN\14818238 (r_npadvmod) induced_10\VBN\1627355 (r_amod) headache_11\NN\5829480 (l_prep) in_12\IN\13603305 (l_pobj) patients_13\NNS\9898892 (l_prep) with_14\IN\0 (l_pobj) headache_19\NN\5829480
D009569_D018781 NONE no_17\JJ\7204911 (r_det) trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (l_prep) in_24\IN\13603305 (l_pobj) patients_26\NNS\9898892 (l_prep) with_27\IN\0 (l_pobj) headache_32\NN\5829480
D005996_D006261 CID trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) headache_13\NN\5829480
D005996_D006261 CID gtn_22\NNP\0 (r_appos) trinitrate_20\NN\0 (r_pobj) by_15\IN\0 (r_agent) induced_14\VBN\1627355 (r_acl) headache_13\NN\5829480
D005996_D006261 CID gtn_13\NNP\0 (l_conj) placebo_15\NN\3740161 (l_prep) over_16\IN\5867413 (l_pobj) min_18\NN\15154774 (l_prep) on_19\IN\0 (l_pobj) days_24\NNS\15140892 (l_amod) free_23\JJ\7942152 (l_npadvmod) headache_21\NN\5829480
D005996_D006261 CID gtn_11\NNP\0 (r_compound) day_12\NN\15154774 (r_pobj) on_9\IN\0 (r_prep) headache_8\NN\5829480
D005996_D006261 CID gtn_11\NNP\0 (r_compound) day_12\NN\15154774 (r_pobj) on_9\IN\0 (r_prep) headache_8\NN\5829480 (r_dobj) developed_4\VBD\1753788 (l_conj) was_21\VBD\0 (l_nsubj) headache_20\NN\5829480
921394
D007649_D013610 CID ketamine_18\NN\3054098 (r_npadvmod) induced_20\VBN\1627355 (r_amod) tachycardia_21\NN\14110674
D007649_D003866 NONE ketamine_2\NN\3054098 (r_pobj) of_1\IN\0 (r_prep) injections_0\NNS\320852 (l_dep) mg_10\NN\13717155 (l_prep) into_11\IN\0 (l_pobj) artery_13\NN\5417975 (l_acl) produced_14\VBD\1617192 (l_dobj) depression_16\NN\14373582
6817363
C036466_D007859 NONE aniracetam_5\RB\0 (l_appos) ro_7\NNP\6894544 (l_prep) upon_12\IN\0 (l_pobj) learning_14\NN\5701944 (l_conj) memory_16\NN\5926676
C036466_D007859 NONE 5057_10\CD\0 (r_prep) 13_8\CD\13745420 (r_nummod) ro_7\NNP\6894544 (l_prep) upon_12\IN\0 (l_pobj) learning_14\NN\5701944 (l_conj) memory_16\NN\5926676
C036466_D008569 NONE aniracetam_5\RB\0 (l_appos) ro_7\NNP\6894544 (l_prep) upon_12\IN\0 (l_pobj) learning_14\NN\5701944 (l_conj) memory_16\NN\5926676
C036466_D008569 NONE 5057_10\CD\0 (r_prep) 13_8\CD\13745420 (r_nummod) ro_7\NNP\6894544 (l_prep) upon_12\IN\0 (l_pobj) learning_14\NN\5701944 (l_conj) memory_16\NN\5926676
D003513_D000647 NONE cycloheximide_140\NN\0 (r_conj) chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
D003513_D000647 NONE cycloheximide_140\NN\0 (r_conj) chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
D003513_D000647 NONE cycloheximide_177\NN\0 (r_pobj) by_176\IN\0 (r_agent) induced_175\VBN\1627355 (r_acl) task_174\NN\575741 (r_pobj) of_170\IN\0 (r_prep) retention_167\NN\809465 (r_pobj) in_166\IN\13603305 (r_prep) deficit_165\NN\5113133 (r_pobj) of_163\IN\0 (r_prep) reversal_149\NN\199130 (r_conj) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
D003513_D000647 NONE cycloheximide_177\NN\0 (r_pobj) by_176\IN\0 (r_agent) induced_175\VBN\1627355 (r_acl) task_174\NN\575741 (r_pobj) of_170\IN\0 (r_prep) retention_167\NN\809465 (r_pobj) in_166\IN\13603305 (r_prep) deficit_165\NN\5113133 (r_pobj) of_163\IN\0 (r_prep) reversal_149\NN\199130 (r_conj) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
D003513_D006935 NONE cycloheximide_140\NN\0 (r_conj) chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
D003513_D006935 NONE cycloheximide_140\NN\0 (r_conj) chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
D003513_D006935 NONE cycloheximide_177\NN\0 (r_pobj) by_176\IN\0 (r_agent) induced_175\VBN\1627355 (r_acl) task_174\NN\575741 (r_pobj) of_170\IN\0 (r_prep) retention_167\NN\809465 (r_pobj) in_166\IN\13603305 (r_prep) deficit_165\NN\5113133 (r_pobj) of_163\IN\0 (r_prep) reversal_149\NN\199130 (r_conj) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
D003513_D006935 NONE cycloheximide_177\NN\0 (r_pobj) by_176\IN\0 (r_agent) induced_175\VBN\1627355 (r_acl) task_174\NN\575741 (r_pobj) of_170\IN\0 (r_prep) retention_167\NN\809465 (r_pobj) in_166\IN\13603305 (r_prep) deficit_165\NN\5113133 (r_pobj) of_163\IN\0 (r_prep) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
C036466_D006935 NONE aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
C036466_D006935 NONE aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_conj) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
C036466_D006935 NONE 5057_8\CD\0 (r_prep) 13_6\CD\13745420 (r_nummod) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
C036466_D006935 NONE 5057_8\CD\0 (r_prep) 13_6\CD\13745420 (r_nummod) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_conj) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
C036466_D006935 NONE 1-anisoyl-2-pyrrolidinone_10\CD\0 (r_appos) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
C036466_D006935 NONE 1-anisoyl-2-pyrrolidinone_10\CD\0 (r_appos) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_conj) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
D002701_D000647 NONE chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
D002701_D000647 NONE chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
D012601_D003072 NONE scopolamine_77\NN\14712692 (r_npadvmod) induced_79\VBN\1627355 (r_amod) amnesia_83\NN\5669934 (r_pobj) of_75\IN\0 (r_prep) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (r_appos) effects_33\NNS\13245626 (r_dobj) produced_30\VBD\1617192 (r_conj) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
C036466_D000647 NONE aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
C036466_D000647 NONE aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
C036466_D000647 NONE 5057_8\CD\0 (r_prep) 13_6\CD\13745420 (r_nummod) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
C036466_D000647 NONE 5057_8\CD\0 (r_prep) 13_6\CD\13745420 (r_nummod) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
C036466_D000647 NONE 1-anisoyl-2-pyrrolidinone_10\CD\0 (r_appos) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_prep) of_75\IN\0 (l_pobj) amnesia_83\NN\5669934
C036466_D000647 NONE 1-anisoyl-2-pyrrolidinone_10\CD\0 (r_appos) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_conj) produced_30\VBD\1617192 (l_dobj) effects_33\NNS\13245626 (l_appos) prevention_40\NN\1073995 (l_conj) rats_67\NNS\2329401 (l_conj) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
D012601_D006935 NONE scopolamine_77\NN\14712692 (r_npadvmod) induced_79\VBN\1627355 (r_amod) amnesia_83\NN\5669934 (r_pobj) of_75\IN\0 (r_prep) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
D012601_D006935 NONE scopolamine_77\NN\14712692 (r_npadvmod) induced_79\VBN\1627355 (r_amod) amnesia_83\NN\5669934 (r_pobj) of_75\IN\0 (r_prep) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_conj) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
D012601_D000647 CID scopolamine_77\NN\14712692 (r_npadvmod) induced_79\VBN\1627355 (r_amod) amnesia_83\NN\5669934
D012601_D000647 CID scopolamine_77\NN\14712692 (r_npadvmod) induced_79\VBN\1627355 (r_amod) amnesia_83\NN\5669934 (r_pobj) of_75\IN\0 (r_prep) prevention_74\NN\1073995 (l_conj) protection_94\NN\407535 (l_prep) against_95\IN\0 (l_pobj) amnesia_96\NN\5669934
D002701_D003072 NONE chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (r_appos) effects_33\NNS\13245626 (r_dobj) produced_30\VBD\1617192 (r_conj) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
C036466_D003072 NONE aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
C036466_D003072 NONE 5057_8\CD\0 (r_prep) 13_6\CD\13745420 (r_nummod) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
C036466_D003072 NONE 1-anisoyl-2-pyrrolidinone_10\CD\0 (r_appos) ro_5\NNP\6894544 (r_appos) aniracetam_3\NN\0 (r_pobj) of_2\IN\0 (r_prep) effect_1\NN\34213 (r_nsubjpass) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
C036466_D003072 NONE aniracetam_12\JJ\0 (r_amod) doses_13\NNS\3740161 (r_pobj) at_10\IN\14622893 (r_prep) seen_9\VBN\2106506 (l_nsubjpass) improvements_1\NNS\7359599 (l_conj) normalizations_3\NNS\1123598 (l_prep) of_4\IN\0 (l_pobj) functions_7\NNS\13783581
D003513_D003072 NONE cycloheximide_140\NN\0 (r_conj) chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (r_appos) effects_33\NNS\13245626 (r_dobj) produced_30\VBD\1617192 (r_conj) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
D003513_D003072 NONE cycloheximide_177\NN\0 (r_pobj) by_176\IN\0 (r_agent) induced_175\VBN\1627355 (r_acl) task_174\NN\575741 (r_pobj) of_170\IN\0 (r_prep) retention_167\NN\809465 (r_pobj) in_166\IN\13603305 (r_prep) deficit_165\NN\5113133 (r_pobj) of_163\IN\0 (r_prep) reversal_149\NN\199130 (r_conj) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (r_appos) effects_33\NNS\13245626 (r_dobj) produced_30\VBD\1617192 (r_conj) studied_13\VBN\0 (l_prep) on_14\IN\0 (l_pobj) forms_16\NNS\6286395 (l_prep) of_17\IN\0 (l_pobj) functions_21\NNS\13783581
D002701_D006935 NONE chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (r_conj) protection_94\NN\407535 (r_conj) prevention_74\NN\1073995 (r_conj) rats_67\NNS\2329401 (r_conj) prevention_40\NN\1073995 (l_prep) of_41\IN\0 (l_pobj) incapacity_43\NN\5644922 (l_acl) learn_45\VB\0 (l_dobj) response_49\NN\11410625 (l_prep) in_50\IN\13603305 (l_pobj) rats_51\NNS\2329401 (l_acl) exposed_52\VBN\2110927 (l_prep) to_53\IN\0 (l_pobj) hypercapnia_55\NN\14034177
D002701_D006935 NONE chloramphenicol_138\NN\2716866 (r_pobj) by_137\IN\0 (r_agent) induced_132\VBN\1627355 (r_acl) task_131\NN\575741 (r_pobj) for_127\IN\0 (r_prep) prevention_116\NN\1073995 (l_conj) reversal_149\NN\199130 (l_conj) prevention_186\NN\1073995 (l_prep) in_190\IN\13603305 (l_pobj) retrieval_192\NN\13450862 (l_prep) of_193\IN\0 (l_pobj) task_197\NN\575741 (l_acl) induced_198\VBN\1627355 (l_agent) by_201\IN\0 (l_pobj) electroshock_203\NN\662681 (l_conj) hypercapnia_205\NN\14034177
8742498
D000431_D056486 CID ethanol_35\NN\14708720 (r_compound) consumption_36\NN\13440063 (r_pobj) of_33\IN\0 (r_prep) influence_32\NN\5190804 (r_dobj) evaluates_30\VBZ\670261 (r_conj) acts_20\VBZ\0 (l_prep) in_22\IN\13603305 (l_pobj) mice_25\NNS\2329401 (l_prep) with_26\IN\0 (l_pobj) hepatitis_28\NN\14127211
D000431_D056486 CID ethanol_25\NN\14708720 (r_pobj) by_24\IN\0 (r_agent) caused_23\VBN\1617192 (r_acl) exacerbation_22\NN\374224 (r_pobj) unlike_20\IN\0 (r_prep) inhibited_37\VBN\2510337 (l_nsubjpass) damage_35\NN\7296428
D000431_D056486 CID ethanol_42\NN\14708720 (r_pobj) by_41\IN\0 (r_prep) %_40\NN\0 (r_pobj) by_38\IN\0 (r_agent) inhibited_37\VBN\2510337 (l_nsubjpass) damage_35\NN\7296428
D000431_D056486 CID ethanol_15\NN\14708720 (r_nmod) mice_19\NNS\2329401 (r_pobj) to_14\IN\0 (r_dative) given_13\VBN\5892096 (r_advcl) observed_8\VBN\2163746 (l_nsubjpass) reduction_4\NN\351485 (l_prep) of_5\IN\0 (l_pobj) hepatitis_6\NN\14127211
D000431_D056486 CID ethanol_14\NN\14708720 (r_pobj) by_13\IN\0 (r_prep) exacerbation_12\NN\374224 (r_conj) hepatitis_9\NN\14127211
D019289_D056486 NONE pyruvate_18\NN\0 (r_compound) transaminase_19\NN\15077571 (r_conj) transaminase_11\NN\15077571 (r_pobj) of_7\IN\0 (r_prep) activities_6\NNS\30358 (r_pobj) as_4\IN\14622893 (r_prep) quantified_3\VBN\947077 (l_nsubjpass) injuries_1\NNS\14052046
D018698_D056486 NONE glutamate_8\NN\15010703 (r_compound) oxaloacetate_10\NN\15010703 (r_compound) transaminase_11\NN\15077571 (r_pobj) of_7\IN\0 (r_prep) activities_6\NNS\30358 (r_pobj) as_4\IN\14622893 (r_prep) quantified_3\VBN\947077 (l_nsubjpass) injuries_1\NNS\14052046
D018698_D056486 NONE glutamate_16\NN\15010703 (r_npadvmod) pyruvate_18\NN\0 (r_compound) transaminase_19\NN\15077571 (r_conj) transaminase_11\NN\15077571 (r_pobj) of_7\IN\0 (r_prep) activities_6\NNS\30358 (r_pobj) as_4\IN\14622893 (r_prep) quantified_3\VBN\947077 (l_nsubjpass) injuries_1\NNS\14052046
D009536_D056486 NONE amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_npadvmod) aap)-hepatitis_33\NNP\0
D009536_D056486 NONE amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_advcl) suggesting_35\VBG\1010118 (l_ccomp) involves_43\VBZ\2676054 (l_nsubj) injury_42\NN\14052046
D009536_D056486 NONE naa_11\NNP\0 (r_nsubjpass) given_13\VBN\5892096 (r_advcl) observed_8\VBN\2163746 (l_nsubjpass) reduction_4\NN\351485 (l_prep) of_5\IN\0 (l_pobj) hepatitis_6\NN\14127211
D009536_D056486 NONE naa_27\NNP\0 (r_pobj) by_26\IN\0 (r_prep) inhibition_23\NN\1068773 (r_pobj) by_19\IN\0 (r_agent) reduced_18\VBN\441445 (l_nsubjpass) hepatitis_9\NN\14127211
D009536_D056486 NONE naa_6\NNP\0 (r_pobj) of_5\IN\0 (r_prep) application_4\NN\947128 (r_dobj) see_1\VBP\8647945 (l_prep) in_17\IN\13603305 (l_pobj) order_18\NN\7168131 (l_acl) avoid_20\VB\0 (l_dobj) damage_22\NN\7296428
D011064_D056486 NONE )_19\-RRB-\0 (r_punct) polymerase_20\NN\14732946 (r_pobj) of_15\IN\0 (r_prep) inhibitor_14\NN\20090 (r_appos) amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_npadvmod) aap)-hepatitis_33\NNP\0
D011064_D056486 NONE )_19\-RRB-\0 (r_punct) polymerase_20\NN\14732946 (r_pobj) of_15\IN\0 (r_prep) inhibitor_14\NN\20090 (r_appos) amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_advcl) suggesting_35\VBG\1010118 (l_ccomp) involves_43\VBZ\2676054 (l_nsubj) injury_42\NN\14052046
D000082_D056486 CID acetaminophen_9\NN\2707683 (r_pobj) on_8\IN\0 (l_pobj) hepatotoxicity_10\NN\0
D000082_D056486 CID acetaminophen_31\NN\2707683 (r_pobj) from_30\IN\0 (r_prep) suffering_29\VBG\14322699 (r_pcomp) on_27\IN\0 (r_prep) inhibitor_14\NN\20090 (r_appos) amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_npadvmod) aap)-hepatitis_33\NNP\0
D000082_D056486 CID acetaminophen_31\NN\2707683 (r_pobj) from_30\IN\0 (r_prep) suffering_29\VBG\14322699 (r_pcomp) on_27\IN\0 (r_prep) inhibitor_14\NN\20090 (r_appos) amide_10\NN\14727670 (r_pobj) of_7\IN\0 (r_prep) effects_6\NNS\13245626 (r_dobj) demonstrated_3\VBD\2137132 (l_advcl) suggesting_35\VBG\1010118 (l_ccomp) involves_43\VBZ\2676054 (l_nsubj) injury_42\NN\14052046
D000082_D056486 CID aap)-hepatitis_33\NNP\0
D000082_D056486 CID aap)-hepatitis_33\NNP\0 (r_npadvmod) demonstrated_3\VBD\2137132 (l_advcl) suggesting_35\VBG\1010118 (l_ccomp) involves_43\VBZ\2676054 (l_nsubj) injury_42\NN\14052046
D000082_D056486 CID aap_38\NNP\0 (r_npadvmod) induced_40\VBN\1627355 (r_amod) injury_42\NN\14052046 (r_nsubj) involves_43\VBZ\2676054 (r_ccomp) suggesting_35\VBG\1010118 (r_advcl) demonstrated_3\VBD\2137132 (l_npadvmod) aap)-hepatitis_33\NNP\0
D000082_D056486 CID aap_38\NNP\0 (r_npadvmod) induced_40\VBN\1627355 (r_amod) injury_42\NN\14052046
D000082_D056486 CID aap_27\NNP\0 (r_compound) hepatitis_28\NN\14127211
D000082_D056486 CID aap_17\NNP\0 (r_pobj) of_16\IN\0 (r_prep) presence_15\NN\13954253 (r_pobj) in_13\IN\13603305 (r_prep) measured_12\VBN\697589 (l_conj) inhibited_37\VBN\2510337 (l_nsubjpass) damage_35\NN\7296428
D000082_D056486 CID aap_17\NNP\0 (r_compound) mice_19\NNS\2329401 (r_pobj) to_14\IN\0 (r_dative) given_13\VBN\5892096 (r_advcl) observed_8\VBN\2163746 (l_nsubjpass) reduction_4\NN\351485 (l_prep) of_5\IN\0 (l_pobj) hepatitis_6\NN\14127211
D000082_D056486 CID aap_6\NNP\0 (r_npadvmod) induced_8\VBN\1627355 (r_amod) hepatitis_9\NN\14127211
D000082_D056486 CID acetaminophen_16\NN\2707683 (r_pobj) of_15\IN\0 (r_prep) preparations_14\NNS\407535 (r_pobj) in_12\IN\13603305 (r_prep) use_11\NN\407535 (r_pobj) for_8\IN\0 (r_prep) as_7\IN\14622893 (r_prep) see_1\VBP\8647945 (l_prep) in_17\IN\13603305 (l_pobj) order_18\NN\7168131 (l_acl) avoid_20\VB\0 (l_dobj) damage_22\NN\7296428
D062907_D056486 NONE oxaloacetate_10\NN\15010703 (r_compound) transaminase_11\NN\15077571 (r_pobj) of_7\IN\0 (r_prep) activities_6\NNS\30358 (r_pobj) as_4\IN\14622893 (r_prep) quantified_3\VBN\947077 (l_nsubjpass) injuries_1\NNS\14052046
D009243_D056486 NONE nad_5\NNP\14800277 (r_compound) precursors_7\NNS\14580897 (r_pobj) of_4\IN\0 (r_prep) free_3\JJ\7942152 (l_prep) on_8\IN\0 (l_pobj) hepatotoxicity_10\NN\0
D009243_D056486 NONE nad_13\NNP\14800277 (l_appos) substrate_16\NN\19613 (l_relcl) acts_20\VBZ\0 (l_prep) in_22\IN\13603305 (l_pobj) mice_25\NNS\2329401 (l_prep) with_26\IN\0 (l_pobj) hepatitis_28\NN\14127211
D009243_D056486 NONE nad_37\NNP\14800277 (r_appos) substrate_36\NN\19613 (r_pobj) of_32\IN\0 (r_prep) depletion_31\NN\351638 (r_pobj) by_29\IN\0 (r_conj) by_26\IN\0 (r_prep) inhibition_23\NN\1068773 (r_pobj) by_19\IN\0 (r_agent) reduced_18\VBN\441445 (l_nsubjpass) hepatitis_9\NN\14127211
1415380
D011803_D006463 CID quinine_8\NN\2721948 (r_pobj) of_7\IN\0 (r_prep) ingestion_6\NN\13440063 (r_pobj) with_5\IN\0 (r_prep) associated_4\VBN\628491 (r_acl) syndrome_3\NN\5870365
D011803_D006463 CID quinine_5\NN\2721948 (r_compound) ingestion_6\NN\13440063 (r_pobj) following_4\VBG\8180190 (r_prep) syndrome_3\NN\5870365
D011803_D006463 CID quinine_0\NN\2721948 (r_npadvmod) associated_2\VBN\628491 (r_amod) syndrome_6\NN\5870365
8480959
D003401_D009135 NONE creatine_7\NN\14601829 (r_compound) kinase_8\NN\14732946 (r_compound) elevations_9\NNS\7445480 (r_pobj) with_6\IN\0 (r_prep) symptoms_5\NNS\5823932 (r_pobj) as_3\IN\14622893 (r_prep) defined_2\VBN\2604760 (r_acl) myopathy_0\NNP\14204950
D008148_D006937 NONE lovastatin_4\NN\3676175 (r_pobj) of_3\IN\0 (r_prep) efficacy_0\NN\5199286 (l_prep) in_5\IN\13603305 (l_pobj) women_7\NNS\9605289 (l_prep) with_8\IN\0 (l_pobj) hypercholesterolemia_10\NN\14299637
D008148_D006937 NONE lovastatin_7\NN\3676175 (r_pobj) of_6\IN\0 (r_prep) efficacy_3\NN\5199286 (r_dobj) evaluate_1\VB\670261 (l_prep) with_10\IN\0 (l_pobj) hypercholesterolemia_12\NN\14299637
D008148_D006937 NONE lovastatin_0\NNP\3676175 (r_nsubj) is_1\VBZ\0 (l_conj) tolerated_7\VBN\802318 (l_prep) as_8\IN\14622893 (l_pobj) therapy_9\NN\657604 (l_prep) for_10\IN\0 (l_pobj) hypercholesterolemia_12\NN\14299637
D008148_D009135 CID lovastatin_31\NN\3676175 (r_pobj) of_30\IN\0 (r_prep) dose_29\NN\3740161 (r_pobj) with_24\IN\0 (r_prep) associated_23\VBN\628491 (r_conj) was_20\VBD\0 (l_nsubj) myopathy_0\NNP\14204950
17965424
D004008_D005767 CID diclofenac_14\NNP\0 (r_pobj) than_13\IN\0 (r_prep) etoricoxib_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) lower_10\JJR\2831724 (r_acomp) was_8\VBD\0 (l_nsubj) rate_3\NN\13815152 (l_amod) due_4\IN\5174653 (l_pcomp) to_5\IN\0 (l_pobj) aes_7\NNS\0
D004008_D005767 CID diclofenac_17\NNP\0 (r_nmod) discontinuations_20\NNS\209943 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) discontinuing_9\VBG\0 (l_prep) due_11\IN\5174653 (l_pcomp) to_12\IN\0 (l_pobj) aes_14\NNS\0
D004008_D005767 CID diclofenac_17\NNP\0 (r_nmod) discontinuations_20\NNS\209943 (r_pobj) with_16\IN\0 (r_prep) compared_15\VBN\644583 (r_prep) discontinuing_9\VBG\0 (r_pcomp) for_8\IN\0 (r_prep) risk_7\NN\14541044 (r_dobj) demonstrated_3\VBD\2137132 (l_advcl) common_27\JJ\8673395 (l_prep) than_28\IN\0 (l_pobj) discontinuations_29\NNS\209943 (l_prep) from_30\IN\0 (l_pobj) aes_32\NNS\0
C422649_D004487 CID etoricoxib_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) higher_15\JJR\0 (r_acomp) were_13\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) discontinuations_3\NNS\209943 (l_prep) for_4\IN\0 (l_pobj) aes_12\NNS\0 (l_amod) related_7\VBN\628491 (l_conj) related_11\VBN\628491 (l_npadvmod) oedema_9\NN\14315192
C422649_D004487 CID etoricoxib_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) higher_15\JJR\0 (r_acomp) were_13\VBD\0 (l_dep) p<0.001_37\VB\0 (l_prep) for_38\IN\0 (l_pobj) hypertension_39\NN\14057371 (l_conj) p<0.01_41\NN\0 (l_prep) for_42\IN\0 (l_pobj) oedema_43\NN\14315192
D004008_D001172 NONE sodium_15\NN\14625458 (r_compound) tolerability_17\NN\0 (r_pobj) vs_13\IN\13634784 (r_prep) etoricoxib_12\NN\0 (r_pobj) of_10\IN\0 (r_prep) results_9\NNS\34213 (r_appos) tolerability_1\NN\0 (l_prep) of_2\IN\0 (l_pobj) etoricoxib_3\NN\0 (l_prep) in_4\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_compound) arthritis_6\NN\14171682
D004008_D001172 NONE diclofenac_22\NN\0 (r_conj) etoricoxib_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) tolerability_14\NN\0 (r_dobj) compare_8\VB\4744814 (l_prep) in_23\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) arthritis_27\NN\14171682
D004008_D001172 NONE diclofenac_22\NN\0 (r_conj) etoricoxib_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) tolerability_14\NN\0 (r_dobj) compare_8\VB\4744814 (l_prep) in_23\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) arthritis_27\NN\14171682 (l_appos) ra_29\NNP\14625458
D004008_D001172 NONE diclofenac_28\NN\0 (r_nmod) mg_30\NN\13717155 (r_compound) twice_31\RB\0 (r_conj) enrolled_15\VBN\2471690 (l_nsubjpass) years_9\NNS\15144371 (l_acl) diagnosed_11\VBD\644583 (l_prep) with_12\IN\0 (l_pobj) ra_13\NNP\14625458
C422649_D006973 CID etoricoxib_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) higher_15\JJR\0 (r_acomp) were_13\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) discontinuations_3\NNS\209943 (l_prep) for_4\IN\0 (l_pobj) aes_12\NNS\0 (l_amod) related_7\VBN\628491 (l_npadvmod) hypertension_5\NN\14057371
C422649_D006973 CID etoricoxib_17\NN\0 (r_pobj) with_16\IN\0 (r_prep) higher_15\JJR\0 (r_acomp) were_13\VBD\0 (l_dep) p<0.001_37\VB\0 (l_prep) for_38\IN\0 (l_pobj) hypertension_39\NN\14057371
C422649_D001172 NONE etoricoxib_3\NN\0 (l_prep) in_4\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_compound) arthritis_6\NN\14171682
C422649_D001172 NONE etoricoxib_12\NN\0 (r_pobj) of_10\IN\0 (r_prep) results_9\NNS\34213 (r_appos) tolerability_1\NN\0 (l_prep) of_2\IN\0 (l_pobj) etoricoxib_3\NN\0 (l_prep) in_4\IN\13603305 (l_pobj) patients_7\NNS\9898892 (l_compound) arthritis_6\NN\14171682
C422649_D001172 NONE etoricoxib_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) tolerability_14\NN\0 (r_dobj) compare_8\VB\4744814 (l_prep) in_23\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) arthritis_27\NN\14171682
C422649_D001172 NONE etoricoxib_20\NN\0 (r_pobj) of_19\IN\0 (r_prep) tolerability_14\NN\0 (r_dobj) compare_8\VB\4744814 (l_prep) in_23\IN\13603305 (l_pobj) patients_24\NNS\9898892 (l_prep) with_25\IN\0 (l_pobj) arthritis_27\NN\14171682 (l_appos) ra_29\NNP\14625458
C422649_D001172 NONE etoricoxib_18\RB\0 (r_dobj) received_17\VBN\2210855 (r_conj) enrolled_15\VBN\2471690 (l_nsubjpass) years_9\NNS\15144371 (l_acl) diagnosed_11\VBD\644583 (l_prep) with_12\IN\0 (l_pobj) ra_13\NNP\14625458
C422649_D005767 NONE etoricoxib_12\NN\0 (r_pobj) with_11\IN\0 (r_prep) lower_10\JJR\2831724 (r_acomp) was_8\VBD\0 (l_nsubj) rate_3\NN\13815152 (l_amod) due_4\IN\5174653 (l_pcomp) to_5\IN\0 (l_pobj) aes_7\NNS\0
C422649_D005767 NONE etoricoxib_0\NNP\0 (r_nsubj) demonstrated_3\VBD\2137132 (l_dobj) risk_7\NN\14541044 (l_prep) for_8\IN\0 (l_pcomp) discontinuing_9\VBG\0 (l_prep) due_11\IN\5174653 (l_pcomp) to_12\IN\0 (l_pobj) aes_14\NNS\0
C422649_D005767 NONE etoricoxib_0\NNP\0 (r_nsubj) demonstrated_3\VBD\2137132 (l_advcl) common_27\JJ\8673395 (l_prep) than_28\IN\0 (l_pobj) discontinuations_29\NNS\209943 (l_prep) from_30\IN\0 (l_pobj) aes_32\NNS\0
C422649_D005767 NONE etoricoxib_38\NN\0 (r_pobj) with_37\IN\0 (r_prep) higher_36\JJR\0 (r_acomp) were_34\VBD\0 (l_ccomp) demonstrated_3\VBD\2137132 (l_dobj) risk_7\NN\14541044 (l_prep) for_8\IN\0 (l_pcomp) discontinuing_9\VBG\0 (l_prep) due_11\IN\5174653 (l_pcomp) to_12\IN\0 (l_pobj) aes_14\NNS\0
C422649_D005767 NONE etoricoxib_38\NN\0 (r_pobj) with_37\IN\0 (r_prep) higher_36\JJR\0 (r_acomp) were_34\VBD\0 (l_ccomp) demonstrated_3\VBD\2137132 (l_advcl) common_27\JJ\8673395 (l_prep) than_28\IN\0 (l_pobj) discontinuations_29\NNS\209943 (l_prep) from_30\IN\0 (l_pobj) aes_32\NNS\0
D004008_D006973 NONE diclofenac_28\NNP\0 (r_pobj) with_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_13\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) discontinuations_3\NNS\209943 (l_prep) for_4\IN\0 (l_pobj) aes_12\NNS\0 (l_amod) related_7\VBN\628491 (l_npadvmod) hypertension_5\NN\14057371
D004008_D006973 NONE diclofenac_28\NNP\0 (r_pobj) with_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_13\VBD\0 (l_dep) p<0.001_37\VB\0 (l_prep) for_38\IN\0 (l_pobj) hypertension_39\NN\14057371
D004008_D004487 NONE diclofenac_28\NNP\0 (r_pobj) with_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_13\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) discontinuations_3\NNS\209943 (l_prep) for_4\IN\0 (l_pobj) aes_12\NNS\0 (l_amod) related_7\VBN\628491 (l_conj) related_11\VBN\628491 (l_npadvmod) oedema_9\NN\14315192
D004008_D004487 NONE diclofenac_28\NNP\0 (r_pobj) with_27\IN\0 (r_prep) compared_26\VBN\644583 (r_prep) were_13\VBD\0 (l_dep) p<0.001_37\VB\0 (l_prep) for_38\IN\0 (l_pobj) hypertension_39\NN\14057371 (l_conj) p<0.01_41\NN\0 (l_prep) for_42\IN\0 (l_pobj) oedema_43\NN\14315192
6381653
D007980_D004409 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesia_3\JJ\14084880
D007980_D004409 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dyskinesia_3\NN\14084880
D007980_D004409 CID levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880
D007980_D020821 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dyskinesia_3\NN\14084880 (l_prep) in_7\IN\13603305 (l_pobj) cases_9\NNS\7283608 (l_prep) of_10\IN\0 (l_pobj) parkinsonism_11\NNP\14085708 (l_relcl) was_14\VBD\0 (l_attr) choreic_15\JJ\0 (l_conj) ballistic_17\JJ\0 (l_conj) dystonic_19\JJ\0
D007980_D013786 NONE levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880 (l_prep) by_6\IN\0 (l_pobj) lesions_8\NNS\14204950
D007980_D010302 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dyskinesia_3\NN\14084880 (l_prep) in_7\IN\13603305 (l_pobj) cases_9\NNS\7283608 (l_prep) of_10\IN\0 (l_pobj) parkinsonism_11\NNP\14085708
D007980_D010302 NONE levodopa_2\NN\14604959 (r_npadvmod) induced_4\VBN\1627355 (r_amod) dyskinesias_5\NNS\14084880 (r_pobj) of_1\IN\0 (r_prep) control_0\NN\5190804 (l_prep) in_9\IN\13603305 (l_pobj) course_11\NN\883297 (l_prep) of_12\IN\0 (l_pobj) treatment_14\NN\654885 (l_prep) of_15\IN\0 (l_pobj) parkinsonism_16\NNP\14085708
12691807
D007980_D008538 NONE levodopa_10\NN\14604959 (r_npadvmod) induced_12\VBN\1627355 (r_amod) dystonia_14\NN\0
D007980_D008538 NONE levodopa_10\NN\14604959 (r_npadvmod) induced_12\VBN\1627355 (r_amod) dystonia_14\NN\0 (l_appos) omd_16\NNP\0
D007980_D004421 CID levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dystonia_4\NN\0
D007980_D004409 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880
D007980_D019578 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880 (r_nsubjpass) reported_6\VBN\831651 (l_prep) in_7\IN\13603305 (l_pobj) disease_10\NN\14061805 (l_conj) atrophy_14\NN\14299637
D007980_D013494 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (l_dobj) dystonia_4\NN\0 (l_prep) in_5\IN\13603305 (l_pobj) palsy_8\JJ\14557898
D007980_D013494 NONE levodopa_10\NN\14604959 (r_npadvmod) induced_12\VBN\1627355 (r_amod) dystonia_14\NN\0 (r_pobj) of_8\IN\0 (r_prep) case_7\NN\7283608 (l_prep) in_18\IN\13603305 (l_pobj) patient_21\NN\9898892 (l_compound) psp_20\NNP\0
D007980_D013494 NONE levodopa_10\NN\14604959 (r_npadvmod) induced_12\VBN\1627355 (r_amod) dystonia_14\NN\0 (r_pobj) of_8\IN\0 (r_prep) case_7\NN\7283608 (r_dobj) describe_4\VBP\1001294 (l_advcl) highlight_23\VB\13809920 (l_dobj) importance_25\NN\5138488 (l_prep) of_26\IN\0 (l_pcomp) recognizing_27\VBG\686447 (l_dobj) complication_31\NN\1073995 (l_prep) in_32\IN\13603305 (l_pobj) management_34\NN\1123598 (l_prep) of_35\IN\0 (l_pobj) psp_36\NNP\0
D007980_D010300 NONE levodopa_0\NNP\14604959 (r_npadvmod) induced_2\VBN\1627355 (r_amod) dyskinesias_3\NNS\14084880 (r_nsubjpass) reported_6\VBN\831651 (l_prep) in_7\IN\13603305 (l_pobj) disease_10\NN\14061805
2055425
D018723_D003920 NONE bethanechol_23\NN\0 (r_conj) atp_20\NNP\14964590 (r_conj) stimulation_18\NN\242808 (r_pobj) to_16\TO\0 (r_prep) responses_8\NNS\11410625 (l_prep) from_13\IN\0 (l_pobj) rats_15\NNS\2329401 (l_amod) diabetic_14\JJ\10595647
D018723_D003920 NONE bethanechol_22\NN\0 (r_conj) atp_19\NNP\14964590 (r_conj) stimulation_17\NN\242808 (r_pobj) to_15\TO\0 (r_prep) responses_7\NNS\11410625 (l_prep) from_12\IN\0 (l_pobj) rats_14\NNS\2329401 (l_amod) diabetic_13\JJ\10595647
D013311_D003920 CID streptozotocin_17\NNS\0 (r_npadvmod) induced_19\VBN\1627355 (r_amod) diabetes_20\NN\14075199 (r_compound) mellitus_21\NN\0
D013311_D003920 CID streptozotocin_15\JJ\0 (r_npadvmod) diabetic_17\JJ\10595647
D013311_D003920 CID streptozotocin_7\NNS\0 (r_npadvmod) induced_9\VBN\1627355 (r_amod) diabetes_10\NNS\14075199
D000255_D003920 NONE atp_20\NNP\14964590 (r_conj) stimulation_18\NN\242808 (r_pobj) to_16\TO\0 (r_prep) responses_8\NNS\11410625 (l_prep) from_13\IN\0 (l_pobj) rats_15\NNS\2329401 (l_amod) diabetic_14\JJ\10595647
D000255_D003920 NONE atp_19\NNP\14964590 (r_conj) stimulation_17\NN\242808 (r_pobj) to_15\TO\0 (r_prep) responses_7\NNS\11410625 (l_prep) from_12\IN\0 (l_pobj) rats_14\NNS\2329401 (l_amod) diabetic_13\JJ\10595647
3769769
D014282_D012559 NONE hydrochloride_12\NN\14817592 (r_dobj) trihexyphenidyl_11\JJ\0 (r_conj) treated_5\VBN\2376958 (l_nsubjpass) patient_3\NN\9898892 (l_amod) schizophrenic_2\JJ\10490141
D014282_D001919 CID hydrochloride_4\NN\14817592 (r_pobj) due_1\JJ\5174653 (r_amod) bradycardia_0\NNS\14110674
6674249
D015119_D013345 NONE acid_12\NN\14818238 (r_nmod) eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (l_prep) in_17\IN\13603305 (l_pobj) patient_23\NN\9898892 (l_prep) with_24\IN\0 (l_pobj) haemorrhage_26\NN\14285662
D015119_D013345 NONE acid_12\NN\14818238 (r_nmod) eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (r_pcomp) of_2\IN\0 (r_prep) case_1\NN\7283608 (r_nsubjpass) described_31\VBN\1001294 (l_punct) (_27\-LRB-\0 (l_preconj) sah_28\NNP\0
D015119_D013345 NONE eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (l_prep) in_17\IN\13603305 (l_pobj) patient_23\NN\9898892 (l_prep) with_24\IN\0 (l_pobj) haemorrhage_26\NN\14285662
D015119_D013345 NONE eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (r_pcomp) of_2\IN\0 (r_prep) case_1\NN\7283608 (r_nsubjpass) described_31\VBN\1001294 (l_punct) (_27\-LRB-\0 (l_preconj) sah_28\NNP\0
D015119_D009336 CID acid_12\NN\14818238 (r_nmod) eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (l_advmod) myopathy_4\NNS\14204950
D015119_D009336 CID eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (l_advmod) myopathy_4\NNS\14204950
D015119_D009135 CID acid_5\NN\14818238 (r_nsubj) induce_9\VBP\1627355 (l_dobj) myopathy_10\NNS\14204950
D015119_D009135 CID eaca_7\NNP\0 (r_appos) acid_5\NN\14818238 (r_nsubj) induce_9\VBP\1627355 (l_dobj) myopathy_10\NNS\14204950
D015119_D009135 CID acid_12\NN\14818238 (r_nmod) eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (l_advmod) myopathy_4\NNS\14204950
D015119_D009135 CID eaca_14\NNP\0 (r_nmod) treatment_16\NN\654885 (r_pobj) due_5\IN\5174653 (r_prep) necrotizing_3\VBG\0 (l_advmod) myopathy_4\NNS\14204950
15686794
D000638_D001281 NONE amiodarone_0\NNP\2715941 (r_nsubj) represents_1\VBZ\2664769 (l_dobj) drug_5\NN\14778436 (l_prep) for_6\IN\0 (l_pobj) cardioversion_7\NN\0 (l_prep) of_8\IN\0 (l_pobj) fibrillation_13\NN\14361664
D000638_D001281 NONE amiodarone_0\NNP\2715941 (r_nsubj) represents_1\VBZ\2664769 (l_dobj) drug_5\NN\14778436 (l_prep) for_6\IN\0 (l_pobj) cardioversion_7\NN\0 (l_prep) of_8\IN\0 (l_pobj) fibrillation_13\NN\14361664 (l_appos) af_15\NNP\0
D000638_D001281 NONE amiodarone_28\NN\2715941 (r_compound) loading_29\NN\4571088 (r_pobj) of_26\IN\0 (r_prep) initiation_25\NN\7450842 (r_pobj) after_24\IN\0 (r_prep) experienced_14\VBD\2108377 (r_relcl) fibrillation_11\NN\14361664
D000638_D017116 CID amiodarone_8\NN\2715941 (r_pobj) of_7\IN\0 (r_prep) administration_6\NN\1133281 (r_pobj) during_4\IN\0 (r_prep) pain_3\NN\14299637
D000638_D017116 CID amiodarone_28\NN\2715941 (r_compound) loading_29\NN\4571088 (r_pobj) of_26\IN\0 (r_prep) initiation_25\NN\7450842 (r_pobj) after_24\IN\0 (r_prep) experienced_14\VBD\2108377 (l_dobj) pain_20\NN\14299637
3413271
D004837_D003866 NONE epinephrine_1\NN\14807929 (r_nsubj) produced_4\VBD\1617192 (l_advcl) evidenced_8\VBN\1015244 (l_agent) by_9\IN\0 (l_pobj) depression_12\NN\14373582
D010100_D007511 NONE oxygen_8\NN\14622893 (r_compound) consumption_9\NN\13440063 (r_nsubjpass) compared_11\VBN\644583 (l_nsubjpass) signs_1\NNS\6643763 (l_prep) of_2\IN\0 (l_pobj) ischemia_3\NN\14195315
D004837_D000787 NONE epinephrine_1\NN\14807929 (r_nsubj) produced_4\VBD\1617192 (l_advcl) evidenced_8\VBN\1015244 (l_agent) by_9\IN\0 (l_pobj) depression_12\NN\14373582 (l_conj) angina_14\NN\14171682
D004837_D003324 NONE epinephrine_3\NN\14807929 (r_pobj) of_2\IN\0 (r_prep) role_1\NN\719494 (r_nsubjpass) examined_9\VBN\0 (l_prep) in_10\IN\13603305 (l_pobj) patients_11\NNS\9898892 (l_prep) with_12\IN\0 (l_pobj) disease_15\NN\14061805
D004837_D017202 CID epinephrine_6\NN\14807929 (r_pobj) by_5\IN\0 (r_prep) induced_4\VBN\1627355 (l_nsubj) mechanisms_0\NNS\13446390 (l_prep) of_1\IN\0 (l_pobj) ischemia_3\NN\14195315
D004837_D017202 CID epinephrine_3\NN\14807929 (r_pobj) of_2\IN\0 (r_prep) role_1\NN\719494 (l_prep) in_4\IN\13603305 (l_pcomp) eliciting_5\VBG\1617192 (l_dobj) ischemia_7\NN\14195315
D004837_D017202 CID epinephrine_1\NN\14807929 (r_nsubj) produced_4\VBD\1617192 (l_dobj) ischemia_6\NN\14195315
D004837_D017202 CID epinephrine_9\NN\14807929 (r_pobj) by_8\IN\0 (r_agent) induced_7\VBN\1627355 (r_acl) mechanisms_3\NNS\13446390 (l_prep) of_4\IN\0 (l_pobj) ischemia_6\NN\14195315
D004837_D017202 CID epinephrine_28\NN\14807929 (r_npadvmod) induced_30\VBN\1627355 (r_amod) ischemia_31\NN\14195315 (r_nsubjpass) characterized_33\VBN\609683 (r_advcl) marked_6\VBN\1296462 (l_nsubjpass) ischemia_4\NN\14195315
D004837_D007511 NONE epinephrine_6\NN\14807929 (l_appos) comparison_8\NN\635850 (l_prep) with_9\IN\0 (l_pobj) ischemia_13\NN\14195315
D004837_D007511 NONE epinephrine_13\NN\14807929 (r_amod) infusion_14\NN\14589223 (r_pobj) during_12\IN\0 (r_prep) compared_11\VBN\644583 (l_nsubjpass) signs_1\NNS\6643763 (l_prep) of_2\IN\0 (l_pobj) ischemia_3\NN\14195315
D004837_D007511 NONE epinephrine_28\NN\14807929 (r_npadvmod) induced_30\VBN\1627355 (r_amod) ischemia_31\NN\14195315
D004837_D007511 NONE epinephrine_7\NN\14807929 (r_pobj) by_6\IN\0 (r_agent) produced_5\VBN\1617192 (r_acl) ischemia_4\NN\14195315
7161250
D006220_D010302 CID haloperidol_10\NN\3713736 (r_pobj) of_9\IN\0 (r_prep) doses_8\NNS\3740161 (r_pobj) at_6\IN\14622893 (r_prep) was_4\VBD\0 (l_nsubj) incidence_1\NN\13821570 (l_prep) of_2\IN\0 (l_pobj) parkinsonism_3\NN\14085708
D008140_D017109 NONE lorazepam_6\NN\2830852 (r_pobj) by_3\IN\0 (r_agent) controlled_2\VBN\0 (l_nsubjpass) akathisia_0\NNP\0
D001569_D017109 NONE benzodiazepine_5\JJ\3771443 (r_amod) lorazepam_6\NN\2830852 (r_pobj) by_3\IN\0 (r_agent) controlled_2\VBN\0 (l_nsubjpass) akathisia_0\NNP\0
19996135
D014148_D012640 CID acid_4\NNP\14818238 (r_nsubjpass) associated_6\VBN\628491 (l_prep) with_7\IN\0 (l_pobj) seizures_10\NNS\14081375
D014148_D012640 CID txa_19\NNP\0 (r_compound) usage_20\NN\407535 (l_conj) seizures_22\NNS\14081375
D014148_D012640 CID txa_9\NNP\0 (r_compound) intraoperatively_10\NN\0 (r_pobj) of_8\IN\0 (r_prep) doses_7\NNS\3740161 (r_dobj) received_5\VBD\2210855 (l_nsubj) patients_2\NNS\9898892 (l_prep) with_3\IN\0 (l_pobj) seizures_4\NNS\14081375
D014148_D012640 CID txa_9\NN\0 (r_pobj) of_5\IN\0 (r_prep) use_4\NN\407535 (r_nsubjpass) associated_25\VBN\628491 (l_prep) with_26\IN\0 (l_pobj) seizures_28\NNS\14081375
